<SEC-DOCUMENT>0001136261-13-000486.txt : 20131101
<SEC-HEADER>0001136261-13-000486.hdr.sgml : 20131101
<ACCEPTANCE-DATETIME>20131101100408
ACCESSION NUMBER:		0001136261-13-000486
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20130930
FILED AS OF DATE:		20131101
DATE AS OF CHANGE:		20131101

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tiger X Medical, Inc.
		CENTRAL INDEX KEY:			0000925741
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				232753988
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21419
		FILM NUMBER:		131184591

	BUSINESS ADDRESS:	
		STREET 1:		10900 WILSHIRE BOULEVARD, SUITE #1500
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90024
		BUSINESS PHONE:		(310) 987-7345

	MAIL ADDRESS:	
		STREET 1:		10900 WILSHIRE BOULEVARD, SUITE #1500
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90024

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cardo Medical, Inc.
		DATE OF NAME CHANGE:	20081027

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CLICKNSETTLE COM INC
		DATE OF NAME CHANGE:	20000823

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NAM CORP
		DATE OF NAME CHANGE:	19960802
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>form10q.htm
<DESCRIPTION>10-Q
<TEXT>
<HTML>
<HEAD>
<TITLE>Q3 2013 DOC</TITLE>
</HEAD>
<BODY LINK="#0000ff" VLINK="#800080" BGCOLOR="#ffffff">
<font FACE="Times New Roman" SIZE="2">

<DIV align=left>
<HR size="4" noshade color="#000000" style="margin-top: -5px">
<HR size="1" noshade color="#000000" style="margin-top: -10px">
</DIV>

<FONT SIZE="3"><B><p align="center">UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549</P></font></B>

<BR>
<HR WIDTH="25%">
<BR>
<FONT SIZE="4"><B><p align="center">FORM 10-Q</P></font></B>
<BR>
<HR WIDTH="25%">

<FONT SIZE="3"><B><p align="center">
   [X]       QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
             SECURITIES EXCHANGE ACT OF 1934
</P></font></B>
<FONT SIZE="3" color="FF0000"><B><p align="center">
             For the quarterly period ended September 30, 2013
</P></font></B>

<FONT SIZE="3"><B><p align="center"> OR </P></font></B>

<FONT SIZE="3"><B><p align="center">
[&nbsp;&nbsp;]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934
</P></font></B>

<FONT SIZE="3"><B><p align="center">
 For the transition period from ________to _________
</P></font></B>

<FONT SIZE="3"><B><U><p align="center">
                       Commission file number: 0-21419
</P></font></U></B>



<FONT SIZE="4"><B><p align="center">
                                    Tiger X Medical, Inc.
</B></font><BR>
<FONT SIZE="2">
               (Exact name of Registrant as Specified in its Charter)
</font></P>

<P>&nbsp;
<TABLE COLS=2 WIDTH="100%" >
<TR>
<TD>
<FONT SIZE="3"><B>
<CENTER><u>Delaware</u></CENTER>
</font></B>
</TD>
<TD>
<FONT SIZE="3"><B>
<CENTER><u>  23-2753988  </u></CENTER>
</font></B>
</TD>
</TR>
<TR>
<TD>
<FONT SIZE="2">
<CENTER>&nbsp; (State or Other Jurisdiction of Incorporation or Organization)&nbsp;</CENTER>
</font>
</TD>
<TD>
<FONT SIZE="2">
<CENTER>(I.R.S. Employer Identification Number)</CENTER>
</font>
</TD>
</TR>
</TABLE>
<BR>



<FONT SIZE="3"><B><p align="center">
                                  10900 Wilshire Blvd, Suite #1500
<BR><U>
                              Los Angeles, CA  &nbsp;&nbsp;  90024
</U></B></font><BR>

<FONT SIZE="2">
        (Address of Principal Executive Offices including Zip Code)
</font></P>

<FONT SIZE="3"><B><U><p align="center">
                                (310) 987-7345
</U></B></font><BR>

<FONT SIZE="2">
                 (Registrant's Telephone Number, Including Area Code)
</font></P>

<FONT SIZE="3"><B><U><p align="center">
   &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; N/A &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</U></B></font><BR>

<FONT SIZE="2">
                 (Former name, former address and former fiscal year, if changed since last report)
</font></P>

<FONT SIZE="2"<P>
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant
was required to file reports), and (2) has been subject to such filing
requirements for the past 90 days.<BR>  YES &nbsp;&nbsp; <FONT FACE="WINGDINGS">&#120; <FONT FACE="Times New Roman">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;   NO &nbsp;&nbsp; <FONT FACE="WINGDINGS">&#168; <FONT FACE="Times New Roman"> </P>

<FONT SIZE="2"<P>
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every
Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&sect;232.405 of this chapter)
during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
&nbsp;&nbsp;&nbsp;&nbsp;YES&nbsp;&nbsp;</FONT><FONT FACE="Wingdings" SIZE=2>&#120; <FONT FACE="Times New Roman"> <FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;NO&nbsp;&nbsp;</FONT><FONT FACE="Wingdings" SIZE=2>&#168; <FONT FACE="Times New Roman"> <FONT SIZE=2></P>

<FONT SIZE="2"><P>
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a
smaller reporting company. See definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company"
in Rule 12b-2 of the Exchange Act. (Check one): </P>


<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=0 WIDTH=100% ALIGN="CENTER">
<TR><TD WIDTH="20%" VALIGN="TOP">
<FONT SIZE=2><P>
Large accelerated filer  &nbsp;&nbsp; <FONT FACE="WINGDINGS">&#168; <FONT FACE="Times New Roman">
</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP">
<FONT SIZE=2><P>
Accelerated filer &nbsp;&nbsp; <FONT FACE="WINGDINGS">&#168; <FONT FACE="Times New Roman">
</FONT></TD>
<TD WIDTH="35%" VALIGN="TOP">
<FONT SIZE=2><P>
Non-accelerated filer &nbsp;&nbsp; <FONT FACE="WINGDINGS">&#168; <FONT FACE="Times New Roman">
<BR>(Do not check if a smaller reporting company)
</FONT></TD>
<TD WIDTH="25%" VALIGN="TOP">
<FONT SIZE=2><P>
Smaller reporting company &nbsp;&nbsp; <FONT FACE="WINGDINGS">&#120; <FONT FACE="Times New Roman"></P>
</FONT></TD>
</TR>
</TABLE>


<FONT SIZE="2"><P>
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).<BR>
YES &nbsp;&nbsp; <FONT FACE="WINGDINGS">&#168; <FONT FACE="Times New Roman">  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
NO &nbsp;&nbsp; <FONT FACE="WINGDINGS">&#120; <FONT FACE="Times New Roman">


<FONT SIZE="2"><P>
As of November 1, 2013, 230,293,141 shares of the issuer's common stock, par value of $0.001 per share, were outstanding.


<DIV align=left>
<HR size="1" noshade color="#000000" style="margin-top: -2px">
<HR size="4" noshade color="#000000" style="margin-top: -10px">
</DIV>
<P style="PAGE-BREAK-BEFORE: always" align=left>




<B><p align="center">
                                    TIGER X MEDICAL, INC.
                                                           </P></B>


<TABLE CELLSPACING=0 BORDER=0 WIDTH=98%>
<TR><TD VALIGN="TOP" COLSPAN=3 HEIGHT=17>
<FONT SIZE=2><B><P>Table of Contents</B></FONT></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><B><P ALIGN="CENTER">Page</B></FONT></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=17><P></P></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17><P></P></TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=3 HEIGHT=17>
<FONT SIZE=2><P>PART I &mdash; FINANCIAL INFORMATION</FONT></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="CENTER">1</FONT></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=17><P></P></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17><P></P></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY">Item 1.</FONT></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY"></FONT><A HREF="#fins"><FONT SIZE=2>Financial Statements</FONT></A></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="CENTER">1</FONT></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="79%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17><P></P></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY">&nbsp;</FONT></TD>
<TD WIDTH="79%" VALIGN="BOTTOM" HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY"></FONT><A HREF="#bs"><FONT SIZE=2>Condensed Consolidated Balance Sheets at September 30, 2013 (Unaudited) and
December 31, 2012</FONT></A><FONT SIZE=2> </FONT></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="CENTER">1</FONT></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="79%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17><P></P></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="79%" VALIGN="BOTTOM" HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY"></FONT><A HREF="#ops"><FONT SIZE=2>Condensed Consolidated Statements of
Operations (Unaudited) &mdash; Three and Nine Months Ended September 30, 2013 and 2012 and the period from January 1, 2013 to September 30, 2013</FONT></A></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="CENTER">2</FONT></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="79%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17><P></P></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY">&nbsp;</FONT></TD>
<TD WIDTH="79%" VALIGN="BOTTOM" HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY"></FONT><A HREF="#flows"><FONT SIZE=2>Condensed Consolidated Statements of Cash
Flows (Unaudited) &mdash; Nine Months Ended September 30, 2013 and 2012 and the period from January 1, 2013 to September 30, 2013</FONT></A></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="CENTER">3</FONT></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="79%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17><P></P></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="79%" VALIGN="BOTTOM" HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY"></FONT><A HREF="#notes"><FONT SIZE=2>Notes to Condensed Consolidated Financial
Statements (Unaudited)</FONT></A><FONT SIZE=2> </FONT></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="CENTER">4</FONT></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="79%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17><P></P></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY">Item 2.</FONT></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY"></FONT><A HREF="#mda"><FONT SIZE=2>Management's Discussion and Analysis of Financial
Condition and Results of Operations</FONT></A><FONT SIZE=2> </FONT></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="CENTER">7</FONT></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="83%" VALIGN="TOP" COLSPAN=2 HEIGHT=17><P></P></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17><P></P></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY">Item 3.</FONT></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY"></FONT><A HREF="#market"><FONT SIZE=2>Quantitative and Qualitative Disclosures About Market Risk</FONT></A><FONT SIZE=2>
</FONT></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="CENTER">10</FONT></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="83%" VALIGN="TOP" COLSPAN=2 HEIGHT=17><P></P></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17><P></P></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY">Item 4.</FONT></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY"></FONT><A HREF="#controls"><FONT SIZE=2>Controls and Procedures</FONT></A><FONT SIZE=2>
</FONT></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="CENTER">10</FONT></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="83%" VALIGN="TOP" COLSPAN=2 HEIGHT=17><P></P></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17><P></P></TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=3 HEIGHT=17>
<FONT SIZE=2><P>PART II &mdash; OTHER INFORMATION</FONT></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="CENTER">11</FONT></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="83%" VALIGN="TOP" COLSPAN=2 HEIGHT=17><P></P></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17><P></P></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY">Item 1.</FONT></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY"></FONT><A HREF="#item1"><FONT SIZE=2>Legal Proceedings</FONT></A><FONT SIZE=2>
</FONT></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="CENTER">11</FONT></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="83%" VALIGN="TOP" COLSPAN=2 HEIGHT=17><P></P></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17><P></P></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY">Item 2.</FONT></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY"><A HREF="#item2">Unregistered Sales of Equity Securities and Use of Proceeds</FONT></A><FONT SIZE=2>
</FONT></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="CENTER">11</FONT></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="83%" VALIGN="TOP" COLSPAN=2 HEIGHT=17><P></P></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17><P></P></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY">Item 3.</FONT></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY"><A HREF="#item3">Defaults upon Senior Securities</FONT></A><FONT SIZE=2>
</FONT></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="CENTER">11</FONT></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="83%" VALIGN="TOP" COLSPAN=2 HEIGHT=17><P></P></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17><P></P></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY">Item 4.</FONT></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY"><A HREF="#item4">Mine Safety Disclosures</FONT></A><FONT SIZE=2>
</FONT></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="CENTER">11</FONT></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="83%" VALIGN="TOP" COLSPAN=2 HEIGHT=17><P></P></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17><P></P></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY">Item 5.</FONT></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY"><A HREF="#item5">Other Information</FONT></A><FONT SIZE=2>
</FONT></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="CENTER">11</FONT></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="83%" VALIGN="TOP" COLSPAN=2 HEIGHT=17><P></P></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17><P></P></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY">Item 6.</FONT></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY"></FONT><A HREF="#item6"><FONT SIZE=2>Exhibits</FONT></A><FONT SIZE=2>
</FONT></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="CENTER">12</FONT></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="83%" VALIGN="TOP" COLSPAN=2 HEIGHT=17><P></P></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17><P></P></TD>
</TR>
<TR><TD WIDTH="92%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=17>
<FONT SIZE=2><P ALIGN="JUSTIFY"></FONT><A HREF="#sign"><FONT SIZE=2>Signatures</FONT></A><FONT SIZE=2> </FONT></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="CENTER">13</FONT></TD>
</TR>
<TR><TD WIDTH="10%" VALIGN="TOP" HEIGHT=17><P></P></TD>
<TD WIDTH="83%" VALIGN="TOP" COLSPAN=2 HEIGHT=17><P></P></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17><P></P></TD>
</TR>
<TR><TD WIDTH="92%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=17>
<FONT SIZE=2><P><FONT SIZE=2>Exhibit Index </FONT></FONT></TD>
<TD WIDTH="8%" VALIGN="TOP" HEIGHT=17>
<FONT SIZE=2><P ALIGN="CENTER"> &nbsp;</FONT></TD>
</TR>
</TABLE>


<P ALIGN="CENTER">                                                    i
<HR WIDTH="100%">
<P style="PAGE-BREAK-BEFORE: always" align=left>

<B><P>PART I &mdash; FINANCIAL INFORMATION </B> </P>

<B><P><A NAME="fins">ITEM 1 &mdash; CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </A></P> </B>

<B><P ALIGN="CENTER"><A NAME="bs">
                                    TIGER X MEDICAL, INC.<BR>
                                  (A Development Stage Company)<BR>
                                  CONDENSED CONSOLIDATED BALANCE SHEETS<BR>
                           (In thousands, except share amounts)</A></P> </B>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85%" BORDER="0" ALIGN="CENTER">
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
September 30, </B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
December 31, </B></FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
2013</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
2012</B></FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
(Unaudited)</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
</TR>
<TR ALIGN="center" VALIGN="bottom">
<TD BGCOLOR=#FFFFFF COLSPAN=7><FONT FACE="Times New Roman" SIZE=-1><B>
Assets</B></FONT></TD>
</TR>
<TR ALIGN="center" VALIGN="bottom">
<TD BGCOLOR=#FFFFFF><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Current assets</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp; Cash </FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               13,263&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               13,268&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp; Prepaid expenses and other current assets</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                      45&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                      33&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp;  &nbsp;&nbsp;&nbsp;&nbsp; Total assets</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               13,308&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               13,301&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR ALIGN="center" VALIGN="bottom">
<TD COLSPAN=7><FONT FACE="Times New Roman" SIZE=-1><B>
Liabilities and Stockholders' Equity</B></FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Current liabilities</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp; Accounts payable and accrued expenses</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                        3&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                      12&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp;  &nbsp;&nbsp;&nbsp;&nbsp; Total liabilities</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                        3&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                      12&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Stockholders' equity</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp; Common stock, $0.001 par value, 750,000,000 shares authorized,</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp;  &nbsp;&nbsp;&nbsp;&nbsp; 230,293,141 issued and outstanding as of September 30, 2013 (unaudited)</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp;  &nbsp;&nbsp;&nbsp;&nbsp; and December 31, 2012</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                    230&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                    230&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp; Additional paid-in capital</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               25,768&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               25,766&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp; Earnings accumulated during the development stage</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                      14&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                         -&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp; Accumulated deficit</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
             (12,707)</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
             (12,707)</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp;  &nbsp;&nbsp;&nbsp;&nbsp; Total stockholders' equity</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               13,305&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               13,289&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Total liabilities and stockholders' equity&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               13,308&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               13,301&nbsp;</FONT></TD>
</TR>
</TABLE>


<P ALIGN="CENTER">
                The accompanying notes are an integral part of these condensed consolidated financial statements.

<P ALIGN="CENTER">                                                    1
<HR WIDTH="100%">
<P style="PAGE-BREAK-BEFORE: always" align=left>



<B><P ALIGN="CENTER"><A NAME="ops">
                                    TIGER X MEDICAL, INC.<BR>
                                  (A Development Stage Company)<BR>
                                  CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS<BR>
                           (In thousands, except share amounts)<BR>
                                           (Unaudited) </A></P> </B>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="95%" BORDER="0" ALIGN="CENTER">
<TR VALIGN="bottom">
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="center" STYLE="vnd.ms-excel.numberformat:d-mmm-yy"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center" STYLE="vnd.ms-excel.numberformat:d-mmm-yy"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center" STYLE="vnd.ms-excel.numberformat:d-mmm-yy"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center" STYLE="vnd.ms-excel.numberformat:d-mmm-yy"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
For the Period from </B></FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD COLSPAN=4 ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
Three Months Ended</B></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF COLSPAN=4 ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
Nine Months Ended</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD ALIGN="center" STYLE="vnd.ms-excel.numberformat:d-mmm-yy"><FONT FACE="Times New Roman" SIZE=-1><B>
January 1, 2013 to </B></FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" COLSPAN=4 ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
September 30, </B></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" BGCOLOR=#FFFFFF COLSPAN=4 ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
September 30, </B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
September 30, </B></FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
2013</B></FONT></TD>
<TD ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
2012</B></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
2013</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
2012</B></FONT></TD>
<TD ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
2013</B></FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF COLSPAN=2 ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Royalty income</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                 71&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                 19&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               178&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                 47&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                            178&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
General and administrative expenses</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                 45&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               102&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               172&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               320&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                            172&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Income (loss) from operations</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                 26&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               (83)</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                   6&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
              (273)</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                                6&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Interest income</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                   4&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                   2&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                   8&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                   8&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                                8&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Income (loss) before income tax provision</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                 30&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               (81)</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                 14&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
              (265)</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                              14&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Provision for income taxes</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  - &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  - &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  - &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  - &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  - &nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Income (loss) from continuing operations</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                 30&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               (81)</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                 14&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
              (265)</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                              14&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Discontinued operations</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Gain from sale of discontinued Reconstructive and Spine Divisions, net of income taxes</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                    -&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               532&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                    -&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               532&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                               -  &nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Net income&nbsp;</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                 30&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               451&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                 14&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               267&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                              14&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Net income per share:</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Basic and diluted</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Continuing operations</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -  &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -  &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -  &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -  &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Discontinued operations</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -  &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -  &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -  &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -  &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Total</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -  &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -  &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -  &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -  &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Weighted average shares outstanding:</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Basic and diluted</FONT></TD>
<TD ALIGN="right"><FONT FACE="Arial" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
 230,293,141&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
 230,293,141&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
 230,293,141&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
 230,293,141&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
</TABLE>

<P ALIGN="CENTER">
        The accompanying notes are an integral part of these condensed consolidated financial statements.

<P ALIGN="CENTER">                                                    2
<HR WIDTH="100%">
<P style="PAGE-BREAK-BEFORE: always" align=left>





<B><P ALIGN="CENTER"><A NAME="flows">
                                    TIGER X MEDICAL, INC.<BR>
                                  (A Development Stage Company)<BR>
                                  CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS<BR>
                                                     (In thousands)<BR>
                                           (Unaudited) </A></P> </B>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="90%" BORDER="0" ALIGN="CENTER">
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center" STYLE="vnd.ms-excel.numberformat:d-mmm-yy"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
For the Period from </B></FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF COLSPAN=5 ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
Nine Months Ended</B></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="center" STYLE="vnd.ms-excel.numberformat:d-mmm-yy"><FONT FACE="Times New Roman" SIZE=-1><B>
January 1, 2013 to </B></FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" BGCOLOR=#FFFFFF COLSPAN=5 ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
September 30, </B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
September 30, </B></FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
2013</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
2012</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
2013</B></FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF COLSPAN=2 ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1><B>
Cash flows from operating activities</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp; Net income</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
             14&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
           267&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                              14&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp; Adjustments to reconcile net income to net cash used in operating activities:</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp;  &nbsp;&nbsp;&nbsp;&nbsp; Stock option compensation</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               2&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               5&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                                2&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp; Changes in operating assets and liabilities:</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp;  &nbsp;&nbsp;&nbsp;&nbsp; Accounts receivable</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                -&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
             43&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                                 -&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp;  &nbsp;&nbsp;&nbsp;&nbsp; Income tax receivable</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                -&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
          (532)</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp;  &nbsp;&nbsp;&nbsp;&nbsp; Prepaid expenses and other current assets</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
            (12)</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
             77&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                            (12)</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp;  &nbsp;&nbsp;&nbsp;&nbsp; Accounts payable and accrued expenses</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
              (9)</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
          (615)</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                              (9)</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Net cash used in operating activities</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
              (5)</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
          (755)</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                              (5)</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1><B>
Cash flows from investing activities</B></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp; Decrease in restricted cash</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                -&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
           900&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                                 -&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Net cash provided by investing activities</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                -&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
           900&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                                 -&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Net change in cash&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
              (5)</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
           145&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                              (5)</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Cash, beginning of period</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
      13,268&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
      12,678&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                       13,268&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1><B>
Cash, end of period</B></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
      13,263&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
      12,823&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                       13,263&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1><I>
Supplemental disclosure of cash flow information:</I></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1><I>
&nbsp;</I></FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1><I>
&nbsp;</I></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1><I>
&nbsp;</I></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1><I>
&nbsp;</I></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp; Interest paid</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                -&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                -&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                                 -&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp; Income taxes paid</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
             26&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
           553&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                              26&nbsp;</FONT></TD>
</TR>
</TABLE>



<P ALIGN="CENTER">
            The accompanying notes are an integral part of these condensed consolidated financial statements.


<P ALIGN="CENTER">                                                    3
<HR WIDTH="100%">
<P style="PAGE-BREAK-BEFORE: always" align=left>


<B><P ALIGN="CENTER"><A NAME="notes">TIGER X MEDICAL, INC. </A><BR>
                  (A Development Stage Company)<BR>
                    Notes to Condensed Consolidated Financial Statements<BR>
                              September 30, 2013<BR>
                                   (Unaudited)</P></B><FONT SIZE=2>


<B><P>NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</P></B>

<P>Tiger X Medical, Inc. ("Tiger X" or the "Company"), formerly known as Cardo Medical, Inc., a corporation organized and existing under
and by the virtue of the General Corporation Law of the State of Delaware,
previously operated as an orthopedic
medical device company specializing in designing, developing and marketing high performance reconstructive joint devices and spinal
surgical devices. </P>

<P>During 2010, the Company discontinued its operations and sold the assets from its previous business lines during 2011. Beginning on
January 1, 2013, the Company became classified as a development stage entity. Our continuing operations include the collection and
management of our royalty income earned in connection with the Asset Purchase Agreement with Arthrex, Inc. ("Arthrex"), as well as continuing to promote
our former products sold to Arthrex and seeking a joint venture partner or buyer for the remaining intellectual property owned by the
Company. The Company will also be evaluating future investment opportunities and uses for its cash. </P>

<B><I><P>Basis of Presentation</P>
</B></I><P>The accompanying condensed consolidated balance sheet as of December 31, 2012, which has been derived from the
Company's audited financial statements as of that date, and the unaudited condensed consolidated financial information of the Company as
of September 30, 2013 and for the three and nine months ended September 30, 2013 and 2012, has been prepared in accordance with
accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and with the
instructions to Form 10-Q and Article 8-03 of Regulation S-X. In the opinion of management, such financial information includes all
adjustments considered necessary for a fair presentation of the Company's financial position at such date and the operating results and cash
flows for such periods. Operating results for the interim period ended September 30, 2013 are not necessarily indicative of the results that
may be expected for the entire year.</P>
<P>Certain information and footnote disclosure normally included in financial statements in accordance with generally accepted accounting
principles have been omitted pursuant to the rules of the United States Securities and Exchange Commission ("SEC"). These unaudited
financial statements should be read in conjunction with our audited financial statements and accompanying notes included in the Company's
Annual Report on Form 10-K for the year ended December 31, 2012 filed on March 22, 2013. </P>
<B><I><P>Principles of Consolidation</P>
</B></I><P>The condensed consolidated financial statements include the accounts of Tiger X Medical, Inc., Accelerated Innovation, Inc.
("Accelerated"), Uni-Knee LLC ("Uni") and Cervical Xpand LLC ("Cervical"). All significant intercompany transactions have been eliminated in
consolidation. </P>
<B><I><P>Royalty Agreement</P>
</B></I><P>On January 24, 2011, the Company entered into an Asset Purchase Agreement with Arthrex (the agreement
being the "Arthrex Asset Purchase Agreement"), pursuant to which the Company agreed to sell the assets of the Reconstructive Division to
Arthrex. The Arthrex Asset Purchase Agreement also provides for the Company to receive royalty payments equal to 5% of net sales of the
Company's products made by Arthrex on a quarterly basis for a term up to and including the 20th anniversary of the closing date. During the
three and nine months ended September 30, 2013, the Company received total royalty payments of $71,000 and $178,000, respectively,
from Arthrex. During the three and nine months ended September 30, 2012, the Company received total royalty payments of $19,000 and
$47,000, respectively. These amounts are reflected as royalty income on the accompanying condensed consolidated statements of operations.
</P>

<P ALIGN="CENTER">                                                4
<HR WIDTH="100%">
<P style="PAGE-BREAK-BEFORE: always" align=left>

<B><I><P>Use of Estimates</P>
</B></I><P>Financial statements prepared in accordance with U.S. GAAP require management to make estimates and assumptions that
affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and
expenses during the reporting period. Among other things, management makes estimates relating to share-based payments and deferred
income tax assets. Actual results could differ from those estimates.</P>

<B><I><P>Revenue Recognition</P>
</B></I><P>The Company's revenue consists of royalty income from Arthrex pursuant to the Arthrex Asset Purchase Agreement. Royalty income
is recognized as the amount becomes known and collectability is reasonably assured. </P>

<B><I><P>Net Income Per Share</P></B></I>

<P>Basic net income per share is computed by using the weighted-average number of
common shares outstanding during the period. Diluted net income per share is computed giving effect to all
dilutive potential common shares using various methods such as the treasury stock or modified treasury
stock method in the determination of diluted shares outstanding at each reporting period.  Dilutive potential
common shares consist of incremental common shares issuable upon exercise of stock options or warrants.
No dilutive potential common shares are included in the computation of any diluted per share amount
because their impact was anti-dilutive.</P>

<B><I><P>Income Taxes</P>
</B></I><P>Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the
future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and
their respective tax bases as well as operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using
enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or
settled. The likelihood of realizing the tax benefits related to a potential deferred tax asset is evaluated, and a valuation allowance is
recognized to reduce that deferred tax asset if it is more likely than not that all or some portion of the deferred tax asset will not be realized.
Deferred tax assets and liabilities are calculated at the beginning and end of the year; the change in the sum of the deferred tax asset,
valuation allowance and deferred tax liability during the year generally is recognized as a deferred tax expense or benefit. The effect on
deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. </P>
<P>The Company evaluates the accounting for uncertainty in income tax recognized in its financial statements and determines whether it is
more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit
is recorded in its financial statements. For those tax positions where it is "not more likely than not" that a tax benefit will be sustained, no tax
benefit is recognized. Where applicable, associated interest and penalties are also recorded. The Company has not accrued for any such
uncertain tax positions as of September 30, 2013 (unaudited) or December 31, 2012.</P>
<B><I><P>Concentration of Credit Risk</P>
</B></I><P>The cash and cash equivalents held in the Company's business money market and other bank accounts are with local and
national banking institutions and subjected to FDIC insurance limits of $250,000 per banking institution. As of September 30, 2013, the
Company's balances in these bank accounts exceeded the insured amount by $12,965,872.</P>

<B><I><P>Recent Accounting Pronouncements</P>
</B></I><P>There are no recently issued accounting pronouncements that the Company has yet to adopt that are expected to have a
material effect on its financial position, results of operations, or cash flows.</P>

<P ALIGN="CENTER">                                                5
<HR WIDTH="100%">
<P style="PAGE-BREAK-BEFORE: always" align=left>


<B>
<P>NOTE 2 - SHARE BASED PAYMENT</P>
</B><P>On August 29, 2008, the Company issued options to certain employees and Board members to purchase membership units in the
Company. The options give the grantees the right to purchase up to 2,398,400 shares of the Company's common stock at an exercise price
of $0.23 per share. The options vest 20% each year over a five-year period and expire after ten years.  Stock option compensation
recognized for the nine months ended September 30, 2013 and 2012 in the accompanying condensed consolidated statements of operations
amounted to $2,000 and $5,000, respectively.</P>

<P>A summary of stock option activity as of September 30, 2013, and changes during the period then ended is presented below.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="90%" BORDER="0" ALIGN="CENTER">
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1 COLOR=#000000>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1 COLOR=#000000>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1 COLOR=#000000>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1 COLOR=#000000>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1 COLOR=#000000>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1 COLOR=#000000>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
Weighted-</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1 COLOR=#000000>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
Weighted-</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
Average </B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
Average</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
Remaining </B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
Aggregate</B></FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
Exercise</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
Contractual</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
Intrinsic</B></FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
Options</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
Price</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
Life (Years)</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
Value</B></FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><I>
&nbsp;</I></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><I>
&nbsp;</I></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><I>
&nbsp;</I></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><I>
&nbsp;</I></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><I>
&nbsp;</I></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1 COLOR=#000000>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1 COLOR=#000000>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1 COLOR=#000000>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1 COLOR=#000000>
&nbsp;</FONT></TD>
</TR>

<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Outstanding at December 31, 2012</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
      385,000&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
          0.23&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               5.66&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Granted</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
             -  &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                   -  &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Exercised</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
             -  &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                   -  &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Forfeited</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
             -  &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                   -  &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Outstanding at September 30, 2013 (unaudited)</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
      385,000&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
          0.23&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               4.92&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Vested and expected to vest</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
 &nbsp;&nbsp;&nbsp;&nbsp;   at September 30, 2013 (unaudited)</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
      385,000&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
          0.23&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               4.92&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Exercisable at September 30, 2013 (unaudited)</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
      385,000&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
          0.23&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               4.92&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -&nbsp;</FONT></TD>
</TR>
</TABLE>

<P>The Company had 575,613 warrants outstanding as of September 30, 2013 which entitle the holders to immediately purchase one share
of the Company's common stock at an exercise price of $0.44 per share. The warrants expire on November 13, 2014. </P>

<B><P>NOTE 3 - STOCKHOLDERS' EQUITY</P>
</B><P>Our authorized capital consists of 750,000,000 shares of common stock and 50,000,000 shares of preferred stock. Our preferred
stock may be designated into series pursuant to authority granted by our Certificate of Incorporation, and on approval from our Board of
Directors. As of September 30, 2013 and December 31, 2012, we did not have any preferred stock issued. </P>

<P ALIGN="CENTER">                                                6
<HR WIDTH="100%">
<P style="PAGE-BREAK-BEFORE: always" align=left>

<B>
<P><A NAME="mda">ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</A></P>
</B><P>The discussion and analysis of our financial condition and results of operations are based on our financial statements, which we
have prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these
condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and
liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as the
reported revenues and expenses during the reporting periods. On an ongoing basis, we evaluate estimates and judgments, including those
described in greater detail below. We base our estimates on historical experience and on various other factors that we believe are reasonable
under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are
not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. </P>
<P>As used in this "Management's Discussion and Analysis of Financial Condition and Results of Operation," except where the context
otherwise requires, the term "we," "us," "our" or "Tiger X" refers to the business of Tiger X Medical, Inc. </P>
<B><I><P>The following discussion should be read together with the information contained in the unaudited condensed consolidated
financial statements and related notes included in Item 1, "Financial Statements," in this Form 10-Q. </P>
</B><P>Overview </P>
</I><P>Tiger X Medical, Inc. ("Tiger X" or the "Company"), formerly known as Cardo Medical, Inc., previously operated as an orthopedic
medical device company specializing in designing, developing and marketing high performance reconstructive joint devices and spinal
surgical devices. During 2010, we discontinued our operations and sold the assets from our previous business lines during 2011. Beginning
on January 1, 2013, the Company became classified as a development stage entity. Our continuing operations include the collection and
management of our royalty income earned in connection with the Asset Purchase Agreement with Arthrex, as well as continuing to promote
our former products sold to Arthrex and seeking a joint venture partner or buyer for the remaining intellectual property owned by the
Company. We will also be evaluating future investment opportunities and uses for our cash. </P>
<P>We are headquartered in Los Angeles, California. Our common stock is quoted on the National Association of Securities Dealers, Inc.'s,
Over-the-Counter Bulletin Board, or the OTC Bulletin Board with a trading symbol of CDOM.OB. </P>
<B><P>Critical Accounting Policies</P>
<I><P>Use of Estimates</P>
</B></I><P>Financial statements prepared in accordance with United States generally accepted accounting principles ("U.S. GAAP") require
management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the reporting period. Among other things, management makes
estimates relating to share-based payments, and deferred income tax assets. Given the short operating history of Tiger X, actual results
could differ from those estimates.</P>

<P ALIGN="CENTER">                                                7
<HR WIDTH="100%">
<P style="PAGE-BREAK-BEFORE: always" align=left>

<B><I>
<P>Royalty Agreement</P>
</B></I><P>On January 24, 2011, the Company entered into an Asset Purchase Agreement with Arthrex, Inc. ("Arthrex") (the agreement
being the "Arthrex Asset Purchase Agreement"), pursuant to which the Company agreed to sell the assets of the Reconstructive Division to
Arthrex. The Arthrex Asset Purchase Agreement also provides for the Company to receive royalty payments equal to 5% of net sales of the
Company's products made by Arthrex on a quarterly basis for a term up to and including the 20th anniversary of the closing date. During the
three and nine months ended September 30, 2013, the Company received total royalty payments of $71,000 and $178,000, respectively,
from Arthrex. During the three and nine months ended September 30, 2012, the Company received total royalty payments of $19,000 and
$47,000, respectively. These amounts are reflected as revenue on the accompanying condensed consolidated statements of operations.
</P>

<B><I><P>Revenue Recognition</P>
</B></I><P>The Company's revenue consists of royalty income from Arthrex pursuant to the Arthrex Asset Purchase Agreement. Revenue
is recognized as the amount becomes known and collectability is reasonably assured. </P>
<B><I><P>Recent Accounting Pronouncements</P>
</B></I><P>There are no recently issued accounting pronouncements that we have yet to adopt that are expected to have a material effect
on our financial position, results of operations, or cash flows. </P>
<B><P>Results of Operations for the Three Months Ended September 30, 2013 as Compared to the Three Months Ended September 30,
2012. </P></B>

<P>The following is a comparison of the condensed consolidated results of operations for Tiger X for the three months ended September 30, 2013 and 2012. </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="CENTER">
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF COLSPAN=4 ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
Three Months Ended</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" BGCOLOR=#FFFFFF COLSPAN=4 ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
September 30, </B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
(In thousands)</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
2013</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
2012</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
$ Change</B></FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Revenue income</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                 71&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                 19&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
              52&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
General and administrative expenses</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                 45&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               102&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
             (57)</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Income (loss) from operations</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                 26&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               (83)</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
            109&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Interest income</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                   4&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                   2&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                2&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Income (loss) from continuing operations</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                 30&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               (81)</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
            111&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Discontinued operations</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Gain from sale of discontinued Reconstructive and Spine Divisions, net of income taxes</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                  -  &nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               532&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
           (532)</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Net income&nbsp;</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                 30&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               451&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
           (421)</FONT></TD>
</TR>
</TABLE>


<B><I><P>Royalty income</P>
</B></I><P>Royalty income amounted to $71,000 for the quarter ended September 30, 2013 as compared to $19,000 for the quarter ended
September 30, 2012.  Revenues represented royalties received from Arthrex in connection with the Arthrex Asset Purchase Agreement. The
increase during 2013 is the result of Arthrex's increased sales of the acquired product line. In the future, we expect our primary source of
revenue to be royalty payments under the Arthrex Asset Purchase Agreement. </P>

<P ALIGN="CENTER">                                                8
<HR WIDTH="100%">
<P style="PAGE-BREAK-BEFORE: always" align=left>

<B><I>
<P>General and Administrative Expenses</P>
</B></I><P>General and administrative expenses for the quarter ended September 30, 2013 decreased by $57,000 as compared to the
same period in 2012 due primarily to higher business insurance expenses in 2012, as well as higher professional services related to tax
issues in 2012. General and administrative expenses primarily represent our continuing operating expenses associated with remaining a
public company, including business insurance expense and professional fees such as legal, accounting and audit services. In the future, we
expect our general and administrative expenses to remain at the same level as 2013. </P>

<B><I><P>Interest Income</P>
</B></I><P>During the quarter ended September 30, 2013, we had interest income of $4,000, which represented an increase of $2,000 from
the same period in 2012 due to a higher average cash balance outstanding.
We had no interest expense in 2013 or 2012, as there was no debt outstanding during this timeframe. </P>

<B><P>Results of Operations for the Nine Months Ended September 30, 2013 as Compared to the Nine Months Ended September 30, 2012.
</P>
</B><P>The following is a comparison of the condensed consolidated results of operations for Tiger X for the nine months ended September 30, 2013 and 2012. </P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="CENTER">
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF COLSPAN=4 ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
Nine Months Ended</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" BGCOLOR=#FFFFFF COLSPAN=4 ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
September 30, </B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
(In thousands)</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
2013</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
&nbsp;</B></FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
2012</B></FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" BGCOLOR=#FFFFFF ALIGN="center"><FONT FACE="Times New Roman" SIZE=-1><B>
$ Change</B></FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD BGCOLOR=#FFFFFF ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Royalty income</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               178&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                 47&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
            131&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
General and administrative expenses</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               172&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               320&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
           (148)</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Income (loss) from operations</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                   6&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
             (273)</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
            279&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Interest income</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                   8&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                   8&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               -  &nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Income (loss) from continuing operations</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                 14&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
             (265)</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
            279&nbsp;</FONT></TD>
</TR>
<TR VALIGN="bottom">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Discontinued operations</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Gain from sale of discontinued Reconstructive and Spine Divisions, net of income taxes</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                    -&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               532&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
           (532)</FONT></TD>
</TR>
<TR VALIGN="top">
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
Net income</FONT></TD>
<TD ALIGN="left"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
                 14&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
               267&nbsp;</FONT></TD>
<TD ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
&nbsp;</FONT></TD>
<TD ALIGN="right" STYLE="vnd.ms-excel.numberformat:@"><FONT FACE="Times New Roman" SIZE=-1>
$</FONT></TD>
<TD STYLE="border-bottom: black 2.25pt double" ALIGN="right"><FONT FACE="Times New Roman" SIZE=-1>
           (253)</FONT></TD>
</TR>
</TABLE>


<B><I><FONT SIZE=2><P>Royalty income</P>
</B></I><P>Royalty income amounted to $178,000 for the nine months ended September 30, 2013 as compared to $47,000 for the same period
in 2012. Revenues represented royalties received from Arthrex in connection with the Arthrex Asset Purchase Agreement. The increase
during the 2013 is the result of Arthrex's increased sales of the acquired product line. In the future, we expect our primary source of revenue
to be royalty payments under the Arthrex Asset Purchase Agreement. </P>
<B><I><P>General and Administrative Expenses</P>
</B></I><P>General and administrative expenses for the nine months ended September 30, 2013 decreased by $148,000 as compared to
the same period in 2012 due to greater business insurance expenses in 2012, as well as greater professional services related to tax issues in
2012. General and administrative expenses primarily represent our continuing operating expenses associated with remaining a public
company, including business insurance expense and professional fees such as legal, accounting and audit services. In the future, we expect
our general and administrative expenses to remain at the same level as 2013. </P>

<P ALIGN="CENTER">                                                9
<HR WIDTH="100%">
<P style="PAGE-BREAK-BEFORE: always" align=left>


<B><I><P>Interest Income</P>
</B></I><P>During the nine months ended September 30, 2013, we had interest income of $8,000. This is consistent with 2012 as our cash
levels were consistent during both periods. We had no interest expense in 2013 or 2012, as there was no debt outstanding during this
timeframe. </P>
<B><P>Liquidity and Capital Resources</P>
</B><P>Net cash used in operating activities was $5,000 for the nine months ended September 30, 2013 compared to net cash used in
operating activities of $755,000 for the same period in 2012. The significant change between years was primarily due to a payment for
income taxes of $556,000 in 2012, which did not recur in 2013. During 2013, our royalty revenue increased by $131,000 as compared to
2012. Our overall operating costs in 2013 also decreased by $148,000 as compared to 2012. </P>
<P>We had no cash flows from investing activities during the nine months ended September 30, 2013. During the nine months ended
September 30, 2012, we had cash provided by investing activities of $900,000, which represented a decrease in restricted cash from the
restrictions being removed on the cash held in escrow associated with the sale of the Reconstructive Division.</P>
<P>We had no cash flows from financing activities during the nine months ended September 30, 2013 or 2012. </P>
<P>We believe our cash and cash equivalents as of September 30, 2013 are adequate to meet our cash needs for the next twelve months
and beyond. </P>
<B><P>Forward-Looking Statements </P>
</B><P>Some of the statements in this Quarterly Report on Form 10-Q are "forward-looking statements," as that term is defined in the
Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "may," "will,"
"should," "anticipate," "estimate," "expect," "plan," "believe," "predict," "potential," "project," "target," "forecast," "intend," "assume," "guide,"
"seek" and similar expressions. Forward-looking statements do not relate strictly to historical or current matters. Rather, forward-looking
statements are predictive in nature and may depend upon or refer to future events, activities or conditions. Although we believe that these
statements are based upon reasonable assumptions, we cannot provide any assurances regarding future results. We undertake no obligation
to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information,
future events or otherwise.</P>

<P>Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and
uncertainties. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in
forward-looking statements. Information regarding our risk factors appears in Part I, Item 1A, "Risk Factors," in our Annual Report on Form 10-K for
the year ended December 31, 2012 filed on March 22, 2013. </P>

<B><P><A NAME="market">ITEM 3 - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</A></P>
</B><P>Not applicable for smaller reporting companies. </P>

<P ALIGN="CENTER">                                                10
<HR WIDTH="100%">
<P style="PAGE-BREAK-BEFORE: always" align=left>


<B>
<P><A NAME="controls">ITEM 4 - CONTROLS AND PROCEDURES</A></P>
</B><I><P>Evaluation of Disclosure Controls and Procedures</P>
</I><P>We maintain disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of
1934, as amended, or the Exchange Act, that are designed to ensure that information required to be disclosed in our reports under the
Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the Commission's rules and forms, and
that such information is accumulated and communicated to our management, including our principal executive officer and our interim principal
financial officer, as appropriate, to allow timely decisions regarding required disclosure. </P>
<P>We carried out an evaluation under the supervision and with the participation of our management, including our principal executive officer
and interim principal financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-
15(e) under the Exchange Act) as of the end of the period covered by this quarterly report. Based on this evaluation, our Chief Executive
Officer and interim Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of September 30,
2013.</P>
<P>The determination that our disclosure controls and procedures were not effective as of September 30, 2013 is a result of:</P>

<UL>
<P><LI>the departure of the former Chief Financial Officer in late June 2011; </LI>
<P><LI>the fact that we no longer have significant operations and as a result have eliminated our internal accounting and finance department;
and </LI>
<P><LI>insufficient segregation of duties.</LI></UL>

<I><P>Changes in Internal Control Over Financial Reporting</P>
</I><P>There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the
Exchange Act) during the quarter ended September 30, 2013 that have materially affected, or are reasonably likely to materially affect, our
internal control over financial reporting.</P>
<B><P>PART II - OTHER INFORMATION</P>
<P><A NAME="item1">ITEM 1 - LEGAL PROCEEDINGS</A></P>
</B><P>We know of no material, existing or pending legal proceeding against our Company, nor are we involved as a plaintiff in any material
proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial
shareholder, is an adverse party or has a material interest adverse to our interest.</P>
<B><P><A NAME="item2">ITEM 2 - UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</A></P>
</B><P>None</P>
<B><P><A NAME="item3">ITEM 3 - DEFAULTS UPON SENIOR SECURITIES</A></P>
</B><P>None</P>
<B><P><A NAME="item4">ITEM 4 - </A>MINE SAFETY DISCLOSURES</P>
</B><P>Not applicable</P>
<B><P><A NAME="item5">ITEM 5 - OTHER INFORMATION</A></P>
</B><P>None</P>

<P ALIGN="CENTER">                                                11
<HR WIDTH="100%">
<P style="PAGE-BREAK-BEFORE: always" align=left>



<B>
<P><A NAME="item6">ITEM 6 - EXHIBITS</A></P>
</B><P>The following exhibits are filed as part of, or incorporated by reference into this Report:</P>

<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=1 WIDTH=75%>
<TR><TD WIDTH="14%" VALIGN="TOP" HEIGHT=1>
<B><FONT SIZE=2><P>Exhibit<BR>
Number</B></FONT></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=1><P></P></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" HEIGHT=1>
<B><FONT SIZE=2><P>Exhibit Title</B></FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="TOP" HEIGHT=1><P></P></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=1><P></P></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" HEIGHT=1><P></P></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="TOP" HEIGHT=1>
<FONT SIZE=2><P>31.1</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=1><P></P></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" HEIGHT=1>
<FONT SIZE=2><P>Certification of Chief Executive Officer of Tiger X Medical, Inc., as adopted pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002 *</FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="TOP" HEIGHT=1>
<FONT SIZE=2><P>31.2</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=1><P></P></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" HEIGHT=1>
<FONT SIZE=2><P>Certification of Chief Financial Officer of Tiger X Medical, Inc., as adopted pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002 *</FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="TOP" HEIGHT=1>
<FONT SIZE=2><P>32.1</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=1><P></P></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" HEIGHT=1>
<FONT SIZE=2><P>Certification of Chief Executive Officer of Tiger X Medical, Inc. pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 **</FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="TOP" HEIGHT=9>
<FONT SIZE=2><P>32.2</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=9><P></P></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" HEIGHT=9>
<FONT SIZE=2><P>Certification of Chief Financial Officer of Tiger X Medical, Inc. pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 **</FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="TOP" HEIGHT=9>
<FONT SIZE=2><P>101.INS***</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=9><P></P></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" HEIGHT=9>
<FONT SIZE=2><P>XBRL Instance Document</FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="TOP" HEIGHT=9>
<FONT SIZE=2><P>101.SCH***</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=9><P></P></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" HEIGHT=9>
<FONT SIZE=2><P>XBRL Taxonomy Extension Schema Document</FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="TOP" HEIGHT=9>
<FONT SIZE=2><P>101.CAL***</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=9><P></P></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" HEIGHT=9>
<FONT SIZE=2><P>XBRL Taxonomy Extension Calculation Linkbase Document</FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="TOP" HEIGHT=9>
<FONT SIZE=2><P>101.DEF***</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=9><P></P></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" HEIGHT=9>
<FONT SIZE=2><P>XBRL Taxonomy Extension Definition Linkbase Document</FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="TOP" HEIGHT=9>
<FONT SIZE=2><P>101.LAB***</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=9><P></P></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" HEIGHT=9>
<FONT SIZE=2><P>XBRL Taxonomy Extension Label Linkbase Document</FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="TOP" HEIGHT=9>
<FONT SIZE=2><P>101.PRE***</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=9><P></P></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" HEIGHT=9>
<FONT SIZE=2><P>XBRL Taxonomy Extension Presentation Linkbase Document</FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="TOP" HEIGHT=9>
<FONT SIZE=2><P>*</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=9><P></P></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" HEIGHT=9>
<FONT SIZE=2><P>Filed herewith</FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="TOP" HEIGHT=9>
<FONT SIZE=2><P>**</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=9><P></P></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" HEIGHT=9>
<FONT SIZE=2><P>Furnished herewith</FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="TOP" HEIGHT=9>
<FONT SIZE=2><P>***</FONT></TD>
<TD WIDTH="4%" VALIGN="TOP" HEIGHT=9><P></P></TD>
<TD WIDTH="83%" VALIGN="BOTTOM" HEIGHT=9>
<FONT SIZE=2><P>Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration
statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Act of 1934 and
otherwise not subject to liability.&nbsp;</FONT></TD>
</TR>
</TABLE>

<P ALIGN="CENTER">                                                12
<HR WIDTH="100%">
<P style="PAGE-BREAK-BEFORE: always" align=left>


<B><P ALIGN="CENTER"><A NAME="sign">SIGNATURES</A></P></B>

<P>Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be
signed on its behalf by the undersigned thereunto duly authorized.  </P>

<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=1 WIDTH=90% ALIGN="CENTER">
<TR><TD WIDTH="35%" VALIGN="TOP">
<FONT SIZE=2><P>&nbsp;</FONT></TD>
<TD WIDTH="65%" VALIGN="TOP" COLSPAN=2>
<B><FONT SIZE=2><P>TIGER X MEDICAL, INC.</B></FONT></TD>
</TR>
<TR><TD WIDTH="35%" VALIGN="TOP">
<B><FONT SIZE=2><P>  </B></FONT></TD>
<TD WIDTH="6%" VALIGN="TOP">
<FONT SIZE=2><P>&nbsp;</FONT></TD>
<TD WIDTH="59%" VALIGN="TOP">
<FONT SIZE=2><P>&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="35%" VALIGN="TOP">
<B><FONT SIZE=2><P>  </B></FONT></TD>
<TD WIDTH="6%" VALIGN="TOP">
<FONT SIZE=2><P>&nbsp;</FONT></TD>
<TD WIDTH="59%" VALIGN="TOP">
<FONT SIZE=2><P>&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="35%" VALIGN="TOP">
<FONT SIZE=2><P>November 1, 2013</FONT></TD>
<TD WIDTH="6%" VALIGN="TOP">
<FONT SIZE=2><P>By:&nbsp;</FONT></TD>
<TD STYLE="border-bottom: black 1.5pt solid" WIDTH="59%" VALIGN="TOP">
<FONT SIZE=2><P>/s/ Andrew A. Brooks&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="35%" VALIGN="TOP">
<FONT SIZE=2><P>&nbsp;</FONT></TD>
<TD WIDTH="6%" VALIGN="TOP">
<FONT SIZE=2><P>&nbsp;</FONT></TD>
<TD WIDTH="59%" VALIGN="TOP">
<FONT SIZE=2><P>Andrew A. Brooks</FONT></TD>
</TR>
<TR><TD WIDTH="35%" VALIGN="TOP">
<FONT SIZE=2><P>&nbsp;</FONT></TD>
<TD WIDTH="6%" VALIGN="TOP">
<FONT SIZE=2><P>&nbsp;</FONT></TD>
<TD WIDTH="59%" VALIGN="TOP">
<FONT SIZE=2><P>Chief Executive Officer and Interim Chief Financial Officer<BR>
(Principal Executive Officer)</FONT></TD>
</TR>
<TR><TD WIDTH="35%" VALIGN="TOP">
<FONT SIZE=2><P>&nbsp;</FONT></TD>
<TD WIDTH="6%" VALIGN="TOP">
<FONT SIZE=2><P>  &nbsp;</FONT></TD>
<TD WIDTH="59%" VALIGN="TOP">
<FONT SIZE=2><P> (Principal Financial and Accounting Officer)</FONT></TD>
</TR>
<TR><TD WIDTH="35%" VALIGN="TOP">
<FONT SIZE=2><P>&nbsp;</FONT></TD>
<TD WIDTH="6%" VALIGN="TOP">
<FONT SIZE=2><P>&nbsp;</FONT></TD>
<TD WIDTH="59%" VALIGN="TOP">
<FONT SIZE=2><P>&nbsp;</FONT></TD>
</TR>
</TABLE>
</CENTER></P>


<P ALIGN="CENTER">                                                13
<HR WIDTH="100%">
<P style="PAGE-BREAK-BEFORE: always" align=left>



<B><P ALIGN="CENTER">INDEX TO EXHIBITS</P></B>

<TABLE CELLSPACING=2 BORDER=0 CELLPADDING=2 WIDTH=100%>
<TR><TD WIDTH="7%" VALIGN="TOP">
<FONT SIZE=2><B><P ALIGN="CENTER">Exhibit<BR>Number</B></FONT></TD>
<TD WIDTH="1%" VALIGN="TOP"><P></P></TD>
<TD WIDTH="92%" VALIGN="BOTTOM">
<FONT SIZE=2><B><P>Exhibit&nbsp;Title</B></FONT></TD>
</TR>
<TR><TD WIDTH="7%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">31.1</FONT></TD>
<TD WIDTH="1%" VALIGN="TOP"><P></P></TD>
<TD WIDTH="92%" VALIGN="BOTTOM">
<FONT SIZE=2><P><A HREF="exh31-1.htm">Certification of Chief Executive Officer of Tiger X Medical, Inc., as adopted pursuant to Section&nbsp;302
of the Sarbanes-Oxley Act of 2002.*</A>&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="exhibit31-1.pdf"> PDF </A></FONT></TD>
</TR>
<TR><TD WIDTH="7%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">31.2</FONT></TD>
<TD WIDTH="1%" VALIGN="TOP"><P></P></TD>
<TD WIDTH="92%" VALIGN="BOTTOM">
<FONT SIZE=2><P><A HREF="exh31-2.htm">Certification of Interim Chief Financial Officer of Tiger X Medical, Inc., as adopted pursuant to Section&nbsp;302 of
the Sarbanes-Oxley Act of 2002.*</A>&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="exhibit31-2.pdf"> PDF </A></FONT></TD>
</TR>
<TR><TD WIDTH="7%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">32.1</FONT></TD>
<TD WIDTH="1%" VALIGN="TOP"><P></P></TD>
<TD WIDTH="92%" VALIGN="BOTTOM">
<FONT SIZE=2><P><A HREF="exh32-1.htm">Certification of Chief Executive Officer of Tiger X Medical, Inc. pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002.**</A>&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="exhibit32-1.pdf"> PDF </A></FONT></TD>
</TR>
<TR><TD WIDTH="7%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">32.2</FONT></TD>
<TD WIDTH="1%" VALIGN="TOP"><P></P></TD>
<TD WIDTH="92%" VALIGN="BOTTOM">
<FONT SIZE=2><P><A HREF="exh32-2.htm">Certification of Interim Chief Financial Officer of Tiger X Medical, Inc. pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002.**</A>&nbsp;&nbsp;&nbsp;&nbsp;<A HREF="exhibit32-2.pdf"> PDF </A></FONT></TD>
</TR>
<TR><TD WIDTH="7%" VALIGN="TOP">
<FONT SIZE=2><P>101.INS***</FONT></TD>
<TD WIDTH="1%" VALIGN="TOP"><P></P></TD>
<TD WIDTH="92%" VALIGN="BOTTOM">
<FONT SIZE=2><P>
XBRL Instance Document
</FONT></TD>
</TR>
<TR><TD WIDTH="7%" VALIGN="TOP">
<FONT SIZE=2><P>101.SCH***</FONT></TD>
<TD WIDTH="1%" VALIGN="TOP"><P></P></TD>
<TD WIDTH="92%" VALIGN="BOTTOM">
<FONT SIZE=2><P>
XBRL Taxonomy Extension Schema Document
</FONT></TD>
</TR>
<TR><TD WIDTH="7%" VALIGN="TOP">
<FONT SIZE=2><P>101.CAL***</FONT></TD>
<TD WIDTH="1%" VALIGN="TOP"><P></P></TD>
<TD WIDTH="92%" VALIGN="BOTTOM">
<FONT SIZE=2><P>
XBRL Taxonomy Extension Calculation Linkbase Document
</FONT></TD>
</TR>
<TR><TD WIDTH="7%" VALIGN="TOP">
<FONT SIZE=2><P>101.DEF***</FONT></TD>
<TD WIDTH="1%" VALIGN="TOP"><P></P></TD>
<TD WIDTH="92%" VALIGN="BOTTOM">
<FONT SIZE=2><P>
XBRL Taxonomy Extension Definition Linkbase Document
</FONT></TD>
</TR>
<TR><TD WIDTH="7%" VALIGN="TOP">
<FONT SIZE=2><P>101.LAB***</FONT></TD>
<TD WIDTH="1%" VALIGN="TOP"><P></P></TD>
<TD WIDTH="92%" VALIGN="BOTTOM">
<FONT SIZE=2><P>
XBRL Taxonomy Extension Label Linkbase Document
</FONT></TD>
</TR>
<TR><TD WIDTH="7%" VALIGN="TOP">
<FONT SIZE=2><P>101.PRE***</FONT></TD>
<TD WIDTH="1%" VALIGN="TOP"><P></P></TD>
<TD WIDTH="92%" VALIGN="BOTTOM">
<FONT SIZE=2><P>
XBRL Taxonomy Extension Presentation Linkbase Document
</FONT></TD>
</TR>
<TR><TD WIDTH="7%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">*</FONT></TD>
<TD WIDTH="1%" VALIGN="TOP"><P></P></TD>
<TD WIDTH="92%" VALIGN="BOTTOM">
<FONT SIZE=2><P>Filed herewith
</FONT></TD>
</TR>
<TR><TD WIDTH="7%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">**</FONT></TD>
<TD WIDTH="1%" VALIGN="TOP"><P></P></TD>
<TD WIDTH="92%" VALIGN="BOTTOM">
<FONT SIZE=2><P>Furnished herewith
</FONT></TD>
</TR>
<TR><TD WIDTH="7%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">***</FONT></TD>
<TD WIDTH="1%" VALIGN="TOP"><P></P></TD>
<TD WIDTH="92%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">
Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for
purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability.
</FONT></TD>
</TR>
</TABLE>






<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>


<HR WIDTH="100%">
<P style="PAGE-BREAK-BEFORE: always" align=left>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exh31-1.htm
<DESCRIPTION>CEO 302 CERTIFICATE
<TEXT>
<HTML>
<HEAD>
<TITLE>Q3 2013 Exhibit 31.1</TITLE>
</HEAD>
<BODY LINK="#0000ff" VLINK="#800080">
<font FACE="Times New Roman" SIZE="2">


<B><FONT SIZE=2><P ALIGN="RIGHT">Exhibit 31.1</P>
<U><P ALIGN="CENTER">CERTIFICATION</P></B></U>

<P>I, Andrew A. Brooks, certify that:</P>

<DIR>

<P>1.&#9;I have reviewed this quarterly report on Form 10-Q of Tiger X Medical, Inc.;</P>
<P>2.&#9;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this report;</P>
<P>3.&#9;Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;</P>
<P>4.&#9;The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</P>

<DIR>

<P>(a)&#9;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is
being prepared;</P>
<P>(b)&#9;Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally accepted
accounting principles;</P>
<P>(c)&#9;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this
report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation; and</P>
<P>(d)&#9;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred
during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that
has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting;
and</P>

</DIR>

<P>5.&#9;The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of
internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions):</P>

<DIR>

<P>(a)&#9;All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize
and report financial information; and</P>
<P>(b)&#9;Any fraud, whether or not material, that involves management or other employees who have a significant role
in the registrant's internal control over financial reporting.</P>

</DIR>
</DIR>


<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=4 WIDTH=633>
<TR><TD WIDTH="50%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">Date: November 1, 2013</FONT></TD>
<TD WIDTH="50%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">/s/ Andrew A. Brooks<BR>
<HR align=left SIZE=1>
                      Andrew A. Brooks<BR>
<I>                    Chief Executive Officer</I></FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<HR WIDTH="100%">

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exh31-2.htm
<DESCRIPTION>CFO 302 CERTIFICATE
<TEXT>
<HTML>
<HEAD>
<TITLE>Q3 2013 Exhibit 31.2</TITLE>
</HEAD>
<BODY LINK="#0000ff" VLINK="#800080">
<font FACE="Times New Roman" SIZE="2">


<B><FONT SIZE=2><P ALIGN="RIGHT">Exhibit 31.2</P>
<U><P ALIGN="CENTER">CERTIFICATION</P></B></U>

<P>I, Andrew A. Brooks, certify that:</P>

<DIR>

<P>1.&#9;I have reviewed this quarterly report on Form 10-Q of Tiger X Medical, Inc.;</P>
<P>2.&#9;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this report;</P>
<P>3.&#9;Based on my knowledge, the financial statements, and other financial information included in this report, fairly
present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;</P>
<P>4.&#9;The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</P>

<DIR>

<P>(a)&#9;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be
designed under our supervision, to ensure that material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is
being prepared;</P>
<P>(b)&#9;Designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally accepted
accounting principles;</P>
<P>(c)&#9;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this
report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation; and</P>
<P>(d)&#9;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred
during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that
has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting;
and</P>

</DIR>

<P>5.&#9;The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of
internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions):</P>
<P>(a)&#9;All significant deficiencies and material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize
and report financial information; and</P>
<P>(b)&#9;Any fraud, whether or not material, that involves management or other employees who have a significant role
in the registrant's internal control over financial reporting.</P>

</DIR>
</DIR>


<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=4 WIDTH=633>
<TR><TD WIDTH="50%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">Date: November 1, 2013</FONT></TD>
<TD WIDTH="50%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">/s/ Andrew A. Brooks<BR>
<HR align=left SIZE=1>
                      Andrew A. Brooks<BR>
<I>                    Interim Chief Financial Officer</I></FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<HR WIDTH="100%">

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exh32-1.htm
<DESCRIPTION>CEO 906 CERTIFICATE
<TEXT>
<HTML>
<HEAD>
<TITLE>Q3 2013 Exhibit 32.1</TITLE>
</HEAD>
<BODY LINK="#0000ff" VLINK="#800080">
<font FACE="Times New Roman" SIZE="2">


<B><FONT SIZE=2><P ALIGN="RIGHT">Exhibit 32.1</P>
<P ALIGN="CENTER">CERTIFICATION PURSUANT TO<BR>
18 U.S.C. SECTION 1350<BR>
AS ADOPTED PURSUANT TO<BR>
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</P></B>


<P>In connection with the Quarterly Report on Form 10-Q of Tiger X Medical, Inc. (the "Company") for the quarterly period
ended September 30, 2013 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I,
Andrew A. Brooks, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &sect;1350, as adopted pursuant
to &sect;906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:</P>
<DIR>

<P>1.&#9;The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of
1934, as amended, and</P>
<P>2.&#9;The information contained in the Report fairly presents, in all material respects, the financial condition and
results of operations of the Company.</P>

</DIR>



<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=4 WIDTH=633>
<TR><TD WIDTH="50%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">&nbsp;</FONT></TD>
<TD WIDTH="50%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">/s/ Andrew A. Brooks<BR>
<HR align=left SIZE=1>
                      Andrew A. Brooks<BR>
<I>                    Chief Executive Officer</I></FONT></TD>
</TR>
</TABLE>
</CENTER></P>


<FONT SIZE=2>
<P>Date: &nbsp;November 1, 2013</P>



<HR WIDTH="100%">


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exh32-2.htm
<DESCRIPTION>CFO 906 CERTIFICATE
<TEXT>
<HTML>
<HEAD>
<TITLE>Q3 2013 Exhibit 32.2</TITLE>
</HEAD>
<BODY LINK="#0000ff" VLINK="#800080">
<font FACE="Times New Roman" SIZE="2">


<B><P ALIGN="RIGHT">Exhibit 32.2</P>
</B>
<B><P ALIGN="CENTER">CERTIFICATION PURSUANT TO<BR>
                  18 U.S.C. SECTION 1350<BR>
                  AS ADOPTED PURSUANT TO<BR>
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</P></B>

<P>In connection with the Quarterly Report on Form 10-Q of Tiger X Medical, Inc. (the "Company") for the quarterly period
ended September 30, 2013 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I,
Andrew A. Brooks, Interim Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &sect;1350, as adopted pursuant
to &sect;906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:</P>

<DIR>

<P>1.&#9;The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of
1934, as amended, and</P>
<P>2.&#9;The information contained in the Report fairly presents, in all material respects, the financial condition and
results of operations of the Company. </P>

</DIR>


<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=2 WIDTH=633>
<TR><TD WIDTH="50%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">&nbsp;</FONT></TD>
<TD WIDTH="50%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="JUSTIFY">/s/ Andrew A. Brooks<BR>
<HR align=left SIZE=1>
                      Andrew A. Brooks<BR>
<I>                    Interim Chief Financial Officer</I></FONT></TD>
</TR>
</TABLE>
</CENTER></P>


<P>Date: &nbsp;November 1, 2013</P>

<BR>
<BR>
<BR>
<HR WIDTH="100%">
<BR>
<BR>
<BR>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>exhibit31-1.pdf
<DESCRIPTION>CEO 302 CERTIFICATE
<TEXT>
<PDF>
begin 644 exhibit31-1.pdf
M)5!$1BTQ+C0*)>+CS],*,R`P(&]B:@H\/`HO3&EN96%R:7IE9"`Q"B],(#4U
M,#DT"B]((%L@-C8Y(#$U."!="B]/(#4*+T4@-30V-#D*+TX@,0HO5"`U-#DQ
M-PH^/@IE;F1O8FH*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`IX<F5F"C,@
M,30*,#`P,#`P,#`Q-2`P,#`P,"!N(`HP,#`P,#`P-C(Q(#`P,#`P(&X@"C`P
M,#`P,#`X,C<@,#`P,#`@;B`*,#`P,#`P,3`R.2`P,#`P,"!N(`HP,#`P,#`Q
M-#(R(#`P,#`P(&X@"C`P,#`P,#$V-3,@,#`P,#`@;B`*,#`P,#`Q,3,P-B`P
M,#`P,"!N(`HP,#`P,#$Q-C$W(#`P,#`P(&X@"C`P,#`P,3$X-#@@,#`P,#`@
M;B`*,#`P,#`R,30Y-B`P,#`P,"!N(`HP,#`P,#(Q.38V(#`P,#`P(&X@"C`P
M,#`P,C(Q.3`@,#`P,#`@;B`*,#`P,#`U,#<Q,B`P,#`P,"!N(`HP,#`P,#`P
M-C8Y(#`P,#`P(&X@"G1R86EL97(*/#P*+U-I>F4@,3<*+U)O;W0@-"`P(%(*
M+TEN9F\@,2`P(%(*+U!R978@("`@("`U-#DP.0HO241;/#%"135$1C,V0T,Q
M0S-&-$(Q-#1!-$-&1C0Q,3)#1D1#/CPQ0D4U1$8S-D-#,4,S1C1",30T031#
M1D8T,3$R0T9$0SY="CX^"G-T87)T>')E9@HQ-S,*)25%3T8*-"`P(&]B:@H\
M/`HO4&%G97,@,B`P(%(*+U1Y<&4O0V%T86QO9PH^/@IE;F1O8FH*,38@,"!O
M8FH*/#P*+T9I;'1E<B]&;&%T941E8V]D90HO22`X-@HO4R`T,`HO3&5N9W1H
M(#<U"CX^"G-T<F5A;0I81V-@8.!F8&":RP`$E^P8>!@0`,1F86`$0H9O`DCB
MW%#,P'"*@1^H]P_#*[\-O`O8@XH9>1AT=S64[`#)`75=N0VA&<X"`-X3#4L*
M96YD<W1R96%M"F5N9&]B:@HU(#`@;V)J"CP\"B]";&5E9$)O>%LP(#`@-C$R
M(#<Y,ET*+U1R:6U";WA;,"`P(#8Q,B`W.3)="B]297-O=7)C97,\/"]0<F]C
M4V5T6R]01$8O5&5X=%TO1F]N=#P\+T8R(#8@,"!2+T8P(#D@,"!2+T8Q(#$R
M(#`@4CX^/CX*+U1Y<&4O4&%G90HO0V]N=&5N=',@,34@,"!2"B]087)E;G0@
M,B`P(%(*+TUE9&EA0F]X6S`@,"`V,3(@-SDR70H^/@IE;F1O8FH*-B`P(&]B
M:@H\/`HO1F]N=$1E<V-R:7!T;W(@-R`P(%(*+TYA;64O1C(*+T)A<V5&;VYT
M+U5(0EA#2"M4:6UE<TYE=U)O;6%N4%,M271A;&EC350*+U1Y<&4O1F]N=`HO
M5VED=&AS6S(U,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@
M,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#8V-R`P(#8Q,2`P
M(#`@,"`P(#`@,"`P(#`@,"`W,C(@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@
M,"`P(#`@,"`P(#`@,"`T-#0@,"`T-#0@,C<X(#`@-3`P(#(W."`P(#`@,"`P
M(#`@,"`P(#`@,S@Y(#`@,C<X(#4P,"`T-#0@,"`T-#1="B]%;F-O9&EN9R]-
M86-2;VUA;D5N8V]D:6YG"B]3=6)T>7!E+U1R=654>7!E"B],87-T0VAA<B`Q
M,C`*+T9I<G-T0VAA<B`S,@H^/@IE;F1O8FH*-R`P(&]B:@H\/`HO1&5S8V5N
M="`M,C$V"B]&;VYT1FEL93(@."`P(%(*+U1Y<&4O1F]N=$1E<V-R:7!T;W(*
M+T-A<$AE:6=H="`X.3$*+TET86QI8T%N9VQE("TQ-@HO4W1E;4@@,`HO1F]N
M=$YA;64O54A"6$-(*U1I;65S3F5W4F]M86Y04RU)=&%L:6--5`HO4W1E;58@
M,`HO6$AE:6=H="`T-#$*+T9L86=S(#DX"B]&;VYT0D)O>%LM-#DX("TS,#<@
M,3,S,R`Q,#(S70HO07-C96YT(#@Y,0H^/@IE;F1O8FH*."`P(&]B:@H\/`HO
M1FEL=&5R+T9L871E1&5C;V1E"B],96YG=&@@.34V-@HO3&5N9W1H,2`R.#8V
M-`H^/@IS=')E86T*6$?M>0ET7,65Z*UZKS=)W?W4>ZNE?J_WEEI[=VNW^FFS
M90MYDPR2L6S)MKRO>,$V&-N`L2T38""&L)HL!&,#;DE>VH:`DS@D)F%(PF0"
M)`?(1#@0(K8QA("M_O>]EFU,^)F9,_^<.6=^WU+5K:I[:[M;U6L!`0`M;`<&
MID_K*"GO';EF)_;\'O/4!2O[UOSU41H`((68#0LVKA<4F@/7`%`10'7OHC6+
M5Y+9S]P-H'D50/'2XA6;%_W^1['5`/H#`.9GE_3W+7SMAZW/`/@6XGP52[!#
M5\8\A^V'L.U=LG+]IBF;F-NP?0KYMZQ8O:!/?*RV&:"V#L#XSRO[-JW1!S+[
M`:9E(;^PJF]E?_['^[^#;6D_9]:L7K=^8)[G#H#IGP&8=&NNZU_3L^(F"T"_
M&B!C%(`%<@X4H&:Q)K4N8EA$$9-+`%^!&`*((,`F-2#G+U0N<E(F$$CQXGZ(
M\JNC_AZ8_X@!P`_!2_7RKZ%/A-;)T';5Q>8LN*:K&Z[]&L;_&5"@]!57`8\Y
MEUD+-H#D'S"_(^6Q*<GSBN7@&5N2_#>F'IGWC><4^.``W$$R82O<#"UX]N_!
MB[`<UL`,.`QU\"'Y+4Q"5?G@>LA'75P`"^F#B:026W>`-?DB4JY-ODO/HH+N
MAQWP,6R`?X4%\`(HX0$2!B]4P2]@0G(Q&!6O0@7<!ON2OP,5&X''X-7D[Y-C
MT`K?@5=)'>E@MBOJX1K8`C?"[<1*"D@5N1'U4@>;X`=PBG*:HZCO=I@*G=`%
MB^$(2W!-!4R'P^0W3!.NU`5[292<2CZ)%N/#D4700"IH*'D2G%``$:B%&.R$
M;\*WX+>DF$Q@RM@38,4S]<$)HB,6XB;/)Q\"'E,[S,&=W@[WPD'X.?R<\*23
MEC"]BB?&W@$=K,8=;H6]\!OXB&20:\@FFF">&HLEER6'DZ=Q="6NTPQ3<-];
MX3X\W>-P#$[!#U$FKY(\,IW<1]YGURO*+^P8^]786TE+\B/0XUYGP1)8!=M@
M#^KF$?@1O`XC\!EAB9IDDQ_14OHZHV,?45B3D-R%6A.@!!I06IM@%^S&=`)'
M_(0()$C"9#WY5ZJC>KJ"WD0/T;\P>YA!YH_LGY)-R0/)'Z/,WP45>##Y829J
M=2MJ[4[4W9/P-!R%!/P,_@P?PCF4Y#*REPR2H^2OU$2?HK]ASRM>57R8?#AY
M'C)1VCXHA%),893@))B,>UD%#Z"FSL!+&+<^A\^)@U23F\@N,D#N(/O(O>1-
M\BF]C;Y,WV#N99Y@XLS/6,*6L\L4>Q5O*6>H^L;N'7L@V8:G,^+<$;2;>I1A
M/]KB.K2)AU".0W`<GL>]_16^0+D8\;1>4DMFDDWD1K*#W$D>):_15KJ,KJ9K
M&,+D,1XFP.QF>?80^ROV=<46Q=XQ_UAWLA@DN\E`:ZC%?7=AF@>+<)4MF/:B
M'`[#LZBMGZ+5OHO6_`E\@:M1U',F,1,7"9`63+-0ZUUD+NDC2\A6\EURB+Q.
MWJ<<M5$WO9-^DWZ7_IK^B5G+W,,\R`PSKS!C;%*1J2C'U*;HQO,>4GRLG*7<
MHVI4S5<]KO[%A8(+/[OPQEC6F'DL,-8Q=NO8,\FNY,;D]<EO)Q]//I4\G#PE
M>RJ#MIN']B5@"D`Q>DX;7`5S<?_+82W:Y`#<!?^$Z7$\PS`<@=-H<;^"7\,;
M\":FL_`.:O8]^4R?P'D\DXUX2!G:2R690^:3160-V2*GF\FWR/WD01(GSY-3
MY$7R"ODM>96\A>E3\E?R&350(RVAE;293J+3Z$RZ@/;3-70;_19]D'Z?'J<G
MZ4]0R_]*?TO?IF-,+FJBA6EE>IBY*)'-S`[FV\QQYE^8WS"O,G]@/D/9L*@C
M%^MA?6P-NYB]A7U+$40Y+50L4^S']"-EIG*9\K!R6/ESY3LJI2JH:E5-5WU?
M-:1*HJ<<AKO12[\$:'$'2#Z]%G?)D!_3(^0>\A(=8D>ICG23+0S0(K80;;P=
MSM(]C(_4,YN(`_WX&S"9,BA#'7V83D+KEF`F>G$8[;!3\0IK)H_C?7L;68+Q
MYF6TGS;DV0TGP9=\%;+AGY++X2BQHD?U)^]'7]A.VL@I]*'%="W],WN>X=!"
M_\"\AG9S%GT_0NY5_ASFT!!:VP38#Q:H1GV^`9N)0(MA-MS/[$9-N\`.!>P*
M!<9P\C$S!`?IO70//9(\@S?A7S#NS68G$6#?PKA?`#QY#Y[&O;U(7Z%[R%%6
M2;Y-IN$><ADUVL=/P4L?AGYF`V'I=OKO[*OP&JVFLYE"\C%;QN"+`_5T"W23
M]X@:GB3WTL^("_:1[7CZM\E[]&U8#_].DO0"<R==0GY&?DHL-$0:F5(8HW\@
M\W$W7GA?825J6HE^I$2[.DL/,HO(@_"*XD?,[]EVYABPY#E22<\S`FTF[4Q5
M<A1\RL\8[=AODDW03)/)N]G,"Q^@=-;":\G33!';QT[YXN@7+U,KN9M9J>A*
M?CRV57$+K8=%BG=5$V`S;<((\3+>18>A@'Q`<U#N//;4H*2L[%U??$%G0![]
MD'P"F\B=Z!U>/$DG1H[#L)@<0%X%WDTQO`4^IX<P:K8S&S#.'(/3:.TW8FPW
MT@5XSRPA,X'B+<'*]\$#:`T?L4MA,[[0IL,/\#8]A#6GXK$Q$?X9X][5Z(N_
M(WO1ZUII-=L%'7B7W@QN`+&A4XS53ZBKK:FNJHQ&PN5EI27%186A@OQ@P._S
M>MPN@7?FY3IR[#:KQ6PR&K(YO4Z;E9FA4:N4"I:A!`I;/!-[A;B_-\[Z/:VM
M15+;TX<=?5_JZ(T+V#7Q2IZXT"NS"5=RBLBYZ"N<8HI3O,1).*$.ZHH*A1:/
M$'^IV2,DR.P975C_1K.G6XB/RO5VN7Z77-=BW>7"`4*+;4FS$">]0DM\XL8E
M`RV]S3C=8&9&DZ>I/Z.H$`8S,K&:B;6XU;-FD%CKB5RAUI::00IJ+6XJGN-I
M;HG;/<W2#N*,KZ5O87SZC*Z69H?+U5U4&"=-"SSSX^!IC.M#,@LTR<O$E4UQ
ME;R,L%0Z#>P5!@M/#=R>X&!^;RAKH6=AWYRN.-/7+:V1'<)UF^/6+2.VRTV<
MW-#4M>O+5`<ST&);*DC-@8%=0OS1&5U?IKJDLKL;Y\"QU#>Q=V`B+GV[)$1;
M"6Y$VKYTE-2A^CTM4D_O,B&N\31ZE@PLZT5]Y`S$8>9FUU!.CG@B^1;DM`@#
MG5T>5SSF\'3W-><.FF!@YN9ANRC8KZ04%0YRV2EI#NKTXY4L[9<K_9=H<DUF
MEVIM,R^)DT@[\DQ&*X@+"P3<29<'#U(E%?U5,+"@"MD0N@F.BB]$-2R-:YIZ
M![@:J5\:'U?X.(\P\`F@VCVC?[FRIV^\1^GC/@&I*AG')?M"^L5Z/!2*%Q1(
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MV^=[!,XS<`+?@/&!-2V]%S6:2)[<ZXA/O+T;#[&$U*"U4F@<])#=,P9%LKMC
M=M<)#E^^NSN[ABBA3;V-W8->I'6=$##0RKWT4J_4$J06M!&T]"&JEDF.$R+`
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M\_TDW/8^V?_*@ALJ;#9O@6+YV.15=7-;`O.WCCS[PY^\=^..PX_M/?]/;Y#O
M?5AB,I4`2?X:WQYZ_.*L)$^(WQ?M1^QTIWV?_3$[LROWML"]N?<5/>YXO.@9
M]JCA:.[QHHS%N1MS;P-&H3?I)]N9L.BH9MWF:KO;:*[/<1"]'HB>XT!5J-/-
M4^>I\KS.O+SB2&7E<R5YQ<I62OL4>4K'K5;KASEY#K:0%/I">87`<4ZOS^3U
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M5$]/#_2@C<AFP7@JHA&_W^-AT%+0+E*=KLH*.1DEHL=3Z9+9`OZ`WT/O>W#;
M[BV%OKU!@V?"_!VW&.W9S9M^_%Z/;_L7[VBG.H(&A^_]W&B[.8OYYTZ?*L?=
M4/J4@KGP3L>:,5-]82AB'XLUN'-,NH%#8[M\-,N0FW\+4[X@X@_YQDX4\U%O
ML<V`SVO8@K[U'/H6AV^GIX\*;J<A9DTDWQ!;L1*QU^36N)OMK;EM[DYZC:[#
M-,L\.V^NL]^\+'<9O]&X)?=&?J?ICKS[E-\T/I3[0-X1\_-Y/W`Z5#JUD6:'
M@<D)JS56R;6RL]"KLL0YT2QQTL)(5C^^;;#7QHJNAA@KFCU8S(FR$HT5[5$V
M0:S'UJ#:^^?80ES/I[+:WN4D_*ZDGE&4[EK4.RFWX`..HKOY)7>K\%K=RLM^
M6&%`B3(?[?KEQ@MC2UY_^)7^XV-$V+[P^6?;YMQ]W[6'YUW_G;L5RS>\?</K
M8Z[S>T>6/T?6_>TV<<$?CKWUTSM^-WOE'O)$8O>O,/;4)=]A5C![($BTXD00
MK;I84"J*H9"$`L7!>J@G-8KZ0'WP=KK7M2=PB'[/>Y0?]G(\Y-`<UJ[("?!!
MY4X_V1(8"'S?Q5@4I`"M>R@[*B.+C$2=)[H_>#A(@P!!K3T[0=@C>=X,E0\5
M,>S@8HA_+[J=U;X`DPEG3&OL`>WVCFB)-J:=IIVG9?5:7DNU.07N!+-#="J1
M%%-.4\Y3KE:RVY6/*N/*4\I?*A5*>W[HZE1$6XL1;2HW)N'1T1$4:2@4&QTE
MV8;J:NY,3\IVU_9`6]S5T18OQEOH&>"3[X`S^4Y553>LE87O4RI1[JDHAUI0
MI5KU5#)>C_NR&AC'DG_9>,?^0\2U=^4*?VX^GZ\OR3#F1>>?:IZY?F'[?7-?
MW[KAT5WWD^"):QOK"]U!IU$H,F6:=::!;0\\L.CZ]GZT41%UL!9UD(-?'&-B
MA9[+]-DXFX\%-:>FA@[U#`T-:@I\59I:9ZMJLGJRIC7C6O4UW"S?/>QWV,>,
M0^PQ'Q>0Y#S!']6X,4BHW8;,F%JCUB@<H-:8!1APB.J,>JTCSU'B8!R.3(_7
MH%($,C.%&KV9-U-S3@`_5B7Q6G4H7MWVX/283L2)]NN(SNX/_?CB31%J_]N(
M%%;:1V5#Q4#2$TH)UE`-V9)XQR,#],A!2X,*QJUH)$5G9\34XU@E84U6O=0>
M0IP*7-!#>HP7Y6K]BOA5R@#:O!Q%W,ISJIMFM^Z\Q3SZV[N_F2"6>Y8M:KSF
MB36GO]ESPPW1LD5OD\WEKNZMM?UY[R56[R-53UU=VW'5@@GY.=GYE?>W%$1>
MPSMW;/_81.:,X@YH(HM.`(/;F5T48R09&F>%8DK1VF!MK`;6T"(&\R,>J3_'
M[HF`B$6+6!YM$2V8;9AU7*0%R8/:Z*"2-G5VB5DNEFUI)AX1Y_$DR'*1\WI!
M&=XWP5L$W#Z'5Z.7;UGIHN4NA.HDX96\Y!!#+G<@P#.TJ9'U>%F>-@4:69;G
M`R;,."PU_DNS&J59I=GXYF"`YRIJJLM*$W1LR%JF35!&Y$J-HI$:GVKFK7QS
M1OGO4A<*ZO#"Z(71T<M7@;P'W`PW(MT&.BFZHQHEA>XZ?5IW>I>".ZVKZTXI
M5099K2S*"S="I4#JP`KKKG/&J%AGBKG=1;-C+JEH$8W5XV.ZB13-5!Z&2GKT
MN`.HV(IQO<IW17F%?$=X*E.5BA0Q90$5*8^31JKH`L/=JR9/6;IYSIRZ`C[L
M<_C,G$IC#,V;XM)->/II74=C96%MQ93OMEXUI]C+!W(T6GNLO"GJ:&76-HZU
MC;WYR)NS&KSVH%#BMEB,.I5&H:I8WE_P'GVLT=K0O0F?9.U%GE*OG2M1ZU09
MP>C:VC]CA,Q'[WP2+:6"3!-7&CI55^=_-Y]9JERJ6>Y<$=BLV>R\P7]#0-T!
MR_VT(TI,;GO4B)D06A`J+`2CJ:*E>'8P6EK13CQ%I!A`E97%.P23PR%`(504
M\D7%IJ*B8D\9JRHJS+!E.BJ#@J.XB#,-&!.D:3A+Y<,/9>]0EL]QDNZ#0LH,
M5;PB/32&[3D1"0]9JV64&Y5[/5ZY=[@@(F/14!/]H(@4V2L=UB*KHS*C_+8K
MWA82M(_@X^_<*/>I9!?CEA&KBXWN4A2'U&@1:!FV$&*PQ8CDYH;J3T9#Y\DG
MW)E=G&[KZ=/J.MD^\#70%B_'B%J!$750<%>AVM%:1`VQ95478\Y`<SEF--6;
MW"G+Z";$,&X&3,KM4?=6'975/OYB2.E=J5)Y2*7<5$5I]]B?COVBIU3,W6+-
MSM1F5U?Q[LW7N'TEGG46NRG/U]QMVUW@$.\EDSTAWN`S*^XX'R6&(XV5C7/'
M>JY2ZPS:PJG&Z+:R$E_A)G)76\ADLQ1<Q_]N8L=+[*8;<X)*)B"]&[J2[]!B
MA04R(9]XQ8!U54W4LK$F:@B)AFA(M#LBW5G$[B$6:WZ+:W8P6)K?G@5KE`GF
M(3$G2Q7,TF?EZWFGR^1TNAR9SH*@R\E9!RRHT"-ZS1HF*T$F#3&]^@3Q',]?
M87"*CJA34EI-;<0YKCP)BQK4IE/DA53+:+1$2IUW.JG37N"T.@LRKA_7Y655
M2O+.=$J1VREJL9`FLVAE/&A-"5UZ'9[EQK4MZUKR?$G/(5L,/AWE+BIW_!6"
M4QZUBEFFF%967[45M2=5C^JKK:+^XIM3?JU<<EGCE_2I'+\Z+RDT2EXLJ*G-
MSZ^MJ7S!9-3JS=4UGN8YS?7Y$?O-`N^PM"@L-07YM;7Y!35CZRXT3=)Q)JZH
MP[ID4K3,Y[N:G%J5:\G-E/YU"04`S`2\-_/A;V(#10MS89Y!9C%S-7,S9N8?
M9)[4'[0]EJ/9F;,O)QEB]K#WL]3)\P1:7'\.YI=".Z$F@?*4N$JT1)L@^T6W
M">]]H@H29.)YP642!)?`9P1=`E>J$373-8SF)!6!1R_,/R-(2BFV5@MB9$)$
M$`NC@NC%[,:,*A/$W+P("`2$_<+SPB^%#X2DH$17WGTT)%C+KY(T)[U44H`Z
MZ9'4$:N[Z'22,C`XC_1(%T2V['7CFMDE16GI^XSTH'J,/L9067'YC2(_K2]Z
MC>0WQHL!=#GIONOPG3/"+K_;5F1UL52ESLS6YT0[^@J<!4KA_A."WN0R5S$S
MJL9R2.CZYH"OL:[(R1N5:K5.G/]08\=UUIOHRA7%ABQ.(TF_$SUD`;L#G$1Y
M`A1X$ZS55^O1(KZG^(!^H6-F.0;@4\)X\VK@6AVC%_($N@V%0)V@TQ-6H5)!
M7J[307)R\YPVA9TE:K#DV.TLR]P#CU*B-&:"2L6C0ULL=@L?M%LX.EG/X`69
M9`BS0H##*OV`[B0AH,+;+LM@$2NJ(Z<LO[10=+):,8/76*P6/N/ZJ\:CG?0I
M)#F'WB(&33&+Y"$6$3\!9..]@%8_(FEC_!OIXH<1!KQ8W<B%.BDJHAJLLA;P
M>I0UH*BKPP\AV4UZUO9(JL`/(97G:RW?@U=:)35-?3C[H2=SN4Q[OJW#-6=F
M575AE?#X?1FK[I[-[AC[,'9A:%YNML%C6FR_K=)?&:I8C8\`Y_7WP/@K_31:
M>AVY3[Q576.OH89HV:2RSKIEELWF+98GS3^!S\V:6<6=M<LT3)NY$V:;F0JH
M,U-7,+^:'M*0:G\L."TX+_B)^5/+)]4J4VU=G5&3X0]45==8K(JPN<[H#S@F
M%(?#XU=32%4'2F`8WEAG,AKK;+I,AW$"7DQU1BYC0-/+2&\,1]U31K$I:A1M
M]HA1-$=YXS3C/..=QOU&A3%!(V(67M!B,2GV"?L,TF?R4$U40L/(+F.3.84+
M(S+&MU4P4NH0'8_B$]4^0>.P&JVX:,;U/Y9UB$J\'.BDH.20OL3E"?"%*>%!
M2[6LSO9SHSW<J,PIW6P7+S6,='5?TFQ=[/*+QR`_>5#!DD)WZ;BZE']):NV1
M[S";V999;<;H`NZLZEK,I9B=F"\]<`AS^>5Z4>^H\RMCGU(E/6*ON/+J:64E
M<_KI@#8S.[_#.:VC,APHU')M!]^>7RP67B-D9Y@+IO!MG6*%KR0X-V`WNY8-
MKFNP,&LO/+G38\CF5UBWUOH+/>ZJ*9^-O?LO8EG;@R2ZVI&5[>RUK*\,E?@J
M]H[]X%:/T=KXQY^^=I5D285H20-H27[X0FPX3DA0Y*)!,0NS+MI-NYAC[&LN
M-C^W-G<R9:K<1*W)(%E:G<JF4A'!.P`OF(F*%S)Y0XDA9F`,&#./ZP,VZ8O1
M)FFX("HAT>&/?F!+VJA@$VW;;7?97K8I;#E!?D"`R7Z)GF6*QOS3_//\S_M9
M_[.,1W)B$"13*(X(J7GDX&KWY6,<Q<FG"]N%NX1'!5802@518(0$S1T.E+]A
MDQQ;-HE1=/`1;G3J>+O]@O1K5EVL[MRH77IA$U2N?*%)1.@Q^C`\8$K]."$I
MY_*+5`J;'BJ'S$+BXHV.;+5NJ^U6DTN;V1/V%(A<SAV/F%[TV:ZRU]B+F;;Z
M*>UK'YQZ?L`US$>#3D=.<X%0WA(.EUSUNX3U5W3SPV$-D.2S*/5;4>H3B5I<
MH!718%6@*H`)I-X$%N(%#YGBN)KLL7^7/&$_6'!@PN$8UXJ*X:P+7.M<9^P_
M=RDTGJR"F1Z&M>?DT(*"4+U87R<&76Z:D\,'15,P*-878/#,CC8.3'P!LA/,
M/I$WUV1D@"KZ0G6@N-B?R1;8ZUT#^]TONZG[C):.M)PDDT#$EV7.S4'IZLNS
MC]2+M6V1>C$O6E\_2="*VCNUA[6L-J>UW#XI04R#;TA?@2/<V1Z4)TI8>C2>
M'46/')7\!Z1/"?F;!B/IJ!0L+[D7=T:EYNK4Z'S<:=FQ>DBH)T0D^4MQ\?+E
M-7YS&2U?#J`!O_39<.FCP2K3*BKQFDL])A:7V0WY79Z%?EM>**S/]9IM)9S-
M57_U3&..UIQ;&?#$^BK]52YSXT-S)U0'7;9"0?#FZ+*,)=^QURNL4UJM3F9/
M).*]_];2:[B,8I=?9]=PN9%]8P>F\=;B*8:-4PMC`9(_]M'4\CR+SU4H6#G_
M^:I_US544"_(/]TKLO_R\\^C]GGZND_4=K7\;][O\HD?2/AG/PIWG5=<N#WC
MH+H4FQJ9/_6;+ZA<8RUP34;-><7GTS,.@@U4\&7XK;*:Y$H5.IXE8.80/_P/
M@^)J&)`P^T?IU]K_.R@/)F49*'X*6_X1WW\5F&]`%0L00"S2ZK$'I3YLY]-J
MZ/H/Q^9);T:49S5TXI@ZG*-0[O]&,O&/1Z;A?P/\9VPD#6E(0QK2D(8TI"$-
M:4A#&M*0AC2D(0UI^"_"3MA)GO[[1.O_<XD!3"?9E]F7%2\J'_IJ4EVKNE:=
MK:G0?*3Y*..-=$JG=$JG=$JG=$JG=$JG=$JG=$JG=$JG=$JG_]^2:CX0`,U9
MF`14_CV.`@<E,`N`?2UC=/PW.C4LDK@0&."Q3-59K//C=276ZI$*K`9[ZJ%G
MO$Y!!P^.UQGL?V*\SF+]3^-U)=03WZS6QJZFUE#GTI7]ZZ;V7S]S]<J^5=,[
MBB:O[UNQ=$%[YW^/C,=IA4;H@B;$(>B$I;`2^F$=3,7R>I@)J['=!ZM@.G1`
M$4R&]=A:@5P+H!VY9R+78MB`/7UPW7]SKO_)T;)V(?G!P1\F7;`0O@;0#F0@
M].NH_U4@J%_"?DV_XN_[O@Z($K.*J+'4D(R_HV9BSB):HD.L_[KQ:4A#&M*0
MAC2D(0UI2$,:TI"&-*0A#6E(P_]F4*Q;T[>@GS21%C*-+"#]9!%90I:2Z\AZ
MLH%L))L`!CNA(8MY%DHQBY@?Q1S'K$B>8IX9;FDI%Q.(0\4R'@KFEY^0"3G^
M\NT-1N89V(_Y,.:7,;,`6/*8*?,,/0P!X)'YQ)#%(8]*##4VCE<JJE*5X8*B
M\C<;,I@$?("9,@GF!`13HX:#Q>4?-NBQ@^"TQX%@9M2`TS_'/`\AF>GY(6]!
M^0GF&+-CJ(;7-UB98>"8(1`P3\>\!O-;F)6XNV%X$_,'F).863`P!X;^;0__
M'+.?+"</X*S?@GO41,SBM[';%'0;W<;0><_0.)#D*6(=LB\J3R1/#??G+,)]
M;R?KI(X?,+<2J[2AY"EZ>*@L+"80%<MH&.4D8W\@A5V^%,X59#SD27';PX\^
MBW**8WZ+'C[*B(PK'Q?Z>+C&/Z'\6>9F*4&-&H[RHF].V)G`<\Y9B`SO#_N*
MPR9L2HI9^ARS`V4T()<ZJ:^DG)-H,ZXMSY+PU!GE;@E/:B_725-,#&<@$C7^
M2>4&7U.7S#14'I;&#!6$#1)KY81RPS,XX00()\^)9M^$L,T7O;:<\_DCY4I?
M03@+UT\DQT2OKRB<55,2+K_?=]!WTG?&QRI\%4@MKRJWU^375-4P-I\5)SP2
M]%7YV&>9'5("GQI$CM?STN;Y33S-Y$O#>*J/AGGYV-NE!#PRF?G*>:K#*CI/
M>5A)W4\BO^;)$ESX]V+&D[R[W.T)S92.M&TH/RPCMR24;4-.`6?[TW%G*%SN
M1&%(EK;MV%73RLO]A>&&C.3[S#:HQH-]ACB$^,\XI"8LX,CAV,1RIX1+:LH-
MTDS%8;F)5BK/[P^S4G/RE(B$49`R<H5MB,2LO+#;7UI>[O:'JW#]S\0,/RZN
M\3M<Y0//X5*$V28E\./!BOE*7EFBC"F9_?0P?9Z^3-G]S&'F>>9EAEV-7'<R
M#,^4,#%F&C./4>@;HG04E3L/R_V8W\3,0`F6,<RKY=9AM"$"T[#$&8$B]3!2
MI5I,LF*9,N\K%,D_"#/$#-%13'%,.(N84TF@E(B$$@(:0D$-5BN&$D.V6FS(
MI#=0#T1`2R;(9:5<.L2<B/;.B/;6B'9)1-L=T79&M*T1;6%$&XQH&S@:!0&T
MU"&5Y+Q<_E@NI\MEH9@C:#\4M,\)VF\*VLV"=IF@[1.T\P1MLZ!MT))Z4@5:
MF""7I7*9)Y7DPA%]NQXTSY,+T`Y:9A!%:P:>FH?\$3Y!34/^&"+UD/,9OL%.
ME>!4$Z0J,!_"S(YC!GA6ZB=0)D4!\@5XR-6(GQ[R%_`)\E0*'9+F;#"3`^"7
M1I''P$E\B+\'A^3V=Z!,QM\>QP\/>5;@L(<DU*`A#X)'6@07",N+;!SR%R-Y
MQ5#9=7Q#-EF.:TK=2\`KL[6@B4@X-C[,,^1\A'^6N,!)I28<\6_F+^!XWQ#_
M>3BA)D/\W[P)>FB(?\>?(-AZ&VD/#/$C9=@2,_D_EHWP_U:VA_^U/T'),?Z7
M_I?XEWP)%AF/E\F,3_OE29YT8B?R/U(VE[_/_PA_3VKN`:_,=`L*\Y!HY&_&
M(VWPC/!K<)J%GNOXN:FI>CSR#F:=E5L=N!]$T\)RYU2_-+&1GU2VF)_H/\0W
ME;W$UWOF\C4\]A_CJ[TC?*5'7JO8(P\O<.+A<"?YGD-\H.P0/ZOR6?("J,@`
MYI!8K-JF6JM:JEJD:E.)JBI5A:I(Y5:Y5":U0<VI=>HL=89:K5:J6355@]J4
M2+XEAJ1_6)J4G(24K%2R<IVC4BG]IPOO&$K4%*9`W,BTT;:.QGAEJ"VA2LZ,
M5X7:XIKIUW8-$G)'-VF+GUH`;?.%^*<=G@3)F#$[KO`TDKBA#=HZ&VW('*>[
M$P0ZNQ(D*8W8Z8@;FKKP$B/BSF\X)-R]\QO=W6#9&+/%#/79U1.;OZ;H'2]#
ME\$6NA)L>?%[VSJZX@?SNN/E4B69U]T6G]0AS.DZ0;?2&UJ:3]`;)=3==8),
MI%M;9DK]9&)S]R4V-*@;D0V-^L84VS9P2FQHW=MDMKDI-AY'(YM/0A+;`>!E
M-IX<D-C0S"2^P4-\2_,@S\L\[!HX)/,<8M>D>'PRS]DO\2@X."OSG%5P\G)6
MF<7K198RK\0RZ/8BPZ#7+9-G7"9[4N2M*?)6F;SJ,CF<(A],D0\B.?3_"/H;
M_R..EJ4=C:1M>M>@&AJ[F^:DL(5;4R_;0?;1"=L=)TDN\QIDAKKC&9[&>*:G
M$6(Q6XBK(R4]RJRX$OM4F"7V6I?M)L=)%E#D$GL6=FO'244-10T2"<U9(NFP
M6S].LMU4Z\)%#HR3..S.QD70CHL[T"Z7M\0+>A%YFKO!UK*T&?_&T3J$#1LV
MK%NW?H,$.,#?T1:?,&-VUZ#?WQ*W]S9WAUIL2YO7_X/S0UN\``?%I$$J54M<
MQ$'KUH7D<:'0AE0%YY:J7X7UJ3Z9%4+K+O43:=YUTBPA@B)-)-\8=N;*M^[1
M4-CF#X5/)#]D=@P:PA)S-UDG[0_'XVRI.=;)\Z[#,`#_!R:^N\D*96YD<W1R
M96%M"F5N9&]B:@HY(#`@;V)J"CP\"B]&;VYT1&5S8W)I<'1O<B`Q,"`P(%(*
M+TYA;64O1C`*+T)A<V5&;VYT+UE(4U=&0BM4:6UE<TYE=U)O;6%N4%,M0F]L
M9$U4"B]4>7!E+T9O;G0*+U=I9'1H<ULR-3`@,"`P(#`@,"`P(#`@,"`P(#`@
M,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#<R,B`P(#<R,B`P(#8V-R`V,3$@,"`P(#,X.2`P(#`@,"`P(#<R,B`W-S@@
M,"`P(#<R,B`P(#8V-UT*+T5N8V]D:6YG+TUA8U)O;6%N16YC;V1I;F<*+U-U
M8G1Y<&4O5')U951Y<&4*+TQA<W1#:&%R(#@T"B]&:7)S=$-H87(@,S(*/CX*
M96YD;V)J"C$P(#`@;V)J"CP\"B]$97-C96YT("TR,38*+T9O;G1&:6QE,B`Q
M,2`P(%(*+U1Y<&4O1F]N=$1E<V-R:7!T;W(*+T-A<$AE:6=H="`X.3$*+TET
M86QI8T%N9VQE(#`*+U-T96U((#`*+T9O;G1.86UE+UE(4U=&0BM4:6UE<TYE
M=U)O;6%N4%,M0F]L9$U4"B]3=&5M5B`P"B]82&5I9VAT(#`*+T9L86=S(#(V
M,C$W.`HO1F]N=$)";WA;+34U."`M,S`W(#(P,#`@,3`R-ET*+T%S8V5N="`X
M.3$*/CX*96YD;V)J"C$Q(#`@;V)J"CP\"B]&:6QT97(O1FQA=&5$96-O9&4*
M+TQE;F=T:"`Y-38P"B],96YG=&@Q(#,V,C<R"CX^"G-T<F5A;0I81^UY>WQ4
MU;7PVGN?>68>9R;)S"238<[,R4S"3%Y,""$A)).G2`PD@)(@D81'Y$T"B((/
M`O5%T$M:+8I:P6=M[97)&=0!?.1:JK9JH;46?%Q`I59;$6XOVELA,W>=,P&A
M]?OZ???^T?O]OEE[UF/OM?;>:^^U7R<!`@!&Z`<&K=-G%H>Z?S*[&TL^0)RV
M8$5W[[:.25L!2`&B=<&ZM4+OG_[M*@`:!M#Z>WJO7;%8Z#X+H%\,H/K3M<O7
M]RQ89XL`\',!3`<6+^I>>/2:GZ&M6\#V)BS&@G3..(CY=LSG+EZQ]H85>^DI
MS-\$(-ZZ?-6"[N\_N6,`H![5V9$5W3?TVIK3?P30B6V"L+)[Q:*VIZ>B?YV'
MT)]H[ZHU:S?NNDD"F'<KVG_:NWI1[[*5D[#O#<L!TFL!.*`O@`JT'$IR[CR'
M'HJ<7`#X*ZA!@#`(,$L+:/FFQD/V*0H"25L#BNJ_KO6WP/Z>02[X(7\L0(&<
M&1<"*(/ROU?G?Q2H_@G<JBL4S&'W@A,@\2'B"<1/XU,3YU3+0(PO31QGZ3AC
MN4D<!1_<BN/_%+;#R]`);U`&C:0(VH$C#L@"2BJ@F?!@!Q710SZ(T`RMD`E3
MX7?$"+MA'/R!-,$FXH/I\!!X81K8H!:^"[O(98G/8!.\39;`TUC[*1*&/+B"
M3$D<@S9H33R/?0!,@OO@`6("-VKT1$P<Q1;6P!VP#WX+"9@#]ZMV82NM,`-6
M)IZ'N?`K,H=<G<B!RV$EW`+WPR/P(IP@=Y)A3I7HPJ#-A]5$0]))/MN<>`HF
MJH[HGDT<2!P"'NT?P58_IT&N*?$%KJE/.9)8C`LC'4HQK81'X3GX@#A(&:L'
M$XS'OCKA)MC-\M''*;`%Q[:/W$AV,U/B<1Q-.2R`C7"<W$"&J4=U1'4ZL0&L
M.+[QZ.D`/`[_`C^%/V)K36066Q&O24S#]:J%(#1B3[?"[?`,SMPKF`X0,_&0
MR['E?R%'R8=L)?L$6_XAG(2OX#](/EE";J$U=+,J-+(I\2RNT3+TO!%'/QN6
MPT^(GX3)U5CW(7H]O85N9,^Q#[A\[E1B8N*GH(9BM-T,/\9Q_1+>AL,8KR;2
M0GY+;V%1U>V)&]'?8EB,H[@5GH"]\"51$1TQD`PBD%)2CB.[D0R3#ZF+BK2=
MS6>[57<EUB?N!@^NE4Y8A#67PG?@-G@>#L)'\$<X2;*Q9C'6K"&MY&ZRC1R@
M!]EL-I=MY\+<=NYI[A7NG,JB>B7^J_AQG'6YG1)HP=0)/;`!YSJ&Z:?P'F'$
M2<9@2Y/)5&QI'NDA-Y%!\GWR&'F2/$=>(X?(9^04^0MUT+OHO70__1D]2`\Q
M%PNP!K:3O<EYN/>XLYKN$5?\Y?BI1%HBF"A-#"8>2KR?.*E$(0=7?`T>;7-@
M&9ZWM\(@?!]^@'.^!]Z"=W#='5/2"3B-,3A+U+B:LM`C+Q%)'BG`T<TF[>1Z
M,D#N(8^35\F'Y`0Y1X$:J!=3@$Z@4^E<NIE^3L\Q/1-9+;N!W<=^S;[FUJM"
MF)Y6/:LZK3ZA\6G?//?@R-$XQ)?$M\<?3)3A6E3CRDO'/3<>ZG#-3<4H+X0^
M3*MA'5R/<[0!9_PA7#F[08+]\#J\B7-_$-['6T+V5TZ?823.P`C$"<5XJH@6
M4]+W$HQ,/:Z6+K((8YM,-Y+-9`NY'].#Y&'R",[OK\BOR=OD&/F8?(EC`EI(
M:^EE.*)6>C7MQ#2/+J";Z%:Z!],OZ6_I^_0C^C7CF86Y61YK9->R.]D`B[`]
M[#?L'<[/U7)3N&7<:]RO<.135)>KYJD6J+:J'E$]IGI%]0O5"55"?8_Z475,
M_:E&KYF@:=7,TFS1_$BS7_.!)J'-P_74@MZ/O>B8NX=<S17309*@,1SW2W0M
M>X/>2YZ^Y"0<0`\6PCP:8R_2']PTR#YB/Z&;\;9I4-23\11[$UZ`-U5O<YFJ
M3^$UF@U?X'EX+^NF+]$=U$$FL$G<;=R;>.JL1S\?H\>HANY&BS]B-.;!E20+
M_L1=!:=P_@^J!G!.F^A1\C1]E4[%E7P$'J?[80?L@D6D'+U;",_"U_!=LI<)
MY#E<=QOA$'P.Q[_QEBL>J:,U:@==IZ[$".TE;8G7Z-C$'W'7?TAN@_?9U[CV
MKR+32#$\"1]CU-\AXXF;BW-.^!6>?&/@05RUOX<H[L%?<+FX@[Z$O6P\S.&.
M8\R+1WX>;U"M9=\A7]%:#*==.;FGRZ<QGL'WXUDEGZ,FV(TK`4\194?_$=XB
M7IS%M]7OP0.P#?:Q3/"Q)V@_3;#7.0&^!\?9%=CKS7@^Y9#QV-(*6(+C$!*?
MQ!_'%I;"1)A(YI,YT(":*3`FL0(]?Q+/HG!B;F*'JD,5A%^2*T@FO(RGEP-G
M<;M*%S^)EGMP'[X/4\A6B,87PC#>*P[B(R%<32=5ZU2#JA^K]JA>4KVE'@<W
MX*Y]$*/X$9S!6T,@"W`N_@!_QK5>A[NG`/=/+7HQ!>^PY;2#O0CU)!MZ\0S,
MQW.[#N=@#D9R#;:R&>["_?0$WB&_A-.$)W/A)3B".\>.^WP!]J_%=IKA2HSZ
M&G@23\?OD"B6+(0Q$,!Y^IJ8R$2Z%ON3S]GM>,X.HT\?P"=X<B04OPK()-*`
MT5L`?Y;W,O8P`5K)$-[)ST$%WI0-[$WX'>3B[5J'>_1QK->%:\,$+JA0?4PH
M%,2G)2;2)>Q%8L/;T(2K:A;>[)-)'WIAQG&,0":9#F7QR["UI_$L:U4]@;=O
M$&^&3)K)S59=B7Z_AS?9+V%UHIT\H,$=$*Z[<E:XIGIRU:3*BHGE9>-+0^-*
MBHL*"X*!L?EY?E^NZ/4([C&N'&=VEL-NR\Q(MUIXL\EH2-/KM!JUBF.40$&C
MV-0E1/Q=$<XO3IE2*.?%;BSHOJB@*R)@4=.E-A&A2S$3+K4,HV7/7UF&DY;A
M"Y:$%ZJ@JK!`:!2%R%L-HA`C<]K:4;Z[0>P0(B<5N461!Q79B++'@Q6$1L?B
M!B%"NH3&2-.ZQ0.-70W8W%":OEZL7Z0O+(`A?1J*:2A%[&+O$+%7$T6@]L;*
M(0I:(SH5R18;&B-98H/L083Y&KL71EK;VAL;G!Y/1V%!A-0O$.='0*R+F(.*
M"=0KW434]1&-THVP1!X-;!6&"H8'[HKQ,+\K:%@H+NR>VQYAW1UR'Y8@]ML0
ML6\XX?@FBXU;Z]OON%CK9`.-CB6"G!T8N$.([&IKOUCKD6E'![:!=:FOJ6N@
M";N^"R>Q>::`O=';.MHCY#;L4I!'(H\J.;Y%8J-<TK54B.C$.G'QP-(N#$WV
M0`1FK/=(V=GAO8GCD-TH#,QJ%SV1&J?8T=V0,Y0!`S/61[/"0M:EFL*"(=Z2
MG-@ADWE4,!@O%A9=T"F28BY+S3,NS"R1/1(OQP41$18(Z$F[B&.:*)-%$V%@
MP40T0^@@6"NR$".R)**K[QK@*^5RN7Y$Y>-%8>!+P!4@GOS\TI+NT1*UC_\2
M9%%>)Q>6&NK/RY%@,!((R$M$4X\Q11^KE7Q98<&Z&-TI]O(",IP^:,6Y[>ZH
M+,;I]WCD`&^-A6$^9B+];>W)O`#SG1*$BX,=$=HE:X;/:S*OE#7]YS47JG>)
MN)+W*%\]F1&M_\+/S-O2&Q=71HCM?Z->E-0WSQ2;V^:T"XT#7:-SVSSKDEQ2
M/_&";E2*I->W,R<=E:B3*5I<E',O&,N9=D.$\^%/K2SJA3&-%E>E4D*$I@C?
M-25)._0>S_]AI5CBM%Q+8=]4&W4S4AF\-#_IDOPE[AD&&#K,^6GSK#D#`_I+
M=$UX`@T,-(E"TT#70'<LT3]?%'AQ8"^^9_(&>AN[SD<TEMBWU1EINJL#![&8
M5.)JI5`W))([VX;"Y,Z9<]KW\OAM?.>L=HD26M]5US&4B[KVO0(>NDHIO5`J
MYP0YAU]6N-(EJE54SKUA@'Y%RRD%2GY!C(!2ICU?1F!!C";+>*4,0=[H];/:
M+PZALB\Z"G%)4/S^`55$M5A^=9.2\#U>/LU:T\.OXZ\7[^!O%W]L?)[7;#=&
MC93DBA2\HNC1F])<>KO'X;*GZ8B.:ETZFR7392.Y>O#:UHAF7A#!PWNH1Z2>
M0@N?8;'P(A4]--]DSC"9S'2=B9CT&RS$@]<'9Q,]%A/EB%TT>W/SE0_^$WR8
M-S.[S:;'B\5L([9]9#.(I"@L"OJL$G^OO]^_RW_(?]R/&],O^,/^5BP9]$?\
MFFTK',%I?7SGF:SLEI&3G>"HJ>(QU51E\R.=52-5E@J+U5Y!9-)IK>BLN,-4
M%-3>S!]`[I"%S@-!2T4%_AS`GR3\<))V7IS1\%55FJJJ<27023I)D'@TZLP,
MN\V>Z2F;,*$</X]LR4QIJ'Q"V?@\?UX>8VQ6W%.14^1<&I]\^36-Y'?IY+.F
M0F_U2*]SNF!3TYREOSA$-M]:%ZQP\EJ?+VW!@USEV:<>'NM6^7PV?HPU75?W
M[^3M>"$&MRWQH6HV?J_G$M=>L"7ZHSK]^)Q8DJM'N1%YN`,%0[;..2&])?MV
MV];L;<XM.=IEEF76]9;UUBV6'ZJ?,CYA?\W^AE.OMH&_WE:;TV^[S7Z[\]:<
MY[G]8_3%_L7NZ]7KC.N<MZ?O,VO*319KK@OF4!<A,9(11M'S(XO5I%KJ8J:E
MF3HRK]A"+-F]?N*W^E;N)2'`./#U[6&=6>_64WU+5M:9EL\ZG=&D=+)C&M_Y
M56?+":@Y67,2I_OS,SBU)\^<!/[GXTJ:9ZX?"FGKUX=S;3EJH\%O]VEU&AU5
M._U&F]X'ZAPD:0Z3#W39*A\)!O$7#`2#FS:1SC[H[).S06(1_7[1JY:#8[65
MAB:49ZK5HC>7EHVWYI:&[$J1:G9>P>G[-_YF7,W<`P_UO[-N]9^?>#>^^_DW
M2,<KVW;.S1**-:IE\4#LP/?6W;?WN?@[.WJW7'?]LF=(4^P5,G>X.K>X5/Y;
M$WZ!<%^KKH!Q9%KXI(W+TE&AM*2TMW2P]"G[X8S#]D_L?[;KUNO79MY4M(5]
M+T.U17\_NU]_3^93["F]6LAHS`R7MI:N9RH]T^MI:3C#4',O]Y#N<>X9W9,9
M*@,!39O!\(;6I1$$E\/K#;:-&_=A@2NH;B/D#95+[1%<8[TB48-!8X1,'I]V
MMF!&IHW9-79;U%KD&)<_EA09#(ZQU*%5:\R:Z1I:@V2;9K?FH.:81FW6K-)0
M3:AT=_#E("T.U@2G!^<%5P4W!K<%=P:UP>_PME[;H(W9LL.EI!3,1K>1&JL]
M0E9H\K-RA,]4M>"^&@UF9Y\%]U3?ZN(JJ*FQ5A2?Y#&=K!K=<16=B/@+8J`_
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M+C.X\02O'C/&E568D5F0GTOS2;[!:,S-,+DJY`(?Y/MR:::VL.@%_&CPX`>"
M!O=F$"-4)<>GZ@S&IZ*XZJ22(4I$^9.=\FE9E8PKYC_A/U&,1F/U9>=?\6!P
M7(F\]Y(A4V*&FV\T:)D7!<Q_2;A*\^:LGFX0Q?0?+<NSUU<4CDQ*ALJ&,G?#
M6-.:%56/8J#>GM"_8F3VO]P8[UX\/L]W/DJR'+]QRZU.<W(/TB_DOW#"0+C0
M$R[/J=$++NKU9@LNJ]?K%%S$*Z8)+HM7M%HH)=ILL]/MI,[J-'TL,1QV-(DU
MQ_6D1!_6]^J']=P\)%2?)7ADI=/I&G_<0WH]PQY:X@E[YGGZ/1',J">OPPV`
MJSW(GY&ILA&@!J\:^?C!^0CZ_G;DF:)7(Q])RLS0+RX>,/V9+)O3<")\EPPR
M*9^[%64<J0O/__MPI![2)UFMZ.%_2,8*F86O-U3P.3EF/L?E,ALK75IEW':O
MEU:Z-%[1(KAL5XS>RK@"/7R.G9A=KFH@&7B(N9Q>L)A-A+CL'BTN.:!VF]:L
M(_*-;23SC,1X<ZM(1-Z2GP-.TNHDX%R%\W>S5YD$_DQ?YVH</ZX47"^*)"^O
MY-5KK5`VO[+UY=OV#N[F`X"%CN3-*D_6'7S5S0?NX`\0>=[JV_?B)W`D'$PO
M`S-O+H?50J^G7^CW?!<&S8/"H&</[/$8.8'S!+B\-&]Z(%O-QQ)72^EER)X,
MIUO+.`)\!N'Y0;(K)\)'<K2`O9"^SF`'OBB?Y;49SAHT/1[661TUH#6EUP"^
M(4=SYHP:<RSQ^RC:(']/,MEKE.LD",%@!R'RD:/!,)IHID4D&$5E>4_``.?A
MDBXC<?H#L:2/#%\UR>,]MVQ9HQ!W][:[@G75JBO./4\OVQ"LI'B]B].[SM['
M+3GWZ'4S?#XR9SE[,7>"E_IP'[=B=$_C[6Z$,>3I<.EB?G'Z_?K#UL-91[*/
MY!QV_=ZJTS@T8^S48;!GVW/R^+STO(S\;/V8?KSL[3+)''T"F"]Z"LA<*S\)
M%LIO!-F*R,1Z']E.=ZAW:+<;[C,^29\TO*9Z3?>JZS`Y;#123J-5Z]1Z.[%3
MN\%NM+ET/5D].3>HKC>LRUKGNL_\G.,YUV'G:6W:5293&3!;F49G3<MRKVQ7
MED,+7OQ9X.1QB;2$&6'9Q4*-0`6SU6VE5GP&R.=*G_P<")LO,;"VG$RJ3G8H
M#X/D4Z!-?@I4D3&\S^7/\.M\*G]6MB.;JLU&JP_GR>DCF5J4[&J4+`:3CQAS
M*%*2KK?Y()M#$@Q685("&5"BB2\%Z.O$Y;!'J[96J&*),^$T:P5U6"L,B#26
M^%2R5!ABB<^1J>2<L4*'N2%C!01'H8.<EW!ID5RP\!KJ$?+\%AY4N,DMO/S$
M*)]@+>/QCK"3!O+]^UZ/WQ/_WNL/DP?)Q'W=TS=<N>/:QO;Y"Q]4S3/$5\9_
M'8\?B)_[CP/$2(K(/5>\]%#\@_@33ZX-A4G61UB6ME)^J?OQI?XN[GX1"LD-
MX9HKLU=GWY_)M*)#;,Z^+.<R;W?.`J_&"BI0\RI>S9447^N\WGF]]T[Q3><;
MXJ%B[0[;;[+_XCB;=39;5:PUQ.@[>_!L\!)%4'M%(PKA"CPRQ1QG,GR%HC=#
M%+T;Q:WX@(=`CL?9[SWA/>-EO+?5>\C+#GF)UQ[(\8I^7Y$S1CX*VT4`=6YA
M47JZE0J_]GB\7K5:H\6CE*C".@,$^``-'+7'&`W;#+D^'X"9N`DEA09#JWS*
M%$W>2[+P?N+QWI'O(/D$X4?D^T@^6Y7<2>0C5<J=-2+?7?+ITK>ZLT)^VE=T
MRD=,IPE?]`[E%,:5(^059&1G^K+\^;Z"C$`QR<M&$K05%I.Q#G\Q9#OYJN03
M4GY!RF]Z>5WLA7P\4M,,%4&MH2+'D9Y939)'0"=:**<W[OO0A-&3O<P3LMDR
M,_!H'WW\$Z9<A&7C\983G`V=(U.OJ7<BI^N^.C&XO/$FTA1VCIT0OS+>W%&Q
M=6#Z=Q^A2^.WKJSP^GSBQ)6L5Y8:GK]Q^_QJ=[RLP^9F/KJ4[AAYIO2V90_>
M*[\YI^(Z,.`Z$.`G>\&;&(XZLL=[Y=MJ$F\=+WC#&)QA+U>"`B7_JM&<PV>[
M0W#Q7J].<)F]HOM?L[//C7&Y-=GY(%#>K(5>(K_K`V$OGOIN'=559_$.(CA:
M'8,.YA!X-Q'<K>Z-[D$WY]Y'`N"@ST0]\F;GO\++KXI'Q&"=&;T`1ZK.O^W.
M/^[P.NSK''V4YWW;RT"Y%T6+RI`K3&OPSUMDKZ\L'*E,WHCSMU3/MOM55\2_
MNW&5QWKV#]]<BIRMLFT[607*GS94EL_[[[JM8)ZYZDMMEE;Y^_FC'Y<UR?SU
M5TJGG]TR<A</VC+,ZN#\_Y*1:SSQ1IC-P]DM7Q_CX8)F%+AEZ@J2`\IG<A*5
MTCZ(P#\(5*_)W^L*;U/X53"6^UA^I2:!N>#B_XF`YFX8B[8N=06T7M2&?[3N
M5/AO`+<&IO\]FV\#=C<T_SV;%*0@!2E(00I2D((4I."_`F1[8M_?L_F?`MPG
M_^_XFH(4I"`%_T@@D-BG1>0A=6ZF(`4I2$$*4I""%*0@!2E(00I2D((4I$"!
MW\)OR4ZRDVYCW4KZ[?G$_4SUCIS4[ZK?U<Q/I51*I51*I51*I51*I51*I51*
MI51*I51*I51*I51*I51*I51*I53Z)@$!,,Z&<J#*_YPH\%`,5P%HMZ;7COX?
M2@L]LA4"`Q?2I,RA[!J5U2A5HA8X'994PNQ1F8()OCLJ,RS?.2IS*+\[*JNA
MDJ1W3)DYNZDN.&O)BD5KIBVZ?L:J%=TK6V<6UJU:OK!EUG]="1TP!6:B.TU0
M!T&8!4M@!2R"-3`-Z?4P`U9AOAM60BM:%:+-*E@."Z$%+6>@Q;5P'>:[8?5_
MHYU_1,W16$+"`S^%;P&,MP*$?IOV_P8(QI!PB"JB5O*:"QHMT2E<CYCVOZJ?
M@A2D(`4I2$$*4I""%*0@!2E(00I2D((4I"`%*4A!"E*0@O\?0;6FMWO!(E)+
MZDDC:2*7DVED.IE!9@W-$F*<(6HPA60NI=M#,2XMFB^XS;4\9X5^1`IFI#6(
M\Q"90@F$.:MT0VDXAFQUDJU,LJ5)-JLT_`(:3H72Q#!GC=H=(;DXJC>$^F6N
MU<EYBS2G-%RKXRQPE6)G@9E)+K66*NH6N14+7)8LC38T)FO5)8NK1XTK2]VU
MN9@7$,.(O8B[$4\CJM%["Q0C#B(F$#DE)]MM1-R&N`OQN&RKM*8M-=<Z.1XU
MO#)V'MR(Q8@,NI3_SD84:N:T."M:F(ZXD],`Q^DE6.[>BXVP:*/B*8L&BQ0N
MY8\-*0HI.R?T(L?H#L@#-Q80R>94-"#5U8T*$R8FA6B@,'2L5L\!G$*D''`$
M\I.UHOE%H=,O8YZP.)@)D4O9N2B?@;VQD:@Y/12NY=E?H!610H0-P3`BA57L
M2]B(2-%\MU0X3NZ([8[J32$>[4^!@-B/R&`74J+DPXBR_:EHNDUN_O>2V:+4
M.R:5C$\*4=X1:JW-8!^@/S]GOP81W.PCY&.0OX;<A?Q5]CH8%3\?CYKY4#_V
M]QB:/\;6PUA4/\$V0`CY4^P6<"IF[TJF9#_O2OF!4*V>_9#=I)BL87TP'OER
MMDP*N87]['%Y/;+/H[HTV;_/)3XS]"+[C"V##+0Z@59VM_E%MA**$>61Q*(Z
M8VBPUL!B.,P83HL;?22P4Z%A]FL)&\+^?L3ZP8:Z@VP39"+_,=LL9;J'][,_
M*V9?R:U@?X_BBI%9U&@*#=?JV*/R"F%_PAG_D]+;F:A_8@AJ_>PN*$&D.*D?
MH_0Q2CS[`J4O,$Q?8&B^P-!\@5Y\@8L6V$G4G$2;8G84>MG[,(BX$V4.FUPO
MX0SN583<_-!>=C.["6>"WX]S1[#TEJC.)'MVDV1-5\QNDC=XS8OL,$Q'I.C\
M$7E'KMK/_DD9RF#4X90K_$;2&7#J;DS&`BMND&/P(NMGFY69V*3,0.0ES.+Z
M9]]1*B>B!DMH(T9_%F97(=V&>`CQ%"*'9K-P#+-@'B)#\]:HR1PR[V=SE,J7
M2Z92]XML"@Y]BC);4Z1,K^+S9:,"9Y:<8T(OR0(4$H`09^+44K&[;3]KQO4S
MG4V3%KK1]S8)VY4K3HM.K`R5[&?3E+F8)KG%9+&4GJ4(39(NN:[JHWJ+[$F#
M8AB4M":E.#BZ)5D@FF$/N7&=5BJC+44*K!S#5XZA*<=]4JH$(Q3EK;CZ%[*0
M,J(0="'N0HP@<ACC$)J',,8A.*Z4F-D$'.X$2"`RC.T$.(V(1PT;!S6(VQ!?
M1CR.J%)*NQ`IEI=@#UU(!Q$IMEB,>1YI&+$+L1]Q%^(PXFE$#1QDA=A/(5J7
M(.U'C"`>0^0P5@7H1P'JK$R`$2V`&S;2'>%*LA$VDHUT(]O(;51MY#=:M.$R
M7T$HO%0F13+)1U+>I>O5]>M8B2ZL:]4Q7B?H:"PQ+&DJ2Y&%K>K*TO=:_M#R
M=0NSE@^J!S7T8*V!6.`8XBE$!@<)CSD><WSX#G:P^ECUJ6IVL.58RZD6=O#H
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MHH0HHK>'%;O#:'=8L3N,=K+T;65=2'L5*8RT59%$I"6R1`]+8KFYUDX?Q!;G
M(=V)>`R103'2&L152LXM6]`'D8;I`]&\`KSPZ0.2'\](9-XD&Y-D.0J+9F6'
MYM6:Z0/8Y`/8Y`/8B)QS(];(N<0PW2$UR+8[I,E)5EEZK+8<;U'9E1VP&Y'"
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M3O9`-?%AL82O/MGL)U(`G2-/28%\9#^4`KG(GDRRQZ2`&]DC4D\1LH>EGGN0
M_4#J.8'L`2E_N=S>#LA7VKD?_`I?([4X4=TGM<@M]$HMQ<A622UER)9)U6\A
M6R)5GY"K7DN&"*YLT@,!Q=-NJ2>`ZGFC`^F$?$4]%\J4EB^36N0I:9(;J362
MQM&!-.`S7E;7D2&EE;`4*$&S:BG@1S8Y.7-54D\0V40I'^>8E$OY#^/,31CM
M8*P<GQ=(+KHA-R1*@:?1R"WUC$4V1NII1.:4:Z)3Z:.]6J%:<<HB!60K7@H(
M[I=(&O0H+>K!3QYXSCV"[9ZMCI&K)/?7X9B62.X_YR-[SOUYRWSW'UMB^.)U
M_P&W\-//N8^AZ=%J%,-I[@\")]SO]WC=OPB@1=CI_GF@R/U3_WIW+'^_.]HR
MQCV$CD5ZYKMW]R@M/./':I+[J?P8)5A[5\\5[OL#0?=]_ICLP_?0^`ZY#VSH
MML!Z]V;_)O=UN!36MFQQKPFXW+WYU[B7YLL=V=U+`C/<BW$@UV*=13W7NKL#
M][B[RA2/KPF\Y9Y9IHRAN4<9T>75BF)*SPQW$WJ`BAI9@1Y,PG49PJI%9?OE
M.<*72GWT+?>5Y2]0O(5)/^+J<)'F1<TMFOF:69HZO&_R-#Z-1S-&DZ&U:GFM
M26O0ZK5:K5K+::D6M$`S8HGCX2#@Z96AYF6FYF3**3)/98I$?I-0HJ7XH15)
M9\VT>69=I#S8'-,D9D0F!ILCVM:KVX<(^:<.TAP97@#-\X7(5S/%&-&WS8FH
MQ#H2L39#\ZPZ!QI'Z)TQ`K/:8R0AU[C-&;'6M^\%0@INN]LI\Z;;[N[H`-NZ
M&D>-M=I2T=3P+:1KE#8V!+\!1_!B<`1=D>W-,]LC/W9U1$*RD'!U-$?&SA3F
MMN^ER^G2QH:]=)G,.MKWDL5T>>,,N9PL;NA`LTF*&53396@&+3)#,SH7JF4S
M+)][D1D9PN*&H>KJI-%T,B0;X::9KAC-21K57VS$MI)ZQ:B>;56,'DYV&$`_
ML,.PS-!,M1P"2H<!U7+%S"&;#?G]V%*/7S89"OG18,@?4M1MWZCSD^I_3JK_
M65;'"/E&7^9/>IL/?J4'/\U'F^`_$!;5_3V+;P$2G;QN97OC(K&Q2VQ<A-@5
MV;INL2/2/U\0AE:NDQ5"A/F[YB]8+//N19%UXJ*&R$JQ01B:W/XMZG99/5EL
M&(+VQEGM0^WA10W2Y/#D1K&[H2,Z;=/$ODOZVG*AKXF;OJ6Q37)C$^6^IO5]
MB[I/5D^3^^J3^^J3^YH6GJ;TU3RCCC2WM@]IH:ZC?FZ21VF:'G=+E]/346?C
M>ZN5K3/)X[C%N8\#\A2D!3LB!K$N8D24586UA;6R"K>TK#)AL7E4Y;AEDL>Y
MCSPUJN*QV"+6P5I'XY(&_*U!6+OV.@2<XS5KDG/M2"K6!AL5/1JL16FM`FB)
MLHQKE-)1_5JX[AL(!I.VL"98WS[4TM+H6-+@Q$=\5'YW!SO60#"8[#`8!.P3
M1ZT\]&W*0S]-;2M]I^5W+5^VL&'EA7\(\;CRPA_&U_TAQ./XPA_#AJL/51^O
M9L,MAUJ.H^W10T>/'V7#A8<*CQ>R\E$/Y*XZ"'KX3;HNN.8ZN3A(E-$JXY8=
M0:=1D$=]?AK6*(JURL0@),N5JD%L*'BA>O`;84U2>9U2)5FZ)G@!4"$WO_:Z
MX-_":"D>P?\)`;637`IE;F1S=')E86T*96YD;V)J"C$R(#`@;V)J"CP\"B]&
M;VYT1&5S8W)I<'1O<B`Q,R`P(%(*+TYA;64O1C$*+T)A<V5&;VYT+U)&6$1/
M1RM4:6UE<TYE=U)O;6%N4%--5`HO5'EP92]&;VYT"B]7:61T:'-;,C4P(#`@
M,"`P(#`@,"`P(#$X,"`S,S,@,S,S(#`@,"`R-3`@,S,S(#(U,"`R-S@@-3`P
M(#4P,"`U,#`@-3`P(#4P,"`U,#`@,"`P(#`@,"`R-S@@,C<X(#`@,"`P(#`@
M,"`W,C(@-C8W(#`@-S(R(#8Q,2`U-38@,"`P(#,S,R`P(#`@,"`X.#D@-S(R
M(#`@,"`W,C(@-C8W(#`@-C$Q(#`@,"`P(#<R,B`P(#`@,"`P(#`@,"`P(#`@
M-#0T(#4P,"`T-#0@-3`P(#0T-"`S,S,@-3`P(#4P,"`R-S@@,"`U,#`@,C<X
M(#<W."`U,#`@-3`P(#4P,"`U,#`@,S,S(#,X.2`R-S@@-3`P(#4P,"`W,C(@
M-3`P(#4P,"`T-#1="B]%;F-O9&EN9R]-86-2;VUA;D5N8V]D:6YG"B]3=6)T
M>7!E+U1R=654>7!E"B],87-T0VAA<B`Q,C(*+T9I<G-T0VAA<B`S,@H^/@IE
M;F1O8FH*,3,@,"!O8FH*/#P*+T1E<V-E;G0@+3(Q-@HO1F]N=$9I;&4R(#$T
M(#`@4@HO5'EP92]&;VYT1&5S8W)I<'1O<@HO0V%P2&5I9VAT(#8Y-`HO271A
M;&EC06YG;&4@,`HO4W1E;4@@,`HO1F]N=$YA;64O4D981$]'*U1I;65S3F5W
M4F]M86Y04TU4"B]3=&5M5B`P"B]82&5I9VAT(#0T-PHO1FQA9W,@,S0*+T9O
M;G1"0F]X6RTU-C@@+3,P-R`R,#`P(#$P,#=="B]!<V-E;G0@.#DQ"CX^"F5N
M9&]B:@HQ-"`P(&]B:@H\/`HO1FEL=&5R+T9L871E1&5C;V1E"B],96YG=&@@
M,C@T,S,*+TQE;F=T:#$@-C$W.#`*/CX*<W1R96%M"EA'Q+EY?!S%M3]:5=W3
M/?OTS&CVK7LVC32:1=*,I)&%IV59WA>!+5NR42PO8+-:$N"`@6NQ&@N"%1)V
M8CLA[/PNLK&-;)(@N(9`B"].0@@D(3B)(691XN0:0@(:_4[52`:2=]_G_?>F
MIVOKZNJJ.MOWG$(8(61"@XA#'4N79>IZ3ZS<#BV_A7O)^DO6]OVQ_B<;$<(U
M<-O6;[E<+F5_=PHAHB(D_OK\OHV7_-?#`1A![T=(J-UX\57GGWKUTR1"4@="
M6X1-YZW=\+OY_^=MA&[N@O$:-D&#[2^F8:C#C:*;+KG\RD^W&FZ`^GZ$(C=>
MO'G]VN-/EE8@]'@30MZ12]9>V6=_SW(,H2,GH;]\Z=I+SIOU\649A%[4PGRN
MZ=M\V>6Q_XFU(?32C0CY;ND;.*^O\-[+)H3^8$3(THX0C_!II$%:'DJT-IVC
M\PGD^,P/_<NO"#^D(AEMU2+H^5-1P8?9`XS*?6%\+/SK6__^X\J9WD#G(UEM
M]@J'T^6F38$@>Q*-H<I$%4*PORA;BU`NCQJA.&-Z@-GM<^;.F[]@X2*T9&G'
MV><L6]ZY8F57]ZK5Y_;\V[?^__EI;H=[$0K![>>^C7P(3?X>[A-PGRPMF/Q<
M<Q&*E"Z</,[9H?/_F;H1BJ&[T&X41:=P+7H!C:$%Z&'4BCK0M]%<]!IZ"IG1
M5?A5(%0$S4:/HA@.`1GF(!?6H'O16^A<-(#>1<=1`BU$O\,V&*<=]2$G*DR^
M#^E"=,OD(>BE1VWH/]%A?#%>AC)0GD=J<!*^O'-R#+E08O+HY)M0^PYZ%T<G
M]Z)Y4'H/65$EVH:^B6SH0O23R<]AIE&T#CV"K\'O(P7UHEOY'#\T>1$0Z`#Z
M)5X(I<7H*LV;N@/H8GCK0>S"8Y/O3/X)_8C'Z#P8Z7IT"\QX'QHC::Y-LP<X
M*H[.0DO06GAZ-7H+VW$MITY63LZ:O!=:'T%_(TGR$B?"/))H/EJ#OH&^"[OQ
M!CJ!/L8&G,??P4_`]3/\9\V;,+>%Z`JT%63W.[![CZ`GT2%<BVN)B[A@MURH
M"G7"LYWH(?C^T^@87HB[\1A^GGM(DRT5)RLF'9-_FIQ$U:@+9K@;/0_?.(VS
MT`>^P(6YR_D@?[FF;N(Z6.$&]``ZAGX&\_@=[/O'Z%-<#=?OR7^0;9,K)Q^=
M?!?FHD4AU(3.1JO09K0%?1U]#ZCZ`CJ"_HH_(SKH^1K_HF:KYM3D';"W<30+
MYKX4>B^#L6\%*NU#HW"]`:NT8AE6T827X'/P1KP3WX5'\5OX+2(0A?23#[@1
M[E7NMWR#1C/9#",Y41"^&T$KT2:@P'_`;M\!ZWT4O8A>P0X<QRE8T1OP_B=D
M!ID-UX/D-?([[B9N)_^YYN;2\=*'I<\FAY`(7#87]N$*]#CLPE^P$^90A2_$
ME^$_PLR'R7[.S$E<A,MSK=QRKIN[A?LV]S+WW_P`_P3_:\U\S5K-$^+:TJ6E
MGTTNG`1-!#I"@'E5@E3G0)S7H?.!FRZ"^?7!-8"N0=>A(70[\,L=:`]Z`M;]
M''H%_1*]C3X""B"LP)PO@*]?`EQW$[X=KGOQD_AY_")^!?\>?T(O$H8K01I(
MD;21.60CN0FN;Y-CY`URDO-SZ[EMW"!<N[B#W%N@\WA^4E,'USS-K9I'A%?%
MA#A/7*?]Z>?C$]43W1._*Z&2M[2Z=%?I^=*?)E=,7@7SCZ$42L-,M\,L[P4>
M?`BNQX$3#Z*7T$_1K]A<_X8)U@#'NW$$N*$&J%;$<_%\N!;CL^'JA&LE7@77
M6KP.;X)K&Q[$U^,;\(WX&_A.=MT#:WL(/X8/PO4,/@S7+_$[^#W\`?X;`28F
M''!SC%22#"G`2MO(7+*4G`/71K(9KCXR0+8`A1XA3Y-#Y`W.SL6X%+>6Z^?N
MY?Z3>X%[G?L'3_@:/L.W\"OXC?P-_&O\S_@W^<\T(4V[9I-FE^8%P2?DA$[A
M0N$>X2GAI/"Y*(@=XCKQ&O%U<5(;`VWU8UCW@:^HO(SP&KY,4\%?2=X!N7!S
M?9KMN!-V3"#+N8NYV[F?:\['IS@9_QH/<1=P%TT^R,TAGW*;\0KR'`YS(4TS
M=SZZ#4WB)\COR6GR)]Z!EY/W<8+_)GZ&;.;:"+,KFE_P#OX&#=@]\BO43*[%
M8^1%[@;NALD?HF;-+OR.9A?Y&9+YX\2.W@&IWD[NAI?^FUQ`;D5=?$[S&;H`
M]OTQS96PWS/)+;B:>YW?A=[E(N1_\"E\%VB-HW@!'R5?(P7\!&C<"1Q$X[@?
M]>$[D8J?Q6_C43"/CW*/X$7$"-0:(2;<"*;O**?@USD]ZJ9SQ''BP!WD%.GD
M?B`<X_)@1X^AGZ.MF,-9X)WI7PE="A+P;5().JT=M,DO<!URH[M!WY\N_8!J
M;,V;FEN!S[[+U:!S4!;UD%=1,\C&NW!UH9M1'3H,/'@+RI)[T#63@W@#Z/W%
MH#\)&L47H@PV@+9TP=RV@;UPDC#HPC7PU4]!__\$M/Y"_&?T=2R#9(VA!$^?
MW,:W@V;J!?U[*UP;4`_4'D!W"`<TOT!+L0OP@5S:!5S^6_0UL#E_A.][40O,
M;Q7Z+E\#LY9!,_?#&P^4Y@%&4&&&KV*"KH4YSP0Y[^#G@>:]:_)"6.$%8*,6
M@4U\!5TP>3=J`]J=,WG#Y*UHS>1W)\]%&]&RR4=!_VZ9W(<:T'9--UFA2?(Y
MT+&OX"-@CWZ#;P6]/0_]&O11#+O1!W#])\Q_IN99-,3_"G1G<?*VR5\B!^Q'
M&'9H'5C1$^@2]&?8MWG<&*HO+2%[)^=P?6"AWD%G3SXR&<)ZM&GR8M"\/T`/
MB1K0/8,HJ'D(>/=6_GR2A?E6(2?.0.NYFMT(J;,ZEZO%F6>US&@N-#4VY'/U
M=;793#I5DZRN2E3&8]%(6)%#P8#?Y_6X7<X*N\TJ6<PFHT&OTXJ"AN<(1C7M
MD3F]\DB\=X2/1^;-2]%Z9"TTK/U20^^(#$USOMIG1.YEW>2O]E2AY_G_TE,M
M]U3/],22W():4C5R>T0>.3H[(H_B56=W0?D;LR/=\L@X*R]FY6%6-D%94>`%
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M76169-/0A;U`&._0"#KG*F6?UZL>FCR.O.WRT/*NB#)2]$6ZU\[V[ZU`0^=<
M];1'E3U??9*JV2M9R]NZUVR9*AA-7RZ<=^89*['NM+3PG#/[BNF,(O.!'4;D
M]3+,I"L":VJBR7E-:&A]$W2#7S>&MT8V`#TN&-&U]0Y)S=`NT?='-#$I(@]]
MC(#^D?&/OMJR=JI%B$D?(UJD7'*&T>#Y='DDF1RIKJ8,(K8!16&.,UD]GZK9
M,DI&(GV2#!EL'^J`O5W;W9R!S5<42MY;1U6T#BHC@V=WE>LR6N?;A]1,LGN$
M]-(G8]-/')WTR>#TDS.O]T:`C_<S/\4QHHV?^5LDI[U]4_,(=OZ_/#ZO_'SA
MLLC"LU=UR>U#O5-[NW#Y5VKEYTUGGDV5</D!;/@('X.=FA\!UCMG51=M@+\F
M-B?2?D'O/!`UF..(O:V+\Y'N<HGX.#84\.^Y9T:FE2XC'8N/"8S_-XR*6F!@
MUH+E.2-2[[QRVJU7E/^/+XU.GJ)OL>R+UZ;6--*<_&I]QE?J7YF><8B#"?-Q
MLG#YJJ$A_5>>S0%E-30T)R+/&>H=6CLZ.;@N(DN1H4-<%]<UU-?>.TW^T<G#
MM_I&YMS6#8O8A)N!M0F:M3>";SE[KXIO6;:JZY`$KN\MR[OV$4S:>F=U[XW"
MLZY#,NAGUDIH*VVD%9E6P.:!5.PC6M;?=TA%:)`]Y5D#JZ\?Q8BU::?;,%H_
M2LIMTG0;@3:^W*:R-OJCFJ)M>=>7>8`)5G>*@0)T-A?!7O#[C.ALU:<W#P8W
M-AC<U?F<L0F24</+AC<-)PV\$:SW\F<$SNQR>75HE,NK>J-1=PDW:%K^?7=2
M^F2\D!E?(K6?-_L]5%P\T5*;Q0/)9-+.Q?.YAOHZIZ-"Y'8UN'*IU`QO`WPP
M<752;9Z1C7VS]!:=P_+2`G(-^*9VU*Q&[K(^8B4W&W=8B?X>G17=`UX7^.2Z
M1\WA#@$+@Q7+OT8_V#,^T=(BM:#B>'&\%E`([L&.>&6<Y"74Z!`$XJAP!0FY
MYN[SAA_`=9]<O6N)XEUP;6ES;-'YW\1#K^,&/'EI]>R/2G>]^,930X_<!W-(
MPQQ6L#D4U&@57ZV=I^'@XU:8A!W`E4X/$Y"%K*`*G##HZ/K^OT\"]]CS3I?3
MYI"0F&]HL.5SE6F2ON>\G0^47OO[U;L7*YZ%UV@V5"\\_X[2UW]9^DD)7QIK
M_Q!?].(O1X8>IC.XM/0$O@>]#+[@,K6RFW2[CC@YG:O7<\S#Z3`2>=ZBM:&#
M-M5HX)LMCI!CT,$Y1G&U:@A9UEB(Q>-^`":U1#K=LWBB9QSF=,)6P%:;JT!G
MAOOM,"6843P2%H5(^`Q=A$LW]NM$T1"S5=0V+VR8M7%GZ8F:\,X.NTE7H6NN
MKYUSV9J->RF-EN%!T@6^*H>*JDPT@X$-#=LT@"$)&N$X1"3<`?IU&._!Q[``
M3F#N`!KDEZ^BNS310_<H,PXIG4K2KCB4940S\1EQW4U'_N;D";P94)T!)54_
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MZQH:&ZS`0&46(@MNNWQ5[P/7W'_++]:]<-TE1]H+_0V7!]/9:*&J>79^7H[L
M.HF7GM.Z^\724Q^5#M[Y[O-_+YW<>^?:@2=QX>3]EV65LY:5'@`:G4*($V#'
MG.ANM4)U][KWN(^[>>16W60+0'5B;K6#=]V*='@/H&:.E;50C@"!/T46?`$@
MX%8H_TTU8XN%Z,#'U6F-A$.'\=^A^WS59C9;5&L^:]EF&;;LL?`6C^LPB>(3
M4YN;;%DLC9^@(@S4M5*!*:"/QS_''R>33*OT]]AC]=8*I]/E4/(S29YN`%W_
M*;Q`L;><6R*]34Z]&//&9O$__NYGVP>:@B06(X':K>2WWZZ6@R'*AS6PQB=@
MC4&\2;U>=!L*+K?_K)Q;A<1#$TO0Z:P26\3YXF.BH,JK^57:U:Y5[HNTEULO
MMSU@^([Y7NN3AB?-KVA><;WL?LOUEONX_`_^'RZ'`P=XC\;G\#@]KH!;U+D,
M;D,@YYGKV>':*8MN#R$NK\?H$4R<AV@$@/R@A>V\:12FH=.I%<;BH`[K1KEZ
MU2AIO#L]>+?G*0_Q'.;J8>.^\30FQN`H_H9J0L(?EMK7V#?;M]EY^R@653NU
M/EXDJ_*@S/7*>V0B>Y[%_P`Y,V%5K5@#KOXVLI,\1UXC[Y"_@,GRA`[CV[_@
MYQ,M98[N60QB)5'!&I_HZ6\I3O3O%:BI>F:G#C^G>TU'4$]_=_($56&,,K9"
M@4CE+ONO]7S#`\^[S2W;)<VU1\P@DKA_H`<H!DR,DIA3\@CE<T`J08PT3)D@
M022B4M?0T,@]L>;SXP`!Y5V7;M@=CWE>N_^AM[,+'O['3+SNXI5SO%A3^BR&
M9^%['KONX2OZ#[WT^O#&C=\[4#K5)-6FJ"8$*5\!]*S#BPXA_>3Q?<:";G1R
M3&TQ%EIU[?HYAH5A_C4=KJIJJE)SO;G7<L=S?]>+*(=;==LB6]./1P]%#Z=?
M2;\3>2?VF_0'X?=CQOG:JE%\V].)A(1&R8FGCV5Q=I3+'>`TDA,[1_'N`P$U
MF<D%1G';TY*I*O$LWH0JD([\435T``W(,*,!4/+I$2,VCN)A:$\-ILAP:D^*
MI*#]P!IQ&ZQ]E+RKZM4<WI,;RY$<Z+V9SZCVY^S$[JFG"N?D&0(QZHSW])^F
MR0GI-+5PR?&!XGC/N`T,/=-!#>E,,*ZW\$)8B2A1):;P@B9FCL?UH%PR?&H=
M#EJ@I!@JUV&]+BUDU^&0*4"UC=125C?)ZNO@QV1L`/4#6&A@.@?HY&3$4J:,
ME`N$CVJ?/-,]\4B$RB&EK+BI>>^-#ZZ<=?C:P;X[2A_N6)]1/%[KE:Y8]?EW
M1[RAY%U+Y*6[YUW7>_\F?L&..R]<NNK;NVH/7CURW:.S*P,U6DU1,.RZ>.G"
MID"B-:C_VHU+-VY[F.IP0&K<(:"N'IG0K]2$TX0MJ-VD6CC5@JN-V"&"PL6<
M3B-@WF@P(=YHX@6C":3*K]I$;84H:K4<+PI&+0J9L.E9_``2D`'O5DT:+.BT
M@J#5\$8C_RR>#_*BQ>>K!IW.PN'=W%,<X4;QWU4W+C+QLN!>T%?'+9Q%4$4L
M>LQ?DJ'^%D:A%A`@*+XG30"!BH6,!!96&I<F!EJL!2L3F.WI)`_VBA8M%@MH
MM`$`2OT#V!&Q1JQ*'M=#AKE#!Q^:>(%<<>E#I2@^?7OI/GS^('?]Y[>1[TZL
MH?IK'?#[59I%2,%!M>W[/+9U!R\(;M-L$[8%;N._$1#S)*]T<IWR2N4B_Q;-
M5?[M9,@[Y'^0>U2W)W(\8D$1S`Y3'$Z7M@(L+T>WRBHK8')Y6?'Z_)SHYC70
MNOMI65;LAT&3N#F["GN*_X#('Q0%\:#-9R(?GGM@4-Q#^1A_#'P<P6JD-T(B
M("#_."B1/0I6Z""J3E:E/1*1/.'#^$[\/MNQ$SV@YJ4>NCN,M4^`TH$RV%/&
MT*#UJ9;9KDTG-;!=B%;*BD8U#>`!,B!?CZ\GU\L":!RJ:$#/@-.B&B[B-]LV
M!/LT?0%-3S>`+%$1><K!@O`EC#7%O,"[E9B[:DEI4S?6W7_3RAO/ONRJK9O3
M$6]E9N'B*_;NNO62'V!>L^CQ@Y6[;AF]Z.!@9>.R.G]24G)[MUW]R^:42"R4
M.T<`*PUS(X"57.!W<)Y1'%,#IHT-PYX]8/)5)!I5F\&B.@!"Y88=>QS$\0,<
M0V[T<\#0#+&>9AIW"J\F\9=`E/W+@$JA,`KNFDSK+)IS(V5DE6Z=L,\JEV;1
M^=P.F'64VPOSB:#UJD^)/6_=V/"2Y4B8&$T^NT/2&0^ZC71>%:/<$C445-V`
M[BRZ$$"Z!I_4;%%"RJ#"*2_[/%$*\("W*7B5&-Z:@%EFI!-,\<.?;OQ7)LS]
M+X@6>Z<F_[5_A;;<7K4\=_6?__QWD$L`MR'-"/A"?A0B[KV$,8`-AX(D&$#^
MH!\%0CCH)Q4_XOZ`7'"+<.NY/Z@N+?$'.8O6[PR@4!\>Q`1CK85H4:8(W-5S
M]-C13(:RE#0^_N>/<*;\DZ[=?N2(!'=MUJ?ZM&:+Q23I@[I0AR(X+';):_7Z
M?'YW0%#`M.R+Y6GV=+8KQ_)DFN7[JLK-<KS<[`V6FUVL>9^#9>K=DCUGLAA@
M\()E@66.-#^X5.FVK)0Z*[J"%UHV2IN"6Z1!?KMYR+)=VF[;$;PE=+_E?NE>
MZ_W!0Y9#T@^]AX*O6GXBO1SX2?`WEC>E#RTGI9/!?U@^E?X1^$>P1F=9Z",A
M`*NP22@0#/IU9KU/Y_2[?$XM$7U:A[7"Y[@R:)%D*>CWAZU2A;7/BFG@T3Q*
M7E&M)`A`/!@*/(10>>-&\0'5J)4LG,/IU&IU6O\H_J>JL\`[Y"&S:ATEV:>7
M!G%PE'RDFF75W&$^9>;,C\@7#3'N]GB!>]Q>*N845U"%".EI$/R)ENWFLG1O
M[S&GW<GM@!J2;B2-8VGLW]/MTK5'6L06^#-Q3T[_\`#(N2(*C@H&"`$1-^)Z
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MD$^GA*60SZE$ZJ.(XVM0/AF*<N&JIIIZ+AU.Y/,Z9U7"Y7*2=()RRG`<QRG;
M-^=9-HMF@T\76W.T^G3;'):K%="^:(T?ZX-9/_%W\LE04TTM?2"UYVTJOX<G
M")+C/,?31KW)FD,\EGD,SN#/U%B-8+>3SAHCN!J0FDR0AH&7+1+IM,BT:ME5
M:/X!_AE2T%KL!HV;7'(Z"3[&./`.8-QD3W];UR%4RZ7>][%LO!O@4`OET(%Q
MQF`#S##1VTH-$X.^KK(Q=Q6H3P+(JS63BR3<02QZ?1X?$81X-$9B]?&$.UZ/
M,V)M/8X$X_5<#M?6<Y6^JGJ<U:3K42P0KD?!.BY?#R`"(%C+M-=W!HD!,,`#
M`P-HH/^,2X@HH':6+5I$R=?7-38P#P@PF$)Q&;3'G-2\-90!F77*U#'8S>W[
MQIRU@^^\.S%8WQES!2H7UY,%WU]_UZYK)JZ.K2G<\:TE+QS>T'%Y_X$?K7AA
MY\PN']D?G'7N3><=ZHPU1`:XB_]#J8FYH\]\_?SO6D2Q>/WBKS_J_&RS[\$K
ME]ZQG-=0RP,>H(:B$B?@$D[M-O@,@9NE.Z5?2IHMTI:*[=(]]GL=K_A>";PN
M:=U66T4@R(D.O-U[2Y`DM$+(AY2P&/*9E(A+\8029K.)>!).)]+Z6Y;:,+))
M-MF6M:DVC6UT\G<'*65M\R.4(V86\X`\Y`CNBU!TPT44%^,)%^,)%^,)%Q@D
MHP0\(;!&P4L;A5WAM>N9A4M2CIA@*:"1@>0GR9Z!Q>-?$+XP36B_-VAQ2+&*
M>-#B7X&]#D@"UM`*[+-[5J`I\E$$#73KZ:__*GEDWN:0`$17`DD02"Q0)U*_
M(NKT4SHD<!:?]?R3SY>N^,VV%2=Q7>F_3ZVZ+-:H7,9=O$VNB0V5?O2+TKL_
M>GV='\_!+NS!LP,4!U:#5MH/.UZ/&]2BFM_H_[K__NQC[B>SSV:/Y[4K/'U"
MG[A-NTTW*`R*.[4[=;IHR!=0PK&0+ZE$M"K=$*UB-H=T/JU(MU*A+:)"2$CP
MB7[)1W`$K&"@'CV43*.41%T7\@M06#5)XJAX*.`[Z?<'M+HGM5KAR2+U9Y`H
MB4M%#L9Z3^U@8VU)/UF3#*4R\.K%WB=EL*OO^#C?LHY\7WY/GLLCB9%*8E21
M&*FD<"S*2!5EC5%&JNBNW/%#>#L#3)1,C%92#^#&TSTG)H!</>,MS&^5/@*[
M`EF)&1@0V):)%@I7I/&/D/1Q$D_E4[&$'FQ5@$2-`+J9(Z/0N$(]BZLTUG-E
M\?J"@/9(G(9:\).X^O+*G!"+F<VV<SI+;TB)IO<NVY2=V9JXXK,/L]FD[/)&
MEV=YAZ7245^7.$]#)DY&TI>7$NO]D42I=56E2\[,O+;T9,PEJ>NY_NN"B5CI
M5Q=U."R4H@I0-`043>'JO8G,*.#[QMB&!AVOTX]DN'N2AY,O)=_B?I%\GW]?
M_QG_F5X'2%?8!C0>U`P*.X'&6E&OJP:?V@A.9UPU:7UB(.1S*6$!B$I;JC0^
MP<PT>##DBRN19$U"KS7R&@*DANUWI5`DCA)2@B0HI6.5E7$"3D)E,O$DJL*H
M*ENE5O55\57#@A`2\5(1/P>.$`4(:61FE#0SHID9)<WA8(!1,L`:`XR2@5WI
M?Q,Z\)D&6@`K]$^<8%$?Z<\]9X@'M)L*-22GJ#<QG0,)^ZGSE,162C(@8II$
M(M8*%P7X]8XO:<=I^L%S_.#?.Y>:8C%<V3[[[R:]7).MG3B<71YWF_0A8`KN
MKZ:(M_V\"X%H'R[<7,HO71`KK=BH>&SN6*Q6WLI=7"Z7WEC3G:#TJ@?%=R70
M*X2>5S<K3*(4E:Y341-YC[+6NJ%!&_(1)>P.^6Q*V!/R826B"_FL2L1FA4W7
MNCV$[IM'2[?(P]-7/6%=GW90>US+36IQ5MNA[=5R:[1CVF-:3LO3;EJVD]K1
MR4_WTW>A4%(#3)C7RGV`WH\K7%;I4'H5;DPYII"UOX7]ABUF6PX&#S:[O.]L
MLY-,&&@:^_<M<U`D[YC:4G+EQ+-3.U63S9+VVF5Q#^Q@,AO[RM[0\N??9F6Z
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MF8JLVY7-N#,X`W-W>3T>%]%IM0AELY4);78U\(XGDPZ#C[U'&5$HK8XK@K)+
MK<-UF-`A3))%ME@IAJEE1`0*`NFHD:*AAHF6%FLA4P(J,EC-@#5<+AHRG7:<
M(7>S@KN,*ZB/"1S0WP^B0QUF7T:J,!9Q.9$*;K>UX)9L!:1U%URCD\<.N`JN
M;$6A',)C-SC5J$?!E"6^*F-Q8!>,O\0Q7WJ,N3D3IWVQCFPID06+5V%>N`Q<
MBX_P"3R860D6,-:1F1C+KHPX)S[FK_A\R[6AZE@L)P]P6U8E`I6QSW[#L^KG
M0V<>#'UV*_#6Y+N3'V@>!]ZJQ,^K"X=LV+838Z(NS>\DV!8@N)*D[$WV*^WW
MD'?()!'MX;`-:*97PD`SGQ+F*%TC%92N$9O-B@D)V\(5-ELX/(J_IUHJG\1Z
MG0X3GU=KTW&,'D;;,JM5EK*2*G'2Z.3Q_58@#A1.[V?V"PH,F$B[JAA^!6!2
MA>4JO*?J>!6ILE?0(1R*D@WCL3`.,]4(6!7>#(].G@)D"Z^&/8FUWYM6CSW]
M0.J),Y@$&J#\'@LME6D]/KY]*CX"*K+`2"S2(QW4,]#6I29T-H^M"A=1P;84
M+;"M0:MLF]&%MJVV^_%C^%E\P/8J_B>V_85@:@F[$>C1?F")0XA,/OITT%8D
M%*0[347`6R</`E.I_@(M[IO*?"P[Z"F`#J/%-U6+K6!SV@I$<L#M*=BA;9^A
M`,,<*V>?'J@H$-5:0&56/`-V*5>A'@Z8*O<5K1/Y5RYCYM>'^[BS*,?@-RDO
M13^_WA=?"HQ%&6G&63,",S2+/A<Y\S2K?+:#G_WY#\\PSE/M-78=8-5YI<V`
M52]"#A1'$VI5.^X2[\2<8,;@4HGGXRWX9CR,[M+^V/(NTO$6%<W"W`HM=S<_
M2HZI&:TS(7$H"+A'1EG4AP81C\[1:DU<,MP2LF?L!-DENVS/VE6[QCX_07G!
M6\S+"17,JK=%,LDF8C&%3,0TOW)#V192N+E8ZD]^0@LGJ)_1@XKC+<5QZ70Y
MMJOJXG+,'S<8]48BN&/12"Q"A)`CG,(!G3>%7!9(XE:H*A7!%*S*9X1,I_68
MG2D<L4'"HKS3@=YJ>K)T'8V:]?=HJ*\<CT8KI\YJ%1E9*Q`&"EC9&5/YB"G.
MW7S^^-U#I9=*?SI_>/G6[7@(@W+&-Y4^+&T]N/FVVR\]\(/+MB\H_-`R\K!1
MUISW]'G-K6NQ[WE`M7>4+BD=_4?I%OZ#ZQ\LC92>V;=CQ_=PR_\\/'C5M,^P
M"20X@7*$J/NB;BH.,887MH>Q[:;XBY$74]S\Z",IX@ZYTN='.1W6Q>*QN:@+
M;R:;HU?CJ\EEH<OD+>$K8T-XNWQ/Z@G\1.R9^`]2DU&'(-^(;XO>6'E?]"'\
M??)P]*G4<ZDWLW])3:9,-N3$7F)+@)]<VYQNSIX?O2"CK]82OQ\[0CZ+$D:Q
MA`^!Z38K$6?(YU<B*JF)1:-A@BO`;$>?)#(1JZL>8K#91:<+T+=#[!6Y8180
M1;XG_;E1_$W54I<(!/S$8C:#EZ>UL3!05SD,U+XTCY2G%+(4U#]1#D@-6&WH
M:SC6P#7DM`Q,:=D^:!F8TH:=#J8Q'*S1P2"`8U=^[2'L0?^"IZ2>`8!4R23U
M;#-ESS9#/=LOXB_CX]*XK=`SD$E.0(/'*XUOIR$8&IBV%;R@2%C,)<E.<FJS
M;NKYI&J#D5`L%<G4X]H@).EP33V*1+-R73U&TYP%/NL`<-4`,RZ'4(P=Q6#0
M;OLJ"B`'QP]6,-4`Q5,'I$)6LH`RP&4=`(8EF5043`.'E?]N7IB#R_Q;D49W
M<-V48PNJ0K.I=%<I7R^;@I(_OB@_\6S]BIB#>E7XSV\>W?G@$]C=.[3Y\[/L
M?MT++^Z^H7D]V4HP+FT9#-7$8DVAR[F+::GXV!77CL9+5]_<923?QH]>OVVW
MG:*7F8#'1QB^^ZO:O`JO(JL"JX(7X8O(18&+@MJ,4E26*O=H[O8]JGG8)Q(<
M"`*S2$I81WDH(KHC*$0DBU89)6.J78>32'69BS8+#->!G@*M,4H2JE>K8]36
M,<+J&+5U89<SE`Q2+C'3-U!0"JX)[@GRP<,D@9R3'ZD&R@M.Q@5.&/UI>4-/
MV3DZW4/)'@0V,^3I`/L,EAPHV.0)J64*;(-IT"'5D(=[^M%[#`I.M%",_8KT
M"D4)8!3L9:\H\B_4H-I9$"-V_KN6N,$>VKC\.=#`F8GGJ3I^<$TBMT",2YI%
MI1>61YL;/SL]K7IYH]E^\;EX)MU5<'4T3\&N%KF:<DQWOY47W;Y1[@_[A>;&
M1`P*JA2W*BC-QSU-)$X\6D$+5J]89$';B6/'QJ3/(<$9&JJ5KK)BDT<7;\97
MHJ\K&EL(&$TU6PH`;0I2JYI46[E6NI,[0Y'<%G2E=6NX+[DU=5_XWLC#^&'I
M,>6Q\&.1AU./99Z-/!M[-GZXZ6#Q9>E%WXORRX6QUE_:?BG_PW"JU6_+2+(M
M+$>3B70F<Y:4M67E&4I#938Y%X$R:95;LZW'6OF74OCRU#69FY([,GQ;LMO8
MK7"ZB"?BG%EL7>AMJQ1L%6D<39^G/*0\E.:GSC/"O+=5K;+&T\2*E#3OB]&M
M\'D%KY9NA2_>%"=4<"=>?/'%J8QN0@\+POO4A6DY@U.*G)'"5BEL*R*<LA4%
M2?0)7AE&J4PE?)6%8K.OH,&\3P.8W.>)A^FHF49?4RHL26&<JL`XE2G:;`RU
MRID*6<ZD%2OB68+#A:8FZ@<"?!4$C793$1>3"&,+ED&[GXM[<1\>P6/X.#X%
M!F&4_%.US):7R1MD3JY#X3UA$AXE_W50;;U+H1%AL'"G>R9Z^D_T?*&,X*(K
MPJX"#0AO-U][A"DC6OA?P\'_6VJ!7S<%0,#E^V!GZ"$0_`#9=!W,X*IP9B;7
MT\TDX`)E0W)SIK>5AWH2#X`&HGC8<G[E!4VDV@VX)R*9*&HYJ=J-A8C;4$C#
M'9GG+,2S3MH^=M!9""><!1ZX;9^S4$&UFX&!9T+1G,%62&EMA;!L*S11N&0I
M5)8S"I4@D\M9LIS-A&ROI7`F_#?]*T,EM@H$R71<N[%\S%+)8>%+@>^&1HP!
M(@%^HJTNN[W<J]Q"19:;C2-77;%JXG"SW^'3B=GW2B=2MH9%I5!];&;?/*R6
M/K[DGO7DLHX9V6-_K;8;+>EY^/>%:,.J<\A?2DOVK]&`UVS0Q>PNEW4N/K?T
M[>9*AUS-Q6(:R=NU&G\;;]^]'FI<VA^;6WH%US8D'`[)8<709'$MN8!:^_F3
MX]P.[BE4A\[BYD^=YLA%YB\75:H#'3XQ'=,:#!0#T-88,M:7=]-&.NN=M`O4
M?[>?*C\HG%8=5&?6L[[U!9'E8BI-I5W6P2OI>A3DJVJR.:.J@T&-:B!`4RL\
M,HY.OJX&:2>CD=_FQF[6ZF8]W%(L*+;4\"@S7AP_`K@;$!DEQ-',!)6ZUY-'
M<08JC#AC8V\GDT>DUX]2)]JG;C;XA^J);5D#MLFAPF#Q4=U!/6=+VJY%U];?
MC&XUW)H7`C9GLU0<+/(Z_R+-(J%=;@\O:E:+.P):O5F447@^7JB?;YB?7]C8
MUCS_K)6&C8:;=#?J;S18ECMO<))0<4V1]&KK4:XE797*/8M]R(B,P(ZZ@C%A
M*!@9VFS.2\8.(U$AZ35R,LNV&'ECBYL"]2I#8:E[C7NSF\NXM[F)^S]"$J8K
MSK:H+026W9<:3)%4'O9ME)NC6GE#>BR%4[TQ5&\R&G,YV/C/@0)"9_VS>".*
M@I6'+YH+*!:*#<:&8[P:.Q4C@S$<DVBGV+.D#8G(`98H5'",XHUJT)<IU(JJ
MN2`#8AH4.4G$IT3<(6*Q;6;;I64\W#\PD%P\?GH\*4TDJ?<#MFO*R97`]47%
MTQ,G>J3Q_N+X``WB6PNT3S*9*:O4?9P1?)KN\7+LJ,``]-S\#']$8V]L:F@B
M@DZKUQ(!?/HP$?*&`B#>@-V/;'9+R.3'X<@,3<&/FK0Y&>=S!IM?\F-S&))F
MH<6/&+ZB8*<,IY/5U314CP<P>-2X?P!1O5.T,8E-H@%0*?MK8:5IJB0DEATT
M%QIE,Y7_DX"-9&JK#*`W9$/!!;>?<KO74-`#*1L3--=#KH=<![GNC.\T_0/'
MJ3LV?;9-54`9$@D.5\69$U@:O'&PR":-=3K*`(LJ!%`=]75D[C>B#6>MN3I8
M]>I'*Y<58W&2B<<R([NW+IGAM^E=%LGH:.D[O[89WUVS=/:*ID4W7F+U7']A
M6^WL*U=$=YP?#M<TI^MRJ17#5:%9R9M*K]PPHT(TM33=-?M;N*?%4]-;F+<&
M)'_RL\D3W"'-[<B)HOCG9<G?&]10"9:H+&LJC,C-'&`W,/![+*QEI&Q&FUB!
MRKF1]C?1_D:CVX5XHK-3I&"M4'70K0*\GIC.H'0#^BZ"W!;?3HXSN\+D].WD
MF/02""T`ABF[&X<A.!@"WJ/OT'>#&DT\AMR@1H1.-Z'<2Z?SZ7Y:A\*?GZ%-
M1F,\9F4*`01_C):.3GWO*/T<121727'\?>&@<$#\(,1KXFVFG@8Y?@6WA;^9
MV\X_S#VA%>>*N%E;46EJM0<K9KM=1L3[G$A2\)F9U(8TPQK2JQD$H,1I/C0Z
M$7)'C4;)U&'J,PV;^$%(1DP<,E%W,@O%,=,QDV@"Z7^F)6_JC;VPL.P4T-`J
M#2*`X$ST#(RSF0X4K:["Q^.?XX^9:"0\,F<0XS(7E+%7[_8CC]M@]&NA%N(5
M&7L,/C\*"#X94>:CC$_YGAYS]%,>[\$#W=T8V`RPN5CF+7;<)%;&ZJU6YQ<P
M7<`S;KKO&S__WJU/=#RTPB*[_=5F;$_57U)8_9WO;,CG$^230W_]V>D[!YN;
MN0,/S/-*D;Z)Q,1OZ^I??F[DAS[P2-$<X*$%8#T4_/$^+8^G[0?Q?N5HA]D`
MP1FSZ,1>I0\<*]B2`Y2?E`!H_/WV"M()A9\<I!8E4,N!B@?UG>PI'AEGC'+T
M".40&SM9NJPZE4,12CV7::6&^.W+^66:9<)RL<O7Y1<W:K9H!M&@LA^@XC'Y
M.'I7HVO$<_$*=Z=_3:37W>O?XA[P#]ENMP];A]T/@P/Z5.1I_#S^L?ACS_O:
M$_X/Y-/8+9`%MI6V6T.WRH.14Q'1*N,?3!Y',MPA4!@H@*@"S@)?]"J#"D&*
MI,@LL-NG#'\I9GA*,2GG!]ZQ8,N/G3&=&*"8HJ)`,[7)5H!%&I2?AHQXJ7&G
MD1@S$LHB%?6B/C2,1M`8.HYTM(&@QR_SWN`E'5Z\VXN]H]BHVDX)&`F2(`M9
M014T0ENX[1#Y9MG;'.A?/-XST#_1WW.BG[%5,ED<'^]GJON$;4K$],L"ZP.7
M!;AO!4`?]W>#;#0U->$F&G@`MD&@LJF"1)*[X`.]=]!>T$@2=1?'0%>"9AS;
M*Q6F3CZ!Q?H![$3"))]#C->@7,D"0E3;591U&[<@]N8-#YS$>/_V_ZRMF1&T
M&B*1F1O..ON[.]8M:<SA<P_\%Q;>>1.;=RZ.9^*.+:'@@G7?_?YG;>FK8/6S
M)T_P&M!0(90B"Z=X*YYA$?TJP<V82EMF,,9L2`XXF<)R&F2JEJR4GV0C9329
M]8;63U7&DK*;OB'[#W-_0`%JJ.F12,C&G!R[JC.33GL%B@'A:FHXACBHYLK`
MC:<0QMN`+\88<P+&F%9?Y]C@+20;.(Z^ZN\+8#70&R"!D`&&,3B9#G/R5&'!
M#"MH+O,6"Z2$/J$0OXKU88L3.@4ADV9:[6BRK-R28T<!?]+)]/0<+=)S;U!P
M(!N'4&9R[.FY<W,9*B*SDNE<;^8:_AK-$#^8>2HSEA'5S&"&H(RSVI'LU'1J
MER?O$L5Y(I8SC?JY^A7Z>_A'JO=DQ+',J221920KAX';#6`%VUODI?+7Y//U
M%\M;Y=UHM_RX>$A\J=H0U]HKC:VVH'VV(U#I;/4'`[-#\)J!KW&P70O5X)J:
M$&<((8-BE"G`L#EZG8/.IYQ<R#GL),X/JSH$&LM,I',T?V9N7FA+MVV;"IHL
M'I\8Z`'7E_[`)P'E.$[5H\3T(Y*^4)/>>)+75L;BVBH9)7E($F),QM6:&J88
MR]$/U--$.9P&UF@@!.PS6.>R(;:!(<Y_H1G+YMBEB>2M:7*&A\F/VP87W'7\
MT_^Z:BEH2&_2A*TIB^+TI0RE4VFA97VFJWWUR,6K-\XYZ[,77\1S%S_V':8H
M/WO[NW/]UDC_*_C-V7V%I9M>_LFO@*,7@;Y<QHV@"A3@KIWBZ(36"?;.:`$6
M1&:639W5.;(JPC2<21"2((&-8KJ2%E0KC7,C9/#%K"(]XR4T[+6?OBTR[0K]
M1/"#WF!O0.$GSU!IX&L-!J88*((&#J)<!;X88VLPQYFC8U\8XX!C$.T!=<3)
M3#MQY4F4OU@^FXY2%I9$61P1.23V`G#<(_+B'?SW^'T\1S\EPM*H),8I.U=4
MA(*P3EJ$U0+;T]5"9G;2)K,Y%/RJ"4\>/4:M>,^1GIYD'9LKS)2RN^JQK7'W
M>'I1;\4;G,8C^P&F^0M.U5\(T5GIVQ;DM"%J(D*,Q1(YUKRL.IWS"1Y=E_UK
MSC6N5>[57A%S.D'4:8T:QWQA![E-V&X<DFX*/$B><!^POT[>LOQ:.DW^A[/;
M>L5>;1^L;H?N>?%ERRD1+)UHNI%P.BHG`LC)@@;='#)7MS2TG"S7K2,#9(=]
MA^=>^_=UW]>/:@_H1O0_)G\BQXVG]17:8R)&XC&1]-.<[AT-3HZ(@G@M7X&R
M3@>=JMU6L*UQ;'/L=KSCX!T.WR]XS-.0?07U;$_NL]/L376>K4#W^%P?IA01
M?ZIU)GP%BQ-O=FYS[G1RSM,5%8/TL')82[+:G=IWM)RD5;6P$NV(]KA6T#YN
M=O!H!^4KKD:U9<VJN</,(;-DELW<*3,VTYGH8"_-;<&V*>0"+L#BB7X*6_I[
M(!L'G"]10S-`62HY8`42`=;>[`"L#>Y!"U@>,#T%%KIJ:J(GPVU=^P6$">GO
M9LX!_3%$?@B)\#5#I&!44P43W%IJ<1(%L9Q1';'/5Z[YRL^F:OIR35^NZ5A-
M->L*#LE3\,C6@DEFAQLX^164WMW=;1=H)+VAT35EP6S4@L44%ET+"[_&&S9L
M7W53*N3XR3T/??C7@_>]-+$=/ZJ1/.L;EMU`9OST\LO77UFQX_<8O_4A%E]]
MO+DKVJ1>!WAH*4+<5LUM*$FT4](=2S%[E5*IV4DQO]J7Q))9P%IS%=;2.K;!
M7G^@VJB`FFU,])F1,@O4/.G`)NFUT5C0A9"ERC**??ML@A9EBN-CTECQZ+@T
M7C9*8Q1.'Y%>HM<1=GH\)<B'D(6]@^!5-5`E1&$D;15F@H@%*H&8X6HVC3=5
M`Y-&U@[U7S-\;3:G:J9-T-LT@<\?/4IQ*Q7'F;?*]SKNC7.SN=G&>9Z;N)N,
MFOMXG$EM4X:%87&W=K=NE[3+.I+220+HJ375:Y+$KS7O#VKO"./]07&4TZJA
M2'!W\+D@"5JC,1=.=H#SFZVNLED%K:B7@,%'\3E/[P2'=Y1\L@]7)T>QI)H2
M5=AFL4IW6"PX2IGUZ=[>',N;F\MYL5C.H[4L5YU^)3=LQI3%UYC[S&/F8V;!
M[*DYS`F<B*;.?!A[+!X'UF6>;0MD[_6<&&"QV):6B8&6X@1XMAEZ:@OVQQ:K
MK'#&8XYXS)GPH\J*J!__2\P=0-*70K4--%2;KP<7D/F`##&5`1-X?HYZ!W[8
M'YNY;.+MJL0LS[Y]70?Z+^AJS@5=]0M"H7A:]7_$+9IX>#!<$XTF9J\CJ^:U
M[/C1%;-33<&\<HG=7KOQC5GS@/W06:4YW&\`D\]`\U$W=[=ZO<W9<7?\W@8.
MI:359$OUEF4$50MIX9Q;9;[8N'3UYL8KXGVK=_([-3>X;G3OS`_-O*%]Y\*;
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M63>UKUDC%8ELOI#F!I?CY71M)I!6*/QDOU3!"K]CL9CEY2-D$*3EL5`"LT-'
MI\N;VYG`2Q-]B;'$L02?,-.>B>GS:BC\6;51A9&X0EZ=7:VNW@-[KEE-7_4;
MC+G5YIUWS<%S6!1G3JWLQ!9GG_,U4/:CDW]3K>S\P4B!@9/-T3E*?JC:[RWB
M8FV6Z^!(!X<1)W&$HUOI">18#J-R]/,4)M/",W2-W`6K5A_&5X)?I]^[@X:(
MJ5B`+A\?F&"%\>3`"2G9_PFK)`>H]D_V2R<`NX%#*XU/&86)]ZB)*$KC`]3K
M[8&,]H?.8"7VOZ:\HQ"P$P.GQP&4)6E+[)T8M`Q,1Y]IH`AN%E6?CAEM7;BR
MN3V:]P=<;JR)Q^IJZVMSM9S0&E\:3\>JXRMBR_W8/R/H1POSBV4T"Q=E=):F
MZ$<=J<5^=$YRN8QGN^?X<6?E2C]>L3+0[(/NOAEH4>T"&2]<D&]029M,SYCX
M%C]>DCG;CY95G2VC=E>;G[G:Y1#3%TGR*^'A:A#\ZUCHB9[BXGYFVE1]6@(>
MS4LV&FLZM=?&_*=N')^*!('=<3$_78A$IGRH<@2975,>?"4+)<'%WL)A&DPN
MN_&5<19P/E.#>G[YJJ-[;NA](6GF!`UG27Z]Z<A#L^?6A)2LO^^_S^K9?.$#
MGSU_TT*#-2^NR24+V+%@P^Q<QZ)U[?6E3S/9Y@T_W/]$?>Z^W^,E5=_JON6(
MJA%T+J]>(\SK&SQ8$2]46&61YS0Z4]\Y_>OO6%G7X';'9NG6AVI#D:^1[5NV
M[EHY:V#K[E6S/K^NOBN6C<[<-B_G=/)@])$)E-/_@#?70'9.V<9`DTH%5]);
M]<P0ZMU16G>S(S0WC?)0F7#3>!SS\-QFRJ3N.+66(=H05W+YRA16>*.1="IL
M#"7EIF.D1B?_N9^V0N$3%K)*3<L8%#Y2+<PHL_%2&+RP5CV86AO<,;@3<%>B
M'!A>2Y[%L?(-J-(:J.%I%"N3H;X@6-V//@*FG/('&6B5CKQ4)QU)EEN.@H-X
MY$N^85?.1D4RSU+X8F4.!J5#6BOUS/SJF<G5,[.LGXITL::IV)>[J1$KK%EA
MS0IK5F`UIYBV@<+?]M,'4/C\&?HLE6IJG++:S&A/E<&'3")813DZ1N4*TRAY
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MF3F$HF`(`I2=;2;&[B:%13(4-^5LQ>[F=&!!F"Z'PG'&^#KJ!;)S[-')_SY(
M>^M,[FF-#X4_[)\2M^/3XO;&`29M,@V'N)8JFY5M8(;#FT&&>P4L,"3+O'8Z
M@!`6[(`&WP"E?K1'>KMG*D)2/HDY"B(!.C-YA/+8M"289"8#"DOI./L7+IPJ
MM+:6"ZJGL5'H5&FH:X]`Z$<1DI6P:*?+^T3UTS=UNFC$Q.3!1"C;FY@\T)65
MY<%-!9_)#[0\4Q:A:.1+,E#V,6'N;Q\M'BT?5DR)@F<XBGNC?='AZ)[HJ:A&
MCG9$B4J3*#68=74YEC<UE_-4MIQ'8BQ7TQYO#@3$OB!LJ@K:0"PJ/:UR4)EM
M]!CMP["4`D)AHVBWZ8=U6%>@-GA?6YYFJJ68YRXR&DT>4]2M)@MNVN9M:,X-
MNW&'&_>Z^]S#[CWN4VZ->U]DWX-,'.BTQZD,@.D=+\-4L+RP-&E*&-B2DO3`
MLK\<%IX*U%$[8C_#UXRM*Z?YNJIZQHSJZI89_^&I;2VUM:5].C'H]2?,N$)S
M.WW04ET]HZ1,R"L*P,C>EDZ\]LX:V6.)]@&'6!'BC<"UC=QS4UH^Z67*V\-2
MF84VK"S%+(46:`\Y:0J:_23C1EI0DV45WU"9#N$IY<XS-A>8ND\S[9UV4G6?
MGM;RZ6DMGZ9R0`>`0DF56).$K2$^KG=Y8PGV(0JXG@5='T=YX'1;`]/U#8TH
M[C$:RZ<<W!\.ZHPF)CO<'_;J!1H[&4].F8")Y-C8V!?'&5-:]B7@>;`"L/%3
M)\64HPY9"J$"L0D2AO^W='?JAPW#QOLM]UGOM]T7VEUX6J\O>`K>-=(:ZYK0
MQ=)FZ^;0_43W87`\1`9UUYE?XEZRO$_>MXQ;_V+3%JU%=S'4)!<+<RP#^BLL
MV@RIEN28',\4FG"3)#JD3GR.M%SF(])*O-+RGO2QI)EOG1=Z0?>"_H]ZC4OG
ME$*!4*B=S+((!JO%;O(:`Y:@.20LXSKY99IN:;EUN5WP6`*!8&@9X:>$-M/@
M9O%*+''ZRCSLT35&;+P:&%@O>"J-1OCTE&UB(1TE34^,:)U"'B:%4/@GD\)T
MNM#TA55B1HE:HZ.@/LX<UX"R4#LE"R96F]TN>4+>H"<-AJ8RK">ZH)[:F<I(
M0V6F-1]LF(TRR&"7I*@<JI`QD4-@V;.85&!,L(SDD!WSE<2BER2WOA$AURC^
M2%WD-O[48-`+P.\>CUMOR!H'C>24$1\S'C>2/N,8C<B[7+O=V.T-%7`!#!.*
M9C(H+:5'TF/I8VE-1QH/IH?3)-W;5!C%5SZM/'PI8.0EI_L'>EH64_2[1!KX
MA!9/]X"].F.D6NBC8HN'+IE"6F`<\#"WF]/NI/E:Z<AV[50!00?WE/Q*XU@:
M*Z?;Z;,CHM@-^S,PT$\#]@.XA_U0/^IG410)Q*8"T&8H`;@9[H`*C)>P%`C5
M,H:"@6;6@J6<Z<H9/9[>:RTP-3'-LMWTM-1*$6<^%Z_,*PY!$$4[0Z147S10
MJ(FI]G"5K6+CE\WBTO<7&+5*'-]^SB6M'WZX+IR->F:6VN*^1.E/GO3B4GI.
MQ&&PF&6OH]J*)<WMG_>_/MMF-%8$B"R3](RW2K^Z6LF8]=$H=MA=]7ACZ5AW
MDQM'HU:#2SF;F[5[KL\:H9KF++"/%M`T#OS-:>OH`N/`K&.%4<#B5'2%Z0S,
M=`8V4I`T=9+Y`<.'QFD#:*1FDAUD@O]V@)UM:GX(RD$+MXCLH"`,]C.GFB(U
M&\FZ,\&7LD4Y0N,O7\)\E79FXRI8J)\>:B(D3L5=RA$7%OVGDRJ;+&-9>;%"
MV609C2[G5V!;D47\J4YY9M@UYCKEXEPLU#$G1W.UN3`CAUW[3!L:.EQ8=76X
M>EU]KF'7'N@H&JN"XH(PK@H*E9'I8TZ8DBCH$8Z:C%/#&)G1R<_(#1MQAQ'W
M&ON,P\8]QE-&C7&?\TM&IPR^BBU?F!EP>%CT@UF9KUJ6:<ZXVI.;6RH6TUYS
MR.U-6+%5<_MGK2N:`LR*<.K]<\O8AUD1(<L]A59ROYBR(JYNYBMTLPB:R\I(
M:^U<E)W6]UE*4$H^VJ):*(VS2=8K6=LX9[K7G.E>M$55:*\YK7-;6;]6QBBM
MC%%:%U70KRV:?F_1M'U9-#T`%/ZI>FC?17HZS*(D>SW)7D\V4M??0!L:)?H:
MU%]7#?2]1C\=N)&Y,+1K(V'/"1VCT<K&L+(QK#*U@6P,.3MU>O5">0RYFIUL
MC4[^6C70KC*9>OXY\"@][7)Z,G7M\RA\D^<N[U1IGTPG7MJYN7-;)]>Y0IA;
MZX[5&,26&HW(3I\SU*+U]`!>FQBCOVF#1IGNWXM3K`XI\'N2Y2\QC'<FY*BV
MP/`PND'4B,L[5XCNVKE6QO%6F1U_R4GFPB196[*QE=5:6:UU$:SC@V?*!V)=
MC=0)I,V-96^0%?[&GC8V=BVB-IXV+IJ6("A\RIXN6M3=-24XUC.I!#-G-RP!
ML34?+1:I4@;N'3$M7-[U')HS>1*UPYV!.SMY\H#7[7&#ZU7^=?M4?TX\UOT7
M)S<(+-Y-?:6D"0]W@TLD5P7=H^3S_>'&JF`M%%1#>%%5<.Z"L+4JZ`*O:'\D
M617,CG*F_9'6JN`<**@S(YV5BUN7!SMG:ZL:%ZN%JH06B;&Y*U92PL1JC'J#
M*/`:<>Z<VJS;I>]VN;R2-:ID9=PGC\A$'L5YU=)8E4Y&F[*-N*]QI)$TTC;G
MXI6MT46+0HL[%I/!Q<.+"5HL+2:+0:X/5CASBWN[ND?)*K!9V]RC>,--U&[1
MR`Y8*QJPIU[5B7+6LJ3]O-GOH2([ABNR_V)FP!CD@<U%9_RM:8\K'#5:3+%(
M/&I4_-AL"9MC7_:XP.%*8A82!7O!'*[_![=KRI:PF*@HNK[0(V>:Q2_Y8U_!
MK?6X8X,MM:E^Q36.C;<OG-^O.$WZAK-*+?89BDO/^RI7Y"]:1(BC>4ZI=E'!
MH%%JEC;DEZ4\M0M+,XIU7H9Q*RVX(DD^VF")5V]8<^7"A9W-UY2VK)"=X)ZY
MI(BU`P_UI=7\/$.RM)#Y;&"5SH&V6C50TUARK&KP1:.^&9WX:W?7*%-XV(@0
M]W?09/7DC";+,TV697BXEJ5FK<49H2HA36N10+1*RU22END#+=,'6B<+CCA9
M<,3)3K6=T^K)60XYLL*?U3CM[D0!]G*`#11@0P2J6&RDB@'GJFF`7%6&:*Q0
M5G)55+?IZ1M5R$^B6:I(=+6JCLZWSO0C,(@2W.%RM$3512W1.M%;0Y@NR618
M:$0"@/Q_V_,6Z+:J*]%S[KV2KJX^]^K_LZ0K2U<?2Y9LR9_(<9&<V/DYB0VA
MQ$XQ=CXF"23X%Q-"$^Q^(.253C(%2H$.3IGATU(FC@S!(:6X3-K23YK,&\JT
M7:4PTY0IKWB:,BEO6K#]]CF2D\!T7N>]]6:]U[>TC_;>YYZS[SU']^ZSS][[
MF#Z8'XG/7&$_)&)`I&**Y++9N"%EI[E5FKVLI74Z@=KB\\403W=/GEH*GEH-
MWLZ0)CMMLO.DR6ZOKT->*NFE#5[:Z:5_E+3&%LU%C!@3(A&+U=?]1U,EX)LV
MU>>KZOEZLOYKZCOK^^H'ZX_4JZHYG*?U<;B:K%=/UI^K9R;K<1\TS-2S7MX>
M\XG%M$DLY@NMJ>1C/N.:H#?F"Q;3)K61JI8:7VUK!0JF,_0?AX)!430*#GM(
M<X3'DSP6^4%^@C_+<SQ)FWAB&6^HRA_KC/7%!F/<>.Q(;#+&HI@48V)D']?"
M@H_UU153)_'_>.K$['2Q:DYQL8X*K%([5>[%90RKN&<(?@AB29HY^7?S)K`B
MKVR\[`1D</N7/M>^2[8;=;7+YI=:\AF!:UFW]U:=D2Q$ZXI:T;^X#F=?:K^N
M>?_\OHU^%\V8B!UX[X&A3\Y[>^Q>6&DKM^%K'UOE)NN,`:-]GCT)ZTQ$7D9?
M6FD5X`92CXX>IY5B.DFG`^KFR-HAG:22MY!&CHIQ#H7720HJ[HQ4?TO)C-J:
M13W5DGXBYR8W>XA.N3DKU3BK7J(>G$3=-X[Z`:3*<3Z]OGC$3;<BHERP%Z'%
M0[0V\[@-/V$_8?\F_H[VM/?'6K7YGP2\2MMFWVB[$]^C/23^V*/QY]/U'#W:
MGO#C;]F^XV;R?KR:7YR-F2,?/0[^?P>H(H?/$=K)]7&#W!%NDE-S;^O)<4E>
M/P$ASJ53W>'XNEF25HNW3T8WM$]V7KWIN-ZW^KB?6WW-IJX7D'YA!G&`_H49
ML@4N[_H:<K-IQ"$KFWY+>LMSQ27L#MVE/P1*U("]9L489I2*L*"HPR;1*B,O
M=LO8KH6:4P,UBT&2L8<%8M,Y9.12`2&O^HJL.FP;F/B;H'5X>5?>-,J,JF\7
M;C?>;K[-/NH<K>![NB$0(GEV;85DRGH`;23-KBNFV4G"@QZTE9+H#0T.<M9F
M-9?2Y0PZ=\?-MYX=.WO[]@/?WU!_\[*)3VZ^8^=*]M@C!X]]_/WQQS[S]!V_
MV]N2>V3_R_,_._HW%^_I@Z!CX7?S:]CG0=<B*,M4EG0MMC1/K&I:J"*,)'-)
M/MOB0C(;LU`;;)'MU#DCF>E%?XW:79DHD8$Z=FPT;N:,:C<Y^'60D`/<CZ1B
M;.A6:R+4"B-JA1$&[00+"Y[;+#6XE[,0K\5G9J1O@6%-48V]?`B<7GC_6:*(
M:8'HI).FF86E33`[JK<6:B,M<G$/4)-)_7/>0YTU&:2B:F,$89<1)J,CLR$3
M(%\Z)Q4M(RY:3#">YXK&\TR<:/4=PE*BK5EIM?0QZ9")NRN!ER9R2]L3'TO<
M9+HI,<+O,^U+?)I_3/,6_SNMH69I5Z:[;E<=EU^*4SP;C9DMX%:Y[JJT@',5
M":)(H"/B0ZV,.1YEN:34@,E,&`V9D\MI3-?ZA2,"TR>,"\<$5OB5S%BF\?:\
M1Y8[`X,!9CR`44`*3`9F`N<"JD!?TTOMI6"F6:)6<7B6!#2S.9(_<US*G[%&
MB?@_5*/E5+W&P"MU87VX1JG7I&6<,@#):!MD7*M+RN2(J*2Z-,%,3H%`!5DE
M8UL\\"T>YD06'9B,_8J,LJIH,-.-5#.)H\-@=WCEX8[_<OW0W8-?6=,033NR
M[?.RJS%BL4E!GU/!=5KC[@W;KKKZ^GQ732K$9H=?W;=YUZ=?F7UXS"96S[]U
M0\:G*-BNJ]W&;NFN<1K'YK\R$&SJ6G_CR?\ZM-YI)EGFUODU'`)=]J(X?J6D
MR^XP-95AFYTP&X32OE(L;20QB8DX$4;JAQBI'V(DN6/JQX#[34-GH^KY8NB<
MES1>M>@S!Q6G.M9MUFF,1;T!E<E=&3S/4(TM*LV,IXJ84$\5T4-/%=%!M^CV
M72>QN)JZW+(STEG-Y*O'J_\J>K2:JW'7!')52^(=4MZ=#W14K8IWB9WN;E]G
M8%-5;WQ`VN+>$ABHVB\-N<=\0X&Q^)WNS\:_*'[>_47?YP-?J'HD_J3]<?=3
M%4_'3]J_#C/X2?SM^'OQ*KEZ1!F)'K8\8'G`.E.MV6#!E;P1(NA(*8+V.$6?
MGPVZ8YC\K:#B=6HT:J/'@_Q^(U&[%/+C(YCIP^/X&&8Q3^/]7X5K)5NGC7G1
M=M;V:QMKH^>XMN6)Y6/4$L>'AM?-SL5[R/9,\V(DP)[-S1%]-&=+>[,S%+4X
M0HZPC*(6((H]*..(-287=:]X^`BA^/"2."(I[<NA>*9X>J$N)G\1];\;V=(1
MA\U*#A#9FYV9-?-IRQ*OU?FQNU??^;?8^C?9OG!3_:<BVW*#1_]R9.GU[+'W
M;NQ*5RB*I,N"Z[NKXYWOO8456:X(S:7P7\-^_?5OG)S)H.)Y'_,<:%84/UO2
MJV@5M9%JO\,4H<YIQ.G'I5#^RLC7O^C7^A<]4C^Q1O1\VT\#<S]U8?TTXJ6"
M6&*==A=)YCI1&-3.V!$9B(Q%V$A4X]2S8*S.D`AW%N+;?^.5DC,*Z8.'=4'R
MN##<.Z`=TS):>(!3#3.EAM)$(U@RQ]]30^DG&0&BKZ3R'.GS^ZMB5V0XI=,H
ME3M3RFX2']*3'X#P34PS:3'/Y,5/<II\%>ZMPGYBY6B\>%<P$I%;PKY(*Q)T
M52:K+&'..4Z."R0]UG>S+-)`1-BKQGDU5B?]5;@*F4)^OU_&X_(1F4&R!!'B
MC'Q.5LE],9*<!.6Z%.,-GQ\J'A1(L\.S/:9B+)=%5QP8#(-_!QNGC3AWQ<."
M4M3EN'0,]H&$W]J1?8VKZD+!C3:SK;K&8EAVU7Q\1:5+4!F";G]$P#;VV`]^
ML#P1:6BSQFZ87[TV`LY;R$[CJ:U'/U)!'#C0EVT+YYD?@K[4<G4E?8EDJ+YD
M\L0[8S`]Z<+TI`N+'C<?T9/V2$!<-#\BV4C3I%^LU?`1,<"9XRJ\3X5WJ;!*
M26&,JS2NO3Z\U8=]BNS&?>Y!-^,VZU#N=$\/^$`IX,!Z8#/-$14!O^_,*V>D
M5XH[Z27M2`?$",]5V7WFI(JIJM44'^,RMZOPS:J/JQB54J5I]>%MOCT^QJ>8
M=9C,\)V\FVB+*&;2;MY(HYB(F;!()),N[9BGB_PT^%`]/02ETZ=[<M)I<Q8Z
M:&+<DX]I$ZX$8S8G\[IL(JK+.JW=^DWAAZ7[0BI!(T2%6%]F,#.>48N9:2SG
M#X*Y_)[A>\;3H=/*WP=?#?TX\2;W9O#-T%L)G3F7Z$G<4GT@<1@?9@ZSX[9Q
M][AGO.)0]>&D0<0B([!:O;I"2+Q<^9T@7\':K>8*N]<5\R0>U#XH/"S?&[PW
MI#/'#='$FD1'IC=S6^RVQ%W&)X/',K]DWZS0Q_A:'WJ!\6$_3F$&3^-X`;V0
MG,;NO*G*Z7.]X/&Y_6XLN65X<Z33]8*==%::S:&@0<>)$<I4/OQME$Q5U2)$
M7JK[#I?+.<VNR%OM*?)BF>^;,3:?#;P>^'6`#4RSUKQN4,1]XJ!X1&3%:=R0
M=T7<KJ2?QWQB(H+[(H.1\0@K1VHB3.1Y+*,TEH^W+RZ.=;/#%VEP-->SO*NP
M$,`]W=D4^)6%!0Q5\`UFST,_;%TD;#HOS9:R((XL>*4"Q&DA@\YJ,.@.&I,T
MB=_M1-+;%V=[AK$T>W&V6*?5HA(]DY2UACH4[Z8VO2(:\\N22:WQFP(56!WC
M*V`)^RJ0)JJJP(N&G<1>,);V/<V[TKNF]Z)<3S<>1K!4H=$U@2>8"79"]Y#A
MB.V(^XCG2,6#E0\$)ZKUX!['\1#9"D!,EPJF0I])/!QZ.*'JZ29.LRDJN[+:
MJ"N+\T*6`?200P$AZZ:GL$(V"4T)BMJL7O*9<T:9$'`A"YXL9:YL")R"@B4;
M+#(]L!.6;,)I*3[+7'R6:(8AS#"$.9N0S>2>"WE1!#$QRTH&&,=`'G`A;S;`
M.`:0`72:**+X_PS@W713<V4*EG8RA]WA*-HMZD4%31GB59&3C!`-`8@G1N)4
MYD@@O/?Z%=?)_M[/?>^%T6MW!6P.0R!0\<B6MHV;YW]67?WPQQO694R26<\>
MFW_YWIO65"^)QI(KMSYZX$&?X,8K[_FSJ[-M-QQIRFX<^H)#-#K!AED7?L,T
M<]]`'CQ7LF&*-V\&&^;-$P.ET],$C-YFP2H+K5KH1F8I9C=IY2+=\"SD7=#<
MD$7')T2[E9O&G@+":MC)YLZ=2<V>+NUAKX&WG_J@?7(Y:/[$3JGMBKJ'G'I2
M=VJQXB+^'#V>&-1AG>C!MIU6O-J*Z7!Y4$486^?!*AH<J&@R145W096EF#Y2
MTYG2_<^R>,)GL7@KKDBFG#M#8L*Y<ST],](9Z73/XHDT?%;/262`";3HL[VX
MEV%RW@=-#[I>M+UHGW;]TJ69\.)#;MRA[S#TZGL-OW6JU$Z;,^)D[3:GR\UB
M0JR>HYBUU91FR]8P#%;KZ\FD[6=MKU,?J]_J^3[2D7._A`R;9S+EG?0R7H0Q
MQZE"UDX+'K=@9)$LDY89RSG+&Q:UI:_BJ4.+H<$<39)(/1?!=Y@%.]&,<G/G
MBR=YT'4>P_:)J'=66P/./O7YATE>Q)2Q!4W4IVK,4(\K7&\*UC?`OMF(U[SZ
M:B8:N,H4"8ZW)KNJ_KQQI-H1X[XQ_W<KYOZZ^ZI8=,O63.]69D?`OG-5N)_L
MC,S">7:.O0\I3$U)J^P1FD/D2VZY3HZ63@1*_I#L*T68Y_,6&EBZJ:#;3$\?
MS(OJ9EZ,1:%R\5DB:`XMAIY&IZ+6R4:GVILPZC0\K.%G2>C)"RCU6OP,?-&B
M"_]V40_/%`\'9EZ+7^E';=3D^3Y^D&=Y02?KG,:0XH"G%A^I*_G$0O$,C)Z*
MR6YZ(N:F+I9;H'D5,\^'9:IYLKIX*A`VDU,\(F(F_B'I(A6J>V9S)'QEWA^(
M1/.-A,P01<R!$E)'#/Q!DM+)U^,(B2KD"-D?)B-<G:[1WR2O\J^256[>TD$B
MST"'3XD$^0ANT?CX5EFG>/EIW):W"$A18$LB_\<HZ`2=+B`3W]^()C$6\2">
MP&<QATFF3C&[W"&SN=-RQ,*,`YFTL$3IY)+:@=*%7QK[H)\&6Q&H'V@?R=3-
M%K-U$DVJ7O+48.N0/!6BJ4)T5R#)Y)&\%8@FZC[Q"8@!>N*+!W'I1H<J6+^H
MA^"W:>H#)>TTD?-==JL8L/LCQOE_KKYU?]NZH41%XRK<TIV+[V[/;F+OF_OA
MQ,H*4W#HI?%EW?>,XP=;TAZLS#T\WMFPEM&L;V04<F('.CH+.BHSWRCJZ`FM
M%KG-:BM)%YL`94"&_<?C"$P8R1#G4K`CI"[GU&J=@M;#:[65`;A/9Z7)7ZM%
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MD%DP^6`5W)5/:-TNV>ERU6@%JU8K>-SND):'&J]1JSB.!Y?,8@:W":G=+IUS
M&L/VU"M@20@)$\()X15!)1S0>H@22WEUZBA_DO\!K-X#6M>H^Q3V(!EI8;ZB
MN4Y+YNWR4EY(UQ/VG+X>:6<@7)K&+YZ0*O%X9?%M@!3A)T1+78`85I<4AT#W
M8@^Q%^XYYYLNT'GG1?<LX</.V6)H0G6=6->#17?JH"KII)4X^%6S6)JYDI+#
MYYZ>H46/@*I^'`^#?_.L(-L-.3!>OWP.N#8$_C($"^"E",#R@B7+R^"F`.+B
MCH1IRM`2L!4="8N%IF+"P?J`30T1$`[B<)BD;_"QBDC,]L-7';RNL@['ZZS!
MBOE3L?F3]JC?E&;O4\)RL&9>S1B6>(U:4:<HG,FWXOU_9E4-*4G+D]AXX;SJ
M&5@M"?9,:;6$`SZ3D4F0))\1:<-.GHLJ?K6H)FJ>RZ52CJPT=PY@YHHU<Q*%
M8?=L)7;/64%#"DJ=-*W`%ZDSK.50E#Y\7P(GT*B"%=UH%$=UQ:<G$M6!0+*Z
ME)<F8^5Z<CW2:SUT,!.-.NA;]1PW)XF25N3J[1$(,$U*1$[V)G=J!Y-O*6]%
M_U7YUZB>"!0L]53N98^_+I!,QK8U>%TNOR<H)3DA[`TGPMGP1QU/.)YP/A'F
M=4ICJ#'2@=;B=9K5_,K0BLBZZ+K8W9IQ:=ST6>7NZ-VQ\>1#TGU$6#DEG51.
M1E],OJR\'/VQ\N/HN:0?J3B-VL8YM(HFHHVJ8_6.Y=)R4Z?J&LUUSFMBAW2'
MI;N=AUR'@G<K=X?'DXZ#VKL<!\.L0=N-]TI[31RL"?B:BB)@#:P*R6'R27(P
MX)-1+.%#HF#TB7Z7SP=A_5U3?#0"F^F!?-ZIA&1>PVLUH5C4&HM%01N42`VO
MM?*\%KP3ERTD*%9!4(*A4(W3974Z7;%PT`7!.JP_`;[#*?PV+"(??GO*CT43
MN9*0$7P3V`4E"0)X&3&D$:,$B,`B=9["-R$%\?CQO!C-PV1#H:A.?E_L%R"F
M.O[,#.J/!:<QG[?E/:E.%S[JPB^XSKI>!ZOWN5`*EK?G.5E4L`0?G2Q%G;Y.
M.84E%$8V6.'ZO)#J#>-\>#S,A,%!>D9[()+BGX=ESH,[)<@HBL>C%Z),E.S]
M<&OTJ(8F5#MC>#R&R2F3',O')F,SL7,Q3:RO^I+7-$M.E%WNV;GS$/0,E=8V
M-+FA`;J=Y]W@2A&<+1U"N25ZL$Q<K.92*=9GBW$6K/ZB%3""%>`7S0%_94O\
M#QF&?TLU$M_,-U.#,81[BL=8<3`7Q%:$):L^1P*3*>`68B>\6<<5S$K8A8(C
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M=F$7L:MZJ3[OFG2]X;K@XD@#V8U=IY@&E$$:O+U0GXR`/9A"&9PYQ7P#95$3
MLVXJ<`:69OS=GMF+L])<O"<^-`OQ3''M]2SNMN!J4B(U]Q!'B@8V9.D9D_&#
MQ@/%A48JV&G.'D@YWY;.]Y!W?)Z^:'.V)]4#+1*]E/:_#34-+S4;FP\:I>8#
MIT\3=IH_K0'&0VLWR3+V])"M>@@-P>([B72PIH2L#D*3Y[19!\DR0/V74\!M
M)$C55IARAKQ'RCE)*UP0GK<XC#D5.=/4.($TD%H3<46`QZ(B>=J%$V)6D46R
MX?^H(&8U9"&+V32P$P;H,-`6DIT(RP1-T&8B]X'+2)V$@KG(3$67P6/(2O`"
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M>QJGD1G,0_!V,H9HM680JLM<<GI>ZSD-<2&U#<44_:34?FW7"\BS\*_(M7`!
MN<'0"](2@&Y/_BFM!.IEC-\?8RQU2?NVAD^I[E0S6JW*S+MXMS9N=8>U(7/(
M'8XOP0WF>L]*\P[M#F&GZT;W5L^.Q&W\/F&?:Z][C^>VQ"'AD.L+Z`O:!]R?
MCY]"Y^I^H0Z"3Q*/)ZJJ!$P]=1=Q[Q/IDGL?YF67VUU3)5A!(!&/4\<^7@6W
M5+FUG,`G@+O`T^"#)1<_0@R&$68;206S7K'.X7"[B+?@.2S@UX4+Y+!T4/BU
MP`H'<MH.;:^6U1Z`P-:8]\9?%64LRA,R(Q_N3>!4(I=@$JY,W9<#CT.4&E\/
MGOJZ\SU#Y^<N]ER$G71N?5M_ZYLHMV[N?+QH3A:3HP?Y*W9NX,2T_+L;]>7-
M&0\1TQ#_]UQQZHN7#K(NI?,:<9ANNGK\E*VZ.O#Z&9.&KXSC*B7JU+KF/]-P
M[.JE:QMK`MFHX%L9:IE_3@RX)$<&=#CBC;3-I_'O8U&S5F<`9]T9,.;>O^7.
MNUL351F[>%7W!#/E3P;UDAZT-P;[ZB[07AO^<CYEYCDG-\%-&":,7^:F.<V$
M`QL<HX;:AD[4)7;:6`_G,%K$&[AKQ->Y<Z*FI)51S#KLK,@85?IV%?ZX"G>J
M^E2,JD:O;A7Q'A'WB@,B(]8P`LK-@9&DQ$3/`.A)#82VZ%U):K'Y2%HKE$^K
M5,\(/AUG%,40RUE9EF-U#"=BO=%A(*-PG2JLJC'HU5*OB,4:S`CB*>8J9$0<
M<U4^P>+D!/RM9*<!UQCRAD$#:W"G'#E'AX-UZ).Z>L1@QF5W?*FXA:R_.+3N
MXOGU4L^[H``7>\Y+4&`?F1MNIF1QCF2:@!"['3QPVHFE67!S?UMBU/2CX3@$
M:=3N&Q?.Y;5@Y=D:(!Q16`-4Q#RY"MFSXO3"3T_8LUS42JH_.F'-<H-F4CUR
MPISEG#92_>4)&U1%6CTN?M!H(G($R@;J<:"2:$VP,6##@30Q>.SUNO=_Q/3-
MO[*YV>+AHFH6S3V$U^]L=T@Z[)K_IQ!;Y0JFU\PK[[\23,C;$2)>%4(JT]L?
MO_^CG;UB\V]AN9-6].C/O2\1_O)+F0?>VS-WCX1X(UQJJ7SI/DU@O@UME-![
M>W[_NH0N]92`NUF=Q16DQI20`-N*[D0?`M@NKV:^@JX%3"ZV@?PM<+T!^)\S
M6<1R"*T!O`"8`-P`*`-N^?"S0'82\,\^W$Y`]6TDJ:Y#E:5ZD/LYJN)&4.#2
MO5\!?^,*T'A1I>K;"[^XXOY5<'^0U.'>JZZ4A3X1_1%@/XM6<VCA/>`K8.ZM
MP-?"F!U0_PB@`>;=3.2@;H+Z1]3@K4!=#]@&]_V.W`/R!M:+MD&_%:X9(@MC
M&X![B"P\,_;'YE&&/UU8U)$RE*$,92A#&<I0AO\,P$\N//_'9/Y?`97G3V>N
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M\>A&(@7`(B?08IV#NK-45T.MACR!TT)+#5I5JC/(B&XKU5EHOZM4YZ!^HE17
M0_W-:U9TM7:LC%^[<W?_R/K^O=<,[-Y\2^>&==?^K[:C:]`*U(5:40=:B>+H
M6K03[4;]:`2M![H7>@?@>C.Z!76B#6@=(O+]:#L:1;N@=?A_X^[_7'FF^`$6
M`F@;^@,`WXT"9JYLQ2SFL(K6U%B#>:S%`M9A/39@(Q8O24G8=,4]9FP!:L4V
M;*?7CE*[$[LH=V,/T(I2JQ=]"+`/^[&,`[@2!W$(*S@,;1$<Q3%<A>,X@:MQ
M$J=P#:[%:9S!=;@>-WSX&64H0QG*4(8RE*$,92A#&<I0AC*4H0QE*$,9RE"&
M,I2A#&7X4P/5R.#FK?VZH=&!/?TC.V_9OJM?.[AYN/^67?TW[A%H;7CG]AU[
M5%L'=N_>K-ZQ;W!'_RWJP?[AG0/;5".[-H_LX&[O'QY@!V[I9_?L'5#MV3'<
MW\_=.#`ZS-VX\]9^N&W7P"W:D?[=.VD-M^!EN!6WX15X-5Z'U^.K\37X6MR%
M-^,M>"O>AOOQC7@[WH%WXIOQ+KP;WX('\"`>PL-X!._!H_A6O!??AO?AVT^B
M:]FWI]@J?Z[%QIY'?>Q;:(+]!7H=D$,2M$A0RP$.0GT!4+4PP_[#5%M;.C\-
M/)ZDO!"-I4^2CH*[(OT"^P_,5U$$^:'A]8+=0WM^5EBVK%1I6%*L3%55IU]O
M$=B?H5\#,NS/V-=1M'C75#29OM!B@`;,WH%$C)$?'65?0Y.`#,JS/YD*A=,3
M+[+?A_[OLM]!V^AMWRD83&EXX+?9YY`9^=D3[+.EGF>GC*8T:AEA/XLPF@%Z
M#O`-P`N`'!I@GT!C@(<!CP%R2`3J!TP!=I`6]BGV*9CG8W"_"#0%.`!X&)"#
M5_@5:+^94/9)]B94"??>P]Z';,`_P]Y+^5\!=P-_%-I]P+\$UX1/E*X?!D[Z
M'RJU/PC7=N!?*/$'H-T#_/-P3?C]I>M;V5%ZWYX2/\J.%'Q^J<4'_3)@#2`+
MM?N@=A^\NOO(V310S'Z*W45'.@X\#7QWD</K.E`(!.DW.C#E<*6/PBL]`*_^
M`+RY`_#F#B`.NO8ORNPORE2S^T%F/\CL!YG]\%9JV!$8;X2<]`*5`&5`%M[[
M"+QWTCX)=`;P'&W_--`C@$?)%;L7WF,,9G6(O:D0]8.2;9_*YM.Y4^R-\*KS
M[(U3+F_Z\.4KK4`4$;BQQ$4BVT][^Z>T>M+:/^7V%CE(W=QB9+>BCP,RR`HT
M!%@'V`K(L5L+H93_>78]VLVCO-$_QHRQ8]R8BJMIQ>87V33JY!&HI)FM1LT@
M$//W-N/&/NV@=ES+2EI96Z/-:SNUJ@%VC#W,LGXVQ>;8#K:754TOS!0T31E@
M^97JILP1W5'=I&Y&=TZGFE3/J,^IWU!?4*MD=8TZK^Y4]ZD'U>/J(^JC:NT1
M]1$-TZ<;U(WK6$DGZVIT>5VG3N77X*,M=[);X&\BH!+@(.`10`[><2^TR^P-
M@+WP-7KA5=P`[0@H@BL)\!S4WP"N@BL1Y$20$Z%5A%816A%0TM,)V`<X6.I5
M7^I9O(?(7R`]@!'H-4*K$=[M&T`OD!K@&K@RP)4!K@P@=8YY'V8H`94!.P%9
MVO8&(&@-T,6^FE)_'Z":]E^@,HM]>7(O\WY^<V0FAB=C^&@,'XGA?'.N)9VO
M!&(VFWN#O4IOM/<Q;B`XH`Q$!Q[C.H(=2D>TXS$N%\PIN6CN,2X53"FI:.HQ
MSA_T*_ZH_S'N\-IC:U]<>W8MU[MV8.W86K81/MU4(5Z3IKQ2(?S9@LN=;A1;
MEC+'X._T`IT`?!V017Z@*<`<X``@QQP#ZF>>AM:GH?5IU`'8"ZB".YXFY@6H
MO]1'VB=H'ZF1?N8#_2S\\:\6FC(=+6O`Y/8"3@"R\.RO0O]7J72Q=HRV3P)]
M@[9WE.2/TG8_T,5[6#!PFZB9VP3+;Q,8_TVH%W`04(7.LAMA<]A(G@S4#S@(
M>`R08S=!V<AN9)Z&\E7FJVPB;ZBU^9'=#ONCV<1++1*C!QTPX"<I_0*EARC-
M41K*&]<8WEUC^/H:PUUK#!&H,%'4`AWW41K(ZUH,S[08.EH,L18#/,V!`LC`
MV"A5$XI_1>EZ2A-Y:\#PNX#A7P*&WP0,?Q$P#`4,'PF0^RI@[1H8*Z4Z0O'G
M*5U#:3BO\QN^Y3=L]!L:_886`WX$P^AH&:4^2CV$XG>>$5M%I#V%WT&M\"1<
M:([YIQE$&5XH-+<`FR\TKP0V5VA^!-CO"\WW^K^&?X?IEH;?+83.^UML^")>
MS9'K?RGQW^#5Z"G@%X!O!_XX:L8*\+\J-'^"R/\EW/\07#^**GDB_R742>^;
M`&^`M/]%Z;XO%A);8-2'"XE],.I#*$%'?:"0.`^M]Q82AX!]KI#8!>QP02$3
MO*G07.5O,>'M*,00V:U(8<A,UI9&7`5/W@5\9?'FMD*"W-5*!IC&RPO!6F`1
M,LNOX2#JI,/Y"T'Z)[TH2!]1@8)TTAZD4&[$(IV\`552SA>"GX"GJ)]1SOO_
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MAE`@Q.HSF&=@[4Q:V':F?<,R/&EN1^W7+IMLC+=/:Q:NF5P2;Y_D.S_6=1SC
M/^N&JTGF[FF,KNT"!25-=WHFS<N[3B*,4W=^UD/X_CL_V]V-VR=GMJ+V+?+D
MNQO@?PA7;YI4!9<YD?W6G#-GOLJ47='Z!TA?B<8O@S-^)3B]DY]OW]`U^15O
M]V2:5!:\W>V3*S?(UW>=9(:8@;;6D\P@8=U=)_'MS%#;-:0=W][:?4D,53*#
M((::"2-B4ZB2B*%*/$7%UE(Q4-/*MM;CE95%H9?P:B($ZO,2%=I>?%8(AH!G
M=1(&8HP/A>BS0HR/B($^%!\F7ODP/<(B?9BH1_1A%43HN**`2$(A(L<;%1`X
MKC32[J<N=P>5XG2ZD4+'47`W'0?CRS+1H@QH04F&X4$F_G\2^I?],8DK`$]M
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MM`GO`6AKI6..`H<?N=PS.D(`P0`C@,7AXJ/QY5TME6@K>+L8//-J9`$,`F8`
M-P"JT-\`_3O`GP/^"R"'/@7T7L"_!)PB+6PU6]WFW-E*1NR.$Z/C9--3-?7I
M)=/`-]]8Y!LV%7G;^B)O;DD[@1=R&:%%!,<;H^>!?A?P)X#_#?#W@"HVS:;I
MPT>+6ML]@D;B&*:/X&(/(2/Q/3@.%4Q>]YZ1>!P1)`H.7P!$X_B#>H_PR"B"
M5P$?!!@(T=81<MLHX8M`.L`4_P\R:48D"F5N9'-T<F5A;0IE;F1O8FH*,34@
M,"!O8FH*/#P*+T9I;'1E<B]&;&%T941E8V]D90HO3&5N9W1H(#,X-C0*/CX*
M<W1R96%M"EA'Q5G;;AM'$GWG5_`M[,"DIWMXD_WD*^`%-D$"`;M`M`^629&$
M*(H623G)UV]W55?7Z9X96MKL8F%8(#E]J<NI4Y=Y>]E[^;'JV_[E3<]6HVI:
MS6?]RO]+7]QT,G+]F9N,JG'_\JY7T>.'5>^WP;L/9C;X]=+_^60N!A^-M?3A
MW1MCW>`R?/S9#/W'G\S,N7]=_JWWX;(GQ[G1?-Z?V]&T7XTNIOV'9>^F]S8(
M8\\),QV/YOWIQ<5H3K+\-OCTPM]0#?IFZ*K!&U.[P6YAZFKPX'^8#9;&C@??
MPJ^RP$LS@AUOC5_%:^_#MGOC?[P]>,E?T/,^K?T2CJ&S>.G1V/E@<V.&L\$?
M9B*KCJ3K^K,93N/G5_2W;]RD"MK7H\EL[EQ_Z$83-Y]Z-=][#6R2Q__]9%SM
M/_I/X1P['3P&J>AJ%M@+8*->CT'6#5T1]91/"Q%H/EC3+EX5U.(G7\/6TV?2
MZ"B*S0;;/\Q8)`$#[LDJ?',XDQ?0CSO^_-%,V7Z\ZRXMLM7PEVA^V7+#*H;O
MEV9X$65;A4=+X\3$K.T_=>_?O?"L'&\@GY"MM\$;XBX7;;@SPSHZCNW[.O?%
MY8_>]`Y-_]9X]>C`0[J*I2#-=N25.SH%G'Y+?W=QG?]#:-LN%V'UBDY!A![7
M]&7#KF@U\Y%7+NZ310ZT$NZ(2T@[%HZT)5B2!AOO@.@:<C+O!>^>=K28;S\)
MOOR#()B<X^%W7-XMS9@.L.E>NE+<Z"J^DLU#MQT5DP_L+/IYRZMI(VWYHHL%
M'Y-*_2^`89MO@E!'NH6WT#,4.EUTC/I$5U?]H1W9\:2J.>!`7-SS8&P]0'%!
ML`Z9DU?H0F6)($_XSS;DP`'CB_RUH.*.%]Z2J<O81>>HA\7&?L.=FGO'/R=T
MQ8,7$8=.+B1C,J*W$'_KW!EYL-+=:P(:H1(PN%$LT??3G4B:L)<;)X*0&(1.
M7)`FZ'J*HQ@MM'D=;7#Z$I:R((6/I_/Y!?L8$0'6\L=X/-=C"9B#<1=X'W`\
MF!U@(I;DB+8B/OE2J?&.\D-RQ3;>[L81$92A*$;)-BN1P'F8D^.%&H3JPRE[
M!1FZJ0$F\9-"QZ_:*\EOR+$Q13"%/!I9#+K'%=?-#$<J=U%8BF!>_!I=Y/->
M-9Y-V$7U_X5\ZRR@"-X<#()5R1J;!@D06%I`58;@X85)>D$$+)2OF,3)3V#U
MAD@D3!9#]3@QE"0^L@RLI_U9+E:.VYA$G#$[P$8**];WM!`/Y$OZ+'=955`,
MN?:20:HE\4,')RO!\J$/V]+7>S@]8607$2^!)[R63,_'1$-Q:#8)E$_>:-93
MP\JE(0MC`!YR3@2:=H4+G;JP1KJ,'A2YRER^X'Q'0G+$[B*L\H@+ICBQELAF
M)7G3]SV`#6P0CZ=K#Z:^B%JPU,@3,3[])6O`*E]^3Z&GW'X/]4$>=QV,#3JM
M-IP^'E@$83N2*;@';DEJICBWF;T7RHME8$"4MB;;/26*ATB7\<Y@Q:*]0#"&
M+,"A(W!'GH_%2TJCF^@PVQXZL=KN9M"Q,*@-I;1OODK6SVW*]#6/1Z-M?S")
MWY"@Q&W!#``#05&4#_H@CEU-:@YKQ1@58<67`"0`XQ49\<J$@]"%3$"?HNMM
MEI[:`H%-MPL?-]?AHV3>Y-0;X"7^)6T&9N>]0&]KB.:5NC8#FHL_WNDYY/JB
M*L>32(>%%@IDWBV)2'%--T$9T$F?D3V<)$/6A=4D#VS3'71G>UK:JVUHDWI[
M<2HLS1NN!L%C2@O\*R</<#?4R"TIQ7__$/K`WZ&N8_E6X#CJW!O%SZ^A;#AM
M42Q_DPW"UQ%'7K:AG5SQ]5?FC/IV0E]P]=GUK`4V.[M&S=#:HHF)":`VZZ=C
M)09M<`==-LR;)1DW)K`55<(9DLGPG33\:_[EU>+;>ASIJ?"MZ_9M:$TA@A5W
MMH[)P/LV2&@GP<(L+<D5_(:9@!R7PM;2Q\EBV+)/=L9LD8P4,UE;;9VQ;(RS
MNHMJ._!DJS@XTE+\5>O<2-G_B@V`K/F>"Q63#570.^I:XA?LJQHT1%\)NH=3
MQD'A.,!U$])*-1F5/Y-B(#^S'R"B2/.3\*0@;^@RO<PP:4N*/X=G64>GI%K&
M[E,XM8.L]T_3GR5OS#JN$T`P&M'GB6R27:SVVHYV:$:GDT\/``JL$GG$>,@+
MT%:QEJH]F]1I8(S%HAP^L?1DXG.Q6\YJ\EKJBY+$F':%J;(8=;/L("L-N'0[
MN8?9=Y^5<]H)L*%F-@090T:F>6)>;S5KV,8$1F,I=`*G1;L4T`HH,+*47[/5
M`9:L/)6_7#3G=6GR]K4$P6:A=T&MM6%XH>22"C+7+0"2MR05=P22Y=&:J20_
M0;N!<X:\_$RRJ/)T-*O('NDNLIG!A"7Z2H92*26D1""4!-21@/=@)#B$YU];
M>9C/U"7&V<VK4E0PX3YK3)/9.MH*-LDDC68@V\8[RI:]/M-WB$("OAQWRC_M
M8&6&YQ,)&7#%HAC"EPW-%9\N.;B1SO)"`^@>!H(VBRUDE%W))&4(M1,\0+)9
MG24:>F*[;Y]?BN$$2]K7&6K`R;`C$?X7+.,JJ66>89AS<Y[_==G:E3/3T!IR
M)G=S[352,V>*UT7OD\X"@%/#DV=ET42(,%M0NT9F!ODAD>E$A$^'_A4([[-,
M5C4W9W-%.T9ZA./)JL!TBT1=F/>:'&9;LJW&P3436/AQ&QQ^%(X<%R^7QE4W
M8MRY@6B.&0F:(\S<U<TX:^A@8Y-;95]8A>N(YG25/L,4#G4I[2]JV/2B+/BJ
M^<+'ZK1YG&9.D)++,5<_@L?O^SV?><[0H!C2>X9VTGF?*N44-YUIL6SM2792
M4%N&"*62)\'@F-_7K-<*].784I<WAL4<%7HM>^V(_(B"#:<QG)$:$](5`=FT
M//B,?BY:U._F.-HJ.8[:XT<C`L7Y>_H.7E\4TW<P%WV,0[9AQ"BQJ6@2_CXN
M%7%)V)C77?.E[O%,/#-I;AB@\XQ+"+!QGLC"<>]U*'LNB%!>1\%\;E1R*,(5
M(_-)_53:3)*V#[[2<K`6.D&Y6H8<'9DNF_.6!HQY#,JLV(<5J1W,`4TYY?I\
M:I_4$W:EG=S8'OOJF2="QR8Z2ZBI8P8Z:"E8TAO;J7%%-EFHOP<"VU9XV);9
MPE.\^3U,P(M<3:1/5JZ#`I<H%9_/!Q8!UO2'ZR[\^:F.))[]RM;EI;QMJZLB
M4JZU:\RJ2K%*S&ZQPJSS40NM[B`T6V3)UYD76<T.VO2FY//?;QA(*1KRY!3E
M+-,0&%NL`*]>BK`T10L$`H)E><@$SW!<+>0`5RN9NLSV*W6+4%X:&28B==CP
M-=)X5KZ[[TR=Z^[ZW<K<A8]Y3F,S;^C5,";X9*4TVIP)=1`J'?<E9>W30Q/X
M"RY:NKJ"\Z/;(%+3%4['MYC8G+SG2>B#\2X@2KDG>@(M>]#V#7JOKQHLT7B-
MWN-J$/:SY8`[,$,#RINJ_$#+8?BB1>,)'":-8[@22M<4?R7LOIZ8.%3R#*@D
M/L1&JU.PK=!+4GCS1??`R_1\!T3"CM<2BK%Y)M"OC+'*\H#&B.FUWI.X4U[R
M^;..$C>>L*&4[JA);TCT98*QF,C);`Y?9+.4PB@E>9,R-5@(*@)H`V'^%/NP
M6Y.(&I\>I6,.X&9I$7J;S]LVG:;MU<,+HRFAA0';,V?&BBWS4WE/G7`;7\$M
M'W::PL^.,6Q>4AKDP;J953/L)_9JMF[,@WIY3BVI`U4FS/CI3!H<MK_[F8PB
M2OR?2V/M^7=2D07:7D>)15U6]J3:7]\3*)'Q(31](:<3'+!!7\4@3?4.<`?Q
M-QCXBH"+[["P&_]4QI_Z)Q)^T5<,G8T)`</H.G%!5B:(C#N@.2[#BRF;,+W_
M]7`LS9LQO*LB;:0`>]1::GM2!;\S+.A(@8#!&)D`R#@U@+=6?PWNY-#S4XH&
MS`-=\9!E=6[,E96^=4M_V5T2Z7Y)8MCZ$.LO-C``9/F`,CX'^^P8/=T=-7N,
M@+"@"948U\;"BC'!?^']#"<#.*BSC:C31*\(U[`A)[^$*XG6MOG+G"%R?9_`
MSH="8U1V((M-B>/<<':FYO4EQS!6CY#*<<J)&<AEG+*'-WHW(=?",6#!LQ5;
MG36L7T\;:3%"8-'C,OQ(T9-@MT[#$,B2D7O\NE?)H$RXD6_G,K,A@R)-O0D3
M*LGT*>%08TX_DAJ[#:F[D4+&R[IC`N$)=$:,(;J6(JZ34*-UVI5BDE!#/?,-
MZC?CXL'TY':GZ#\DAM0[(Q6(3RAT\VAIO(-&2L,7S0DODH9P0,5D#,0,4&UY
M<?&=(2;D_J[VIV#9V&:<ZX5VF1-<08I.)6@PXR05`$R/X@F/HC4@8*VE`/!A
M>5Y1\4&QYY&A!5KX@<^^7:IY&L.!>P42G;0HTT+"1'Y\HLGVFC;#RYGJQ.14
M?[;>4TTW\$[AF.GEM)(M.+)992J?1[*$K-4]1@K"'K#`H$F(9`0*Q60[$O!/
M,E.67FPJ<L#/:2RH]H/:L]%^9YBW69"TTVQ>>DR$!E^GHA60W1S%)#+,7M*^
MX>4`"A*9K^6D3$R%KS$9]@J*K$&0N$8*,9QQG$C,5:HRFA!@V;(D7@Q-(`S[
M&FW>$,Q'A9%<PN:E[TN33PC!IAR"/`"2MS,$8V&SB2J1M"JK(%P`)^V5LN[)
MRDM%4Q2FCIR^CK>YJ.9:@Z:LG-E872%2YC'#'!Q^8$#&C)8`>2SZ'N!9N#1U
M_J7V;<1`47XX.X>!%,6NLU@8NV=DA>!IR#S_26%L6WO`]M%BHJ[=:A11*0W?
M=#2>SR<AY.9V'-WQGI%*![T";7XJA+V[5O!@\K)A&<#?5;;V2*(+K1U=S&9N
MUJ_\O_2EKN8C7U+:>CJJ?-S?>2%>!G._Y`-]T-<RW:9@77XS2:HWX:.H%?Z^
M-3->=7]/NV\]H\\OPN4?+GO5:!HNA[\/JYY<[^QH.N^[VH[JJ7\Z<_V'9>]&
M'SN/67ILG7_LQOQX,J[HV9A_&\J3?%O^[.9'+XF'O_[Q8O!!WB;Q=+VB*6"+
M!/2LV/@U/`O?K/6>[M=AGZW#0O_X'_U=[Y?>V\O>RX^V;_N7-SU;C:II-8_>
MD2]RN_]A')Q3T6,O\&]"QPNE?D(#,6[T7>8>%]PSGD6X$$CISVW69;S\Z%B>
MLB-]MX8R]8;`16\T?P_?M2(X`>0?39$,?S9$*_/!32B-XH2`^A=%R;\!Y&ZE
M9PIE;F1S=')E86T*96YD;V)J"C$@,"!O8FH*/#P*+T-R96%T;W(H941O8W5M
M96YT($QI8G)A<GD@=F5R<VEO;B`R+C8I"B]#<F5A=&EO;D1A=&4H1#HR,#$S
M,3$P,3`V-#,R,2TP-R<P,"<I"B]-;V1$871E*$0Z,C`Q,S$Q,#$P-C0S,C$M
M,#<G,#`G*0HO4')O9'5C97(H941O8W5M96YT($QI8G)A<GD@=F5R<VEO;B`R
M+C8@4$1&($9I;'1E<BD*+T%U=&AO<B@I"B]4:71L92@I"CX^"F5N9&]B:@HR
M(#`@;V)J"CP\"B]4>7!E+U!A9V5S"B]+:61S6S4@,"!270HO0V]U;G0@,0H^
M/@IE;F1O8FH*>')E9@HP(#,*,#`P,#`P,#`P,"`V-34S-2!F(`HP,#`P,#4T
M-C0Y(#`P,#`P(&X@"C`P,#`P-30X-30@,#`P,#`@;B`*=')A:6QE<@H\/`HO
M4VEZ92`S"B])1%L\,4)%-41&,S9#0S%#,T8T0C$T-$$T0T9&-#$Q,D-&1$,^
M/#%"135$1C,V0T,Q0S-&-$(Q-#1!-$-&1C0Q,3)#1D1#/ET*/CX*<W1A<G1X
..<F5F"C$W,PHE)45/1@H_
`
end
</PDF>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>exhibit31-2.pdf
<DESCRIPTION>CFO 302 CERTIFICATE
<TEXT>
<PDF>
begin 644 exhibit31-2.pdf
M)5!$1BTQ+C0*)>+CS],*,R`P(&]B:@H\/`HO3&EN96%R:7IE9"`Q"B],(#4U
M.#@V"B]((%L@-C8Y(#$U."!="B]/(#4*+T4@-34T-#$*+TX@,0HO5"`U-3<P
M.0H^/@IE;F1O8FH*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`IX<F5F"C,@
M,30*,#`P,#`P,#`Q-2`P,#`P,"!N(`HP,#`P,#`P-C(Q(#`P,#`P(&X@"C`P
M,#`P,#`X,C<@,#`P,#`@;B`*,#`P,#`P,3`R.2`P,#`P,"!N(`HP,#`P,#`Q
M,S,Y(#`P,#`P(&X@"C`P,#`P,#$U-C@@,#`P,#`@;B`*,#`P,#`Q,3(Q,"`P
M,#`P,"!N(`HP,#`P,#$Q-C`P(#`P,#`P(&X@"C`P,#`P,3$X,S$@,#`P,#`@
M;B`*,#`P,#`R,C(X,B`P,#`P,"!N(`HP,#`P,#(R-S4R(#`P,#`P(&X@"C`P
M,#`P,C(Y-S8@,#`P,#`@;B`*,#`P,#`U,30Y-R`P,#`P,"!N(`HP,#`P,#`P
M-C8Y(#`P,#`P(&X@"G1R86EL97(*/#P*+U-I>F4@,3<*+U)O;W0@-"`P(%(*
M+TEN9F\@,2`P(%(*+U!R978@("`@("`U-3<P,0HO241;/#9&,S9"1C,R.3=#
M,T(P0C4R,#=&1C0R,C9!.30X1D5%/CPV1C,V0D8S,CDW0S-",$(U,C`W1D8T
M,C(V03DT.$9%13Y="CX^"G-T87)T>')E9@HQ-S,*)25%3T8*-"`P(&]B:@H\
M/`HO4&%G97,@,B`P(%(*+U1Y<&4O0V%T86QO9PH^/@IE;F1O8FH*,38@,"!O
M8FH*/#P*+T9I;'1E<B]&;&%T941E8V]D90HO22`X-@HO4R`T,`HO3&5N9W1H
M(#<U"CX^"G-T<F5A;0I81V-@8.!F8&":RP`$5\,8>!@0`,1F86`$0H9O#4CB
MW%#,P'"*@9^!@7$#PRT_!O$&]A"61AX&W5TU)1]`<D!=US]#:(:S`.2S#14*
M96YD<W1R96%M"F5N9&]B:@HU(#`@;V)J"CP\"B]-961I84)O>%LP(#`@-C$R
M(#<Y,ET*+U!A<F5N="`R(#`@4@HO0FQE961";WA;,"`P(#8Q,B`W.3)="B]4
M>7!E+U!A9V4*+U)E<V]U<F-E<SP\+U!R;V-3971;+U!$1B]497AT72]&;VYT
M/#PO1C`@-B`P(%(O1C(@.2`P(%(O1C$@,3(@,"!2/CX^/@HO5')I;4)O>%LP
M(#`@-C$R(#<Y,ET*+T-O;G1E;G1S(#$U(#`@4@H^/@IE;F1O8FH*-B`P(&]B
M:@H\/`HO4W5B='EP92]4<G5E5'EP90HO3&%S=$-H87(@.#0*+T9I<G-T0VAA
M<B`S,@HO1F]N=$1E<V-R:7!T;W(@-R`P(%(*+T5N8V]D:6YG+TUA8U)O;6%N
M16YC;V1I;F<*+U1Y<&4O1F]N=`HO0F%S949O;G0O1$5014I)*U1I;65S3F5W
M4F]M86Y04RU";VQD350*+TYA;64O1C`*+U=I9'1H<ULR-3`@,"`P(#`@,"`P
M(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@
M,"`P(#`@,"`P(#<R,B`P(#<R,B`P(#8V-R`V,3$@,"`P(#,X.2`P(#`@,"`P
M(#<R,B`W-S@@,"`P(#<R,B`P(#8V-UT*/CX*96YD;V)J"C<@,"!O8FH*/#P*
M+T9L86=S(#(V,C$W.`HO0V%P2&5I9VAT(#@Y,0HO1F]N=$9I;&4R(#@@,"!2
M"B]4>7!E+T9O;G1$97-C<FEP=&]R"B]&;VYT3F%M92]$15!%2DDK5&EM97-.
M97=2;VUA;E!3+4)O;&1-5`HO6$AE:6=H="`P"B]3=&5M5B`P"B]!<V-E;G0@
M.#DQ"B]$97-C96YT("TR,38*+U-T96U((#`*+T9O;G1"0F]X6RTU-3@@+3,P
M-R`R,#`P(#$P,C9="B])=&%L:6-!;F=L92`P"CX^"F5N9&]B:@HX(#`@;V)J
M"CP\"B]&:6QT97(O1FQA=&5$96-O9&4*+TQE;F=T:"`Y-34U"B],96YG=&@Q
M(#,V,C<R"CX^"G-T<F5A;0I81^UY>WQ4U;7PVGN?>68>9R;)S"238<[,R4S"
M3%Y,""$A)).G2`R$AY(@D81'Y$T"B((/`O5%T))6BZ)6\%FKO3(Y@SJ`C]12
MM54+U5KP44"E5EL1;B_:5LC,7>=,0&C]OG[?O7_T?K]OUI[UV'NM_5QK/TX"
M!`",T`<,6J?.*`YU_616%Y9\@#AE_O*NGJWM$[8`D`)$Z_RU:X2>/__[%0`T
M#*#U=_=<O7R1T'4&0+\(0/7GJY>MZYZ_UA8!X.<`F/8O6MBUX,A5/T=;MX#M
MC5N$!>F<<0#S;9C/7;1\S77+]]"3F+\!0+QYV<KY73]X?'L_0#VJLR/+NZ[K
ML36G_QB@`]L$8477\H5L^WMUF#^(XXGVK%R]9L/.&R2`N3>C_:<]JQ;V+%TQ
M`?M>OPP@O1:``_H\J$#+H23GSG'HILC)>8"_@QH$"(,`,[6`EF]H/&2OHB"0
MM#6@J/[[6O\([)\9Y((?\D<#%,B9,2&`,BC_9W7^1X'JN^!67:9@#KL;G`")
M#Q&/(WX:GYPXJUH*8GQ)XAA+QQ7+3>((^.!FG/^GL`U>@@YXG3)H)$70!AQQ
M0!904@'-A`<[J(@>\D&$9FB%3)@,OR=&V`5CX(^D"382'TR%!\`+4\`&M?`]
MV$DN27P&&^%MLAB>PMI/D##DP65D4N(H3(/6Q'/8!\`$N`?N(R9PHT9/Q,01
M;&$UW`9[X;>0@-EPKVHGMM(*TV%%XCF8`[\FL\F5B1RX%%;`37`O/`0OP'%R
M.QGB5(E.=-H\6$4T))WDLTV))V"\ZK#NF<3^Q$'@T?XA;/5S&N2:$E]@3'W*
MD<0B#(QT*,6T`AZ&9^$#XB!EK!Y,,!;[ZH`;8!?+QS%.@LTXM[WD>K*+F1*/
MXFS*83YL@&/D.C)$/:K#JE.)]6#%^8W%D?;#H_!3^!G\"5MK(C/9\GA-8@K&
MJQ:"T(@]W0RWPM.X<B]CVD_,Q$,NQ99_2HZ0#]D*]@FV_",X`5_!7TD^64QN
MHC5TDRHTO#'Q#,9H&8Z\$6<_"Y;!3XB?A,F56/<!>BV]B6Y@S[(/N'SN9&)\
MXF>@AF*TW01/XKQ^!6_#(?17$VDAOZ4WL:CJUL3U.-YB6(2SN!D>@SWP)5$1
M'3&0#"*04E*.,[N>#)$/J8N*M(W-8[M4=R36)>X$#\9*!RS$FDO@.W`+/`<'
MX"/X$YP@V5BS&&O6D%9R)]E*]M,#;!:;P[9Q86X;]Q3W,G=695&]'/]U_!BN
MNMQ.";1@ZH!N6(]K'</T,WB/,.(DH["EB60RMC27=),;R`#Y`7F$/$Z>):^2
M@^0S<I+\C3KH'?1NNH_^G!Z@!YF+!5@#V\'>X#S<>]P93=>P*_Y2_&0B+1%,
ME"8&$@\DWD^<4+R0@Q%?@T?;;%B*Y^W-,``_@!_BFN^&-^$=C+NC2CH.I]`'
M9X@:HRD+1^0E(LDC!3B[6:2-7$OZR5WD4?(*^9`<)V<I4`/U8@K0<70RG4,W
MT<_I6:9G(JMEU[%[V%OL:VZ=*H3I*=4SJE/JXQJ?]HVS]P\?B4-\<7Q;_/Y$
M&<:B&B,O'??<6*C#F)N,7EX`O9A6P5JX%M=H/:[X`Q@YNT""??`:O(%K?P#>
MQUM"'J^</D-/G(9AB!.*_E01+:;DV$O0,_48+9UD(?HVF:XGF\AF<B^F^\F#
MY"%<WU^3M\C;Y"CYF'R)<P):2&OI)3BC5GHE[<`TE\ZG&^D6NAO3K^AOZ?OT
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M]\%VV`D+23F.;@$\`U_#]\@>)I!G,>XVP$'X'(Y],UJN>+B.UJ@==*VZ$CVT
MATQ+O$I')_Z$N_Y#<@N\S[[&V+^"3"'%\#A\C%Y_AXPE;B[..>'7>/*-@OLQ
M:O\`4=R#O^1R<0=]"7O86)C-'4.?%P__(MZ@6L.^0[ZBM>A.NW)R3Y5/8SR#
M[\6S2CY'3;`+(P%/$65'_PG>)%Y<Q;?5[\%]L!7VLDSPL<=H'TVPUS@!O@_'
MV&78ZXUX/N60L=C2<EB,\Q`2G\0?Q1:6P'@83^:1V="`FDDP*K$<1_XXGD7A
MQ)S$=E6[*@B_(I>13'@)3R\'KN(VE2Y^`BUWXSY\'R:1+1"-+X`AO%<<Q$="
M&$TG5&M5`ZHG5;M5+ZK>5(^!ZW#7WH]>_`A.XZTAD/FX%G^$OV"LU^'N*<#]
M4XNCF(1WV#+:SEZ`>I(-/7@&YN.Y78=K,!L]N1I;V01WX'YZ#.^07\$IPI,Y
M\"(<QIUCQWT^'_O78CO-<#EZ?34\CJ?C=T@42Q;`*`C@.GU-3&0\78/]R>?L
M-CQGAW!,'\`G>'(DE'$5D`FD`;TW'_XB[V7L81RTDD&\DY^%"KPI&]@;\'O(
MQ=NU#O?HHUBO$V/#!"ZH4'U,*!3$IR3&T\7L!6+#V]"$4343;_:)I!='8<9Y
M#$,FF0IE\4NPM:?P+&M5/8:W;Q!OADR:R<U278[C?@]OLE_!JD0;N4^#.R!<
M=_G,<$WUQ*H)E17CR\O&EH;&E!07%18$`Z/S\_R^7-'K$=RC7#G.["R'W9:9
MD6ZU\&:3T9"FUVDU:A7'*(&"1K&I4XCX.R.<7YPTJ5#.BUU8T'5!06=$P**F
MBVTB0J=B)EQL&4;+[K^S#"<MP^<M"2]4055A@=`H"I$W&T0A1F9/:T/YS@:Q
M78B<4.0611Y09"/*'@]6$!H=BQJ$".D4&B--:Q?U-W8V8'.#:?IZL7ZAOK``
M!O5I**:A%+&+/8/$7DT4@=H;*P<I:(TXJ$BVV-`8R1(;Y!%$F*^Q:T&D=5I;
M8X/3XVDO+(B0^OGBO`B(=1%S4#&!>J6;B+H^HE&Z$1;+LX$MPF#!4/\=,1[F
M=08-"\0%77/:(JRK7>[#$L1^&R+V]<<=WV2Q<6M]VVT7:IVLO]&Q6)"S_?VW
M"9&=T]HNU'IDVMZ.;6!=ZFOJ[&_"KN_`16R>(6!O]);VM@BY!;L4Y)G(LTK.
M;Z'8*)=T+A$B.K%.7-2_I!-=D]T?@>GK/%)V=GA/XAAD-PK],]M$3Z3&*;9W
M->0,9D#_]'71K+"0=;&FL&"0MR07=M!D'A$,Q@N%A>=UBJ28RU+S]/,K2^01
MB9=B0$2$^0*.I$W$.8V7R<+QT#]_/)HAM!.L%5F`'ED<T=5W]O.5<KE</Z+R
M\:+0_R5@!(@G/K^XI&ND1.WCOP19E./D?*BA_IP<"08C@8`<(IIZ]"F.L5K)
MEQ46K(W1'6(/+R##Y8-67-NN]LIB7'Z/1W;PEE@8YF$FTC>M+9D78)Y3@G!Q
ML#U".V7-T#E-YN6RIN^<YGSU3A$C>;?RU9,9T?K/_\R\+;UQ466$V/XWZH5)
M??,,L7G:[#:AL;]S9&V;9UZ42^K'G]>-2)'T^C;FI",2=3)%BT$YY[RQG&DS
M1#@?_M1*4"^(:;08E4H)$9HB?.>D)&W7>SS_AY5BB5-R+85]4VUDF)'*X,7Y
M"1?E+QJ>H9_A@#D_;9XYN[]??Y&N"4^@_OXF46CJ[^SOBB7ZYHD"+_;OP?=,
M7G]/8^<YC\82>[<X(TUWM.,D%I%*C%8*=8,BN7W:8)C</F-VVQX>OXUOG]DF
M44+K.^O:!W-1U[9'P$-7*:7G2^6<(.?PRPHC7:):1>7<$P;H4[2<4J#DY\<(
M*&7:<V4$YL=HLHQ7RA#DC5X_L^U"%RK[HKT00X+B]P^H(JI%\JN;E(3O\O)I
MUIIN?BU_K7@;?ZOXI/$Y7K/-&#52DBM2\(JB1V]*<^GM'H?+GJ8C.JIUZ6R6
M3)>-Y.K!:ULMFGE!!`_OH1Z1>@HM?(;%PHM4]-!\DSG#9#+3M29BTJ^W$`]>
M'YQ-]%A,E"-VT>S-S5<^^(_S8=[,[#:;'B\6LXW8]I)-()*BL"CHLTK\/?X^
M_T[_0?\Q/VY,O^`/^UNQ9,`?\6NV+G<$I_3R':>SLEN&3W2`HZ:*QU13E<T/
M=U0-5UDJ+%9[!9%)A[6BH^(V4U%0>R._'[E#%CKV!RT5%?AS`'^"\$-)VG%A
M1L-756FJJL:40`?I($'BT:@S,^PV>Z:G;-RX<OP\LB4SI:'R<65C\_QY>8RQ
MF7%/14Z1<TE\XJ57-9+?IY//F@J]U<,]SJF"34USEOSR(-ET<UVPPLEK?;ZT
M^?=SE6>>>'"T6^7SV?A1UG1=W7^0M^.%Z-QIB0]5L_![/9>X]H`MT1?5Z<?F
MQ))</<*-R,/M*!BR=<YQZ2W9M]JV9&]U;L[1+K4LM:ZSK+-NMOQ(_83Q,?NK
M]M>=>K4-_/6VVIP^VRWV6YTWYSS'[1NE+_8O<E^K7FM<Z[PU?:]94VZR6'-=
M,)NZ"(F1C#"*GA];K";5$A<S+<G4D;G%%F+)[O$3O]6W8@\)`?J!KV\+Z\QZ
MMY[J6[*R3K=\UN&,)J43[5/XCJ\Z6HY#S8F:$[C<GY_&I3UQ^@3POQA3TCQC
MW6!(6[\NG&O+41L-?KM/J]/HJ-KI-]KT/E#G($ESF'R@RU;Y2#"(OV`@&-RX
MD73T0D>OG`T2B^CWBUZU[!RKK30TKCQ3K1:]N;1LK#6W-&17BE2S\@I.W;OA
M-V-JYNQ_H.^=M:O^\MB[\5W/O4[:7]ZZ8TZ64*Q1+8T'8ON_O_:>/<_&W]G>
ML_F::Y<^39IB+Y,Y0]6YQ:7RWYKP"X3[6G49C"%3PB=L7):."J4EI3VE`Z5/
MV`]E'+)_8O^+7;=.OR;SAJ+-[/L9JLWZ>]F]^KLRGV!/Z-5"1F-FN+2U=!U3
MZ9E>3TO#&8::N[D'=(]R3^L>SU`9"&BF&0RO:UT:07`YO-[@M#%C/BQP!=73
M"'E=Y5)[!-=HKTC48-`8(9/'IYTMF)%I8W:-W1:U%CG&Y(\F10:#8S1U:-4:
MLV:JAM8@V:K9I3F@.:I1FS4K-503*MT5?"E(BX,UP:G!N<&5P0W!K<$=06WP
M.[RMQS9@8[;L<"DI!;/1;:3&:H^0%9KXC.SATU4MN*]&G-G1:\$]U;NJN`IJ
M:JP5Q2=X3">J1G9<10<B_H+HZ,^!'QYAY[*,5XULJF!O!P+T$HOLHU*+6$1%
M2X;-5JID67)GX=ZRR)O++XIE'MG7*-$BY\8UO-]O:.GN2A];.>W%WX=\$\\L
M*YR0FVU*4^F=_KI";J7?M;AS_'U<?/CPPP\.5ZZYNS2^J2<D1';'I_DR35Y'
M-[MA3J:8GN.+K[RK;Y05_5N$_GT<_5M`/.$6#:?3%S!OVN0TE5JEUONIG_DY
MO]Z?YC=,94WZJ6G=^K7Z6_6F]:,'BI[AGM&_PKVB_X3[1/^5ZBN]WB2X,KRB
M2W!E>KW^:04%,9H?7I+G\IOQ0UQVLLZE!0W13*/T=;5+,TIPY7I%K4;CIX:I
M1CJ5^%_R$5]VI(@4`3&:36X3-56[S.#&$[QZU"A75F%&9D%^+LTG^0:C,3?#
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M]'B&/+3$$_;,]?1Y(IA13UR+&P"C/<B?EJFR$:`&KQKY^,'U"/K^<>:9HE<C
M'TG*RM`O+IPP_;DLF]-P(7P733(IG[T999RI"\__>W"F'M(K6:TXPK]*Q@J9
MA:\U5/`Y.68^Q^4R&RM=6F7>=J^75KHT7M$BN&R7C=S*&($>/L=.S"Y7-9`,
M/,1<3B]8S"9"7':/%D,.J-VF->N(?&,;R5PC,=[8*A*1M^3G@).T.@DX5^+Z
MW>A5%H$_W=NQ"N>/D8+QHDAR>"6O7FN%LOF5K2_?MK=Q-^X'+'0D;U9YL6[C
MJV[<?QN_G\CK5M^V!S^!(^%@>AF8>7,YK!)Z/'U"G^=[,&`>$`8\NV&WQ\@)
MG"?`Y:5YTP/9:CZ6N%)*+T/V>#C=6L81X#,(SP^0G3D1/I*C!>R%]'8$V_%%
M^0ROS7#6H.FQL,[JJ`&M*;T&\`TYDC-GU)ACB3]$T0;Y>Y+)7J-<)T$(!ML)
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M`^1SI5=^#H3-%QE86TXD52?:E8=!\BDP37X*5)%1O,_ES_#K?"I_5K8CFZK-
M1JL/U\GI(YE:E.QJE"P&DX\8<RA2DJZW^2";0Q(,5F%2'!E0O(DO!>CMP'#8
MK55;*U2QQ.EPFK6".JP5!D0:2WPJ62H,L<3GR%1RSEBAP]R@L0*"(]!.SDD8
M6B07++R&>H0\OX4'%6YR"R\_,<K'6<MXO"/LI('\X)[7XG?%O__:@^1^,GYO
MU]3UEV^_NK%MWH+[57,-\17QM^+Q_?&S?]U/C*2(W'79BP_$/X@_]OB:4)AD
M?81E:2ODE[H?7^KOXNX7H9!<%ZZY/'M5]KV93"LZQ.;L2W(N\7;ES/=JK*`"
M-:_BU5Q)\=7.:YW7>F\7WW"^+AXLUFZW_2;[;XXS66>R5<5:0XR^LQO/!B]1
M!+57-*(0KL`C4\QQ)MU7*'HS1-&[0=R"#W@(Y'B<?=[CWM->QGM;O0>][*"7
M>.V!'*_H]Q4Y8^2CL%T$4.<6%J6G6ZGPEL?C]:K5&BT>I405UAD@P`=HX(@]
MQFC89LCU^0#,Q$TH*3086N53IFCB'I*%]Q./]XY\!\DG"#\LWT?RV:KD3B`?
MKE+NK&'Y[I)/E]Y5'17RT[ZB0SYB.DSXHG<HIS!&CI!7D)&=Z<ORY_L*,@+%
M)"\;2=!66$Q&._S%D.WDJY)/2/D%*;_IY;C8`_EXI*89*H):0T6.(SVSFB2/
M@`ZT4$YOW/>A<2,G>YDG9+-E9N#1/O+X)TRY",O&XBTG.!LZAB=?5>]$3M=^
M=7Q@6>,-I"GL'#TN?GF\N;UB2__4[SU$E\1O7E'A]?G$\2M8CRPU/'?]MGG5
M[GA9N\W-?'0)W3[\=.DM2^^_6WYS3L8X,&`<"/"3/>!-#$4=V6.]\FTU@;>.
M%;QA=,Z0ERM!@9+?:31G\=GN$%R\UZL37&:OZ/Y==O;942ZW)CL?!,J;M=!#
MY'=](.S%4]^MH[KJ+-Y!!$>K8\#!'`+O)H*[U;W!/>#FW'M)`!STZ:A'WNS\
M5WCY5?&(Z*S3(Q?@<-6YM]VYQQU>A[T=(X_RO&][&2CWHFA1&7*%*0W^N0OM
M]96%PY7)&W'>YNI9=K_JLOCW-JST6,_\\9M+D;-53MM&5H+RIPV5Y?.<70N7
MS#57?:G-TBI_/W_XX[(FF;_V<NG4,YN'[^!!6X99'9S[7S)RC2?>"+-X.+/Y
MZZ,\G->,`+=474%R0/E,3J)2V@L1^!>!ZE7Y>UWATQ1^!8SF/I9?J4E@+KCP
M?R*@N1-&HZU+70&M%[3A'ZD[&?X;P*V&J?_,YMN`W0G-_\PF!2E(00I2D((4
MI"`%*?BO`-F6V/O/;/ZG`/?)_SMC34$*4I""?R402.S5(O*0.C=3D((4I"`%
M*4A!"E*0@A2D(`4I2$$*4J#`;^&W9`?90;>R+B7]]ESB?JYZ1T[J=]7O:N:E
M4BJE4BJE4BJE4BJE4BJE4BJE4BJE4BJE4BJE4BJE4BJE4BJE4BI]DX``&&=!
M.5#E?TX4>"B&*P"T6])K1_X/I85NV0J!@0MI4N90=HW(:I0J40N<#DLJ8=:(
M3,$$WQN1&9;O&)$YE-\=D=502=(;&EL;)U\:G+EX^<+54Q9>.WWE\JX5K3,*
MZU8N6]`R\[^NA`9HA%;$R7`I!&$F+(;EL!!6PQ2DU\)T6(GY+EB!-C.@$.HP
MOPP60`M:3D>+J^$:S'?!JO]&._^*FB.^A(0'?@;?`NAO!0C]-NW_#1#T(>$0
M542MY#7G-5JB4[@>,>U_53\%*4A!"E*0@A2D(`4I2$$*4I""%*0@!2E(00I2
MD((4I"`%_S^":G5/U_R%I);4DT;21"XE4\A4,IW,')PIQ#A#U&`*R5Q*MX=B
M7%HT7W";:WG."GV(%,Q(:Q#G(C*%$@AS5NFZTG`,V:HD6Y%D2Y)L9FGX>32<
M#*6)(<X:M3M"<G%4;PCUR5RKD_,6:79IN%;'6>`*Q<X",Y)<:BU5U"UR*Q:X
M)%D:;6A,UJI+%E>/&%>6NFMS,2\@AA%[$'<AGD)4X^@M4(PX@)A`Y)2<;+<!
M<2OB3L1CLJW2FK;47.OD>-3PRMQY<",6(S+H5/X[&U&HF=/BJFAA*N(.3@,<
MIY=@F7L/-L*BC<I(6318I'`I?W1(44C9.:$7.$:W0QZXL8!(-J>B`:FN;D08
M-SXI1`.%H:.U>@[@)"+E@".0GZP5S2\*G7H)\X3%P4R(7,K.1OD,[(T-1\WI
MH7`MS_X&K8@4(FP0AA`IK&1?P@9$BN:[I,(Q<D=L5U1O"O%H?Q($Q#Y$!CN1
M$B4?1I3M3T;3;7+S?Y#,%J7>4:ED;%*(\HY0:VT&^P#'\POV%HC@9A\A'X7\
M5>0NY*^PU\"HC//1J)D/]6%_CZ#Y(VP=C$;U8VP]A)`_P6X"IV+VKF1*]O.N
ME!\(U>K9C]@-BLEJU@MCD2]C2Z606]C''I7CD7T>U:7)X_M<XC-#+[#/V%+(
M0*OC:&5WFU]@*Z`849Y)+*HSA@9J#2R&TXSALKAQC`1V*#3,WI*P(>SOQZP/
M;*@[P#9")O(GV28ITSVTC_U%,?M*;@7[>Q@C1F91HRDT5*MC#\L1POZ,*_YG
MI;?34?_X$-3ZV1U0@DAQ43]&Z6.4>/8%2E^@F[Y`UWR!KOD"1_$%!BVP$Z@Y
M@3;%[`CTL/=A`'$'RAPVN4["%=RC"+GYH3WL1G8#K@2_#]>.8.E-49U)'MD-
MDC5=,;M!WN`U+[!#,!61XN`/RSMRY3[V764J`U&'4Z[P&TEGP*6[/ND+K+A>
M]L$+K(]M4E9BH[("D1<QB_'/OJ-43D0-EM`&]/Y,S*Y$NA7Q(.))1`[-9N(<
M9L)<1(;FK5&3.63>QV8KE2^53*7N%]@DG/HD9;4F29E>9<R7C`B<67*."KTH
M"U!(`$*<B5-+Q>YI^U@SQL]4-D5:X,:Q3Y.P7;GBE.CXRE#)/C9%68LIDEM,
M%DOI68K0).F2<54?U5ODD30HAD%):U**@R-;D@6B&?:0&^.T4IEM*5)@Y>B^
M<G1-.>Z34L49H2AOQ>A?P$+*C$+0B;@3,8+(H8]#:!Y"'X?@F%)B9N-PNN,@
M@<C0M^/@%"(>-6P,U"!N17P)\1BB2BGM1*187H(]="(=0*388C'F>:1AQ$[$
M/L2=B$.(IQ`U<(`58C^%:%V"M`\Q@G@4D4-?%>`X"E!G90(,:P'<L(%N#U>2
M#;"!;*`;V`9N@VH#O\&B#9?Y"D+A)3(IDDD^DO).78^N3\=*=&%=JX[Q.D%'
M8XDA25-9BBQL55>6OM?RQY:O6YBU?$`]H*$':@W$`D<13R(R.$!XS/&8X\.W
ML0/51ZM/5K,#+4=;3K:P`T>.'CEYA!TH/%IXLI"%6YR5H?*Y9"790+82SDV*
M20W>7]Q<MI)M8%L9YV;%K`9C@>M,ZTGK2V,E:>&TUC3&IPEI="!M9UHD;2CM
M8)HJHAY2'U0?4Y]2JUK5G>H>=9]Z0+U3K79KBC4UFK":.U5;3]_'1=V)-()(
MH0_I@"+QBF8(Z4$E/Z#D.Y'V*/DPTE9%$I&6R!*BB&V]AW9]2`<093LY+R(M
MD?.((I[N[V)9#](!1$K?#>=X2W+#N93/%7(IY))3N>1@[K%<&LD=RJ5#M97T
ML#+*PSC*P\HH#V/-PTK?A[%=E!!%'.TAQ>X0VAU2[`ZAG2Q]6UDGTAY%"B-M
M5201:8DLT4.26&ZNM=/[L<6Y2'<@'D5D4(RT!G&EDG/+%O1^I&%Z7S2O`"]\
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M>8V7>>6F\D$`(W7)E%RET)RP73">%8P?"L;7!>-K@O$AP=@N&"L%-"=_QOO4
M2!Y0Z#T*+7MNK-$]UN@::]Q+\60B5TIFT.VCE%P)1J:7`M7N&-,IC'JD%A^R
M'*FE%IE3:IF.+%MJ684L76JYRUVKHV8RB(\5-S610:W,#5)@(ZK3DDPK!:Y"
MII("%>X8B4L!$=D9J=N%[&NI>Q2RKZ3NL<B^E-GSY#^@FV(SY-^E[@>Q>?)'
MR)>;)7\`/WT*>4QJJ4'KYY*]D]U037Q8+.&K3S;[B13`P9$GI$`^LA])@5QD
MCR?9(U+`C>PAJ;L(V8-2]UW(?BAU'T=VGY2_3&YO.^0K[=P+?H6OEEJ<J.Z5
M6N06>J268F0KI98R9$NEZC>1+9:JC\M5KR:#!".;=$-`&6F7U!U`]=R1B71`
MOJ*>`V5*RY=(+?*2-,F-U!I)X\A$&O`9+ZOKR*#22E@*E*!9M13P(YN87+DJ
MJ3N(;+R4CVM,RJ7\!W'EQHUT,%KVS_,D%X<A-R1*@:?0R"UUCT8V2NIN1.:4
M:^*@TD=ZM4*U,BB+%)"M>"D@N%\D:="MM*@'/[GO6?<PMGNF.D:ND-Q?AV-:
M(KG_DH_L6??G+?/<?VJ)X8O7_4?<PD\]ZSZ*ID>J40RGN3\(''>_W^UU_S*`
M%F&G^Q>!(O?/_.O<L?Q][FC+*/<@#BS2/<^]JUMIX6D_5I/<3^3'*,':.[LO
M<]\;"+KO\<?D,7P?C6^3^\"&;@FL<V_R;W1?@Z&PIF6S>W7`Y>[)O\J])%_N
MR.Y>')CN7H03N1KK+.R^VMT5N,O=6::,^*K`F^X99<H<FKN5&5U:K2@F=4]W
M-^$(4%$C*W`$$S`N0UBUJ&R?O$;X4JF/ONF^O/QYBK<PZ4-<%2[2O*"Y23-/
M,U-3A_=-GL:G\6A&:3*T5BVO-6D-6KU6JU5K.2W5@A9H1BQQ+!P$/+TRU+S,
MU)Q,.47FJ4R1R&\22K04/[0BZ:R9-L^HBY0'FV.:Q/3(^&!S1-MZ9=L@(=]M
M)\V1H?G0/$^(?#5#C!']M-D1E5A'(M9F:)Y9YT#C"+T]1F!F6XPDY!JW."/6
M^K8]0$C!+7<Z9=YTRYWM[6!;6^.HL59;*IH:OH5TCM#&AN`WX`A>"(Z@*[*M
M>49;Y$E7>R0D"PE7>W-D]`QA3ML>NHPN:6S80Y?*K+UM#UE$ES5.E\O)HH9V
M-)N@F$$U78IFT"(S-*-SH%HVP_(Y%YB102QN&*RN3AI-)8.R$6Z:J8K1[*11
M_85&;`NI5XSJV1;%Z,%DAP$<!W88EAF:J99!0.DPH%JFF#EDLT&_'UOJ]LLF
M@R$_&@SZ0XIZVC?J_*3ZWY+J?Y/5,4*^T9?YDZ/-![_2@Y_FHTWP7P@+Z_Z9
MQ;<`B4Y<NZ*M<:'8V"DV+D3LC&Q9N\@1Z9LG"(,KULH*(<+\G?/F+Y)YU\+(
M6G%A0V2%V"`,3FS[%G6;K)XH-@Q"6^/,ML&V\,(&:6)X8J/8U=`>G;)Q?.]%
M?6T^W]?XC=_2V$:YL?%R7U-ZOT7=*ZNGR'WURGWURGU-"4]1^FJ>7D>:6]L&
MM5#77C\GR:,T38^[I=/I::^S\3W5RM:9X''<Y-S+`7D"TH+M$8-8%S$BRJK"
MVL):685;6E:9L-@\HG+<-,'CW$N>&%'Q6&P1ZV"-HW%Q`_Y6(ZQ9<PT"KO'J
MU<FU=B05:X*-BAX-UJ"T1@&T1%G&U4KIB'X-7/,-!(-)6U@=K&\;;&EI="QN
M<.(C/BJ_NX/MJR$83'88#`+VB;-6'OHVY:&?IK:5OM/R^Y8O6]B0\L(_B'A,
M>>$/X>O^(.(Q?.&/8D/5!ZN/5;.AEH,MQ]#VR,$CQXZPH<*#A<<*6?G(".2N
MV@F.\)MT37#U-7)QD"BS5>8M#P0'C8(\ZW/+L%I1K%$6!B%9KE0-8D/!\]6#
MWPBKD\IKE"K)TM7!\X`*N?DUUP3_$49*\0C^3XD3DEP*96YD<W1R96%M"F5N
M9&]B:@HY(#`@;V)J"CP\"B]3=6)T>7!E+U1R=654>7!E"B],87-T0VAA<B`Q
M,38*+T9I<G-T0VAA<B`S,@HO1F]N=$1E<V-R:7!T;W(@,3`@,"!2"B]%;F-O
M9&EN9R]-86-2;VUA;D5N8V]D:6YG"B]4>7!E+T9O;G0*+T)A<V5&;VYT+UI7
M5%I902M4:6UE<TYE=U)O;6%N4%,M271A;&EC350*+TYA;64O1C(*+U=I9'1H
M<ULR-3`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`V-C<@,"`P(#8Q,2`P(#`@
M,S,S(#`@,"`P(#`@,"`W,C(@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`P(#4P,"`P(#0T-"`P(#0T-"`R-S@@,"`U,#`@,C<X(#`@,"`R-S@@
M-S(R(#4P,"`P(#`@,"`S.#D@,"`R-SA="CX^"F5N9&]B:@HQ,"`P(&]B:@H\
M/`HO1FQA9W,@.3@*+T-A<$AE:6=H="`V.30*+T9O;G1&:6QE,B`Q,2`P(%(*
M+U1Y<&4O1F]N=$1E<V-R:7!T;W(*+T9O;G1.86UE+UI75%I902M4:6UE<TYE
M=U)O;6%N4%,M271A;&EC350*+UA(96EG:'0@,`HO4W1E;58@,`HO07-C96YT
M(#@Y,0HO1&5S8V5N="`M,C$V"B]3=&5M2"`P"B]&;VYT0D)O>%LM-#DX("TS
M,#<@,3,S,R`Q,#(S70HO271A;&EC06YG;&4@+3$V"CX^"F5N9&]B:@HQ,2`P
M(&]B:@H\/`HO1FEL=&5R+T9L871E1&5C;V1E"B],96YG=&@@,3`S-C(*+TQE
M;F=T:#$@,S`P-#0*/CX*<W1R96%M"EA'[7D)=%S%L6AUWSO[JME'HYD[HUFE
MT3J:T6[I:K,E"^%%,DBR95NV9;POV`;;8"Q#`%LFD)A]BR%``!O02++-V`:L
M),Y"$@()68!P6%[,%A"0/,,CP9YY=>_(&_"3_\][Y[QS_IMJ=5=W5W7?[JKJ
MZFH-$`#0P"`P,'-&9W%DX8E+=V#/ZY@O7KRZ?YUM[^>7`9`"S(;%5VQT2Q2/
M70I`>0#9'4O77;::]![=`Z!X!4#RPF6KMBS]A2]5`J![#,"1LVR@?\FK/VP]
M"I!_'.<K7X8=VE+F.6R?PK9OV>J-FV?+F0\!PFX`\]95:Q?W-[T^I0V`OP_`
M^.O5_9O7Z8*JRP&Z5B&_>TW_ZH&_V#@<WW43KN?Y=6LW;+SIB/_/`)=T`Y@,
MZRX?6->WZAH+P`KD5TX`L$!.@@3D+-:$UAD,2REB<A;@*U"/`#RX8:,<D/-7
M,@\Y(A((I'G56)5^==37@?E7#``!@#R``K$>^1JU&:9":QNT7P0P8^8L[)@#
MEWZ-Z7\2)#=CO@@XS#G,>K`!I-[&_+Z0D]-3IR0KP9M<EOHWI@Z9;Y_,:?##
M8W`S4<$VN!9:<.\/PR]@):R#63`,M?`I^2-,0U7YX4H4$`^GP4+Z82JIP-;-
M8$W]`BES4Q_0=U%!=\,.^!ML@C_`8O@I2.$>4@8^J(1?P93496"4O`+E<`/<
MGOH3R-@H/`*OI%Y/):$5O@^OD%K2R0Q*ZE"L6^%JN(E823ZI)%>C7FIA,SP+
MXU2O.(CZ[H"+H0NZX3(XP!+\I@1FPC#Y/=.$7^J&W21&QE-/H,7X<60A-)!R
M&DX=`1?D0Q1JH!ZNA]O@+O@C*2)3F%+V,%AQ3_UPF&B)A>228ZG[@,/4`?-P
MI3?!';`/?@F_)!SIHL7,0LGCR?=!"VMQA=M@-_P>_DJ4Y%*RF2:8)Y/UJ16I
ML=1Q'%V!WVF&Z;CN;7`G[NY1.`3C\$.4R2O$26:2.\G'[$9)Y/2.Y&^2;Z4L
MJ;^"#M<Z!Y;!&M@.NU`WWX,?P6MP`KX@+)&3+/(C6D)?8[3L]R36%*1N1*VY
MH1@:4%J;X4;8B>DPCO@)<9,0*2,;R1^HENKH*GH-W4\_8G8Q(\R?V?=23:G'
M4C]&F7\`,O!B"L!LU.HVU-HMJ+LGX"DX"`GX.?P%/H63*,D59#<9(0?)?U`3
M?9+^GCTE>47R:>K^U"E0H;3]>%I*,)6A!*=!&ZYE#=R#FGH>7D"_]0_X!W&0
M*G(-N9$,D9O)[>0.\B;YG-Y`7Z1O,'<PCS-QYN<L82/L"LENR5O26;+^Y!W)
M>U+MN#LCSAU%NZE#&0Z@+6Y`F[@/Y3@*3\,Q7-M_P)<H%R/NUD=JR&RRF5Q-
M=I!;R`/D5=I*5]"U=!U#&"?C98+,3I9C][._85^3;)7L3@:2/:DB$.Q&B=90
M@^ONQK0`EN)7MF+:C7(8AF=06S]#J_T`K?DS^!*_1E'/*F(F'A(D+9CFH-:[
MR7S23Y:1;>0ALI^\1CZF>FJCN?06>AM]B/Z6OL>L9VYE[F7&F)>9))N2J"01
M3.V2'MSO?LG?I'.DNV2-LD6R1^6_.IU_^N>GWTBJD^9D,-F9_%;R:*H[=47J
MRM2#J4=33Z:&4^/B2670=IUH7VY,02C"D],.%\%\7/]*6(\V.03?@>]B>A3W
M,`8'X#A:W&_@M_`&O(GI77@?-?NAN*?/X!3NR4:\I!3MI8+,(XO(4K*.;!73
MM>0N<C>YE\3),3).?D%>)G\DKY"W,'U._H-\00W42(MI!6VFT^@,.ILNI@-T
M'=U.[Z+WTA_0I^D1^A/4\A_H'^D[-,GDH"9:F%:FCYF/$MG"[&`>9)YF?L?\
MGGF%>9OY`F7#HHX\K)?UL]7L9>QU[%N2$,IIB62%9"^F'TE5TA728>F8])?2
M]V5264C6*ILI^X%L5);"DS(,>_"4G@=H<8^1/#H75\F0'],#Y%;R`AUE)ZB6
M])"M#-!"M@!MO`/>I;L8/ZEC-A,'GN-O0QME4(9:>C^=AM8MP&P\Q65HAUV2
MEUDS>13OVQO(,O0W+Z+]M"//3C@"_M0KD`7?3:V$@\2*)VH@=3>>A4'23L;Q
M#%U&U]._L*<8/5KHV\RK:#?OXMF/DCNDOX1Y-(S6-@7V@@6J4)]OP!;BID70
M"W<S.U'3'K!#/KM*@CZ<_(T9A7WT#KJ+'D@]CS?A1^CW>MEI!-BWT._G`T<^
MA*=P;;^@+]-=Y"`K)0^2&;B&'$:.]O$S\-'[88#91%@Z2/^=?05>I56TERD@
M?V-+&8PX4$_700_YD,CA"7('_8)XX'8RB+M_AWQ(WX&-\.\D14\SM]!EY.?D
M9\1"PZ21*8$D?9LLPM7XX&.)E<AI!9XC*=K5NW0?LY3<"R]+?L2\SG8PAX`E
MSY$*>HIQTV;2P52F)L`O_8+1)'^?:H)FFDKM856G/T'IK(=74\>90K:?G?[E
MP2]?I%:RAUDMZ4[]+;E-<AVM@Z62#V138`MM0@_Q(MY%PY!//J'9*'<.>ZI1
M4E;V.U]^26>!DWY*/H/-Y!8\'3[<21=ZCF&XC#R&O!*\F^KQ%O@'W8]>LX/9
MA'[F$!Q':[\:?;N1+L9[9AF9#11O"5:\#^Y!:_@KNQRV8(0V$Y[%VW0_UER2
M1Y(\_!K]WB5X%O]$=N.I:Z55;#=TXEUZ+>1B!-70Q=?73:FMJ:ZJK(A%RR*E
M)<5%A07A_+Q0,.#W>7,];L[ES'%DVVU6B]ED-&3I=5J-6J54R&52"<M0`@4M
MWJD+W?'`PC@;\+:V%@IM;S]V])_7L3#NQJZI%_+$W0M%-O>%G#QR+OT*)Y_F
MY,]R$KV[%FH+"]PM7G?\A6:O.T%Z9W5C_=O-WAYW?$*L=XCU[XAU#=8]'AS@
M;K$M:W;'R4)W2WSJ%<N&6A8VXW0C*F63MVE`65@`(TH55E58BUN]ZT:(M8Z(
M%6IMJ1ZA(-?@HN+9WN:6N-W;+*P@SOA;^I?$9\[J;FEV>#P]A05QTK38NR@.
MWL:X+BRR0)/XF;BT*2X3/^->+NP&=KM'"L:';DKH8='"L'J)=TG_O.XXT]\C
M?",KC-]MCENWGK"=:^+DAJ;N&\^G.IBA%MMRM]`<&KK1'7]@5O?Y5(]0]O3@
M'#B6^J<N')J*G[Y)$**M&!<B+%_82GI3`]X6H6?A"G=<X6WT+AM:L1#UD3T4
MA]E;/*/9V?SAU%N0W>(>ZNKV>N+U#F]/?W/.B`F&9F\9L_-N^X64PH(1?59:
MFB-:W61%K3F_,G"6)M9$=J'6/ONL.(FP(F\;6D'<O=B-*^GVXD8JA6*@$H86
M5R(;0@_!4?$EJ(;E<473PB%]M=`OC(]+_'JO>^@S0+5[)SZZL*=_LD?JUW\&
M0E4PCK/VA?0S]7@X',_/%^Q"UH2*Q#76B>U88<$5"?JQ=YW>C0C%!S.[<5A/
M=3'*W.,1M+H[P<,B;,0'9W6GVVY8Y!@%OCC<$Z<+!<KX&8IYCD`9/$,Y.WRA
M%\WW@/BR,,?E@;-_.KW%V+*L.DXL_X0\D*:W=WK;9_5VNUN&%D[*MKWK@E::
M7GF6-EF+&YNZ&0>=K%$'(U+1$N>=918:W>HXZ\<_J6C)2Q(R.9JBV$/<4^/Z
MA:WILD?I\?Q?#DJD/A5&B>C<L,EEQJO#%[9K+FA?L#SU$(,+9@.TO:MW:$AY
M`6TJNIVAH:E>]]2AA4/]B=3@(J];[QTZC#%@?&A=R\(S&DVDCNQVQ*?>U(.;
M6$:JT5HI-(YXR<Y9(SS9V=G;?5B/D>_.KNY12FC3PL:>$1_2N@^[T=&*O?1L
MK]!R"RUH)VCIHU0NDAR'>8!!D<J*'6)[<8*`V"<_TT=@<8*F^_1B'T*A&%[`
M4.IMR8-X`P3A%M[GTS>IFO3SI)>I-BJO4%WIND%_AUX(]P^H-3\P_-1`I3I"
M$Z2#5\A]>^1E03=C3E#CTUE+;`HP$W."<8W2G21!&D>#.R&1&C]@JH*3V@2S
MG3?D\-/:HSF\J6IO#LD9"`ULLX4OUI_L"X<[/C@=GC@Y<:(/ZD^?J*^=^$A_
MHK0$^M:3/L)X@T6,-Q>#)*G99"F+E%>425EOKB\0BQI\91&KV"5Y<,#'2GRM
M:YK&;MC?/_/=Q.Y7^XK7)$\>_4$*;OB8['UY\57E-ILO7[(RV;:F=GY+<-&V
M$\_\\"<?7KUC^)'=I[[[!GGXTV*3J1A(ZM<8>_3@B[.8M!XTY^JRZDIQ"_QU
M]NJH1&O6WAEX-/`L>S#KZ8",:+5`M#H=R`HTF@5RI\SBM#HMP67%Q?TA9U#:
M2FF_Q"DUZTQ.,QJEW^5S^D&G<SE=)J?355SDIT4:K=;LIQ:SW%D2<CGUTL=!
MQLOHB[(W9506W`.!D@`?F!E8%Y`$LDOA=[HC#`$7T\*K#3HGYRQV,H-.XDR0
M#8=*%/CE$B561T[9PF%];5B4ZGH\)8?!F1H<"UCKG6B@8R&;B'E5(7;PMBHG
MGU45%J"'=)PX?>)B_>?K.TX4]ZT_(<RA'X?ZVGI#57'MA'[B1FU16+)-?]P&
M^@FB'^]+HZ*)CT#_&4FC\WINE.AKMQV7Z6M+2P@JES"BUAAO>2P:\'H908]6
MF:>B7$Q&H3?@K?"DZ<&`E][SP.CF*^L#WP[I9JT]<(6[8J7Z]/N:B[-#1H?_
M$V=VV45J-F=)0-56%=HM84^_-WU+TE`;G-*4O&RUSQ^2^?U4G>7,&V1*%U=F
M^PW^Y.-UH<8.O1)U.X[/C5;4K8O<>H#DZJHLB=0;/*\SU@&G<],YUKN-8PYF
MT$VH@G%2A8$8;$:G@=C!2;*4>F>6S6YW*90FA4)IR**4R!5<2*G0VYZA1K"C
M;I34R&<9=`I.4:S8KKA%(5$,VJH4:#VCX9B`GBZ+*?A`,"K4>6LH-J@85[RD
M>$OQ*7*B(A0\&IM"T">G4%@5G/((V4",<$ZAX7"?J"Q!K[Q9P1M4]0K>I,;"
MHL'"JJT79U;D9&'+91!;8VZC@$434$R:@-BO<XEX-%B5'F3VUBL&=?8T464X
M@^M$[!7;@[P"[4;!ATPB=<24MIT+(6U)Y^RG5K`<[3G+.;^<M"+!2/K6A\/^
MKYN$+""32F6BP5C(WU6G?ZOM<A28/=Z/7-FQ#C55JWBNL-C_H=M>X1?5[BK>
MPD261K-]1K^?Z$S3MY_Z]7K.[C7BVV8K>KCGT,/I,8)]ZJ`[%P5D%=3?BI6H
MO3JG.K?9WIK3GMM%+]5VFN:8>YWS70/F%3DKN"N,6W.NYJXWW>R\4WJ;\;Z<
M>YP'S,><S[H<,JW<2+/*@,DNDRNL@H/+4J-O4_/S8FI^VI*H>@`C3.RUL;RG
MH9[E4<8LTEB!QO+V&)L@UD/K?,0W,,\6UO=]+@KP`[V`/X#ZB?H)E,QZX?Q$
M+!A&4W1Z`<'IE?NLN=)SWK#<@,)B_GKC2U><3BY[[?Z7!YY.$O?@DF//M,_;
M<^?<X057?G^/9.6F=ZYZ+>DYM?O$RN?(AK_?P"]^^]!;/[OY3[VK=Y''$SM_
M@_(I2;W/_)#9A2^)&'F5MRG<<D^,?(M\*_]V<I?CUOR[BIXH.Q16E0@BLZI-
M]0];'BZEY?G3W52=:X^IM;FAJ%:@56&EWCK#NL#*3"DA:AZ;:MSJ8<NK@?<#
M#*$L"Q:+U1\(F-4:2[`X$O!;V%)S09DSD&!NYXT0].7F@BP$^'PV!TQF<Z`X
MD7I]#'54G&"*>$UVMEYE+@\%S'K-D/I9T@0L/G#-^(AEG@X\:1:LWBR8L];K
MCX)9;RXQ,]\1KJ34X&AGS/PLO1T*F!U@0*<X/E84C3K%DXA'TCG8&=OK_,1)
MG9%RL]5<KHS\.'WNTK=3>-*3CH_-#`D>='PL8D]CVV0;52MBW60_+D3$QG1[
MQ'KVK/1T?'`R+)C[R0G]Z<\GSIX4_43XS%$)V^H!V_H3)*LJRU"5585_@!6B
M?_Y&@2['0Z4_?EPX-X!.X7*"T_9!>SR_LSU>C1'-,8BE?@=1S*'4^Q!,O5^)
MT`-]8>$V%>Q&N#/QF%FE4C2I6+2B`JU)K!DJRLLB%FN%#*];*MI7A7`4F1_^
MV,(HY6J-.=B0V[*G+ARVF*];,^.BMA7';MVP=,HLL^\G?.O2O<T%JP?W-S*[
M3O?.U2CT:H7>.=>V;'4XKW1F^_[FTBTK]I+^%5W\],MS:N<D1V]LGO'@']Z>
M<Y$0?=2B[:U"VPL1#3\5!$\6$HHB*"#A8%&H#NI(M:0N6!>ZB>[V[`KNIP_[
M#G)C/CT'V32;M4NR@UQ(>GV`;`T.!7_@82P2DB_XMJR8B"PB0IN([0T-AV@(
M(*2Q9R4(>\#I4\K\:+5C#GT]XM?Y7%>5/\BHX'G3.GM0@T91K*G7S-`LT+`Z
M#:>AFNS\W`2S@W=)D50OG2%=(%TK90>E#TCCTG'I2U*)U)X7OB0=TZS'F.9B
M?5+`$Q,G\#B'P_43$P356*5_O@]U)WAR06L>U%H1:NTH<*@MEZ"M'E@O'GS_
MI(*$.`<]P*22ZF@LBK=D[CD7P#B6_>Z*F_?N)Y[=JU<%<O*X/%VQTNB,+1IO
MGKUQ2<>=\U_;MNF!&^\FH<-S&^L*<D,NH[O0I#)K34/;[[EGZ94=`WC^>=3!
M>M1!-O@AR9?K]"J_36_SLR#7RZFA4SY+04.*?'^EHL;5*FN3MRE:E7/EE^KG
M^&]EO\\^8AQE#_GU04'.4P(Q12[>0?)<O*#D"KE"X@"YPNR&(0<O5]9I'$Y'
ML8-Q.%1>GT$F":I4[FJ=F3-3<W80VJ@@7JL6Q:L=#,VLU_(XT5XMT=H#X1^?
MB17#'7\70I6^C@G126*$TA=."]:`QT00;UJZ?=`GGEL%*EBX*P5%9RGKY9-8
M)F"%NDYHCR).GT[H(WW&,W*U?D7\,FD0_:T8Q>1*3\JNZ6V]_CKSQ!_WW)8@
MEEM7+&V\]/%UQV_KN^JJ6.G2=\B6B*=G6\V`\\/$VMM)Y9.7U'1>M'A*7G96
M7L7=+?G15]'NDWN34YGG)3=#$UEZ&!A<3F]A/2/(T#@G7"_EK0W6QBI@#2U\
M*"_J%?JS[=XH\%BT\)%8"V_!;,.LU4=;!"^CB8U(:5-7-Z_VL&Q+,_'R.(\W
M05;R>I\/I&6W3_$5@OYVAT^A$^-L(=36GP[7"L(K?L'!ASVYP2#'T*9&UNMC
M.=H4;$0_S`5-F'%8>OQYLQJ%6879N.90D-.75U>5EB1H<M1:JDE0AM>7&'DC
M-3[9S%FY9F7D3VF7BCH\/7%ZXJSGFTBO`1>C/W'&`Q+!YZ%";SQ^7'L<H\GC
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M*.^$E0':&2,FO)*-F`FA^>&"`C":REN*>D.QDO(.XBTD10`RM9ISN$T.AQL*
MH+R`*RPR%186>4M966&!TJ9R5(3<CJ)"O6G(F"!-8VJ9WYT@OE&UWW%$N$,I
M,UK^<J%PO]FSHP(>M5:)*"<F]GI]8N]8?E3$O*$Z]DDA*;17.*R%5D>%,G+#
M><^4M'HZ3N#S#Z]$\4:<M`P,'R=NE!2%Y6@1:!FV,&*PU1.#>!M^-A$^13[#
M*U&OW78<[T31/OKZ^MKC$?2HY>A11]RYE:AV(5Q6$)NZJ@BS$LWED-%49\I-
M6T8/(89),V"DDS=>A55+TQ>C,7W61;U+93(OJ1";LACM2;YWZ%=])7S.5FN6
M2I-55<GE;KDTUU_LW6"QFYS^YA[;SGP'?P=I\X8Y@]\LN?E4C!@.-%8TSD_V
M7237&C0%%QMCVTN+_06;R7?:PR:;)?]R[D]3.U]@-U^='9(R08QIH#OU/BV2
M6$`%><3'!ZUKJF.6*ZICAC!OB(5YNR/:HR9V+[%8\UH\O:%025Z'&M9)$\Q]
M?+9:%E+KU'DZSN4QN5P>A\J5'_*X]-8A"RKT@$ZQCE$GR+119J$N0;Q/YZTR
MN'A'S"4HK;HFZII4GDM\&J`V73SG3K>,1DNTQ'6+B[KL^2ZK*U]YY0T71$KI
MT\FK7(+G=O$:+(3)\(7B.A<']0AOA'?UD]H6=2V<?/ED[//YA/Z,<B<C8)SR
MH)7'L%,CJJ_*BMH3J@=U559>=^8-*T;*9X^L\3Q]GHEOSBHT1GZ17UV3EU=3
M7?%3DU&C,U=5>YOG-=?E1>W7NCF'I45BJ<[/JZG)RZ].;CC=-$VK-^D+.ZW+
MIL5*_?Y+R/B:'$N.*BC$+C-01_UX,ITDCY^N`&(`CG!\=JP+NG(^X?YN995N
M58F*5\U4L2IGB[DWE%/B[!!_]W(RG,%L,AC,.I7!%3(;].<85^'C[RA.Z>/5
MC-\`!C)N>,E`#0E2PRM="H/5X%)>>='D&<*;,/W2-Z"<,6HRB$K#`-4@O-2$
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MD$?PR7:3OR0A&(C=G\=K8POSWLRC>0D:/;2VF@Q7DVKA`C;7\-Y8#>_(B:ZM
M(34SE43IKWNRY@@9AU;*'&A_<O;S;6GG+2)O3$2<B,9PD-BTIYOY!6*3MQ9'
MHVO;/FFC;?:N/&N-M<V:UW7.GY_G!="CHTL_.=&GQ[?.1-]Z[#_/OY]]]6"J
M/^OC)>CCM1<Z^Q/X$,(_(4+)2OM]_#O?/?2)D+:W+`UZ^%K,D*NNFHZX7-B!
MKDHGA'BZ*C:-(-W9F4;6R0LA-]=XOJT+@2`CQ@'IRT%FJ#COFK!^[9ZH.#]$
M\)Z]-S#88+S&BLEFD#QS[:53%O3&JB.-UFD/[9DUHZC&L,:GD"J5]JJ(Q[Z]
M-^`MSIO+44:EUN47#VV>T7+G_AR+WN.O?39JGW_;89LLQ&EJ%,RNY)2],Z^N
M=/.1TAE)4GI5<WUC=4/RJNU:K5)F+&@UAVZ*E'A+ODL:UJJ-!KM6&][^SIT?
MT;Y%'D>V+9B"317)/]"=74:%Q:L63@X^$9DG\>24DUO2-V7AY$W)WS=Y5<J+
M+>"@CF)VEFRV8K9KEGL+N:IPE^L'P8=#1^B1@&H>F1<Z1IA>1:^KURT&)BM<
MZ;!$>DG^K-BJ`)Z;"\.2L!B5%*:C$@PJ"P@4[O42#$%8D)T7GH2A/,P5%)H*
M"@H+PF="D\*";PA-!'W.BSD2]/;1V/.%SQ`?A"D#!:*!%Z2)(JH6D7"_%4P&
M*P7IV*5`])$8TGQ20`J$8*7@_Q"LX)/NQ(F3X:_'*]\0K:#Q7DXF35=_0<SR
M3T(6X16R7O@08;XA.OG:;29-1R=GFFAGQZ\_^K-YD0;G5K->H<Z*U7-]G=5%
M_H+<C99L8TYP^@,]Q5SDCD-N;[;:%9"B.541:[PQ5KLD.;=-KS5J\B\Q7E\5
M+`R4;")[VO--=EOABP_.&7B$7K[>:O&P4A_:3#Y>85/09O+@[WP#17OQ8)Y%
MYC#S%?.5L_/V,4_H]MD>R59<GWU[=BK,[&+O9JF+XPBT>/X2RBN!#D)-;LI1
MXBG6$$V"[.5S3?C>);(002:.<WM,;K?'S2E#'K>^1,$K9BH8Q1'*`YZ.T;SG
MW8*NBJQ5;CXZ)>KF"V)NWH<Y%S.&*FX^QQD%-P'W7O<Q]TON3]PIMQ3M9.?!
ML-L:$6_.DVD!(V`L(MYHY]27_@<,=HMNYWS5B?]_$7Z90+\3#AO]S%FW(*@D
M&#CK`LYI1.Q:27J^,WS+K#)/(-=6:/6P5"979>FR8YW]^:Y\J?ONPVZ=R6.N
M9&95)K-)^,KFH+^QMM#%&:5RN99?=%]CY^76:^CJ544&M5XA1!U=&'4L9G>`
MBT@/@P0/ZGKT<A@)/2SYA'ZI9>8XAN!SPOB<U3!7R^C<3C?=CD*@+M#J""N1
MR<"9XW*0[!RGRR:QLT0.EFR[G6696^$!2J1&%1Y!#@-9B\5NX4)VBYZVZ1A\
M&*88PJQRP[!,-Z0]0@C(\))1&RQ\>55TW/*2A5K$"(536*P6[H((10P*=18A
M(K$(D:%%^%>=&`R<QFCOA*"-R7\:G_FE`8].?>V)T^(-@6JPIGT_/@D%#4AJ
M:XG^^;3_7]_7E_Z-0>;]QC/BQ:=<!35=?'_6?4_DZ%7V/%NG9][LRJJ"2O>C
M=RK7[.EE=R0_K3\]NB`GR^`U76:_H2)0$2Y?BX]?UY6W@OC3J"3K(],C>]Y;
MH*O]3&Z7"[^8P4-<XED!__Q'9=VG)*=O4NZ3EV!3(?*G?U,#F2?9`I<JJT])
M_C%3N0]L((/SX8_2*I(C5.AD%H"91P+P/PR22V#H3)W]L_"+6!KH/N$7E',@
MW9<292#Y&6R%_P9@`009`O-MJ,1Z$#%/JY+W3M+R:!5TG^'%^@S\KE?@.W\.
MQBEX)I'>!1GX7P?GVT@&,I"!#&0@`QG(0`8RD($,9"`#&<A`!C+PWP37"XEL
M$!)=?RXQY%\GMIZMEQ!,1Z4O25^2_5)^OY`4BY0IM7TRO:)^17-S)F52)F52
M)F52)F52)F52)F52)F52)F52)F72_]94PP`!4+P+74#%_\=1T$,QS`%@7U5.
M3/Z/3@Y+!2X$!C@LTW46Z]QD78JU.J0"J\">.NB;K%/0PKV3=0;['Y^LLUA_
M;[(NA3KB[[VTJ[>G(=RU?/7`AHL'KIR]=G7_FIF=A6T;^U<M7]S1]5\C0R]<
M"D+9`PT0QMIR6`T#L`$NQO)*F`UKL=T/:V`F=$(AM,%&;*U"KL70@=RSD>LR
MV(0]_7#Y?W&N_\G1HG8A]<F^'Z8\L`2^`=`.1"#TFZC_KT`8L63%4G)>O_2;
M^<\'(L,LQZP@2BQ51"WV:HB6Z"8Y])BS_MD<&<A`!C*0@0QD(`,9R$`&,I"!
M#&0@`QG(P/_/(-FPKG_Q`&DB4TD;F4'ZR6(R0):2960Y6456DS7D<K(18*0+
M&M3,,U""F<?\`.8X9DEJG#DZUM(2X1.(PT4B'@WE10Z+A.Q`9+#!R!R%O9B'
M,;^(F07`DL-,F:-T&(+`(?/A48M#')48;6R<K)17IBMC^861-QN43`(^P4R9
M!',80NE18Z&BR*<-.NP@..W30#`S<L#IGV..05AD.C;JRX\<9@XQ.T:K.5V#
ME1D#/3,*;LPS,:_#_!9F*:YN#-[$_`GF%&86#,QCH_^VBWN.V4M6DGMPUKO@
M5CGAU=QV=KN$;J?;&;K@*(T#28T3ZZA]:221&A\;R%Z*ZQXD&X2.9YEO$:NP
MH-0X'1XM+>,3B(I$-(9R$G$@F,8>?QKGN$4\ZDUSV\L>>`;E%,?\%AT^R/",
M)P\_]+>QZL"4R#/,M4*":CD<Y'C_O#)7`O<Y;PDR?#SF+RHS85-0S/+GF!TH
MHR&QU`I]Q1&]0)LU-Z(6\,6S(KD"GM81T0I33"U3(N(5@6D1@[^I6V0:C90)
M8T;SRPP":\64B.$H3C@%RE(G>;-_2IG-'YL;T?L#T8C4GU^FQN\G4DG>YR\L
M4U<7ET7N]N_S'_$_[V<E_G*D1BHC]NJ\ZLIJQN:WXH0'0OY*/_L,LT-(X)<#
MK^=TG+!X;C-'55Q)&>[JKV.<N.U!(0&'3&:N8H%L6$872(>E-/<)Y%<\48P?
M?IU7/L'E1G*]X=G"EK:/YI6)*%<0RO91EQMG>^]I5[@LXD)A"):V_=!%,R*1
M0$%9@S+U,;,=JG!C7R`.(_X+#JDN<^/(L?JI$9>`BZLC!F&FHC*QB58JSA\H
M8X5FV_2H@%&0(O*4V1#Q:F=9;J`D$LD-E%7B][_@E0'\N"+@\$2&GL-/$6:[
MD""`&ROB*CAIL;1>RNREP_08?9&R>YEAYACS(L.N1:Y;&(9CBIEZ9@:S@)'H
M&F)T`I6[`,N]F-_$S$`QEO68UXJM8;0A`C.PQ!F!(G48J4*M7K!BD;+@*Q3A
M?!!FE!FE$YCBF'`6/KN"0`GA"24$%(2"'*Q6=">&+#G?H*)742]$04.FB&6%
M6#KX[*CFEJCF6U'-LJBF)ZKIBFI:HYJ"J"84U33H:0S<H*$.H22GQ/+'8CE3
M+`OX;+?F4[?F.;?F-K=FBUNSPJWI=VL6N#7-;DV#AM212M#`%+$L$4NG4)+3
M!W0=.E`<(Z>A`S3,"(K6#!PUCP:B7(*:1@/UB.2CKJ-<@YU*P24G2)5@WH^9
MG<0,<*S03Z!4\`+D2_"22Q`_-1K(YQ+DR33:+\S98":/04`811X!%_$C?ACV
MB^WO0ZF('YS$]X]Z5^&P^P34H"#W@E?X"'Z@3/S(%:.!(B2O&BV]G&O((BOQ
MFT+W,O");"UH(@*NGQSF'75]CWN&>,!%A28<"&SA3N-X_RCWC[*$G(QR?_<E
MZ/Y1[OU`@F#K':3=,\J=*,46K^+^7'J"^[?27=QO`PE*#G$O!5[@7O`G6&1\
MNE1D?"H@3O*$"SN1_WNE\[D[`]_C;DW//>03F:Y#8>[GC=RUN*5-WA/<.IQF
MB?=R;GYZJCZON((Y[XJM3EP/HAEE8N?%`6%B(S>M]#)N:F`_UU3Z`E?GG<]5
M<]A_B*ORG>`JO.*WBKSB\'P7;@Y7DN?=SP5+]W-S*IXA/P49&<(<YHMDVV7K
M9<ME2V7M,EY6*2N7%<IR91Z926Z0Z^5:N5JNE,OE4CDKIW*0FQ*IM_BP\*.E
M22K\9`125BA9L:ZG0BG\VH5W#"5R"M,A;F3::7MG8[PBW)Z0I6;'*\/M<<7,
MN=TCA-S<0]KCXXNA?9$[_GFG-T&4LWKC$F\CB1O:H;VKT8;,<;HS0:"K.T%2
MPHCK'7%#4S=>8H2__ML.`?=<_^V>'K!<46^K-]1E54UM_H9BX609/@>V\(5@
M<\;O:._LCN]S]L0C0B7E[&F/3^MTS^L^3+?1JUJ:#].K!=33?9A,I=M:9@O]
M9&ISSUDV-*BKD0V-^NHTVW9P"6QHW=M%MOEI-@Y'(YM?0`+;8\");!QY3&!#
M,Q/X1O9S+<TC'"?RL.M@O\BSGUV7YO&+/.^>QR/1P[LBS[L2O?@YJ\CB\R%+
MJ4]@&<GU(<.(+U<DSSI']J;)V]+D;2)YS3ER69J\+TW>A^3P?Q,,-/XKCI;E
MG8VD?6;WB!P:>YKFI;%%OZY.M(.L@U,&'4=(#O,JJ,(]<:6W,:[R-D)]O2VL
MKR7%?5)U7(I],LP">XW'=HWC"`LH<H%=C=V:25)A0V&#0$)S%DA:[-9-DFS7
MU'CP(X]-DO38G84?03LNZD2[7-D2SU^(R-O<`[:6Y<WX-XDV(&S:M&G#AHV;
M!,`!@<[V^)19O=TC@4!+W+ZPN2?<8EO>O/&?[!_:X_DXJ%X8)).UQ'D<M&%#
M6!P7#F]*5W!NH?I5V)CN$UDAO.%L/Q'FW2#,$B8HTD3JC3%7CGCK'@R7V0+A
MLL.I3YD=(X8R@;F';!#6A^-QMO0<&\1Y-Z`;@/\$G:1;2@IE;F1S=')E86T*
M96YD;V)J"C$R(#`@;V)J"CP\"B]3=6)T>7!E+U1R=654>7!E"B],87-T0VAA
M<B`Q,C(*+T9I<G-T0VAA<B`S,@HO1F]N=$1E<V-R:7!T;W(@,3,@,"!2"B]%
M;F-O9&EN9R]-86-2;VUA;D5N8V]D:6YG"B]4>7!E+T9O;G0*+T)A<V5&;VYT
M+TM004I(42M4:6UE<TYE=U)O;6%N4%--5`HO3F%M92]&,0HO5VED=&AS6S(U
M,"`P(#`@,"`P(#`@,"`Q.#`@,S,S(#,S,R`P(#`@,C4P(#,S,R`R-3`@,C<X
M(#4P,"`U,#`@-3`P(#4P,"`U,#`@-3`P(#`@,"`P(#`@,C<X(#(W."`P(#`@
M,"`P(#`@-S(R(#8V-R`P(#<R,B`V,3$@-34V(#`@,"`S,S,@,"`P(#`@.#@Y
M(#<R,B`P(#`@-S(R(#8V-R`P(#8Q,2`P(#`@,"`W,C(@,"`P(#`@,"`P(#`@
M,"`P(#0T-"`U,#`@-#0T(#4P,"`T-#0@,S,S(#4P,"`U,#`@,C<X(#`@-3`P
M(#(W."`W-S@@-3`P(#4P,"`U,#`@-3`P(#,S,R`S.#D@,C<X(#4P,"`U,#`@
M-S(R(#4P,"`U,#`@-#0T70H^/@IE;F1O8FH*,3,@,"!O8FH*/#P*+T9L86=S
M(#,T"B]#87!(96EG:'0@-CDT"B]&;VYT1FEL93(@,30@,"!2"B]4>7!E+T9O
M;G1$97-C<FEP=&]R"B]&;VYT3F%M92]+4$%*2%$K5&EM97-.97=2;VUA;E!3
M350*+UA(96EG:'0@-#0W"B]3=&5M5B`P"B]!<V-E;G0@.#DQ"B]$97-C96YT
M("TR,38*+U-T96U((#`*+T9O;G1"0F]X6RTU-C@@+3,P-R`R,#`P(#$P,#==
M"B])=&%L:6-!;F=L92`P"CX^"F5N9&]B:@HQ-"`P(&]B:@H\/`HO1FEL=&5R
M+T9L871E1&5C;V1E"B],96YG=&@@,C@T,S(*+TQE;F=T:#$@-C$W.#`*/CX*
M<W1R96%M"EA'Q+EY?!S%M3]:5=W3/?OTS&CVK7LVC32:1=*,I)&%IV5Y7P6V
M;,E&L;Q@F]62``<,7(O56!"L$':([82P\[O(QC:R28+@&L(27YR$$$A"<!)#
MS*+$R36$!#3ZG:J1#"3OOL_[[TU/U];5U55UMN\YA3!"R(0&$(?:ERS-U/6<
M6+$=6GX+]^)U%Z_I_6/]JQL1PC5PV]9MN4PN97]W"B&B(B3^>D/OQHO_Z^$`
MC*#W(R34;KSHR@VG7OLLB9#4CM`68=-Y:];_;M[_>0>AFSIAO(9-T&#[BVD(
MZG"CZ*:++[OBLZV&ZZ&^'Z'(#1=M7K?F^).EY0@]WH20=_CB-5?TVM^W'$/H
MR$GH+U^RYN+SQO?-NP.A%[4PGZM[-U]Z6>Q_8FT(O70#0KZ;>_O/ZRV\_[()
MH3\8$;+,0HA'^#32("T/)5J;RM$&`CD^\T/_\BO"#ZE(1ENU"'K^5%3P8?8`
MHW)?&!\+__K6O_^X<J8WT/E(5IN]PN%TN6E3(,B>1&.H,E&%$.PORM8BE,NC
M1BA.FQI@YJS9<^;.F[]@(5J\I/WL<Y8NZUB^HK-KY:ISN__M6____#2WP;T0
MA>#V<W<@'T(3OX?[!-PG2_,GOM!<B"*E"R:.<W;H_'\F;X1BZ"ZT&T71*5R+
M7D"C:#YZ&+6B=G0'FH->1T\A,[H2OP:$BJ"9Z%$4PR$@PVSDPAIT+WH;G8OZ
MT7OH.$J@!>AWV`;CS$*]R(D*$Q]`N@#=/'$(>NE1&_I/=!A?A)>B#)3GDAJ<
MA"_OG!A%+I28.#KQ%M2^B][#T8F]:"Z4WD=65(FVH6\C&[H`O3KQ!<PTBM:B
M1_#5^`.DH!YT"Y_C!R<N!`(=0+_$"Z"T"%VI>4MW`%T$;SV(77ATXMV)/Z$?
M\QB=!R-=AVZ&&>]#HR3-M6GV`$?%T5EH,5H#3Z]";V,[KN74B<J)&1/W0NLC
MZ&\D25[B1)A'$LU#J]&WT/=@-]Y$)]`GV(#S^+OX";A^AO^L>0OFM@!=CK:"
M['X7=N\1]"0ZA&MQ+7$1%^R6"U6A#GBV$ST$WW\:'<,+<!<>Q<]S#VFRI>)$
MQ81CXD\3$Z@:=<(,=Z/GX1NG<1;ZP!>X,'<9'^0OT]2-7PLK7(\>0,?0SV`>
MOX-]_P1]AJOA^CWY#[)M8L7$HQ/OP5RT*(2:T-EH)=J,MJ!OHN\#55]`1]!?
M\>=$!SU?YU_4;-6<FK@=]C:.9L#<ET#OI3#V+4"E?6@$KC=AE58LPRJ:\&)\
M#MZ(=^*[\`A^&[]-!**0/O(A-\R]QOV6;]!H)IIA)"<*PG<C:`7:!!3X#]CM
MVV&]CZ(7T2O8@>,X!2MZ$][_E$PC,^%ZD+Q.?L?=R.WDO]#<5#I>^JCT^<0@
M$H'+YL`^7(X>AUWX"W;"'*KP!?A2_$>8^1#9SYDYB8MP>:Z56\9U<3=S=W`O
M<__-]_-/\+_6S-.LT3PAKBE=4OK9Q(()T$2@(P285R5(=0[$>2W:`-QT(<RO
M%ZY^=#6Z%@VBVX!?;D=[T!.P[N?0*^B7Z!WT,5``807F?#Y\_6+@NAOQ;7#=
MBY_$S^,7\2OX]_A3>I$P7`G20(JDC<PF&\F-<-U!CI$WR4G.SZWCMG$#<.WB
M#G)O@\[C^0E-'5QS-;=H'A%>$Q/B7'&M]J=?C(U7CW>-_ZZ$2M[2JM)=I>=+
M?YI8/G$ES#^&4B@-,]T.L[P7>/`AN!X'3CR(7D(_1;]B<_T;)E@#'._&$>"&
M&J!:$<_!\^!:A,^&JP.N%7@E7&OP6KP)KFUX`%^'K\<WX&_A.]EU#ZSM(?P8
M/@C7,_@P7+_$[^+W\8?X;P28F'#`S3%223*D`"MM(W/($G(.7!O)9KAZ23_9
M`A1ZA#Q-#I$W.3L7XU+<&JZ/NY?[3^X%[@WN'SSA:_@,W\(OYS?RU_.O\S_C
MW^(_UX0TLS2;-+LT+P@^(2=T"!<(]PA/"2>%+T1!;!?7BE>+;X@3VAAHJY_`
MN@]\3>5EA-?QI9H*_@KR+LB%F^O5;,<=L&,"6<9=Q-W&_5RS`9_B9/QK/,B=
MSUTX\2`WFWS&;<;+R7,XS(4TS=P&="N:P$^0WY/3Y$^\`R\C'^`$_VW\#-G,
MM1%F5S2_X!W\]1JP>^17J)E<@T?)B]SUW/43/T+-FEWX7<TN\C,D\\>)';T+
M4KV=W`TO_3<YG]R".OF<YG-T/NS[8YHK8+^GDYMQ-?<&OPN]QT7(_^!3^"[0
M&D?Q?#Y*OD$*^`G0N.,XB,9P'^K%=R(5/XO?P2-@'A_E'L$+B1&H-4Q,N!%,
MWU%.P6]P>M1%YXCCQ(';R2G2P?U0.,;EP8X>0S]'6S&'L\`[4[\2N@0DX`Y2
M"3IM%FB37^`ZY$9W@[X_7?HAU=B:MS2W`)]]CZM!YZ`LZB:OH6:0C??@ZD0W
MH3IT&'CP9I0E]Z"K)P;P>M#[BT!_$C2"+T`9;`!MZ8*Y;0-[X21AT(6KX:N?
M@?Y_%;3^`OQG]$TL@V2-H@1/G]S*SP+-U`/Z]Q:XUJ-NJ#V`;A<.:'Z!EF`7
MX`.YM`NX_+?H&V!S_@C?]Z(6F-]*]#V^!F8M@V;N@S<>*,T%C*#"#%_#!%T#
M<YX.<M[.SP7->]?$!;#"\\%&+02;^`HZ?^)NU`:T.V?B^HE;T.J)[TV<BS:B
MI1./@O[=,K$/-:#MFBZR7)/D<Z!C7\%'P![]!M\">GLN^C7HHQAVHP_A^D^8
M_W3-LVB0_Q7HSN+$K1._1`[8CS#LT%JPHB?0Q>C/L&]SN5%47UI,]D[,YGK!
M0KV+SIYX9"*$]6C3Q$6@>7^('A(UH'L&4%#S$/#N+?P&DH7Y5B$GSD#KN9K=
M"*DS.I:IQ>EGM4QK+C0U-N1S]76UV4PZ59.LKDI4QF/12%B10\&`W^?UN%W.
M"KO-*EG,)J-!K].*@H;G"$8ULR*S>^3A>,\P'X_,G9NB]<@::%CSE8:>81F:
M9G^]S[#<P[K)7^^I0L\-_])3+?=4S_3$DMR"6E(U\JR(/'QT9D0>P2O/[H3R
MMV9&NN3A,59>Q,I#K&R"LJ+`"_(L]Z:9\C#ND6<-S]ZR:7!6STP8;J]!WQ9I
M.T^?JD%[]08H&J`T[(KT[L6NZ9@5B&M6\UZ"M":8U+`W,G/6L"<RD\Y@F(O-
M6K-^N/WLSEDS?8K2E:H9QFWK(FN'463&L"7)NJ`V]IEAH6U89)^1SZ>K0;?(
M>VM&!V\=D=#:GJ1Q?63]FG,[A[DU7?0;UB1\=^:P:^L)]Y=5&-S6UKG]JT]]
MW.`L]_DRK0X.;I>']YS=^=6G"DV[NF",81*;W3,X&SY\*VSA@J4R?(O<V-4Y
MC&^$#\IT'71-Y=6=%YE%6WHND(=UD1F138,7]`!AO(/#Z)PKE7U>KWIHXCCR
MSI('EW5&E.&B+]*U9J9_;P4:/.?*ISVJ[/GZDU3-7LE:WM:]9LMDP6CZ:N&\
M,\]8B76GI07GG-E73&<4F0?L,"RODV$FG1%84Q--SFM"@^N:H!O\NC"\-;P>
MZ''^L*ZM9U!JAG:)OC^LB4D1>?`3!/2/C'W\]98UDRU"3/H$T2+EDC.,!L^G
MRL/)Y'!U-640L0TH"G.<SNKY5,V6$3(<Z95DR&#[4#OL[9JNY@QLOJ)0\MXR
MHJ*U4!D>.+NS7)?16M\^I&:27<.DASX9G7KBZ*!/!J:>G'F])P)\O)_Y*8YA
M;?S,WR(Y[;,V-0]CY__+X_/*SQ<LC2PX>V6G/&NP9W)O%RS[6JW\O.G,L\D2
M+C^`#1_F8[!3\R+`>N>L[*0-\-?$9D=FG=\S%T0-YCAL;^OD?*2K7"(^C@T%
M_'ONF9%II=-(Q^)C`N/_]2.B%AB8M6!Y]K#4,[><=ND5Y?_C2R,3I^A;+/OR
MM<DU#3<GOUZ?]K7ZUZ9G'.1@PGR<+%BV<G!0_[5GLT%9#0[.CLBS!WL&UXQ,
M#*R-R%)D\!#7R74.]L[JF2+_R,3A6WS#LV_M@D5LPLW`V@3-V!O!-Y^]5\4W
M+UW9>4@"U_?F99W[""9M/3.Z]D;A6><A&?0S:R6TE3;2BDPK8/-`*O81+>OO
M.Z0B-,">\JR!U=>-8,3:M%-M&*T;(>4V::J-0!M?;E-9&_U13=&VK/.K/,`$
MJRO%0`$ZFXM@+_A]1G2VZM.;!X(;&PSNZGS.V`3)B.%EPUN&DP;>"-9[V3,"
M9W:YO#HTPN55O=&HNY@;,"W[@3LI?3I6R(PMEF:=-_-]5%PTWE*;Q?W)9-+.
MQ?.YAOHZIZ-"Y'8UN'*IU#1O`WPP<552;9Z6C7V[]#:=P[+2?'(U^*9VU*Q&
M[K(^8B4W&7=8B?X>G17=`UX7^.2Z1\WA=@$+`Q7+OD$_V#TVWM(BM:#B6'&L
M%E`([L:.>&6<Y"74Z!`$XJAP!0FY^N[SAA[`=9]>M6NQXIU_36ES;.&&;^/!
M-W`#GKBD>N;'I;M>?/.IP4?N@SFD80[+V1P*:K2*K];.U7#P<2M,P@[@2J>'
M"<A"5E`%3AAP=/[@WR>!N^UYI\MI<TA(S#<TV/*YRC1)WW/>S@=*K__]JMV+
M%,^"JS7KJQ=LN+WTS5^67BWA2V*S/L(7OOC+X<&'Z0PN*3V![T$O@R^X5*WL
M(EVN(TY.Y^KQ'/-P.HQ$GK=H;>B@334:^&:+(^08<'".$5RM&D*6U19B\;@?
M@$DMEDYW+QKO'H,YG;`5L-7F*M"9X3X[3`EF%(^$12$2/D,7X9*-?3I1-,1L
M%;7-"QIF;-Q9>J(FO+/=;M)5Z)KK:V=?NGKC7DJCI7B`=(*ORJ&B*A/-0&!]
MPS8-8$B"ACD.$0FW@WX=PGOP,2R`$Y@[@`;X92OI+HUWTSW*C$%*IY*T*PYE
M*=&,?TY<=].1OSUQ`F\&5&=`2=6/5,'`J3JU.:]3B_G5.KQ;]Y2.Z&XT7K"5
MCM4';$775IN-L=F75X)11FU-IUM;7V!I.J/2<;F)$V0Z4)1#YZ@ZI'DMM+$!
M"#G"5:HFPE40`M-&!/#H"`ZI%3*7Y7JX7FX/=YP3N&?Q_R&O\2-X\]YW&7>?
MIAO:4FS9KDDGKY&.U&:3&-PH,KWD:,<?:6[[YW+-XS`6FC]QDGM&LPE)*(H.
M[UNC!2`C[--H'#0SF;PCV*+:=%X45^-$C??$]\2/Q_FXE3:;5X,CO@W<_SU(
M@SRQPS@(6SM)31"L[KY/%XU-LEG;E>I"'(U$PU'PL@&\$T&,^7T!7]#'"?:X
M)6:(NSTN#Q$4WKH6A03O6EQAAI+3"*4HEM=BGQ82F^18BSQZ2$!.DY@FU>RN
MKK[6GK,U`G>XG-8*`CM<&6^47,[ZNH;&!BLP4)F%R/Q;+UO9\\#5]]_\B[4O
M7'OQD5F%OH;+@NELM%#5/#,_-T=VG<1+SFG=_6+IJ8]+!^]\[_F_ET[NO7--
M_Y.X</+^2[/*64M+#P"-3B'$";!C3G2W6J&Z>]Q[W,?=/'*K;K(%H#HQM]K!
MNVY%.KP'4#/'REHH1X#`GR$+/A\0<"N4_Z::L<5"=.#CZK1&PJ'#^._0?9YJ
M,YLMJC6?M6RS#%GV6'B+QW681/&)R<U-MBR2QDY0$0;J6JG`%-`G8U_@3Y))
MIE7ZNNVQ>FN%T^ER*/GI)$\W@*[_%)ZOV%O.+9&>)J=>C'EC,_B??._S[?U-
M01*+D4#M5O+;.ZKE8(CR80VL\0E88Q!O4J\3W8:"R^T_*^=6(?'0Q!)T.JO$
M%G&>^)@HJ/(J?J5VE6NE^T+M9=;+;`\8OFN^U_JDX4GS*YI77"^[WW:][3XN
M_X/_A\OAP`'>H_$Y/$Z/*^`6=2Z#VQ#(>>9X=KAVRJ+;0XC+ZS%Z!!/G(1H!
M(#]H83MO&H%IZ'1JA;$XH,.Z$:Y>-4H:[TX/WNUYRD,\A[EZV+AO/8V),3B"
MOZ6:D/"')?;5]LWV;7;>/H)%U4ZMCQ?)JCP@<SWR'IG(GF?Q/T#.3%A5*U:#
MJ[^-["3/D=?)N^0O8+(\H</XMB_Y^41+F:.[%X%8252PQL:[^UJ*XWU[!6JJ
MGMFIP\_I7M<1U-W7E3Q!51BCC*U0(%*YR_YK/-_RP/,N<\MV27/-$3.().[K
M[P:*`1.C).:4/$+Y')!*$",-DR9($(FHU#4T-')/K/[B.$!`>=<EZW?'8Y[7
M[W_HG>S\A_\Q':^]:,5L+]:4/H_A&?B>QZY]^/*^0R^],;1QX_</E$XU2;4I
MJ@E!RI<#/>OPPD-(/W%\G[&@&YD855N,A5;=+/ULPX(P_[H.5U4U5:FYGMSK
MN>.YO^M%E,.MNFV1K>G'HX>BA].OI-^-O!O[3?K#\`<QXSQMU0B^]>E$0D(C
MY,33Q[(X.\+E#G`:R8F=(WCW@8":S.0"([CM:<E4E7@6;T(52$?^J!K:@09D
MB-$`*/GTL!$;1_`0M*<&4F0HM2=%4M!^8+6X#=8^0MY3]6H.[\F-YD@.]-[T
M9U3[<W9B]]13A7/R#($8=<:Z^T[3Y(1TFEJXY%A_<:Q[S`:&GNF@AG0F&-=;
M>"&L1)2H$E-X01,SQ^-Z4"X9/K46!RU04@R5:[%>EQ:R:W'(%*#:1FHIJYMD
M];7P8S+6C_H`+#0PG0-T<C)B*9-&R@7"1[5/GNF>>"1"Y9!25MS4O/>&!U?,
M.'S-0._MI8]VK,LH'J_U"E>L>L/=$6\H>==B><GNN=?VW+^)G[_CS@N6K+QC
M5^W!JX:O?71F9:!&JRD*AET7+5G0%$BT!O7?N&')QFT/4QT.2(T[!-35(Q/Z
ME9IPFK`%S3*I%DZUX&HC=HB@<#&GTPB8-QI,B#>:>,%H`JGRJS916R&*6BW'
MBX)1BT(F;'H6/X`$9,"[59,&"SJM(&@UO-'(/XOG@;QH\0;5H--9.+R;>XHC
MW`C^N^K&129>%MP#^NJXA;,(JHA%C_DK,M37PBC4`@($Q?>E<2!0L9"1P,)*
M8])X?XNU8&4"LSV=Y,%>T:+%8@&-U@]`J:\?.R+6B%7)XWK(,'?HX$/C+Y#+
M+WFH%,6G;RO=AS<,<-=]<2OYWOAJJK_6`K]?J5F(%!Q4VW[`8UM7\/S@-LTV
M85O@5OY;`3%/\DH'UR&O4"[T;]%<Z=].!KV#_@>Y1W5[(L<C%A3![##%X71I
M*\#R<G2KK+(")I>7%:_/SXEN7@.MNY^69<5^&#2)F[.KL*?X#XC\05$0#]I\
M.O+A.0<&Q#V4C_$GP,<1K$9Z(B0"`O*/@Q+9HV"%#J+J9%7:(Q')$SZ,[\0?
ML!T[T0UJ7NJFN\-8^P0H'2B#/64,#5J?:IGMVG12`]N%:*6L:%13/^XG_?)U
M^#IRG2R`QJ&*!O0,."VJX4)^LVU]L%?3&]!T=P'($A61IQPL"%_!6)/,"[Q;
MB;DK%Y<V=6'=_3>NN.'L2Z_<NCD=\59F%BRZ?.^N6R[^(>8U"Q\_6+GKYI$+
M#PY4-BZM\R<E);=WVU6_;$Z)Q$*Y<QBPTA`W#%C)!7X'YQG!,35@VM@PY-D#
M)E]%HE&U&2RJ`R!4;LBQQT$</\0QY$8_!PS-$.MIIG$G\6H2?P5$V;\*J!0*
MH^"NR;3.H#DW7$96Z=9Q^XQR:0:=SVV`64>XO3"?"%JG^I38\]:-#2]9CH2)
MT>2S.R2=\:#;2.=5,<(M5D-!U0WHSJ(+`:1K\$G-%B6D#"B<\K+/$Z4`#WB;
M@E>)X:UQF&5&.L$4/_SIQG]MPMS_@FBQ=W+RW_A7:,OM5<MS5__YSW\'N01P
M&](,@R_D1R'BWDL8`]AP*$B"`>0/^E$@A(-^4O%C[@_(!;<(MY[[@^K2$G^0
MLVC]S@`*]>(!3##66H@698K`7=U'CQW-9"A+26-C?_X89\H_Z9KM1XY(<-=F
M?:I/:[983)(^J`NU*X+#8I>\5J_/YW<'!`5,R[Y8GF9/9SMS+$^F6;ZOJMPL
MQ\O-WF"YV<6:]SE8IMXMV7,FBP$&+UCF6V9+\X)+E"[+"JFCHC-X@66CM"FX
M11K@MYL'+=NE[;8=P9M#]UONE^ZUWA\\9#DD_<A[*/B:Y57IY<"KP=]8WI(^
MLIR43@;_8?E,^D?@'\$:G66!CX0`K,(FH4`PZ->9]3Z=T^_R.;5$]&D=U@J?
MXXJ@19*EH-\?MDH5UEXKIH%'\PAY1;62(`#Q8"CP$$+EC1O!!U2C5K)P#J=3
MJ]5I_2/XGZK.`N^0A\RJ=81DGUX2Q,$1\K%JEE5SN_F4F3,_(E\XR+C;XP7N
M<7NIF%-<014BI*=!\,=;MIO+TKV]VYQV)[<#:DBZD32&I=%_3[=+UQQI$5O@
MS\0].?7#_2#GBB@X*A@@!$3<B.MQ&1TR9C00[K'Q_SDW/&UMJ:/#4S\=OQ/!
M;Q6ZEXY_<'8A<<G['^.7WEQ2&<J(L9C%G?T.?^[G]]Q\MB86X]-*S6IL(M'Q
MW])CZ#!"_/N@<8,HB9K(-6IV)5H9W(%N#NZHO]?[W<HGO4]6?N#]L/)/&6,3
MVEIY9?U]=??6/Q1]O/XM[UN5;R7T?/,(^=/3EHT-S90K_.$<S=4_.ERY>E6I
M@<03S-6ID00DOD!N9G1F;(?W;?QF]-?U[\5$/HICICJ)<P@^;T70&74F'-ET
MW:SH_-P*W.E967D7L4I(:N[`*Z,]S;W-`\U[FK7>K+>N'7&2Z(T&$YX,+Q`N
MZ`HNJ;\Y>E_T[7I1;E:;VYO7D75<CZ9'Z!%[LEN$2[V7^GJ#ET4OK=R:N$&X
MR7=3<&?]0/.KF5]G/HK^,^KITEI"/IT2ED(^IQ*ICR*.KT'Y9"C*A:N::NJY
M=#B1S^N<50F7RTG2"<HI0W$<IVS?G&?9#)H-/%ULS='JTVVS6:Y60/O"U7ZL
M#V;]Q-_!)T---;7T@30K;U/Y/3Q!D!SG.9XVZDW6'.*QS&-P!G^FQFH$NYUT
MU!C!U8#49((T#+QLD4B'1:95RZY"\P_QSY""UF`W:-SDXM-)\#'&@'<`XR:[
M^]HZ#Z%:+O6!CV5C70"'6BB']H\Q!NMGAHG>5FJ8&/1UE8VYJT!]$D!>K9E<
M).$.8M'K\_B((,2C,1*KCR?<\7J<$6OK<208K^=RN+:>J_15U>.L)EV/8H%P
M/0K6<?EZ`!$`P5JFO+XS2`R``>[O[T?]?6=<0D0!M;-LT2)*OKZNL8%Y0(#!
M%(K+H#WFI.:MH0S(K).FCL%N;M^W9J\9>/>]\8'ZCI@K4+FHGLS_P;J[=ET]
M?E5L=>'V[RQ^X?#Z]LOZ#OQX^0L[IW?ZR/[@C'-O/.]01ZPATL]=]!]*3<P=
M?>:;&[YG$<7B=8N^^:CS\\V^!Z]8<OLR7D,M#WB`&HI*G(!+.+7+X#,$;I+N
ME'XI:;9(6RJV2_?8[W6\XGLE\(:D=5MM%8$@)SKP=N_-09+0"B$?4L)BR&=2
M(B[%$TJ8S2;B23B=2.MO66+#R";99%O6IMHTMI&)WQVDE+7-BU".F%[,`_*0
M([@W0M$-%U%<C"=<C"=<C"=<8)",$O"$P!H%+VT4=H77K&,6+DDY8IRE@$;Z
MDY\FN_L7C7U)^,(4H?W>H,4AQ2KB08M_.?8Z(`E80\NQS^Y9CB;)1Q$TT*V[
MK_[KY)%YFT,"$%T))$$@L4"=2/WRJ--/Z9#`67S6\T\^7[K\-]N6G\1UI?\^
MM?+26*-R*7?1-KDF-ECZ\2]*[_WXC;5^/!N[L`?/#%`<6`U::3_L>#UN4(MJ
M?J/_F_[[LX^YG\P^FSV>UR[W]`J]XC;M-MV`,"#NU.[4Z:(A7T`)QT*^I!+1
MJG1#M(K9'-+YM"+=2H6VB`HA(<$G^B4?P1&P@H%Z]%`RC5(2=5W(+T!AU22)
MH^*A@.^DWQ_0ZI[4:H4GB]2?0:(D+A$Y&.M]M9V-M27]9$TRE,K`JQ=YGY3!
MKK[KXWQ+V_.]^3UY+H\D1BJ)445BI)+"L2@C590U1AFIHKMRQP_A[0PP43(Q
M6DG=@!M/=Y\8!W)UC[4POU7Z&.P*9"5F8$!@6\9;*%R1QCY&TB=)/)E/QA*Z
ML54!$C4"Z&:.C$+C"O4LKM)8SY7%ZTL"VB-Q&FK!3^+JRRIS0BQF-MO.Z2B]
M*26:WK]T4W9Z:^+RSS_*9I.RRQM=EN4=EDI'?5WB/`T9/QE)7U9*K/-'$J76
ME94N.3/]FM*3,9>DKN/ZK@TF8J5?7=CNL%"**D#1$%`TA:OW)C(C@.\;8^L;
M=+Q./YSA[DD>3KZ4?)O[1?(#_@/]Y_SG>AT@76$;T'A`,R#L!!IK1;VN&GQJ
M(SB=<=6D]8F!D,^EA`4@*FVITO@$,]/@P9`OKD22-0F]ULAK")`:MM^50I$X
M2D@)DJ"4CE56Q@DX"97)Q).H"J.J;)5:U5O%5PT)0DC$2T3\'#A"%""DD9E1
MTLR(9F:4-(>#`4;)`&L,,$H&=J7_3>C`9^IO`:S0-WZ"17VD/W>?(1[0;C+4
MD)RDWOA4#B3LH\Y3$ELIR8"(:1*)6"M<%.#7.[ZB':?H!\_Q@W_O6&**Q7#E
MK)E_-^GEFFSM^.'LLKC;I`\!4W!_-46\L\Z[`(CVT8+-I?R2^;'2\HV*Q^:.
MQ6KEK=Q%Y7+IS=5="4JO>E!\5P"]0NAY=;/")$I1Z3H5-9'W*&NLZQNT(1]1
MPNZ0SZ:$/2$?5B*ZD,^J1&Q6V'2MVT/HOGFT=(L\/'W5$];U:@>TQ[7<A!9G
MM>W:'BVW6CNJ/:;EM#SMIF4[J1V9^&P_?1<*)37`A'F-W`OH_;C"995VI4?A
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MA'R58+/<[C#"%<CM0=CC=E,D/3V;J<BZ7=F,.X,S,'>7U^-Q$9U6BU`V6YG0
M9E<![W@RZ3#XV'N48872ZK@B*+O4.ER'"1W")%EDBY5BF%I&1*`@D(X:*1IJ
M&&]IL18R):`B@]4,6,/EHB'3*<<9<C<KN,NX@OJ8P`%]?2`ZU&'V9:0*8Q&7
M$ZG@=EL+;LE60%IWP34R<>R`J^#*5A3*(3QV@U.-NA5,6>+K,A8'=L'X*QSS
ME<>8FSU^VA=KSY826;!X%>8%2\&U^!B?P`.9%6`!8^V9\='LBHAS_!/^\B^V
M7!.JCL5R<C^W964B4!G[_#<\JWXQ>.;!X.>W`&]-O#?QH>9QX*U*_+RZ8-"&
M;3LQ)NJ2_$Z";0&"*TG*WF2_PGX/>9=,$-$>#MN`9GHE##3S*6&.TC520>D:
ML=FLF)"P+5QALX7#(_C[JJ7R2:S7Z3#Q>;4V'<?H8;0MM5IE*2NI$B>-3!S?
M;P7B0.'T?F:_H,"`B;2KBN%7`"956*[">ZJ.5Y$J>P4=PJ$HV3`>#>,P4XV`
M5>'-\,C$*4"V\&K8DUCS_2GUV-T'I!X_@TF@`<KOL]!2F=9C8]LGXR.@(@N,
MQ"(]TD'=_6V=:D)G\]BJ<!$5;$O0?-MJM-*V&5U@VVJ['S^&G\4';*_A?V+;
M7PBFEK`+@1[M`Y8XA,C$HT\';45"0;K35`2\=?(@,)7J+]#BOLG,Q[*#G@+H
M,%I\2[78"C:GK4`D!]R>@AW:]AD*,,RQ<O;9@8H"4:T%5&;%,V"7<A7JYH"I
M<E_3.I%_Y3)F?GVXESN+<@Q^B_)2](OK?/$EP%B4D::=-2TP3;/P"Y$S3['*
MYSOXF5_\Z`SC/#6KQJX#K#JWM!FPZH7(@>)H7*V:A3O%.S$GF#&X5.(&O`7?
MA(?07=J?6-Y#.MZBHAF86Z[E[N9'R#$UHW4F)`X%`??(*(MZT0#BT3E:K8E+
MAEM"]HR=(+MDE^U9NVK7V.<E*"]XBWDYH8)9];9()ME$+*:0B9CF5:XOVT(*
M-Q=)?<E/:>$$]3.Z47&LI3@FG2['=E5=7([YXP:CWD@$=RP:B46($'*$4SB@
M\Z:0RP))W`I5I2*8@E7YC)#IM!ZS,X4C-DA8E'<JT%M-3Y:NI5&SOFX-]97C
MT6CEY%FM(B-K!<)``2L[8RH?,<6YFS:,W3U8>JGTIPU#R[9NQX,8E#.^L?11
M:>O!S;?>=LF!'UZZ?7[A1Y;AAXVRYKRGSVMN78-]SP.JO;UT<>GH/THW\Q]>
M]V!IN/3,OAT[OH];_N?A@2NG?(9-(,$)E"-$W1=U4W&(,;RP/8QM-\9?C+R8
MXN9%'TD1=\B5WA#E=%@7B\?FH$Z\F6R.7H6O(I>&+I6WA*^(#>+M\CVI)_`3
ML6?B/TQ-1!V"?`.^-7I#Y7W1A_`/R,/1IU+/I=[*_B4UD3+9D!-[B2T!?G)M
M<[HYNR%Z?D9?K25^/W:$?!8EC&()'P+3;58BSI#/KT144A.+1L,$5X#9CCY)
M9")65SW$8+.+3A>@;[O8(W)#+""*?$_Z<R/XVZJE+A$(^(G%;`8O3VMC8:#.
M<AAHUI(\4IY2R!)0_T0Y(#5@M:&WX5@#UY#3,C"E9?N@96!*&W8ZF,9PL$8'
M@P".7?DUA[`'_0N>DKK[`5(ED]2SS90]VPSU;+^,OXR-26.V0G=_)CD.#1ZO
M-+:=AF!H8-I6\((B83&7)#O)J<VZJ>>3J@U&0K%4)%./:X.0I,,U]2@2S<IU
M]1A-<1;XK/W`5?W,N!Q",784@T&[[:LH@!P</UC!5`,43QV0"EG)`LH`EW4`
M&)9D4E$P#1Q6_KMY80XN\V]%&MW!=9..+:@*S:;27:5\O6P*2O[XPOSXL_7+
M8P[J5>$_OW5TYX-/8'?/X.8OSK+[=2^\N/OZYG5D*\&XM&4@5!.+-84NXRZB
MI>)CEU\S$B]==5.GD=R!'[UNVVX[12_3`8\/,WSW5[5Y)5Y)5@96!B_$%Y(+
M`Q<&M1FEJ"Q1[M'<[7M4\[!/)#@0!&:1E+".\E!$=$=0B$@6K3)"1E6[#B>1
MZC(7;188KAT]!5ICA"14KU;'J*UCA-4Q:NO"+F<H&:1<8J9OH*`47!W<$^2#
MATD".2<^5@V4%YR,"YPP^M/R^NZR<W2ZFY(]"&QFR-,!]ADL.5"PR1-2RR38
M!M.@0ZHA#_?4H_<9%!QOH1C[%>D5BA+`*-C+7E'D7ZA!M;,@1NS\]RQQ@SVT
M<=ESH($SX\]3=?S@ZD1NOAB7-`M++RR+-C=^?GI*]?)&L_VB<_%TNJO@ZFB>
M@ETM<C7EF.Y^*R^Z?2/<'_8+S8V)&!14*6Y54)J/>YI(G'BT@A:L7K'(@K;C
MQXZ-2E]`@C,T5"M=:<4FCR[>C*]`WU0TMA`PFFJV%`#:%*16-:FV<JUT)W>&
M(KDMZ`KKUG!O<FOJOO"]D8?QP])CRF/AQR(/IQ[+/!MY-O9L_'#3P>++THN^
M%^67"Z.MO[3]4OZ'X52KWY:19%M8CB83Z4SF+"EKR\K3E(;*;'(.`F72*K=F
M6X^U\B^E\&6IJS,W)G=D^+9DE[%+X7013\0YO=BZP-M6*=@JTCB:/D]Y2'DH
MS4^>9X1Y;ZM:98VGB14I:=X7HUOA\PI>+=T*7[PI3JC@CK_XXHN3&=V$;A:$
M]ZD+TG(&IQ0Y(X6M4MA61#AE*PJ2Z!.\,HQ2F4KX*@O%9E]!@WF?!C"YSQ,/
MTU$SC;ZF5%B2PCA5@7$J4[39&&J5,Q6RG$DK5L2S!(<+34W4#P3X*@@:[:8B
M+B81QA8L@W8_%_?@7CR,1_%Q?`H,P@CYIVJ9*2^5U\N<7(?">\(D/$+^ZZ#:
M>I="(\)@X4YWCW?WG>C^4AG!15>$704:$-YNON8(4T:T\+^&@_^WU`*_+@J`
M@,OWP<[00R#X`;+I/)C!5>',=*Z[BTG`^<KZY.9,3RL/]23N!PU$\;!E0^7Y
M3:3:#;@G(IDH:CFIVHV%B-M02,,=F>LLQ+-.VCYZT%D()YP%'KAMG[-00;6;
M@8%G0M&<P59(:6V%L&PK-%&X9"E4EC,*E2"3RUFRG$V';*^E<";\-_4K0R6V
M"@3)5%R[L7S,4LEAX2N![X9&C`$B`7ZBK2Z[O=RKW$)%EIN)(U=>OG+\<+/?
MX=.)V?=+)U*VAH6E4'UL>N]<K)8^N?B>=>32]FG98W^MMALMZ;GX]X5HP\IS
MR%]*B_>OUH#7;-#%["Z7=0X^MW1'<Z5#KN9B,8WD[5R%[\#;=Z^#&I?VQ^:4
M7L&U#0F'0W)8,3197(O/I]9^WL08MX-["M6AL[AYDZ<Y<I'YRT65ZD"'3TS'
MM`8#Q0"T-8:,]>7=M)&.>B?M`O7?[:?*#PJG50?5F?6L;WU!9+F82E-IEW7P
M2KH>!?FJFFS.J.I@4*,:"-#4"H^,(Q-OJ$':R6CDM[FQF[6Z60^W%`N*+34\
MRHP5QXX`[@9$1@EQ-#-.I>Z-Y%&<@0HCSNCH.\GD$>F-H]2)]JF;#?[!>F);
MVH!M<J@P4'Q4=U#/V9*V:]`U]3>A6PRWY(6`S=DL%0>*O,Z_4+-0F"7/"B]L
M5HL[`EJ]6911>!Y>H)]GF)=?T-C6/.^L%8:-AAMU-^AO,%B6.:]WDE!Q=9'T
M:.M1KB5=E<H]BWW(B(S`CKJ",6$H&!G:;,Y+QG8C42'I,7(RR[88>6.+FP+U
M*D-AB7NU>[.;R[BWN8G[/T(2IBO.MJ@M!);=FQI(D50>]FV$FZU:>4-Z-(53
M/3%4;S(:<SG8^"^``D)'_;-X(XJ"E8<OF@LH%HH-Q(9BO!H[%2,#,1R3:*?8
MLZ0-B<@!EBA4<(S@C6K0ERG4BJJY(`-B&A`Y2<2G1-PN8K%M>MLE93S<U]^?
M7#1V>BPIC2>I]P.V:]+)E<#U1<73XR>ZI;&^XE@_#>);"[1/,IDIJ]1]G!%\
MFJZQ<NRHP`#TG/PT?T1C;VQJ:"*"3JO7$@%\^C`1\H8"(-Z`W8]L=DO(Y,?A
MR#1-P8^:M#D9YW,&FU_R8W,8DF:AQ8\8OJ)@IPRGD]75-%2/^S%XU+BO'U&]
M4[0QB4VB?E`I^VMAI6FJ)"26'307&F4SE?^3@(UD:JL,H#=D0\$%MY]RN]=0
MT`,I&Q,TUT.NAUP'N>Z,[S3U`\>I*S9UMDU50!D2"0Y7Q9D36!J\<;#()HUU
M.LH`BRH$4!WU=63.MZ(-9ZV^*ECUVL<KEA9C<9*)QS+#N[<NGN:WZ5T6R>AH
MZ=U0VXSOKEDR<WG3PALNMGJNNZ"M=N85RZ,[-H3#-<WINEQJ^5!5:$;RQM(K
MUT^K$$TM37?-_`[N;O'4]!3FK@;)G_A\X@1W2',;<J(H_GE9\O<&-52")2K+
MF@HC<C,'V`T,_#X+:QDIF]$F5J!R;J3]3;2_T>AV(9[H[!0I6"M4'72K`*\G
MIC,H78"^BR"WQ7>28\RN,#E])SDJO01""X!ATN[&80@.AH#WZ#OTW:!&$X\A
M-Z@1H<--*/?2Z7RVG]:A\.=G:)/1&(]9F4(`P1^EI:.3WSM*/T<1R952'/]`
M."@<$#\,\9IXFZF[08Y?SFWA;^*V\P]S3VC%.2)NUE94FEKMP8J9;I<1\3XG
MDA1\9B:U(<V0AO1H!@`H<9J/C$Z$W%&C43*UFWI-0R9^`))A$X=,U)W,0G'4
M=,PDFD#ZGVG)FWIB+RPH.P4TM$J#""`XX]W]8VRF_46KJ_#)V!?X$R8:"8_,
M&<2XS`5E[-6[_<CC-AC]6JB%>$7&'H//CP*"3T:4^2CC4[ZGQQQ]E,>[<7]7
M%P8V`VPNEGF+'3>)E;%ZJ]7Y)4P7\+0;[_O6S[]_RQ/M#RVWR&Y_M1G;4_47
M%U9]][OK\_D$^?307W]V^LZ!YF;NP`-SO5*D=SPQ_MNZ^I>?&_Z1#SQ2-!MX
M:#Y8#P5_LD_+XRG[0;Q?.]IA-D!PQBPZL4?I!<<*MN0`Y2<E`!I_O[V"=$#A
MU8/4H@1J.5#QH+Z3W<4C8XQ1CAZA'&)C)TN75J=R*$*IYS*MT!"_?1F_5+-4
M6"9V^CK]XD;-%LT`&E#V`U0\)A]'[VETC7@.7N[N\*^.]+A[_%O<_?Y!VVWV
M(>N0^V%P0)^*/(V?QS\1?^+Y0'O"_Z%\&KL%,M^VPG9+Z!9Y('(J(EIE_,.)
MXTB&.P0*`P405<!9X(L>94`A2)$4F05V>Y6AK\0,3RDF94/@70NV_,09TXD!
MBBDJ"C13FVP%6*1!^6G(B)<8=QJ),2.A+%)1#^I%0V@8C:+C2$<;"'K\4N_U
M7M+NQ;N]V#N"C:KME("1(`FRD!5402.TA=L.D6^7O<W^OD5CW?U]XWW=)_H8
M6R63Q;&Q/J:Z3]@F14R_-+`N<&F`^TX`]'%?%\A&4U,3;J*!!V`;!"J;*D@D
MN0L^T'L'[06-)%%W<11T)6C&T;U28?+D$UBL#\!.)$SR.<1X#<J5+"!$M5U%
M6;=Q\V-O7?_`28SW;__/VIII0:LA$IF^_JRSO[=C[>+&'#[WP']AX=VWL'GG
MHG@F[M@2"LY?^[T??-Z6OA)6/W/B!*\!#15"*;)@DK?B&1;1KQ+<C*FT909C
MS(;D@),I+*=!IFK)2OE)-E)&DUEO:/U,92PIN^D;LO\P]P<4H(::'HF$;,S)
ML:LZ,^FP5Z`8$*ZFAF.(@VJN#-QX$F&\`_ABE#$G8(PI]76.#=Y"LH'CZ*O^
MW@!6`ST!$@@98!B#D^DP)T\5%LRP@N8R;[%`2N@3"O&K6!^V.*%#$#)IIM6.
M)LO*+3EZ%/`GG4QW]]$B/?<&!0>R<0AE)D:?GC,GEZ$B,B.9SO5DKN:OU@SR
M`YFG,J,94<T,9`C*.*L=R0Y-AW99\BY1G"MB.=.HGZ-?KK^'?Z1Z3T8<S9Q*
M$EE&LG(8N-T`5G!6B[Q$_H:\07^1O%7>C7;+CXN'Q)>J#7&MO=+8:@O:9SH"
ME<Y6?S`P,P2O&?@:!]NU4`VNJ0EQAA`R*$:9`@R;H\<YX'S*R86<0T[B_*BJ
M7:"QS$0Z1_-GYN2%MG3;MLF@R:*Q\?YN<'WI#WP24(YC5#U*3#\BZ4LUZ8TG
M>6UE+*ZMDE&2AR0AQF1<K:EABK$<_4#=393#:6"-!D+`/H-U+AMB&QCB_)>:
ML6R.79I(WIHF9WB8_*1M8/Y=QS_[KRN7@(;T)DW8FK(H3E_*4#J5%EK693IG
MK1J^:-7&V6=]_N*+>,ZBQ[[+%.7G[WQOCM\:Z7L%OS6SM[!DT\NO_@HX>B'H
MRZ7<,*I``>Z:28Y.:)U@[XP68$%D9MGD69TCJR),PYD$(0D2V"BF*VE!M=(X
M-T(&7\PJTC->0L->^^G;(M.NT$\$/^A-]@847GV&2@-?:S`PQ4`1-'`0Y2KP
MQ1A;@SG.'!W]TA@''`-H#Z@C3F;:B2M/HOS%\METE+*P),KBL,@AL0>`XQZ1
M%V_GO\_OXSGZ*1&61B4Q3MFYHB(4A'72(JP6V)ZN%C*SDS:9S:'@UTUX\N@Q
M:L6[CW1W)^O87&&FE-U5CVVUN]O3@WHJWN0T'MD/,,U?<*K^0HC.2M\V/Z<-
M41,18BR6R+'FI=7IG$_PZ#KMWW"N=JUTK_**F-,)HDYKU#CF"3O(K<)VXZ!T
M8^!!\H3[@/T-\K;EU])I\C^<W=8C]FA[874[=,^++UM.B6#I1-,-A--1.1%`
M3N8WZ&:3.;HEH65DF6XMZ2<[[#L\]]I_H/N!?D1[0#>L_PGY$SEN/*VOT!X3
M,1*/B:2/YG3O:'!R6!3$:_@*E'4ZZ%3MMH)MM6.;8[?C70?O</A^P6.>ANPK
MJ&=[<I^=9F^I<VT%NL?G^C"EB/A3K3/A*UB<>+-SFW.GDW.>KJ@8H(>50UJ2
MU>[4OJOE)*VJA95HA[7'M8+V<;.#1SLH7W$UJBUK5LWM9@Z9);-LYDZ9L9G.
M1`=[:6X+MDTB%W`!%HWW4=C2UPW9&.!\B1J:?LI2R7XKD`BP]F8'8&UP#UK`
M\H#I*;#055,3/1ENZ]PO($Q(7Q=S#NB/(?)#2(2O&2(%HYHJF.#64HN3*(CE
MC.J(?;YRS5=^-EG3EVOZ<DW':JI95W!(GH)'MA9,,CO<P,FOH?2NKBZ[0"/I
M#8VN20MFHQ8LIK#H6ECX-5Z_?OO*&U,AQZOW//317P_>]]+X=ORH1O*L:UAZ
M/9GVT\LN6W=%Q8[?8_SV1UA\[?'FSFB3>BW@H24(<5LUMZ(DT4Y*=RS%[%5*
MI68GQ?QJ7Q)+9@%KS5582^O8!GO]H6JC`FJV,=%G1LHL4/.D`YNDUT9C01="
MEBK+"/;MLPE:E"F.C4JCQ:-CTEC9*(U2.'U$>HE>1]CI\:0@'T(6]@Z"5]5`
ME1"%D;15F`DB%J@$8H:KV33>4@U,&ED[U'_-\+79G*J9,D'OT`0^?_0HQ:U4
M'*??(M_KN#?.S>1F&N=Z;N1N-&KNXW$FM4T9$H;$W=K=NEW2+NMP2B<)H*=6
M5Z].$K_6O#^HO3V,]P?%$4ZKAB+!W<'G@B1HC<9<.-D.SF^VNLIF%;2B7@(&
M'\'G/+T3'-X1\ND^7)T<P9)J2E1AF\4JW6ZQX"AEUJ=[>G(L;VXNY\5B.8_6
MLEQU^I7<D!E3%E]M[C6/FH^9!;.GYC`G<"*://-A[+%H#%B7>;8MD+W??:*?
MQ6);6L;[6XKCX-EFZ*DMV!];K++"&8\YXC%GPH\J*Z)^_"\Q=P!)7PG5-M!0
M;;X>7$#F`S+$5`9,X/DYZAWX87]L^M+Q=ZH2,SS[]G4>Z#N_LSD7=-7/#X7B
M:=7_,;=P_.&!<$TTFIBYEJR<V[+CQY?/3#4%\\K%=GOMQC=GS`7V0V>59G._
M`4P^#<U#7=S=ZG4V9_O=\7L;.)225I$MU5N6$E0MI(5S;I'Y8N.259L;+X_W
MKMK)[]1<[[K!O3,_./WZ63L7W+3D3M>=[GN7C/"'-/M=^]VOY%Y9,+KJV*KC
MJTZM\GEE1[V4KV@(K=(\HIW?4/0A)]>@S/<A3YO-*EG,)J-!K]/9[14Z[4`,
MVV(T/F0#.Q2CY*@P%FFN&FR&XN[84['G8EQL!.\ZT)D<`&<+NJHFVM>V6WE*
M>4[AE,EW6`ZO*-!7=0_-Q_-5:)VO0M/\&BHZ\]LK<,4(UJKVS5J\30L%*PRC
MS0OWMN&V$:Y6-7KFZS,>W.X9\!#/C\C/D0#"M0BUP".]('K.QF?7U%@6_9C+
M@KT+0EI`B[BL&I*R>'-V9W9WELNZJ7W-&JE(9/.%-#>P#"^C:S.!M$+AU?U2
M!2O\CL5BEI6/D$&0EL5""<P.'9TN;VYG`B])]"9&$\<2?,),>R:FSJNA\&?5
M1A5&XG)Y57:5NFH/[+EF%7W5;S#F5IEWWC4;SV91G-FULA-;G+W.UT'9CTS\
M3;6R\P<C!09.-D?G"/F1:K^WB(NU6:Z=(^T<1IS$$8YNI2>08SF,RM'/4YA,
M"\_0-7+GKUQU&%\!?IU^[PX:(J9B`;I\K'^<%<:2_2>D9-^GK)+LI]H_V2>=
M`.P&#JTT-FD4QM^G)J(HC?53K[<;,MH?.H.5V/^Z\JY"P$[TGQX#4):D+;%W
M8]#2/Q5]IH$BN%E4?2IFM'7!BN99T;P_X')C33Q65UM?FZOEA-;XDG@Z5AU?
M'EOFQ_YI03]:D%\DHQFX**.S-$4_:D\M\J-SDLMD/-,]VX\[*E?X\?(5@68?
M=/=-0PMKY\MXP?Q\@TK:9'K&Q+?X\>+,V7ZTM.IL&<URM?F9JUT.,7V9)+\6
M'JX&P;^6A9[H*2[N8Z9-U:<EX-&\9*.QIE-[;<Q_ZL+QR4@0V!T7\].%2&32
MARI'D-DUZ<%7LE`27.PM'*;!Y+(;7QEG`><S-:CGEZT\NN?ZGA>29D[0<);D
M-YN./#1S3DU(R?I[__NL[LT7//#Y\S<N,%CSXNI<LH`=\]?/S+4O7#NKOO19
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MP)23_B`#K=*1E^JD(\ERRU%P$(]\Q3?LS-FH2.99"E^LS,&@=$AKI9Z97STS
MN7IFEO63D2[6-!G[<C<U8H4U*ZQ98<T*K.84TS90^-M^^@`*7SQ#GZ5238V3
M5IL9[<DR^)!)!*LH1\>H7&$:)<\TJ=5Y?5,/X&9+S!(?:!IJXH>;1IN.-7%)
M`;<W]33UTB:U"<M:=U70.L)95&LX516LG!_65P6E^1&E*A@?X<QJ.I*O3+?F
M@OF96*YL0&R5`*NL5DGO<4=U0WH\K,<6?:]^M_YU/:^G2BJ60DHT'4JUIWI2
MO2E^(#64(L,I#!8K-9HZEN)3/8T/;Z.'J1104F0Y7LZG3JS&BBW60CE^1C>?
MJ8H*KU^C%6*^N%_C\6-1ZQ4#U#Q/1LI88!B#\J)Q#"NUQ^60+(C<I*UFI]P,
M#8K,-836.GK*<R:6AA=MOJYU<:_/;M9GU=)TAUJGYT(SL[47S'<49I>:SXI4
MN"TAKR-CQC;-;>-KM\Y:?J[Z>.F'*V2W/QJMC$N+\<R[OI')+2GYOY$.1:-V
M?=-R[JRR]TA/9EH@$4%>#"A,)D]F#J$H&((`96>;B;&[26&1#,5-.5NQNSD=
M6!"FRZ%PG#&^CGJ![!Q[9.*_#]+>.I-[2N-#X0_[)\7M^)2XO7F`29M,PR&N
M)<IF91N8X?!FD.$>`0L,R3*OG0X@A`4[H,$W0:D?[9;>Z9Z,D)1/8HZ"2(#.
M3!ZA/#8E"2:9R8#"4CK._@4+)@NMK>6"ZFEL%#I4&NK:(Q#Z481D)2S:Z?(^
M5?WT39TN&C$Q>3`1RO8F)@]T965Y<%/!9_(#+<^412@:^8H,E'U,F/L[1XM'
MRX<5DZ+@&8KBGFAO="BZ)WHJJI&C[5&BTB1*#69=78[E3<WE/)4MYY$8R]6T
MQYL#`;'/#YNJ@C80BTI/JQQ49AH]1OL0+*6`4-@HVFWZ(1W6%:@-WM>6IYEJ
M*>:Y"XU&D\<4=:O)@INV>1N:<T-NW.[&/>Y>]Y![C_N46^/>%]GW(!,'.NTQ
M*@-@>L?*,!4L+RQ-FA0&MJ0D/;#L*X>%)P-UU([8S_`U8^O**;ZNJIXVK;JZ
M9=I_>&I;2VUM:9].#'K]"3.NT-Q&'[145T\K*>/R\@(PLK>E`Z^YLT;V6**]
MP"%6A'@C<&TC]]RDED]ZF?+VL%1FH0TK2S%+H07:0TZ:@F8_R;B1%M1D6<4W
M5*9#>%*Y\XS-!:;NTTQ[IYU4W:>GM'QZ2LNGJ1S0`:!04B76)&%KB(_K7=Y8
M@GV(`JYG0=?'41XXW=;`='U#(XI[C,;R*0?WAX,ZHXG)#O>'O7J!QD[&DI,F
M8#PY.CKZY7'&I)9]"7@>K`!L_.1),>6H0Y9"J$!L@H3A_QW=G?HAPY#Q?LM]
MUOMM]X5V%Y[6ZPN>@G>UM-JZ.G21M-FZ.70_T7T4'`N1`=VUYI>XERP?D`\L
M8]:_V+1%:]%=##7)Q<)L2[_^<HLV0ZHE.2;',X4FW"2)#JD#GR,MD_F(M`*O
ML+PO?2)IYEGGAE[0O:#_HU[CTCFE4"`4FD5F6`2#U6(W>8T!2]`<$I9R'?Q2
M39>TS+K,+G@L@4`PM)3PDT*;:7"S>"66.'UE'O;H:B,V7@4,K!<\E48C?'K2
M-K&0CI*F)T:T3B$/DT(H_)-)83I=:/K2*C&C1*W145`?9XYK0%FH'9(%$ZO-
M;I<\(6_0DP9#4QG6$UU03^U,9:2A,M.:#S;,1!EDL$M25`Y5R)C((;#L64PJ
M,"981G+(COE*8M%+DEO?B)!K!'^L+G0;?VHPZ`7@=X_'K3=DC0-&<LJ(CQF/
M&TFO<91&Y%VNW6[L]H8*N`"&"44S&926TL/IT?2QM*8]C0?20VF2[FDJC.`K
MGE8>O@0P\N+3??W=+8LH^ETL]7]*BZ>[P5Z=,5(M]%&QQ4.73"$M,`YXF-O-
M:7?2?(UT9+MVLH"@@WM2?J4Q+(V6T^WTV1%1[(+]Z>_OHP'[?MS-?J@/];$H
MB@1B4P%H,Y0`W`QW0`7&2U@*A&H90\%`,VO!4LYTY8P>3^^U%IB:F&+9+GI:
M:J6(,Y^+5^85AR"(HITA4JHO&BC4Q%1[N,I6L?&K9G')!_.-6B6.;SOGXM:/
M/EH;SD8]TTMM<5^B]"=/>E$I/3OB,%C,LM=1;<62YK8O^MZ8:3,:*P)$EDEZ
MVMNE7UVE9,SZ:!0[[*YZO+%TK*O)C:-1J\&EG,W-V#W'9XU037,6V$<+:!H'
M_O:4=72!<6#6L<(H8'$RNL)T!F8Z`QLI2)H\R?R0X4/CE`$T4C/)#C+!?SO`
MSC8U/P+EH(5;1'90$`;[F5--D9J-9-V9X$O9HARA\9>O8+Y*.[-Q%2S43P\U
M$1(GXR[EB`N+_M-)E4V6L:R\6*%LLHQ&E_-KL*W((OY4ISPSY!IUG7)Q+A;J
MF)VCN=I<F);#KGVF]0WM+JRZVET]KE[7D&L/=!2-54%Q?AA7!87*R-0Q)TQ)
M%/0(1TW&R6&,S.CDI^6&C+C=B'N,O<8AXQ[C*:/&N,_Y%:-3!E_%EB_-##@\
M+/K!K,S7+<L49USER<TI%8MIKSGD]B:LV*JY[?/6Y4T!9D4X]?XY9>S#K(B0
MY9Y"*[A?3%H15Q?S%;I8!,UE9:2U=BS,3NG[+"4H)1]M42V4QMDDZY6L;9P]
MU6OV5"_:HBJTU^S6.:VL7RMCE%;&**T+*^C7%DZ]MW#*OBR<&@`*_U0]M.]"
M/1UF89*]GF2O)QNIZV^@#8T2?0WJ;Z@&^EZCGP[<R%P8VK61L.>$CM%H96-8
MV1A6F=I`-H:<G3R]>J$\AES-3K9&)GZM&FA7F4P^_P)XE)YV.3V9NEES*7R3
MYRSK4&F?3`=>TK&Y8UL'U[%<F%/KCM48Q)8:C<A.GS/4HG5W`UX;'Z6_*8-&
MF>[?BY.L#BGP>Y+E+S&,=R;DJ+;`\#"Z0=2(RSJ6B^[:.5;&\5:9'7_)2>;"
M)%E;LK&5U5I9K74AK./#9\H'8IV-U`FDS8UE;Y`5_L:>-C9V+J0VGC8NG)(@
M*'S&GBY<V-4Y*3C6,ZD$,V<W+`&Q-1\M%JE2!NX=-BU8UOD<FCUQ$LV".P-W
M=N+D`:_;XP;7J_SK\JG^G'BLZR].;@!8O(OZ2DD3'NH"ETBN"KI'R!?[PXU5
MP5HHJ(;PPJK@G/EA:U70!5[1_DBR*I@=X4S[(ZU5P=E04*='.BH7M2X+=LS4
M5C4N4@M5"2T28W.6KZ"$B=48]091X#7BG-FU6;=+W^5R>25K5,G*N%<>EHD\
M@O.JI;$JG8PV91MQ;^-P(VFD;<Y%*UJC"Q>&%K4O(@.+AA81M$A:1!:!7!^L
M<.86]71VC9"58+.VN4?P^ANIW:*1';!6-&!/O:H3Y:QE\:SS9KZ/BNP8KLC^
MBY@!8Y`'-A>=\;>F/*YPU&@QQ2+QJ%'Q8[,E;(Y]U>,"ARN)64@4[`5SN/X?
MW*Y)6\)BHJ+H^E*/G&D6O^*/?0VWUN/V];;4IOKE5SLVWK9@7I_B-.D;SBJU
MV*<I+CWOJUR>OW`A(8[FV:7:A06#1JE9TI!?FO+4+BA-*]9Y&<:MM."*)/EX
MO25>O7[U%0L6=#1?7=JR7':">^:2(M9V/-B;5O-S#<G2`N:S@54Z!]IJU4!-
M8\FQLL$7C?JF=>!OW%VC3.)A(T+<WT&3U9,SFBS/-%F6X>%:EIJU%F>$JH0T
MK44"T2HM4TE:I@^T3!]HG2PXXF3!$2<[U79.J2=G.>3("G]6X[2[$P78RP$V
M4(`-$:ABL9$J!IRKI@!R51FBL4)9R551W::G;U0A/XEFJ2+1U:HZ.M\ZTX_!
M($IPA\O1$E47M43K1&\-8;HDDV&A$0D`\O]MSUN@VZJN1,^Y]TJZNOK<J__/
MDJXL77TL6;(ERXX<%\F)G9^3V!!*XA1CA\0D@03_8D)H@MT/A+S22:;04J"#
M4UH^+67BR!`<4HK+I"W]I&3>4*;M*H69IDQYQ=.427G3@NVWSY&<!*;S.K/6
MF_5>W](^VGN?>\Z^]QS=N\\^>^]C>G]^)#YSF?V0B`&12BF22V;CNI2=YE9I
M]K*>UND$ZDO/%T,\W3UY:BEX:C5X.T.:[+3)SI,FNSW;@+Q4TDL;O+332_\H
M:8TMFHL8,29$(A;+-OQ'4R7@FS9G"S59/DO6?UVV*]N7'<P>R:IJ.5R@]7&X
MFLRJ)[-GL\QD%O=!PTR6]?+VF$\LI4UB,5]H334?\QG7!+TQ7["4-JF/U+36
M^>K;JE`PG:'_.!0,BJ)1<-A#FB,\GN2QR`_R$_Q+/,>3M(DGEO&&:ORQKEA?
M;##&C<>.Q"9C+(I),29&]G$M+/A87T,I=1+_CZ=.S$X7J^84%^NHPBJU4^5>
M7,:PBGN&X(<@EJ29DW\W;P(K\O+&2TY`!G=\\3,=NV2[45>_;'ZII9`1N-9U
M>V_1&<E"M*ZH%_V+ZW#VA8YK6O;/[]OH=]&,B=B)]QX8^OB\M\?NA96V<AN^
M^I%5;K+.&##:Y]B3L,Y$Y&7TY956!6X@]>CH<5HYII-T.J!NCJP=TDDJ!0MI
MY*@8YU!XG:2@TLY(];><S*BO6]13+>DG<FYRLX?HE)NS4HVSZB7JP4G4?>.H
M'T"J'.?3ZTM'W'0K(LH%>Q%:/$1K-X_;\&/V$_9OX>]J3WM_HE6;_TG`J[3M
M]HVV._#=VD/B3SP:?R&=Y>C1]H0??]OV73=3\./5_.)LS!SYZ''P_SM!%3E\
MEM`NKH\;Y(YPDYR:>TM/CDL*^@D(<2Z>Z@['U\V2M%J\8S*ZH6.RZ\K-Q_6^
MU<?]W.JK-F]Z#ND79A`'Z%^8(5O@\DU?1VXVC3AD9=-O2F]Z+KN$W:&[_(=`
MB1JQUZP8PXQ2%184==@D6F7DQ6X9V[50<VJ@9C%(,O:P0&PZAXQ<*B#D55^6
M58=M`Q-_$[0.+]]4,(TRH^K;A-N,MYEOM8\Z1ZOXGFX(A$B>75LEF7(>0!M)
ML^M*:7:2\*`';>4D>F.C@YRU6<WE=#F#SMY^TRTOC;UTV_8#/]B0O6G9Q,>W
MW+YS)7OLH8/'/OK>^".?>O+VW^]MS3^T_\7YGQ_]FPMW]T'0L?#[^37LLZ!K
M$91CJLNZ%EM:(%8U+=001I*Y))]M<2&9C5FH#;;(=NJ<D<STHK]&[:Y,E,A`
M'3LV&C=S1K6;'/PZ2,@![D=2,39VJS41:H41M<((@W:"A07/;98:W$M9B%?C
M,S/2M\&PIJC&7CH$3B^\]S11Q+1`=-))T\S"TF:8'=5;"[61%KFT!ZC)I/ZY
MX*'.F@Q24;4Q@K#+")/1D=F0"9`OG9=*EA&7+"88S[,EXWDF3K3Z=F$IT=:<
MM%KZB'3(Q-V9P$L3^:4=B8\D;C3=F!CA]YGV)3[)/Z)YD_^]UE"W=%.FNV%7
M`U=8BE,\&XV9+>!6N>ZLMH!S%0FB2*`SXD-MC#D>9;FDU(C)3!@-F9/+:4S7
M^X4C`M,GC`O'!%;XM<Q8IO'V@D>6NP*#`68\@%%`"DP&9@)G`ZI`7_,+'>5@
MID6B5G%XE@0TLWF2/W-<S)^Q1HGX/U2CY5168^"5AK`^7*=D-6D9IPQ`,MI&
M&=?KDC(Y(BJK+DTPDU,@4$%6R=@6#WQ+ASF110<F8[\LHZPJ&<QT$]5,XN@P
MV!U>>;CSOUT[=-?@5]<T1M..7,>\[&J*6&Q2T.=4<(/6N'O#MBNNO+:PJ2X5
M8G/#K^S;LNN3+\\^.&83:^??O"[C4Q1LU]5O8Z_OKG,:Q^:_.A!LWK3^AI/_
M?6B]TTRRS&WS:S@$NNQ%<?QR69?=86HJPS8[838(I7WE6-I(8A(3<2*,U`\Q
M4C_$2'+'U(\!]YN&SD;5LZ70N2!IO&K19PXJ3G6LVZS3&$MZ`RJ3OSQXGJ$:
M6U*:&4\-,:&>&J*'GAJB@V[1[;M&8G$M=;EE9Z2KEBG4CM=^.7JTEJMSUP7R
M-4OBG5+!70ATUJR*;Q*[W-V^KL#FFM[X@'2]^_K`0,U^:<@]YAL*C,7O<'\Z
M_@7Q<^XO^#X7^'S-0_''[8^ZGZAZ,G[2_@V8P4_C;\7?C=?(M2/*2/2PY3[+
M?=:96LT&"Z[FC1!!1\H1M,<I^OQLT!W#Y&\%%:]3HU$;/1[D]QN)VJ60'Q_!
M3!\>Q\<PBWD:[_\Z7"_9NFS,\[:7;+^QL39ZCFM;GE@^1BUQ?&AXW>Q<O(=L
MSS0O1@+LV?P<T4=SKKPW.T-1BR/D",LH:@&BV(,RCEAC<DGW2H>/$(H/+XDC
MDM*^%(IG2J<7ZE+R%U'_NXDM'W'8K.0`D;W)F5DSG[8L\5J='[EK]1U_BZU_
MD^L+-V<_$=F6'SSZI9&EU[+'WKUA4[I*421=#ES?79UO?_]-K,AR56@NA?\:
M]NMO?//D3`:5SON89T"SHOCILEY%:ZB-5/L=I@AU3B-./RZ'\I='OOY%O]:_
MZ)'ZB36BY]M^&IC[J0OKIQ$O%<02Z[2[2#+7B<*@=L;.R$!D+,)&HAJGG@5C
M=89$N+,0W_X;KY2<44CO/ZP+DL>%X=X![9B6T<(#G&J8*364)AK!DCG^@1I*
M/\D($'TEE6=(G]]?$[LLPRF=1JG\F7)VD_B0GL(`A&]BFDF+!:8@?IS3%&IP
M;PWV$RM'X\4[@Y&(W!KV1=J0H*LQ664)<\YQ<EP@Z;&^FV61!B+"7C4NJ+$Z
MZ:_!-<@4\OO],AZ7C\@,DB6($&?DL[)*[HN1Y"0HU\48;_C<4.F@0)H=GNTQ
ME6*Y'+KLP&`8_#O8.&W$N2L=%I2C+L?%8[#W)?S6CNQK6M40"FZTF6VU=1;#
MLBOFXRNJ78+*$'3[(P*VL<=^^,/EB4ACNS5VW?SJM1%PWD)V&D]M/?JA*N+`
M@;YL6SC'_`CTI9YK*.M+)$/U)5,@WAF#Z4D7IB==6/2X^8B>M$<"XJ+Y$<E&
MFB;]8KV&CX@!SAQ7X7TJO$N%54H*8URC<>WUX:T^[%-D-^YS#[H9MUF'\J=[
M>L`'2@$'U@.;:9ZH"/A]9UX^([U<VDDO:D<Z($9XKL;N,R=53$V]IO08E[E#
MA6]2?53%J)0:39L/;_/M\3$^Q:S#9(9O%]Q$6T0QDW;S1AK%1,R$12*9='G'
M/%WBI\&'ZNDA*)T^W9.73IMST$$3XYY"3)MP)1BS.5G0Y1)17<YI[=9O#C\H
MW1M2"1HA*L3Z,H.9\8Q:S$QCN7`0S.7W#=\WG@Z=5OX^^$KH)XDWN#>";X3>
M3.C,^41/XN;:`XG#^#!SF!VWC;O'/>-5AVH/)PTB%AF!U>K554+BQ>KO!ODJ
MUFXU5]F]KI@G<;_V?N%!^9[@/2&=.6Z()M8D.C.]F5MCMR;N-#X>/);Y%?M&
ME3[&U_O0<XP/^W$*,W@:QXOHN>0T=A=,-4Z?ZSF/S^UW8\DMPYLCG:[G[*2S
MVFP.!0TZ3HQ0IO+A[Z!DJJ8>(?)2W;>[7,YI=D7!:D^1%\O\P(RQ^:7`:X'?
M!-C`-&LMZ`9%W"<.BD=$5IS&C057Q.U*^GG,)R8BN"\R&!F/L'*D+L)$GL4R
M2F/Y>,?BXE@W.WR!!D=S/<LW%1<"N*<[EP*_LKB`H0J^P>PYZ(>MBX1-YZ39
M<A;$D0.O5(`X+63060T&W4%CDB;QNYU(>NO";,\PEF8OS);JM%I2HJ>2LM;0
M@.+=U*9716-^63*I-7Y3H`JK8WP5+&%?%=)$555XT;"3V`O&TKZK>4=ZQ_1N
ME.OIQL,(EBHTNB;P!#/!3N@>,!RQ'7$?\1RINK_ZON!$K1[<XS@>(EL!B.E2
MP53H4XD'0P\F5#W=Q&DV16573AMUY7!!R#&`'G(H(.3<]!16R"6A*4%1F]-+
M/G/>*!,"+F31DZ/,E0N!4U"TY((EI@=VPI)+."VE9YE+SQ+-,(09AC#G$K*9
MW'.^((H@)N98R0#C&,@#SA?,!AC'`#*`3A-%%/_?`;R;;FJN3,'R3N:P.QPE
MNT6]J*`I0[PJ<I(1HB$`\<1(G,H<"83W7KOB&MG?^YGO/S=Z]:Z`S6$(!*H>
MNKY]XY;YG]?6/OC1QG49DV36L\?F7[SGQC6U2Z*QY,JM#Q^XWR>X\<J[_^+*
M7/MU1YIS&X<^[Q"-3K!AUH7?,BW<-Y$'SY5MF.(MF,&&>0O$0.GT-`&CMUFP
MRD*K%KJ164K935JY0#<\"WD7-#=DT?$)T6[EIK&GB+`:=K*YLV=2LZ?+>]BK
MX.VGWF^?7`Z:/[%3:KNL[B&GGM2=6JRXB#]'CR<&=5@G>K!MIQ6OMF(Z7`%4
M$<;6>;"*!@<JFDQ1T5U092FEC]1TIG3_LRR>\%DLWJK+DBEGSY"8<.YL3\^,
M=$8ZW;-X(@V?U7,2&6`"K?I<+^YEF+SW?M/]KN=MS]NG7;]R:2:\^)`;=^H[
M#;WZ7L/OG"JUT^:,.%F[S>ERLY@0J^<H9FUUY=FR=0R#U?HLF;3])=MKU,?J
MMWI^@'3DW"\AP^:93'DGO8P78<QQJI"URX+'+1A9),ND9<9RUO*Z16WIJWKB
MT&)H,$>3)%+/!?`=9L%.M*#\W+G221YTG<.P?2+JG=77@;-/??YADA<Q96Q!
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M%(^(F(E_2+I(A>J>V1P)7Y[W!R+1?",A,T01\Z"$U!$#?Y"D=`I9'"%1A1PA
M^\-DA&O0-?F;Y57^5;+*S5LZ2>09Z/0ID2`?P:T:']\FZQ0O/XW;"Q8!*0IL
M2>3_&`6=H-,%9.+[&]$DQB(>Q!/X)<QADJE3S"YWR&SNLARQ,.-`)BTL43JY
MK':@=.$7QM[OI\%6!.H'VD<R=;.E;)U$DZH7/378.B1/E6BJ$MU52#)Y)&\5
MHHFZCWT,8H">^.)!7+K)H0IF%_40_#9--E#63A,YWV6WB@&[/V*<_^?:6_:W
MKQM*5#6MPJW=^?CNCMQF]MZY'TVLK#(%AUX87]9]]SB^OS7MP<K<@^-=C6L9
MS?HF1B$G=J"CLZ"C,O/-DHZ>T&J1VZRVDG2Q"5`&9-A_/([`A)$,<3X%.T+J
M4DZMWBEH/;Q66QV`^W16FORU6M0F&O^9S&J&ML#ZEFE%)L\Y$[_T,Y=R$*^>
MD5ZEGU5KWB!L<G[$Q8*-^W%1EZTFN]`66];JLKJ#VFHA8)+-(:?LDMW-VIS0
M;,XYLZYF]QI^M;9-:'>VNU:[=_)?X._7_I7[`<]$]5?0X_PCVH==#[L?]WR#
M?UI[0CCA?,;UK/N49Z;Z1\YWA'><[[IK)[28C#*5[FN@/%Y?XKY8B:]<6>*1
M2(D'@R5N,E%>*+BJ&L3J_6@8#S.#JOWRQU1WF`Y7:YOY!J'!F?-\6ST3^+%;
M<Y=PR'G0Q3:95SD9B]/JLR"/[$-FP>2#57!G(:%UNV2GRU6G%:Q:K>!QNT-:
M'FJ\1JWB.!Y<,HL9W":D=KMTSFD,VU.O@"4A)$P()X27!95P0.LA2BP5U*FC
M_$G^A[!Z#VA=H^Y3V(-DI(7YBN8&+9FWRTMY,9TE[!E]%FEG(%R:QL^?D*KQ
M>'7I;8`4X2=$2T.`&%:7%(=`]T(/L1?N.><;+M!YYP7W+.'#SME2:$)UG5C7
M@R5WZJ`JZ:25./A5LUB:N9R2P^>>GJ%%CX"J?AP/@W_SM"#;#7DP7K]Z!K@V
M!/XR!`O@I0C`"H(EQ\O@I@#BTHZ$:<K0$K"5'`F+A:9BPL%LP*:&"`@'<3A,
MTC?X6%4D9OO1*PY>5]V`XPW68-7\J=C\27O4;TJS]RIA.5@WKV8,2[Q&K:A3
M%,[D6_'>/[.JQI2DY4ELO'!.]12LE@1[IKQ:P@&?R<@D2)+/B+1A)\]%%;]:
M5!,US^=3*4=.FCL+,'/9FCF)PK![MA&[YZRB(06E3II6X$O4&=9R*$H?OB^!
M$VA4P8IN-(JCNM+3$XG:0"!96\Y+D['R/?D>Z=4>.IB)1AWTK7J.FY-$2:OR
M67L$`DR3$I&3O<F=VL'DF\J;T7]5_C6J)P)%2Y;*O>CQ-P22R=BV1J_+Y?<$
MI20GA+WA1#@7_K#C,<=CSL?"O$YI"C5%.M%:O$ZSFE\96A%9%UT7NTLS+HV;
M/JW<%;TK-IY\0+J7""NGI)/*R>CSR1>5%Z,_47X2/9OT(Q6G4=LXAU;11+11
M=2SK6"XM-W6IKM)<X[PJ=DAW6+K+><AU*'B7<E=X/.DXJ+W3<3#,&K3=>*^T
MU\3!FH"OJ2@"UL"JD!PFGR0'`SX9Q1(^)`I&G^AW^7P0UM\YQ4<CL)D>*!2<
M2DCF-;Q6$XI%K;%8%+1!B=3Q6BO/:\$[<=E"@F(5!"48"M4Y75:GTQ4+!UT0
MK,/Z$^`[G,)OP2+RX;>F_%@TD2L)&<$W@5U0DB"`EQ%#&C%*@`@L4N<I?"-2
M$(\?+8C1`DPV%(KJY/?$?@%BJN-/S:#^6'`:\P5;P9/J<N&C+OR<ZR77:V#U
M/A-*P?+V/".+"I;@HY.EJ-,W**>PA,+(!BM<7Q!2O6%<"(^'F3`X2$]I#T12
M_+.PS'EPIP091?%X]'R4B9*]'VZ-'M70A&I7#(_',#EEDF.%V&1L)G8VIHGU
MU5[TFF;)B;++/3MW#H*>H?+:AB8W-$"W\YP;7"F"L^5#*+=$#Y:)B]52+J7Z
M;"G.@M5?L@)&L`+\HCG@+V^)_S'#\&^I1N);^!9J,(9P3^D8*P[F@MB*L&35
MYTE@,@7<0NR$-^>XC%D).U]TY!3";/3JN"UW\;"B9#G4)<,1(7:B9#86#4GY
M&@?9DATQX''8AD]_J\$9L;?@IU;YK/S9;UHC.1S8&)O_8>R7\[]3YG_J7=("
M]H3S5?D3<[_%3QYL<1A916$=4M!JFWL;O]LH6WR,HAAVOO=K9O7<,RRS.F,@
M/J,'(?:?P,(L8=\N^XSZL.!L"'.U"!Z5`COS5*U%8I9`Y02J]9E*AB:5(E9F
MAI+2F0+92@^:VP5\V'#8>-AT,'RPX17=*XZ?1GZ:T8K)L*#H0OIA853W1EI3
MU9P4-S=RR;PJ+^5-2\+Y:*ZAKGFUKE/J-*WPK0ZOC78T%)JO<5VC=#6/:L9T
M8]*8:<P^YOBL9D*:,#WF/!7V&56B))K$A%_RF_R)F!!SI)H%J?G#VLV-7<U<
MV5,(P;SW+<%+R!^Y)853R7"#4^!0DOP'7]+KS263S;E%@Y9*Y?/DGU"+-E.B
MY#\]'(:UZ;#;(PT-64&GUV?`_=!H7.&&;$,FJY@/VU,F;,J"6VK7>P^XNGS8
MEU(&@F-!)G@XB(,N)9G,96K?CL4BF2YXVP>R.*M2:1271A/**M9L5M';(Y&Z
MC-Z:R>CARSNU>D<FHKAT2U)AI\#J&S19L0I7^>%+I)+D,\`&;C*173G)U>+:
M6I_/*^C!Q7QZP([M264:&Z=D%W81NZJ7L@77I.MUUWD71QK(;NPZQ32B#-+@
M[<5L,@+V8`IE<.84\TV40\W,NJG`&5B:\7=Z9B_,2G/QGOC0+,0SI;77L[C;
M@JM)B=320QPI&MB0I6=,Q@\:#Y06&JE@ISEW(.5\2SK70][Q.?JBS;F>5`^T
M2/12VO\6U#2\U&)L.6B46@Z</DW8:?ZT!A@/K=TDR]C30[;J(30$B^\DTL&:
M$G(Z"$V>T>8<),L`]5]-`;>1(%5;9<H;"AXI[R2M<$%XP>(PYE7D3%/C!-)(
M:LW$%0$>BXKD:>=/B#E%%LF&_^.BF-.0A2SFTL!.&*##0%M(=B(L$S1!FXG<
M!RXC=1**YA(SE5P&CR$GP0LP`3H*YIPDB3D38*)@RUE*5L%>8F:R%=I([N-\
MP6++-?*V7+3.FHL!FGA[3DL?9L_%"B9`6RY-$$9VD-$!R>W'39=LR_OA@QF1
MBV*T@YJAQ40(.4RZZ+]H+':[HY3`!;\F0DP3O29A:1/Q<SSX6"P0U-E;.U95
MAW%C?:C^PP?.7;TJ-]]5Z[(4[KRGK;9V_D<A3WCSS%^ON?)#8)BJ',ZT5+UC
MQU:WS0MFR5D]_-C\]+YZ-A2R&AV.GM.G/V)R1IA02&7U[EUX;U<3K!7]_`KV
M`EBF],6S4_!.XS4LNC6"(UZ(&&B>UTH,DXE63:3*T"I#JFE:34\O!A/QV?A;
M4/*I,SV+)JML*7S:./):3<QM:9Q&9C`/P=O(&*+5FD&H(7/1Z7FUYS3$A=0V
ME%+TDU+'U9N>0YZ%?T6NA?/(#89>D)8`='L*3V@E4"]C_+,QQM*0M&]K_(3J
M#C6CU:K,O(MW:^-6=U@;,H?<X?@2W&C.>E::=VAW"#M=-[BW>G8D;N7W"?M<
M>]U[/+<F#@F'7)]'G]?>Y_Y<_!0ZV_!+=1!\DG@\45,C8.JINXA[GTB7W?LP
M+[O<[KH:P0H"B7B<.O;Q&KBEQJWE!#X!W`6>!A\LN_@18C",,-M(*ICSB@T.
MA]M%O`7/80&_)IPGAZ6#PF\$5CB0UW9J>[6L]@`$ML:"-_Z**&-1GI`9^7!O
M`J<2^023<&4:OA)X%*+4^'KPU->=ZQDZ-W>AYP+LI'/KV_O;WD#Y=7/GXB5S
MLI@</<A?MG,#)Z;EW]VH+VW.>(B8AOB_YXI37[Q\D'4QG=>$PW33U>,G;+6U
M@=?.F#1\=1S7*%&GUC7_J<9C5RY=VU07R$4%W\I0Z_PS8L`E.3*@PQ%OI'T^
MC?\0BYJU.@,XZ\Z`,?_>S7?<U9:HR=C%*[HGF"E_,JB7]*"],=A7=X'VVO!7
M"BDSSSFY"6[",&'\"C?-:28<V.`8-=0W=J%-8I>-]7`.HT6\CKM*?(T[*VK*
M6AG%K,/.BHQ1I>]0X8^J<)>J3\6HZO3J-A'O$7&O."`R8ATCH/P<&$E*3/0,
M@)[40&B+WI&D5IN/I+5"A;1*]93@TW%&40RQG)5E.5;'<"+6&QT&,@K7I<*J
M.H->+?6*6*S#C"">8JY`1L0Q5Q02+$Y.P-]*=AEPG:%@&#2P!G?*D7=T.EB'
M/JG+(@8S+KOCBZ4M9/V%H747SJV7>MX!!;C0<TZ"`OO(W'`+)8MS)-,$A-CM
MX('33BS-@IO[NS*CIA\-QR%(HW;?N'"VH`4KS]8!X8C"&J`B%LA5R)X3IQ=^
M=L*>XZ)64OWQ"6N.&S23ZI$3YASGM)'JKT[8H"K2ZG'Q_483D2-0-I#%@6JB
M-<&F@`T'TL3@L=?JWOLQTS?_\I86BX>+JEDT]P!>O[/#(>FP:_Z?0FR-*YA>
M,Z^\]W(P(6]'B'A5"*E,;ZD]C]_9*[;\#I8[:44/_\+[`N$OOI"Y[]T]<W=+
MB#?"I9;*E^_3!.;;T48)O;OG#Z])Z&)/&;B;U#E<16I,&0FP;>@.]`&`[?)*
MYJOH:L#D8AO(WPS7&X#_)9-#+(?0&L#S@`G`#8`RX/4??!;(3@+^Q0?;":B^
M@R35-:BZ7`]ROT`UW`@*7+SWJ^!O7`8:+ZI6?6?AEY?=OPKN#Y(ZW'O%Y;+0
M)Z(_`>RGT6H.+;P+?`7,O0WX6ABS$^H?`C3`O%N('-1-4/^0&KP5J.L!V^&^
MWY-[0-[`>M$VZ+?"-4-D86P#<`^1A6?&_M0\*O#G"XLZ4H$*5*`"%:A`!2KP
M7P'X\85G_Y3,_RN@\OSYS+4"%:A`!?YO`D8+S_*`$JK8S0I4H`(5J$`%*E"!
M"E2@`A6H0`4J4('_#V$9^B3Z%BG8BEOQ;OPHDV>.L_=S=ZE,JK]?+&J_^LY+
M1?,][;7::P6;,*][A13]]E(Q?-98)$6\1?JV]&W34*E8=G^PV&ZTW^TXY0IY
MK%77^!Z6FP.?#7PV^+W0=,0;_=L:37QWXH':8IVU/I_^RX9H8_>21YM52]E*
MJ91*J91*J91*J91*J91*J91*J91*J91*J91*J91*J91*J91*^7,O""-DV(@V
M(Y:>4S%(0BET#4)J16POGUWQZ`8B!<`B)]!2G8.ZLUQ70ZV./('30DL=6E6N
M,\B(;BW766B_LUSGH'ZB7%=#_8V.KM8UJZZ,7[US=__(^OZ]5PWLWG)SUX9U
M5_]GVU$'ZD*M:`W,X$H41U>CG6@WZD<C:#W0O>@J-`#76]#-(+4!K8/^JZ!]
M.QI%NZ!U^#]]]W^U/%/Z``L!M`W]$8#O1@$SE[=B%G-816MJK,$\UF(!Z[`>
M&[`1BQ>E)&RZ[!XSM@"U8ANVTVM'N=V)792[L0=H5;G5BSX`V(?]6,8!7(V#
M.(05'(:V"([B&*[!<9S`M3B)4[@.U^,TSN`&G,6-'WQ&!2I0@0I4H`(5J$`%
M*E"!"E2@`A6H0`4J4($*5*`"%:A`!?[<0#4RN&5KOVYH=&!/_\C.F[?OZM<.
M;AGNOWE7_PU[!%H;WKE]QQ[5UH'=N[>H=^P;W-%_LWJP?WCGP#;5R*XM(SNX
MV_J'!]B!F_O9/7L'5'MV#/?W<S<,C`YS-^R\I1]NVS5PLW:D?_=.6L.M>!EN
MP^UX!5Z-U^'U^$I\%;X:;\);\/5X*]Z&^_$->#O>@7?BF_`NO!O?C`?P(!["
MPW@$[\&C^!:\%]^*]^';3J*KV;>FV!I_OM7&GD-][)MH@OTE>@V00Q*T2%#+
M`PY"?0%0M3##_L-4>WNZ,`T\GJ2\&(VE3Y*.HKLJ_1S[#\S74`3YH>&UHMU#
M>WY>7+:L7&E<4JI,U=2F7VL5V)^CWP`R[,_9UU"T=-=4-)D^WVJ`!LS>CD2,
MD1\=95]%DX`,*K`_G0J%TQ//LS^`_N^QWT7;Z&W?+1I,:7C@=]AGD!GYV1/L
MT^6>IZ>,IC1J'6$_C3":`7H6\'7`\X`<&F`?0V.`AP&/`7)(!.H'3`%VDA;V
M"?8)F.<C<+\(-`4X`'@8D(-7^%5HOXE0]G'V1E0-]][-WHMLP#_%WD/YEX&[
M@3\,[3[@7X1KPB?*UP\")_T/E-OOAVL[\,^7^7W0[@'^.;@F_+/EZUO847K?
MGC(_RHX4?7ZIU0?],F`=(`NU>Z%V+[RZ>\G9-%#,?H+=14<Z#CP-?'>)P^LZ
M4`P$Z3<Z,.5PI8_"*ST`K_X`O+D#\.8.(`ZZ]B_*["_)U++[068_R.P'F?WP
M5NK8$1AOA)ST`I4`94`6WOL(O'?2/@ET!O`L;?\DT".`1\D5NQ?>8PQF=8B]
ML1CU@Y)MG\H5TOE3[`WPJ@OL#5,N;_KPI2NM0!01N+',12+;3WO[I[1ZTMH_
MY?:6.$C=U&IDMZ*/`C+("C0$V`#8!LBQ6XNAE/]9=CW:S:."T3_&C+%CW)B*
MJVO#YN?9-.KB$:BDF:U%+2`0\_>VX*8^[:!V7,M*6EE;IRUHN[2J`7:,/<RR
M?C;%YME.MI=532_,%#7-&6"%E>KFS!'=4=VD;D9W5J>:5,^HSZI?5Y]7JV1U
MG;J@[E+WJ0?5X^HCZJ-J[1'U$0W3IQO4C>M822?KZG0%79=.Y=?@HZUWL-?#
MWT1`)<!!P".`'+SC7FB7V>L`>^%K],*KN`[:$5`$5Q+@6:B_#EP%5R+(B2`G
M0JL(K2*T(J"DIPNP#W"PW*N^V+-X#Y$_3WH`(]!KA%8CO-O7@9XG-<`U<&6`
M*P-<&4#J+/,>S%`"*@-V`;*T[75`T!J@BWUUY?X^0#7M/T]E%OL*Y%[FO<*6
MR$P,3\;PT1@^$L.%EGQKNE`-Q&PV]P9[E=YH[R/<0'!`&8@./,)U!CN5SFCG
M(UP^F%?RT?PC7"J84E+1U".</^A7_%'_(]SAM<?6/K_VI;5<[]J!M6-KV2;X
M=%/%>%V:\FJ%\*>++G>Z26Q=RAR#O],+=`+P-4`6^8&F`/.``X`<<PRHGWD2
M6I^$UB=1)V`OH`KN>)*8%Z#^<A]IGZ!]I$;ZF??UL_#'OU9LSG2VK@&3VPLX
M`<C"L[\&_5^CTJ7:,=H^"?1UVMY9EC]*V_U`%^]AP<!MIF9N,RR_S6#\-Z->
MP$%`%7J)W0B;PT;R9*!^P$'`8X`<NQG*1G8C\R24KS%?8Q,%0[W-C^QVV!_-
M)EYJE1@]Z(`!/T[IYRD]1&F>TE#!N,;PSAK#-]88[EQCB$"%B:)6Z+B7TD!!
MUVIXJM70V6J(M1K@:0X40`;&1JF:4/QK2M=3FBA8`X;?!PS_$C#\-F#XJX!A
M*&#X4(#<5P5KU\!8*=41BC]'Z1I*PP6=W_!MOV&CW]#D-[0:\$,81D?+*/51
MZB$4O_V4V"8B[2G\-FJ#)^%B2\P_S2#*\$*QI178?+%E);"Y8LM#P/Y0;+G'
M_W7\>TRW-/Q.,73.WVK#%_!JCES_2YG_%J]&3P`_#WP[\$=1"U:`?[G8\C$B
M_R6X_P&X?AA5\T3^BZB+WC<!W@!I_ZOR?5\H)JZ'41\L)O;!J`^@!!WUOF+B
M'+3>4TP<`O:98F(7L,-%A4SPQF)+C;_5A+>C$$-DMR*%(3-96QYQ%3QY%_"5
MI9O;BPER5QL98!HO+P;K@47(++^.@ZB+#N<O!NF?]*(@?405"M))>Y!"N1&+
M=/(&5$TY7PQ^#)ZB?DHYY_^?+:?('T>_PV+Q(?\OO@[_[QJX_$>\NOB$_V]/
MDM=5]+^4F,;*"?\/@Z?\WPI-XVN*_IG$-`\=SR>F&?RT_SB\Y$F09?`)_['$
M=O^30=K[2!!ZX5-/M-3Z'PQN]M^OP'71_['$U\DTT&[XQ]=`=W?B"O_:EB?\
M*Y1I#-V%%ABL(/B;@\/^'#0OF<:KIY[PUX>FR53JX!E/G/#7P(CA()W*AYN>
M9;)(@T<+"<T>S?6::S17:I9J,II:C:SQ:JHT5M[,2[R1U_,"S_-JGN,9'O'6
MZ877"W$$J]"JE@A3<X1RM"XQA`(A5I_!/`-K9]+"=C`=&Y;A27,'ZKAZV613
MO&-:LW#5Y))XQR3?]9%-QS'^BVZXFF3NFL;HZDV@H*3I#L^D>?FFDPCCU!V?
M]A"^_XY/=W?CCLF9K:CC>GGRG0WP/X0K-T^J@LN<R'Y+WIDW7V'*K6C[(Z2O
M3..7P!F_')S>R<]U;-@T^55O]V2:5!:\W1V3*S?(UVXZR0PQ`^UM)YE!PKHW
MG<2W,4/M5Y%V?%M;]T4Q5,T,@AAJ(8R(3:%J(H:J\1056TO%0$VKV]N.5U>7
MA%[`JXD0J,\+5&A[Z5DA&`*>U448B#$^%*+/"C$^(@;Z4'J8>/G#]`B+]&&B
M'M&'51&AXXH"(@F%B!QO4D#@N-)$NY^XU!U42M/I1@H=1\'==!R,+\E$2S*@
M!649A@>9^/])Z%_VIR0N`SRUY6?;MK;W!]O[@NW]@'V3G[IEAW-R_'I9/K[M
M9Z1#GF3#?==OW4'XEO[)GP7[VR:W!=ODXUNV_I'NK:1[2[#M.-K:?O6FXUL+
M_6W%+84M[<$M;=U3CXXM[WC?6(<NCK5\[(\\;(P\;#D9Z]&./]+=0;H?)6-U
MD+$ZR%B/%AZE8W5<M0QW=&TZSJ-EW<NO+?$I1B?`>NCS!+J7V:7!*^CB6!IP
MWNYYED.P;>GBW9/ZX+))`R#IJFVM;25=L#I)EQ&:Q7*7\_:E`<^S^/%REP3-
MIN`R%$?.]IUM%W\C(R-["(Z.QH'N&772MCVP:`,;.B977+EYTV3+9$O[9*&O
MK1N3SS%:AN6;"M+S+2^U,`,M8RV'6R9:CK6H1D>[H=G\?/5+U4QO]4#U6/7A
MZHGJ8]5JTG'MIA.%EHGJWU2SHZ!->`]`>QL=<Q0X_,CEGM$1`@@&&`$L#1<?
MC2_?U%J-MH*WB\$SKT46P"!@!G`#H`K]#="_`_P%X+\`<N@30.\!_!+@%&EA
M:]G:=N?.-C)B=YP8'2>;GJK+II=,`]]R0XEOV%SB[>M+O*4U[01>S&>$5A$<
M;XR>!?H]P)\"_@_`/P"JV#2;I@\?+6EM]P@:B6.8/H*+/82,Q/?@.%0P>=U[
M1N)Q1)`H.'P!$(WC]^L]PB.C"%X%?!!@($1;1\AMHX0O`ND`4_R_`,9_1B0*
M96YD<W1R96%M"F5N9&]B:@HQ-2`P(&]B:@H\/`HO1FEL=&5R+T9L871E1&5C
M;V1E"B],96YG=&@@,S@W,0H^/@IS=')E86T*6$?%6=MN&T<2?>=7\"V<(*2G
M>X87.4]V;`->8!,D(+`+6/L@B90T*Y*215))]NNWNZJKZW3/#"TYQBZ,*,.9
MOE17G3IUZ;?+P:L/Y=`,E]<#4T[*6;F8#TOW+_ZPL^G$#N>5G=AZN-P.2OK\
M>#/X-/KI?3$?_;9T?SX69Z,/A3'T\-.;PMC1TC_^4HS=X\_%W-I_+?\V>+\<
MR')N^<5P82:S83DYFPT?UX/KP5LOC#DES'3N)LS+^:0D63Z-/O[@=BA'PV)L
MR]&;HK*CW:JHRM&C>S$?K0M3CW[W;V6`DV8",]X6;A2/O??3[@OW\F[O)/^!
MO@]I[)5?AM;BH8?"+$;-=3&>C_XLIC+J0&>]O2C&L_#\FOX."SLM_>FKR72^
ML'8XMI.I7<S<,=^Y$Y@HC_O[L;"5>W1/?ATS&SUYJ6AK%M@)8,*YGKRL#6T1
MSBE/*Q%H,;JE63S*'XN_?/93CQ=THH,<;#[:_%G4(@DH\(&TPCO[-7D`O=SQ
M\X=BQOKC6=LXR)3C7X/Z9<HU']'_7A;CLR#;C?^T+JRHF$_[3YW[=R<\'XXG
MD$U(UQMO#3&7#3K<%>,J&([U^V-JBU*LP$:P:(2WA3LH+;V/F[(\=,8=V6=+
MZX'Y[^CO+HQS?PAWF_7*C[ZA51"KAUOZT;!1.A5^X)&K^ZB;/8V$/<(0.B<+
M1^<F@-()&F>*8"0R-\\%.Q]W-)AW/PK2W`<OF*SC@'A8;]=%30N8N"]M*0:U
M)6_)ZJ'=#HK.1S8;O=[P:)I(4ZYTL"!E6BH2!#JL\\8+=:!=>`I]0Z'C1@?P
MG`M^5/N;B:FG9<4`V.:3R"&:BPVOVR-J-`9-49KP8OC_6'5\CA93D/)8MBT/
MO`OBFF#!6UV;QZ%-9JC=;7CT!N+7ZNQ;->(JP#!"G709\+%Q4&G(#V]ICPX3
M1]EO"6:`%CI[HTBBW\?MOK")078*UZ@HWN>HZ%W1.<@`O#AY$F_97!55'12C
M.CE>^1FWH*0+MN)V'7;UDN\SZ\\6BS.V_N_`/'"H/LU9D51\T"@V1?<;FA`F
M,U-[59.$-PI8.AK/$I,3*DQ"]7[!!QI/@K;<I>4'L!8ID]\^K+WR^)@-C5Z!
M]>C%$X0YC"67`E]_X%N,)R:G+@X#+E1T4FY9SZ>L].K_PKDI;`G8;!G!IX2-
MAJD*M)R`&?RO5O_S2QSVX&"`^I6:AW%#-@)]MT0B81*_J>I1HP)LV$U-B>-I
M?A*,E=D:Q<D."2"<NI;S'E=B@73(D.7.TPI[QE^Z<@9)EZ(=C+*IF07*V*!A
M>QCZ`5:/&-D=@HCB6O0S*&?A`PW!9M$R6'""R*6;8O$"KU-R566T4>5'[G+:
MPS`(V,HC.%.&7YT==2?Z2]V-R(]@(()9D2Q/MNCW@XK*JP2]^'P6L!%X-*X%
MOK'2J*4I&`V]A</ST>[)'559]UUQ1%67'NU&T%6=D9;9,"P)Q-_(&<`6M$W,
M"+LI/W',#)K@/>#*:.H**!70%#6XTD,_:/+,)B,P29X6:4/T*FA&'O\F=%L+
MW1J?>+M2[:3N`]=UJ?V[(I(ALIEPJX\P@&G!6J@=H&H*#D)2W.36`Q>Z\A8&
MR)Z3)LX+S0]8.F:KC\1$%SJ\\X#DVHQU_]A<^L>-6B.``4B,W\3)$`9X+G#A
M;1+J6>DV<R(;7FYU'3)[EKGC2G2&E6*!U+LA$8D&:"<`6B^3:K3GE?DL?$RR
MP";%6W<,>U#=T"2U]NJ8:9HGG(^\Q90O^"U'&F1,A65'_'&_W_NJ\0_.^"!"
MWH#AJ,YO94F_^1SCN$&QW$[&"U\%'#G9QF9ZSMN?%R>.;Z;T`T>?',^GP()H
M]\4@`)79/0/4)-4W=0"2HKF'[%KJ39(=6Q/8LI2B*YB+$W>FLG_-OCQ:;!MS
M_,RVMM^VOGP%#U;<F8J]S]O62VBF7L,L+<GE[:8TDH0$PH=_G*[&'?-D9H@:
M44G#X%=F\4TB7(XG4X8V4P"`^_ZZL\ND['_."D#6?,<MA2)IP:!UU+2AQC*U
M!/D6#14<^IR"]L>$@V*BP+AN0UJI)J'R%U(,Q&FV`W@4G?PH/"G(&]OD7,4X
MGC:4:\_G63ZC55+-??>K.-7&`]LZ`!)5RTOU4'RKPW")?40C`&<$-!RD4L>D
M[101,KZ.T9T$/#X"0/@($JF=G$^I(ETF6\MZ25X5TZ9AV*42W?"Z-G$;F>6=
M*Z2O@;*VTJJB).29A9(58V*A1(^-%$JIVVYP""W'H;FE\[_N_])O8",OOW>6
M30HV+PVK?862-'F5DD3\BM4*J&0Y*`.-&C2".3#PI?A`PY]"^61B`LS`_"&8
MTE)[TTJ@E6Z*-%-XX3N5BB2BD@&B_>%>5SM&]XGMB"H6T_X(H&R6"`)1=Z<%
M@P^\9B8#,==L%9C/CT!`05G6N[%D)8^4F4L>ZUYPL08ZZR]]-7P[M@.SW_0@
M#&L2V3KI\D!=(1VUZ)\<<E$//46'(PRNB:'R")Z58NXRQJ8DT>\D.UA65",T
M1^SXA=+FG#>3:-P*;!FSV4C\,85,N"'"B7EDAQ32Y4W=5`\LV<[3_!Y)H\=F
M.9FIQ;N^-BE#0*JMX`0<%GM"XC?0C"V%U5ZB&-/=/JEZ$M6>^)?J*0)5^T2`
MPU;\4>3R[U5T\D9RI`K@9-)`B15P.T9&W[02'O?/#8O02%#E-1*8H[1R]%IZ
M,U!00+VZ'C+5>ZDTRN;=JNZX!3Z:M+8KJ5*_%/DV2J`J4D,7$'SL<$&%@0^;
M1Z?KF<QW"";=KF/E+K>372^T40,Y6D]K/=^"==3=7@-P/.=0-AZ*%6:ZVM*0
ME)``%&W7JA9_^Q%W:94J-/"/HDI:4IE_NV$/Q^A+#Q`BE?2#^/R#9I/DR@NL
MHA6H%G'F9_7=B/3$QALYHYSB,5:A)'@27UFKB51LK0-2((X8SX(3(_O%7`LM
M/T>6!'L]L+N)GKX8RFBJA#*JA\G1PXG\Y&/\C?W#K#</&J7'T%4;!WP2F<II
M_-^G7(]"#*R3_*8WO4HQ24'$Y03=;%,``!R314,#,9`KDV!>9($K\3A*4$[U
M1O8".O-5!>3SJK(X'+35T<2UW8DE:>6E,4OT;\,=*4;*/-Y"+7[4_.?>@W\7
M$_]P4J%=VNJ(O92$X;I0M([>$Q`4P5.UP6.@[]\%G-6SC&^Z\@J)A%);5X+6
M+]KQ2VB`VQ8.HMV4G6C*2BN`PD*(&^UY.8\MI&+O4GI(%S2-MU$9U7,O:Q5W
MIX-@F!O))<D,Y1`!T?ND&T2CGK1\##4IAR0,?#\F7L;ZZ2%"9SA>_!T1"2`[
MX@2%RYO$D(%(86*UDC&G=0`"PF4SGQB^8<=9W+W3?5+%Q[+_+))8K/HC-5J\
MU!2&J4-T:\5EA40'.5;]B;>1-(Z7>4E%\M595=*X,2=R>%KN*L;BXV,;Z"O.
M6KO[T:U8:%(S>)':IK#:@<%09>6J)J(/.K2`*.648`G4[%[K+BB:/H=X'ETY
M]*\*Y?GSD9_/FA/0V33F`LK;1_F.A@-!ZC7G$0PFJ9;?$K+1Z'\Y[#X?L=%!
MJR!027R3A\*.!$47EY9+7^(/B`Q4PGFDD<B@N=$SBF8O['G1IG,3TRM9XE:B
M@"W;?<+`T9"8ITFG+'==&`J>-@F>C.=8K8N'HOD3!DN=#DL\)M_+X/!5K*+\
M$J'1=[=6(3%(0)D)-Y(M<Z;5=]<IG0#79*]U=%QI9>H!VR543U!,6'//N,;^
MJ%Q%1UR'6[;UXZZ(\ISL3Y@TB2R0)ZN,)VW6H(CLUB[4F"=-/PJKC"D3_CH1
M)L?=USO325"O^[,LC#G==@XLT=5Q%HW&MBGI)29MVMI0HA-O<L>@^H(`D?3\
MV#9:0@"W$+^#@L^);?":*B;T[ODCP1\\5.T3`D*63(ZMZ7"PGAQ'9-P!#29Y
MMX@DD<"]W1]R]281P#+C\31Z^9PT";8&[@LJ#=$!(K2@MB>.MD'OAR?9063T
M`'J6MM66,\_.#OJI-^_!0:;]\@L42I-BG5EPQ(L1`2-XK$5(ZB-?ET"+C2=G
MA>`JI:M$##;A<:59!"20JG*&"O]MO)3<:0#(MFL*/S8I*G+_+20J]S-B]%\*
M!_<!\$YB]E:$>T]=(G</C7*DXAM,A9KS&[I<91SH-%#%`T00/PZPN&^/2!I4
M[O>6`-/75^1'IZ7/M-"QR9LE<)DH!A)]']79KUH^R.(Q%[FQKUL^1OR[D*X-
M[8BT]<:WL20;B,#0HIP[R0T[E21`SCX[)A3N.2=$Z5UL+5'&2GN)QF7P#D$#
M8[JX)K;O"0EY0]T/_[VP86'Z<K=3C>\C8^J>2=,OF`@L%$\#AT>*PUXYWAY#
MAB6&J9@<,^1JX`=^@VJIS92IC^[^4KFT2_1N.WJU+69^^1V%W-=%LN$;&K`Y
MK)801BW`8L^+B+^(#:!6&B>Y8L%AP!\!,LF4I2,3KO*[G`B45BX:DN%Q\/4\
M4TQ)]]NPH)ZV":=3_N_)@W/*`TI:P0WW@W)@*%A-K0Z"O20AE.-V6R17P"3+
M?V(BA(Z\:O'RV3.:A2_/3]F-XP0M#VE9*0ELES_2W&<T=B)5)G>U;U@L0!_M
M+;%\3"'6IK>9<'F]9MB8I)QX5!9.2BDKV.><5D^^57U@[9VV.Y)$Q6@+HT-]
M3S'F,MCH][H0+Y1-(T-P/X?;2?R:\\?8^YVF]:#*+UK(^@6PTH,2VCUIF>5`
M"J\"X]^&W6PXYFT@SHX\FY7%S^1F>#/:Y&$+71,*6-!0</%NK)_H[76GA:=*
MQ9#@?=6-=O4_Z:R9$VT+F[76;(@2DP!.J1+MQ)S5,^]Y"U,'-;YCP-*"KT'L
MG[-*=WNI&,(S&#\,O,"6IG*`H@V-F9S-YW8^+-V_^*,J%Q-7RINZFECG_MO!
MZ%6Q_/?`E)-R5B["8/E1&3NQ-0S^1-9Z!9)23B7)395HB#B!Y7Q3N`FB$/_B
M;5'/PTE(C_3G;E]4BS,O^_OEH)S,O.SP]_%F(-);^I^MS*2:N:]S.WQ<#Z[U
M\YE_[S\;ZSZ[(]#G:5W2MQF_&\N7=%KZ[?I[)XE#O?YQ8LA"LKINT1:P0P+Z
MEDW\[+^1LFWE!*S\/..>%O[S/X:[P:^#M\O!JP]F:(;+ZSY[A=W-W"WAS%72
M9R?P)R'U;V&C,P7UJP^6Y<D+W(\[<>&QKV\DR=R&[=P>/U%"VJRO^><'WR%Q
MB9MWQ!VF:^#XOUS[YVN?C84>!2VNF/DO+>?!@`IE;F1S=')E86T*96YD;V)J
M"C$@,"!O8FH*/#P*+T-R96%T;W(H941O8W5M96YT($QI8G)A<GD@=F5R<VEO
M;B`R+C8I"B]#<F5A=&EO;D1A=&4H1#HR,#$S,3$P,3`V-#0Q,"TP-R<P,"<I
M"B]-;V1$871E*$0Z,C`Q,S$Q,#$P-C0T,3`M,#<G,#`G*0HO4')O9'5C97(H
M941O8W5M96YT($QI8G)A<GD@=F5R<VEO;B`R+C8@4$1&($9I;'1E<BD*+U1I
M=&QE*"D*+T%U=&AO<B@I"CX^"F5N9&]B:@HR(#`@;V)J"CP\"B]4>7!E+U!A
M9V5S"B]+:61S6S4@,"!270HO0V]U;G0@,0H^/@IE;F1O8FH*>')E9@HP(#,*
M,#`P,#`P,#`P,"`V-34S-2!F(`HP,#`P,#4U-#0Q(#`P,#`P(&X@"C`P,#`P
M-34V-#8@,#`P,#`@;B`*=')A:6QE<@H\/`HO4VEZ92`S"B])1%L\-D8S-D)&
M,S(Y-T,S0C!"-3(P-T9&-#(R-D$Y-#A&144^/#9&,S9"1C,R.3=#,T(P0C4R
I,#=&1C0R,C9!.30X1D5%/ET*/CX*<W1A<G1X<F5F"C$W,PHE)45/1@H_
`
end
</PDF>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>exhibit32-1.pdf
<DESCRIPTION>CEO 906 CERTIFICATE
<TEXT>
<PDF>
begin 644 exhibit32-1.pdf
M)5!$1BTQ+C0*)>+CS],*,R`P(&]B:@H\/`HO3&EN96%R:7IE9"`Q"B],(#8Q
M,3(R"B]((%L@-C8Y(#$U-2!="B]/(#4*+T4@-C`V-S<*+TX@,0HO5"`V,#DT
M-0H^/@IE;F1O8FH*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`IX<F5F"C,@
M,30*,#`P,#`P,#`Q-2`P,#`P,"!N(`HP,#`P,#`P-C(Q(#`P,#`P(&X@"C`P
M,#`P,#`X,C0@,#`P,#`@;B`*,#`P,#`P,3`R-B`P,#`P,"!N(`HP,#`P,#`R
M-C<S(#`P,#`P(&X@"C`P,#`P,#,R-#(@,#`P,#`@;B`*,#`P,#`P,S0V-"`P
M,#`P,"!N(`HP,#`P,#,T-S4Q(#`P,#`P(&X@"C`P,#`P,S4Q-#8@,#`P,#`@
M;B`*,#`P,#`S-3,W.2`P,#`P,"!N(`HP,#`P,#0U,#,S(#`P,#`P(&X@"C`P
M,#`P-#4S.3,@,#`P,#`@;B`*,#`P,#`T-38R-"`P,#`P,"!N(`HP,#`P,#`P
M-C8Y(#`P,#`P(&X@"G1R86EL97(*/#P*+U-I>F4@,3<*+U)O;W0@-"`P(%(*
M+TEN9F\@,2`P(%(*+U!R978@("`@("`V,#DS-PHO241;/$)%13-%,4%".3E$
M-4(X.$(U-4,V049!,34U-3`Q,T-&/CQ"144S13%!0CDY1#5".#A"-35#-D%&
M03$U-34P,3-#1CY="CX^"G-T87)T>')E9@HQ-S,*)25%3T8*-"`P(&]B:@H\
M/`HO5'EP92]#871A;&]G"B]086=E<R`R(#`@4@H^/@IE;F1O8FH*,38@,"!O
M8FH*/#P*+T9I;'1E<B]&;&%T941E8V]D90HO22`X-@HO4R`T,`HO3&5N9W1H
M(#<R"CX^"G-T<F5A;0I81V-@8.!F8&":RP`$+\^"V'``8K,P,`(AP]D':.(0
M=:<8^!D8Q*9P5S#ZZRXP<.!?\H;1AJ'T@@1(#JCK31:$9C@+`!TA#3$*96YD
M<W1R96%M"F5N9&]B:@HU(#`@;V)J"CP\"B]#;VYT96YT<R`V(#`@4@HO5'EP
M92]086=E"B]087)E;G0@,B`P(%(*+U1R:6U";WA;,"`P(#8Q,B`W.3)="B]"
M;&5E9$)O>%LP(#`@-C$R(#<Y,ET*+U)E<V]U<F-E<SP\+U!R;V-3971;+U!$
M1B]497AT72]&;VYT/#PO1C$@-R`P(%(O1C(@,3`@,"!2+T8P(#$S(#`@4CX^
M/CX*+TUE9&EA0F]X6S`@,"`V,3(@-SDR70H^/@IE;F1O8FH*-B`P(&]B:@H\
M/`HO1FEL=&5R+T9L871E1&5C;V1E"B],96YG=&@@,34W-0H^/@IS=')E86T*
M6$>56-MNVT80?==7$'WB!B:]%][4-UFV41>M'3L,FJ+N@Q-9MA!+5FPIE[_O
M7':Y0TH*4!B@2>[L[IDS9V:6.FE'Q^<Z,4D['QF=ZTHW=:+AKWNPMDEJ>&J:
MI%V.-`V^/(S^2:=GJDYO6KA<J'%ZKHRAF^E$&9NV>'NE,KB]Q.<$;G7Z%HW>
MW^"+=ZI*W^/-A,9;-FAY2J)LJ?]M?Q_9W%:533*3FZ+4+FE/86/3L/'[G/Z]
M4ZY*^7::*ZMQ+ZMI`T0X)817E\H&%,:5RNE4TT.W%>SA&E<V@\TF[Y2I_,3)
M*4)EB&^5-6E[=AH<LSW'B(/.,4#3*ENG`^>R*M?EV+![58,$XXX$?,HD7EWR
M^F.-B*N`6/NEB'3/'&[P&[T]2SPO53JY4<ZF)P#!I8P)*<&13,$K7N7#'_#N
M#.?_[?U$2^(M46;/7A81:&T[3X[/#4LH:_*RT-HDF<V+1H_9HXL5S_ND3)$^
MX^35BEBYQQ?T=D-[+.CZC+[Z*=\P;(N-:M)'FD&`-LK0L_,KL.DUHM[2[1V^
M?=G<*P?_8%Z=/OU0A?:&-^@J35S3&H0(S$SM8;`9`^7[<V",S98<3T,49->J
M;SY'5D-`LC$XU*0/M!6OSY,_8%#8ZD]($QJ?L>]$QIW*JO0)G3Q2)J"^P*57
M!)B,\CAT>X"17Y1MTBD!6ZX],;;PB_Q0)5C<*C:=JZQFXIDO?AMY)RJ[>.M!
MDGS9WGD?8>HAVM?WT48$>L:C-(F1S>X1Y4QEG8,H6`X8+[ZDZ1]5<%=B=AK]
M/?*S4:W:.%\6B`'@]E79<1H<!UH9SA-=.1I!?2Z(,C`<-1BI(<(E3`K0ED,>
MII.^:?15C=F>2/,^HR^LCC,4SO=/JBC21V'Q(`+K8XJ0F(K%*RZZD)*5]X?B
MV+Z!X,V(DDUTGK`)<V:7@C(4^6V*NMGL*D_D6$@OE`;H#2>'Z.`6%[T7!JL/
MD+Z:Q5FTS+>8,Y-<6)_@1FQ'&]'E,[(AUX1R6GN7%M%1X0B3+H*W8;NORO8<
MNYK/E0N"(<L=`0XYVF4GA`_76&/@19@I+24_?A/;I9>*E9)VZ<^`ZWK+EDC"
M%G<*RUM6PB"-H?/X.LU+/T<I=IT6R0_=MFNVR&D(!6K!%C6TUF'Z^80;BZ<9
M^;\6DIL%Y+$4#]"'RHR$/L=TQDW'NHHO=MBG>;U,Y=,!='51M#X.>.H2-4.!
M7V&9_R[J`W'NU<C]BY=]%CM;Z)"B?G,!`?]-Q?<2G^!\*4KF9\IA7AEO*0ED
MF7J(8']5O<.%R\NZL18;<:F+NO1')Q&O%AMZGQB#S='$Q.W:@>R+Y.*6VA-#
M"6206#/?*)=K'A3IQB+`)61=?511N;TV5OA*)(K`E^T"+<2;I>@;&U'6AS)X
MI3Z+W'.X?`/R]=$X*&1@R]$)/?$9_9*934V_A%H=U_T_<NNWAIJ/-;XE',S)
MT`V,Z`96=`/KCVO^%,6Z(KVX"`Q3>>R*(Y\F=F]6+GVD7-ACQAK;R><.Q$RB
M[NG,_E1G!JLP(.6P$4BA-<9QQ_Z0A&0K$V?(KJ`1?+&BQ]VE%`\=DAA:[&E7
M9H_J61]"@[WSC9#E:SC6K3:OH@9((.0@Y\A3+`?+X$XHCD4\,IG&`_#V)N#D
M+=?4),1INM<$;72]+TU_`$)@(K2TS")&XNF@0(<!\0?9D&&80QR5'?6P&OL9
M3E7_*>+?(^:0=?(\Z2D#)\*V'9X#JQSD8ZK\2>(G_3FHVU-BFMS4M2LQ"1I3
MP$<S,7/<>7$<$A5/-M'Y@\>;+DUW3S?.GVZZS<_:D<XK"U_MX@H?Z$XW^,U>
M:DC,*K$./F\K&*UM\G(_FL=AE^N"AN%#5.>VX&'XBJ,Q^/BGEUD8ZL_KC\W?
M`!301;P`#EX)B&'CN,4NP#T(:&PP\0N.X5,QKO.Z2AQ.-"8OR;6_DM7H>G32
MQH_2_;]K^.V+L4%'^C]M3$*0W-X@65]SNW,H1:JH?3H.SJ'B*]DRH.'GT_11
M'DHI);CLX_,]2MN?2;D<HFR_4B&0!U,$-(?J,<=O3NK#-/-%N6;<_T:W)J_+
M$GA%N;H&%$$H3CF)>H>)KG)=DO+B:1B2PQWZ`C.BXEFZTJ\7QDG-_@=@V..K
M"F5N9'-T<F5A;0IE;F1O8FH*-R`P(&]B:@H\/`HO1FER<W1#:&%R(#,R"B]3
M=6)T>7!E+U1R=654>7!E"B]4>7!E+T9O;G0*+U=I9'1H<ULR-3`@,"`T,#@@
M,"`P(#`@,"`P(#,S,R`S,S,@,"`P(#(U,"`S,S,@,C4P(#(W."`U,#`@-3`P
M(#4P,"`U,#`@-3`P(#4P,"`U,#`@,"`U,#`@-3`P(#(W."`P(#`@,"`P(#`@
M,"`W,C(@-C8W(#8V-R`W,C(@-C$Q(#4U-B`P(#`@,S,S(#`@,"`P(#@X.2`W
M,C(@-S(R(#`@-S(R(#8V-R`U-38@-C$Q(#<R,B`P(#`@-S(R(#`@,"`P(#`@
M,"`P(#`@,"`T-#0@-3`P(#0T-"`U,#`@-#0T(#,S,R`U,#`@-3`P(#(W."`P
M(#4P,"`R-S@@-S<X(#4P,"`U,#`@-3`P(#4P,"`S,S,@,S@Y(#(W."`U,#`@
M-3`P(#<R,B`U,#`@-3`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@
M,"`P(#`@,"`P(#`@,"`P(#4P,%T*+TQA<W1#:&%R(#$V-PHO1F]N=$1E<V-R
M:7!T;W(@."`P(%(*+T5N8V]D:6YG+U=I;D%N<VE%;F-O9&EN9PHO0F%S949O
M;G0O5E=&0TI&*U1I;65S3F5W4F]M86Y04TU4"B].86UE+T8Q"CX^"F5N9&]B
M:@HX(#`@;V)J"CP\"B]82&5I9VAT(#0T-PHO4W1E;4@@,`HO1F]N=$9I;&4R
M(#D@,"!2"B]4>7!E+T9O;G1$97-C<FEP=&]R"B]&;&%G<R`S-`HO1&5S8V5N
M="`M,C$V"B]&;VYT3F%M92]65T9#2D8K5&EM97-.97=2;VUA;E!3350*+T%S
M8V5N="`X.3$*+T-A<$AE:6=H="`V.30*+T9O;G1"0F]X6RTU-C@@+3,P-R`R
M,#`P(#$P,#=="B])=&%L:6-!;F=L92`P"B]3=&5M5B`P"CX^"F5N9&]B:@HY
M(#`@;V)J"CP\"B]&:6QT97(O1FQA=&5$96-O9&4*+TQE;F=T:"`S,3$Y.0HO
M3&5N9W1H,2`V-3$Y,@H^/@IS=')E86T*6$><N0E\&]6Y-WS.F=&,=HWV79J1
M-))L699L28[EF'@29U]P0C8[P8VSD(0UM@F!!')CEF#B`$DI.S0)A;"F%V?%
M"10"#90ME]!2"K0TH3=0-K=I;Z!0L/P^9^0$:-_[?=_OTVC.-MLYS_)_EH,P
M0LB$>A"#9K;,SM1VG)R_#T;^`.>Y2R]=W/GH9Y]:$,)5<-Z[=,UJL93]XRF$
MR,L(\>\M[UQQZ2\?#L(;]`\AQ-6LN&3M\C?ZKYF%D/`.0M<=67G!XF5_G/+S
M]Q'ZR?WPOKJ5,&#[JVDK]-^"?FSEI:NO<MUK:H/^5PA%;[ADU=+%ST9./(/0
M4]<@Y.N_=/%5G?:/+,<0^C5\'XF7+;[T`N/+G6NA/QWF<TWGJLM7/U*%CR#T
M&YB/_^[.[@LZBQ^];$+HKQT(628@Q")\&FF0EH46[9VIT7("-3[[0__R:X(?
M4I"('M$BN/-U7L*'U`L$E>]U`+V@A7UP<O_Z]+__&)@$_1F,,"_!:K,[G"ZW
MQXO\@6#YAI@<3R0K$*+KS-;4HGRA;E0]0J//O&#\A(F3)D^9.FTZ.K=EYJSS
M9L^9.V]^:]N"A>?_W[[VO_YN_'^[X?_WCP4)0BB`!%BJ$>@6016H#C6@B6@*
M:D%S42NZ$*U%CPP/PUWT:A)66H_&PM49:!9<78PNIE>'__M_.8ZC?^/1#W^:
M6^&<CL)P!IC;D1^AX0_@/`GGQZ6IP]]J+D;1TD7#)Q@[W/SSD1,A&=V)MJ,8
M.H5KT`OH,)J*'H99S42WHTGH#?0D,J.U^#58712-1X\B&8=!`B8B-]:@>]"[
MZ'S4C3Y$)V`UT]`?L0W>,P%U(A<J#G\"Y31TT_!!N$N/FM%_HD/X$CP;9:`]
MF53A%'QYR_!AY$;)X:/#[T#OI^A#'!O>C29#ZR-D10FT`?T8V=!%Z-7A;V&F
M,;0$/8*OP9\@"76@S6R>[1N^&`1D/_HMG@:M&6BMYAW=?G0)//4@=N/#P\>'
M_XR>93&Z`-YT';H)9KP''2;53+-F!_`@CLY!YP+=+T!7HW>Q'=<PRG!B>-SP
M/3#Z"/H[29&7&![FD0(>+4*WH`>`&F^CD^@+;,`%_%/\!!QOXK]H0--AI5>@
M=2`!/P7J/8)VH8.X!M<0-W$#M=P@"7/AVA:T$[Z_%QW#TW`;/HR?9W9JLJ6F
M8<>P<_C/(!>5(`7W`"^>AV^<QEFX![[`1)C5;(A=K:D=NA96N`S=CXZA-V$>
M?P2Z?X&^PI5P?$#^@VP8GC_\Z/"',!<M"H-DS4(+T"JT!EV)?@9<?0$=07_#
MWQ`=W/D&^Z)FG>;4\&U`VS@:!W-O@;MGP[LW`Y?VH`$XWH956K$(JZC'Y^+S
M\`J\!=^)!_"[^%W"$8ETD4^9?N8UY@]LG48SW`!O<J$0?#>*YJ.5P('_`&K?
M!NM]%+V(7L%.',=I6-';\/R79#09#\>#Y`WR1V8CLX7]5G-CZ43IL](WPWV(
M!RF;!'2X`CT.5/@K=L$<*O!%^'+\WS#SK60?8V8$)LH4F+','*:-N8FYG7F9
M^2^VFWV"?4\S1;-8\P2_N'19Z<WA:<,W`"TPXF!>"="U/!H%\K,<I.EBF%\G
M'-WH&G0MZD.W@KS<AG:@)V#=SZ%7T&_1^^ASX`#"$LSY0OCZI2!U&_&M<-R#
M=^'G\8OX%?P!_I(>)`)'DM21)M),)I(59",<MY-CY&WR,1-@EC(;F!XXMC$'
MF'<!>UEV6%,+QV3-9LTCW&M\DI_,+]&^_NW@4.50V]`?2ZCD*RTLW5EZOO3G
MX7G#:V'^,DJC:IAI+\SR'I#!G7`\#I)X`+V$7D>_4^?Z=TRP!B3>@Z,@#57`
MM28\"4^!8P:>!<=<..;C!7`LQDOP2C@VX!Y\';X>WX!OP7>HQ]VPMIWX,7P`
MCJ?P(3A^BX_CC_"G^.\$A)@P(,TR29`,*<)*F\DDTD+.@V,%605')^DF:X!#
MCY"]Y"!YF[$S,I-F%C-=S#W,?S(O,&\Q7[.$K6(S;",[CUW!7L^^P;[)OL-^
MHPEK)FA6:K9I7N#\7)Z;RUW$W<T]R7W,?<MS_$Q^"7\-_Q8_K)4!K7X%Z][_
M`\C+<&_@RS4.]BIR'/3"PW1J>O%<H!A'YC"7,+<RO]8LQZ<8$;^'^Y@+F8N'
M'V0FDJ^857@>>0Y'F+"F@5F.;D;#^`GR`3E-_LPZ\1SR"4ZR/\9/D55,,U'M
MFN8WK).]7O,QF+[?H0:R'A\F+S+7,]</_P(U:+;AXYIMY$TDLB>('1T'K>XE
M=\%#_T4N))M1*YO7?(,N!+H_IKD*Z#V&W(0KF;?8;>A#)DK^!Y_"=P)J',53
MV1CY$2GB)P!QAW`(#>(NU(GO0`I^&K^/!\!,/\H\@J<3(W"KGYCP*#`%1QD)
MO\7H41N=(XX3)YY)3I&YS#/<,:8`]OP8^C5:AQF<!=DY\RNART`#;B<)P+0)
M@":_P;7(@^X"O#]=>H8BMN8=S6:0LP>8*G0>RJ)V\AI8L-L`:3X$G;P1U:)#
M((,WH2RY&UTSW(.7`>[/`/PD:`!?A#+8`&CIAKEM`'OA(A'`PD7PU:\`_U\%
MU)^&_X*NQ")HUF&49.F5F]D)@$P=@+^;X5B&VJ%W/[J-VZ_Y#6K!;C"J8FD;
M2/D?T(_`YOPW?-^'&F%^"]`#;!7,6@1D[H(G[B]-!E]%@1F^A@E:#W,>`WH^
MDYT,R'OG\$6PP@O!1DT'F_@*NG#X+M0,O#MO^/KAS6C1\`/#YZ,5:/;PHX"_
M:X;W@,WNU;21>9H4FP>,?05\J\GH]W@SX/9D]![@D8P]Z%,X_A/F/T;S-.IC
M?P?8V31\\_!OD1/H$0$*+0$K>A)=BOX"=)O,'$:YTKED]_!$IA,LU'$T:_B1
MX3#6HY7#EP#R/H-V\AK`GAX4TNP$V=W,+B=9F&\%<N$,C)ZOV8Z0,F[N'*5I
MS#F-HQN*]:/J"OE<;4TV4YVN2E56)!-Q.1:-2&(X%`SX?5Z/V^6PVZR"Q6PR
M&O0Z+<]I6(9@5#4A.K%#[(]W]+/QZ.3):=J/+H:!Q=\;Z.@786CB#^_I%SO4
MV\0?WJG`G<O_Y4ZE?*=R]DXLB(VH,5TE3HB*_4?'1\4!O&!6*[1O&1]M$_L'
MU?8,M;U5;9N@+4GP@#C!LW*\V(\[Q`G]$]>L[)O0,1Y>M]N@;XXV7Z!/5Z'=
M>@,T#=#J=T<[=V/W&*PVB'M"PVZ"M":85+\O.GY"OS<ZGLZ@GY$G+%[6/W-6
MZX3Q?DEJ2U?UX^:ET27]*#JNWY)2;T'-ZF?ZN>9^7OV,>"%=#=HL[JXZW'?S
M@("6=*2,RZ++%I_?VL\L;J/?L*;@N^/[W>M.>K[KPLMMS:V]W[_J9_HF>"X4
M:;>OKU?LWS&K]?M7)5JVM<$[^HD\L:-O(GSX9B#AM-DB?(ML;&OMQQOA@R)=
M!UU3>7471"?0D8Z+Q'Y==%QT9=]%'<`87U\_.F^MM,?G4PX.GT"^"6+?G-:H
MU-_DC[8M'A_8[4!]YZW=ZU5$[P^OI*MV"]8R67>;+2,-H^G[C0O.7E-;ZNVT
M->V\LW3%=$;1*2`._>)2$6;2&H4UU=/B@GK4M[0>;H-?&X:G^I<!/R[LUS5W
M]`D-,"[0Y_LULA`5^[Y`P/_HX.<_'%D\,L+)PA>(-JF4G!4TN'ZFW9]*]5=6
M4@'AFX&C,,<Q:K^0KEHS0/JCG8((%9`/S03:+FYKR`#Q)8FR=_.`@I9`I[]G
M5FNY+Z(E_CU(R:3:^DD'O7+XS!7G7'JEY\R5LX]W1$&.]ZE^N[-?&S_[MP@N
M^X25#?W8]?]P^8+R]6FSH]-F+6@5)_1UC-!VVIP?],K7Z\]>&VGA\@4@>#\K
M`Z6F1$'TSEO02@?@KY$G1B=<V#$95`WFV&]O;F7\I*W<(GY&?17([_EGWTP[
MK4;Z+E;F5/E?-L!K08#5$2Q.[!<Z)I?+-KTD_7]\:&#X%'U*K;Y[;&1-_0VI
M'_9'_Z#_@^D9^QB8,!LGT^8LZ.O3_^#:1`"KOKZ)47%B7T??XH'AGB5148CV
M'61:F=:^S@D=9]@_,'QHL[]_XLUML(B5N`%$FZ!QNZ/XIEF[%7S3[`6M!P4(
MW6Z:T[J'8-+<,:YM=PRNM1X4`9_544)'Z2#MB+0#-@^T8@_1JO?[#RH(]:A7
M675`[2\=P$@=TYX9PVCI`"F/"6?&"(RQY3%%':,_BA3-<UJ_+P.J8K6EJ;4G
M:"-X&<]`W&<"NWG_4P/>E[W_,#+&@>&O]D;EO%JGLWD\,/SQWLI"'@T,OZP$
MH>'U0.&KA^(?1LP;W4:B#VPTKZ@S@96?LY=G?&:H]S@8-,`4]IE,>M8,#<7E
M\[FM^DO97[HO159LW>@/W"Y=M,Z32GW9/O3EH-56S)0+U#34"/^:;`IWM:?4
M'^[&3")>R-?E:EU.!\](S/<Z1*ESD?KJ5-%>+"T9Y0+5;?#5,5$<6^OU-C4T
MU,Q=6OH]3JZK4AI&UR1N+;U+??XYI:GD&HB'[:A!B=YI?<1*;C1NLA+]W3HK
MNALB/83TND?-D9D<YGH<<W[D20E?M@\.-38*C:AIL&FP!CP?W(Z=\42<%`0T
MRLEQQ.EPAPBYYJX+MMZ/:[^\>MNYDF_J^M(J>?KR'^.^MW`='KZL<OSGI3M?
M?/O)OD?NA3E4PQSFJ7,H*K$*ME([6</`QZTP"3LX=#H]3$#DLIS",5R/L_6A
M?Y\$;K<77&Z7S2D@OE!79ROD$]6D^NX+MMQ?>N,?5V^?(7FG7:-95CEM^6VE
M*W];>K6$+Y,G?(8O?O&W_7T/TQE<5GH"WXU>AOASMI)H(VWN(RY&Y^[P'O,R
M.HQXEK5H;>B`33$:V`:+,^SL<3+.`5RI&,*6119B\7KNATF=*YQNGS'4#FP;
M/&DK8JO-7:0SPUUVF!+,*!Z-\%PT<I9AW&4KNG0\;Y!MCIJ&:77C5FPI/5$5
MV3+3;M(Y=`VYFHF7+UJQF_)H-NXAK1`?,ZA)$8FF)[BL;H,&_%:"^AD&$0'/
M!$S?BG?@8YB#P#._'_6P<Q90*@VU4QIE!J&D4TG9):<TFVB&OB'NN^B;?SQ\
M$J\"3]*`4DH`*9R!471*0T&G-!46Z?!VW9,ZHMMHI+(I?-G5G4K1M=5D977V
MY95@E%'&5E>/'?N"6E9G%/I>9O@D&0,<9=!YB@YI7@NOJ`-&#C`)Q408!R$P
M;43`!Q[`8<4A,EFF@^ED=C`G&(YY&O^<O,8.X%6[C].O#IZF!&UL:NS55*?6
M"T>H,D#H1L:4G#/Q9YI;_SE/\SC5WZG#'S-/:58B`<70H3V+M>`\<7LT&B>M
M3";?`+8H-IT/Q94X4>(=\1WQ$W$V;J7#YD40_&]`6R"LU2"O?`B'@+0CW!P\
M5VCO^G+&X(B8-:]5IN-8-!:)060/`0/A>#G@#_I#?H:SQRVR(>[QNKV$DUCK
M$A3F?$NPPPPMEQ%:,2PNP7XM%#;!N01Y]5"H&DV+2O6LK+S6GK>-`NEPNZP.
M`A1.Q$<);E>NMFY4G14$J"Q"9.K-JQ=TW'_-?3?]9LD+UUYZ9$*QJVYUJ#H;
M*U8TC"],SI-M'^.6\\9N?['TY.>E`W=\^/P_2A_OOF-Q]RY<_/B^R[/2.;-+
M]P./3B'$<$`Q%[I+<2B>#L\.SPD/BSR*AZR!\("8Q]HAHA^+='@'>.J,VM9"
M.PH,_@I9\(7@=8^%]M\5,[98B`[B:IW62!AT"/\#;I^BV,QFBV(M9"T;+%LM
M.RRLQ>L^1&+XY`AQ4XTSA,&35(6!NU:J,$7TQ>"W^(M42D65KG:[G+,Z7"ZW
M4RJ,(05*`+K^4WBJ9&\\OT0ZZEUZ7O;)X]A?/?!-;W=]B,@R"=:L(W^XO5(,
MA:D<5L$:GX`UAO!*Y3K>8RBZ/8%S\AX%"B\M+"&7JX)OY*?PC_&<(BYD%V@7
MNA=X+M:NMJZVW6_XJ?D>ZR[#+O,KFE?<+WO>=;_K.2%^S7[M=CIQD/5J_$ZO
MR^L.>GB=V^`Q!//>2=Y-[BTB[_$2XO9YC5[.Q'B)AH,P`^#9SIH&8!HZG>(P
M-O7HL&Z`R2E&0>/;XL7;O4]ZB?<0DP/"W;(7$V-H`-^BF!#WIQ;[(OLJ^P8[
M:Q_`O&*G%L^'1$7L$9D.<8=(1._3^&O0,Q-6%,<BLHIL(%O(<^0-<IS\%<RD
M-WP(W_J=/)]L+$MT^PQ0*X$JUN!0>Q<8F:[='#6/3VW1X>=T;^@(:N]J2YVD
M$*9RQE8L$J%\R[[UWEN\<+W-W-@K:-8?,8-*XJ[N=N`8"#%*848J(%3(`ZLX
M/EHW8ILXGO!2;5W=*.:)1=^>`+=3W';9LNUQV?O&?3O?STY]^.LQ>,DE\R?Z
ML*;TC8S'X;L?N_;A*[H.OO36UA4K?K:_=*I>J$E3)`0MGP?\K,73#R+]\(D]
MQJ)N8/BPTF@LCM5-T$\T3(NP;^AP145]A9+OR+^1/Y'_AYY'>3Q6MR&ZKOKQ
MV,'8H>I7JH]'C\N_K_XT\HELG**M&,`W[TTF!31`3NX]EL79`2:_G]$(+NP:
MP-OW!Y54)A\<P,U[!5-%\FF\$CF0CORW8I@)/"!;51X`)_?V&[%Q`&^%\71/
MFFQ-[TB3-(SO7\1O@+4/D`\5O9+'._*'\P3\!SSF*<7^G)W8O3D*.!^?99#*
MG<'VKM.T."F<IA8N-=C=--@^2%T"%8/JJC.AN-["<A$I*L4D66(YC6R.Q_4`
M+ADVO02'+-"2#(DE6*^KYK)+<-@4I&@C-);A)E5Y+?Q4'>M&7:F4O4[%'."3
M2V66-&*DW*!\%'T**O;$HU&JAY2S_,J&W3<\.'_<H?4]G;>5/MNT-"-Y?=:K
MW'+E\KNBOG#JSG/%ENV3K^VX;R4[==,=%[4LN'U;S8&K^Z]]='PB6*75-'&&
M;9>T3*L/)L>&]#^ZH67%AH<IAH-WR!P$[NK!"_N=DG29L`5-,"D61K'@2B-V
M\@"XF-%I.,P:#2;$&DTL9S2!5@44&Z]U\+Q6R[`\9]2BL`F;GL;W(PX9\';%
MI,&<3LMQ6@UK-+)/XRF@+UJ\7#'H=!8&;V>>9`@S@/^A>'"3JEX6W`%X=<+"
M6#B%Q[S7_#T=ZFI4.=0("@3-CX0A8%!3,2.`A14&A:'N1FO1JBI,;W6*!7M%
MFQ:+!1"M&QREKF[LC%JC5JF`<U!AYN"!G4,OD"LNVUF*X=.WEN[%RWN8Z[Z]
MF3PPM(CBUQ*0][6:Z4C"(:7Y(1;;VD(7AC9H-G`;@C>SMP3Y`BE(<YFYXGSI
MXL`:S=I`+^GS]04>9![5[8B>B%I0%*L;2$Z76^L`R\M04EE%"4PN*TH^?X#A
M/:P&1K?O%47)?@B0Q,/8%:`I_A,B?Y(DQ`*:CT%^/&E_#[^#RC'^`N0XBI5H
M1Y1$04&^/B"0'1*6Z$L4G:@(.P0B>".'\!WX$Y5B)]L!YH5V2AU5M$\"Z$`;
M[*DJT(#Z%&5ZM=4I#9`+T4X9:!13-^XFW>)U^#IRG<@!XE"@`9R!0$DQ7,RN
MLBT+=6HZ@YKV-G"R>(EGJ01SW/=\K!'A!=E-8&;MN:65;5AWW\;Y-\RZ?.VZ
M5=517R(S;<85N[=MOO09S&JF/WX@L>VF@8L/]"1&S:X-I`0IOWO#U;]M2//$
M0J6S%7BQ&Z33@Y+H6Z7R"MT:_97FZW3ORI_(',?@]<PZ=IUKHYMMU"8Y#1/U
M)KT<(R[28BU@QP$QCN-Q"SAGM^SU(`UU3O9:3!B(JU`>*3:##U4JE42I[*C<
M47FBDJWTEND.EY!=L(OVK%VQ;[7OL/-V;\5W+LJWX'">'/%15*@`0`>JM@]V
M`QGQ=[3<9^#\'%%)"/A1%9!UMF`@%""<53;%95T4$$+P+T&2&5HQ?7P)#MC$
M)2ABA`*=\5$H:*B0@9UFAC^#Z]1'L>9ML;H<YIR.LQ0'\&?NO.&1!R^.;?WQ
MYM=77//ZYL7/WH8M7UT\]+IMTL3<E/F;;EH?GZ]9*9M:?O:K34M/]#]^\^/G
M[\7!`WARJ75H?._LC@_&91ZZ^XE_BJ"KUP#E^X#R7A1'.;Q..=0&04$NG*M,
MK,JMB_08>HP]OA[_=7)/O"_WF&>G[Q%YKW&?[ZGXTXD7]2\:?F=R\4B/.1/Q
MZ1(ND]LGFV3S-'PSOMZTT?P8,H]&#7@:1)]3DHOPPL3YN8O01?A"LB)^46)E
M[FI\36)-U36Y+>P630_?H[W.>IUMBV.+ZV[V3NWMUCMM][D>CO\\\?/<`'M`
M^XGA4^,GYD\2G]16\"9=H@$5<7VM9KP6&7T)5BT$M^J5<IHTK>RFX%@=()P.
M9(">66@+@$H"*B@%HA0Z"CL*)PIL(?H,7&!`&BI!&O19M^+>ZF;<WOPA_)<1
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MTUK[E>)F[?5VO4Z[I8*,UFH2'BGAT3`AF46\YA!>BCQ8V9>8"1@/.JKH,O(J
M&7Q(%*+L,6M`6V_>YW8CDX?JH@];GD(VP2;:&-L`O@#TLD*IZ*E@E(J.BAT5
M)RK8"DRU68+;%/US>J+W)G]@V0?+IGVHC']-(VHJG*:AOK6LK<4RORK],:W5
M&!?D0#P:#YND)2AHH0&$%EJB(011A!6*B$[^OG)21JGHZ*;Q[Z@R!HX:,>L$
M]!13!I4YI"KI)=>=>+/BIQNVO+[\ZI<>N?*V/[[TP+,D9QNW=D;;C6UC%U7_
M1T`F5^#8DQ>\_]2>S8_U/?'-GTIKK[V('+SNW,4?7+5CVV^NG%=%XT^('[<R
M_1`_NM&XW8QW`,M*T+2B;JMW!X1!"N*-`&T6Q0EA97ZK<X>3.)_!,B#HKS%"
M:A1_6O5"1V+X%/Y>8&G_?I`IT=`2SJK,V'&T9OK+T6;UV"'[N')K',5H`2%-
MO^9B%$!AXME-5#-BP^$0"041X!T*AC&@GN-9YD_(#2</IY[YD^+6DD"(L6@#
MKB`*=^(>3##66H@699HHFXX>.YK)4!X)@X-_^1QGRC]A?>^1(P*<-5F_XM>:
M+1:3H`_IPC,ESFFQ"SZKS^\/>(*<!`[J'KE`J[W9UKQ:IZK5>D]%>5B,EX=]
MH?*P6QW>XU0KY2[!GC=9#/#RHF6J9:(P)=0BM5GF"W,=K:&++"N$E:$U0@_;
M:^ZS]`J]MDVAF\+W6>X3[K'>%SIH.2C\PG<P])KE5>'EX*NAWUO>$3ZS?"Q\
M'/K:\I7P=?#K4)7.,LU/PF!/@$@H&`H%=&:]7^<*N/TN+>']6J?5X7=>%;((
MHA`*!")6P6'MM&*Z96(>(*\H5A*"<#X4#NY$J$RX`;Q?,6H%"^-TN;1:G38P
M@/^IZ"SP#-EI5JP#)+NW)81#`^1SQ2PJYIGF4V;&_(AX<9\J#U[?4/N@QT>=
M!1J=4+<*RM/@/@PU]IK+/D)ON[G:D^J%V"/E0<(@%@[_>]DKK#_2R#?"7W4:
M4F=^N!N\!8E780K"2HBK1^$<+L>8:I+&0)C'AO[G_,CH):6Y<[VY,?C]*'ZG
MV#Y[Z)-9Q>1E'WV.7WJ[)1'.\+)L\61_PI[_S=TWS=+(,ELM52W")A(;^@,X
ML1`O(_8C\-M"*(7JR7HENP`M"&U"-X4VY>[Q_32QR[<K\8GOT\2?,\9ZM"ZQ
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M5T72[7:1ZB25E*W@(U&Q;RBHU3A:]>QM&INGW;W-$]5:<<#X]$4!K`]E`R0P
METV%ZZMJZ`5A0L&FL#M8@J`XP3(L'=2;K'G$8I'%[`!^4Y&K.+N=S*TR6BRT
M-)F@C(`L6P0RUR+2KF5;L>$9_":2T&+L`8Q*G7LZE6J<,0BR`Y%RJKVKN?4@
MJF'2G_C5:K`-@JI&*J'=@ZJ`=9?A'4XUA:L&T.YR2.`NTLP&`/S83#Z:](0P
M[_-[_83CXC$P.[EXTA//X0Q?D\/14#S'Y'%-CDGX*W(XJZG.(3D8R:%0+5/(
M@>\'@5SC]Z"_',]!>(&[N[M1=]=9\XUH6%XVU%Q4*N1J1]6I>12(Y"0:W<&X
M[*+6H&R]>>N(^Z8&[\R>6R8N[CG^X5!/;J[L#B9FY,C4AY;>N>V:H:OE1<7;
M?G+N"X>6S5S=M?_9>2]L&=/J)_M"X\[?>,'!N7)=M)NYY#^D*MD3>^K*Y0]8
M>+[INAE7/NKZ9I7_P:M:;IO#:FAL,W7X`XT%L#J&B3).%\K@#,DPF?"=EGM"
M#UH>M!VP/&4S:$,P>W"MKW9>Y;J%Z7/]E+G3MXMYFM$9&3-+@I.9-D:3T0K6
MF!]":LU^XL?X$!I@IAT0[]4D`PP>(,?W6U/]`A8&F+'[MYBVFXAI@,DH&8>.
M[$(8XUIAUY-6'+8V68G5IX``ZAI%#[9XPA[B4<7#,T5>ME0UX:GV;C4?^&5W
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MU4:WJHUNE=SN",3O`F@CIPYR/CK(;8LL'N$!U<4AM01OJCOUI<J4[U2N>$;%
M`KZ0Q2G(CGC($IB'?4XH@M;P/.RW>^>=(3\-9T!CVKMR/U0,D;4Y!9Z3$D!U
M!%@)>A'-S8NY`E0#DCB+SWE^U_.E*WZ_8=['N+;T7Z<67"Z/DBYG+MD@5LE]
MI6=_4_KPV;>6!/!$[,9>/#Y(9;T2[,$^H'@.URE-2F%%X,K`?=G'/+NR3V=/
M%+3SO)U<)[]!NT'7P_7P6[1;=+I8V!^4(G+8GY*B6H421"N9S6&=7\M34DIT
MA)<("7-^/B#X"8Z"_Q',H9VI:I06:.J)_`9,154*!&IGT/]Q(!#4ZG9IM=RN
M)IJ/0KS`M_`,O.LC9:;ZKC75NZI2X70&'KW$MTL$C^:XG_'/GEGHA#"$*2!!
M996@<D50625$Y)C*JI@Z&%-9%=N6/W$0]ZK.'663RBO0F?;!T^TGAX!=[8.-
M:MY1^!PL.E0EU;0#5#8.-5(76!C\'`E?I/!(/9(+;L=6B6I`SAI5$U$2S0OG
MU+SXJ!Q3!K;O&$AU"5IX%ZY<G<ASLFPVV\Z;6WI;2-9_=/G*[)BQR2N^^2R;
M38EN7VQ.EG5:$LY<;?("#1GZ.%J]NI1<&H@F2V,7)-QB9LSZTB[9+2A+F:YK
M0TFY]+N+9SHME*,2<#0,'$WCRMW)S``.*:/D974Z5J?OSS!WIPZE7DJ]R_PF
M]0G[B?X;]AN]KE/3R6T`'O=H>K@MP&,MK]=5$EXR&@=P7#%I_7PP['=+$0Z8
M2D<J-'[.K-K.4-@?EZ*IJJ1>:V0U!%@-Y'>G432.DD*2)"FGY40B3EQN;2*5
MW(4J,*K(0G#2"3')5HX+\[B%Q\^I0<Y^I1J954Z:5::954Z:(Z&@RLF@.AA4
M.1G<5OUO2G<:=*X1O+0N-8H![OVE_2SSU#!&C6)2(]P;.E,#"[MH\BN%K91E
MP,1J$HU:(0X!8,LYOV>7SO`/KN,'_S&WQ23+.#%A_#],>K$J6S-T*#LG[C'I
MPR`4S-],4=^$"RX"IGTV;56IT#)5+LU;(7EM'EFN$=<QEY3;I;<7M24IOW(`
M?%<!O\+H>665I&J4I-!U2DJRX)466Y?5:<-^(D4\8;]-BGC#?BQ%=6&_58K:
MK$!TK<=+*-V\6DHB+TL?]49TG=H>[0DM,ZS%6>U,;8>66:0]K#VF9;0LO4VK
M4E([,/S5/OHL-$I*4%7FQ6*GU".=D)BL-%/JD)C#TC&)+/X#T!M(K)(<7`T@
M=IGN*K%3JC+04OYWDCGIQI!SA*3DJJ&G1RA5E<V2"36SXUZ@8"HK_X`VM/WM
M[6J;4@A\5N[O0*$L?D7YV.+!9J1UF[VFI*7"4LEF>=LY^)Q,FV<57NFY-+/6
M<Q>^-_.:YSW/Q_@SC\GD`</&92=FF3I/77:2AW%E$YYXEN$\FJS;S:10!?1&
MHP9WT5/P%K)-M2VU*]$ZM,:SUKLZVX<V>39F[T%W91]##V=WU/;7ONY^Q7.X
M]@_N=SW':@?=GWH^]9ZH_1+]T_V/K#P93W%/S"S`;>YYF8O<5WE?\KR8?=OS
M=O9#SX=9<]GC%,-^GQ2I#ON34H2$_5HI6O9!I;`_`3;+XXD@[$`>+\)>CX?&
M,&.R&4?6X\YF/."#P-S=/J_7371:+4+9;"*IS2X$V?%FJB.B*.V0^B7*JQ,2
M)VU3:G$M)O05)L$B6JS4>ZQ1F0@<!-91(T53Q4.-C=9BI@1<5`,:-:2!@\;\
M9Q.?4'O4AJ?L&=!X&"2@JPM4AR8\_1G!86S"Y4(H>CS6HD>P%9'64W0/#!_;
M[RZZLXYB>0M&/=LP^'X2IB+Q0QV+@[A@_#V)^=YES$P<.NV79V9+R2Q8/(=Y
MVFP(ZC[')W%/9CY80'EF9NAP=G[4-?0%>\6W:]:'*V4Y+W8S:Q8D@PGYF]^S
M:O?;OK,7^K[9#+(U_.'PIYK'0;82^'EE6I\-V[9@\/I:"EL(M@4)3I"TO=Y^
ME?UN<IP,$]X>B=B`9WHI`CSS2Q&&\C7JH'R-VFQ63$C$%G'8;)'(`/Z98DGL
MPGJ=#A._3VO3,2H_C+;95JLH9`5%8(2!X1/[K,`<:)S>I]HO:*B.B;"M0HT<
MP#&IP&(%IGD<4F%WT%<X)2D;P8<C.*)"(T0)\&1D8/@4Q!3P:,2;7/RS,_#8
MW@6L'CKKD\``M#]2MP;*O!X<[!W);P-$%E46\T(C-6W=S:U*4F?SVBIP$RK:
M6M!4VR*TP+8*761;9[L//X:?QOMMK^%_8MM?"::6L`T!CG:!2!Q$9/C1O2%;
M$Z'AD<O4!/[6QP=`J)1`D3;WC%1^M3K@+0*&T>8[BL56M+EL12(XX?06[3"V
MQU"$UQPK5U_M=Q2)8BVBLBB>#3.H5*%V!H0J_P/4B?ZKE*GFUX\[F7.HQ.!W
MJ"S%OKW.'V\!P:*"-/J<T<'1FNG?\HSYC*A\LXD=_^TOS@K.DQ.J[#KP52=#
ME'`51`E&Y$>[E9J[;(_RC^D?$]@K\5J^%]_$L\U:4Q(QSB2G\S2&F0Q#((QE
M1";+*(R&F1*D_/4U%<2@$B1!:Z.@$W7$H@OKB&Y*8,2QIR[D#*$K]679EU23
M431MBOT6V1#WQ>UQL]&:1G[L26,'#RV7!EJ"WI3&7@*%3>M,(S<+Q?>)E8)X
MK!V+U(&4:#FJCOJV5H'Z\C:K`/9Z$&OQ]:5UI<]*'Y>N_\-S_SAPV:9;+]W[
MW->;+@,??E7IK=)KI97X5MR(FU_?/:7WT=(SI7U[;\*5>"P^_XF;J!\_N;0*
M_/B+D1/%T9!2,0&W\G=@AC-C"/3YY7@-OA%O17=J?V7Y$.E8BX+&86:>EKF+
M'2#'E(S6E108%`*?4$19U(EZ$(O.TVI-3"K2&+9G[.2[?0>-?4KR#!V3"K@<
MOD;!))J(Q12&>&I*XO]&QY,T^FT':C8V#0JGRQ15='%1#L0-1KV1<!XY%I6C
MA`L[(VD<U/F`A!8HXE;H2HY0&E;E-T*ETWK-KC2.VJ!0=S#/;&)6PI$:24UK
M:`8G'HM1<T@*98H[$#Y+\%%U*O(Q-RX?O*NO]%+IS\NWSEG7B_LP&"Z\$3BP
M[L"JFV^];/\SE_=.+?["TO^P4=1<L/>"AK&+L?]Y\/AO*UU:.OIUZ2;VT^L>
M+/67GMJS:=//<./_/-RS]DP\M1+0+8GRA"A[8AX*%;+J2_5&L&UC_,7HBVEF
M2NR1-/&$W=7+8XP.Z^2X/`FUXE5D5>QJ?#6Y/'RYN"9RE=R'>\6[TT_@)^2G
MXL^DAV-.3KP!WQR[(7%O;"=^B#P<>S+]7/J=[%_3PVF3#;FPC]B2OJROIJ&Z
M(;L\=F%&7ZDE@0!VAOT6*8+DI!^!6V.6HJZP/R!%%5(EQV(1@AW@TL1V$9'P
ME14[U9#"3:<+8<%,OH-GMJJ;?<B_*Y`?P#]6++7)8#!`+&8SQDAK4Y.3K>7D
MY(26`I*>E$@+F$8B[1?JL%+767>LCJG+:U5'4ZO20:LZFMJ(RZFBJ5,==*KN
MD7-;8?%![$7_XFL*[=W@;J92--^2*>=;,C3?\EU6<'!0&+05V[LSJ2$8\/J$
MP5Z:&*2;KK:B#T!6S02F>@7-^B,U60^-"M,UH6A83D<S.5P3@J(Z4I5#T5A6
MK,UA=$:R("CO+D?E*LK*PR?V&(L8D'^/HPAZ<.*`0X5-:)[:+Q2S@@6`$I?Q
M$8QN*B5)F.:M$_]N>M6TBYIUX6G.$=>>W2WC-2M+=Y8*.=$4$@+QZ86AIW/S
M9">-./%?WCFZY<$GL*>C;]6WY]@#NA=>W'Y]PU*RCF!<6M,3KI+E^O!JYA+:
M:GKLBO4#\=+5-[8:R>WXT>LV;+=3SZYG^`-6`SA13^8K7ML=5=B"+<3`(`N;
M1!6:5`MN(3IKPP">J!RKJZ_S,7YVD6>1=Y%OD9_3F#1F5'FX@5UM6&U:;5YC
MZ0QUACLSG=E-VAL-O:9>\PV6WM2C[*,YP6;*F?*F0C`7S`<+-)F39L60&*ZH
M2.?&X#&DB<UZLZ%L."N=DS^G,-DTN7*.89YIOC"O8EXJ&,9AXL^%"_ZZ.9XY
MWCF^MMKS<^?GSR^<7[=@E)DQ&"KL!G]%U"`VC*[(-G3;NNV;8G?S=V?NR3Z:
M.9Q\OO*EU.&&4PV.<[7U?K2*^)_$;V""-^"17)!B*MQ;$_`'5X7]H="A(!W)
M>^]U`'@T&LT.H]&<,E::V;A.K;@H'@(_.%G#1),T1X254"2/<9BF)G%4$3+6
MYZSDN!6+UB>MQZV,=8#T/A7>%4H)H-'TAO#V:OQ<]5^KAZN9:F520:E^`SH,
MJA:KL]6'J]GJ9_!$5,03U=0BA<SV5!>`9??IP2%P'8:ZBYE4V0*I^<.1+5R:
M]S93SQ`)9S)-:JL="UV#(]!:%\OR]F3<4*7+H0I+/(=C=BCX+'3U:6,.&8Q5
MJ810F<,6<T6E;(OFD#;#49E/464J%V?V^\!Q[&X'MT2WU+#<M$)8FF+;V]HQ
M>#:H"ZF^J-'@L139K*68RUI4)Z$-JR%=>6_)'2(C^X)J%C%JS85(6<P3\=C(
M!J*Z`S6*>4*VM>\Z?^5-J3&?/+MYVE^?&9T/_]+G#?*R[&O=?\GZ'X]J2)0>
M^LGT$S^_9&V]VR?IP2ZF>G?\:,.L,;EIZY=?>ONL>X_K-$VA#'[SMA]WW+"@
M=GE5Z)>K;YYSVV\*WG"&2OX8B-+[U:CO;TK#`KR`+`@N"%V,+R87!R\.:3-2
MD]0BW:VYR_^HYF$_3W`P!#`I2!$=1<\H[XFB,!$L6FF`'%;L.IQ"BMO<9+/`
MZV:B)\%>#I"DXM/J5)S3J9"F4W%.%W&[PJD0Q4<S?0*%A-"BT(X0&SI$DL@U
M_+EBH"CH4O'/!6_?*RYK+Z=,3K=3P`L!P!H*]`5[#)8\$#AU4F@<"<$I9Y!B
M*,!YYM)':H`XU$@C[U=H%I+Z_C2E2'D0_1<<HCX;L,7./F")&^SA%7.>`[\L
M,_0\==(>7)3,3^7C@F9ZZ84YL891WYP^XY"Q1K/]DO/Q&$I5P_`)S6Z@:C6^
M_B#*@O-9F<EGU7VLF%HK<UR!?))KX*9S:RVL')43M=':Q(3HA,3.!%^1*";(
MS.QJP]66>Q//);Z*<XWF<N0=#ON]4J12C;SM8;]'BD*`!G:*R$F3KA(\];_M
MHU2#QD>J&Z\V*`4KJ+\NZ'1:Q5C4*N"D:+-:`L'V:<7J<%#;H]HA3@V\J>M?
M#LW5F8YO*@A9W)G=D>W/GLBRV;"H,E-4F2FJS!0C-ML&.UYEQW;5=MG-])H]
M1*_9O9G3WT4!U.M7F70N!`)J')!J5U.5(T'\8-ETT?&:[+19:W>/TH+JQJ6D
MWAJ!^)1P%CDAQ\QB&@G6N+$BC0UZ29#3*&F0J6^)R\Z/FNW'[:"+J(NJ+/XN
M^N=4NQ,'6_.#I("J?R,6B'D3G\C-3#EG#;[^QX^RX@2:U,_/B7F#T[>LW/CK
M&6!Q-`E9;@YW#;WW^@</W'M=VQ?$MOY<62[$NH=VM[S>/77U_G>(O$&L`CFP
M@-_S),A!$U-5WFO=9V5YCW^`^=,^KF%44H:&(L2M$JIFX]YZ$B=>+:>%F*BI
M2=U,'3IV[+#P+10X0[=0A;56;/+JX@WX*G2EI+&%P=0J9DL1`M^B,%9)*6.9
ML91E6\+1_!ITE75=I#.U+GUOY)[HP_AAX3'IL<ACT8?3CV6>CCXM/QT_5'^@
MZ67A1?^+XLO%PV-_:_NM^+7AU-B`+2.(MH@82R6K,YESA*PM*XZ6ZA+9U"0$
M[M18<6QV[+&Q[$MIO#I]369C:E.&;4ZU&=LD1A?U1EUCFL9.\S4G.)NC&L>J
M+Y!V2CNKV=V<NLT<87UCE0IKO)I8D53-^F5*"K^/\VDI*?SQ^CBAKLO0BR^^
M.%)1(K33A%G1KTRK%C,X+8D9(6(5(K8FA-.V)D[@_9Q/A+<DTDE_HMC4X"]J
M,.O7>&T>OS<>H6_-C/+7IR."$,%I!\;I3)/-IN8TQ(Q#%#/5DA6Q:H$CQ?IZ
MFB7T>;T<I]&N;,)-*83!%1#!OST?=^!.W(\/XQ/X%+C$`^2?BF6\.%M<)C)B
M+8KLB)#(`/GE`67LG1+=J04?_W0[F*R3[=^Y8W"H)JMLL'K-ZX^H[AAM_*_;
MM/];:8%?&PV/`>WV`&7:P;&"'\2]K0<RN"*2&<.`3:)(>*&T++4JTS&6VJ@4
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MM^/>[4NAQU0'Y$FE5W!-7=+I%)Q6#$,6][D7TGAGRO`@LXEY$M6B<Y@I9<U7
MQ"8UF]JD4/AT^OEJ66LPT"B(CLK(F"M3TT;FYEST%NC_487S',5I)X74G'IO
MKLBK-9^NIMHNZN"1ZAP*L155V;Q1T<%+C4HP2$LK7#(.#+^EA.A-1B.[P8,]
MZJA'O<,CR"&^L8I%&?"HC@`80TQ*&7$T,T2U[JW449R!CLJ<PX??3Z6."&\=
MI2E6O[+*$.C+$=OL.FP3P\6>ID=U!_2,+65;C];G;D2;#9L+7-#F:A":>II8
M76"Z9CHW09P0F=Z@-&T*:O5F7D21*7B:?HIA2F':J.:&*>?,-ZPP;-3=H+_!
M8)GCNMY%PDV+FDB'-H?RC=45Z?S3V(^,R`CBJ"L:DX:B48VW&PJ"<::1*%!T
M&!E1K=8866.CAZ9Q*@S%%L\BSRH/D_%L\!#/?X0%3%><;50:"2R[,]V3)ND"
MT&V`F:A864/UX31.=\@H9S(:\WD@_+?``6YN[FF\`L4@SH$OFHM(#LL]\E:9
M5>13,NF1L2S0F^2G23/BD1,\DG#1.8!7*"%_IEC#*^:B"#%C#\\(/#[%XYD\
MYIO'-%]6=F^[NKM3,\!'38$)I+DQ\&%&4J#"E^U@$4\/G6P7!KN:!KL!3%+6
M(KTGE<J4(74/8\2@+H/EG86BZN=.*HP.1#7V4?5U]833:?5:PDD1,4*X@J$(
M,7_0'D`VNR5L"N!(=+2F&$#UVKR("WF#+2`$L#D"10/7&*`*679Y1VQJ9248
M58C[<!<8U:YN1'&GR:9J;`IU`Z3LJX&55E.0$-3J@+DX2C13_?\8HD.1VBH#
MX(9H*+KA#%!I]QF*>F#EJ"2M]5#KH=9!K3N;63OS:X-URJ#<8+X+>0H!Y:"0
M<[H=Y3'59W:[G.J^%]T)<Y9#3`H(`!VY6C+IEEC=.8NN#E6\]OG\V4URG&3B
M<J9_^[IS1P=L>K=%,#H;.Y?7-."[JEK&SZN??L.E5N]U%S77C+]J7FS3\DBD
MJJ&Z-I^>M[4B/"ZUL?3*]:,=O*FQ_L[Q/\'MC=ZJCN+D1:#YP]\,GV0.:FY%
M+A3#ORYK_NZ0AFJP0'59XS`BCYH>]1BI<T85W4C%C`ZI#:KG1GJ_B=YO-'K<
MB"4Z._44K`Y%![<YG,@OZPQ2&^'52*CI_50Y%%+U]/W48>$E4%IP&$;L;AQ>
MP<`KX#GZ#'TVI-'$9>0!&.'F>@B57CJ=K_;1/C3^\A0=,AKCLE4%!%#\P[1U
M=.1[1^GGJ$>R5HCCA[@#W'[^TS"KB3>;VNO$^!7,&O9&II=]F'E"RT_B<8/6
MD3"-M8<<XSUN(V+]+B1(^.Q,:L*:K1K2H>D!1XG1?&9T(>2)&8V":::IT[35
MQ/9`T6]BD(DFU++0/&PZ9N)-H/U/-19,'?(+T\K>)=UXHREF4)RA]NYRC-C=
M9'47OQC\%G^AJD;2*S(&/BXR(1'[])X`\GH,QH`6>F%6$K'7X`^@(.<7$14^
MG!KQ1*^]%@0>9+P==[>U81`SE]/!EV4K3P,X/B'GK%;7=XD*#H_>>.\MO_[9
MYB=F[IQG$3V!2C.VIW.7%A?^]*?+"H4D^?+@W]X\?4=/0P.S__[)/B':.90<
M^D-M[N7G^G_A=X#7.!%D:"I8#PE_L4?+XC/V@_@XU;WF5->;4VT`YY(M.KY#
MZI0(33;MI_(D!0'Q]]G!KX?&JP>H10G6,`#Q`-^I]J8C@ZJ@'#U")<06I3!Z
M>64ZCZ*4>V[3?`T)V.>PLS6SN3E\J[\UP*_0K-'TH!YI'[B*Q\03Z$.-;A2>
MA.=YY@8613L\'8$UGNY`G^U6^U;K5L_#^"'R9'0O?A[_BO^5]Q/MR<"GXFGL
MX<A4VWS;YO!FL2=Z*LI;1?S,\`DDPAD&P$!!1`$X"W+1(?5(!$F")*K;?IW2
MUN_M*)V23-+RX'$+MOS*)>OX(/4I'$5:*?6V(BS2(+T>-N(6XQ8C,68$E$4*
MZD"=:"OJ1X?1":2C`P0]?KGO>A^9Z</;?=@W@(V*[12'$2=P(I?E%$[#-4>:
M#Y(?EQ,0W5TS!MN[NX:ZVD]VJ6*52C4-#G:IT'W2-J)B^MG!I<'+@\Q/@H#'
M76V@&_7U];B>IEY!;!!`-@5()'B*?L"]`_:B1A!HPNPP8"4@X^'=0G$D-0XB
MUH5IE$(*>:3*6CE1D"BCG:.,;<Q4^9WK[_\8XWV]_UE3-3ID-42C8Y:=,^N!
M34O.'97'Y^__)>:.OX/-6V;$,W'GFG!HZI(''OJFN7HMK'[\\$E6`P@51FDR
M;42VXAEUO[>"\ZA"I2T+F"IL2`RZ5,!R&40U8*3R)*H!HZC>#:-?*>5HT$.?
M$`.'F#^A(#74T`N&;6J08U=T9H@&'4@&QE55,:K'09$K`R<>\3#>!__BL"J<
MX&.<@:_S;/`4$@T,0Q\-=`:Q$NP(DF#8`*\QN%0,<[$4L&"&#EJ+K,4"):%7
MJ(M?H=ZC+HZ;RW&9:A75CJ;*X)8Z?!3\3SJ9]O:C38.`;`!PH!L'408"]DF3
M\AFJ(N-2U?F.S#7L-9H^MB?S9.9PAE<R/1F",JY*9VJN9JYV3NI.GI_,8S$S
M2C])/T]_-_M(Y8X,?SAS*D5$$8G2(9!V`UC!"8UBB_@C<;G^$G&=N!UM%Q_G
M#_(O51KB6GO".-86LH]W!A.NL8%0<'P8'C.P54Z5:N$J7%459@QA9)",(G4P
M;,X.5X_K21<3=FUU$==G%3,YFF1(5N=I_=2D`M=<W;QA)/J>,3C4W=XXU$A_
M$),`.`Y2>!14?$3"=S#IBZ=8;4*.:RM$E&*A2/*RB"LU52HPEO._J+V>2CC=
M6J"I8+#/8)W+AM@&AKCP'3*6S;%;$RU8:0)L1(;)KYI[IMYYXJM?KFT!A/2E
M3-B:MD@N?]I0.E7--2[-M$Y8V'_)PA43S_GFQ1?QI!F/_50%RF_>?V!2P!KM
M>@6_,[ZSV++RY5=_!Q(]'?!R-M./'"C(K!^1Z*36!?;.:`$11&:U,JN`:79F
M%83IA@Y!2(`""*5B)6TH5KH+BI#!+UMYQ`L\H8G_??1I7D57N(^'..AM]0EH
MO/H4U0:VQF!0@8%ZT"!!5*H@%E/%&LQQYNCA[XQQT-F#=@`<,:**3DQY$N4O
M:M5MAA@588$7^7Z>07P'.(X[>):_C?T9NX=EZ*=X6!K5Q#@59X<C'()UTB:L
M%L2>KA8JLXL.F<WAT`]->.KH,6K%VX^TMZ=JU;G"3*FX*U[;(D^[MP-U.-YF
M-%XQ`&Y:H.A2`L4PG96^>6I>&Z8F(JR*6#*O#L^NK,[[.:^NU?XCUR+W`L]"
M'X\9'<?KM$:-<PJWB=S,]1K[A(W!!\D3GOWVM\B[EO>$T^1_&+NM@^_0=L+J
M-NF>YU^VG.+!TO&F&PBCHWK"@9Y,K=--))-T+>$Y9(YN">DFF^R;O/?8'](]
MI!_0[M?UZW]%_DQ.&$_K'=IC/$;\,9YTT9K2CF[/]/,<OYYUH*S+2:=JMQ5M
MBYP;G-N=QYVLT^G_#8M9NJ'KH)'MQWOLM'I'F6PK4AJ?[\>4(_SK6E?27[2X
M\"K7!M<6%^,Z[7#T:'%6NU5+LMHMVN-:1M`J6EB)ME][0LMI'S<[6;2)RA53
MI=BR9L4\T\P@LV`6S<PI,S;3F>B`EN;F4/.(YP(AP(RA+NJV=+5#-0A^OD`-
M33<5J52W%5@$OO8J)_C:$!XTTIQX5W=136'6UZ.N=MS<NH]#F)"N-C4XH#_5
M(S^(>/B:(5HT*NFB"4XMM3C)(E^N*$;L\9=[_O*UD9Z^W-.7>SJUIYAU1:?@
M+7I%:]$$IPH%/_#2V]K:[%PY;^T>L6`V:L%D*5[.=+^'ERWK7;`Q'7:^>O?.
MS_YVX-Z7AGKQHQK!N[1N]O5D].NK5R^]RK'I`XS?_0SSKSW>T!JK5ZX%?Z@%
M(6:=YF:4(MH1[9;3JKU**]3LI-6XVI_"@IG#6G,%UM(^M@&M/U5L5$'--E7U
M52-EYJAYTH%-TFMC<LB-D*7",H#]>VR<%F6:!@\+AYN.#@J#9:-TF+K31X27
MZ'&$!KYGS-)!9%&?0?"H$JS@8O`F;056%1%S5`.QZE>KTWA',:C:J(Y#_SW5
MOS:;TU5G3-#[M(#/'SU*_5:JCF,VB_<X[XDSXYGQQLG>C<Q&H^9>%F?2&Z2M
MW%9^NW:[;INPS=J?U@D<X-2BRD4I$M":]X6TMT7POA`_P&B5<#2T/?1<B(2L
M,=F-4S,A^,U65MBLG);7"R#@`_B\O5L@X!T@7^[!E:D!+"BF9`6V6:S";18+
MCE%AW=O1D5?KAH9RW=14KF,U:JVX`E)^JQE3$5]D[C0?-A\S<V9OU2&&8_B1
M+9RR4,X8!-%5(]M&J#YJ/]FMYN0;&X>Z&YN&(++-T*0OV!^;G'"XXK(S+KN2
M`91PQ`+X7W8=P4GZ7LJ>)FZCA1R$@&H,J'I,98<)(C]GSHD?#LAC9@^]7Y$<
MY]VSIW5_UX6M#?F0.S<U'(Y7*X'/F>E##_=$JF*QY/@E9,'DQDW/7C$^71\J
M2)?:[34KWAXW&<0/G5.:R/P>?/+1:`IJ8^Y2KK.Y9MX5OZ>.06EA(5E3N68V
M095<-7?>9I%M&M6R<-6H*^*="[>P6S37NV_P;"GTC;E^PI9I-[;<X;[#<T_+
M`'M0L\^]S_-*_I5IAQ<>6WABX:F%?I_HS`D%1UUXH>81[=2Z)C]R,7725#_R
M-MNL@L5L,AKT.IW=[M!I>V1LDVE^R`9V2*;L<!B;:*T8;(:F[?*3\G,R(P_@
M;?M;4ST0;,&MBHG>:]LN/2D])S'2R#-J#8](<*_BV3H53U5@=*H"0U.KJ.I,
MG>G`C@&L5>RKM'B#%AI6NF%0X.YIQLT#3(UB]$[59[QXIK?'2[R_(+]&'"C7
M#-0(E_0<[YV%9U55668\RV3!WH6@+*(93%8)"UF\*KLENSW+9#W4OF:-5"6R
MA6(UTS,'SZ%K,X&V0N/5?8)#;?Q1S<7,H8D#O0D4:8X<3N*D*H-N7WY+$K<D
M.Y.'D\>2;-),[X1+I]5P&AI_46P4,))7B`NS"Y6%.X#FFH7TT8#!F%]HWG+G
M1#Q1S>),K!%=V.+J=+T!8#\P_'?%JNY#&:ECX%+GZ!H@OU#L]S3AIIHL,Y,A
M,QF,&($A#"6E-YA7:W@K0S]/W63:>(JND;EPP<)#^"J(Z_2[-]$4,54+P/+!
M[B&U,9CJ/BFDNKY4.ZENBOZI+N$D^&X0T`J#(T9AZ"-J(IJ$P6X:];9#1>^'
MF\%*['M#.BX1L!/=IP?!*4O1$?FX#"/=9[+/-%$$IYI5/Y,S6C=M?L.$6"$0
M='NP)B[7UN1J\C4,-S;>$J^6*^/SY#D!'!@="J!IA1DB&H>;1'2.IBF`9J9G
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M!*LYI:(--/Z^CUZ`QK=/T6OI=/VH$:NM&NV1-L20_Z<]=X&/HS@3Q*NZY]'3
M\^IY]\QHIGO>,YK1C#322!I9,"U;DA^2+1F_)(.0_!#88"SYQ2LV5I(%X\W#
MRD(@0#;R9@/A0EC+,A@9!U"(ETTN<?#]-^$V^2^!3;QL6-#&FR7<)F#YOJJ>
ML<TN>[G[W=[_?W>_J9ZOONJJKZNJ>[[ZGFD$;Z%&Q\BYPB1*GFM5:@M\ZPC8
MS=:8-3[1.MFJF6Z=:SW7RJ9UN+]UI'6<="FM6.;$5-`VRUH56[@N%4RL"/.I
MH+`B$DH%X[.L1<E&"HEL1U.PT(GE1#.B;PEFE<TF\%XQ:ICD\32/K?PX/\6_
MRFMX(J1B=2@4S4IU_74C=>-UFHFZR3IFN@Z#QJJ;JSM7IZD;:7D"O$/A?6)0
M$LORHHHK&:OY4KNMJ,;/R,>GHL+IJ]%RNI@_7J/UUF`]Y],'B'HN1\IH8!B#
M\")Q#!O1QVI(%HY<65>WD"PKM0;UU#6$WGQ+<Z43/$:\<NQ3':O&_0X+7Z\L
M7.M2\CPK==8WW++"5>Q>:+LFXA2MDL^5LV"[]O,7-]_=M?X&Y1L+W]H@BS71
M:"(NK,*=#]V8:^I;J+DQ*T6C#KYU/7N-ZCV2S$P[5'HX+T849LJ9F5,H"HH@
M0-C9;J;L;@[12$9())P=<HBL`30(E>70>),ROH%X@608&C\\2:@-9K$B\:'Q
M\V?*Q^W-RG%[[5EZVF02#O'TA<9"!T$-A\?@#(_HL(Y:LM1K)Q/HPCH'6(.O
M@5`_.R2\/E2.D*B9F+-P)$!FIL\0'JN<!+-,ST"(UF2>9WIZRHV.#K6A>%M:
M=.L4$NHZJF/(H@C)H;#>05[O?:6&/&DP1"-F>A[,#&%[,ST/Y,W4\R"2@T_/
M#_0\IQZA:.2J,Z#ZF+#WU\^6SJK)BO)1\$Y&\4AT/#H9/1J]$-7*T?XHHY`J
M2A1F/M]$<6N;BNOJ51R)4:QDO;XF."".%6%S*FB'8Y'P=LC!4*?):W),PJL4
M$0J;]`X[/VG`AB+1P3-+"@0IUE*!O=5D,GO-45%)%T72YVMN:YH4<;^(1\1Q
M<5(\*EX0M>),9.9/Z7$@VYXG9P!4[[QJIH+FA5<3RH>!OE*:)"QWJ6'A<J".
MZ!''9;ZF;)VH\'6J=M&BVMKV1?=X&SH6EBS)^@WZH*\F:<%.[>?)0'MM[:*%
MT$5Y?1$8V=>^#F_Z8D;V6J/CP"$VA#0FX-H6]J6RE$_[J/#VTEJFH0T;K3&M
MH0?Z)3>I0;+_DG(C:2AI5<0W)[(2+@MW#65S'17W62J]LVXB[K,5*9^M2/DL
M.0=D`F@L*`+M$K!-TL1YCR^6I`L1@^LTR/HX*@"GVYNIK&]N07&OR:1F.=B?
MGS28S/3LL#\_SNM([&0^758!%]-S<W-7TAEE*?L*\#QH`?CPY4PQX:A3UJ)4
M9.PZ`</O`<,7^4GCI.DQZZ.VQ^R/2E/%$SQ?]!9]P\*P;5C:(8S9QJ3'&,,[
MP7F)F3!\TO(*^XKU;>9MZ[SM5W:N9"N)):E5+A6[K;OY?58NQ]0*<DR.YXJM
MN%70NX1U^#IAK:R)"!OP!NM;PF\$[7+;,NEEP\O\+WBMQ^`6I(`D=3&+K3JC
MS>HP^TP!:]`BZ=:PZS1KM(/"6MM:A\YK#02"TAI&4SZTN6:1QBNQP/*)`GRC
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M#)7:O>25B4D+C`,>YB%+5DQ;#@AG#G'E!@("L7Q^A7DLS*GU(3)V1J\?A.^S
M>_<N$K#?C8=H0;O0+AI%$>#8.,':E))@-P,$%&"\I+7($"EC+!H)LA6M*C*H
MB*2GC]N*5$Q46':09$MMQ.(L-,43A9!+I]/K'=0B)?*BF9B:F$@/CZH56ZY6
MBWUOKS!QH3C^_'6W=;SSSN9P?=1[[<*2N#^Y\'?>[,J%;'?$9;1:9)^KUH8%
M[><_W/6C3KO)Y`PPLLQD%_UDX3]_(I2S\-$H=CD\C?CFA7.#K2*.1FU&3V@U
MNWAJJ=\6(9+F&M"/5I`T+OR%BG;T@'*@VM%ITF%].;I"90:F,@.;B)%4SF3^
M/;4/314%:")JDB8RP7][EN8VM2^`<.``],@!`L+HN)S5U!.UD<Y?#KZH&N4,
MB;]<9?,E'%3'.6FHGR0U$=*7XRYJQ(5&_\FF5)5E4H47;:@JRV3RN#]BMI5H
MQ)_(E.<F/7.>"Q[60T,=W4T$*VW%14W8,V/>VMSOP8JGWS/B&?=,>HX"H=Z4
M"NI7A'$JJ$M$*FE.V))>QR,<-9O*TYBHTBDL:IHTX7X3'C&-FR9-1TT73%K3
MC/LJI:,:7Z7V*VH&'!X:_:!:YJ.:I<(9G_`V+5THE;(^BR3ZDC9LTW[^@X[U
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M&Y;:*,?;9)K^DM/4A4G3OG1+![WKH'<=O?`>?_^<FA`;:"%.(.EN4;U!VO@U
M'6UI&>@E.IYT]E9.$#3^F8[V]@X.E`^.[7(MP,XIP"L@^LYG2R4BE(%[I\T]
M:P=>0MV7?HFZ`'(`]9=^^:Q/](K@>JEET*_4-.G/#?[*S4X`BP\27REMQI.#
MX!+)J:`XRWSX3+@E%6R`AF(,]Z:"2U>$;:F@![RB9R+I5+!^EC4_$^E(!;NA
MH5P;69=8V;$VN*Z32[6L5(JI)(?TL:7K-Y`_)I8Q\4:]3J/5+^UNJ!<]_*#'
MXQ-LT5"]C,?E:9F19W%!L;:DLNEH:WT+'F^9;F%:2)][Y8:.:&^OM+)_)3.Q
M<G(E@U8**YF5<*Y/.MU-*T<&!F>9C:"S#HJS>.N]1&^1R`YH*Q*P)U[5>16U
MK^H:[7P+E6@:KD1_*ZD"HR8/?%QTV=^J>%SAJ,EJCD7B45.H!ENL84OL:H\+
M'*XTIB%1T!?4X?H8MZNL2VA,5*_W7)$CE[OU5_EC'[%;&W'_5GO=ML;U^UTW
M?[YG^:Z0V\PW7[/0[E@4\O`:?V)]X=9>AG&U=2\T]!:-VE"FK[FPIL[;T+.P
MJ)3W41LW8<7.-//N5FN\=NOPG3T]Z]KV+]R^7G:#>^81(K9^_(?C6:6PS)A>
MZ*$^&VBEZZ"O00ED6A9<&YO]T:A_T3I\X\.94-D>-B'$_A>09(W,94E6H)*L
MGMK##;2V<%9WA(B$++F+!*(ICHHDCLH#CLH#SDV#(VX:'''3K+:[(I[<:LB1
M-OY!B1-R-PK0AP-TH@"=(I"BL9$4-9Q3%0,YI9IHM*$*N121;3QY(H5JF&@]
M$22&!L5`]ILWOP@*40`(J]$2Q1"U1O-Z7X:ALB27HZ$1`0QDVT?C(^FYJ^2'
M0`2(H(9(KHB-&W-N&ENET<L&VJ8;:%#GMT8YJCTY*BDX*C4X-T.ZW+3+S9$N
MM[O0A`*4,D`[`G0P0%^4]*8JXB)%A`FA2*4*3?^]H1*P3=L*2FV!*Y#S7U_H
M+XP4Q@N3!6V=!BNT/0%WTP7==.%<@9DNX!'HF"NP`<Z="EK5L$DJ%8RN"'.I
MH&5%))`*1M2P24.BMJ,^V-!9@R+Y1OK&T4C$:K7P'G=4/\GA:0Y;N7%NBGN5
MTW`D;.)/-0:BM5*J/S62&D]I)E*3J>D4BU)"BDD1/6Z``Y\::5)#)^G__M")
M7?2R.DW,RWIJL%8G:GV58PRG>&@7_!#XDC1R\F_&3>!$7MUYQ0AHQ#U_\D<]
M.V2WQ=BP>&&10VGD-1TK[[C=:"$'T=G=8)4JYW#^Y9[U[?L7[MH@>6G$Q-J'
M[SBPZU,+@2%W`$[:TJUX[>/+?.2<,2"TS[.GX)Q948`QE4]:#9B!U**CZ;2R
M3R<8C5#[-.3LD$'24!RD4T/)-)X89Q1B2-6,E'_+P8R&^@J?&L@XH?.1A_V$
MIWP:)^4XITF@%IQ`S3<-M0-(4Z,)FDQJBINJ(L)<H(M0)8G699]PX:^[3[K_
M''_/<";P$X/._G<\7F;H<F]PW8L_:SAL_8E?+RGY@H:FMJ<D_(KK>SY&D?!R
MKK(;NX;\Z6FP__N`%37X'*G[-2.:<<VD9EJCT[QK(ND2Q30%+L[EK.[N],IY
M$E9+]TPGU_1,]Z_>>-P47'Y<TBR_;N/`"\AT:0YI`*1+<T0%+AGX%O*Q>:1!
M3C;_MO"V_ZI;T`Z#Y1<")FK&`7O,$F=B-7$^IHO;K$X9!;!/QFX#M$0]M!QF
M0<9^%BJ7T2,CKQ8J\JFOBJJ#VL#$W@2NPTL&%-L^9I_N;OYNR]WV.]W[Q'TU
MW-`@.$(DSFZH$6Q%/X"+A-F-:IB=!#QHHJT<1&]N]I!<F]->#I<SZ-P]M][^
MZL%7[[[YP`_6%&Y=//6I3?=L7\H>^\JA8Y_X<.+QSSQ]SV_OZ"A]9?]W%WYV
M]#OO?78$G(Y+OUU8P3X/O)9`129<YK74(H5(U3Q?2Q`)YI)XML.+9#;EH#+8
M(;NI<48BTQ5[C<I=F3"1F1IV;#)MUUAT/I+X]1"7`\R/;,S2/*C3)Z@41E0*
M(PS<"1(6++=Y*G"O1"%>3\_-":^`8,U1CKV2!,Y?^O!9PHAYGO"D2,/,_*(V
MV!WE6P>5D0Y9U0$ZLJE_4/S46).!*JFS)!#V6F`S1K(;L@'R3Y<$53)B56*"
M\#RG"L^S:<+5]_"+"+<6A>7"]<)AF^:^#%Z4*2WJR5R?N<5V2V8/=Y?MKLP?
M<(_KW^9^:S#7+QIH'&S:T:11%N$<QR93=@>85=[[P@XPKA(1E`CU)8*HD[&G
MDZPF*S1CLA-&3_;D%2WY!HF?Y)D1?H(_QK/\.S+CF,4W*WY9[@^-AYB)$$8A
M(30=F@N="VE#(VTO]Y2=F7:!2L7=\\2AF2^1^)GG<OR,M0C$_J$<+><*>C,7
M:XJ;XO6Q@CXOXYP9JD9#LXP;C%F9I(C*K$L#S"0+!"S(QAI=E82OFLQ)5`R8
M1O=5$66M*C#S+90SB:'#8%]\Z9&^/[QAU_WCWUC1G,Q[BCT+LK<EX7`)D:`8
MPTT&RVUKMEZ[^@9EH#X798N[7[MKTXX_^-'\8P==UKJ%MV]L#,9BV&ULV,IN
M'JP7+0<7OC$6:1M8==.I_V?7*M%.HLR="RLT"'@Y@-+X1V5>]L6IJ(R[W`2Y
MP)4.EGUI"_%);,2(L%`[Q$+M$`N)'5,[!LQOZCI;M,^KKK,BZ`,Z:]`>B8FZ
MU*#=J+>H?`,L4[K:>9ZC'*LRS9R_EHA0?RWA0W\MX4&?U1=<+["XCIK<LICH
MKV.4NHFZKR6/UFGJ??6A4FUKND]0?$JHKW99>L#:[QL,]H<VU@ZGQX3-OLVA
ML=K]PB[?P>"NT,'TO;[/I;]L?<CWY>!#H2_5?B7]I/L)WU,U3Z=/N5^$'?PT
M_6[Z@W2M7+<GMB=YQ/&PXV'G7)U^C0.'.0MXT(FR!^T7K4&)C?A2F+Q6)!80
M]7J=Q>]'DF0A;)=#$I[$S`B>P,<PBSGJ[[\3;Q!<_2[F)=>KKE^Y6!?-X[J6
M9)8<I)(XO6OWROF+Z2&BGFE<C#C8\Z6+A!_MQ;)N%J-)AR?JB<LHZ8`JYH[(
M..%,R2KOJ<E'<,5WMZ81"6E?<<4;U>R%3@W^(FI_M[#E%(?+21*([*UBXXJ%
MO*,UX!2OOW_YO?\).[]3'(FW%3Z=V%H:/_JG>Q;=P![[X*:!?$TL)AB+8/KN
MZ/OU]]_&,5FNB5[,X3\#??WBMT_--2(UW\<\!YR5Q,^6^2I92V6D3O+8$M0X
M38@2+KOR5WN^4L6NE2H6J42D$<UO2]0QEZ@)*U&/EQ)B@17=7A+,%5$<V,[2
MEQA+'$RPB:1>-+$@K,X2#W<>_-M_9962'(7PT61=A$P7AV?'#`<-C`$F$'6P
M4RHH;=2#)7O\'164$HD($'XEC>?(F"35IJZ*<`IG4*YTMAS=)#:D7QD#]\V:
M9_)6A5&LG]+HE5H\7(LE(N6HOWA?))&0.^+!1"?BC;4VIRQ@C3A!T@6""9L&
M61;IP2,<UF%%AW59J1;7(EM4DB093\B3,H-D`3S$.?F<K)5'4B0X"<QUV<?;
M?7Z7FB@0YG?/#]E47ZZ(KDH8[`;[#A2GBQAW:K*@['5Y+J?!/A+PZ]US5\NR
MIFAD@\ONJJMWF!=?NY#N#GMYK3GBDQ(\=K''?OC#)9E$<Y<S=>/"\MX$&&]1
M-_6GMAR]IH88<,`O6R^=9WX,_-*@:2KS2Z*1\DNC0JPS!M-,%Z:9+FSU^[B$
MB?0G0M:*^+$219HGX]8&/9>PAC3VM!;?I<4[M%@;RV&,:_7>.X)X2Q`'8[(/
MC_C&?8S/;D2E,T-#8`/E``,:`F5:(BP"=M_9'YT5?J1JTLO<D0]9$YRFUAVT
M9[5,;8->G<9K[]'B6[6?T#+:6*V^,XBW!O<&F6#,;L1DA[]6?(1;K-;&O(^S
M4"\F82<HD6C,ES7F&16?`1MJ:(B`<.;,4$DX8R_"``V,^Y64(>/-,'9[5C$6
M,TEC470.FC;&'Q,>C&IY/9_D4R.-XXT3C3IKXRR6E4,@+K]O_K[E3/1,[#]'
M7HO^)/.6YJW(6]&W,T9[*3.4V5EW(',$'V&.L!.N"=^$?Z+F<-V1K-F*K0S/
M&DRZ&C[SW?#W(EP-ZW;::]P!;\J?><3P"/^8_$#D@:C1GC8G,RLR?8W#C7>F
M[LS<9WDR<JSQE^Q;-:84UQ!$+S!!+.$<9O`L3L^@%[*SV*?8:L6@]P5_T"?Y
ML."3X<N10>\+;C(8MMNC$;-18TU0I`WBOT#97&T#0N2C^N[Q>L59MEMQNG/D
MPS(_L&-L?S7T1NA7(38TRSH5X[@5CUC'K9-6UCJ+FQ5OPN?-2ASF,E,)/)(8
M3TPD6#E1GV`2SV,9Y;%\O*=R.%;.[WZ/.D<7AY8,S%P*X:'!8@[LRIE+&)I@
M&\R?AW%07<1M.B_,EZ,@GB)8I3SX:5&ST6DV&P]9LC2(/R@BX=WWYH=V8V'^
MO7FU39LJ$SV3E0WF)I0>I#*])IF29,&FTTNV4`W6I;@:.,+!&J1/:FMP1;`3
MWPO6,GR@?U]XW_9!4C,TB'<C.*K0Z9W"4\P4.V5\U#SIFO1-^B=K'@D_')FJ
M,X%YG,:[B"H`,F,NDHM^)O-8]+&,=FB0&,VVI.PM&I+>(E;X(@/@)TD!ONBC
M65B^F(6N#`5#T20$[26+3"HP(6?\18J\Q2@8!3..8D1%)D`G'<6,Z%#GLJMS
M6>VPA!V6L!<SLIT\<T&Q6H',6F0%,ZQC)A-<4.QF6,<,-`"BC0)*_[<*?)M!
M*JYLD;(F\[@]'E5N42LJ8FLD5A7)9$2I"T`L,>*G,I.A^!TW=*^7I>$_^OX+
M^];N"+D\YE"HYBN;NS9L6OA97=UCGVA>V6@3[";VV,)W'[AE15UK,I5=NN6K
M!QX)\CZ\]+.?7UWLNG&RK;AAUY<\5HL(,LQYZ1^9=LVWD1]?+,NP6$"Q@PP+
M*$1`&4TT`&-R.;#609L.JL@<:G23-MZC"L]!O@6-#3F,7,;J=FIFL7\&81UH
MLHOGSN;FSY1UV.M@[><^*I^\'AH_<=/:=57;3[*>U)RJ-+S$GJ/IB7$C-EK]
MV+7=B9<[,5U.`5:$M8U^K*7.@98&4[14"VH=:OA(1W=*]9^CDN%S.`(U5P53
MSITE/N'%<T-#<\)9X<Q0)2,-?ZO_%#+#!CI,Q6$\S#"EP".V1[PON5YRSWI_
MZ=5/!?!A'^XS]9F'3</FWXA:G>@2$R+K=HE>'XM)Y?0?Q:RKOKQ;MIYAL,Y4
M()MVO^IZ@]I8HT[_#Y"1Y/TR,BC/;"XP'6`""&.-1AMU]COPA`,CA^"8=LPY
MSCG>=.@<(S5/':ZX!A=ID$08>@]LAWF0$^VH=/&\FLF#H?,8U">BUEE#/1C[
MU.;?3>(BMD97Q$9MJI9&:G'%"[9(H1GT9@M>\=IKC<G0M;9$9*(S.U#[A98]
M=9Z4YML+?]E]\<\&KTTE-V]I'-[";`NYMR^+CQ+-R%PZSUYD'T0QIK[,5>X$
MC2%R9;/<*"?+&8&R/20'RQ[F><5!'4L?)?39:?;!7F$W>\47A<9[SQ)">[3B
M>EK$F,XH6T1=(&,QZCDXP\\2UY/C4>[U]%GX1U43_EV5#\^JR8&YU]-7VU$;
M]`HWPHUS+,<;9:-HB<8\,*LZI;%L$_-J#HQFQ60?S8CYJ(GEXVE<Q<YQ<9ER
MGJQ3LP)Q.\GB$1([L0_)$&E0WK/;$_&KX_Y0"33>2*HYPH@E8$)JB($]2$(Z
M2@$GB%<A)XA^F$YHFHPM4IN\3%HF:WV<HX]XGJ&^8"P1X1*X0Q_D.F5C+,#-
MXB[%P:-8#%02>1\+;^2-QI!,;'\+FL;8BL?Q%'X5:S")U,7L7E_4;N]W3#J8
M":BF'2QA.KG,=L!T\9</?M1.`U4$[`?<1R)U\VJT3J!!U<N6&J@.P5]CM=58
M?35(L/F%0`VB@;I/?A)\@*%T)1&7;_%H(X4*'X+=IB^$RMQI(_E==HLUY)82
MEH5_J+M]?]?*79F:EF6X8["4OJVGN)%]\.*/IY;6V"*[7IY8//C9"?Q(1]Z/
M8Q<?F^AO[F7TJUJ8&,G8`8_.`X_*S+=5'CUI,""?7><DX6(;@`S`L#\_CD"$
MD0AQ*0<:(7<EIM8@\@8_9S"$0_"<T4F#OTZ'SD;]/YM=Q]`>.-\R;<ADGK/I
M*S^[&H-X_:SP.OU;#?8U_(!XO9<%&?=7,\9"F&BA3:Z"T^OT10QA/F23[5%1
M]LJ^-D.1;[,7Q8*WS;>"6V[HY+O$+N]RWW;NR]PCAC_V/>J?"O\']"3WN.&K
MWJ_ZGO2_R#UK.,F?%)_S/N\[[9\+_UA\GW]?_,!7-V7`9)43^9$FBM,-*@ZF
M5+QTJ8H3"15'(BJVV2A6%&]-DS6\'^W&NYEQ[7[YD]I[;4?"AC:NB6\2B_Y7
M='.AO_+I[^</BX>\;(M]F<@X1&?0@?QR$-EY6Q!.P7U*QN#SRJ+76V_@G08#
M[_?YH@8.6IQ>I]5H.##)''8PFY#.YS6*LQC4TS"/!3[*3_$G^1_Q6OZ`P4^8
M6%!TN:/<*>Z'<'H/&+S[?*>Q'\G(`/NUVIL,9-_>`,4S^0)!SYD*R#`'[M(L
M?NFD$,838?5K`!7!)ZV.IA`1K%XA#8[N>T-$7O@NBF]Y@>?%]WSS!.\6YU77
MA/(ZD:Z'5'/JD#8KTD8:[*IY+,Q=79/D\]#0KHI%0%D_C7>#??,L+[O-)1!>
MOWP.L"$*]C(X"V"E\(`4WE'D9#!3`+"JD3`-&3I"+M60<#AH*"8>*81<.O"`
M<`3'XR1\@X_5)%*N'[_FX8SA)IQN<D9J%DZG%DZYDY(MSSX8B\N1^@4=8VX-
M6`Q68RRFL06[/_P'5MN<$PP<\8TOG=<^`Z<EPYXMGY9X*&BS,!D2Y+,@0USD
M-,F8I+/J")N72KF<IRA</`=E[JHS<PK%07MV$KDGUE"7@M8B#2MP:BW&#1J4
MI)/?E<$9M"^&8\9]29PTJK-G,G6A4+:N')<F:Y6&2D/"ZT-T,1OU.NA7]1^W
M9PF3UI0*[@0XF+980LX.9[<;QK-OQ]Y._G/LGY,F0C#C*%"Z[_JEIE`VF]K:
M'/!Z)7]$R&KX>"">B1?CZSQ?]WQ=_'J<,\9:HBV)/M2+5^J7<TNCW8F5R96I
M^_43PH3M<['[D_>G)K*/"@\2XMAIX53L5/*E['=CWTW^)/:3Y+FLA+0:O<ZE
M\1AB^H0AJ4L5/$N$);9^[77Z]>)UJ</&(\+]XF'OX<C]L?OC$UG/(<-]GD-Q
MUFP8Q'<(=]@T<";@WXS%>*R'4R%X;$%!CH2",DIE@LC*6X)6R1L,@EM_WPDN
MF0!E>D!1Q%A4YO2<01]-)9VI5!*X(9:HYPQ.CC.`=>)U1?F8D^=CD6BT7O0Z
M1=&;BD>\X*S#^>/A?SB-WX5#%,3OGI"PU4;N!&0!VP2TH""``R\CAG1BE`$2
M.*3B:7P+BB$./Z%8DPIL-AI-&N4/K:,\^%3'GYE#HZG(+.84E^+/]7OQ42]^
MP?NJ]PV0>G\4S<'Q]C\G6V-8@#^='$6CJ2EV&@LHCEQPPDT*GQN.8R4^$6?B
M8"`]8SB0R''/PS'GP)SB993$$\D+229)=#\\FCRJIP'5_A2>2&&299)32FHZ
M-9<ZE]*G1NHN6TWS)*/L]<U?/`].SZ[RV88N'W3`L'C>!Z84@?ER$LHGT,0R
M,;':RY?:GE?]+#C]JA2P@!3@*N*`N[HG_7&"X5_7>H%KY]JIP-B%A]0T5AK$
M!9$5<<%I*A''Y`1@!Y$3@:+G*N0DZ,*,IQ@CR$7OCKN*EY,5JN30J8(C0>2$
M*C8J@J1\CR.L*D?,>`+4\)D_;Q(3[G;\S+*@DSOW;6>BB$,;4@L_3/WMPF]B
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MO`F5:'-J3=[IJW$XFQZW.]'45."-)E,CF!]ZO3?>5&AJ+,3L1]PY&[85P"QU
MFP('O/U!',S%QB('(TSD2`1'O+%LMMA8]^M4*M'8#U_[0`$7M%I]S*O71PLQ
M9Z$0,[D3B?I&D[.QT03_O&@P>1H3,:^Q-1<7>=;4I"]8:W"-!/]$+DO^!E#@
M-AO1REE-':ZK"P8#O`E,S&?'W-B=C<UBRPG9B[U$KIJ$@N*=]K[IO>#5D`ZB
MC;VGF6;4B/3XYIE"-@'RX`1JQ(VGF6^C(FIC5IX(G86CF7Y_:/Z]>>%B>BB]
M:Q[\&?7L#56T+9B:M!+:AX@A11T;<O0LV?0ARP'UH)$&%NW%`SGQ7>'\$/G&
MY^F'MA>'<D/0(]!;8?^[T-)S0KNE_9!%:#]PY@Q!9[@S>D`<]`Z2*./0$%'5
MN]`N.'RGD!'.%%\T@FORG*'H(5$&:/_R!&`7<5(--;:26?$+)9'TP@W!BL-C
M*6E)3E,O0M5,6FW$%`&<2EK);!=.6HLQV4H4_E_-6(MZ<I"MQ3R@DV88,-,>
M$IV(RP1LT&<CSX')2(V$&;N*;*K)X#<7!?@`-@"/8B\*@K5H`\@HKJ)#E0IN
M%=F)*G21V,<%Q>$J-G.N8K+>64P!V#AWT4`G<Q=3B@W`5<P3@)4]9'4`\OAQ
MVQ79\M'R+R,BE\GH`!5#E4`(229=ME_T#K?;HP9PP:Y)$-%$[XE;VD+L'#\^
ME@I%C.Z.GF7A.&YNB#:L.W!^[;+B0G^=UZ'<]T!G7=W"CZ/^^,:Y/UNQ^AH0
M3#4>,2^$MVW;XG,%0"R)X=U?7YB]JX&-1IT6CV?HS)GK;6*"B4:USL`=ES[<
MT0)GQ;30S;X'DBE_.7<*UFFZED5W)G`B`!X#C?,ZB6"RT::--!G:9$@S3YOY
MV8HSD9Y/OPM7*7=VJ"*RRI(B:$BC@-/&W)W'>60'\1"YFZQA=3H;$6IJO&ST
MO#YT!OQ"*AO4$/VTT+-VX`7DO_3/R'OI`O*!H.>%5BB#?N4I@P#L94E_,<4X
MFK+NK<V?UMZK8PP&K9WS<CY#VNF+&Z+VJ"^>;L7-]H)_J7V;81N_W7N3;XM_
M6^9.[B[^+N\=OKW^.S.'^</>+Z$O&1[V/90^C<XU_:TN`C9).IVIK>4QM=2]
MQ+S/Y,OF?9R3O3Y??2WO!(),.DT-^W0M/%+K,VAX+@/8"Y8&%RF;^`DB,"RP
MVT0N4@Q8FSP>GY=8"_XC/'Z#OT"2I>/\KWB6/U`R]!F&#:SA`#BV%B60?LTJ
M8ZL\)3/RD>$,SF5*&2;C;6SZ#Z$GP$M-KP)+?>7YH5WG+[XW]!YHTHNKND8[
MWT*EE1?/IU5Q4@F.'N*NTMR`B6CY-Q7U%>6,=Q'1D/ZW3'%JBY<369?#>2TX
M3I6N"3_EJJL+O7'6IN?":5P;2XH&[\)GFH^M7M3;4A\J)OG@TFC'PG/6D%?P
M-`(/)P*)KH4\_ETJ:3<8S6"LBR%+Z<.=]][?F:EM=%NO'9QB3DC9B$DP(09]
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MG:V&5J$Y^2W6CJYE7D%K6/N),>+6X8%GN[.M3<TL&?'!2`]K5VQ"M]Q=WWVT
M>[I;V_V=@5ONIN;@_$6J=2B^"/8<RLWGAN:A46&1BI:YS":D@<KA]6)1/9!H
M:(A:;$/`%6`[T;_=[7+J51Y0A5Q9Y+EI\%?O+J>N*J1TD(:!*9>0_I;*`]0X
MB^.[EA2_=N?.(SY'.)SAM&V-RT?]=;=\;T73+7NZ"U^[<\>1'.AKP9MH77*;
M5'_/MSH;=WSAX5C3%[J;'ADX?!W;L^+NTK['[UN?"+JRDC7N<:::;UJNU':O
M_,*>ZS9>?[)KY7C'W5\[/!!KS"7]';:`([CMFFL;>H8_>^OJZV\X$;O^T]V+
M5N\LU`\=[/C<K260D@AI;>\^+HK986O[;T"P(%*^^HO`RP1_]^7&AS_8>_&S
M`N(L<&N@]*0`UH<6NM`&`7VP]W=O".CR2+EH;M45<0UI,64@A>U$]Z*/*<PW
MT%J`[.5[A';"_1K`7V"*B-4@M`+@`D`&8`V`#+`98(#0`]X/L!IHIS]N?E*T
M?X$$[7H4!E@![8CF%ZA6LP>%+J_Y#;!LKBKZ`-#^Q:6_!=IEY>>7P;,1>&8"
MGKT6[HU7S6U%OZ>PGX-S@RY]`+@;]MH)N!?6[(/V-0!FV'L[H8.V#=K7Z,`N
M@K8)H`N>^RUY!NC-;`!MA7$GW#.$%M8V`_83VM^WA_\="NSSR[^/IEH^OE1X
MI%JJI5JJI5JJI5JJY7]%P4]>>O[WT?SO4K3^_W/V6BW54BW5\O]GP>C2\QR`
M@*IRLUJJI5JJI5JJI5JJI5JJI5JJI5JJI5JJY?^:LO^JZT5TB5QX%?X$_CI^
MD[F+>8?]2\W+VAZ=3?=#W0_U?\4]QOWBZHM/&$^9;C?G+*+E`KFLGU0OX9CM
M!_:-]HV.H'.GZQWW0YY'R>5]Z%]>_@=JG@V<EU:&K@D?C'X_OB7Q8N+%U#_5
M_DU==_9W]?4-#^6_T_C_-E_3LJWU^;;5[9^Z]E4E^^]_=6RN7M6K>E6OZE6]
MJE?UJE[5JWI5K^I5O:I7]:I>U:MZ5:_J5;VJ5_6J7O_?7@@C9-Z`-B*69JP8
M)*`<6H^0+F;M*F>Q.'03H8+"(A%JM:V!MEANZZ!53V;0&*"G'BTKMQED07>6
MVRSTWU=N:Z!]LMS60?NM]1NZEZSH3J_=?MOHGE6C=UPW=MNFG?UK5J[]'^V'
MG6]`W6@)6@%U&JU%V]%M:!3M0:N@O@-=A\;@?A/:B?K1&K02QJ^#_IO1/K0#
M>G?_#S_]OYJ>4?^`2R&T%7U,@?^-%@QTF+W2CS582[$.ZS&'#9C'1FS"9FS!
M5BQ`OPW;L>/JF;`3N[`;>["(O?3>5^[WXQH<`!S$$I9Q"(=I;P3]BX*C.(;C
M.(&3.(5K<1IGH*\.9W$.U^,&G,>-N`D7<#-NP:VXB-OPHG\YP_]\P>V_CZ):
MJJ5:JJ5:JJ5:JJ5:JJ5:JJ5:JJ5:JJ5:JJ5:JJ5:JJ5:JJ5:_GV+=L_XIBVC
MW*Y]8WM'MV[>81C?M'MTYX[1F_;RM+5[^\W;]FJWC-UVVR;=MKO&MXWNU(V/
M[MX^ME6[9\>F/=LT=X_N'F/'=HZR>^\8T^[=MGMT5'/3V+[=FINVWS[*[ME^
MIW:43*#9N7WG*,RR8VPG[L"+\1+<B;MP-UZ.5^)5N`^OQM?A-7@M7H<'\":\
M&6_!6_$HO@G?C+?A[?A6O`/?AG?B,3R.=^'=>`_>B_?AV_$=^$Y\EW[/Z):]
MV\=VGD)KV7=/L+52J</%GD<C[-MHBOU;]`:`!@G0(T"K!#`.[4L`VDMS[-^<
MZ.K**[.`TUF*9Y*I_"DR,..KR;_`_@WS391`$G2\,>/VTY&?S2Q>7&XTMZJ-
M$[5U^3<Z>/9GZ%<`#/LS]@V45)\ZD<SF+W28H0.S]R`KQDA"1]G7T30`@Q3V
MIR>B\?S42^P/8/P_LM]#6^ECWYLQV_(PX5^PSR$[DMB3[+/ED6=/6&QYU+&'
M_1S":`[J<P!O`EP`T*`Q]NOH(,`1@&,`&F2%6@+(`?21'O8I]BG8Y^/PO!7J
M',`8P!$`#7S";T#_K:1FGV1O06%X]K/L@\@%^#/L`Q1_#;`/\%>A/PCX3^">
MX*GR_6.`R?BCY?Y'X-X-^$ME_##T^P$_!/<$?[%\?SN[CSZWMXR/LGMF@I+0
M$81Q&:`>@(76@]!Z$#[=@R17#35F/\WNH"L=!YP'?)N*X7,=F`E%Z']TX(3'
MFS\*G_0`?/H#\.4.P)<[@#0PM+]"LU^EJ6/W`\U^H-D/-/OAJ]2S>V"]/23S
M"[4`(`.P\-WWP'<G_=-0SP&<H_U_`/4DP%%RQ]X!WS$%NSK,WC*3E(#);CY1
M5/*ET^Q-\*D5]J83WD#^R)4[`T\8$;"EC*V$=I2.CIXPF$COZ`E?0,5`=6N'
MA=V"/@'`("?448`F@$X`#;ME)IJ3GF=7H=LXI%BD@\Q!]J#FH%93WXGM+[%Y
MU,\A8$D[6X?:@2`E#;?CEA'#N&'"P`H&V5!O4`S]!NT8>Y`]PK(2FV-+;!\[
MS&IG+\W-Z-L:`2E+=6V-D\:CQFGCG/&<43NMF].=T[VINZ#3RKIZG:+KUXWH
MQG43NDG=49UA4C>I9T:,X\8)(RL896.]43'V&[62'A_MN)?=#*^)H!8`Q@$F
M`33PC8>A7V9O!!B&?V,8/L6-T(^@1G`G`)R#]IN`M7!G!3HKT%FAUPJ]5NA%
M4).1?H`1@/'RJ.[R2.490G^!C``D8-0"O1;XMF]"?8&T`%;`G1GNS'!G!JIS
MS(>P0P%J&:`?@*5];P(`UT!=&:LOCX\`Z.CX!4I3&5/(L\R'RJ;$7`I/I_#1
M%)Y,8:6]U)%7PE#9[?;AR'!L.#G\N&8L,A8;2XX]KNF+],7ZDGV/:TJ14JR4
M+#VNR45RL5PR][A&BD@Q*2D]KCG2>ZSWI=Y7>S7#O6.]!WO9%OCK3LRDZ_,4
MAV,$/SOC]>5;K!V+F&/P.L-03P&\`<`B">H<0`E@#$##'(-:8IZ&WJ>A]VG4
M!S`,H(4GGB;B!6JI/$;ZI^@8:9%QYB/C++SX-V?:&OLZ5H#('0:8`F!A[F_"
M^#<IM=HZ1ONGH7Z3]O>5Z8_2?@GJRC,L"+B-5,QMA..W$83_1C0,,`Z@1:^R
M&T`Y;"`S0RT!C`,<`]"P&^':P&Y@GH;KF\PWV8QB;G!)R.T&?6FW<4*'P)B`
M!\SX25I_B=:':5VB=52QK#"_O\+\X@KS?2O,"6@P2=0!`P_2.J08.\S/=)C[
M.LRI#C/,YD$A9&9<M-:1&K]#ZU6TSBC.D/FW(?,_A<S_&#+_<<B\*V2^)D2>
MJX&S:V:<M#:2&C]$ZQ6TCBM&R?R*9-X@F5LD<X<9?P7#ZF@QK8.T]I,:__H9
M:Z<5&4[C7Z-.F`G/M*>D6091A"_-M'<`6IAI7PKHXDS[5P#];J;]`>E;^+>8
MJC3\_DSTO-3APN_AY1IR_T]E_(]X.7H*\`7`-P-^`K7C&."OS;1_DM#_*3S_
M*-Q_%84Y0O\GJ)\^-P66`>G_X_)S7Y[);(95'YO)W`6K/HHR=-6'9S+GH?>!
MF<QA0'\TD]D!Z,A,C&SPEIGV6JG#AF]&48;0;D$QANRDM[SB,IAY!^"EZL-=
M,QGR5"=98!8OF8DT`$J077X+1U`_74Z:B="7#*`(G:(&1>BF_2A&L05;Z>;-
M*$PQ-Q/Y),RB>R9V7OHO[:?)BZ/?8.O,5Z1??`O>;SW<_APOGWE*^D^GR.>:
MD5[-S.+82>F'D=/2GT=G\?H9:2XSR\'`2YE9!C\K'8>//`VT##XI'<O<+#T=
MH:./1V`4_NJI]CKIL<A&Z9$8W,](G\Q\BVP#W09OO!Z&!S/72KWM3TG=L5D,
MPTH[+*;P4EMDMU2$[M99O/S$4U)#=)9LI1[F>.JD5`LKQB-T*^M:GF<*2(_W
M*1G]7OUF_7K]:OTB?:.^3B_K`_H:O9.S<P)GX4P<SW&<CM-P#(<XY^RE-Y4T
M@E/HU`D$Z32DUM"VP)`:*B+U&<PQ<':F'6P/T[-F,9ZV]Z">M8NG6](]L_I+
MUTVWIGNFN?[K!XYC_/E!N)MF[I_%:.T`,"CINM<_;5\R<`IAG+OW<WZ"]]_[
MN<%!W#,]MP7U;):GWU\#[\&OWCBMC2P6D?OVDEBR7VLK=G=^3#52KM-7BIB^
MNHB!Z8=ZU@Q,?R,P.)TGC4N!P9[II6OD&P9.,;N8L:[.4\PX08,#I_#=S*ZN
MZT@_OKMS\#(9"C/C0(;:"2)D)U"8D*$P/D')>BD9L&FXJ_-X.*P2O8R7$R)@
MGY<IT<WJ7%%8`N;J)PC(F""*TKFB3)"0`3^HDUFOGLR$L)5.9C4A.ED-(3H>
MBP%))D9(CK?$@.!XK(4./W5E.!)3MS.(8G2=&!ZDZV!\A2:IT@`7E&D8#FC2
M_YYE=/'OH[BJX!.;_GKKEJ[12-=(I&L48&3Z,[=O$Z<G-LOR\:U_30;D:38^
MLGG+-H(WC4[_=62T<WIKI%,^OFG+QPQO(<.;(IW'T9:NM0/'MRBCG3.;E$U=
MD4V=@R>>.+BDYR-K';Z\UI*#'S/903+9$K+6$ST?,]Q#AI\@:_60M7K(6D\H
M3]"U>JY;C'OZ!XYS:/'@DAM4?((Q\G`>1ORAP<5N8?Q:>C@6A<1[_,]K$*@M
M8WIPVA19/&T&($-U'74=9`A.)QFR0+>U/"3>LRCD?QX_61X2H-L668S22.S:
MWGGYMV?/GKT$]NU+0[UWGTC[]L*A#:WIF>Y>O7%@NGVZO6M:&>D<Q.3OV%<N
M2P84X:7V5]N9L?:#[4?:I]J/M6OW[1N$;OM+X5?#S'!X+'PP?"0\%3X6UI&!
M&P9.*NU3X5^%V7W`37@OE*Y.NN8^P/`CMWOW[2$%P0)[`-3ETOO22P8ZPF@+
M6+L8+/,ZY`"(`#0"K`'0HN]`_9<`OP#X)P`-^C34#P#\*<`)TL/6L75=XO9.
MLN)@F@@=D<V?J"_D6V<!;[I)Q6LVJKAKE8K;._(BX)E2(]]A!<,;H^>A_H\`
M/P7X>X#?`6C9/)NGD^]3N79P#]J3QK!]!#=[2;4GO1>GH8')Y]Z[)YU&!`B#
MPS\`I&G\4;Y'>,\^!)\"_A!`0$1[]Y#']A%<*60`1/%_!9F%\?`*96YD<W1R
M96%M"F5N9&]B:@HQ,"`P(&]B:@H\/`HO1FER<W1#:&%R(#,R"B]3=6)T>7!E
M+U1R=654>7!E"B]4>7!E+T9O;G0*+U=I9'1H<ULR-3`@,"`P(#`@,"`P(#`@
M,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`P(#`@,"`V-C<@,"`V,3$@,"`P(#`@,"`P(#`@,"`P(#`@-S(R(#`@
M,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@-#0T(#`@-#0T
M(#(W."`P(#4P,"`R-S@@,"`P(#`@,"`P(#`@,"`P(#,X.2`P(#(W."`U,#`@
M-#0T(#`@-#0T70HO3&%S=$-H87(@,3(P"B]&;VYT1&5S8W)I<'1O<B`Q,2`P
M(%(*+T5N8V]D:6YG+TUA8U)O;6%N16YC;V1I;F<*+T)A<V5&;VYT+TQ(1%I'
M1RM4:6UE<TYE=U)O;6%N4%,M271A;&EC350*+TYA;64O1C(*/CX*96YD;V)J
M"C$Q(#`@;V)J"CP\"B]82&5I9VAT(#0T,0HO4W1E;4@@,`HO1F]N=$9I;&4R
M(#$R(#`@4@HO5'EP92]&;VYT1&5S8W)I<'1O<@HO1FQA9W,@.3@*+T1E<V-E
M;G0@+3(Q-@HO1F]N=$YA;64O3$A$6D='*U1I;65S3F5W4F]M86Y04RU)=&%L
M:6--5`HO07-C96YT(#@Y,0HO0V%P2&5I9VAT(#@Y,0HO1F]N=$)";WA;+30Y
M."`M,S`W(#$S,S,@,3`R,UT*+TET86QI8T%N9VQE("TQ-@HO4W1E;58@,`H^
M/@IE;F1O8FH*,3(@,"!O8FH*/#P*+T9I;'1E<B]&;&%T941E8V]D90HO3&5N
M9W1H(#DU-C8*+TQE;F=T:#$@,C@V-C0*/CX*<W1R96%M"EA'[7D)=%S%E>BM
M>J\W2=W]U'NKI7ZO]Y9:>W=KE_II\R;+FV20C&5+MN5]Q0NVP=@&C&V9``,Q
MA-5D(1@;<$ORTC8$G,0A,0E#$B83(#E`)L*!$+%D#"'!5O_[7LLV)OS,S)E_
MSIPSOV^IZE;5O;7=K>JU@`"`%G8``S.F=Y24]XY<NPM[?HMYVL)5?6O_\A@-
M`)!"S(:%FS8("LW!:P&H"*"Z;_':):O(G&?O`="\!J!X><G*+8M_^X/8&@#]
M00#S<TO[^Q:]_OU)SP+X%N%\%4NQ0U?&/(_MA['M7;IJP^8IFYG;L7T:^;>N
M7+.P3WR\M@6@M@[`^,^K^C:OU0<R^P&F9R&_L+IO5;_PP4./8UO:S]FU:]9O
M&)CON1-@QF<`)MW:Z_O7]JR\V0+0KP;(&`5@@9P'!:A9K$FM2Q@64\3D,L"7
M((8`(@BP60W(^3.5BYR2"012O+@?HOSRJ+\'YC]B`/!#\'*]_"OH$V#29&B;
M>JDY&Z[MZH;KOH+Q?P84*'W%5.`QYS+KP`:0_!WF=Z4\-B5Y0;$"/&-+D__&
M-"#S_O&<`A\<A#M))FR#6Z`5S_X=>`E6P%J8"4>@#CXBOX:)J"H?W`#YJ(N+
M8"%],(%48NM.L"9?0LIUR??H.530`[`3_@P;X5]A(;P(2GB0A,$+5?`SJ$\N
M`:/B-:B`VV%_\C>@8B/P.+R6_&UR#";!M^`U4D<ZF!V*!K@6ML)-<`>QD@)2
M16Y"O=3!9O@>G*:<YACJNQVF02=TP1(XRA)<4P$SX`CY%=.,*W7!/A(EIY-/
MH<7X<&01-)(*&DJ>`B<40`1J(0:[X.OP#?@U*2;U3!E[$JQXICXX273$0MSD
MA>3#P&-JA[FXTSO@/C@$/X6?$IYTTA*F5_'DV+N@@S6XPVVP#WX%'Y,,<BW9
M3!/,TV.QY/+D</(,CJ[$=5I@"NY[&]R/IWL"CL-I^#[*Y#621V:0^\D'[`9%
M^<6=8[\8>SMI27X,>MSK;%@*JV$[[$7=/`H_@#=@!#XC+%&3;/(#6DK?8'3L
MHPIK$I*[46L"E$`C2FLS[(8]F$[BB!\1@01)F&P@_TIU5$]7TIOI8?HG9B\S
MR/R>_4.R.7DP^4.4^7N@`@\F/\Q"K6Y#K=V%NGL*GH%CD("?P!_A(SB/DEQ.
M]I%!<HS\A9KHT_17[`7%:XJ/DH\D+T`F2ML'A5"**8P2G`B3<2^KX4'4U%EX
M&>/6W^!OQ$&JR<UD-QD@=Y+]Y#[R%OF4WDY?H6\R]S%/,G'F)RQAR]GEBGV*
MMY4S57UC]XT]F&S#TQEQ[@C:30/*L!]M<3W:Q,,HQR$X`2_@WOX"GZ-<C'A:
M+ZDEL\AF<A/92>XBCY'7Z22ZG*ZA:QG"Y#$>)L#L87GV,/L+]@W%5L6^,?]8
M=[(8)+O)0&NHQ7UW89H/BW&5K9CVH1R.P'.HK1^CU;Z'UOP)?(ZK4=1S)C$3
M%PF05DRS4>M=9![I(TO)-O)M<IB\03Z@'+51-[V+?IU^F_Z2_H%9Q]S+/,0,
M,Z\R8VQ2D:DHQ]2FZ,;S'E;\63E;N5?5I%J@>D+]LXL%%W]R\<VQK#'S6&"L
M8^RVL6>37<E-R1N2WTP^D7PZ>21Y6O94!FTW#^U+P!2`8O2<-I@*\W#_*V`=
MVN0`W`W_A.D)/,,P'(4S:'&_@%_"F_`6IG/P+FKV??E,G\`%/).->$@9VDLE
MF4L6D,5D+=DJIUO(-\@#Y"$2)R^0T^0E\BKY-7F-O(WI4_(7\ADU4",MH96T
MA4ZDT^DLNI#VT[5T._T&?8A^EYZ@I^B/4,O_2G]-WZ%C3"YJHI69Q/0P\U`B
M6YB=S#>9$\R_,+]B7F-^QWR&LF%11R[6P_K8&G8)>RO[MB*(<EJD6*XX@.D'
MRDSE<N41Y;#RI\IW54I54#5)-4/U7=60*HF><@3N02_]`J#%'23Y]#K<)4-^
M2(^2>\G+=(@=I3K23;8R0(O80K3Q=CA']S(^TL!L)@[TXZ_!9,J@#'7T$3H1
MK5N"6>C%8;3#3L6KK)D\@??M[60IQIM7T'[:D&</G`)?\C7(AG]*KH!CQ(H>
MU9]\`'UA!VDCI]&'EM!U](_L!89#"_T=\SK:S3GT_0BY3_E3F$M#:&WU<``L
M4(WZ?!.V$($6PQQX@-F#FG:!'0K8E0J,X>3/S!`<HO?1O?1H\BS>A'_"N#>'
MG4B`?1OC?@'PY'UX!O?V$GV5[B7'6"7Y)IF.>\AEU&@?/P8O?03ZF8V$I3OH
MO[.OP>NTFLYA"LF?V3(&7QRHIUNAF[Q/U/`4N8]^1ERPG^S`T[]#WJ?OP`;X
M=Y*D%YF[Z%+R$_)C8J$ATL24PAC]'5F`N_'"!PHK4=-*]",EVM4Y>HA93!Z"
M5Q4_8'[+MC/'@27/DTIZ@1%H"VEGJI*CX%-^QFC'?I5LAA::3-[#9E[\$*6S
M#EY/GF&*V#YVRN?'/G^%6LD]S"I%5_+/8]L4M](&6*QX3U4/6V@S1HA7\"XZ
M`@7D0YJ#<N>QIP8E967O_OQS.A/RZ$?D$]A,[D+O\.)).C%R'($EY"#R*O!N
MBN$M\#=Z&*-F.[,1X\QQ.(/6?A/&=B-=B/?,4C(+*-X2K'P?/(C6\#&[#+;@
M"VT&?`]OT\-8<RH>'Q/AGS'N78.^^!NR#[UN$JUFNZ`#[]);P`T@-G:*L8;Z
MNMJ:ZJK*:"1<7E9:4EQ4&"K(#P;\/J_'[1)X9UZN(\=NLUK,)J,AF]/KM%F9
M&1JU2JE@&4J@L-4SH5>(^WOCK-\S:5*1U/;T84??%SIZXP)V3;B:)R[TRFS"
MU9PB<B[^$J>8XA0O<Q).J(.ZHD*AU2/$7V[Q"`DR9V87UK_6XND6XJ-RO5VN
MWRW7M5AWN7"`T&I;VB+$2:_0&I^P:>E`:V\+3C>8F='L:>[/*"J$P8Q,K&9B
M+6[UK!TDU@8B5ZBUM6:0@EJ+FXKG>%I:XW9/B[2#..-K[5L4GS&SJ[7%X7)U
M%Q7&2?-"SX(X>)KB^I#,`LWR,G%E<UPE+R,LDTX#^X3!PM,#=R0X6-`;REKD
M6=0WMRO.]'5+:V2'<-V6N'7KB.U*$R<W-'?M_B+5P0RTVI8)4G-@8+<0?VQF
MUQ>I+JGL[L8Y<"SU3>@=F(!+WR$)T5:"&Y&V+QTE=:A^3ZO4T[M<B&L\39ZE
M`\M[41\Y`W&8M<4UE),CGDR^#3FMPD!GE\<5CSD\W7TMN8,F&)BU9=@N"O:K
M*46%@UQV2IJ#.OUX)4O[Q4K_99I<D]FE6MNLR^(DTHX\D]$*XL)"`7?2Y<&#
M5$E%?Q4,+*Q"-H1N@J/BBU`-R^*:YMX!KD;JE\;'%3[.(PQ\`JAVS^B?KN[I
M&^]1^KA/0*I*QG'9OI!^J1X/A>(%!9)=J)I1D;C'!KD=+2K<E*`?>-9R`B(4
M'\SHPF'=-24H<Y=+TNJ^A`@+L!'?,;,KU19@@6,(Q))0=YSV2I33ERCFV1)E
MQR7*Y>&]'C3?H_*7A3FN]E_^TW,68^O2FCBQ_`-R?XK>UN%IFSFG2V@=Z!V7
M;5OG5:T4O>HR;;P6-S9W,0XZ7J,.1J:B)<Z]S"PUNK+BK`__E+(E+TJHU&B*
M<@\1)L2YWDFILCO#Y?I/#DHD/Y)&R>C*L/%MQFM"5[=KKVI?M;VL`08WS/II
M6^><@8&,JV@3,.P,#$SP"!,&>@?Z$LD="SP"YQDXB6_`^,#:UMY+&DTD3^US
MQ"?<T8V'6$IJT%HI-`UZR)Z9@R+9TS&GZR2'+]\]G5U#E-#FWJ;N02_2NDX*
M&&CE7GJY5VH)4@O:"%KZ$%7+),=)$6"'3&7E#KF],$%`[E-?ZB.P,$%3?9S<
MAU`D/R]@(/D[Q3?Q!@C`7:+7RS5G-G-SE4LR-V1LRKS!>3MW'R<]]X]F:;]K
M>-%`E7I"$Z1=U*B]]ZC#`8$Q)ZCQ1/8BFP;,Q)Q@G$-T#TF0IJ'`'D@D3Q\U
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MD/Y)>(`[Q1#P,:U'#7HO\4I\F29KQ"MF5^^0VF3]\2J-U^JMRCA%UI,:L(5"
M7%UH7#WKT.%.@C=Y>C@W.X9C=PS[K2D<M,GX>!&V15MU2()NTCYR<>3\N?/G
MIG&?]H3:SU\(A49*>D(CTHS<:8B-Q@S5)76CW.AN77%(L8T[8P-NE'"G>XI'
M_P3<)^0J)%-2596"JZO;C?R$.UM62G"IGIX>Z$$;D<V"\51$(WZ_Q\.@I:!=
MI#I=E15R,DI$CZ?2);,%_`&_A][_T/8]6PM]^X(&3_V"G;<:[=DMFW_X?H]O
MQ^?O:J<Y@@:'[X/<:+LYB_GG3I\JQ]U8^K2"N?ANQ]HQ4T-A*&(?BS6Z<TRZ
M@<-CNWTTRY";?RM3OC#B#_G&3A;S46^QS8#/:]B*OO4\^A:';Z=GC@ENIR%F
M323?%"=A)6*OR:UQM]@GY;:Y.^FUN@[3;/.<O'G.?O/RW.7\)N/6W)OX7:8[
M\^Y7?MWX<.Z#>4?-+^1]S^E0Z=1&FAT&)B>LUE@EU\K.0J_*$N=&L\2)BR)9
M_?BVP5X;*[H:8ZQH]F`Q-\I*-%:T1]D$L1Y?BVKOGVL+<3V?RFI[CY/P>Y)Z
M1E&ZZU#OI-R"#SB*[N:7W*W":W4KK_AAA0$ERGR\^^>;+HXM?>.15_M/C!%A
MQZ(7GFN;>\_]UQV9?\.W[E&LV/C.C6^,N2[L&UGQ/%G_U]O%A;\[_O:/[_S-
MG%5[R9.)/;_`V%.7?)=9R>R%(-&*$T"TZF)!J2B&0A(*%`<;H('4*!H"#<$[
MZ#[7WL!A^AWO,7[8R_&00W-8NR(GP`>5N_QD:V`@\%T78U&0`K3NH>RHC"PR
M$G6>Z('@D2`-`@2U]NP$88_F>3-4/E3$L(.+(?ZMZ'96^P),)IPUK;4'M#LZ
MHB7:F':Z=KZ6U6MY+=7F%+@3S$[1J4123#E=.5^Y1LGN4#ZFC"M/*W^N5"CM
M^:%K4A%M'4:T:=R8A$='1U"DH5!L=)1D&ZJKN;,]*=M=UP-M<5='6[P8;Z%G
M@4^^"\[DNU55W;!.%KY/J42YIZ(<:D&5:C50R7@][BMJ8!Q+_V73G0<.$]>^
M52O]N?E\OKXDPY@777"Z9=:&1>WWSWMCV\;'=C]`@B>O:VHH=`>=1J'(E&G6
MF0:V/_C@XAO:^]%&1=3!.M1!#GYQC(D5>B[39^-L/A;4G)H:.M0S-32H*?!5
M:6J=DU23U9,UDS*N4U_+S?;=RWZ+?=PXQ![W<0%)SO7^J,:-04+M-F3&U!JU
M1N$`M<8LP(!#5&<T:!UYCA('XW!D>KP&E2*0F2G4Z,V\F9IS`OBQ*HG7JD/Q
MZG8$9\1T(DYT0$=T=G_HAY=NBE#[7T>DL-(^*ALJ!I*>4$JPAFK(EL0['AF@
M1PY:&E0P;D4C*3H[(Z8>QRH):[(:I/80XE3@@A[28[PD5^N7Q*]2!M#FY2CB
M5IY7W3QGTJY;S:._ON?K"6*Y=_GBIFN?7'OFZSTWWA@M6_P.V5+NZMY6VY_W
M?F+-?E+U]#6U'5,7UN?G9.=7/M!:$'D=[]RQ`V,3F+.*.Z&9+#X)#&YG3E&,
MD61HG!V**45KH[6I&EA#JQC,CWBD_AR[)P(B%JUB>;15M&"V8=9QD58D#VJC
M@TK:W-DE9KE8MK6%>$2<QY,@*T3.ZP5E>'^]MPBX_0ZO1B_?LM)%RUT,U4G"
M*WG9(89<[D"`9VAS$^OQLCQM#C2Q+,\'3)AQ6&K\%V8U2K-*L_$MP0#/5=14
MEY4FZ-B0M4R;H(S(E1I%(S4^W<);^9:,\M^D+A34X<71BZ.C5ZX">0^X&6Y$
MN@UT4G1'-4H*W7WFC.[,;@5W1E?7G5*J#+):6907;H1*@=2!%=9=YXQ1L<X4
M<[N+YL1<4M$J&JO'QW03*9JI/`R5].AQ!U"Q%>-ZE>^*\@KYCO!4IBH5*6+*
M`BI2'B>-5-&%AGM63YZR;,O<N74%?-CG\)DYE<88FC_%I:M_YAE=1U-E86W%
ME&]/FCJWV,L'<C1:>ZR\.>J8Q*QK&FL;>^O1MV8W>NU!H<1ML1AU*HU"5;&B
MO^!]^GB3M;%[,S[)VHL\I5X[5Z+6J3*"T76U?\0(F8_>^11:2@69+JXR=*JN
MR?]V/K-,N4RSPKDRL$6SQ7FC_\:`N@-6^&E'E)C<]J@1,R&T(%18"$9316OQ
MG&"TM**=>(I(,8`J*XMW"":'0X!"J"CDBXI-147%GC)655288<MT5`8%1W$1
M9QHP)DCS<);*AQ_*WJ$LG^,4W0^%E!FJ>%5Z:`S;<R(2'K)6RR@W*O=ZO'+O
M<$%$QJ*A)OIA$2FR5SJL159'94;Y[5>]+21H'\''W_E1[E/)+L8M(U87&]VM
M*`ZIT2+0,FPAQ&"+$<G-#=6?C(8ND$^XL[LYW;8S9]1ULGW@:Z`M7HX1M0(C
MZJ#@KD*UH[6(&F++JB[&G('F<MQH:C"Y4Y;138AAW`R8E-NC[JTZ*JM]_,60
MTKM2I?*02KFIBM+NL3\<_UE/J9B[U9J=J<VNKN+=6ZYU^TH\ZRUV4YZOI=NV
MI\`AWD<F>T*\P6=6W'DA2@Q'FRJ;YHWU3%7K#-K":<;H]K(27^%F<G=;R&2S
M%%S/_V9"Q\OLYIMR@DHF(+T;NI+OTF*%!3(AGWC%@'5U3=2RJ29J"(F&:$BT
M.R+=6<3N(19K?JMK3C!8FM^>!6N5">9A,2=+%<S29^7K>:?+Y'2Z')G.@J#+
MR5D'+*C0HWK-6B8K028.,;WZ!/&<R%]I<(J.J%-26DUMQ#FN/`F+&M2F4^2%
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M`JVN/P;S2Z&=4)-`>4I<)5JB39`#HMN$]SY1!0DR\;S@,@F"2^`S@BZ!*]6(
MFAD:1G.*BL"C%^:?%22E%%NK!3%2'Q'$PJ@@>C&[,:/*!#$W+P("`>&`\(+P
M<^%#(2DHT97W'`L)UO*IDN:DETH*4"<]DCIB=9><3E(&!N>1'NF"R):];EPS
MNZ4H+7V?D1Y4C]''&"HKKKQ1Y*?U):^1_,9X*8"N(-UW'[EK9MCE=]N*K"Z6
MJM29V?J<:$=?@;-`*3QP4M";7.8J9F;56`X)W=`2\#75%3EYHU*MUHD+'F[J
MN-YZ,UVULMB0Q6DDZ7>BARQD=X*3*$^"`F^"=?IJ/5K$=Q0?TL]US&S'`'Q*
M&&]>#5RG8_1"GD"WHQ"H$W1ZPBI4*LC+=3I(3FZ>TZ:PLT0-EAR[G669>^$Q
M2I3&3%"I>'1HB\5NX8-V"T<GZQF\(),,858*<$2E']"=(@14>-ME&2QB177D
MM.7G%HI.5BMF\!J+U<)GW#!U/-I)GT*2<^@M8M`4LT@>8A'Q$T`VWHMH]2.2
M-L:_D2Y]&&'`B]6-7*R3HB*JP2IK`:]'60.*NCK\$)+=I&==CZ0*_!!2>;[2
M\CUXI552T[1'LA]^*I?+M.?;.EQS9U55%U8)3]R?L?J>.>S.L8]B%X?FYV8;
M/*8E]MLK_96ABC7X"'#><"^,O]+/H*77D?O%V]0U]AIJB)9-+.NL6V[98MYJ
M><K\(_B;63.[N+-VN89I,W?"'#-3`75FZ@KF5]/#&E+MCP6G!^<'/S%_:OFD
M6F6JK:LS:C+\@:KJ&HM5$3;7&?T!1WUQ.#Q^-854=:`$AN&-=2:CL<ZFRW08
MZ_%BJC-R&0.:7D9Z8SCJGC:*S5&C:+-'C*(YRANG&^<;[S(>,"J,"1H1L_""
M%HM)L4_8;Y`^DX=JHA(:1G89F\PI7!B1,;ZM@I%2A^AX#)^H]GJ-PVJTXJ(9
M-_Q0UB$J\4J@DX*20_H2ER?`%Z:$!RW5LCK;SX_V<*,RIW2S7;K4,-+5?4&S
M=;$K+QZ#_.1!!4L*W:WCZE+^):FU1[[#;&9;9K49HPNXLZIK,9=B=F*^_,`A
MS)67ZR6]H\ZOCGU*E?2(O>K*:Z"5E<R99P+:S.S\#N?TCLIPH%#+M1UZ9T&Q
M6'BMD)UA+IC"MW6*%;Z2X+R`W>Q:/KB^T<*LN_C4+H\AFU]IW5;K+_2XJZ9\
M-O;>OXAE;0^1Z!I'5K:SU[*A,E3BJ]@W]KW;/$9KT^]__/I4R9(*T9(&T)+\
M\+G8>(*0H,A%@V(69EVTFW8QQ]G776Q^;FWN9,I4N8E:DT&RM#J53:4B@G<`
M7C03%2]D\H820\S`&#!FGM`';-(7HTW2<$%40J+#'_W0EK11P2;:=MCNMKUB
M4]AR@OR``)/]$CW+%(WYI_OG^U_PL_[G&(_DQ"!(IE`<$5+SR,'5[LO'.(J3
MSQ!V"'<+CPFL()0*HL`("9H['"A_TR8YMFP2H^C@(]SHM/%V^T7IUZRZ6-WY
M4;OTPB:H7/E"DXC08_1A>,"4^G%"4LZ5%ZD4-CU4#IF%Q,4;'=EJW3;;;2:7
M-K,G["D0N9P['S6]Y+--M=?8BYFVABGMZQZ:=F'`-<Q'@TY'3DN!4-X:#I=,
M_4W"^@NZY9&P!DCR.93Z;2CU"40M+M2*:+`J4!5`/6DP@85XP4.F.*XA>^W?
M)D_:#Q4<K#\2XR:A8CCK0M=ZUUG[3UT*C2>K8):'8>TY.;2@(-0@-M2)09>;
MYN3P0=$4#(H-!1@\LZ--`Q->A.P$LU_DS349&:"*OE@=*"[V9[(%]@;7P`'W
M*V[J/JNE(ZVGR$00\669<TM0NOKR[",-8FU;I$',BS8T3!2THO8N[1$MJ\V9
M5&Z?F""FP3>EK\`1[EP/RA,E+#T:SXVB1XY*_@/2IX3\38.1=%0*EI?=BSNK
M4G-U:G0^[HSL6#TDU!,BDOREN'CE\AJ_N8R6+P;0@%_Z;+C\T6"5:165>,VE
M'A-+RNR&_"[/(K\M+Q36YWK-MA+.YFJX9I8Q1VO.K0QX8GV5_BJ7N>GA>?75
M09>M4!"\.;HL8\FW[`T*ZY1)5B>S-Q+Q/G!;Z;5<1K'+K[-KN-S(_K&#TWEK
M\13#IFF%L0#)'_MX6GF>Q><J%*R<_T+5O^L:*Z@7Y)_N%=E_>I/6&^?KZSY1
MV]7ROWF_S2>^)^&?_"#<=4%Q\8Z,0^I2;&ID_M1OOJ!RC;7"M1DU%Q1_FY%Q
M"&R@@B_"KY75)%>JT/$L`3.7^.%_&!37P("$V=]+O];^WT%Y*"G+0/%CV/J/
M^/ZKP'P-JEB``&*15H\])/5A.Y]60]=_.#9/>C.B/*NA$\?4X1R%<O_7DHE_
M/#(-_QO@/V,C:4A#&M*0AC2D(0UI2$,:TI"&-*0A#6E(PW\1=L$N\LS?)]KP
MGTL,8#K%OL*^HGA)^?"7D^HZU77J;$V%YF/-QQEOIE,ZI5,ZI5,ZI5,ZI5,Z
MI5,ZI5,ZI5,ZI5,Z_?^6`(``:,[!1*#R[W$4."B!V0#LZQFCX[_1J6&QQ(7`
M`)\:@<!BG1^O*['6@%1@-=C3`#WC=0HZ>&B\SF#_D^-U%NM_&*\KH8'XIDYJ
MF3-Q8JASV:K^]=/Z;YBU9E7?ZAD=19,W]*U<MK"]\[]'AJDP"5I@#AYR(H2@
M$Y;!*NB']3`-RQM@%JS!=A^LAAG0`44P&39@:R5R+81VY)Z%7$M@(_;TP?7_
MS;G^)T?+VH7DAX>^GW3!(O@*0#N0@="OHOY7@:!^"?L5_8J_[_LJ($K,*J+&
M4D,R_HZ:B3F+:(D.L?ZKQJ<A#6E(0QK2D(8TI"$-:4A#&M*0AC2D(0W_FT&Q
M?FW?PG[23%K)=+*0])/%9"E91JXG&\A&LHEL!ACLA,8LYCDHQ2QB?@QS'+,B
M>9IY=KBUM5Q,(`X5RW@HF%]^4B;D^,MW-!J99^$`YB.87\',`F#)8Z;,L_0(
M!(!'YI-#%H<\*C'4U#1>J:A*588+BLK?:LQ@$O`A9LHDF),03(T:#A:7?]2H
MQPZ"TYX`@IE1`T[_//,"A&2F%X:\!>4GF>/,SJ$:7M]H98:!8X9`P#P#\UK,
M;V-6XNZ&X2W,'V).8F;!P!P<^K>]_//,`;*"/(BS?@/N51,QB]_.;E?0[70[
M0^<_2^-`DJ>)=<B^N#R1/#W<G[,8][V#K)<ZOL?<1JS2AI*GZ9&ALK"80%0L
MHV&4DXS]@11V^5(X5Y#QD"?%;0\_]AS**8[Y;7KD&",RKGQ<Z,_#-?[Z\N>8
M6Z0$-6HXQHN^N6%G`L\Y=Q$R?##L*PZ;L"DI9MGSS$Z4T8!<ZJ2^DG).HLV\
MKCQ+PM-FEKLE/+&]7"=-,2&<@4C4^">6&WS-73+34'E8&C-4$#9(K)7UY89G
M<<)Z""?/BV9??=CFBUY7SOG\D7*EKR"<A>LGDF.BUU<4SJHI"9<_X#OD.^4[
MZV,5O@JDEE>5VVOR:ZIJ&)O/BA,>#?JJ?.QSS$XI@4\-(L?K>6GS_&:>9O*E
M83S5Q\.\?.P=4@(>F<Q\Y7S5$16=KSRBI.ZGD%_S5`DN_%LQXRG>7>[VA&9)
M1]H^E!^6D5L2RO8AIX"S_>&$,Q0N=Z(P)$O;?GSJ]/)R?V&X,2/Y`;,=JO%@
MGR$.(?XC#JD)"SAR.#:AW"GADIIR@S13<5ANHI7*\_O#K-2</"4B812DC%QA
M&R(Q*R_L]I>6E[O]X2I<_S,QPX^+:_P.5_G`\[@48;9+"?QXL&*^DE>6*&-*
MY@`]0E^@KU#V`'.$>8%YA6'7(-==#,,S)4R,F<[,9Q3ZQB@=1>7.Q_(`YK<P
M,U""90SS&KEU!&V(P'0L<4:@2#V"5*D6DZQ8ILS_$D7R#\(,,4-T%%,<$\XB
MYE02*"4BH82`AE!0@]6*H<20K18;,^F-U`,1T))ZN:R42X>8$]'>%='>%M$N
MC6B[(]K.B'921%L8T08CVD:.1D$`+75();D@ES^4RQER62CF"-J/!.WS@O;K
M@G:+H%TN:/L$[7Q!VR)H&[6D@52!%NKELE0N\Z227#RJ;]>#Y@5R$=I!RPRB
M:,W`4_.0/\(GJ&G('T.D'G(^RS?:J1*<:H)4!>;#F-EQS`#/2OT$RJ0H0#X'
M#[D&\3-#_@(^09Y.H</2G(UF<A#\TBCR.#B)#_%WX+#<_A:4R?B;X_B1(<]*
M'/:PA!HUY"'P2(O@`F%YD4U#_F(DKQPJNYYOS"8K<$VI>REX9;96-!$)Q\:'
M>8:<C_+/$1<XJ=2$H_XM_$4<[QOB_Q9.J,D0_U=O@AX>XM_U)PBVWD':@T/\
M2!FVQ$S^]V4C_+^5[>5_Z4]0<IS_N?]E_F5?@D7&$V4RXS-^>9*GG-B)_(^6
MS>/O]S_*WYN:>\`K,]V*PCPL&OE;\$@;/2/\6IQFD>=Z?EYJJAZ/O(/9Y^16
M!^X'T?2PW#G-+TULY">6+>$G^`_SS64O\PV>>7P-C_W'^6KO"%_ID=<J]LC#
M"YQX.-Q)ON<P'R@[S,^N?(Z\""HR@#DD%JNVJ]:IEJD6J]I4HJI*5:$J4KE5
M+I5);5!S:ITZ2YVA5JN5:E9-U:`V)9)OBR'I'Y8F)2<A)2N5K%SGJ%1*_^G"
M.X82-84I$#<R;;2MHRE>&6I+J)*SXE6AMKAFQG5=@X3<V4W:XJ<70ML"(?YI
MAR=!,F;.B2L\321N:(.VSB8;,L?IG@2!SJX$24HC=CGBAN8NO,2(N.MK#@EW
M[_I:=S=8-L5L,4-#=O6$EJ\H>L?+T!6PA:X&6U[\OK:.KOBAO.YXN51)YG6W
MQ2=V"'.[3M)M],;6EI/T)@EU=YTD$^BVUEE2/YG0TGV9#0WJ)F1#H[XIQ;8=
MG!(;6O=VF6U>BHW'T<CFDY#$=A!XF8TG!R4V-#.);_`PW]HRR/,R#[L6#LL\
MA]FU*1Z?S'/N"SP*#L[)/.<4G+R<56;Q>I&ES"NQ#+J]R##H=<ODF5?(GA1Y
M6XJ\32:OOD(.I\B'4N1#2`[]/X+^IO^(HW591Q-IF]$UJ(:F[N:Y*6SAUC;(
M=I!]K'Z'XQ3)95Z'S%!W/,/3%,_T-$$L9@MQ=:2D1YD55V*?"K/$7NNRW>PX
MQ0**7&+/PF[M.*FHL:A1(J$Y2R0==NO'2;:;:UVXR,%Q$H?=V;@(VG%Q!]KE
MBM9X02\B3TLWV%J7M>#?.%J/L''CQO7K-VR4``?X.]KB]3/G=`WZ_:UQ>V]+
M=ZC5MJQEPS\X/[3%"W!03!JD4K7&11RT?GU('A<*;4Q5<&ZI^F78D.J362&T
M_G(_D>9=+\T2(BC21/+-86>N?.L>"X5M_E#X9/(C9N>@(2PQ=Y/UTOYP/,Z6
MFF.]/.]Z#`/P?P"QKKIA"F5N9'-T<F5A;0IE;F1O8FH*,3,@,"!O8FH*/#P*
M+T9I<G-T0VAA<B`S,@HO4W5B='EP92]4<G5E5'EP90HO5'EP92]&;VYT"B]7
M:61T:'-;,C4P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#,S,R`R-3`@,"`U
M,#`@-3`P(#4P,"`U,#`@,"`U,#`@-3`P(#`@-3`P(#4P,"`P(#`@,"`P(#`@
M,"`P(#<R,B`V-C<@-S(R(#<R,B`V-C<@-C$Q(#`@-S<X(#,X.2`P(#`@-C8W
M(#`@-S(R(#<W."`V,3$@,"`W,C(@-34V(#8V-R`W,C(@,"`P(#<R,B`W,C)=
M"B],87-T0VAA<B`X.0HO1F]N=$1E<V-R:7!T;W(@,30@,"!2"B]%;F-O9&EN
M9R]-86-2;VUA;D5N8V]D:6YG"B]"87-E1F]N="]8559344DK5&EM97-.97=2
M;VUA;E!3+4)O;&1-5`HO3F%M92]&,`H^/@IE;F1O8FH*,30@,"!O8FH*/#P*
M+UA(96EG:'0@,`HO4W1E;4@@,`HO1F]N=$9I;&4R(#$U(#`@4@HO5'EP92]&
M;VYT1&5S8W)I<'1O<@HO1FQA9W,@,C8R,3<X"B]$97-C96YT("TR,38*+T9O
M;G1.86UE+UA55E-122M4:6UE<TYE=U)O;6%N4%,M0F]L9$U4"B]!<V-E;G0@
M.#DQ"B]#87!(96EG:'0@.#DQ"B]&;VYT0D)O>%LM-34X("TS,#<@,C`P,"`Q
M,#(V70HO271A;&EC06YG;&4@,`HO4W1E;58@,`H^/@IE;F1O8FH*,34@,"!O
M8FH*/#P*+T9I;'1E<B]&;&%T941E8V]D90HO3&5N9W1H(#$T.38T"B],96YG
M=&@Q(#0S,S0P"CX^"G-T<F5A;0I81^VY>7Q4U=TP_CWGSK[>F63V3.;.W)E)
M,I-D0C9(",G-AFR!L"@)$@E;9!,20!`4P16)6F*U*KBA==>680(X@`M5'[55
M"U:MMO(H5NK2&O5I$=MJ9M[ON1,06M_G>3_O[X_G_;WOG#/G?,_R/=MW.]]S
M!P@`&&$+<-`^;6:L?/Z3LWNPY1BFJ0LOF=_[UX<[9P.08DS6A>O6"KU_^8\+
M`*@$H`GW]%Y\R1)A_K<`NB4`RK]<O&)##W]]\#4`?BY`Q+YD\?Q%[U_T;XA;
MNQ;GJUZ"#3D*XP#6G\1Z<,DE:R][X:"Z#NM'`<1K5ZQ:./^)JKT6@(MF`;CC
ME\R_K-<^)6<_P`8%X@LKYU^R>/>S_9=C/8C[&>Q=M6;M=6VS=0`;WP7PQ'I7
M+^Y=OG(LKGV[!B"G$4`!]&E0@D8!;`(%G(;00Q&2,P'^*31@``D$Z-0`8KZF
M]I.#<@>!#*X!BZI_'O6O@3N[PEL@)]=F!Z<+/'DC;<%0N*"P"*)(WQB,*J^`
MJNK18P#&UOW`9/]'!N6/P*><(J<\[C;P`*0_Q'0"TZ>I2>GOE,M!3"U+'^=R
MD&+!3!H)(;@6@O`IW`[/01>\2CEH):70`0KB!!=04@.3"0\.4!(=%(((DZ$=
M;#`)_DB,L!M&P9_(>+B*A&`:W`T!F`IV:(1;8!<Y+_T97`5ODJ7P!(Y^E$A0
M`%/(A/0',!W:TT_A&DA@N`-V$A/XL$='Q/3[.,,:V`H'X;>0ACEPIW(7SM(.
M,V!E^BF8"V^0.>3"=!Y,A)5P)=P)]\,S<(+<0`XKE.ENJ((%L)JH20XIY*Y.
M/PICE.]J]Z5?3!\%'O'OQUD_IU'%^/07*%.?*DAZ"0I&#E1@7`D/P'XX1IRD
MBFL&$U3B6EUP!>SF"G&/$V`;GNT@N9SLYDSI!_$THV$A;(;CY#)RF/J5[RJ_
M2F\$*YZO$G?:#P_"+^`%^#/.-I[,XBY)-:2GHKQJ(`JMN-*U<#W\'"GW/,87
MB9GXR42<^1?D??(AMY+[&&=^!(;@%/R-%)*EY$K:0*]6E@]?E=X'83RAA'-,
MA-FP`IXD82*1"W'LW70]O9)NYO9SQQ2%BB_38](O@`H%68*KX7$\UZ_A37@'
M^36>M)'?TBNY0>7UZ<MQOS%8@J>X%AZ"`_`U41(M,9!<(I`*,AI/=CDY3#ZD
M7BK2#FX!MUMY4WI#^F;PHZQTP6(<N0RN@>O@*3@"?X`_PQ!QX\@8CFP@[>1F
MLIV\2(]PL[FYW.T*27&[X@G%\XKOE!;E\ZDW4L>1ZFR>,FC#V`4]L!%IG<3X
M`OR><,1#\G&F<602SC2/])`KR`#Y"?DI>9CL)R^3H^0S\B7Y.W72F^AM]!#]
M-WJ$'N6\7(1KX>[C7E/X%;]7?*N>/^Q-/9?Z,JU/1],5Z8'TW>GWTD,R%_)0
MXAN@&:5K.=K;:V$`?@+W(,WWPNOP-LK=!W(\`5\A#[XE*I0F%^XH0$120(KQ
M=+-)!UE/^LFMY$'R$OF0G"#?4:`&&L`8H=5T$IU+KZ:?T^\X'2=RC=QEW!W<
M;[A_*#8HRS$^H=RG_$IU0AW2O/;=7</OIR"U-'5[ZJYT%<JB"B4O!W6N$II0
MYB8AEQ=!'\;5L`[6(XTV(L7O1LG9#0DX!*_`:TC[(_`>WA)LORQ^AIPX"<.0
M(A3YJ20:C)F]ER%GFE%:NLEBY&TF7DZN)MO(G1CO(O>2^Y&^;Y#?D#?)!^0C
M\C6>"6@);:3GX8G:Z86T"^,\NI!>16^D>S'^FOZ6OD?_0/_!\9R%\W$%7"MW
M,7<#U\_%N;W<6]S;BK"B43%!L5SQLN(-//D$Y43E/.5"Y8W*^Y4_53ZO_)7R
MA#*MNE7U@"JI^E2M4U>KV]6SU-O4CZD/J8^ITYH"E*<VW'W166;N5G*A(D8'
M2)HF\=S/TK7<J_0V\L0YEK`?=[`(YM$D]PR]YXH![@_<D_1JO&U:Y.YQ:,5>
M@Z?A->6;"IOR4WB9NN$+M(>W<?/ILW0'=9)J;JSB.L5K:'4VX#Y_2C^@:KH;
M,?Z,W)@'YQ,7_$5Q`7R)]#^B[$>:CJ?ODR?H2W022O*[\"`]!#M@%RPFHW%W
MBV`?_`-N(0<X@>Q'N=L,1^%S./[];A6QX2;:H'+2=:I:Y-`!,CW],BU*_QFU
M_D-R';S'_0-E_P(RE<3@8?@(N?XVJ20^14KA@3?0\N7#72BUG\`@ZN"O%$'4
MH*_A`%<)<Q3'D>>QX5^F6I1KN6O(*=J(['3(EGL:L\9H@^]$6\7LJ`EVHR2@
M%9$U^L_P.@D@%=]4_1YVPG8XR-D@Q#U$M]`T]XI"@!_#<6X*KKH)[5,>J<29
M+H&E>`XA_7'J09QA&8R!,60!F0,MV#,!\M.7X,X?1ELDI>>F=R@[E5'X-9E"
M;/`<6B\G4O%VI38UA)A[40_?@PGD1AA,+8+#>*\X28B4HS0-*=<I!Y2/*_<J
MGU6^KAH%EZ'6WH5<_`.<Q%M#(`N1%G^";U#6FU![BE%_&G$7$_`.6T$[N6>@
MF;BA%VU@(=KM)J3!'.3D&ISE:K@)]>DAO$-^#5\1GLR%9^%=U!P'ZOE"7%^#
M\TR&\Y'K:^!AM([7D$%L603Y$$$Z_8.8R!BZ%M=C=O9VM+.'<4_'X&.T'&EY
M7\5D+&E![BV$;Y@NXPK5T$[VX)V\'VKPIFSA7H,_0A!OUR;4T0=Q7#?*A@F\
M4*/\B%`H3DU-CZ%+N6>('6]#$TK5++S9QY$^W(49SS$,-C(-JE+GX6Q/H"UK
M5SZ$MV\4;P8;M2EF*\_'??\>;[)?P^IT!]FI1@V0FLZ?)374CZL;6ULS9G15
M947YJ+)8:4EQ-%)46!`.!<6`7_#E>_,\;I?38;?EYE@MO-ED-.AU6HU:I51P
ME$!QJSB^6XB'N^.*L#AA0@FKB_.Q8?Y9#=UQ`9O&GXL3%[IE-.%<3`DQ>_X)
M4\I@2F<P"2_405U)L=`J"O'76T0A2>9,[\#RS2UBIQ`?DLMM<GE`+ANQ[/?C
M`*'5N:1%B)-NH34^?MV2_M;N%IQNCU[7+#8OUI44PQZ='HMZ+,4=8N\>XJ@G
M<H$Z6FOW4-`8<5-QM]C2&G>)+6P'<2[4.G]1O'UZ1VN+Q^_O+"F.D^:%XH(X
MB$UQ<U1&@69YF;BJ.:Z6EQ&6LM/`C<*>XL/]-R5Y6-`=-2P2%\V?VQ'GYG>R
M-2Q17+<E[MAXPOE]%2>W-G=L/;O7P_6W.I<*K-K?OU6([YK><7:OG^6=G3@'
MCJ6A\=W]XW'IFY"(DV<*N!J]KK,C3J[#)05V$G:JS/D6BZVLI7N9$->*3>*2
M_F7=R!IW?QQF;/`GW&[I0/HXN%N%_ED=HC_>X!$[Y[?D[<F%_AD;!EV2X#JW
MIZ1X#V_)$':/R3Q2,!C/+BP^TR>79'16FCSC#&4)VY$X$04B+BP4<"<=(IYI
M#,L6CX'^A6,0#4,GP5'Q1<B1I7%M<W<_7\O:V?BX,L2+0O_7@!(@#GU^;LO\
MD195B/\:6)')R1E1P_[3Y7@T&H]$F(BHFY&GN,=ZN5Y54KPN2>\3>WD!`9(/
MVI&V\SMK8TA^OY\Q^,:D!`NP$M\RO2-3%V"!)P%2+-H9I]VLY_#I'MOYK&?+
MZ9XSP[M%E.2]\JO'%M>$S_S,O#VG=4EMG-C_D^[%F?[),\7)T^=T"*W]W2.T
MG3SKG%JF?\R9OI%2/*>Y@_/0D1+U<'(O"N7<,\BLTF&(*T+X4\E"O2BIUJ!4
MRBU$&!_GNR=D\DZ=W_^_."B9_HJ-DL'WPT:V&:^-GEL?>T[]G.T9^CG<L"),
M)\^:T]^O.Z=O/%J@_O[QHC"^O[M_?C*]98$H\&+_`?1G"OI[6[M/<S29/GBC
M)S[^IDX\Q!)2B])*H6F/2&Z8OD<B-\R<TW&`Q[?Q#;,Z$I30YNZFSCU![.LX
M(*#1E5OIF596$U@-7U8HZ0FJD;L\!R2`+7*O0FZ0ZPN3!.0VS>DV`@N3--/&
MRVT8F*(WS^HXFX6R7G26`'LMEY-5=`.M1Q_3+1GH>_BJ5Q*7XF<W.Z-3^1/\
MQQ!K&QI51OQ5?KIA^``]CZPZPD;-27]"'L$[7@^!O3!1I>>2)$?2"]HR+=6Z
M#*NVL='?=;4-00,;78[7A4H,A*LJJPF,G[^@M77^?%(I@];6!8#^QZ3T"6Z?
M<@F[H\@DR:7UJ'RJD+;(H79Z;((MY"S2JC5DO<:;)+J$55F`8%!EM#J2G$X*
M@10,5X(4+<6LHAJSL>,J);P#=[$SE5C-`1_ZWPS3M-U(C%*.K=+H*O[Z/]@6
M3T57MPUU-7=(CH`4+*@,L$D";)(`FV15@/1%,70BHEQH&VKN.`".].%!1'8D
M$2*^#'$(@_MP5+=C9!2>G9V^>8.T@$0$O\]/5683;Z*JH!@2J4IOT!FT!HU!
MH;+9<^U4Y7*ZG1XGIZ+XS%$03A6)%D6I*M\26`!A-69Y.8X%I%")F=_D74!$
M0\$"<-JQ%"588BL2ED5&PE701_I(KMI$D?`%&*LJ1U=75Y3;'78ES^IB0*U2
M67B'W5Y1/KIZ-+>O)K#FQQ<LN'=<L3]:7W%T[;K7RYI3KRET8=>8J"ODSC6/
M*2UW153TX5?C*_JG+^IJZ=OQTW\_L..G]]]PZ!A9-/;&48)3W#/\9>KX@O/*
MA#&7,BG9"L`M1*XZX)JGP41^1JI`0Q[:'YBG7J6FI-$HMZC)WT$$.WD(S.0;
M=%NJP$ZI9#)K0*E1&[#1AWY7DM-*O,G4;EYEWFWF>#,QNYRF9RF`AKX$3NH@
M'X`SRI\Z,94_V=55U\8/=]5!0UV#M>;KH>_(UU'2%44QM.3B62ML_JJ*\NKJ
M*DMEF-&@($3OLH]O\PU7!V=/<EM'"143K>2ORB7?/K&IM3@4*AR_A3YW4<PO
M!$_(VH(GNAM/E`>?2L$;Z,_IDQQ78/@)1W5ZG9Z`TF/=9=]KI_8\BGO2Z35Y
M2=*]WQISQ!W4D22!!+%JF+CHC96:)!?<:U(2`ZK.2<D#2EY)E<>L;YKSR'-Y
M),^=;R;D.4*(RWL07Y4#(.MC5Q]_JJNO[>1PUPEH:!B*HI64<C22W=B@D1PF
MS%QFS(PULOPA$;`_(Z^((<LI(LG0P\LPD6=ID'%/6&IJ+-8:@JG+4F.MP2K_
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M;*F)N=Q#=>!L:'`/1:/\\`G^A+4FUC5DK<F0BU35T[.IA99/S4@&_@#306R2
M-:X:<4AL=8>T8<Y-"T(3/NR_^:GS+[ST\M3KJ=23TVJ:HGXO_\+YDY8=IH^*
M_II+ZV:NO\WXR*-/KIE\8U7-(U>^E7JGIK"AM-&DN>_2.=L^07JVHOT<5$Z!
M`&F72DTJHM6Y=(50R"ER=3:/+8\;HYJH>DK)Z97$[='E*;P\YEX%<2LX%+^Y
M$@^!7(``VDH"`5XVE]J]5E`019)\N=\J<,]Q%!$#@P04[B39*>G,.;X<FG/,
M8*1)^LH@>4,#AZ@*`N`E7TMN2=.NV:7A-.X@_\;V``DPH@9<8L;FGD2;>P))
M.H37RTD4XZ&NH88Z652E7$Y"@>0DE$Z.R3/')%N6SU2?+,H*Y#%B*$9$6#$B
MTC)$5`83N09Y2+1SJ(L-DO(#;-(`FS3`)@VP20,2H@4DJSZ#&^W<JBR-;N)?
M!(O5P;3`@=R$OBZRNJN/^#F_6L%>/"J%>)J':$4=&2X&_0$U/O8N7SS\IPK2
M>7#'CU*IG0]WUC=&"]KGCROV%<Q8D]J5.NFI5DY)I;8:[[OFA4U?7E5?/";:
M)+1$>,-EL^+'"`KV%.3?\[*E+$"-T.9RI,>^SDYUR?3?))LUMS+"!6TOV[@&
MC3+@=/J4VK#M&?HK("C6`%JR<U\XS(/2A]?B7MX8.&9(D@\'P5WD3-)?[C.[
M?6[J9F*NSV6,R'45GF8$2O40WFUMI]@]C<8R-L0/G4`3D#$$\M55Z@GI<H+A
M/(_70U76D"D<T@46D'R+>P$(9BR)^O`"XLGQ+0"_$3,X?0U%(]&KKH(NM+Q=
MQ&:BZNK1(\K`_`!4$&N0J&RYU@P1>78;<<_O>V^S6.QM;+KSU96_6K/IK?7O
MD5M3O]14E?I+2B<T1R<6*I?DE=YR9$>^-O??G[O^^,9M1'/7";+ML^&5_5)_
M*E496OX@R5W:@K?^!*1F4KD0J1E$_V:"5,@9%#D60VY.JV%)>$-8'2*C'1>4
MKU=<0Z]U[33>%7S<^'@PJ=F?:]BC8JZ2Y-!R-G-D5,!C"#G!4%G!@,)7ZLMX
M'Z4(]JB,\O5^1EP\Z+)#`U0:N)F&]M!"PQK#-:`,&8S&<F<P"`:S,S0J`#9/
MR&D`A<I:3H)!=J79C.6YB$*"7*#<.,IL#))RA>JL91(JHV?DOO`D.9"\MK)1
MQR2NG=O%<9R[,N/:'#.7122ML3+",$S;M43+V*QU53`V,Q=G*,IL%VK<R>&H
MO.O,IF6+7[/55!K=:MIT1O+E1FN-VL37;37Q+[Z(%JVK$Y4!`;%_[\>-#H\H
M`K-O>)M6,A8B1^V<"MT*6^Z(C:,'MZ_ZYJU?'MM\V_T7?O++Y]_H>R$4'!.9
MU'S1TA*?,5<HZXQ-7$132_==^N!'+VV_Y,&6R^^^^(8C3VWIOE53?L6DJUNK
MYD^8>$_JE3R'>/W$BS:/6=[U/.I*`W+W*=E7+(3#DD?'N;D(Q]VI?52;U+YB
M4+1HE`Y1J7'X"L@A63\T9.=@00$PLDH&LQ*,CC?`Q;NHB^F$-<<=$8_IWR",
M9L15=$8U3LJ:,7+19E3C7,TH=X>U5G_(&+:$/.X\M]?-J4)AP20N@'S>M8"$
MM5@*&'P+B-N*65!7<)9V1#`Q]2!=#KPN1JM&B,KH:;7E4@61"9KQT6P\4Y*&
MAS_9ZJF?7;;S]56_7K7^K2M?3RTC1;J(,^8J+,\K:(I.+,C+"]_V^Q\)KO=_
M<?T'E]^02CWTV]1E0_2&WO/WWS.[R!X=^W#JSZ@<2#]\C"CC2#\_!$F9=&N`
MUUL;>OAU_'IQ*W^]^+CQ*5Y]NW'02$E0I!`01;_.I/?J''ZGUZ%'X:(:K]9N
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M(1E#)I")GO-IIV<QO9Y>6_8H>;GXK>*/\S\-G,K_6^!O998)FG`H+Q@L,`E>
M;2!@%KRY`;$LE,\%H50H&Q6!4'XP#Z^3W+S24$B;&RRUH2A&2C4:K08$7J#"
M^ZY[K`IW17"4N<!70`M*S"97>462*`;]XSJ<T>C4DW5,7YC:-'?LAU*^E):V
M?=;EV5/:-M2)%@@=<GZ()0M3)Q?+98T:\3N11SB)FC?5,6HS!8N6^$6[4ZEV
MA`)A1T@5+@Z)=B%&`BR+JDMCQ.\,LDS$-K%$&8FA@O%UIR\@6<4R2L;<`.O&
MLL]*:+@X6E83Z"R^OOBW:I5LVC"S.V27%AW=,^^"*K_LYZJ4K`4;U!:+.M=>
M,5+CMO]B:N_E=Z2.#T^[J-GC:>FB_9\]W_NCX0]_M'7">=?^F(RN;M\ZH6,G
M/5(B77C+CD4;0N*8E5SORII`:.9#70MV6*6U<^:LJ2/#=Z?:RJM'G[=UYKP[
MZIA7/#W]H7*V<CGJI?<`V--;!K6ZRKQD!JI&H!&AU(D%@UOKJ<YI<U]OO]&]
MW;,M3[/<LMRZP;+!NLWRB.I1XT..EQVO>G0J.X2;[8UY6^S7.:[W7)OWE.)0
MOBX67N);KUIG7.>Y/N>@63W:9+$&O3"'>@DZV[D2%OV/6:PFY3(O9UIFTY)Y
M,0NQN'O#)&P-K3Q`RF7'&%_-6K/.IZ.Z-I?K)&/T8*8TA._EKE-=;2<R-V1-
MS><G49&&3@X!>U),GKEA3[D&V1NTYZF,!F2L1JO64I4G;+3K0J#*PTSO-(5`
MZU:&2(:9$<9*TM4'Z(W)#UV+R-YN*J:*5L:5T39F0H.R7\$<;-:DG%U0_-6=
MF]\:U3#WQ;NWO+UN]3</_2ZU^ZE72>?SV^^;ZQ)B:N7R5"3YXH_7W7%@?^KM
M';W;+EV__.=D?/)Y,O=P?3!6P6RE!_6O3]:_*-%+<]U;D/`BRWB615EV<<X2
MY\6AG47)0N7%EJ58N<-RI_W!'-5"DUKP0B"@$;RF@)A7:C;10)7'`QIK29[9
MZ_-2;[VF3$W:U42]J7C</OG:Z>IC*H3O5R0N#V$^3,-MD,OGEN5RN=5(4B3R
M_G!;62Z1:T.=(RJ%#Y$,82]BA)TD1GFW-<>20U6%!44%D0).]7V-JNPVA\UI
M<]D4JF`HRH=#),(RT8U904X>RZ+8%@W9`J&SU"GS34'6)E:M8&_HT2/*PK3%
MP2XN]/-4(H?/;(?\3<$B?V?PE(QM,&OMS34E=-Y?;]MW:.Z/G^L?=\T</L=3
M\4C'93,:>R:$0H)M*7?%DLJ"4-/T5/+(]O^X9Y[;H$A_^_ZLL,Z\>B=I(<J[
M-Q;[4$.*`!3_0'Z,(E.E(;O"I:5"15E%;\5`Q:..=W+?<7SL^,:AW:!;:[NB
M=!OWXUSE-MV=W)VZ6VV/<H_J5$)NJTVJ:*_8P"EUG$Y'*]@CX#;%W=H'%3_7
M/IRK-!!03S<87M5XU8+@=08"T>FC1GU8[(VJIA/RJM*K\@O>HH!(5&!0&\'&
MVZC-'LVUV3F'VF$?M)8Z1Q46D5*#P5E$G1J5VJR>IJ8-F&U7[U8?47^@5IG9
M=P]U><7NZ'-1&HLV1*=%YT5713='MT?OBVJBU_#V7ON`G;.[I0I2`6:CSTB-
M]7[!53XB'K)PC"A75Q][J_>MCM6A@Y+Q3_BAH;K37EQ7QI.+HN)]#OSP"#A=
MY7CER)46[>O"`'W$PAA:81%+J9CY3L*J7.9>DQDM^R/(:J9[6**EGJO6\N&P
MH:UG?DYE[?1G_U@>&O?MBI*Q0;=)K]1YPDTEBE5A[]+N,3L5J>%W'[AWN';M
M;16IJWO+A?C>U/20S11P]G!7S+6)*'2I5;=NR;<B?TN1OP\C?XN)7VI3*[2Z
M8BZ@GZ17JI0J'2H#%U:$=6%]V#"-&Z^;IN_1K=-=KS-M+!HHW:?8IWM)\9+N
M8\7'NE/*4SJ=2;[>O(+7%@B$IQ<7)VFAM*S`&S9KB(8Q6>O5`*K>=$I?57G5
M^8(W&!`U:G68&J89Z302?BY$0NYX*2D%8C2;?"9JJO>:P8<VH3X_W^LJR;45
M%P9I(2E$'S^8:_+6L(80%(:"U*8I*7V:4'2PQA$UVDITNE%'D3]U)^O8K5<W
M)%>(S%$>77/D:EV&KUC_F/]81AKAU===_P29KC-;F&&9S#.F@V=]W!I]MF:>
M9E=%P9S5TPRBF//8\@('*N/PV`RKF&(J+BLRK;FD[@%DU)O56RX9GOV+RU/S
MF3J>YA(KIR[?=JW'C#Q"GT25BSQJ)@V2M3F`OA]Z!UY-(.!D[VDGOE<DT^B\
M!G#RSEU.CFE2DO[NJ4"YX(T$`K6L.P?Q:B7$,=?Z:G?7<DV"MQ9Q]@?4;`;U
MF1G4O'J7FB."5\UF$"V"UQ$0BT[/4"3/4.0KVEW$B:B9B"-=)%8(WIJ`&/`7
M-@-C5P,Z4>I(49'3Z:"U-34:C5HC0A/?1)OJR\T5!'_S4-<V06MW*Y5:VUMW
MM<9;%:U"YJMCO05X@K]VGO";6L:M&['1JT>,=%??J=,5..UXLMQ:@UHYS"RG
M;"OE_*RBK'P\TS_R/V.:C3G^>+M9_/_2\L\C:-D_<Y/^&RN;]>0#>TM-,7VQ
MN$[$&BL/UV7*]*;4W']F;Z:<VD*V?%_[[MKOR^1!R-A?^@7RW@?]4HF?,4`G
M>&D@X!:\UD#`(WC1$],+7DM`M%HH)1JWV>/S4$^]7L>XYAPO-AS7D3*=I.O5
M'=8IYF%&=2[!SSH]'F_E<3_I]1_VTS*_Y)_GW^*/8T4ETQT)'95I'SU-[X8Z
M1E$D(EY5_W,",G+1+WZ(/$BVT`]00#XSGC2,-[\13QJ"[5+U`K*>7"[V%B@&
MQ('@PT'N^T-/"62.&Q0#G$<,`H3X4&]H2VA72!E*D@,2+_@+*=*":*@F]!NX
MAR3I;LG^/5E<X;("J6!7`<=<Z*E=(S;^Y,EAM!DH3<-U)[OJ:M"B.VKDP\J/
M$.X_.ZY#-MWH_A@KOIURUJG?'"N?VBFZNOM6#"R-D6.IX`^<?M>2&I-VRH.[
MD`)>]$;O0`KX25_":D4>_2UAK&%`6F^HX?/RS'R>UVLVUC+5]S#5#-!:KSK`
MU-0^9>1%B/;7S^<YB-GKK0>2BR+D]03`8C81XG7X41O50!UVC5E+V&O12.89
MB7%3NTA$WE*8!Q[2[B'@686DVA084;^^+J9Q3/M.94K,N)[6N\Q#@EU\\F<-
MQ:87`1N=F5<=$Y>M?-VF%[?R+Q)&3/9G#J3C4C2G"LR\>32L%GK]6X0M_EM@
MP#P@#/CWPEZ_42$H_!%%@3Z0$W&K^&3ZPD1.%8*'T095*=`ZY!*>'R"[\N)\
M/$\#N`KIZXIVXI-C'Z_)]30@ZG%):W4V@,:4TP#)]%<C-7-N@SF9_F00<1#^
M/F%R-&0>+A"-=A+"+EPU<M9$;1:1&0I9Z]G[I``->A5)T7O$LCYR^(*Q_L!W
MRY>W"BE?;X<WVE2OG/+=4_2\C=%:BD]+<5KWMW<HEG[WP*4S0B$R9P7W3+`Z
M0$-XB[4C=[_"MX81\LD34L42?DG.G;IWK.^XWG6_F_>.]Q.K5NU4YSNHT^!P
M._(*^(*<@MQ"MRZ?N;P.EME&'B3FLQXF#&K8`V41>[$P+,(RZQWD=KI#M4-S
MN^$.X\/T8</+RI>U+WG?(>\8C52AUJBT*IV#.*C#X##:O=H>5T_>9<KUAG6N
M==X[S/N=^[WO>+[2Z"\PF:J`LU>IM5:]R[>R0Q8'?&I*+O#P*")M$D<X=TQH
MP*>JV>JS4BOZR^Q6[6-^LV0^!\':-I3I&CK]/QWSGZ<S_[F.Y/,A;S@WK`TI
MPRZWTTU59J,UA'3RA(A-@R6'"DL6@RE$C'D4<Y*CLX?`K<`L&JW#>.8C#SY<
M"'I7[`6Z5Z.RUBB3Z9.2WEI#G=8:`R::3'^:L-08DNG/$2A9S5BCQ=H>8PV<
M?L9VGGG0HFB1(%AX-?4+!6$+#TK4>PN?<;>M53QZ2`[TEG]RQRNI6U,_?N5>
M<A<9<W#^M(WG[[BXM6/!HKN4\PRIE:G?I%(OIK[[VXO$2$K)K5.>O3MU+/70
MPVO+)>+Z`[;I5[*73R5Z8@^A]KLA"$<.@(#:;Z@1F/;/U==,"Y,[G*<<IX2_
M!Q0131X0`][1@0#>U*J`:&1W@>@IM4)I7IXJQXJ/`@WO)_[WN^U;[/>A>]L?
MPY>D)W/%EAC!P!MHNZ';0`V;0N%S_*:I)[O.W+7LO=,EF_V,LWOZ(I4_%>3[
MQ%RWT^%R4)68ZX\1GQNS@"T8(X(CGWT68!P9>;ZPBGPMV,YY[PORETP59QGY
M<T:D19[6N6<>^--(,/7@P/Q/_):-UUY[#>U)W<">\]\_[(_>?>W3`2>]<W@_
MO>7..VYB%&0WR.^0@B*4D,NDAO/=J]UWVCB-Z!0GN\_+.R\P/V]A0&T%):AX
M):]2E,4N]JSWK`_<(+[F>54\&M/LL+_E_KOS6]>W;F5,8TC2M_?*-)8+C,Q8
MD&H8J?,\&04H$0.YHAC8+-XH4A$B>7[/EL")P,D`QP?:`T<#W-$`"3@B>0$Q
M'"KU),D?)(>(KERPI#0'F23\QN\/!%0JM0:O8Z*4M`:(\!$:>=^1Y*AD-P1#
M(1CY,[;$8&AG=KITW`'BDO]W[:IC/BRSP?PP\V=/^T/R]Y[A.MGG':X;^=#3
MM[JKAGV8J^EB1KK+M(E_T2E?;LA(H:`XUVT+N<*%H>+<2(P4N#&+VDMBI,@9
MCH';\_WWG0PW,W]Q%J)8Z@TU48VA)L^98ZLG&2/*_H[[`5:/_(6I'OET1SC+
MR(<=D0K(Z^%)(SQ?=^K$P(K6*\AXR5-4G3H_-;FSYL;^:;?<3Y>EKCV7^RU/
M77[[@GI?JJK3[N-"=!G=,?SSBNN6WW4;\YF6I8\K_&AI:TB)5.,LFUVTWL^I
M3$1K5D=594ZS(UIBCO)%EEA`B`:+JR/5T8N+MA5MBSQ6F8P<K,RI.?-A9J)D
M@SGF:E\UK7YLE->;/T?P^@0?\251NL;GSP$W[Z;NQVQ%4;,F;-:;S7GZ/+-B
MG7E=T5WFA_3[]"^:5=$BLUXA*JM&<6*533N-S".KR&:RG2C)[,S'AB3A)9/5
M/5;2&RO'FC4^=%JP::]O5*FK-DEJ]HS8W!-#:%>CIU`A3W1E/O(X\"DJ_Z50
M`_SG[*_2D0\^K"P71_Y9$3@]9Z:AHG!TF7ZI>:-^@_GZHNNB/S$_J3^D_Y7^
M5V8C=/7)_S;TH9^3D_G*(W]NE:,M5R$&Y,_B*K5HJ3C]/VJXH)2>]<_J:.YY
M?9'WHVM[UMN\4NSQ+V;.2'WSFK3Z@C*?N]8:"A5_>TOO=15+KCWPP.PO]C75
MQ[9ZW/E&Y?)4W>-'+CFO1(R5^F==NF3)]8]_[0[F%A91>/>CC=/+YDQOO'#+
MO?,>.,$;&H5QC*N34+L-J-T"/'D``NG#@TYW98#YL6-Y:Z40D%#E#@<495B@
MY-_5ZN^0AT[!RP<"6L%K#HB^?W>[O\OW^M3N0A`H;]9`+V%,CD@!](9\6JJM
M=_%.(CC;G0-.SBGP/B+XVGV;?0,^A>\@B8"3_GS0SRY!_A3[;(2/D3KF.(ZX
MQL-UIU_\IY_\Z"CW=8U\.BOXH?>B[$**%J4A*$QM"<];[&BN+1FNS?C*"[;5
MSW:$E5-2MVQ>Y;=^^Z?O'4:%O7;Z[605HTA9^KCR0:1(*>&D^YUF5X`Z=06!
MB'BY>+/I1^)N\74Q+6J!_=O)X7N*\EPOZ:6;[9L=!TRO%+Y;^&FA22G:3'Q`
M\(?%4?XY`?7S_J]%^K!IOXE6:-3L:1'PR9]E(D*I%P+!S'/0Z7`0G-.P+*A%
MGU'8["/S?&D?]6TJ*Y/*VLMZRW:5*<LT9K5/3=7U147M$1+9%#O]E,.+Y?3M
MTI?Q)8<RABMZVB#A0U)KUH7#(5-(']+$H*#0*/)XM_BU!888F`.8,1+713-C
MF%'J6XW/\]4YS"E7C;Q`1HQ/03CCJV=<=?;)$GTYV2JIR^C3XK2QKM%7=J^\
MJRWL+9E!WLZKF6(Q-IQ\,]Y]S0JW=(%R2LA?NW9XR?YU4Q?^_%U:=.%4LR,4
M*BT59@X/?_E6(B:]\AB]\]*:`&&\,*%T'D!>-)!;I)>M$XT3^(GYDWQ;R=_'
MJ8I&%XV91"XF/:4;A8W^RV*W%S\F/$4/",_Y#Y8>+#O8\%6C)9?/S7>5<6:B
M+3#'?,2C\,5493$R*M\GF$;EFP53`P\QTL"K3&JORI7O]KH&"DA!K-!;4--0
MZZU1$H57"4[BY!U>9UA`7VK,J-'>,64^,RB4<AYV-?!\8?ZHW/S\421VDXG$
MZ@53KH`3CXH)^;R):)1G2F%7H\/A5LZK>99&\6A70QBACT8EL\LEU8PI"%.7
M4Z742(U)\O:@?_LE3E2BZ]@WE[JZ.I;89Y8V?%"=/#FU=7'+QYG_.3%M-;7A
M[7/ZSR"$9WK.^3/H!_X2RN3DG#8S!O9=I@OO'/9W0ZZ/=YD;3')6B(X_$=#I
M)QEOCMA'_CZ2_R_BV%=L]FQC3:B*A(1E#U\6%+1]CIS1LI%CHH/7LTK-S2?K
MNJ95#R^?5JHVC7GI2%=9S-8X_$UG1?-EQ)AZY'R#I[*4WA^H+56W/KI]I:]V
M'/GKV`E%[B6<9_CM_K&J4$@5=%M-^3-(:'A-D;=<CRU&L?3'9`+Y=I/)GZ?&
M5W&>G5^2AMU;JSVE;GPW>$+.34RJK/(_AU/0G[GP``33GP[F^AM$]J)YU%CC
M"Q4[BIV18#2DS'7FNGS!96%%?_@AY0/!_<JD<W\P&8['/@EJ:USC12EV<?XB
M<;VX+KBA0!-2!)7!<+@X7%(-U:1<H;$%H\[>&`=*X@6[X#5-"42]Q!O,]WK1
M!ABGB'P>R7-ZO'E\"2D)%WM+@B%SB(1*',Y<1RCL<(9#H4*5,E<5"JJ4>%0'
ME)1XO7G4:-*4H=>9)-6#DI(HD]0H:57!M3[G-"=%B0E+-H=*[1@Q$V"7[+WV
MN%UA/T@_A1@:=:/96GD\1DIC*YB$1:-=T5-=0[+'<[)KB*6,:\I,!Y'_V=JJ
M0:%BKHU<R#@YYXA25_1L(%MG67C0FM@8E__UVQ`Y6RIR<C+24Z6,-P?+5Z1^
M;V^LGC*L/D_^OI/ZQ;RIC;3?.S;6_O7)"]V!"]%V:/,CAU*V5')IQ9DO.CQM
M?7(<"84".<%;4@UDQ^VC/%:7,@359<AK9+7E\^=*7XS.,]=]K7%I@(4'/JH:
MS^`KSU=,^W;;\$T\:*JPJI7Q64"H]J=:838/WV[[QP<\G.D9"8KEJAJ2QTIT
M),FM?1"'_\5`'X=R'#>'E14`DS!MQ52.R3_2UHIIRDAY`J:&_VP^Y<O`*R^`
M*,+IF#Q8+E)\Q+Y$HW.,CS#.R[YZC>!>`&'US5"$>%[L:T>\RI$YPHHUL`S[
M)V&Y[*RY39BL_[KJ#P><8]I_A?-#@;L9)O]7.-F0#=F0#=F0#=F0#=F0#?\[
M@=R>/OA?X?R?$A0?__]GK]F0#=F0#?^=@4#ZH`83#UF[F0W9D`W9D`W9D`W9
MD`W9D`W9D`W9D`W9\']Y\$`S-)-2<@<=2S^B'W$O*)8IEBD[E7\_-ZJ.J%_2
M;-?.UIVG=^E=!H?A)A:-+'QG-IA_9OX9O\=RMS5D_3.+N7:;/ANS,1NS,1NS
M,1NS,1NS,1NS,1NS,1NS,1NS,1NS,1NS,1NS,1NS$0B`<3:T`"?_-T6!AQA<
M`*"Y,:=QY/\J#?0P+`P<>#'/E!58]HZ455BJ93,HM-A2"[-'RA1,<,M(F</V
M^T;*"BS_;J2L@EJ2TW'^!3.G3XS.6GK)XC53%Z^?L>J2^2O;9Y8TK5JQJ&W6
M_WXG=,#Y>)B9,!TF0A1FP5*X!!;#&IB*^7J8`:NP/A]60COBE$`3UE?`(FA#
MS!F(<3%<BO7YL/K_PSS_'2.1[G)(^^$%^(&`_)8#H3_4*_=P1(&YDJB(FFBP
MI"4ZS/7$\$]X1F(B9L(3"[%B+8?DRJTV3';B($Z$+N(F'I(GMWM)_K^NE0W9
MD`W9D`W9D`W9D`W9D`W9D`W9D`W9D`W9D`W9D`W9D`W9D`W_KP7EFM[Y"Q>K
MEFSH7;)XI:IW\>JEJQ8I-BY>O8I;M7(QMW;]*N7:):L7+U;T+%VWF%NS]#+E
MXJ47+UFK6+ETY6+22)I(,VDAK60\F4`FDBED*IE&VLD,,I/,(N>3#M()>V8)
M285AT&`J9S"1XRA/*O2#A8+/W,@KK+`%$P4SY@V8YF'BY)R`I+`F+JN0D@A6
M9\#*#%B6`;,JI*<1<1)4I`\KK(,.9SEK'M09RK<PJ-&RNB4QIT)JU"HL<(&,
M9X&9&9AHKY"[V]@L%C@OTSK8TIH9U91IKA]!KJWP-0:Q+F"2,/5BVHWI*TPJ
MW+T%8I@&,*4Q*>0:P]N,:3NF79B.,UQY-DV%N=&CX+&'E\_.@P]3#!,'W?*_
MO'$Y-RLT2!4-3,-TGT(-"H4N`2M\!W`2;K!5WBDW&"V58:*PJ%SN2+CSRI]1
M<'0'%(`/&TC"[I%[(-'4-%*H'I,I#$9*RC]HU"D`OL1$%:`@4)@9-5A86O[5
M<U@G7`K,A+!6[KM!/A=7XX8'S3GE4B//_1W:,5&(<WO@,"8*J[BO83,FBNB[
M$R6CV$+<[D&=J9Q'_"]!P+0%$P>[,"=R7<+$\+\<S+&SZ3])F"WRN`\29969
MPB#O+&]OS.6.X7Y^R?T&1/!Q?T"8C_!EA%Z$+W&O@%'>YX.#9KY\"Z[W4T3_
M*;<!BK#[(6XCE"-\E+L2/#+:[Q*FS#J_2Q1&RAMUW"/<%3+*&JX/*A&NX)8G
MRGW"(>Y!)H_<YX-:/=O?YPG>5OX,]QFW''(1ZP1B.7SF9[B5$,/$3I(<U!K+
M!QH-7!*/F42R^'"/!.Z3<XG[30(GPO4>X[:`'?N.<%>!#>'CW-4)F^_P(>X;
M&>T4FP77>P`EAH%!HZG\<*.6>X!)"/<7I/A?Y-5.#H;'E$-CF+L)RC!1).I'
M6/H(2SSW!9:^0#9]@:SY`EGS!>[B"Q1:X(:P9PAQ8MS[T,N]!P.8[L.R`J?<
MD$`*'I`+P<+R`]PF[@JD!'\(:4>P]<I!K8GM[(J$-4=&NX(I>,,SW#LP#1/%
MS;_+-'+5(>Y'\E$&!IT>-N"MA-:`I+L\PPL<N)'QX!EN"W>U3(FK9`K$G\4J
MRC]WC3PX/6BPE&]&[L_"ZBK,MV,ZBNE+3`I$FX5GF`7S,'&(WCYH,I>;#W%S
MY,$3$Z8*WS/<!#SZ!)E:$Q*V@+SG\T8*"G/"DU_^+"M`"0$H5Y@4JD3,-_T0
M-QGE9QHW-;'(AWN?GL!YV<"I@V-JR\L.<5-E6DQ-^,1,<R+')1?&)[09N6H>
MU%G83EIDQ&A"8Y*;HR,JR44&<QWE/I336OFT%9@#-QK9-QI9,QKUI$)F1OD@
M;T7I7\25RR<JAVY,NS#%,2F0Q^6(7HX\+H?C<HN9J\;C5D,:$X>\K8:O,*&I
MX49!`Z;MF)[#=!R34F[MQD2QO0Q7Z,9\`!/%&6-8YS&7,'5CVH)I%Z;#F+["
MI(8C7`FN4X+899AOP13']`$F!?*J&/=1C'U63H!A#8`/-M,=4BW9#)O)9KJ9
MVZS8K-S,;[9HI*I0<;FTC&6E+"O$;'2WME>[1<N5:25MNY;CM8*6)M.'$^K:
M"@22555;\?NV/[7]HXVSCAY0#:CID48#L<`'F+[$Q,$1PF.-QQHO;>6.U']0
M_V4]=Z3M@[8OV[@C[W_P_I?O<T=*/BCYLH23VCRUY:/GD55D,]E.%#X2(PUX
ME2GF<:NXS=QV3N'C8EP#RH*B6]^KWZ+GRO22OEW/\7I!3P?TN_1Q_6']4;TR
MKCJL.JHZKOI*I6Q7=:MZ55M4`ZI=*I5/'5,WJ"65XJO&9OH>$G47YG%,%+9@
M/B"7>+GG,.9'Y?J`7._&O%>N2YBWRR41\S)6PB3B7+]'O"V8#V!B>*PN8E[&
MZIA$M.Z_P[9>S`<P4?H[*2]0%I2"E`\*00I!\E60'`T>#])X\'"0'FZLI>_*
MNWP7=_FNO,MW<>2[\MKOXKQ8PB3B;M^1\=Y!O'=DO'<0CY5^J*T;\UZY)&'>
M+I=$S,M8B;Z3$$>;&QWT+IQQ'N;W8?H`$P<QS!LPK9)K/H9![\)<HCL'"XKQ
MPJ<[$V&TD0@"&9"?`7DR&'2YR^<UFNE.G'(G3KD3)V$U'Z8&5DL?ICL2+0QW
M1V)<!M16?-`X&F]1MI4=L!L3A6F8WR>78I@WR*7=,H[Y3#V.^7&YU(OYKC/C
MYLDE'^:GQW)T)\8=6#+3C=BZ4=)3L-O1)[-:--8D/9A8:O4EZ=Y$(8]@,`,2
M##3F4`YI;R1?R/G/Y?P^.;]-SF?+N5G2B\:_B\9_$XV/B,9&'9T$06S^2LX_
MD_-EDBEH_#1H?"EH_&G0^$#0>(A\!`'L\$ON@/&/`>._!XQ/!8R/!XRW!HQS
M`\;I`>.4`)NJ$`0P4B_+R45RGB<Y!.-W@O%#P?BJ8'Q%,-XO&#L%8ZV`Z.0O
M>)\:R=UR?H><5SU5:?15&KV5QH,4+1.Y,&$&[2%*R85@Y'2)2+TOR6EE0/V)
MMA""O$1;(P)/HFT&`G>B;36"G$3;K;Y&+363/>BL^*B)[-$P:$A$KL)N?09H
M$I&+$"@3D1I?DJ02$1'!MXD>+X)_)'KR$9Q*]%0B^)J!I\E?H8?B-.0_$CWW
MXO3D3U#(IB6?0)@^@3"9:&M`[*<RJY.]4$]"V)Q`KX^A/9F(X.;(HXE((8)'
M$I$@@H<SX*>)B`_!_8F>4@3W)GIN17!/HN<$@IV)PA5LOAU0*,]S)X1EN";1
MYL'NOD0;FZ$WT19#L"K15H5@>:+^=01+$_4GV-"+R1Z"DDUZ("+O='ZB)X+=
M\T8.T@6%<O=<J))G/B_1QD@RGDW2:"2M(P=I0;^>=3>1/?(L4B)2AFCUB4@8
MP;@,Y>H2/5$$8Q*%2&,R.E%X+U*N>F2!(L:?ITD0M\$F$A.1)Q#)E^@I0I"?
MZ&E%X&$C<5,Y(ZM:H5[>E"4185A\(B+XGB5ZZ)%GU$&8[-SO&\9YOZU/D@L2
MOG](20U)^+XI1+#?]WG;`M^?VY+H\?K^A"K\Q'[?!XCZ?CT6);WO6.2$[[V>
M@.]7$<20/+Y?1DI]+X0W^)*%AWR#;?F^/;BQ>,\"W^X>>8:?AW%8PO=H89(2
M'+VK9XKOSDC4=T<XR?;P8T3>RM;`B:Z+;/!=';[*=RF*PMJV;;XU$:^OM_`B
MW[)"MI##MS0RP[<$#W(QCEG<<[%O?N167W>5O..+(J_[9E;)9YC<(Y]H8KW<
M,:%GAF\\[@`[&E@'[F`LRF4Y#BVM.L1HA)Y*\^#KOO-'/TWQ%B9;,*V62M7/
MJ*]4+U#/4C?A?5.@#JG]ZGQUKL:JX34FC4&CTV@T*HU"0S6@`9J;3!^7HH#6
M*U?%,Z!2L%PAEWG*<LR83T*)AN)#*Y[#3::39S;%1T<G)]7I&?$QT<EQ3?N%
M'7L(^5$GF1P_O!`F+Q#BIV:*2:*;/B>N%)M(W#H9)L]J<B)RG-Z0)#"K(TG2
M;,1UGKBUN>,`$%)\W<T>!L=?=W-G)]C7-3@;K/66FO$M/Y!UC^2M+='O@S-Z
M=G!&O?';)\_LB#_N[8R7LT+:VSDY7C13F-MQ@*Z@RUI;#M#E#'1V'"!+Z(K6
M&:R=+&GI1+2Q,AK4T^6(!FT,(!J="_4,#=OGGH5&]F!SRY[Z^@S2-+*'(:'2
M3).1YF20FL]&XFXDS3)2,W>CC'1O9L$([@,7E!A`-.4*B,@+1I0K9#0G0]L3
M#N-,/6&&LJ<\C`A[PN5R]_3ONPLSW3_+=/^,=2<)^;Z_*IS9;2&$Y17"M!!Q
MHO^-87'3?X7Q`X$,CENWLJ-UL=C:+;8NQM0=OW'=$F=\RP)!V+-R'>L0XERX
M>\'")0S.7QQ?)RYNB:\46X0]XSI^H+N#=8\36_9`1^NLCCT=TN*6Q#AI7*LX
MOZ5S<.I58_K.66O;F;7&7/4#DUW%)AO#UIK:]P/=?:Q[*ENKCZW5Q]::*DV5
MUYH\HXE,;N_8HX&FSN:Y&3A(]3K4EFZ/O[/)SO?6RZHSUN^\TG-0`>11T$<[
MXP:Q*6[$Q+I*&DL:61>J-.LR8;-YI,MYY5B_YR!Y=*2+QV:+V`1KG:U+6_"W
M!L/:M9=B0!JO69.AM3/3L3;:*O<CPEHLK94#8F*9I35RZTC_6KCT^Q"-9G!A
M3;2Y8T];6ZMS:8L'G?A!YG='.]=`-)I9,!H%7!-/+3OZ=MG1UZOL%6^W_;'M
MZS;NL.SA'\5T7/;P#Z-W?Q33<?3P\[G#]4?KC]=SA]N.MAU'W/>/OG_\?>YP
MR=&2XR7<Z)$=L*4Z">[P^WAI=,VEK#E*Y-/*YV8;P4UC@9WZ-!G6R!UK9<)@
MR+3+0Z,X4?3,\.CWA369SDOE(9G6-=$S`3O8]&LOC?YK&&E%$_P_`*EH;O\*
M96YD<W1R96%M"F5N9&]B:@HQ(#`@;V)J"CP\"B]#<F5A=&]R*&5$;V-U;65N
M="!,:6)R87)Y('9E<G-I;VX@,BXV*0HO0W)E871I;VY$871E*$0Z,C`Q,S$Q
M,#$P-C0V,CDM,#<G,#`G*0HO36]D1&%T92A$.C(P,3,Q,3`Q,#8T-C(Y+3`W
M)S`P)RD*+U!R;V1U8V5R*&5$;V-U;65N="!,:6)R87)Y('9E<G-I;VX@,BXV
M(%!$1B!&:6QT97(I"B]!=71H;W(H*0HO5&ET;&4H*0H^/@IE;F1O8FH*,B`P
M(&]B:@H\/`HO5'EP92]086=E<PHO2VED<ULU(#`@4ET*+T-O=6YT(#$*/CX*
M96YD;V)J"GAR968*,"`S"C`P,#`P,#`P,#`@-C4U,S4@9B`*,#`P,#`V,#8W
M-R`P,#`P,"!N(`HP,#`P,#8P.#@R(#`P,#`P(&X@"G1R86EL97(*/#P*+U-I
M>F4@,PHO241;/$)%13-%,4%".3E$-4(X.$(U-4,V049!,34U-3`Q,T-&/CQ"
M144S13%!0CDY1#5".#A"-35#-D%&03$U-34P,3-#1CY="CX^"G-T87)T>')E
,9@HQ-S,*)25%3T8*
`
end
</PDF>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>exhibit32-2.pdf
<DESCRIPTION>CFO 906 CERTIFICATE
<TEXT>
<PDF>
begin 644 exhibit32-2.pdf
M)5!$1BTQ+C0*)>+CS],*,R`P(&]B:@H\/`HO3&EN96%R:7IE9"`Q"B],(#8Q
M.3(V"B]((%L@-C8Y(#$U-2!="B]/(#4*+T4@-C$T.#$*+TX@,0HO5"`V,3<T
M.0H^/@IE;F1O8FH*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`IX<F5F"C,@
M,30*,#`P,#`P,#`Q-2`P,#`P,"!N(`HP,#`P,#`P-C(Q(#`P,#`P(&X@"C`P
M,#`P,#`X,C0@,#`P,#`@;B`*,#`P,#`P,3`R-B`P,#`P,"!N(`HP,#`P,#`Q
M-3DU(#`P,#`P(&X@"C`P,#`P,#$X,3<@,#`P,#`@;B`*,#`P,#`S,S$P,R`P
M,#`P,"!N(`HP,#`P,#,S-#DS(#`P,#`P(&X@"C`P,#`P,S,W,C0@,#`P,#`@
M;B`*,#`P,#`T-#$W."`P,#`P,"!N(`HP,#`P,#0T-3,X(#`P,#`P(&X@"C`P
M,#`P-#0W-CD@,#`P,#`@;B`*,#`P,#`U.3@R,"`P,#`P,"!N(`HP,#`P,#`P
M-C8Y(#`P,#`P(&X@"G1R86EL97(*/#P*+U-I>F4@,3<*+U)O;W0@-"`P(%(*
M+TEN9F\@,2`P(%(*+U!R978@("`@("`V,3<T,0HO241;/#0S1C8Y04$V-S="
M1CE!131&.48V1C(S1C(U03DQ,$-"/CPT,T8V.4%!-C<W0D8Y044T1CE&-D8R
M,T8R-4$Y,3!#0CY="CX^"G-T87)T>')E9@HQ-S,*)25%3T8*-"`P(&]B:@H\
M/`HO4&%G97,@,B`P(%(*+U1Y<&4O0V%T86QO9PH^/@IE;F1O8FH*,38@,"!O
M8FH*/#P*+T9I;'1E<B]&;&%T941E8V]D90HO22`X-@HO4R`T,`HO3&5N9W1H
M(#<R"CX^"G-T<F5A;0I81V-@8.!F8&":RP`$;SZ"V'``8K,P,`(AP_D%:.(0
M=:<8^!D86/<P+)]V0+R!/82-81Z#U0L6W1D@.:"N]WT0FN$L`"K7#8T*96YD
M<W1R96%M"F5N9&]B:@HU(#`@;V)J"CP\"B]4<FEM0F]X6S`@,"`V,3(@-SDR
M70HO0FQE961";WA;,"`P(#8Q,B`W.3)="B]297-O=7)C97,\/"]0<F]C4V5T
M6R]01$8O5&5X=%TO1F]N=#P\+T8Q(#8@,"!2+T8R(#D@,"!2+T8P(#$R(#`@
M4CX^/CX*+TUE9&EA0F]X6S`@,"`V,3(@-SDR70HO0V]N=&5N=',@,34@,"!2
M"B]4>7!E+U!A9V4*+U!A<F5N="`R(#`@4@H^/@IE;F1O8FH*-B`P(&]B:@H\
M/`HO3&%S=$-H87(@,38W"B]&;VYT1&5S8W)I<'1O<B`W(#`@4@HO0F%S949O
M;G0O54A'24=+*U1I;65S3F5W4F]M86Y04TU4"B].86UE+T8Q"B]&:7)S=$-H
M87(@,S(*+T5N8V]D:6YG+U=I;D%N<VE%;F-O9&EN9PHO4W5B='EP92]4<G5E
M5'EP90HO5'EP92]&;VYT"B]7:61T:'-;,C4P(#`@-#`X(#`@,"`P(#`@,"`S
M,S,@,S,S(#`@,"`R-3`@,S,S(#(U,"`R-S@@-3`P(#4P,"`U,#`@-3`P(#4P
M,"`U,#`@-3`P(#`@-3`P(#4P,"`R-S@@,"`P(#`@,"`P(#`@-S(R(#8V-R`V
M-C<@-S(R(#8Q,2`U-38@,"`P(#,S,R`P(#`@,"`X.#D@-S(R(#<R,B`P(#<R
M,B`V-C<@-34V(#8Q,2`W,C(@,"`P(#<R,B`P(#`@,"`P(#`@,"`P(#`@-#0T
M(#4P,"`T-#0@-3`P(#0T-"`S,S,@-3`P(#4P,"`R-S@@,"`U,#`@,C<X(#<W
M."`U,#`@-3`P(#4P,"`U,#`@,S,S(#,X.2`R-S@@-3`P(#4P,"`W,C(@-3`P
M(#4P,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@
M,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`U,#!="CX^"F5N9&]B:@HW(#`@;V)J"CP\"B]3=&5M5B`P"B]&;VYT
M1FEL93(@."`P(%(*+U1Y<&4O1F]N=$1E<V-R:7!T;W(*+U-T96U((#`*+T-A
M<$AE:6=H="`V.30*+T1E<V-E;G0@+3(Q-@HO1F]N=$YA;64O54A'24=+*U1I
M;65S3F5W4F]M86Y04TU4"B]&;&%G<R`S-`HO1F]N=$)";WA;+34V."`M,S`W
M(#(P,#`@,3`P-UT*+TET86QI8T%N9VQE(#`*+UA(96EG:'0@-#0W"B]!<V-E
M;G0@.#DQ"CX^"F5N9&]B:@HX(#`@;V)J"CP\"B]&:6QT97(O1FQA=&5$96-O
M9&4*+TQE;F=T:"`S,3$Y.`HO3&5N9W1H,2`V-3$Y,@H^/@IS=')E86T*6$><
MN0E\&]6Y-WS.F=&,=HWV79J1-))L699L28[EF'@29U]P0C8[P8VSD(0UM@F!
M!')CEF#B`$DI.S0)A;"F%V?%"10"#90ME]!2"K0TH3=0-K=I;Z!0L/P^9^0$
M:-_[?=_OTVC.-MLYS_)_EH,P0LB$>A"#9K;,SM1VG)R_#T;^`.>Y2R]=W/GH
M9Y]:$,)5<-Z[=,UJL93]XRF$R,L(\>\M[UQQZ2\?#L(;]`\AQ-6LN&3M\C?Z
MKYF%D/`.0M<=67G!XF5_G/+S]Q'ZR?WPOKJ5,&#[JVDK]-^"?FSEI:NO<MUK
M:H/^5PA%;[ADU=+%ST9./(/04]<@Y.N_=/%5G?:/+,<0^C5\'XF7+;[T`LO1
M9=.A#R>^IG/5Y:L?J<)'$/H-S,=_=V?W!9W%CUXV(?37#H0L$Q!B$3Z--$C+
M0HOVSM1H.8$:G_VA?_DUP0\I2$2/:!'<^3HOX4/J!8+*]SJ`7M#"/CBY?WWZ
MWW\,3(+^#$:8EV"UV1U.E]OC1?Y`L'Q#3(XGDA4(T75F:VI1OE`WJAZAT6=>
M,'["Q$F3ITR=-AV=VS)SUGFSY\R=-[^U;<'"\_]O7_M??S?^O]WP__O'@@0A
M%$`"+-4(=(N@"E2'&M!$-`6UH+FH%5V(UJ)'AH?A+GHU"2NM1V/AZ@PT"ZXN
M1A?3J\/__;\<Q]&_\>B'/\VM<$Y'83@#S.W(C]#P!W">A//CTM3A;S47HVCI
MHN$3C!UN_OG(B9",[D3;40R=PC7H!708344/PZQFHMO1)/0&>A*9T5K\&JPN
MBL:C1Y&,PR`!$Y$;:]`]Z%UT/NI&'Z(3L)IIZ(_8!N^9@#J1"Q6'/X%R&KII
M^"#<I4?-Z#_1(7P)GHTRT)Y,JG`*OKQE^#!RH^3PT>%WH/=3]"&.#>]&DZ'U
M$;*B!-J`?HQLZ"+TZO"W,-,86H(>P=?@3Y"$.M!F-L_V#5\,`K(?_19/@]8,
MM%;SCFX_N@2>>A"[\>'AX\-_1L^R&%T`;[H.W00SWH,.DVJF6;,#>!!'YZ!S
M@>X7H*O1N]B.:QAE.#$\;O@>&'T$_9VDR$L,#_-(`8\6H5O0`T"-M]%)]`4V
MX`+^*7X"CC?Q7S2@Z;#2*]`ZD("?`O4>0;O005R#:XB;N(%:;I"$N7!M"]H)
MW]^+CN%IN`T?QL\S.S794M.P8]@Y_&>0BTJ0@GN`%\_#-T[C+-P#7V`BS&HV
MQ*[6U`Y="RM<ANY'Q]";,(\_`MV_0%_A2C@^(/]!-@S/'WYT^$.8BQ:%0;)F
MH05H%5J#KD0_`ZZ^@(Z@O^%OB`[N?(-]4;-.<VKX-J!M'(V#N;?`W;/AW9N!
M2WO0`!QOPRJM6(15U.-S\7EX!=Z"[\0#^%W\+N&(1+K(ITP_\QKS![9.HQEN
M@#>Y4`B^&T7ST4K@P'\`M6^#]3Z*7D2O8">.XS2LZ&UX_DLRFHR'XT'R!ODC
MLY'9PGZKN;%THO19Z9OA/L2#E$T".ER!'@<J_!6[8`X5^")\.?YOF/E6LH\Q
M,P(390K,6&8.T\;<Q-S.O,S\%]O-/L&^IYFB6:QY@E]<NJSTYO"TX1N`%AAQ
M,*\$Z%H>C0+Y60[2=#',KQ..;G0-NA;UH5M!7FY#.]`3L.[GT"OHM^A]]#EP
M`&$)YGPA?/U2D+J-^%8X[L&[\//X1?P*_@!_20\2@2-)ZD@3:283R0JR$8[;
MR3'R-OF8"3!+F0U,#QS;F`/,NX"]+#NLJ85CLF:SYA'N-3[)3^:7:%__=G"H
M<JAMZ(\E5/*5%I;N+#U?^O/PO.&U,'\9I5$US+079GD/R.!..!X'23R`7D*O
MH]^I<_T[)E@#$N_!49"&*N!:$YZ$I\`Q`\^"8RX<\_$".!;C)7@E'!MP#[X.
M7X]OP+?@.]3C;EC;3OP8/@#'4_@0'+_%Q_%'^%/\=P)"3!B09IDD2(848:7-
M9!)I(>?!L8*L@J.3=),UP*%'R%YRD+S-V!F923.+F2[F'N8_F1>8MYBO6<)6
ML1FVD9W'KF"O9]]@WV3?8;_1A#43-"LUVS0O<'XNS\WE+N+NYI[D/N:^Y3E^
M)K^$OX9_BQ_6RH!6OX)U[_\!Y&6X-_#E&@=[%3D.>N%A.C6]>"Y0C"-SF$N8
M6YE?:Y;C4XR(W\-]S(7,Q<,/,A/)5\PJ/(\\AR-,6-/`+$<WHV'\!/F`G"9_
M9IUX#OD$)]D?XZ?(*J:9J'9-\QO6R5ZO^1A,W^]0`UF/#Y,7F>N9ZX=_@1HT
MV_!QS3;R)A+9$\2.CH-6]Y*[X*'_(A>2S:B5S6N^01<"W1_37`7T'D-NPI7,
M6^PV]"$3)?^#3^$[`36.XJELC/R(%/$3@+A#.(0&<1?JQ'<@!3^-W\<#8*8?
M91[!TXD1N-5/3'@4F(*CC(3?8O2HC<X1QXD3SR2GR%SF&>X84P![?@S]&JW#
M#,Z"[)SYE=!EH`&WDP1@V@1`D]_@6N1!=P'>GRX]0Q%;\XYF,\C9`TP5.@]E
M43MY#2S8;8`T'X).WHAJT2&0P9M0EMR-KAGNP<L`]V<`?A(T@"]"&6P`M'3#
MW#:`O7"1"&#A(OCJ5X#_KP+J3\-_05=B$33K,$JR],K-[`1`I@[`W\UP+$/M
MT+L?W<;MU_P&M6`W&%6QM`VD_`_H1V!S_AN^[T.-,+\%Z`&V"F8M`C)WP1/W
MER:#KZ+`#%_#!*V'.8\!/9_)3@;DO7/X(ECAA6"CIH--?`5=.'P7:@;>G3=\
M_?!FM&CX@>'ST0HT>_A1P-\UPWO`9O=JVL@\38K-`\:^`K[59/1[O!EP>S)Z
M#_!(QA[T*1S_"?,?HWD:];&_`^QL&KYY^+?("?2(`(66@!4]B2Y%?P&Z368.
MHUSI7+)[>"+3"1;J.)HU_,AP&.O1RN%+`'F?03MY#6!/#PII=H+L;F:7DRS,
MMP*Y<`9&S]=L1T@9-W>.TC3FG,;1#<7Z476%?*ZV)INI3E>E*BN2B;@<BT8D
M,1P*!OP^K\?M<MAM5L%B-AD->IV6YS0L0S"JFA"=V"'VQSOZV7AT\N0T[4<7
MP\#B[PUT](LP-/&']_2+'>IMX@_O5.#.Y?]RIU*^4SE[)Q;$1M28KA(G1,7^
MH^.CX@!>,*L5VK>,C[:)_8-J>X;:WJJV3="6)'A`G.!9.5[LQQWBA/Z):U;V
M3>@8#Z_;;=`W1YLOT*>KT&Z]`9H&:/6[HYV[L7L,5AO$/:%A-T%:$TRJWQ<=
M/Z'?&QU/9]#/R!,6+^N?.:MUPGB_)+6EJ_IQ\]+HDGX4'==O2:FWH&;U,_U<
M<S^O?D:\D*X&;19W5QWNNWE`0$LZ4L9ET66+SV_M9Q:WT6]84_#=\?WN=2<]
MWW7AY;;FUM[O7_4S?1,\%XJTV]?7*_;OF-7Z_:L2+=O:X!W]1)[8T3<1/GPS
MD'#:;!&^13:VM?;CC?!!D:Z#KJF\N@NB$^A(QT5BORXZ+KJR[Z(.8(ROKQ^=
MMU;:X_,I!X=/(-\$L6].:U3J;_)'VQ:/#^QVH+[SUN[U*J+WAU?25;L%:YFL
MN\V6D8;1]/W&!6>OJ2WU=MJ:=MY9NF(ZH^@4$(=^<:D(,VF-PIKJ:7%!/>I;
M6@^WP:\-PU/]RX`?%_;KFCOZA`88%^CS_1I9B(I]7R#@?W3P\Q^.+!X9X63A
M"T2;5$K."AI</]/N3Z7Z*RNI@/#-P%&8XQBU7TA7K1D@_=%.080*R(=F`FT7
MMS5D@/B21-F[>4!!2Z#3WS.KM=P7T1+_'J1D4FW]I(->.7SFBG,NO=)SYLK9
MQSNB(,?[5+_=V:^-G_U;!)=]PLJ&?NSZ?[A\0?GZM-G1:;,6M(H3^CI&:#MM
MS@]ZY>OU9Z^-M'#Y`A"\GY6!4E.B('KG+6BE`_#7R!.C$R[LF`RJ!G/LMS>W
M,G[25FX1/Z.^"N3W_+-OIIU6(WT7*W.J_"\;X+4@P.H(%B?V"QV3RV6;7I+^
M/SXT,'R*/J56WSTVLJ;^AM0/^Z-_T/_!](Q]#$R8C9-I<Q;T]>E_<&TB@%5?
MW\2H.+&OHV_QP'#/DJ@H1/L.,JU,:U_GA(XS[!\8/K39WS_QYC98Q$K<`*)-
MT+C=47S3K-T*OFGV@M:#`H1N-\UIW4,P:>X8U[8[!M=:#XJ`S^HHH:-TD'9$
MV@&;!UJQAVC5^_T'%81ZU*NL.J#VEPY@I(YISXQAM'2`E,>$,V,$QMCRF**.
MT1]%BN8YK=^7`56QVM+4VA.T$;R,9R#N,X'=O/^I`>_+WG\8&>/`\%=[HW)>
MK=/9/!X8_GAO92&/!H9?5H+0\'J@\-5#\0\CYHUN(]$'-II7U)G`RL_9RS,^
M,]1['`P:8`K[3"8]:X:&XO+YW%;]I>POW9<B*[9N]`=NERY:YTFEOFP?^G+0
M:BMFR@5J&FJ$?TTVA;O:4^H/=V,F$2_DZW*U+J>#9R3F>QVBU+E(?76J:"^6
MEHQR@>HV^.J8*(ZM]7J;&AIJYBXM_1XGUU4I#:-K$K>6WJ4^_YS25'(-Q,-V
MU*!$[[0^8B4W&C=9B?YNG17=#9$>0GK=H^;(3`YS/8XY/_*DA"_;!X<:&X5&
MU#38-%@#G@]NQ\YX(DX*`AKEY#CB=+A#A%QSUP5;[\>U7UZ][5S)-W5]:94\
M??F/<=];N`X/7U8Y_O/2G2^^_63?(_?"'*IA#O/4.1256`5;J9VL8>#C5IB$
M'1PZG1XF(')93N$8KL?9^M"_3P*WVPLNM\OF%!!?J*NS%?*):E)]]P5;[B^]
M\8^KM\^0O-.NT2RKG+;\MM*5ORV]6L*7R1,^PQ>_^-O^OH?I#"XK/8'O1B]#
M_#E;2;21-O<1%Z-S=WB/>1D=1CS+6K0V=,"F&`UL@\49=O8X&><`KE0,8<LB
M"[%X/??#I,X53K?/&&H'M@V>M!6QU>8NTIGA+CM,"684CT9X+AHYRS#NLA5=
M.IXWR#9'3<.TNG$KMI2>J(ILF6DWZ1RZAES-Q,L7K=A->30;]Y!6B(\9U*2(
M1-,37%:W00-^*T']#(.(@&<"IF_%._`QS$'@F=^/>M@Y"RB5AMHIC3*#4-*I
MI.R24YI--$/?$/==],T_'CZ)5X$G:4`I)8`4SL`H.J6AH%.:"HMT>+ON21W1
M;312V12^[.I.I>C::K*R.OOR2C#**&.KJ\>.?4$MJS,*?2\S?)*,`8XRZ#Q%
MAS2OA5?4`2,'F(1B(HR#$)@V(N`##^"PXA"9+-/!=#([F!,,QSR-?TY>8P?P
MJMW'Z5<'3U."-C8U]FJJ4^N%(U09('0C8TK.F?@SS:W_G*=YG.KOU.&/F:<T
M*Y&`8NC0GL5:<)ZX/1J-DU8FDV\`6Q2;SH?B2IPH\8[XCOB).!NWTF'S(@C^
M-Z`M$-9JD%<^A$-`VA%N#IXKM'=].6-P1,R:URK3<2P:B\0@LH>`@7"\'/`'
M_2$_P]GC%MD0]WC=7L))K'4)"G.^)=AAAI;+"*T8%I=@OQ8*F^!<@KQZ*%2-
MID6E>E967FO/VT:!=+A=5@<!"B?BHP2W*U=;-ZK."@)4%B$R]>;5"SKNO^:^
MFWZSY(5K+STRH=A5MSI4G8T5*QK&%R;GR;:/<<MY8[>_6'KR\]*!.SY\_A^E
MCW??L;A[%RY^?-_E6>F<V:7[@4>G$&(XH)@+W:4X%$^'9X?GA(=%'L5#UD!X
M0,QC[1#1CT4ZO`,\=49M:Z$=!09_A2SX0O"ZQT+[[XH96RQ$!W&U3FLD##J$
M_P&W3U%L9K-%L1:RE@V6K98=%M;B=1\B,7QRA+BIQAG"X$FJPL!=*U68(OIB
M\%O\12JEHDI7NUW.61TNE]LI%<:0`B4`7?\I/%6R-YY?(AWU+CTO^^1Q[*\>
M^*:WNSY$9)D$:]:1/]Q>*8;"5`ZK8(U/P!I#>*5R'>\Q%-V>P#EYCP*%EQ:6
MD,M5P3?R4_C'>$X1%[(+M`O="SP7:U=;5]ON-_S4?(]UEV&7^17-*^Z7/>^Z
MW_6<$+]FOW8[G3C(>C5^I]?E=0<]O,YM\!B">>\D[R;W%I'W>`EQ^[Q&+V=B
MO$3#09@!\&QG30,P#9U.<1B;>G18-\#D%*.@\6WQXNW>)[W$>XC)`>%NV8N)
M,32`;U%,B/M3BWV1?95]@YVU#V!>L5.+YT.B(O:(3(>X0R2B]VG\->B9"2N*
M8Q%913:0+>0Y\@8Y3OX*9M(;/H1O_4Z>3S:6);I]!JB50!5K<*B]"XQ,UVZ.
MFL>GMNCP<[HW=`2U=[6E3E((4SEC*Q:)4+YEWWKO+5ZXWF9N[!4TZX^8025Q
M5W<[<`R$&*4P(Q40*N2!51P?K1NQ31Q/>*FVKFX4\\2B;T^`VRENNVS9]KCL
M?>.^G>]GIS[\]1B\Y)+Y$WU84_I&QN/PW8]=^_`570=?>FOKBA4_VU\Z52_4
MI"D2@I;/`W[6XND'D7[XQ!YC43<P?%AI-!;'ZB;H)QJF1=@W=+BBHKY"R7?D
MW\B?R/]#SZ,\'JO;$%U7_7CL8.Q0]2O5QZ/'Y=]7?QKY1#9.T58,X)OW)I,"
M&B`G]Q[+XNP`D]_/:`07=@W@[?N#2BJ3#P[@YKV"J2+Y-%Z)'$A'_ELQS`0>
MD*TJ#X"3>_N-V#B`M\)XNB=-MJ9WI$D:QO<OXC?`V@?(AXI>R>,=^<-Y`OX#
M'O.48G_.3NS>'`6<C\\R2.7.8'O7:5J<%$Y3"Y<:[&X:;!^D+H&*0775F5!<
M;V&YB!258I(LL9Q&-L?C>@"7#)M>@D,6:$F&Q!*LUU5SV24X;`I2M!$:RW"3
MJKP6?JJ.=:.N5,I>IV(.\,FE,DL:,5)N4#Z*/@45>^+1*-5#REE^9</N&QZ<
M/^[0^I[.VTJ?;5J:D;P^ZU5NN7+Y75%?.'7GN6++]LG7=MRWDIVZZ8Z+6A;<
MOJWFP-7]USXZ/A&LTFJ:.,.V2UJFU0>38T/Z']W0LF+#PQ3#P3MD#@)W]>"%
M_4Y)NDS8@B:8%`NC6'"E$3MY`%S,Z#0<9HT&$V*-)I8SFD"K`HJ-USIX7JME
M6)XS:E'8A$U/X_L1APQXNV+28$ZGY3BMAC4:V:?Q%-`7+5ZN&'0Z"X.W,T\R
MA!G`_U`\N$E5+PON`+PZ86$LG,)CWFO^G@YU-:H<:@0%@N9'PA`PJ*F8$<#"
M"H/"4'>CM6A5%::W.L6"O:)-B\4"B-8-CE)7-W9&K5&K5,`YJ#!S\,#.H1?(
M%9?M+,7PZ5M+]^+E/<QUW]Y,'AA:1/%K"<C[6LUT).&0TOP0BVUMH0M#&S0;
MN`W!F]E;@GR!%*2YS%QQOG1Q8(UF;:"7]/GZ`@\RC^IV1$]$+2B*U0TDI\NM
M=8#E92BIK*($)I<5)9\_P/`>5@.CV_>*HF0_!$CB8>P*T!3_"9$_21)B`<W'
M(#^>M+^'WT'E&'\!<AS%2K0C2J*@(%\?$,@."4OT)8I.5(0=`A&\D4/X#OR)
M2K&3[0#S0CNECBK:)P%TH`WV5!5H0'V*,KW:ZI0&R(5HIPPTBJD;=Y-N\3I\
M';E.Y`!Q*-``SD"@I!@N9E?9EH4Z-9U!37L;.%F\Q+-4@CGN>S[6B/""["8P
ML_;<TLHVK+MOX_P;9EV^=MVJZJ@OD9DVXXK=VS9?^@QF-=,?/Y#8=M/`Q0=Z
M$J-FUP92@I3?O>'JWS:D>6*ATMD*O-@-TNE!2?2M4GF%;HW^2O-UNG?E3V2.
M8_!Z9AV[SK71S39JDYR&B7J37HX1%VFQ%K#C@!C'\;@%G+-;]GJ0ACHG>RTF
M#,15*(\4F\&'*I5*HE1V5.ZH/%')5GK+=(=+R"[817O6KMBWVG?8>;NWXCL7
MY5MP.$^.^"@J5`"@`U7;![N!C/@[6NXS<'Z.J"0$_*@*R#I;,!`*$,XJF^*R
M+@H((?B7(,D,K9@^O@0';.(2%#%"@<[X*!0T5,C`3C/#G\%UZJ-8\[9870YS
M3L=9B@/X,W?>\,B#%\>V_GCSZRNN>7WSXF=OPY:O+AYZW39I8F[*_$TWK8_/
MUZR432T_^]6FI2?Z'[_Y\?/WXN`!/+G4.C2^=W;'!^,R#]W]Q#]%T-5K@/)]
M0'DOBJ,<7J<<:H.@(!?.5296Y=9%>@P]QAY?C_\ZN2?>EWO,L]/WB+S7N,_W
M5/SIQ(OZ%PV_,[EXI,><B?AT"9?)[9--LGD:OAE?;]IH?@R91Z,&/`VBSRG)
M17AAXOS<1>@B?"%9$;\HL3)W-;XFL:;JFMP6=HNFA^_17F>]SK;%L<5U-WNG
M]G;KG;;[7`_'?Y[X>6Z`/:#]Q/"I\1/S)XE/:BMXDR[1@(JXOE8S7HN,O@2K
M%H);]4HY39I6=E-PK`X03@<R0,\LM`5`)0$5E`)1"AV%'843!;80?08N,"`-
ME2`-^JQ;<6]U,VYO_A#^RXB*44?UM*I>@R=/EWU5RGI,XP]@=VTJ$XI87:S6
M*4N:*#BF?'`)KG)4+D'5-K`-$1:,18@ZIBE7>@G*6--EIH]PG5H*JG;P[P89
M/AN\\"YW.0I0PU&Y;H3K5`;L'*U&[`;>]$#[ZX\]]/(E3_07I[^W^_E+YJW%
M-5<I:Y8O[RG4U,V>><NEEUP7GT2>N&''O!N>V],]?=O%-YV[O&O+:VL77[Y@
M]]N7K&^Y\,HU+?F5F=*?)^[LN/:^=?,G%R\";9PU?))Y%&3"C1+8J.2N3KRK
M^5WDW02[DEVK6:]=I[O2>)5IK?U*<;/V>KM>I]U2049K-0F/E/!HF)#,(EYS
M""]%'JSL2\P$C`<=5709>94,/B0*4?:8-:"M-^]SNY')0W71ARU/(9M@$VV,
M;0!?`'I9H53T5#!*14?%CHH3%6P%IMHLP6V*_CD]T7N3/[#L@V73/E3&OZ81
M-15.TU#?6M;68IE?E?Z8UFJ,"W(@'HV'3=(2%+30`$(++=$0@BC""D5$)W]?
M.2FC5'1TT_AW5!D#1XV8=0)ZBBF#RAQ2E?22ZTZ\6?'3#5M>7W[U2X]<>=L?
M7WK@69*SC5L[H^W&MK&+JO\C(),K<.S)"]Y_:L_FQ_J>^.9/I;777D0.7G?N
MX@^NVK'M-U?.JZ+Q)\2/6YE^B!_=:-QNQCN`925H6E&WU;L#PB`%\4:`-HOB
MA+`RO]6YPTF<SV`9$/37&"$UBC^M>J$C,7P*?R^PM'\_R)1H:`EG56;L.%HS
M_>5HLWKLD'U<N36.8K2`D*9?<S$*H##Q[":J&;'A<(B$@@CP#@7#&%#/\2SS
M)^2&DX=3S_Q)<6M)(,18M`%7$(4[<0\F&&LM1(LR391-1X\=S60HCX3!P;]\
MCC/EG["^]\@1`<Z:K%_Q:\T6BTG0AW3AF1+GM-@%G]7G]P<\04X"!W6/7*#5
MWFQK7JU3U6J]IZ(\+,;+P[Y0>=BM#N]QJI5REV#/FRP&>'G1,M4R49@2:I':
M+/.%N8[6T$66%<+*T!JAA^TU]UEZA5[;IM!-X?LL]PGW6.\+';0<%'[A.QAZ
MS?*J\'+PU=#O+>\(GUD^%CX.?6WY2O@Z^'6H2F>9YB=AL"=`)!0,A0(ZL]ZO
M<P7<?I>6\'ZMT^KP.Z\*6011"`4"$:O@L'9:,=TR,0^05Q0K"4$X'PH'=R)4
M)MP`WJ\8M8*%<;I<6JU.&QC`_U1T%GB&[#0KU@&2W=L2PJ$!\KEB%A7S3/,I
M,V-^1+RX3Y4'KV^H?=#CH\X"C4ZH6P7E:7`?AAI[S64?H;?=7.U)]4+LD?(@
M81`+A_^][!76'VGD&^&O.@VI,S_<#=Z"Q*LP!6$EQ-6C<`Z78TPU26,@S&-#
M_W-^9/22TMRYWMP8_'X4OU-LGSWTR:QB\K*//L<OO=V2"&=X6;9XLC]AS__F
M[IMF:629K9:J%F$3B0W]`9Q8B)<1^Q'X;2&40O5DO9)=@!:$-J&;0IMR]_A^
MFMCEVY7XQ/=IXL\98SU:EUB;N[?VGMS.V..Y=WSO)-Y)ZMF&`?+GO985=0U4
M*@*1/*V5_W:Z\SE%JH+"&\K7*M$D%/Y@?GQLO+S)]RY^._9>[D.99V-8-M4*
MC)/S^QPA5\R5=&:K:R?$IN;GXU;O@L2=Q"H@H6$N7A#K:.ALZ&G8T:#U97VU
M,Q$C\+Y8*.G-L!QA0NY02^ZFV+VQ=W.\V*`TS&Q82I8R'9H.KH/OR*[A+O==
M[N\,K8Y=GEB7O(&[T7]C:$NNI^'5S'N9SV+_C'G;M):P7R=%A+#?)45S,<2P
M5:B0"L>82$5]58ZICB0+!9VK(NEVNTAUDDK*5O"1J-@W%-1J'*UZ]C:-S=/N
MWN:):JTX8'SZH@#6A[(!$IC+IL+U537T@C"A8%/8'2Q!4)Q@&98.ZDW6/&*Q
MR&)V`+^IR%6<W4[F5ADM%EJ:3%!&0)8M`IEK$6G7LJW8\`Q^$TEH,?8`1J7.
M/9U*-<X8!-F!2#G5WM7<>A#5,.E/_&HUV`9!52.5T.Y!5<"ZR_`.IYK"50-H
M=SDD<!=I9@,`?FPF'TUZ0ICW^;U^PG'Q&)B=7#SIB>=PAJ_)X6@HGF/RN";'
M)/P5.9S55.>0'(SD4*B6*>3`]X-`KO%[T%^.YR"\P-W=W:B[ZZSY1C0L+QMJ
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M"P/,V/U;3-M-Q#3`9)2,0T=V(8QQK;#K22L.6YNLQ.I30`!UC:('6SQA#_&H
MXN&9(B];JIKP5'NWF@_\LKL+W*TNFIV'*/WT1TV#GY\&R*$>V"LJ>T6GGS/R
MLB]NB+MDSJ]+(Z,3"JU7D\9ZMRE-K3;^OLWN!I_:'E6)3IP.FYKO<W-L5*2N
ME2U&;3CEW"CVS7!XS$</]+ZW?LW@W3>\NC:\O'3JZ=*3!_L.X*9?_&1+I<WO
M\!DT%Y=R;QS85'KK^$#I[UN['G7L?_2?A[Y]#<]Y>K++[L]2*QD%*TFC2A=X
M*XS29O`;@C<*=PB_%31KA#6.7N%N^SW.5_RO!-\2M!ZKS1$,,;P3]_IN"I&D
ME@O[D13APWZ3%'5+WG#2;#81;]+E0MI`8XL-EUVDK$VQ:6P#PW\\0&EHFQ*E
MNCBFJ0"1HQC%G5$:G3)1R:UJHUO51K=*;G<$XG<!M)%3!SD?'>2V11:/\(#J
MXI!:@C?5G?I29<IW*E<\HV(!7\CB%&1'/&0)S,,^)Q1!:W@>]MN]\\Z0GX8S
MH#'M7;D?*H;(VIP"STD)H#H"K`2]B.;FQ5P!J@%)G,7G/+_K^=(5O]\P[V-<
M6_JO4PLNET=)ES.7;!"KY+[2L[\I??CL6TL">")V8R\>'Z2R7@GV8!]0/(?K
ME":EL")P9>"^[&.>7=FGLR<*VGG>3JZ3WZ#=H.OA>O@MVBTZ72SL#TH1.>Q/
M25&M0@FBE<SFL,ZOY2DI)3K"2X2$.3\?$/P$1\'_".;0SE0U2@LT]41^`Z:B
M*@4"M3/H_S@0"&IUN[1:;E<3S4<A7N!;>`;>]9$R4WW7FNI=5:EP.@./7N+;
M)8)'<]S/^&?/+'1"&,(4D*"R2E"Y(JBL$B)R3&553!V,J:R*;<N?.(A[5>>.
MLDGE%>A,^^#I]I-#P*[VP48U[RA\#A8=JI)JV@$J&X<:J0LL#'Z.A"]2>*0>
MR06W8ZM$-2!GC:J)*(GFA7-J7GQ4CBD#VW<,I+H$+;P+5ZY.Y#E9-IMMY\TM
MO2TDZS^Z?&5VS-CD%=]\ELVF1+<O-B?+.BT)9ZXV>8&&#'T<K5Y=2BX-1).E
ML0L2;C$S9GUIE^P6E*5,U[6AI%SZW<4SG1;*40DX&@:.IG'E[F1F`(>44?*R
M.AVKT_=GF+M3AU(OI=YE?I/ZA/U$_PW[C5[7J>GD-@"/>S0]W!;@L9;7ZRH)
M+QF-`SBNF+1^/ACVNZ4(!TRE(Q4:/V=6;6<H[(]+T5154J\ULAH"K`;RN],H
M&D=)(4F2E--R(A$G+K<VD4KN0A48560A..F$F&0KQX5YW,+CY]0@9[]2C<PJ
M)\TJT\PJ)\V14%#E9%`=#*J<#&ZK_C>E.PTZUPA>6I<:Q0#W_M)^EGEJ&*-&
M,:D1[@V=J8&%733YE<)6RC)@8C6)1JT0AP"PY9S?LTMG^`?7\8/_F-MBDF6<
MF##^'R:]6)6M&3J4G1/WF/1A$`KF;Z:H;\(%%P'3/INVJE1HF2J7YJV0O#:/
M+->(ZYA+RNW2VXO:DI1?.0"^JX!?8?2\LDI2-4I2Z#HE)5GP2HNMR^JT83^1
M(IZPWR9%O&$_EJ*ZL-\J16U6(+K6XR64;EXM)9&7I8]Z([I.;8_VA)89UN*L
M=J:V0\LLTA[6'M,R6I;>IE4IJ1T8_FH??18:)26H*O-BL5/JD4Y(3%::*75(
MS&'IF$06_P'H#21620ZN!A"[3'>5V"E5&6@I_SO)G'1CR#E"4G+5T-,CE*K*
M9LF$FMEQ+U`PE95_0!O:_O9VM4TI!#XK]W>@4!:_HGQL\6`STKK-7E/24F&I
M9+.\[1Q\3J;-LPJO]%R:6>NY"]^;><WSGN=C_)G'9/*`8>.R$[-,G:<N.\G#
MN+()3SS+<!Y-UNUF4J@">J-1@[OH*7@+V:;:EMJ5:!U:XUGK79WM0YL\&[/W
MH+NRCZ&'LSMJ^VM?=[_B.5S[!_>[GF.U@^Y//9]Z3]1^B?[I_D=6GHRGN"=F
M%N`V][S,1>ZKO"]Y7LR^[7D[^Z'GPZRY['&*8;]/BE2'_4DI0L)^K10M^Z!2
MV)\`F^7Q1!!V((\78:_'0V.8,=F,(^MQ9S,>\$%@[FZ?U^LF.JT6H6PVD=1F
M%X+L>#/5$5&4=DC]$N75"8F3MBFUN!83^@J38!$M5NH]UJA,!`X"ZZB1HJGB
MH<9&:S%3`BZJ`8T:TL!!8_ZSB4^H/6K#4_8,:#P,$M#5!:I#$Y[^C.`P-N%R
M(10]'FO1(]B*2.LIN@>&C^UW%]U91[&\!:.>;1A\/PE3D?BACL5!7##^GL1\
M[S)F)@Z=]LLSLZ5D%BR>PSQM-@1UG^.3N"<S'RR@/#,S=#@[/^H:^H*]XMLU
MZ\.5LIP7NYDU"Y+!A/S-[UFU^VW?V0M]WVP&V1K^</A3S>,@6PG\O#*MSX9M
M6S!X?2V%+03;@@0G2-I>;[_*?C<Y3H8);X]$;,`SO10!GOFE"$/Y&G50OD9M
M-BLF)&*+.&RV2&0`_TRQ)'9AO4Z'B=^GM>D8E1]&VVRK512R@B(PPL#PB7U6
M8`XT3N]3[1<T5,=$V%:A1@[@F%1@L0+3/`ZIL#OH*YR2E(W@PQ$<4:$1H@1X
M,C(P?`IB"G@TXDTN_MD9>&SO`E8/G?5)8`#:'ZE;`V5>#P[VCN2W`2*+*HMY
MH9&:MN[F5B6ILWEM%;@)%6TM:*IM$5I@6X4NLJVSW8<?PT_C_;;7\#^Q[:\$
M4TO8A@!'NT`D#B(R_.C>D*V)T/#(96H"?^OC`R!42J!(FWM&*K]:'?`6`<-H
M\QW%8BO:7+8B$9QP>HMV&-MC*,)KCI6KK_8[BD2Q%E%9%,^&&52J4#L#0I7_
M`>I$_U7*5//KQYW,.51B\#M4EF+?7N>/MX!@44$:?<[HX&C-]&]YQGQ&5+[9
MQ([_]A=G!>?)"55V'?BJDR%*N`JB!"/RH]U*S5VV1_G'](\)[)5X+=^+;^+9
M9JTIB1AGDM-Y&L-,AB$0QC(BDV441L-,"5+^^IH*8E`)DJ"U4=").F+1A75$
M-R4PXMA3%W*&T)7ZLNQ+JLDHFC;%?HMLB/OB]KC9:$TC/_:DL8.'EDL#+4%O
M2F,O@<*F=::1FX7B^\1*03S6CD7J0$JT'%5'?5NK0'UYFU4`>SV(M?CZTKK2
M9Z6/2]?_X;E_'+ALTZV7[GWNZTV7@0^_JO16Z;722GPK;L3-K^^>TOMHZ9G2
MOKTWX4H\%I__Q$W4CY]<6@5^_,7(B>)H2*F8@%OY.S##F3$$^OQRO`;?B+>B
M.[6_LGR(=*Q%0>,P,T_+W,4.D&-*1NM*"@P*@4\HHBSJ1#V(1>=IM28F%6D,
MVS-V\MV^@\8^)7F&CDD%7`Y?HV`23<1B"D,\-27Q?Z/C21K]M@,U&YL&A=-E
MBBJZN"@'X@:CWD@XCQR+RE'"A9V1-`[J?$!""Q1Q*W0E1R@-J_(;H=)IO697
M&D=M4*@[F&<V,2OA2(VDIC4T@Q./Q:@Y)(4RQ1T(GR7XJ#H5^9@;EP_>U5=Z
MJ?3GY5OGK.O%?1@,%]X('%AW8-7-MUZV_YG+>Z<6?V'I?]@H:B[8>T'#V,78
M_SQX_+>5+BT=_;IT$_OI=0^6^DM/[=FTZ6>X\7\>[EE[)IY:">B61'E"E#TQ
M#X4*6?6E>B/8MC'^8O3%-#,E]DB:>,+NZN4Q1H=U<ER>A%KQ*K(J=C6^FEP>
MOEQ<$[E*[L.]XMWI)_`3\E/Q9]+#,2<GWH!OCMV0N#>V$S]$'HX]F7XN_4[V
MK^GAM,F&7-A';$E?UE?34-V071Z[,*.OU))``#O#?HL407+2C\"M,4M15]@?
MD*(*J9)CL0C!#G!I8KN(2/C*BIUJ2.&FTX6P8";?P3-;U<T^Y-\5R`_@'RN6
MVF0P&"`6LQECI+6IR<G6<G)R0DL!24]*I`5,(Y'V"W58J>NL.U;'U.6UJJ.I
M5>F@51U-;<3E5-'4J0XZ5??(N:VP^"#VHG_Q-87V;G`W4RF:;\F4\RT9FF_Y
M+BLX."@,VHKMW9G4$`QX?<)@+TT,TDU76]$'(*MF`E.]@F;]D9JLAT:%Z9I0
M-"RGHYD<K@E!41VIRJ%H+"O6YC`Z(UD0E'>7HW(59>7A$WN,10S(O\=1!#TX
M<<"APB8T3^T7BEG!`D")R_@(1C>5DB1,\]:)?S>]:MI%S;KP-.>(:\_NEO&:
ME:4[2X6<:`H)@?CTPM#3N7FRDT:<^"_O'-WRX!/8T]&WZMMS[`'="R]NO[YA
M*5E',"ZMZ0E7R7)]>#5S"6TU/7;%^H%XZ>H;6XWD=OSH=1NVVZEGUS/\`:L!
MG*@G\Q6O[8XJ;,$68F"0A4VB"DVJ!;<0G;5A`$]4CM75U_D8/[O(L\B[R+?(
MSVE,&C.J/-S`KC:L-JTVK[%TACK#G9G.[";MC89>4Z_Y!DMOZE'VT9Q@,^5,
M>5,AF`OF@P6:S$FS8D@,5U2D<V/P&-+$9KW94#:<E<[)GU.8;)I<.<<PSS1?
MF%<Q+Q4,XS#QY\(%?]T<SQSO'%];[?FY\_/G%\ZO6S#*S!@,%7:#OR)J$!M&
M5V0;NFW=]DVQN_F[,_=D'\T<3CY?^5+J<,.I!L>YVGH_6D7\3^(W,,$;\$@N
M2#$5[JT)^(.KPOY0Z%"0CN2]]SH`/!J-9H?1:$X9*\UL7*=67!0/@1^<K&&B
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M?=:]QW6:IE`&OWG;CSMN6%"[O"KTR]4WS[GM-P5O.$,E?PQ$Z?UJU/<WI6$!
M7D`6!!>$+L87DXN#%X>T&:E):I'NUMSE?U3SL)\G.!@"F!2DB(ZB9Y3W1%&8
M"!:M-$`.*W8=3B'%;6ZR6>!U,]&38"\'2%+Q:74JSNE42-.I.*>+N%WA5(CB
MHYD^@4)":%%H1X@-'2))Y!K^7#%0%'2I^.>"M^\5E[674R:GVRG@A0!@#07Z
M@CT&2QX(G#HI-(Z$X)0S2#$4X#QSZ2,U0!QJI)'W*S0+27U_FE*D/(C^"PY1
MGPW88F<?L,0-]O"*.<^!7Y89>IXZ:0\N2N:G\G%!,[WTPIQ8PZAO3I]QR%BC
MV7[)^7@,I:IA^(1F-U"U&E]_$&7!^:S,Y+/J/E9,K94YKD`^R35PT[FU%E:.
MRHG::&UB0G1"8F>"KT@4$V1F=K7A:LN]B><27\6Y1G,Y\@Z'_5XI4JE&WO:P
MWR-%(4`#.T7DI$E7"9[ZW_91JD'C(]6-5QN4@A747Q=T.JUB+&H5<%*T62V!
M8/NT8G4XJ.U1[1"G!M[4]2^'YNI,QS<5A"SNS.[(]F=/9-EL6%29*:K,%%5F
MBA&;;8,=K[)CNVJ[[&9ZS1ZBU^S>S.GOH@#J]:M,.A<"`34.2+6KJ<J1('ZP
M;+KH>$UVVJRUNT=I077C4E)OC4!\2CB+G)!C9C&-!&O<6)'&!KTDR&F4-,C4
MM\1EYT?-]N-VT$741546?Q?]<ZK=B8.M^4%20-6_$0O$O(E/Y&:FG+,&7__C
M1UEQ`DWJY^?$O,'I6U9N_/4,L#B:A"PWA[N&WGO]@P?NO:[M"V);?ZXL%V+=
M0[M;7N^>NGK_.T3>(%:!'%C`[WD2Y*")J2KOM>ZSLKS'/\#\:1_7,"HI0T,1
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M<QIBQB&*F6K)BEBUP)%B?3W-$OJ\7H[3:%<VX:84PN`*B.#?GH\[<"?NQX?Q
M"7P*7.(!\D_%,EZ<+2X3&;$6179$2&2`_/*`,O9.B>[4@H]_NAU,ULGV[]PQ
M.%235398O>;U1U1WC#;^UVW:_ZVTP*^-AL>`=GN`,NW@6,$/XM[6`QE<$<F,
M8<`F422\4%J66I7I&$MM5`J#C4I1"V59GKBPGE1Z("J."B8:TWZLV(W%J,=0
MK(8S.ME5C&===/SP`5<QDG0569"V/:ZB@_IW!C6U0FBL;[`5TUI;,2+:BO4T
MF+84$^6*!M)0B>4J5:[&0+7;4CP;`I[YE0-I=14(BC/[S:/4'>=X@L'<]S:D
MZT9A#`$TJ"\===OMY;O*(Q2ZF?$XNO:*!4.'&@).OX[/?E0ZF;;532^%<_*8
MSLE8*7UQZ=U+R>4S1V>/_:W2;K143\8?%&-U"\XC?RV=NV^11I:Q02?;W6[K
M)'Q^Z?:&A%.L9&19(_A:%^+;<>_VI=!CJ@/RI-(KN*8NZ70*3BN&(8O[W`MI
MO#-E>)#9Q#R):M$YS)2RYBMBDYI-;5(H?#K]?+6L-1AH%$1'963,E:EI(W-S
M+GH+]/^HPGF.XK230FI.O3=7Y-6:3U=3;1=U\$AU#H78BJILWJCHX*5&)1BD
MI14N&0>&WU)"]":CD=W@P1YUU*/>X1'D$-]8Q:(,>%1'`(PA)J6,.)H9HEKW
M5NHHSD!'9<[AP^^G4D>$MX[2%*M?664(].6(;78=MHGA8D_3H[H#>L:6LJU'
MZW,WHLV&S04N:',U"$T]3:PN,%TSG9L@3HA,;U":-@6U>C,OHL@4/$T_Q3"E
M,&U4<\.4<^8;5A@VZF[0WV"PS'%=[R+AID5-I$.;0_G&ZHIT_FGL1T9D!''4
M%8U)0]&HQML-!<$XTT@4*#J,C*A6:XRLL=%#TS@5AF*+9Y%GE8?)>#9XB.<_
MP@*F*\XV*HT$EMV9[DF3=`'H-L!,5*RLH?IP&J<[9)0S&8WY/!#^6^``-S?W
M-%Z!8A#GP!?-122'Y1YYJ\PJ\BF9],A8%NA-\M.D&?'("1Y)N.@<P"N4D#]3
MK.$5<U&$F+&'9P0>G^+Q3![SS6.:+RN[MUW=W:D9X*.FP`32W!CX,",I4.'+
M=K"(IX=.M@N#74V#W0`F*6N1WI-*9<J0NH<Q8E"7P?+.0E'U<R<51@>B&ONH
M^KIZPNFT>BWAI(@8(5S!4(28/V@/()O=$C8%<"0Z6E,,H'IM7L2%O,$6$`+8
M'(&B@6L,4(4LN[PC-K6R$HPJQ'VX"XQJ5S>BN--D4S4VA;H!4O;5P$JK*4@(
M:G7`7!PEFJG^?PS1H4AME0%P0S04W7`&J+3[#$4]L')4DM9ZJ/50ZZ#6G<VL
MG?FUP3IE4&XPWX4\A8!R4,@YW8[RF.HSNUU.==^+[H0YRR$F!02`CEPMF71+
MK.Z<15>'*E[[?/[L)CE.,G$YT[]]W;FC`S:]VR(8G8V=RVL:\%U5+>/GU4^_
MX5*K][J+FFO&7S4OMFEY)%+54%V;3\_;6A$>E]I8>N7ZT0[>U%A_Y_B?X/9&
M;U5'<?(BT/SA;X9/,@<UMR(7BN%?ES5_=TA#-5B@NJQQ&)%'38]ZC-0YHXIN
MI&)&A]0&U7,CO=]$[S<:/6[$$IV=>@I6AZ*#VQQ.Y)=U!JF-\&HDU/1^JAP*
MJ7KZ?NJP\!(H+3@,(W8W#J]@X!7P''V&/AO2:.(R\@",<',]A$HOG<Y7^V@?
M&G]YB@X9C7'9J@("*/YAVCHZ\KVC]'/4(UDKQ/%#W`%N/_]IF-7$FTWM=6+\
M"F8->R/3RS[,/*'E)_&X0>M(F,;:0X[Q'K<1L7X7$B1\=B8U8<U6#>G0]("C
MQ&@^,[H0\L2,1L$TT]1IVFIB>Z#H-S'(1!-J66@>-ATS\2;0_J<:"Z8.^85I
M9>^2;KS1%#,HSE![=SE&[&ZRNHM?#'Z+OU!5(^D5&0,?%YF0B'UZ3P!Y/09C
M0`N],"N)V&OP!U"0\XN("A].C7BBUUX+`@\RWHZ[V]HPB)G+Z>#+LI6G`1R?
MD'-6J^N[1`6'1V^\]Y9?_VSS$S-WSK.(GD"E&=O3N4N+"W_ZTV6%0I)\>?!O
M;YZ^HZ>A@=E__V2?$.T<2@[]H3;W\G/]O_`[P&N<"#(T%:R'A+_8HV7Q&?M!
M?)SJ7G.JZ\VI-H!SR18=WR%U2H0FF_93>9*"@/C[[.#70^/5`]2B!&L8@'B`
M[U1[TY%!55".'J$28HM2&+V\,IU'4<H]MVF^A@3L<]C9FMG<'+[5WQK@5VC6
M:'I0C[0/7,5CX@GTH48W"D_"\SQS`XNB'9Z.P!I/=Z#/=JM]JW6KYV'\$'DR
MNA<_CW_%_\K[B?9DX%/Q-/9P9*IMOFUS>+/8$ST5Y:TB?F;X!!+A#`-@H""B
M`)P%N>B0>B2")$$2U6V_3FGK]W:43DDF:7GPN`5;?N62=7R0^A2.(JV4>EL1
M%FF07@\;<8MQBY$8,P+*(@5UH$ZT%?6CP^@$TM$!@AZ_W'>]C\STX>T^[!O`
M1L5VBL.($SB1RW(*I^&:(\T'R8_+"8CNKAF#[=U=0UWM)[M4L4JEF@8'NU3H
M/FD;43'][.#2X.5!YB=!P..N-M"-^OIZ7$]3KR`V""";`B02/$4_X-X!>U$C
M"#1A=ABP$I#Q\&ZA.)(:!Q'KPC1*(84\4F6MG"A(E-'.4<8V9JK\SO7W?XSQ
MOM[_K*D:';(:HM$QR\Z9]<"F)>>.RN/S]_\2<\??P>8M,^*9N'--.#1UR0,/
M?=-<O196/W[X)*L!A`JC-)DV(EOQC+K?6\%Y5*'2E@5,%38D!ETJ8+D,HAHP
M4GD2U8!15.^&T:^4<C3HH4^(@4/,GU"0&FKH!<,V-<BQ*SHS1(,.)`/CJJH8
MU>.@R)6!$X]X&.^#?W%8%4[P,<[`UWDV>`J)!H:ACP8Z@U@)=@1),&R`UQA<
M*H:Y6`I8,$,'K4768H&2T"O4Q:]0[U$7Q\WEN$RUBFI'4V5P2QT^"OXGG4Q[
M^]&F04`V`#C0C8,H`P'[I$GY#%61<:GJ?$?F&O8:31_;DWDR<SC#*YF>#$$9
M5Z4S-5<S5SLG=2?/3^:QF!FEGZ2?I[^;?:1R1X8_G#F5(J*(1.D02+L!K."$
M1K%%_)&X7'^)N$[<CK:+C_,'^9<J#7&M/6$<:PO9QSN#"=?80"@X/@R/&=@J
MITJU<!6NJ@HSAC`R2$:1.A@V9X>KQ_6DBPF[MKJ(Z[.*F1Q-,B2K\[1^:E*!
M:ZYNWC`2?<\8'.IN;QQJI#^(20`<!RD\"BH^(N$[F/3%4ZPV(<>U%2)*L5`D
M>5G$E9HJ%1C+^5_47D\EG&XMT%0PV&>PSF5#;`-#7/@.&<OFV*V)%JPT`38B
MP^17S3U3[SSQU2_7M@!"^E(F;$U;))<_;2B=JN8:EV9:)RSLOV3ABHGG?//B
MBWC2C,=^J@+E-^\_,"E@C7:]@M\9WUEL6?GRJ[\#B9X.>#F;Z4<.%&36CTAT
M4NL">V>T@`@BLUJ95<`T.[,*PG1#AR`D0`&$4K&2-A0KW05%R."7K3SB!9[0
MQ/\^^C2OHBO<QT,<]+;Z!#1>?8IJ`UMC,*C`0#UHD"`J51"+J6(-YCAS]/!W
MQCCH[$$[`(X8444GICR)\A>UZC9#C(JPP(M\/\\@O@,<QQT\R]_&_HS=PS+T
M4SPLC6IBG(JSPQ$.P3II$U8+8D]7"Y7918?,YG#HAR8\=?08M>+M1]K;4[7J
M7&&F5-P5KVV1I]W;@3H<;S,:KQ@`-RU0="F!8IC.2M\\-:\-4Q,15D4LF5>'
M9U=6Y_V<5]=J_Y%KD7N!9Z&/QXR.XW5:H\8YA=M$;N9ZC7W"QN"#Y`G/?OM;
MY%W+>\)I\C^,W=;!=V@[876;=,_S+UM.\6#I>-,-A-%1/>%`3Z;6Z2:22;J6
M\!PR1[>$=)--]DW>>^P/Z1[2#VCWZ_KUOR)_)B>,I_4.[3$>(_X83[IH36E'
MMV?Z>8Y?SSI0UN6D4[7;BK9%S@W.[<[C3M;I]/^&Q2S=T'70R/;C/79:O:-,
MMA4IC<_W8\H1_G6M*^DO6EQXE6N#:XN+<9UV.'JT.*O=JB59[1;M<2TC:!4M
MK$3;KSVAY;2/FYTLVD3EBJE2;%FS8IYI9I!9,(MFYI09F^E,=$!+<W.H><1S
M@1!@QE`7=5NZVJ$:!#]?H(:FFXI4JML*+`)?>Y43?&T(#QII3KRKNZBF,.OK
M45<[;F[=QR%,2%>;&AS0G^J1'T0\?,T0+1J5=-$$IY9:G&21+U<4(_;XRSU_
M^=I(3U_NZ<L]G=I3S+JB4_`6O:*U:()3A8(?>.EM;6UVKIRW=H]8,!NU8+(4
M+V>ZW\/+EO4NV)@..U^]>^=G?SMP[TM#O?A1C>!=6C?[>C+Z]=6KEU[EV/0!
MQN]^AOG7'F]HC=4KUX(_U((0LTYS,TH1[8AVRVG57J45:G;2:ESM3V'!S&&M
MN0)K:1_;@-:?*C:JH&:;JOJJD3)SU#SIP";IM3$YY$;(4F$9P/X]-DZ+,DV#
MAX7#34<'A<&R43I,W>DCPDOT.$(#WS-FZ2"RJ,\@>%0)5G`Q>).V`JN*B#FJ
M@5CUJ]5IO*,85&U4QZ'_GNI?F\WIJC,FZ'U:P.>/'J5^*U7',9O%>YSWQ)GQ
MS'CC9.]&9J-1<R^+,^D-TE9N*[]=NUVW3=AF[4_K!`YP:E'EHA0):,W[0MK;
M(GA?B!]@M$HX&MH>>BY$0M:8[,:IF1#\9BLK;%9.R^L%$/`!?-[>+1#P#I`O
M]^#*U``6%%.R`MLL5N$VBP7'J+#N[>C(JW5#0[EN:BK7L1JU5EP!*;_5C*F(
M+S)WF@^;CYDYL[?J$,,Q_,@63EDH9PR"Z*J1;2-4'[6?[%9S\HV-0]V-34,0
MV69HTA?LCTU..%QQV1F77<D`2CAB`?PONX[@)'TO94\3M]%"#D)`-094/::R
MPP21GS/GQ`\'Y#&SA]ZO2([S[MG3NK_KPM:&?,B=FQH.QZN5P.?,]*&'>R)5
ML5AR_!*R8'+CIF>O&)^N#Q6D2^WVFA5OCYL,XH?.*4UD?@\^^6@T!;4Q=RG7
MV5PS[XK?4\>@M+"0K*E<,YN@2JZ:.V^SR#:-:EFX:M05\<Z%6]@MFNO=-WBV
M%/K&7#]AR[0;6^YPW^&YIV6`/:C9Y][G>27_RK3#"X\M/+'PU$*_3W3FA(*C
M+KQ0\XAV:EV3'[F8.FFJ'WF;;5;!8C89#7J=SFYWZ+0],K;)-#]D`SLD4W8X
MC$VT5@PV0]-V^4GY.9F1!_"V_:VI'@BVX%;%1.^U;9>>E)Z3&&GD&;6&1R2X
M5_%LG8JG*C`Z58&AJ554=:;.=&#'`-8J]E5:O$$+#2O=,"AP]S3CY@&F1C%Z
MI^HS7CS3V^,EWE^07R,.E&L&:H1+>H[WSL*SJJHL,YYELF#O0E`6T0PFJX2%
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M*()3S:J?R1FMFS:_84*L$`BZ/5@3EVMK<C7Y&H8;&V^)5\N5\7GRG``.C`X%
MT+3"#!&-PTTB.D?3%$`STS,"Z+S4'!&/]TP,X+F)^0$\;WZPP0^W^T>CZ353
M13QM:J%.(<TBW6MD&P/XW,RL`)I=,4M$$]S-`3743IW97QTI4C](#U>"XE^K
MII[:J;'K4DV;HJ\60$8+@HWFFD[MMHWLLI[9/06[XU;C="X:'8FARAED]1B)
MX!-J*@D.]2E<WIQ5P_A$7$TXG^U!OS!GP=$=UW>\D#(SG(:QI*ZL/[)S_*2J
ML)0-=/[7.>VK+KK_F^<W3C-8"_RB?*J(G5.7C<_/G+YD0J[T52;;L.P7^Y[(
MY>_]`)];\9.VFXXH&D[G]NDUW.3.G@..>-%A%7F6T>A,G>=U+;UM?FV=QR./
MTRT-UX2C/R*]:]9MFS^N>]WV!>.^O3;7*F=C8S9,SKM<+!A]9`)P^A^(YNK(
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M8LC_TYZ[P,=1G`GB5=WSZ.EY];Q[9C33/>\9S6A&&FDDC2R8EBW)#\F6C%^2
M04A^"&PPEOSB%1LKR8+QYF%E(1`@&WFS@7`AK&49C(P#*,3+)I<X^/Z;<)O\
ME\`F7C8L:./-$FX3L'Q?5<_89I>]W/UN[_^_N]]4SU=?==775=4]7WW/-(*W
M4*-CY%QA$B7/M2JU!;YU!.QF:\P:GVB=;-5,M\ZUGFMETSK<WSK2.DZZE%8L
M<V(J:)MEK8HM7)<*)E:$^5106!$)I8+Q6=:B9".%1+:C*5CHQ'*B&=&W!+/*
M9A-XKQ@U3/)XFL=6?IR?XE_E-3P14K$Z%(IFI;K^NI&Z\3K-1-UD'3-=AT%C
MU<W5G:O3U(VT/`'>H?`^,2B)97E1Q96,U7RIW594XV?DXU-1X?35:#E=S!^O
MT7IKL)[SZ0-$/9<C930PC$%XD3B&C>AC-20+1ZZLJUM(EI5:@WKJ&D)OOJ6Y
MT@D>(UXY]JF.5>-^AX6O5Q:N=2EYGI4ZZQMN6>$J=B^T71-QBE;)Y\I9L%W[
M^8N;[^Y:?X/RC85O;9#%FF@T$1=6X<Z';LPU]2W4W)B5HE$'W[J>O4;U'DEF
MIATJ/9P7(PHSY<S,*10%11`@[&PW4W8WAV@D(R02S@XY1-8`&H3*<FB\21G?
M0+Q`,@R-'YXDU`:S6)'XT/CY,^7C]F;EN+WV+#UM,@F'>/I"8Z&#H(;#8W"&
M1W181RU9ZK63"71AG0.LP==`J)\=$EX?*D=(U$S,63@2(#/39PB/54Z"6:9G
M($1K,L\S/3WE1D>'VE"\+2VZ=0H)=1W5,611A.106.\@K_>^4D.>-!BB$3,]
M#V:&L+V9G@?R9NIY$,G!I^<'>IY3CU`T<M494'U,V/OK9TMGU61%^2AX)Z-X
M)#H>G8P>C5Z(:N5H?Y112!4E"C.?;Z*XM4W%=?4JCL0H5K)>7Q,<$,>*L#D5
MM,.Q2'@[Y&"HT^0U.2;A58H(A4UZAYV?-&!#D>C@F24%@A1KJ<#>:C*9O>:H
MJ*2+(NGS-;<U38JX7\0CXK@X*1X5+XA:<28R\Z?T.)!MSY,S`*IW7C530?/"
MJPGEPT!?*4T2EKO4L'`Y4$?TB.,R7U.V3E3X.E6[:%%M;?NB>[P-'0M+EF3]
M!GW05Y.T8*?V\V2@O;9VT4+HHKR^"(SL:U^'-WTQ(WNMT7'@$!M"&A-P;0O[
M4EG*IWU4>'MI+=/0AHW6F-;0`_V2F]0@V7])N9$TE+0JXIL360F7A;N&LKF.
MBOLLE=Y9-Q'WV8J4SU:D?):<`S(!-!84@78)V"9IXKS'%TO2A8C!=1ID?1P5
M@-/MS536-[>@N-=D4K,<[,]/&DQF>G;8GQ_G=21V,I\NJX"+Z;FYN2OIC+*4
M?05X'K0`?/ARIIAPU"EK42HR=IV`X?>`X8O\I''2])CU4=MC]D>EJ>()GB]Z
MB[YA8=@V+.T0QFQCTF.,X9W@O,1,&#YI>85]Q?HV\[9UWO8K.U>RE<22U"J7
MBMW6W?P^*Y=C:@4Y)L=SQ5;<*NA=PCI\G;!6UD2$#7B#]2WA-X)VN6V9]++A
M9?X7O-9C<`M20)*ZF,56G=%F=9A]IH`U:)%T:]AUFC7:06&M;:U#Y[4&`D%I
M#:,I']I<LTCCE5A@^40!OM%^$S9]`AB8UWD3)A,L7=9--*03RI*,$;DG)@\]
MA=#X'3V%V6RQ]8I6HDJ):*.S(#XNIVM`6"CK!"MF;':'0_!*OJ`W"XHF$>89
M0Y`G>B81:4[D.@K!YDZ40T:'($1ER2EC1I9`L]=CQHDQ@V4D2PZL23!67A!$
MO@4ASRQ^5^D533\P&GD=\+O7*_+&>M.$B;E@PN=,;YJ8<=,<B<A[/%,B%GU2
M$1=!,:%H+H>R0G8Z.Y<]E]7V9_%$=C++9$=:B[/XSA.A)W:"C;SJO5V[A]I7
M$NMWE;#[?=)\;PCTU64EU4Z&2NU>\LK$I`7&`0_SD"4KIBT'A#.'N'(#`8%8
M/K_"/!;FU/H0&3NCUP_"]]F]>Q<)V._&0[2@76@7C:((<&R<8&U*2;";`0(*
M,%[26F2(E#$6C039BE85&51$TM/';44J)BHL.TBRI39B<1::XHE"R*73Z?4.
M:I$2>=%,3$U,I(='U8HM5ZO%OK=7F+A0''_^NMLZWGEG<[@^ZKUV84G<GUSX
M.V]VY4*V.^(R6BVRSU5KPX+V\Q_N^E&GW61R!AA99K*+?K+PGS\1REGX:!2[
M')Y&?//"N<%6$4>C-J,GM)I=/+74;XL027,-Z$<K2!H7_D)%.WI`.5#MZ#3I
ML+X<7:$R`U.9@4W$2"IG,O^>VH>FB@(T$35)$YG@OSU+<YO:%T`X<`!ZY``!
M871<SFKJB=I(YR\'7U2-<H;$7ZZR^1(.JN.<--1/DIH(Z<MQ%S7B0J/_9%.J
MRC*IPHLV5)5E,GG<'S';2C3B3V3*<Y.>.<\%#^NAH8[N)H*5MN*B)NR9,6]M
M[O=@Q=/O&?&,>R8]1X%0;TH%]2O".!74)2*5-"=L2:_C$8Z:3>5I3%3I%!8U
M39IPOPF/F,9-DZ:CI@LFK6G&?97248VO4OL5-0,.#XU^4"WS4<U2X8Q/>)N6
M+I1*69]%$GU)&[9I/_]!Q_K6`-4BK/+84M7VH5I$5\\>0QO8ORQK$<\@]14&
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M?TY-B`VT$">0=+>HWB!M_)J.MK0,]!(=3SI[*R<(&O],1WM[!P?*!\=VN19@
MYQ3@%1!]Y[.E$A'*P+W3YIZU`R^A[DN_1%T`.8#Z2[]\UB=Z17"]U#+H5VJ:
M].<&?^5F)X#%!XFOE#;CR4%PB>144)QE/GPFW)(*-D!#,89[4\&E*\*V5-`#
M7M$SD70J6#_+FI^)=*2"W=!0KHVL2ZSL6!M<U\FE6E8JQ5220_K8TO4;R!\3
MRYAXHUZGT>J7=C?4BQY^T./Q";9HJ%[&X_*TS,BSN*!86U+9=+2UO@6/MTRW
M,"VDS[UR0T>TMU=:V;^2F5@YN9)!*X65S$HXUR>=[J:5(P.#L\Q&T%D'Q5F\
M]5ZBMTAD![05"=@3K^J\BMI7=8UVOH5*-`U7HK^55(%1DP<^+KKL;U4\KG#4
M9#7'(O&H*52#+=:P)7:UQP4.5QK3D"CH"^IP?8S;5=8E-":JUWNNR)'+W?JK
M_+&/V*V-N'^KO6Y;X_K]KIL_W[-\5\AMYINO66AW+`IY>(T_L;YP:R_#N-JZ
M%QIZBT9M*-/77%A3YVWH65A4RONHC9NP8F>:>7>K-5Z[=?C.GIYU;?L7;E\O
MN\$]\P@16S_^P_&L4EAF3"_T4)\-M-)UT->@!#(M"ZZ-S?YHU+]H';[QX4RH
M;`^;$&+_"TBR1N:R)"M0259/[>$&6ELXJSM"1$*6W$4"T11'11)'Y0%'Y0'G
MIL$1-PV.N&E6VUT13VXUY$@;_Z#$";D;!>C#`3I1@$X12-'82(H:SJF*@9Q2
M333:4(5<BL@VGCR10C5,M)X($D.#8B#[S9M?!(4H`(35:(EBB%JC>;TOPU!9
MDLO1T(@`!K+MH_&1]-Q5\D,@`D100R17Q,:-.3>-K=+H90-MTPTTJ/-;HQS5
MGAR5%!R5&IR;(5UNVN7F2)?;76A"`4H9H!T!.AB@+TIZ4Q5QD2+"A%"D4H6F
M_]Y0"=BF;06EML`5R/FO+_071@KCA<F"MDZ#%=J>@+OI@FZZ<*[`3!?P"'3,
M%=@`YTX%K6K8))4*1E>$N530LB(22`4C:MBD(5';41]LZ*Q!D7PC?>-H)&*U
M6GB/.ZJ?Y/`TAZW<.#?%O<II.!(V\:<:`]%:*=6?&DF-IS03J<G4=(I%*2'%
MI(@>-\"!3XTTJ:&3]']_Z,0N>EF=)N9E/358JQ.UOLHQAE,\M`M^"'Q)&CGY
M-^,F<"*O[KQB!#3BGC_YHYX=LMMB;%B\L,BA-/*:CI5WW&ZTD(/H[&ZP2I5S
M./]RS_KV_0MW;9"\-&)B[<-W'-CUJ87`D#L`)VWI5KSV\64^<LX8$-KGV5-P
MSJPHP)C*)ZT&S$!JT=%T6MFG$XQ&J'T:<G;((&DH#M*IH60:3XPS"C&D:D;*
MO^5@1D-]A4\-9)S0^<C#?L)3/HV3<IS3)%`+3J#FFX;:`:2IT01-)C7%3541
M82[01:B21.NR3[CPU]TGW7^.OV<X$_B)06?_.QXO,W2Y-[CNQ9\U'+;^Q*^7
ME'Q!0U/;4Q)^Q?4]'Z-(>#E7V8U=0_[T--C_?<"*&GR.U/V:$<VX9E(SK=%I
MWC61=(EBF@(7YW)6=W=ZY3P)JZ5[II-K>J;[5V\\;@HN/RYIEE^W<>`%9+HT
MAS0`TJ4YH@*7#'P+^=@\TB`GFW];>-M_U2UHA\'R"P$3->.`/6:),[&:.!_3
MQ6U6IXP"V"=CMP%:HAY:#K,@8S\+E<OHD9%7"Q7YU%=%U4%M8&)O`M?A)0.*
M;1^S3W<W?[?E;ON=[GWBOAIN:!`<(1)G-]0(MJ(?P$7"[$8US$X"'C315@ZB
M-S=[2*[-:2^'RQET[IY;;W_UX*MWWWS@!VL*MRZ>^M2F>[8O98]]Y="Q3WPX
M\?AGGK[GMW=TE+ZR_[L+/SOZG?<^.P).QZ7?+JQ@GP=>2Z`B$R[S6FJ10J1J
MGJ\EB`1S23S;X44RFW)0&>R0W=0X(Y'IBKU&Y:Y,F,A,#3LVF;9K+#H?2?QZ
MB,L!YD<V9FD>U.D35`HC*H41!NX$"0N6VSP5N%>B$*^GY^:$5T"PYBC'7DD"
MYR]]^"QAQ#Q/>%*D869^41OLCO*M@\I(AZSJ`!W9U#\H?FJLR4"5U%D2"'LM
ML!DCV0W9`/FG2X(J&;$J,4%XGE.%Y]DTX>I[^$6$6XO"<N%ZX;!-<U\&+\J4
M%O5DKL_<8KLELX>[RW97Y@^XQ_5O<[\UF.L7#30.-NUHTBB+<(YCDRF[`\PJ
M[WUA!QA7B0A*A/H20=3)V--)5I,5FC'9":,G>_**EGR#Q$_RS`@_P1_C6?X=
MF7',XIL5ORSWA\9#S$0(HY`0F@[-A<Z%M*&1MI=[RLY,NT"EXNYYXM#,ETC\
MS',Y?L9:!&+_4(Z6<P6]F8LUQ4WQ^EA!GY=QS@Q5HZ%9Q@W&K$Q21&76I0%F
MD@4"%F1CC:Y*PE=-YB0J!DRC^ZJ(LE85F/D6RIG$T&&P+[[T2-\?WK#K_O%O
MK&A.YCW%G@79VY)PN(1(4(SA)H/EMC5;KUU]@S)0GXNRQ=VOW;5IQQ_\:/ZQ
M@RYKW<+;-S8&8S'L-C9L93</UHN6@PO?&(NT#:RZZ=3_LVN5:"=1YLZ%%1H$
MO!Q`:?RC,B_[XE14QEUN@ES@2@?+OK2%^"0V8D18J!UBH7:(A<2.J1T#YC=U
MG2W:YU7761'T`9TU:(_$1%UJT&[46U2^`98I7>T\SU&.59EFSE]+1*B_EO"A
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MSDKB9\M\E:RE,E(G>6P):IPF1`F77?FK/5^I8M=*%8M4(M*(YK<EZIA+U(25
MJ,=+";'`BFXO">:**`YL9^E+C"4.)MA$4B^:6!!69XF'.P_^[;^R2DF.0OAH
MLBY"IHO#LV.&@P;&`!.(.M@I%90VZL&2/?Z."DJ)1`0(OY+&<V1,DFI35T4X
MA3,H5SI;CFX2&]*OC('[9LTS>:O"*-9/:?1*+1ZNQ1*1<M1?O"^22,@=\6"B
M$_'&6IM3%K!&G"#I`L&$38,LB_3@$0[KL*+#NJQ4BVN1+2I)DHPGY$F90;(`
M'N*<?$[6RB,I$IP$YKKLX^T^OTM-%`CSN^>';*HO5T17)0QV@WT'BM-%C#LU
M65#VNCR7TV`?"?CU[KFK95E3-++!97?5U3O,BZ]=2'>'O;S6'/%)"1Z[V&,_
M_.&23**YRYFZ<6%Y;P*,MZB;^E-;CEY30PPXX)>ME\XS/P9^:=`TE?DET4CY
MI5$AUAF#::8+TTP7MOI]7,)$^A,A:T7\6(DBS9-Q:X.>2UA#&GM:B^_2XAU:
MK(WE,,:U>N\=0;PEB(,QV8='?.,^QF<WHM*9H2&P@7*``0V!,BT1%@&[[^R/
MS@H_4C7I9>[(AZP)3E/K#MJS6J:V0:].X[7W:/&MVD]H&6VL5M\9Q%N#>X-,
M,&8W8K+#7RL^PBU6:V/>QUFH%Y.P$Y1(-.;+&O.,BL^`#34T1$`X<V:H))RQ
M%V&`!L;]2LJ0\688NSVK&(N9I+$H.@=-&^./"0]&M;R>3_*ID<;QQHE&G;5Q
M%LO*(1"7WS=_WW(F>B;VGR.O17^2>4OS5N2MZ-L9H[V4&<KLK#N0.8*/,$?8
M"=>$;\(_47.X[DC6;,56AF<-)ET-G_EN^'L1KH9U.^TU[H`WY<\\8GB$?TQ^
M(/)`U&A/FY.9%9F^QN'&.U-W9NZS/!DYUOA+]JT:4XIK"*(7F""6<`XS>!:G
M9]`+V5GL4VRU8M#[@C_HDWQ8\,GPY<B@]P4W&0S;[=&(V:BQ)BC2!O%?H&RN
MM@$A\E%]]WB]XBS;K3C=.?)AF1_8,;:_&GHC]*L0&YIEG8IQW(I'K./622MK
MG<7-BC?A\V8E#G.9J00>28PG)A*LG*A/,(GGL8SR6#[>4SD<*^=WOT>=HXM#
M2P9F+H7PT&`Q!W;ES"4,3;`-YL_#.*@NXC:=%^;+41!/$:Q2'ORTJ-GH-)N-
MARQ9&L0?%)'P[GOS0[NQ,/_>O-JF396)GLG*!G,32@]2F5Z33$FR8-/I)5NH
M!NM27`T<X6`-TB>U-;@BV(GO!6L9/M"_+[QO^R"I&1K$NQ$<5>CT3N$I9HJ=
M,CYJGG1-^B;]DS6/A!^.3-69P#Q.XUU$%0"9,1?)13^3>2SZ6$8[-$B,9EM2
M]A8-26\1*WR1`?"3I`!?]-$L+%_,0E>&@J%H$H+VDD4F%9B0,_XB1=YB%(R"
M&4<QHB(3H)..8D9TJ'/9U;FL=EC"#DO8BQG93IZYH%BM0&8MLH(9UC&3"2XH
M=C.L8P8:`-%&`:7_6P6^S2`55[9(69-YW!Z/*K>H%16Q-1*KBF0RHM0%()88
M\5.9R5#\CANZU\O2\!]]_X5]:W>$7!YS*%3SE<U=&S8M_*RN[K%/-*]LM`EV
M$WMLX;L/W+*BKC69RB[=\M4#CP1Y'U[ZV<^O+G;=.-E6W+#K2QZK1009YKST
MCTR[YMO(CR^695@LH-A!A@44(J",)AJ`,;D<6.N@30=59`XUNDD;[U&%YR#?
M@L:&'$8N8W4[-;/8/X.P#C39Q7-G<_-GRCKL=;#V<Q^53UX/C9^X:>VZJNTG
M64]J3E4:7F+/T?3$N!$;K7[LVN[$RYV8+J<`*\+:1C_64N=`2X,I6JH%M0XU
M?*2C.Z7ZSU')\#D<@9JK@BGGSA*?\.*YH:$YX:QP9JB2D8:_U7\*F6$#':;B
M,!YFF%+@$=LCWI=<+[EGO;_TZJ<"^+`/]YGZS,.F8?-O1*U.=(D)D76[1*^/
MQ:1R^H]BUE5?WBU;SS!89RJ03;M?=;U!;:Q1I_\'R$CR?AD9E&<V%Y@.,`&$
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MJ@G_KLJ'9]7DP-SKZ:OMJ`UZA1OAQCF6XXVR4;1$8QZ859W26+:)>34'1K-B
MLH]FQ'S4Q/+Q-*YBY[BX3#E/UJE9@;B=9/$(B9W8AV2(-"COV>V)^-5Q?Z@$
M&F\DU1QAQ!(P(37$P!XD(1VE@!/$JY`31#],)S1-QA:I35XF+9.U/L[11SS/
M4%\PEHAP"=RA#W*=LC$6X&9QE^+@42P&*HF\CX4W\D9C2":VOP5-8VS%XW@*
MOXHUF$3J8G:O+VJW]SLF'<P$5-,.EC"=7&8[8+KXRP<_:J>!*@+V`^XCD;IY
M-5HGT*#J94L-5(?@K['::JR^&B38_$*@!M%`W2<_"3[`4+J2B,NW>+210H4/
MP6[3%T)E[K21_"Z[Q1IR2PG+PC_4W;Z_:^6N3$W+,MPQ6$K?UE/<R#YX\<=3
M2VMLD5TO3RP>_.P$?J0C[\>QBX]-]#?W,OI5+4R,9.R`1^>!1V7FVRJ/GC08
MD,^N<Y)PL0U`!F#8GQ]'(,)(A+B4`XV0NQ)3:Q!Y@Y\S&,(A>,[HI,%?IT-G
MH_Z?S:YC:`^<;YDV9#+/V?25GUV-0;Q^5GB=_JT&^QI^0+S>RX*,^ZL98R%,
MM-`F5\'I=?HBAC`?LLGVJ"A[95^;H<BWV8MBP=OF6\$M-W3R76*7=[EO._=E
M[A'#'_L>]4^%_P-ZDGO<\%7O5WU/^E_DGC6<Y$^*SWF?]YWVSX5_++[/OR]^
MX*N;,F"RRHG\2!/%Z085!U,J7KI4Q8F$BB,1%=ML%"N*MZ;)&MZ/=N/=S+AV
MO_Q)[;VV(V%#&]?$-XE%_RNZN=!?^?3W\X?%0UZVQ;Y,9!RB,^A`?CF([+PM
M"*?@/B5C\'EET>NM-_!.@X'W^WQ1`P<M3J_3:C0<F&0..YA-2.?S&L59#.II
MF,<"'^6G^)/\CW@M?\#@)TPL*+K<4>X4]T,XO0<,WGV^T]B/9&2`_5KM30:R
M;V^`XIE\@:#G3`5DF`-W:1:_=%((XXFP^C6`BN"35D=3B`A6KY`&1_>](2(O
M?!?%M[S`\^)[OGF"=XOSJFM">9U(UT.J.75(FQ5I(PUVU3P6YJZN2?)Y:&A7
MQ2*@K)_&N\&^>9:7W>82"*]?/@?8$`5[&9P%L%)X0`KO*'(RF"D`6-5(F(8,
M'2&7:D@X'#04$X\40BX=>$`X@N-Q$K[!QVH2*=>/7_-PQG`33C<Y(S4+IU,+
MI]Q)R99G'XS%Y4C]@HXQMP8L!JLQ%M/8@MT?_@.K;<X)!H[XQI?.:Y^!TY)A
MSY9/2SP4M%F8#`GR69`A+G*:9$S2676$S4NE7,Y3%"Z>@S)WU9DYA>*@/3N)
MW!-KJ$M!:Y&&%3BU%N,&#4K2R>_*X`S:%\,QX[XD3AK5V3.9NE`H6U>.2Y.U
M2D.E(>'U(;J8C7H=]*OZC]NSA$EK2@5W`AQ,6RPA9X>SVPWCV;=C;R?_.?;/
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M&<`Z\;JB?,S)\[%(-%HO>IVBZ$W%(UYPUN'\\?`_G,;OPB$*XG=/2-AJ(W<"
MLH!M`EI0$,"!EQ%#.C'*``D<4O$TO@7%$(>?4*Q)!38;C2:-\H?641Y\JN//
MS*'15&06<XI+\>?ZO?BH%[_@?=7[!DB]/XKFX'C[GY.M,2S`GTZ.HM'4%#N-
M!11'+CCA)H7/#<>Q$I^(,W$PD)XQ'$CDN.?AF'-@3O$R2N*)Y(4DDR2Z'QY-
M'M73@&I_"D^D,,DRR2DE-9V:2YU+Z5,C=9>MIGF24?;ZYB^>!Z=G5_EL0Y</
M.F!8/.\#4XK`?#D)Y1-H8IF86.WE2VW/JWX6G'Y5"EA`"G`5<<!=W9/^.,'P
MKVN]P+5S[51@[,)#:AHK#>*"R(JXX#25B&-R`K"#R(E`T7,5<A)T8<93C!'D
MHG?'7<7+R0I5<NA4P9$@<D(5&Q5!4K['$5:5(V8\`6KXS)\WB0EW.WYF6=#)
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M)>\0S`8"Q6RVK5@1:+E<J43>A$JT.;4F[_35.)Q-C]N=:&HJ\$:3J1',#[W>
M&V\J-#468O8C[IP-VPI@EKI-@0/>_B`.YF)CD8,1)G(D@B/>6#9;;*S[=2J5
M:.R'KWV@@`M:K3[FU>NCA9BS4(B9W(E$?:/)V=AH@G]>-)@\C8F8U]B:BXL\
M:VK2%ZPUN$:"?R*7)7\#*'";C6CEK*8.U]4%@P'>!";FLV-N[,[&9K'EA.S%
M7B)734)!\4Y[W_1>\&I(!]'&WM-,,VI$>GSS3"&;`'EP`C7BQM/,MU$1M3$K
M3X3.PM%,OS\T_]Z\<#$]E-XU#_Z,>O:&*MH63$U:">U#Q)"BC@TY>I9L^I#E
M@'K02`.+]N*!G/BN<'Z(?./S]$/;BT.Y(>@1Z*VP_UUHZ3FAW=)^R"*T'SAS
MAJ`SW!D](`YZ!TF4<6B(J.I=:!<<OE/("&>*+QK!-7G.4/20*`.T?WD"L(LX
MJ88:6\FL^(622'KAAF#%X;&4M"2GJ1>A:B:M-F**`$XEK62V"R>MQ9AL)0K_
MKV:L13TYR-9B'M!),PR8:0^)3L1E`C;HLY'GP&2D1L*,744VU63PFXL"?``;
M@$>Q%P7!6K0!9!17T:%*!;>*[$05NDCLXX+B<!6;.5<Q6>\LI@!LG+MHH).Y
MBRG%!N`JY@G`RAZR.@!Y_+CMBFSY:/F7$9'+9'2`BJ%*((0DDR[;+WJ'V^U1
M`[A@UR2(:*+WQ"UM(7:.'Q]+A2)&=T?/LG`<-S=$&]8=.+]V67&AO\[K4.Y[
MH+.N;N''47]\X]R?K5A]#0BF&H^8%\+;MFWQN0(@EL3P[J\OS-[5P$:C3HO'
M,W3FS/4V,<%$HUIGX(Y+'^YH@;-B6NAFWP/)E+^<.P7K-%W+HCL3.!$`CX'&
M>9U$,-EHTT::#&TRI)FGS?QLQ9E(SZ??A:N4.SM4$5EE21$TI%'`:6/NSN,\
MLH-XB-Q-UK`ZG8T(-35>-GI>'SH#?B&5#6J(?EKH63OP`O)?^F?DO70!^4#0
M\T(KE$&_\I1!`/:RI+^88AQ-6??6YD]K[]4Q!H/6SGDYGR'M],4-47O4%T^W
MXF9[P;_4OLVPC=_NO<FWQ;\M<R=W%W^7]P[?7O^=F</\8>^7T)<,#_L>2I]&
MYYK^5A<!FR2=SM36\IA:ZEYBWF?R9?,^SLE>GZ^^EG<"02:=IH9]NA8>J?49
M-#R7`>P%2X.+E$W\!!$8%MAM(A<I!JQ-'H_/2ZP%_Q$>O\%?(,G2<?Y7/,L?
M*!GZ#,,&UG``'%N+$DB_9I6Q59Z2&?G(<`;G,J4,D_$V-OV'T!/@I:97@:6^
M\OS0KO,7WQMZ#S3IQ55=HYUOH=+*B^?3JCBI!$</<5=I;L!$M/R;BOJ*<L:[
MB&A(_UNF.+7%RXFLR^&\%ARG2M>$GW+5U87>.&O3<^$TKHTE18-WX3/-QU8O
MZFVI#Q63?'!IM&/A.6O(*W@:@8<3@4370A[_+I6T&XQF,-;%D*7TX<Y[[^_,
MU#:ZK=<.3C$GI&S$))@0@[Z\,,YNU6Y#R]`&?+OR8GCP.[:MS6D,9N%@/MJZ
MK'[P[N6WK_[#Y4<'IP>-]\7O6\WP&FUJ7_S^F,8@6U=YI92T5%JA+%^RO)-+
M<,E,KB.W)->96[5LW895=Z*[\1VQ.^'YP^@POG_Y$](W%C^YY/2RMS3GKWE[
MB:=EP])5`^O8Y_I>B?^DAKUO]<GX*WVO*9K5L>[D<F1@5\?0<DU:%Y"DUG78
MN6X=[EBRI'55W+EJ57S)JHZX)MF-`^LD39@EB/1PNH;3K!&ED9DU*@'/MIRN
MI!O6'=5-Z][4Z72+MJ5;6K/.5D.KT)S\%FM'US*OH#6L_<08<>OPP+/=V=:F
M9I:,^&"DA[4K-J%;[J[O/MH]W:WM_L[`+7=3<W#^(M4Z%%\$>P[EYG-#\]"H
ML$A%RUQF$])`Y?!ZL:@>2#0T1"VV(>`*L)WHW^YV.?4J#ZA"KBSRW#3XJW>7
M4U<54CI(P\"42TA_2^4!:IS%\5U+BE^[<^<1GR,<SG#:ML;EH_ZZ6[ZWHNF6
M/=V%K]VYXT@.]+7@3;0NN4VJO^=;G8T[OO!PK.D+W4V/#!R^CNU9<7=IW^/W
MK4\$75G)&O<X4\TW+5=JNU=^8<]U&Z\_V;5RO./NKQT>B#7FDOX.6\`1W';-
MM0T]PY^]=?7U-YR(7?_I[D6K=Q;JAPYV?.[6$DA)A+2V=Z<L]?</6]M_`X(%
MD?+57P1>)OB[+S<^_,'>BY\5$&>!6P.E)P6P/K30A38(Z(.]OWM#0)='RD5S
MJZZ(:TB+*0,I;">Z%WU,8;Z!U@)D+]\CM!/NUP#^`E-$K`:A%0`7`#(`:P!D
M@,T``X0>\'Z`U4`[_7'SDZ+]"R1HUZ,PP`IH1S2_0+6:/2AT><UO@&5S5=$'
M@/8O+OTMT"XK/[\,GHW`,Q/P[+5P;[QJ;BOZ/87]')P;=.D#P-VPUT[`O;!F
M'[2O`3##WML)';1MT+Y&!W81M$T`7?#<;\DS0&]F`V@KC#OAGB&TL+89L)_0
M_KX]_.]08)]?_GTTU?+QI<(CU5(MU5(MU5(MU5(M_RL*?O+2\[^/YG^7HO7_
MG[/7:JF6:JF6_S\+1I>>YP`$5)6;U5(MU5(MU5(MU5(MU5(MU5(MU5(MU5(M
M_]>4_5==+Z)+Y,*K\"?PU_&;S%W,.^Q?:E[6]NALNA_J?JC_*^XQ[A=77WS"
M>,ITNSEG$2T7R&7]I'H)QVP_L&^T;W0$G3M=[[@?\CQ*+N]#__+R/U#S;."\
MM#)T3?A@]/OQ+8D7$R^F_JGV;^JZL[^KKV]X*/^=QO^W^9J6;:W/MZUN_]2U
MKRK9?_^K8W/UJE[5JWI5K^I5O:I7]:I>U:MZ5:_J5;VJ5_6J7M6K>E6OZE6]
MJE?U^O_V0A@A\P:T$;$T8\4@`>70>H1T,6M7.8O%H9L(%106B5"K;0VTQ7);
M!ZUZ,H/&`#WU:%FYS2`+NK/<9J'_OG);`^V3Y;8.VF^M6[9T^=*>]-KMMXWN
M635ZQW5CMVW:V;]FY=K_T7ZT#M9>BI8#]*`T6HNVH]O0*-J#5D%]![H.C<']
M)K03]:,U:"6,7P?]-Z-]:`?T[OX??OI_-3VC_@&70F@K^I@"_QLM&.@P>Z4?
M:["68AW68PX;,(^-V(3-V(*M6(!^&[9CQ]4S82=V83?V8!%[Z;VOW._'-3@`
M.(@E+.,0#M/>"/H7!4=Q#,=Q`B=Q"M?B-,Y`7QW.XARNQPTXCQMQ$R[@9MR"
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M'KP7[\.WXSOPG?@N_9[1+7NWC^T\A=:R[YY@:Z52AXL]CT;8M]$4^[?H#0`-
M$J!'@%8)8!S:EP"TE^;8OSG1U9579@&GLQ3/)%/Y4V1@QE>3?X']&^:;*($D
MZ'ACQNVG(S^;6;RXW&AN51LG:NOR;W3P[,_0KP`8]F?L&RBI/G4BF<U?Z#!#
M!V;O05:,D82.LJ^C:0`&*>Q/3T3C^:F7V!_`^']DOX>VTL>^-V.VY6'"OV"?
M0W8DL2?99\LCSYZPV/*H8P_[.831'-3G`-X$N`"@06/LU]%!@",`QP`TR`JU
M!)`#Z",][%/L4[#/Q^%Y*]0Y@#&`(P`:^(3?@/Y;2<T^R=Z"PO#L9]D'D0OP
M9]@'*/X:8!_@KT)_$/"?P#W!4^7[QP"3\4?+_8_`O1OPE\KX8>CW`WX([@G^
M8OG^=G8??6YO&1]E]\P$):$C".,R0#T`"ZT'H?4@?+H'2:X::LQ^FMU!5SH.
M.`_X-A7#YSHP$XK0_^C`"8\W?Q0^Z0'X]`?@RQV`+W<`:6!H?X5FOTI3Q^X'
MFOU`LQ]H]L-7J6?WP'I[2.87:@%`!F#AN^^![T[ZIZ&>`SA'^_\`ZDF`H^2.
MO0.^8PIV=9B]928I`9/=?**HY$NGV9O@4ROL32>\@?R1*W<&GC`B8$L96PGM
M*!T=/6$PD=[1$[Z`BH'JU@X+NP5]`H!!3JBC`$T`G0`:=LM,-"<]SZY"MW%(
ML4@'F8/L0<U!K::^$]M?8O.HGT/`DG:V#K4#04H:;L<M(X9QPX2!%0RRH=Z@
M&/H-VC'V('N$924VQY;8/G:8U<Y>FIO1MS4"4I;JVAHGC4>-T\8YXSFC=EHW
MISNG>U-W0:>5=?4Z1=>O&]&-ZR9TD[JC.L.D;E+/C!C'C1-&5C#*QGJC8NPW
M:B4]/MIQ+[L97A-!+0",`TP":.`;#T._S-X(,`S_QC!\BANA'T&-X$X`.`?M
M-P%KX<X*=%:@LT*O%7JMT(N@)B/]`",`X^51W>61RC.$_@(9`4C`J`5Z+?!M
MWX3Z`FD!K(`[,]R9X<X,5.>8#V&'`M0R0#\`2_O>!`"N@;HR5E\>'P'0T?$+
ME*8RII!GF0^538FY%)Y.X:,I/)G"2GNI(Z^$H;+;[<.1X=AP<OAQS5AD+#:6
M''M<TQ?IB_4E^Q[7E"*E6"E9>ER3B^1BN63N<8T4D6)24GI<<Z3W6.]+O:_V
M:H9[QWH/]K(M\->=F$G7YRD.QPA^=L;KR[=8.Q8QQ^!UAJ&>`G@#@$42U#F`
M$L`8@(8Y!K7$/`V]3T/OTZ@/8!A`"T\\3<0+U%)YC/1/T3'2(N/,1\99>/%O
MSK0U]G6L`)$[##`%P,+<WX3Q;U)JM76,]D]#_2;M[RO3'Z7]$M259U@0<!NI
MF-L(QV\C"/^-:!A@'$"+7F4W@'+80&:&6@(8!S@&H&$WPK6!W<`\#=<WF6^R
M&<7<X)*0VPWZTF[CA`Z!,0$/F/&3M/X2K0_3ND3KJ&)987Y_A?G%%>;[5I@3
MT&"2J`,&'J1U2#%VF)_I,/=UF%,=9IC-@T+(S+AHK2,U?H?6JVB=49PA\V]#
MYG\*F?\Q9/[CD'E7R'Q-B#Q7`V?7S#AI;20U?HC6*V@=5XR2^17)O$$RMTCF
M#C/^"H;5T6):!VGM)S7^]3/63BLRG,:_1ITP$YYI3TFS#*((7YII[P"T,-.^
M%-#%F?:O`/K=3/L#TK?P;S%5:?C]F>AYJ<.%W\/+->3^G\KX'_%R]!3@"X!O
M!OP$:L<QP%^;:?\DH?]3>/Y1N/\J"G.$_D]0/WUN"BP#TO_'Y>>^/)/9#*L^
M-I.Y"U9]%&7HJ@_/9,Y#[P,SF<.`_F@FLP/0D9D8V>`M,^VU4H<-WXRB#*'=
M@F(,V4EO><5E,/,.P$O5A[MF,N2I3K+`+%XR$VD`E""[_!:.H'ZZG#03H2\9
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MKW_:OF3@%,(X=^_G_`3OO_=S@X.X9WIN"^K9+$^_OP;>@U^]<5H;62PB]^TE
ML62_UE;L[OR8:J1<IZ\4,7UU$0/3#_6L&9C^1F!P.D\:EP*#/=-+U\@W#)QB
M=C%C79VGF'&"!@=.X;N975W7D7Y\=^?@93(49L:!#+431,A.H#`A0V%\@I+U
M4C)@TW!7Y_%P6"5Z&2\G1,`^+U.BF]6YHK`$S-5/$)`Q012E<T69("$#?E`G
MLUX]F0EA*YW,:D)TLAI"=#P6`Y),C)`<;XD!P?%8"QU^ZLIP)*9N9Q#%Z#HQ
M/$C7P?@*35*E`2XHTS`<T*3_/<OHXM]'<57!)S;]]=8M7:.1KI%(URC`R/1G
M;M\F3D]LEN7C6_^:#,C3;'QD\Y9M!&\:G?[KR&CG]-9(IWQ\TY:/&=Y"AC=%
M.H^C+5UK!XYO448[9S8IF[HBFSH'3SQQ<$G/1]8Z?'FM)0<_9K*#9+(E9*TG
M>CYFN(<,/T'6ZB%K]9"UGE">H&OU7+<8]_0/'.?0XL$E-ZCX!&/DX3R,^$.#
MB]W"^+7T<"P*B??XG]<@4%O&]."T*;)XV@Q`ANHZZCK($)Q.,F2!;FMY2+QG
M4<C_/'ZR/"1`MRVR&*61V+6]\_)OSYX]>PGLVY>&>N\^D?;MA4,;6M,SW;UZ
MX\!T^W1[U[0RTCF(R=^QKUR6#"C"2^VOMC-C[0?;C[1/M1]KU^[;-PC=]I?"
MKX:9X?!8^&#X2'@J?"RL(P,W#)Q4VJ?"OPJS^X";\%XH79UTS7V`X4=N]^[;
M0PJ"!?8`J,NE]Z67#'2$T1:P=C%8YG7(`1`!:`18`Z!%WX'Z+P%^`?!/`!KT
M::@?`/A3@!.DAZUCZ[K$[9UDQ<$T$3HBFS]17\BWS@+>=).*UVQ4<=<J%;=W
MY$7`,Z5&OL,*AC=&ST/]'P%^"O#W`+\#T+)Y-D\GWZ=R[>`>M">-8?L(;O:2
M:D]Z+TY#`Y//O7=/.HT($`:'?P!(T_BC?(_PGGT(/@7\(8"`B/;N(8_M([A2
MR`"(XO\*FRGQ\`IE;F1S=')E86T*96YD;V)J"CD@,"!O8FH*/#P*+TQA<W1#
M:&%R(#$Q-@HO1F]N=$1E<V-R:7!T;W(@,3`@,"!2"B]"87-E1F]N="]+04E1
M3$8K5&EM97-.97=2;VUA;E!3+4ET86QI8TU4"B].86UE+T8R"B]&:7)S=$-H
M87(@,S(*+T5N8V]D:6YG+TUA8U)O;6%N16YC;V1I;F<*+U-U8G1Y<&4O5')U
M951Y<&4*+U1Y<&4O1F]N=`HO5VED=&AS6S(U,"`P(#`@,"`P(#`@,"`P(#`@
M,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`P(#8V-R`P(#`@-C$Q(#`@,"`S,S,@,"`P(#`@,"`P(#<R,B`P(#`@
M,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@-3`P(#`@-#0T(#`@-#0T
M(#(W."`P(#4P,"`R-S@@,"`P(#(W."`W,C(@-3`P(#`@,"`P(#,X.2`P(#(W
M.%T*/CX*96YD;V)J"C$P(#`@;V)J"CP\"B]3=&5M5B`P"B]&;VYT1FEL93(@
M,3$@,"!2"B]4>7!E+T9O;G1$97-C<FEP=&]R"B]3=&5M2"`P"B]#87!(96EG
M:'0@-CDT"B]$97-C96YT("TR,38*+T9O;G1.86UE+TM!25%,1BM4:6UE<TYE
M=U)O;6%N4%,M271A;&EC350*+T9L86=S(#DX"B]&;VYT0D)O>%LM-#DX("TS
M,#<@,3,S,R`Q,#(S70HO271A;&EC06YG;&4@+3$V"B]82&5I9VAT(#`*+T%S
M8V5N="`X.3$*/CX*96YD;V)J"C$Q(#`@;V)J"CP\"B]&:6QT97(O1FQA=&5$
M96-O9&4*+TQE;F=T:"`Q,#,V-0HO3&5N9W1H,2`S,#`T-`H^/@IS=')E86T*
M6$?M>0ET7,6Q:'7?._NJV4>CF3NC6:71.IK1;NEJLR4+8<N20;(MV[(MXWW!
M-M@&8QD"MF4"B=FW&`($L`&-)-N,;<!.XBPD(9"0!0B'Y<40"`A(ON&18,W\
MNG?D#?AY_Y_WSGGG_#?5ZJ[NKNJ^W575U=4:(`"@@4%@8.:,KN+(PE.7[\">
M-S!?NGAU_SK;OL^O`"`%F`V+K]KHEB@>OQR`\@"R.Y>NNV(UF7-L+X#B50#)
MBU>LVK+T%[Y4"8#N<0!'SK*!_B6O_;#U&$#^29RO?!EV:$N9Y[%]!MN^9:LW
M;IXE9SX$"+L!S%M7K5W<W_3&E#8`_GX`XZ]7]V]>IPNJK@3H7H7\[C7]JP?R
MW[GR'FS?C.MY8=W:#1MO/NK_,\!E/0`FP[HK!];UK;K.`K`"^97C`"R0TR`!
M.8LUH746PU**F)P#^`K4(P`/;M@H!^3\E<Q#CHH$`FE>-5:E7QWU=6#^(P:`
M`$`>0(%8CWR-V@Q3H;4-VB\!F#&S$SMFP^5?8_KO!,DMF"\!#G,.LQYL`*EW
M,+\OY.3TU!G)2O`FEZ7^C:E#YCLF<QK\\#C<0E2P#:Z'%MS[(_`+6`GKH!.&
MH18^)7^$::@J/UR-`N)A`BRD'Z:2"FS=`M;4+Y`R-_4!?0\5=`_L@+_#)O@#
M+(:?@A3N)67@@TKX%4Q)70%&R:M0#C?!':D_@8R-PJ/P:NJ-5!):X?OP*JDE
M7<R@I`[%NA6NA9N)E>232G(MZJ46-L-S<(+J%8=0WQUP*71##UP!!UF"WY3`
M3!@FOV>:\$L]L(?$R(G4DV@Q?AQ9"`VDG(931\$%^1"%&JB'&^%VN!O^2(K(
M%*:4/0)6W%,_'"%:8B&YY'CJ?N`P=<`\7.G-<"?LAU_"+PE'NFDQLU#R1/)]
MT,):7.$VV`._A[\1);F<;*8)YJED?6I%:BQU$D=7X'>:83JN>QO<A;M[#`[#
M"?@ARN15XB0SR5WD8W:C)#*Q(_F;Y-LI2^IOH,.USH9EL`:VPV[4S??@1_`Z
MG((O"$OD)(O\B);0UQDM^SV)-06IG:@U-Q1#`TIK,^R$79B.X(B?$#<)D3*R
MD?R!:JF.KJ+7T0/T(V8W,\+\F?U+JBGU>.K'*/,/0`9>3`&8A5K=AEJ[%77W
M)#P-AR`!/X>_PJ=P&B6Y@NPA(^00^7=JHD_1W[-G)*]*/DT]D#H#*I2V'T]+
M":8RE.`T:,.UK(%[45,OP(OHM_X)_R0.4D6N(SO)$+F%W$'N)&^1S^E-]"7Z
M)G,G\P039W[.$C;"KI#LD;PM[93U)^],WIMJQ]T9<>XHVDT=RG``;7$#VL3]
M*,=1>`:.X]K^';Y$N1AQMSY20V:1S>1:LH/<2AXDK]%6NH*NI>L8PC@9+Q-D
M=K$<>X#]#?NZ9*MD3S*0[$T5@6`W2K2&&EQW#Z8%L!2_LA73'I3#,#R+VOH9
M6NT':,V?P9?X-8IZ5A$S\9`@:<$T&[7>0^:3?K*,;",/DP/D=?(QU5,;S:6W
MTMOIP_2W]"_,>N8VYCYFC'F%2;(IB4H2P=0NZ<7]'I#\73I;NEO6*%LD>TS^
MJXG\B9]/O)E4)\W)8+(K^:WDL51/ZJK4U:F'4H^EGDH-ITZ()Y5!VW6B?;DQ
M!:$(3TX[7`+S<?TK83W:Y!!\![Z+Z3'<PQ@<A)-H<;^!W\*;\!:F]^!]U.R'
MXIX^@S.X)QOQDE*TEPHRCRPB2\DZLE5,UY.[R3WD/A(GQ\D)\@OR"ODC>96\
MC>ES\N_D"VJ@1EI,*V@SG49GT%ET,1V@Z^AV>C>]C_Z`/D./TI^@EO]`_TC?
MI4DF!S71PK0R?<Q\E,@69@?S$/,,\SOF]\RKS#O,%R@;%G7D8;VLGZUFKV!O
M8-^6A%!.2R0K)/LP_4BJDJZ0#DO'I+^4OB^3RD*R5ME,V0]DH[(4GI1AV(NG
M]`)`BWN<Y-&YN$J&_)@>)+>1%^DH.TZUI)=L98`6L@5HXQWP'MW-^$D=LYDX
M\!Q_&]HH@S+4T@?H-+1N`6;A*2Y#.^R6O,*:R6-XW]Y$EJ&_>0GMIQUY=L%1
M\*=>A2SX;FHE'")6/%$#J7OP+`R2=G("S]`5=#W]*WN&T:.%OL.\AG;S'I[]
M*+E3^DN81\-H;5-@'UB@"O7Y)FPA;EH$<^`>9A=JV@-VR&=72="'D[\SH["?
MWDEWTX.I%_`F_`C]WAQV&@'V;?3[^<"1#^%I7-LOZ"MT-SG$2LE#9`:N(8>1
MHWW\#'ST`1A@-A&6#M+_Q;X*K]$J.H<I(']G2QF,.%!/-T`O^9#(X4ER)_V"
M>.`.,HB[?Y=\2-^%C?"_2(I.,+?29>3GY&?$0L.DD2F!)'V'+,+5^.!CB97(
M:06>(RG:U7MT/[.4W`>O2'[$O,%V,(>!)<^3"GJ&<=-FTL%4IL;!+_V"T21_
MGVJ"9II*[655$Y^@=-;#:ZF33"';ST[_\M"7+U$KV<NLEO2D_I[<)KF!UL%2
MR0>R*;"%-J&'>`GOHF'()Y_0;)0[ASW5*"DK^YTOOZ2=X*2?DL]@,[D53X</
M=]*-GF,8KB"/(Z\$[Z9ZO`7^20^@U^Q@-J&?.0PGT=JO1=]NI(OQGEE&9@'%
M6X(5[X-[T1K^QBZ'+1BAS83G\#8]@#67Y-$D#[]&OW<9GL4_D3UXZEII%=L#
M77B77@^Y&$$U=//U=5-J:ZJK*BMBT;)(:4EQ46%!.#\O%`SX?=Y<CYMS.7,<
MV7:;U6(V&0U9>IU6HU8I%7*95,(RE$!!BW?J0G<\L##.!KRMK85"V]N/'?T7
M="R,N[%KZL4\<?="D<U],2>/G$N_PLFG.?ESG$3OKH7:P@)WB]<=?['9ZTZ0
M.9T]6/]VL[?7'1\7ZQUB_3MB78-UCP<'N%MLRYK=<;+0W1*?>M6RH9:%S3C=
MB$K9Y&T:4!86P(A2A545UN)6[[H18JTC8H5:6ZI'*,@UN*AXMK>Y)6[W-@LK
MB#/^EOXE\9F=/2W-#H^GM[`@3IH6>Q?%P=L8UX5%%F@2/Q.7-L5EXF?<RX7=
MP![W2,&)H9L3>EBT,*Q>XEW2/Z\GSO3W"M_("N-WF^/6K:=LYYLXN:&I9^>%
M5`<SU&);[A::0T,[W?$'.WLNI'J$LK<7Y\"QU#]UX=!4_/3-@A!MQ;@08?G"
M5M*;&O"V"#T+5[CC"F^C=]G0BH6HC^RA.,S:XAG-SN:/I-Z&[!;W4'>/UQ.O
M=WA[^YMS1DPP-&O+F)UWVR^F%!:,Z+/2TAS1ZB8K:LV%E8%S-+$FL@NU]EGG
MQ$F$%7G;T`KB[L5N7$F/%S=2*10#E3"TN!+9$'H)CHHO034LCRN:%@[IJX5^
M87Q<XM=[W4.?`:K=._[1Q3W]DSU2O_XS$*J"<9RS+Z2?K<?#X7A^OF`7LB94
M)*ZQ3FS'"@NN2M"/O>OT;D0H/IC9@\-ZJXM1YAZ/H-4]"1X682,^V-F3;KMA
MD6,4^.)P;YPN%"@GSE+,LP7*X%G*N>$+O6B^!\67A3DN#YS[T^DMQI9EU7%B
M^1?D@32]O<O;WCFGQ]TRM'!2MNW=%[72],ISM,E:W-C4PSCH9(TZ&)&*ECCO
M'+/0Z%''63_^245+7I*0R=$4Q1[BGAK7+VQ-E[U*C^?_<E`B]:DP2D3GATTN
M,UX=OKA=<U'[HN6IAQA<,!N@[=USAH:4%]&FHML9&IKJ=4\=6CC4GT@-+O*Z
M]=ZA(Q@#QH?6M2P\J]%$ZN@>1WSJS;VXB66D&JV50N.(E^SJ'.')KJXY/4?T
M&/GNZNX9I80V+6SL'?$AK>>(&QVMV$O/]0HMM]""=H*6/DKE(LEQA`<8%*FL
MV"&V%R<(B'WRLWT$%B=HND\O]B$4BN$%#*7>D3R$-T`0;N5]/GV3JDD_3WJ%
M:J/R*M75KIOT=^J%</^@6O,#PT\-5*HC-$$Z>(7<MU=>%G0SY@0U/I.UQ*8`
M,S$G&-<HW442I'$TN`L2J1,'355P6IM@MO.&''Y:>S2'-U7MRR$Y`Z&!;;;P
MI?K3?>%PQP<3X?'3XZ?ZH'[B5'WM^$?Z4Z4ET+>>]!'&&RQBO+D8)$G-)DM9
MI+RB3,IZ<WV!6-3@*XM8Q2[)0P,^5N)K7=,T=M.!_IGO)?:\UE>\)GGZV`]2
M<-/'9-\KBZ\IM]E\^9*5R;8UM?-;@HNVG7KVAS_Y\-H=PX_N.?/=-\DCGQ:;
M3,5`4K_&V*,77YS%I/60.5>755>*6^!OL%=')5JS]J[`8X'GV$-9SP1D1*L%
MHM7I0%:@T2R0.V46I]5I"2XK+NX/.8/25DK[)4ZI66=RFM$H_2Z?TP\ZG<OI
M,CF=KN(B/RW2:+5F/[68Y<Z2D,NIESX!,EY&7Y*]):.RX%X(E`3XP,S`NH`D
MD%T*O],=90BXF!9>;=`Y.6>QDQET$F>";#A<HL`OERBQ.G+&%@[K:\.B5-?C
M*3D"SM3@6,!:[T0#'0O91,RK"K&#MU4Y^:RJL`"]I./4Q*E+]9^O[SA5W+?^
ME#"'_@34U]8;JHIKQ_7C.[5%8<DV_4D;Z,>)_D1?&A6-?P3ZST@:7="S4Z*O
MW792IJ\M+2&H7,*(6F.\Y;%HP.ME!#U:99Z*<C$9A=Z`M\*3I@<#7GKO@Z.;
MKZX/?#NDZUQ[\"IWQ4KUQ/N:2[-#1H?_$V=VV25J-F=)0-56%=HC82?^,GU+
MTE`;G-*4O&*USQ^2^?U4G>7,&V1*%U=F^PW^Y!-UH<8.O1)U>P*?&ZVH6Q>Y
M[2#)U559$JDW>5YGK`-.YZ:SK?<8QQS,H)M0!>.D"@,QV(Q.`[&#DV0I]<XL
MF]WN4BA-"H72D$4ID2NXD%*AMSU+C6!'W2BID<\RZ!2<HEBQ77&K0J(8M%4I
MT'I&PS$!/5,64_"!8%2H\]90;%!Q0O&RXFW%I\B)BE#P:&P*09^<0F%5<,JC
M9`,QPGF%AL-]HK($O?)F!6]0U2MXDQH+BP8+J[9>G%F1DX4MET%LC;F-`A9-
M0#%I`F*_SB7BT6!5>I#96Z\8U-G31)7A+*X3L5=L#_(*M!L%'S*)U!%3VG8N
MAK0EG;>?6L%RM.<MY\)RTHH$(^E;'P[[OVX2LH!,*I6)!F,A_U!-_%;;[2@P
M>[P?N;)C'6JJ5O%<8;'_0[>]PB^JW56\A8DLC6;[C'X_T9FF;S_SZ_6<W6O$
MM\U6]'#/HX?38P3[]"%W+@K(*JB_%2M1>W5.=6ZSO36G/;>;7J[M,LTVSW'.
M=PV85^2LX*XR;LVYEKO1=(OS+NGMQOMS[G4>-!]W/N=RR+1R(\TJ`R:[3*ZP
M"@XN2XV^3<W/BZGY:4NBZ@&,,+'7QO*>AGJ61QFS2&,%&LO;8VR"6`^O\Q'?
MP#Q;6-_WN2C`#_0"_@#JQ^O'43+KA?,3L6`83='I!02G5^ZSYDK/>\-R`PJ+
M^=O.EZ^:2"Y[_8%7!IY)$O?@DN//ML_;>]?<X057?W^O9.6F=Z]Y/>DYL^?4
MRN?)AG_<Q"]^Y_#;/[OE3W-6[R9/)';]!N53DGJ?^2&S&U\2,?(:;U.XY9X8
M^1;Y5OX=Y&[';?EW%SU9=CBL*A%$9E6;ZA^Q/%)*R_.GNZDZUQY3:W-#4:U`
MJ\)*O76&=8&5F5)"U#PVU;C5(Y;7`N\'&$)9%BP6JS\0,*LUEF!Q)."WL*7F
M@C)G(,'<P1LAZ,O-!5D(\/EL#IC,YD!Q(O7&&.JH.,$4\9KL;+W*7!X*F/6:
M(?5SI`E8?.":\1'+/!-XRBQ8O5DP9ZW7'P6SWEQB9KXC7$FIP=&NF/DY>@<4
M,#O`@$[QQ%A1-.H43R(>2>=@5VR?\Q,G=4;*S59SN3+RX_2Y2]].X4E/>F)L
M9DCPH"?&(O8TMDVV4;4BUDWVXT)$;$RW1ZSGSDIOQP>GPX*YGQ[73WP^?NZD
MZ,?#9X]*V%8/V-:?(EE568:JK"K\`ZP0_0L[!;H<#Y7^Y$GAW``ZA2L)3ML'
M[?'\KO9X-48TQR&6^AU$,8=2[T,P]7XE0B_TA87;5+`;X<[$8V:52M&D8M&*
M"K0FL6:H*"^+6*P5,KQNJ6A?%<)19'[X8PNCE*LUYF!#;LO>NG#88KYAS8Q+
MVE8<OVW#TBF=9M]/^-:E^YH+5@\>:&1V3\R9JU'HU0J]<ZYMV>IP7NG,]@/-
MI5M6["/]*[KYZ5?FU,Y.CNYLGO'0']Z9?8D0?=2B[:U"VPL1#3\5!$\6$HHB
M*"#A8%&H#NI(M:0N6!>ZF>[Q[`X>H(_X#G%C/CT'V32;M4NR@UQ(>F.`;`T.
M!7_@82P2DB_XMJR8B"PB0IN([0L-AV@((*2Q9R4(>]#I4\K\:+5C#GT]XC?X
M7%>5/\BHX`73.GM0@T91K*G7S-`LT+`Z#:>AFNS\W`2S@W=)D50OG2%=(%TK
M90>E#TKCTA/2EZ42J3TO?%DZIEF/,<VE^J2`Q\=/X7$.A^O'QPFJL4K_0A_J
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MVJ@@7JL6Q:L=#,VLU_(XT3XMT=H#X1^?C17#'?\00I6^CG'126*$TA=."]:`
MQT00;UJZ?=`GGEL%*EBX*P5%9RGKY9-8)F"%NDYHCR).GT[H(WW&LW*U?D7\
M,FD0_:T8Q>1*3\NNF]-ZXPWF\3_NO3U!++>M6-IX^1/K3M[>=\TUL=*E[Y(M
M$4_OMIH!YX>)M7>0RJ<NJ^FZ9/&4O.RLO(I[6O*CKZ'=)_<EIS(O2&Z!)K+T
M"#"XG#F%]8P@0^/L<+V4MS98&ZN`-;3PH;RH5^C/MGNCP&/1PD=B+;P%LPVS
M5A]M$;R,)C8BI4W=/;S:P[(MS<3+XSS>!%G)ZWT^D);=,<57"/H['#Z%3HRS
MA5!;/Q&N%817_**##WMR@T&.H4V-K-?'<K0IV(A^F`N:,..P]/@+9C4*LPJS
M<<VA(*<OKZXJ+4G0Y*BU5).@#*\O,?)&:GRJF;-RS<K(G](N%74X,3XQ?L[S
MC:?7@(O1GSKK`8G@\U"A.T^>U)[$:/*DMK8WK5011+6R*"]<"!5N'0=6V-Q:
M5SWE:TWUN;F%<^H]0M'"&\\ZWEXQ$I5Y&2H3O5T0%5L^J=>T1RP70P]O1;I2
MGB:F+:`\?>*$D3*ZV+!W3=OTY5OFS:O-Y\K\#K]9+U,8PPNF>[13GGY:V]58
M45!3/OWAUDOF%?FX8+9"8Z^/-,4<K<SZQF1[\JWOO36[P6</N8MS+1:C5J:0
MR,I7#N1_2!]MM#;T;L9'64>AM\1GUQ?+M3)E*+:^YJ_H(?/P=#Z)EE).9O"K
M#=VRR_(>SF.62Y<K5KI6!;<HMKBN"5P3E'?!R@#MBA$37LE&S(30_'!!`1A-
MY2U%<T*QDO(.XBTD10`RM9ISN$T.AQL*H+R`*RPR%186>4M966&!TJ9R5(3<
MCJ)"O6G(F"!-8VJ9WYT@OE&UWW%4N$,I,UK^2J%PO]FSHP(>M5:)*"<F]GI]
M8N]8?E3$O*$Z]DDA*;17.*R%5D>%,G+3!<^4M'HZ3N'S#Z]$\4:<M`P,'\=W
M2HK"<K0(M`Q;&#'8ZHE!O`T_&P^?(9_AE:C7;CN)=Z)H'WU]?>WQ"'K4<O2H
M(^[<2E2[$"XKB$U=5819B>9RV&BJ,^6F+:.7$,.D&3#2R1NOPJJEZ8O1F#[K
MHMZE,IF75(A-68SV)O]R^%=])7S.5FN62I-55<GE;KD\UU_LW6"QFYS^YE[;
MKGP'?R=I\X8Y@]\LN>5,C!@.-E8TSD_V72+7&C0%EQICVTN+_06;R7?:PR:;
M)?]*[D]3NUYD-U^;'9(R08QIH"?U/BV26$`%><3'!ZUKJF.6JZICAC!OB(5Y
MNR/:JR9V+[%8\UH\<T*ADKP.-:R3)IC[^6RU+*36J?-TG,MC<KD\#I4K/^1Q
MZ:U#%E3H09UB':-.D&FCS$)=@GB?R5ME</&.F$M06G5-U#6I/)?X-$!MNGC.
MG6X9C99HB>M6%W79\UU65[[RZILNBI32IY-7N03/[>(U6`B3X0O%=3X.ZA7>
M"._I)[4MZEHX^?+)V.?S<?U9Y4Y&P#CE(2N/8:=&5%^5%;4G5`_IJJR\[NP;
M5HR4SQU9XP7Z/!O?G%-HC/PBO[HF+Z^FNN*G)J-&9ZZJ]C;/:Z[+B]JO=W,.
M2XO$4IV?5U.3EU^=W##1-$VK-^D+NZS+IL5*_?[+R(DU.98<55"(76:@COKQ
M9#I)'C]=`<0`'.'X[%@W=.=\POW#RBK=JA(5KYJI8E7.%O.<4$Z)LT/\W<O)
M<`:SR6`PZU0&5\ALT)]G7(6/OV,XI8]7,WX#&,@)P\L&:DB0&E[I4ABL!I?R
MZDLFSQ#>A.F7O@'EC%&3050:!J@&X:4FM,;\EG2OT6O&7@_V"N&5@=<[TG2,
M6M.CM%;LU:2Y#]FJ#+SEXC=>+QD_=?JCOJ\J#0]E6F&@[WM!?/,3\9&J4@G?
M40H%06V->*O2CIB0;U`-.:L:VI_<;S=JT="J7`MFUL0"96ZB\P1"UF+)+5_.
MZ37I3%EYEW$WQ0+17-\Z9O^&+!LG\Z,FO*GW)6LP@NFB+?RW['BN*PM)KV*N
M>H'F<M.\RK[JOIKYM;-G+3,NMZPHV*+>8ME:L+EV-[.G8$_M[J8'F/NT]Y4_
MT/08.:!YJ.*)RN&JX>KAFJ=K]S<_W'*H\G#UX5;_RO)E%2N:F5G0VSQK%K.[
M?%?SW2W,0-76\DW5US1?U?IPE31$_%7!:<6SUW9+/+E=R?8$R>&[0[-*NCI`
M4RTC;0T:936!]FAI5E9#J4S6]5.0F>QV+J_$E)=7HJRNYFKJ3#4U==`*7:U<
M6[NIK:T]H&IK;:VIJ5;F=>/QKJMI;]/G#GD$GVPW^4L2@H'8_7F\-K8P[ZT\
MFI>@T<-KJ\EP-:D6+F!S#>^-U?".G.C:&E(S4TF4_KJG:HZ2$]!*F8/M3\UZ
MH2WMO$7DC8F($]$8#A*;]G0SOT!L\M;B:'1MVR=MM,W>G6>ML;99\[K/^_,+
MO`!Z='3II\?[]/C6&>];C_T7^/=SKQY,]>=\O`1]O/9B9W\*'T+X)T0H66F_
MCW\7NH<^$=+VEJ5!#U^+&7+55=,1EPL[T%7IA!!/5\6F$:0[N]+(.GDAY.8:
M+[1U(1!DQ#@@?3G(#!477!/6K]T3%1>&"-YS]P8&&XS76#'9#))GK[]\RH(Y
ML>I(HW7:PWL[9Q35&-;X%%*ETEX5\=BWSPEXB_/F<I11J77YQ4.;9[3<=2#'
MHO?X:Y^+VN???L0F"W&:&@6S.SEEW\QK*]U\I'1&DI1>TUS?6-V0O&:[5JN4
M&0M:S:&;(R7>DN^2AK5JH\&NU8:WOWO71[1OD<>1;0NF8%-%\@]T5[=18?&J
MA9.#3T3F*3PYY>36]$U9.'E3\O=/7I7R8@LXJ*.8[93-4LQR=;JWD&L*=[M^
M$'PD=)0>#:CFD7FAXX29HYCCFN,6`Y,5KG18(KTLOS.V*H#GYN*P)"Q&)87I
MJ`2#R@("A?N\!$,0%F07A"=A*`]S!86F@H+"@O#9T*2PX!M"$T&?\V*.!+UC
M-/9"X;/$!V'*0(%HX`5IHHBJ123<;P63P4I!.G8I$'TDAC2?%)`"(5@I^#\$
M*_BD.W7J=/CK\<HW1"MHO%>22=/57Q2S_(N017B%K!<^1)AOB$Z^=IM)T]')
MV2;:V<D;C_UL7J3!N=6L5ZBS8O5<7U=UD;\@=Z,EVY@3G/Y@;S$7N?.PVYNM
M=@6D:$Y5Q!IOC-4N2<YMTVN-FOS+C#=6!0L#)9O(WO9\D]U6^-)#LP<>I5>N
MMUH\K-2'-I./5]@4M)D\^`??0-%>/)@[R6QFOF*^<E;>?N9)W7[;H]F*&[/O
MR$Z%F=WL/2QU<1R!%L]?0WDET$&HR4TY2CS%&J))D'U\K@G?NT06(LC$<6Z/
MR>WVN#EER./6ERAXQ4P%HSA*><#3,9KW@EO059&URLU'IT3=?$',S?LPYV+&
M4,7-YSBCX";@WN<^[G[9_8D[Y9:BG>PZ%'9;(^+->3HM8`2,1<0;[;SZTO^`
MP6[1[5RH.O'_+\(O$^AWPF&CGSGG%@25!`/G7,!YC8A=*TGO=X9O[2SS!')M
MA58/2V5R598N.];5G^_*E[KO.>+6F3SF2J:S,IE-PE<W!_V-M84NSBB5R[7\
MHOL;NZZT7D=7KRHRJ/4*(>KHQJAC,;L#7$1Z!"1X4->CE\-(Z!'))_1++3/;
M,02?$\;GK(:Y6D;G=KKI=A0"=8%61UB)3`;.')>#9.<X73:)G25RL&3;[2S+
MW`8/4B(UJO`(<AC(6BQV"Q>R6_2T3<?@PS#%$&:5&X9ENB'M44)`AI>,VF#A
MRZNB)RPO6ZA%C%`XA<5JX2Z*4,2@4&<1(A*+$!E:A'_5B<'`!$9[IP1M3/[3
M^.PO#7ATZFM/38@W!*K!FO;]^"04-""IK27Z%]+^?WU?7_HW!IGW&\^(%Y]R
M%=1TZ0-9]S^9HU?9\VQ=GGFS*JL**MV/W:5<LW<.NR/Y:?W$Z(*<+(/7=(7]
MIHI`1;A\+3Y^75??!N)/HY*LCVXSC)<NT-5^)K?+A5_,X&$N\9R`?_ZCLIXS
MDHF;E?OE)=A4B/SIW]1`YDFVP.7*ZC.2?\Y4[@<;R.!"^*.TBN0(%3J9!6#F
MD0#\-X/D,A@Z6V?_+/PBE@:Z7_@%Y3Q(]Z=$&4A^!EOAOP!8`$&&P'P;*K$>
M1,S3JN1]D[0\6@4]9WFQ/@._ZQ7X+IR#<0J>2:1W0P;^Q\&%-I*!#&0@`QG(
M0`8RD($,9"`#&<A`!C*0@0S\%\&-0B(;A$37GT\,^8\36\_62PBF8]*7I2_+
M?BE_0$B*1<J4VCZ97E6_JKDEDS(IDS(IDS(IDS(IDS(IDS(IDS(IDS(IDS+I
M?VIJ6`0$0/$>=`,5_Q]'00_%,!N`?4TY/OD_.CDL%;@0&."P3-=9K'.3=2G6
MZI`*K`)[ZJ!OLDY!"_=-UAGL?V*RSF+]+Y-U*=01?WM#6^<E4\/=RU</;+AT
MX.I9:U?WKYG95=BVL7_5\L4=W?\Y,K1#`[1!)UP"4R&,6UT.JV$`-L"E6%X-
MLV`MMOMA#<R$+BA$SHW86H5<BZ$#N6<AUQ6P"7OZX<K_Y%S_G:-%[4+JD_T_
M3'E@"7P#H!V(0.@W4?]?@3!BR8JEY()^Z3?S7PA$AEF.64&46*J(6NS5$"W1
M37+H,6?]JSDRD($,9"`#&<A`!C*0@0QD(`,9R$`&,I"!_Y]!LF%=_^(!TD2F
MDC8R@_23Q62`+"7+R'*RBJPF:\B59"/`2#<TJ)EGH00SC_E!S'',DM0)YMA8
M2TN$3R`.%XEX-)07.2(2L@.1P08C<PSV81[&_!)F%@!+#C-ECM%A"`*'S$=&
M+0YQ5&*TL7&R4EZ9KHSE%T;>:E`R"?@$,V42S!$(I4>-A8HBGS;HL(/@M,\`
MP<S(`:=_GCD.89'I^*@O/W*$.<SL&*WF=`U69@STS"BX,<_$O`[SVYBEN+HQ
M>`OS)YA3F%DP,(^/_MMN[GEF'UE)[L59[X;;Y(17<]O9[1*ZG6YGZ()C-`XD
M=8)81^U+(XG4B;&![*6X[D&R0>AXCOD6L0H+2IV@PZ.E97P"49&(QE!.(@X$
MT]CC3^,<MXA'O6EN>]F#SZ*<XIC?IL.'&)[QY.&'_CY6'9@2>9:Y7DA0+8=#
M'.^?5^9*X#[G+4&&C\?\164F;`J*6?X\LP-E-"266J&O.*(7:)US(VH!7]H9
MR17PM(Z(5IAB:ID2$:\(3(L8_$T](M-HI$P8,YI?9A!8*Z9$#,=PPBE0ECK-
MF_U3RFS^V-R(WA^(1J3^_#(U?C^12O(^?V&9NKJX+'*/?[__J/\%/ROQER,U
M4AFQ5^=55U8S-K\5)SP8\E?ZV6>9'4("OQQX/:?CA,5SFSFJXDK*<%=_&^/$
M;0\*"3AD,G,5"V3#,KI`.BREN4\BO^+)8OSP&[SR22XWDNL-SQ*VM'TTKTQ$
MN8)0MH^ZW#C;7YYQA<LB+A2&8&G;#U\R(Q()%)0U*%,?,]NA"C?V!>(PXK_B
MD.HR-XX<JY\:<0FXN#IB$&8J*A.;:*7B_($R5FBV38\*&`4I(D^9#1&O=I;E
M!DHBD=Q`625^_PM>&<"/*P(.3V3H>?P48;8+"0*XL2*N@I,62^NES#XZ3(_3
MERB[CQEFCC,O,>Q:Y+J583BFF*EG9C`+&(FN(4;'4;D+L-R'^2W,#!1C68]Y
MK=@:1ALB,`-+G!$H4H>1*M3J!2L6*0N^0A'.!V%&F5$ZCBF."6?ALRL(E!">
M4$)`02C(P6I%=V+(DO,-*GH-]4(4-&2*6%:(I8//CFINC6J^%=4LBVIZHYKN
MJ*8UJBF(:D)138.>QL`-&NH02G)&+'\LEC/%LH#/=FL^=6N>=VMN=VNVN#4K
MW)I^MV:!6]/LUC1H2!VI!`U,$<L2L70*)9DXJ.O0@>(XF8`.T#`C*%HS<-0\
M&HAR"6H:#=0CDH^ZCG$-=BH%EYP@58+Y`&9V$C/`L4(_@5+!"Y`OP4LN0_ST
M:""?2Y"GTNB`,&>#F3P.`6$4>11<Q(_X$3@@MK\/I2)^:!(_,.I=A</N%U"#
M@MP'7N$C^($R\2-7C0:*D+QJM/1*KB&+K,1O"MW+P">RM:")"+A^<IAWU/4]
M[EGB`1<5FG`PL(6;P/'^4>Z?90DY&>7^X4O0`Z/<^X$$P=:[2+MWE#M5BBU>
MQ?VY]!3W;Z6[N=\&$I0<YEX.O,B]Z$^PR/A,J<CX=$"<Y$D7=B+_]TKG<W<%
MOL?=EIY[R"<RW8#"/,`;N>MQ2YN\I[AU.,T2[Y7<_/14?5YQ!;/?$UM=N!Y$
M,\K$SDL#PL1&;EKI%=S4P`&NJ?1%KLX[GZOFL/\P5^4[Q55XQ6\5><7A^2[<
M'*XDSWN`"Y8>X&97/$M^"C(RA#G,%\FVR];+ELN6RMIEO*Q25BXKE.7*/#*3
MW"#7R[5RM5PIE\NE<E9.Y2`W)5)O\V'A1TN35/C)"*2L4+)B74^%4OBU"^\8
M2N04ID/<R+33]J[&>$6X/2%+S8I7AMOCBIES>T8(N:67M,=/+(;V1>[XYUW>
M!%%VSHE+O(TD;FB']NY&&S+'Z:X$@>Z>!$D)(VYTQ`U-/7B)$?[&;SL$W'OC
MMWM[P7)5O:W>4)=5-;7Y&XJ%DV7X/-C"%X/-&;^SO:LGOM_9&X\(E92SMST^
MK<L]K^<(W4:O:6D^0J\54&_/$3*5;FN9)?23J<V]Y]C0H*Y%-C3J:]-LV\$E
ML*%U;Q?9YJ?9.!R-;'X!"6R/`R>R<>1Q@0W-3.`;.<"U-(]PG,C#KH,#(L\!
M=EV:QR_RO'<!CT0/[XD\[TGTXN>L(HO/ARRE/H%E)->'#".^7)'<>9[L39.W
MI<G;1/*:\^2R-'E_FKP?R>'_(AAH_(\X6I9W-9+VF3TC<FCL;9J7QA;]NCK1
M#K(.31ET'"4YS&N@"O?&E=[&N,K;"/7UMK"^EA3W2=5Q*?;),`OL-1[;=8ZC
M+*#(!78U=FLF284-A0T""<U9(&FQ6S=)LEU7X\&//#Y)TF-W%GX$[;BH"^UR
M94L\?R$B;W,OV%J6-^/?)-J`L&G3I@T;-FX2``<$NMKC4SKG](P$`BUQ^\+F
MWG"+;7GSQG^Q?VB/Y^.@>F&03-82YW'0A@UA<5PXO"E=P;F%ZE=A8[I/9(7P
MAG/]1)AW@S!+F*!($ZDWQUPYXJU[*%QF"X3+CJ0^97:,&,H$YEZR05@?CL?9
MTG-L$.?=@&X`_C>?2%FP"F5N9'-T<F5A;0IE;F1O8FH*,3(@,"!O8FH*/#P*
M+TQA<W1#:&%R(#@Y"B]&;VYT1&5S8W)I<'1O<B`Q,R`P(%(*+T)A<V5&;VYT
M+TA614Q(2"M4:6UE<TYE=U)O;6%N4%,M0F]L9$U4"B].86UE+T8P"B]&:7)S
M=$-H87(@,S(*+T5N8V]D:6YG+TUA8U)O;6%N16YC;V1I;F<*+U-U8G1Y<&4O
M5')U951Y<&4*+U1Y<&4O1F]N=`HO5VED=&AS6S(U,"`P(#`@,"`P(#`@,"`P
M(#`@,"`P(#`@,"`S,S,@,C4P(#`@-3`P(#4P,"`U,#`@-3`P(#`@-3`P(#4P
M,"`P(#4P,"`U,#`@,"`P(#`@,"`P(#`@,"`W,C(@-C8W(#<R,B`W,C(@-C8W
M(#8Q,2`P(#<W."`S.#D@,"`P(#8V-R`P(#<R,B`W-S@@-C$Q(#`@-S(R(#4U
M-B`V-C<@-S(R(#`@,"`W,C(@-S(R70H^/@IE;F1O8FH*,3,@,"!O8FH*/#P*
M+U-T96U6(#`*+T9O;G1&:6QE,B`Q-"`P(%(*+U1Y<&4O1F]N=$1E<V-R:7!T
M;W(*+U-T96U((#`*+T-A<$AE:6=H="`X.3$*+T1E<V-E;G0@+3(Q-@HO1F]N
M=$YA;64O2%9%3$A(*U1I;65S3F5W4F]M86Y04RU";VQD350*+T9L86=S(#(V
M,C$W.`HO1F]N=$)";WA;+34U."`M,S`W(#(P,#`@,3`R-ET*+TET86QI8T%N
M9VQE(#`*+UA(96EG:'0@,`HO07-C96YT(#@Y,0H^/@IE;F1O8FH*,30@,"!O
M8FH*/#P*+T9I;'1E<B]&;&%T941E8V]D90HO3&5N9W1H(#$T.38R"B],96YG
M=&@Q(#0S,S0P"CX^"G-T<F5A;0I81^VY>7Q4U=TP_CWGSK[>F<P^F<R=N3.3
M9"8;V2`A)#<;L@7"HB1()&R134@`05`$5R1JB=6JX(;675N&">``+E1]U%8M
M6+7:RJ-8J4MKU*=%;*N9>;_G3D!H?9_G_;R_/Y[W][YSSISS/<OW;-_M?,\=
M(`!@A"W`0?NTF:7E\Y^<W8,MQS!-77C)_-Z_/MPY&X`48;(N7+=6Z/W+?UP`
M0"4`3:2G]^)+E@CSOP70+0%0_N7B%1MZ^.M#KP'P<P&BCB6+YR]Z_Z)_0]S:
MM3A?]1)LR%$8![#^)-9#2RY9>]D+!]5U6#\*(%Z[8M7"^4]4[;4`7#0+P!._
M9/YEO8XI.?L!-B@07U@Y_Y+%XQ]ZZT*LAW`_@[VKUJR]KFVV#F#CNP#>TM[5
MBWN7KQR+:]^N`<AI!%``?1J4H%$`FT`!IR'T4(3D3(!_"@T80`(!.C6`F*^I
M`^2@W$$@@VO`HNJ?1_UKX,ZN\!;(L=D=X'*#-W>D+12.Y!<40@SI6PJCRBN@
MJGKT&("Q=3\PV?^10?DC\"NGR"F7NPV\`.D/,9W`]&EJ4OH[Y7(04\O2Q[D<
MI%@HDT9"&*Z%$'P*M\-ST`6O4@Y:20ET@(*XP`V4U,!DPH,3E$0'!2#"9&@'
M.TR"/Q(C[(91\"<R'JXB89@&=T,0IH(#&N$6V$7.2W\&5\&;9"D\@:,?)1+D
MPQ0R(?T!3(?V]%.X!A(8[H"=Q`1^[-$1,?T^SK`&ML)!^"VD80[<J=R%L[3#
M#%B9?@KFPAMD#KDPG0L3825<"7?"_?`,G"`WD,,*9;H;JF`!K"9JDD,*N*O3
MC\(8Y;O:?>D7TT>!1_S[<=;/:4PQ/OT%RM2G"I)>@H*1`Q485\(#L!^.$1>I
MXIK!!)6X5A=<`;NY`MSC!-B&9SM(+B>[.5/Z03S-:%@(F^$XN8P<I@'EN\JO
MTAO!BN>KQ)WVPX/P"W@!_HRSC2>SN$M2#>FI**\:B$$KKG0M7`\_1\H]C_%%
M8B8!,A%G_@5YGWS(K>0^QID?@2$X!7\C!60IN9(VT*N5Y<-7I?=!!$\HX1P3
M83:L@"=)A$CD0AQ[-UU/KZ2;N?W<,46!XLOTF/0+H$)!EN!J>!S/]6MX$]Y!
M?HTG;>2W]$IN4'E]^G+<;RDLP5-<"P_!`?B:*(F6&(B-"*2"C,:374X.DP^I
MCXJT@UO`[5;>E-Z0OAD"*"M=L!A'+H-KX#IX"H[`'^#/,$0\.+(41S:0=G(S
MV4Y>I$>XV=Q<[G:%I+A=\83B><5W2HOR^=0;J>-(=39/&;1A[((>V(BT3F)\
M`7Y/..(E>3C3.#()9YI'>L@59(#\A/R4/$SVDY?)4?(9^9+\G;KH3?0V>HC^
M&SU"CW(^+LJU</=QKRD"BM\KOE7/'_:EGDM]F=:G8^F*]$#Z[O1[Z2&9"[DH
M\0W0C-*U'.WMM3``/X%[D.9[X75X&^7N`SF>@*^0!]\2%4J3&W<4)"+))T5X
MNMFD@ZPG_>16\B!YB7Q(3I#O*%`##6*,TFHZB<ZE5]//Z7><CA.Y1NXR[@[N
M-]P_%!N4Y1B?4.Y3?J4ZH0YK7OONKN'W4Y!:FKH]=5>Z"F51A9*7@SI7"4TH
M<Y.0RXN@#^-J6`?KD48;D>)WH^3LA@0<@E?@-:3]$7@/;PFV7Q8_0TZ<A&%(
M$8K\5!(-QLS>RY`SS2@MW60Q\C83+R=7DVWD3HQWD7O)_4C?-\AOR)OD`_(1
M^1K/!+28-M+S\$3M]$+:A7$>74BOHC?2O1A_37]+WZ-_H/_@>,["^;E\KI6[
MF+N!Z^?BW%[N+>YM1431J)B@6*YX6?$&GGR"<J)RGG*A\D;E_<J?*I]7_DIY
M0IE6W:IZ0)54?:K6J:O5[>I9ZFWJQ]2'U,?4:4T^RE,;[K[P+#-W*[E044H'
M2)HF\=S/TK7<J_0V\L0YEK`?=[`(YM$D]PR]YXH![@_<D_1JO&U:Y.YQ:,5>
M@Z?A->6;"KOR4WB9>N`+M(>W<?/ILW0'=9%J;JSB.L5K:'4VX#Y_2C^@:KH;
M,?Z,W)@'YQ,W_$5Q`7R)]#^B[$>:CJ?ODR?H2W022O*[\"`]!#M@%RPFHW%W
MBV`?_`-N(0<X@>Q'N=L,1^%S./[];A6EPTVT0>6BZU2UR*$#9'KZ95J8_C-J
M_8?D.GB/^P?*_@5D*BF%A^$CY/K;I)+X%2F%%]Y`RY<'=Z'4?@*#J(._4H10
M@[Z&`UPES%$<1YZ7#O\RU:)<RUU#3M%&9*=3MMS3F#5&&WPGVBIF1TVP&R4!
MK8BLT7^&UTD0J?BFZO>P$[;#0<X.8>XANH6FN5<4`OP8CG-3<-5-:)]R227.
M=`DLQ7,(Z8]3#^(,RV`,C"$+R!QHP9X)D)>^!'?^,-HB*3TWO4/9J8S!K\D4
M8H?GT'JYD(JW*[6I(<3<BWKX'DP@-\)@:A$<QGO%1<*D'*5I2+E..:!\7+E7
M^:SR==4HN`RU]B[DXA_@)-X:`EF(M/@3?(.RWH3:4X3ZTXB[F(!WV`K:R3T#
MS<0#O6@#"]!N-R$-YB`GU^`L5\--J$\/X1WR:_B*\&0N/`OOHN8X4<\7XOH:
MG&<RG(]<7P,/HW6\A@QBRR+(@RC2Z1_$1,;0M;@>L[.WHYT]C'LZ!A^CY4C+
M^RHB8TD+<F\A?,-T&5>HAG:R!^_D_5"#-V4+]QK\$4)XNS:ACCZ(X[I1-DS@
M@QKE1X1"46IJ>@Q=RCU#''@;FE"J9N'-/H[TX2[,>(YAL)-I4)4Z#V=[`FU9
MN_(AO'UC>#/8J5TQ6WD^[OOW>)/]&E:G.\A.-6J`U'3^+*FA?ES=V-J:,:.K
M*BO*1Y65EA07Q:*%!?F1<$@,!@1_GB_7ZW&[G`Z[+<=JX<TFHT&OTVK4*J6"
MHP2*6L7QW4(\TAU71,0)$XI979R/#?//:NB."]@T_ER<N-`MHPGG8DJ(V?-/
MF%(&4SJ#27BA#NJ*BX1648B_WB(*23)G>@>6;VX1.X7XD%QND\L#<MF(Y4``
M!PBMKB4M0IQT"ZWQ\>N6]+=VM^!T>_2Z9K%YL:ZX"/;H]%C48RGN%'OW$&<]
MD0O4V5J[AX+&B)N*>\26UKA;;&$[B'/AUOF+XNW3.UI;O(%`9W%1G#0O%!?$
M06R*FV,R"C3+R\15S7&UO(RPE)T&;A3V%!WNORG)PX+NF&&1N&C^W(XX-[^3
MK6&)X;HM<>?&$Z[OJSBYM;ECZ]F]7JZ_U;548-7^_JU"?-?TCK-[`RSO[,0Y
M<"P-C^_N'X]+WX1$G#Q3P-7H=9T=<7(=+BFPD[!39<ZW6&QE+=W+A+A6;!*7
M]"_K1M9X^N,P8T,@X?%(!]+'P=,J],_J$`/Q!J_8.;\E=X\-^F=L&'1+@OO<
MGN*B/;PE0]@])O-(P6`\N[#X3)]<DM%9:?*,,Y0E;$?B1!2(N+!0P)UTB'BF
M,2Q;/`;Z%XY!-`R=!$?%%R%'EL:US=W]?"UK9^/CRC`O"OU?`TJ`./3YN2WS
M1UI48?YK8$4F)V=$#?M/E^.Q6#P:92*B;D:>XA[KY7I5<=&Z)+U/[.4%!$@^
M:$?:SN^L+47R!P*,P3<F)5B`E?B6Z1V9N@`+O`F02F.=<=K->@Z?[K&?SWJV
MG.XY,[Q;1$G>*[]Z['%-Y,S/S#MR6I?4QHGC/^E>G.F?/%.</'U.A]#:WSU"
MV\FSSJEE^L><Z1LIQ7.:.S@O'2E1+R?WHE#./8/,*AV&N"*,/Y4LU(N2:@U*
MI=Q"A/%QOGM")N_4!0+_BX.2Z:_8*!E\/VQDF_':V+GUL>?4S]F>H9_##2LB
M=/*L.?W]NG/ZQJ,%ZN\?+PKC^[O[YR?36Q:(`B_V'T!_)K^_M[7[-$>3Z8,W
M>N/C;^K$0RPAM2BM%)KVB.2&Z7LD<L/,.1T'>'P;WS"K(T$);>YNZMP3PKZ.
M`P(:7;F5GFEE-8'5\&6%DIZ@&KG+>T`"V"+W*N0&N;XP24!NTYQN([`P23-M
MO-R&@2EZ\ZR.LUDHZT5G,;#7<CE913?0>O0Q/9*!OH>O>B5Q*WYVLRLVE3_!
M?PRE;4.CRDB@*D`W#!^@YY%51]BH.>E/R"-XQ^LAN!<FJO1<DN1(>D%;IJ5:
MMV'5-C;ZNZZV(6A@H\OQNE")P4A5936!\?,7M+;.GT\J9=#:N@#0_YB4/L'M
M4RYA=Q29)+FU7I5?%=86.M4NKUVPAUV%6K6&K-?XDD27L"KS$0RJC%9GDM-)
M89!"D4J08B68551C-G9<I81WX"YVIF*K.>A'_YMAFK8;B5'*L5<:W45?_P?;
MXJG8ZK:AKN8.R1F40OF5039)D$T29).L"I*^&(9.1)0+;4/-'0?`F3X\B,C.
M)$+$ER$.87`?CNIVCHS"L[/3-V^0%I"H$/`'J,ILXDU4%1+#(E7I#3J#UJ`Q
M*%1VA\U!56Z7Q^5U<2J*SQP%X5316&&,JO(LP04046.6F^-<0`J4F`5,O@5$
M-.0O`)<#2S&");8B85ET)%P%?:2/V-0FBH3/QUA5.;JZNJ+<X70H>587@VJ5
MRL(['8Z*\M'5H[E]-<$U/[Y@P;WCB@*Q^HJC:]>]7M:<>DVAB[C'Q-QAC\T\
MIJ3<'571AU^-K^B?OJBKI6_'3__]P(Z?WG_#H6-DT=@;1PDN<<_PEZGC"\XK
M$\9<RJ1D*P"W$+GJA&N>!A/Y&:D"#7EH?W">>I6:DD:CW*(F?P<1'.0A,)-O
MT&VI`@>EDLFL`:5&;<!&/_I=24XK\293NWF5>;>9X\W$[':9GJ4`&OH2N*B3
M?`"N&'_JQ%3^9%=771L_W%4'#74-UIJOA[XC7\=(5PS%T&+#LU;8`U45Y=75
M59;*"*-!?IC>Y1C?YA^N#LV>Y+&.$BHF6LE?E4N^?6)3:U$X7#!^"WWNHM*`
M$#HA:PN>Z&X\42Y\*H5NH#^G3W)<ON$G'-7I=7H"2J]UEV.O@SIR*>Y)I]?D
M)DGW?FNI,^ZDSB0))HA5P\1%;ZS4)+G07I.2&%!U3DI>4/)*JCQF?=.<2Y[+
M);F>/#,ASQ%"W+Z#^*H<`%D?N_KX4UU];2>'NTY`0\-0#*VDE*.1',8&C>0T
M8>8V8V:LD>4/B8#]&7E%#%E.$4F&7EZ&B5Q+@XQ[PE)38['6$$Q=EAIK#5;Y
M7R+)NJ`K$*@":U6E3"M9@%"9U2H20!J.KN#:O_L#677/U1?M/#]<?6S@XL>[
M)RU./4G"*QJCP9"#[",E`TMOW&D\G.Q^9.)UVPZD]EECK8R.@?1'7#_2,09'
M)+_:[#0OB6V(76>_SG%7SD\<CUD?=AS,T1?G-N12FX8DR4\D+0#/OO,%](U:
MTHU/]0!]#2+TU^`!#1[':*F4Z6JU(Z2_WB^9E!XCV)(T9Z]`B%)WD/P$],2S
M/R]#9C0&3UG>A$*^D!8RPV`Q.XG34VS.(WG,/.2YB\ZB>0QIWH=6XN10%W]R
MV%)3ZO8,U8&KH<$S%(OQPR?X$]::TJXA:TV&7*2JGIY-+;1\:D8R"`29#F*3
MK''5B$-*5W=(&^;<M"`\X</^FY\Z_\)++T^]GDH].:VF*1;P\2^</VG98?JH
M&*BYM&[F^MN,CSSZY)K)-U;5/'+E6ZEW:@H:2AI-FOLNG;/M$Z1G*]K/0>44
M"))VJ<2D(EJ=6U<`!9S"IK-[[;G<&-5$U5-*3J\D'J\N5^'C,?<IB$?!H?C-
ME7@(V@"":"L)!'G97&KW6D%!%$GRY7ZKP#W'440,#A)0>))DIZ0SY_AS:,XQ
M@Y$FZ2N#Y`T-'*(J"(*/?"UY)$V[9I>&TWA"_!O;@R3(B!ITBQF;>Q)M[@DD
MZ1!>+R=1C(>ZAAKJ9%&5;)R$`LE)*)T<DV>.2;8LGZD^6905R&/$4(R(L&)$
MI&6(J`PF;`9Y2*QSJ(L-DO*";-(@FS3()@VR28,2H@4EJSZ#&^O<JBR);>)?
M!(O5R;3`B=R$OBZRNJN/!+B`6L%>/"J%>)J':$6=&2Z&`D$U/O8N7SS\IPK2
M>7#'CU*IG0]WUC?&\MOGCRORY\]8D]J5.NFM5DY)I;8:[[OFA4U?7E5?-";6
M)+1$><-EL^+'"`KV%.3?\[*ES$>-T-HXTN-8YZ"Z9/IODMUJJXQR(?O+=JY!
MHPRZ7'ZE-F)_AOX*"(HU@);LW!>)\*#TX[6XES<&CQF2Y,-!\!2ZDO27^\P>
MOX=ZF)CK;8P1-G?!:4:@5`_AW=9VBMW3:"Q+A_BA$V@",H9`OKI*O&%=3BB2
MZ_5YJ<H:-D7"NN`"DF?Q+`#!C"51'UE`O#G^!1`P8@:GKZ%8-';55="%EK>+
MV$U473UZ1!F8'X`*8@T1E=UFS1"19[<1]_R^]S:+1;[&ICM?7?FK-9O>6O\>
MN37U2TU52:"X9$)S;&*!<DENR2U'=N1I;?_^W/7'-VXCFKM.D&V?#:_LE_I3
MJ<KP\@>);6D+WOH3D)I)Y4*D9@C]FPE2`6=0Y%@,MIQ6PY+(AH@Z3$8[+RA?
MK[B&7NO>:;PK]+CQ\5!2L]]FV*-BKI+DU')V<W14T&L(N\!06<&`PE_BSW@?
M)0CVJ(SR]7Y&7+SHLD,#5!JXF8;V\$+#&L,UH`P;C,9R5R@$!K,K/"H(=F_8
M90"%REI.0B%VI=F-Y39$(2$N6&X<93:&2+E"==8R"971.W)?>),<2#Y[V:AC
M$M?.[>(XSE.9<6V.F<NBDM98&648INU:HF5LUKHK&)N9BS,48[8+->[D<$S>
M=6;3LL6OV6HJB6TU;3HC^7*CM49MXNNVFO@77T2+UM6)RH"`.+[WXT9'1A2!
MV3>\32L9"Y&C#DZ%;H7=-F+CZ,'MJ[YYZY?'-M]V_X6?_/+Y-_I>"(?&1"<U
M7[2TV&^T"66=I1,7T=32?9<^^-%+VR]YL.7RNR^^X<A36[IOU91?,>GJUJKY
M$R;>DWHEURE>/_&BS6.6=SV/NM*`W'U*]A4+X+#DU7$>+LIQ=VH?U2:UKQ@4
M+1JE4U1JG/Y\<DC6#PW9.9B?#XRLDL&L!*/S#7#S;NIF.F'-\43%8_HW"*,9
M<1>>48V3LF:,7+09U3A7,\H]$:TU$#9&+&&O)]?C\W"J<$0PB0L@CW<O(!$M
MEH(&_P+BL6(6TN6?I1U13$P]2)<3KXO1JA&B,GI:[3:J(#)!,SZ:G6=*TO#P
M)UN]];/+=KZ^ZM>KUK]UY>NI9:10%W65N@O*<_.;8A/S<W,CM_W^1X+[_5]<
M_\'E-Z12#_TV==D0O:'W_/WWS"YTQ,8^G/HS*@?2#Q\CRCC2+P`A4B;=&N3U
MUH8>?AV_7MS*7R\^;GR*5]]N'#12$A(I!$4QH#/I?3IGP.5SZE&XJ,:G=5CL
M/@>>"8*.-:*9%T0(\`$:$&F@V,+;+!9>I&*`%IC,-I/)3->9B$FWT4("%MZL
M<(@!BPE/Z!3-P5"!_!??"5[BS1Q>BSJ=5F-V$,=!<C6(I$02!9V[+-(;V1+9
M%3D:.1[!IWA$B$B1=FP9B,0CZNV7(+?Z^*Z3;D_;\%`7WLIU/,:&.@_S`(?K
M+#5G%+0+/1M9V#5HYA&Z6*'KQ1AS?&IJ7,`/$?YP)N\ZNZ+FZ^K4=74C&A`C
M`>2(#:T_NI'H`)$*XLA4F!,M,RT?57-6*E"36^)=EAHW\:)6\L<<\MGXXF#]
M<*]WFN!0T=QEOSI*KKZV*5;CY37AL'[A78K:;Q^]M]"O#(<=?)XU1]OT5_)F
MJA@M60QY9<)[W8N6;!0Y7[KE3B>Q+O:NH^O*'G$]470P[V#1:^ICQ7\OU160
M,60"F>@]GW9Z%]/KZ;5ECY*7B]XJ^CCOT^"IO+\%_U9FF:")A'-#H7R3X-,&
M@V;!9PN*9>$\+@0E0MFH*(3S0KEXG=AR2\)AK2U48D=1C)9H-%H-"+Q`A??=
M]U@5GHK0*'.^/Y_F%YM-[O**)%$,!L9UN&*QJ2?KF+XPM6GNV`\E?`DM:?NL
MR[NGI&VH$RT0.N3\$$L6IDYNELL:->)W(H]P$C5OJF/49@H6*PZ(#I=2[0P'
M(\ZP*E(4%AU"*0FR+*8N*24!5XAE(K:)Q<IH*2H87W?Z`I)5+*-DS`VP;BS[
MK)A&BF)E-<'.HNN+?JM6R:8-,X=3=FG1T3WS+J@*R'ZN2LE:L$%ML:AMCHJ1
M&K?]%U-[+[\C=7QXVD7-7F]+%^W_[/G>'PU_^*.M$\Z[]L=D='7[U@D=.^F1
M8NG"6W8LVA`6QZSD>E?6!,,S'^I:L,,JK9TS9TT=&;X[U59>/?J\K3/GW5''
MO.+IZ0^5LY7+42]]!\"1WC*HU57F)C-0-0*-"*5.+!@\6F]U3IOG>L>-GNW>
M;;F:Y9;EU@V6#=9MED=4CQH?<K[L?-6K4SD@TNQHS-WBN,YYO??:W*<4A_)T
MI9$E_O6J=<9UWNMS#IK5HTT6:\@'<ZB/H+-MD[`8>,QB-2F7^3C3,KN6S"NU
M$(NG-T(BUO#*`Z1<=HSQU:PUZ_PZJFMSNT\R1@]F2D/X7NXZU=5V(G-#UM1\
M?A(5:>CD$+`GQ>29&_:4:Y"](4>NRFA`QFJT:BU5>2-&ARX,JES,]"Y3&+0>
M99ADF!EEK"1=?8#>F/S0M8CL[:9BJFAE7!EM9R8T)/L5S,%F3<K9^45?W;GY
MK5$-<U^\>\O;ZU9_\]#O4KN?>I5T/K_]OKENH52M7)Z*)E_\\;H[#NQ/O;VC
M=]NEZY?_G(Q//D_F'JX/E58P6^E%_>N3]2]&]-)<SQ8DO,@RGF4QEEV<L\1U
M<7AG8;)`>;%E*5;NL-SI>#!'M="D%GP0#&H$GRDHYI:83318Y?6"QEJ<:_;Y
M?=17KRE3DW8U46\J&K=/OG:Z^I@*X?L5B<M#A(_02!O8>%N9C;-5(TF1R/LC
M;64V(M>&.D=4"A\B&<)>Q`@[28SQ'FN.)8>J"O(+\Z/YG.K[&E4Y[$Z[R^ZV
M*U2A<(R/A$F49:('L_R<7);%L"T6M@?#9ZE3YIN"K$VL6L'>T*-'E(5IBY-=
M7.CGJ40.G]E.^9N"1?[.X"T>VV#6.IIKBNF\O]ZV[]#<'S_7/^Z:.7R.M^*1
MCLMF-/9,"(<%^U+NBB65^>&FZ:GDD>W_<<\\CT&1_O;]61&=>?5.TD*4=V\L
M\J.&%`(H_H'\&$6F2D,.A5M+A8JRBMZ*@8I'G>_8WG%^[/S&J=V@6VN_HF0;
M]V.;<ION3NY.W:WV1[E'=2K!UFJ7*MHK-G!*':?3T0KV"+A-<;?V0<7/M0_;
ME`8"ZND&PZL:GUH0?*Y@,#9]U*@/BWPQU71"7E7Z5`'!5Q@4B0H,:B/8>3NU
M.V(VNX-SJIV.06N):U1!(2DQ&%R%U*51J<WJ:6K:@-EV]6[U$?4':I69??=0
MEU?LCCT7HZ6QAMBTV+S8JMCFV/;8?3%-[!K>T>L8<'`.CU1!*L!L]!NIL3X@
MN,M'Q$,6CA'EZNIC;_6^U:5UZ*!D_!-^:*CNM!?7E?'D8JAXGP,_/`).5SE>
M.7*EQ?JZ,$`?L3"&5EC$$BIFOI.P*I>YUV1&R_X(LIKI'I9HB?>JM7PD8FCK
MF9]363O]V3^6A\=]NZ)X;,ACTBMUWDA3L6)5Q+>T>\Q.16KXW0?N':Y=>UM%
MZNK><B&^-S4];#<%73W<%7/M(@I=:M6M6_*LR-\2Y._#R-\B$I#:U`JMKH@+
MZB?IE2JE2H?*P$44$5U$'S%,X\;KINE[=.MTU^M,&PL'2O8I]NE>4KRD^UCQ
ML>Z4\I1.9Y*O-Y_@LP>#D>E%14E:("W+]T7,&J)A3-;Z-("J-YW25U4^=9[@
M"P5%C5H=H89I1CJ-1)X+D[`G7D)*@!C-)K^)FNI]9O"C3:C/R_.YBVWVHH(0
M+2`%Z..';"9?#6L(0T$X1.V:XI*G"44':QQ1HZU$IQMU%/E3=[*.W7IU0W*%
MR!SET35'KM9E^(KUC_F/9:017GW=]4^0Z3JSA1F6R3QC.GC6QZW19VOF:795
MY,]9/<T@BCF/+<]WHC(.C\VPBBFFXK)"TYI+ZAY`1KU9O>62X=F_N#PUGZGC
M:2ZQ<NKR;==ZS<@C]$E4-N11,VF0K,U!]/W0._!I@D$7>T^[\+TBF4;G-H"+
M=^UR<4R3DO1W3P7+!5\T&*QEW3F(5RLACKG67[N[EFL2?+6(LS^H9C.HS\R@
MYM6[U!P1?&HV@V@1?,Z@6'AZAD)YAD)_X>Y"3D3-1!SI(K%"\-4$Q6"@H!D8
MNQK0B5)'"PM=+B>MK:G1:-0:$9KX)MI47VZN(/B;A[JV"5J[6ZG4VMZZJS7>
MJF@5,E\=ZRW`$_RU\X3?U#)NW8B-7CUBI+OZ3IVNP&G'D^76&M3*868Y95LI
MYV<59>7CF?Z1_QG3[,SQQ]O-$OB7EG\>0<O^F9OTWUC9K"<?.%IJBNB+174B
MUEAYN"Y3IC>EYOXS>S/EU!:RY?O:=]=^7R8/0L;^TB^0]W[HEXH#C`$ZP4>#
M08_@LP:#7L&'GIA>\%F"HM5"*=%XS%Z_EWKK]3K&-==XL>&XCI3I)%VO[K!.
M,0\SJG,+`=;I]?HJCP=(;^!P@)8%I,"\P)9`'"LJF>Y(Z)A,^]AI>C?4,8HB
M$?&J^I\3D)&+?O%#Y$&RA7^``O*9\:01O/F->-(P;)>J%Y#UY'*Q-U\Q(`Z$
M'@YQWQ]Z2C!SW)`8Y+QB""#,AWO#6\*[PLIPDAR0>"%00)$61$,UX=_`/21)
M=TN.[\GBCI3E2_F[\CGF0D_M&K'Q)T\.H\U`:1JN.]E55X,6W5DC'U9^A'#_
MV7&=LNE&]\=8\>V4LT[]YECYU"[1W=VW8F!I*3F6"OW`Z7<MJ3%IISRX"RG@
M0V_T#J1`@/0EK%;DT=\2QAH&I/6&&CXWU\SG^GQF8RU3?2]3S2"M]:F#3$T=
M4T9>A&A_`WRNDYA]OGH@-A0AGS<(%K.)$)\S@-JH!NIT:,Q:PEZ+1C+/2(R;
MVD4B\I:"7/"2=B\![RHDU:;@B/KU=3&-8]IW*E-BQO6TWF4>$NSBDS]K*#:]
M"-CHRKSJF+ALY>LVO;B5?Y$P8K(_<R`=EV(Y56#FS:-AM=`;V")L"=P"`^8!
M82"P%_8&C`I!$8@J\O7!G*A'Q2?3%R9RJA`\C#:H2H'6P49X?H#LRHWS\5P-
MX"JDKRO6B4^.?;S&YFU`U..2UNIJ`(TIIP&2Z:]&:F9;@SF9_F00<1#^/F%R
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MYOVN_;YWO%]I]!>83%7`.:K46JO>[5_9(8L#/C4E-WAY%)$VB2.<IU1HP*>J
MV>JW4BOZR^Q6[6-^LV0^!\':-I3I&CK]/QWSGZ<S_[F.Y/%A7\06T8:5$;?'
MY:$JL]$:1CIYP\2NP9)3A26+P10FQER*.<G1.<+@46`6B]5A//.1!Q\N!+TK
M]@+=JU%9:Y3)]$E);ZVA+FN-`1--IC]-6&H,R?3G")2L9JS18FV/L09./V,[
MSSQH4;1(""R\F@:$_(B%!R7JO87/N-O6*AX])"=ZRS^YXY74K:D?OW(ON8N,
M.3A_VL;S=US<VK%@T5W*>8;4RM1O4JD74]_][45B)"7DUBG/WITZEGKHX;7E
M$G'_`=OT*]G+IQ(]L8=0^ST0@B,'0$#M-]0(3/OGZFNF1<@=KE/.4\+?@XJH
M)A>(`>_H8!!O:E50-+*[0/266*$D-U>58\5'@88/D,#[W8XMCOO0O>TOQ9>D
M-W/%%AO!P!MHNZ';0`V;PI%S_*:I)[O.W+7LO=,EF_V,LWOZ(I4_%>3Y19O'
MY70[J4JT!4J)WX-9T!XJ)8(SCWT68!P9>;ZPBGPMV,]Y[PORETP59QGY<T:D
MA=[6N6<>^--(*/7@P/Q/`I:-UUY[#>U)W<">\]\_[(_>?>W301>]<W@_O>7.
M.VYB%&0WR.^0@B(4D\NDAO,]JSUWVCF-Z!(G>\[+/2\X/W=A4&T%):AX):]2
ME)5>[%WO71^\07S-^ZIXM%2SP_&6Y^^N;]W?>I2E&D.2OKU7IK%<8&3&@E3#
M2)WKS2A`L1BTB6)PLWBC2$6(Y@:\6X(G@B>#'!]L#QX-<D>#).B,Y@;%2+C$
MFR1_D)PBNG*AXI(<9)+PFT`@&%2IU!J\CHE2TAH@RD=I]'UGDJ.2PQ`*AV'D
MS]AB@Z&=V>F2<0>(6_[?M:N.^;#,!O/#S)\][0_)WWN&ZV2?=[ANY$-/W^JN
M&O9AKJ:+&>DNTR;^19=\N2$CA?PBF\<>=D<*PD6V:"G)]V`6<Q27DD)7I!0\
MWN^_[V2XF?F+LP#%4F^HB6D,-;FN''L]R1A1]G?<#[!ZY"],]<BG.\)91C[L
MB%1`7@]/&N'YNE,G!E:T7D'&2]["ZM3YJ<F=-3?V3[OE?KHL=>VYW&]YZO+;
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M`R=X0Z,PCG%U$FJW`;5;@"</0#!]>-#EJ0PR/W8L;ZT4@A*JW.&@H@P+E/R[
M6OT=\M`E^/A@4"OXS$'1_^\>SW=Y/K_:4P`"Y<T:Z"6,R5$IB-Z07TNU]6[>
M1017NVO`Q;D$WD\$?[M_LW_`K_`?)%%PT9\/!M@ER)]BGXWP,5+'',<1UWBX
M[O2+__23'QWEOJZ13V?Y/_1>E%U(T:(TA(2I+9%YBYW-M<7#M1E?><&V^MG.
MB')*ZI;-JP+6;__TO<.H<-1.OYVL8A0I2Q]7/H@4*2&<=+_+[`Y2ERX_&!4O
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M$68.#W_Y5J)4>N4Q>N>E-4'">&%"Z3R`O&@@MT@O6R<:)_`3\R;YMY*_CU,5
MCBX<,XE<3'I*-@H;`Y>5WE[TF/`4/2`\%SA8<K#L8,-7C18;;\MSEW%FHLTW
ME_J)5^$O5965DE%Y?L$T*L\LF!IX*"4-O,JD]JG<>1Z?>R"?Y)<6^/)K&FI]
M-4JB\"G!15R\T^>*".A+C1DUVC>FS&\&A5+.(^X&GB_(&V7+RQM%2F\RD=)Z
MP603<.)1I4(>;R(:Y9E2Q-WH='J4\VJ>I3$\VM400>BG,<GL=DLU8_(CU.U2
M*3528Y*\/1C8?HD+E>@Z]LVEKJZ.)?:9I0T?5"=/3FU=W/)QYG].3%M-;7C[
MG/XS".&9GG/^#/J!OX0R.3FGS8R!?9?IPCN'_=U@\_-N<X-)S@K0\2<".OTD
MX\T1Q\C?1_+_11S[BLV>;:P)59&0B.SARX*"ML^9,UHV<DQT\'I6J;GY9%W7
MM.KAY=-*U*8Q+QWI*BNU-PY_TUG1?!DQIAXYW^"M+*'W!VM+U*V/;E_IKQU'
M_CIV0J%G"><=?KM_K"H<5H4\5E/>#!(>7E/H*]=CBU$L^3&90+[=9`KDJO%5
MG.O@EZ1A]]9J;XD'WPW>L&L3DRJK_,_A%/1G+CP`H?2G@[9`@\A>-(\::_SA
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M6_L@#O^+@3X.Y3AN#BLK`"9AVHJI'%-@I*T5TY21\@1,#?_9?,J7@5=>`#&$
MTS%YL5RH^(A]B4;G&!]AG(]]]1K!O0`BZINA$/%\V->.>)4C<T04:V`9]D_"
M<ME9<YLP6?]UU1\..,>T_PKGAP)W,TS^KW"R(1NR(1NR(1NR(1NR(1O^=P*Y
M/7WPO\+Y/R4H/O[_SUZS(1NR(1O^.P.!]$$-)AZR=C,;LB$;LB$;LB$;LB$;
MLB$;LB$;LB$;LN'_\N"%9F@F)>0..I9^1#_B7E`L4RQ3=BK_?FY4'5&_I-FN
MG:T[3^_6NPU.PTTL&EGXSFPP_\S\,WZ/Y6YKV/IG%FT.NSX;LS$;LS$;LS$;
MLS$;LS$;LS$;LS$;LS$;LS$;LS$;LS$;LS$;LQ$(@'$VM``G_S=%@8=2N`!`
M<V-.X\C_51KH85@8./!AGBDKL.P;*:NP5,MF4&BQI19FCY0IF."6D3*'[?>-
ME!58_MU(606U)&?"!:U3)DR(S5IZR>(U4Q>OG['JDODKVV<6-ZU:L:AMUO]^
M)TS`H[3"%(03(`:S8"E<`HMA#4S%?#W,@%58GP\KH1UF0C$T87T%+((VQ)R!
M&!?#I5B?#ZO_/\SSWS$2Z2Z'=`!>@!\(R&\Y$/I#O7(/1Q28*XF*J(D&2UJB
MPUQ/#/^$9R0F8B8\L1`KUG*(36ZU8W(0)W$A=!,/\9)<N=U'\OYUK6S(AFS(
MAFS(AFS(AFS(AFS(AFS(AFS(AFS(AFS(AFS(AFS(AFSX?RTHU_3.7[A8M61#
M[Y+%*U6]BU<O7;5(L7'QZE7<JI6+N;7K5RG7+EF]>+&B9^FZQ=R:I9<I%R^]
M>,E:Q<JE*Q>31M)$FDD+:27CR00RD4PA4\DTTDYFD)ED%CF?=)!.V#-+2"H,
M@P93.8.)'&=Y4J$?+!#\YD9>884MF"B8,6_`-`\3)^<$)(4U<5F%E$2P.@-6
M9L"R#)A5(3V-B).@(GU881UTNLI9\Z#.4+Z%08V6U2V).152HU9A@0MD/`O,
MS,!$>X7<W<9FL<!YF=;!EM;,J*9,<_T(<FV%OS&$=0&3A*D7TVY,7V%2X>XM
M4(II`%,:DT*N,;S-F+9CVH7I.,.59]-4F!N]"AY[>/GL//@QE6+BH%O^ES<N
MYV:%!JFB@6F8[E.H0:'0)6"%_P!.P@VVRCOE!F,E,DP4%);+'0E/;ODS"H[N
M@'SP8P-).+QR#R2:FD8*U6,RA<%H<?D'C3H%P)>8J`(4!`HRHP8+2LJ_>@[K
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MX))XS"22Q8][)'"?G$O<;Q(X$:[W&+<%'-AWA+L*[`@?YZY.V/V'#W'?R&BG
MV"RXW@,H,0P,&DWEAQNUW`-,0KB_(,7_(J]V<C`RIAP:(]Q-4(:)(E$_PM)'
M6.*Y+[#T!;+I"V3-%\B:+W`77Z#0`C>$/4.(4\J]#[W<>S"`Z3XL*W#*#0FD
MX`&Y$"HH/\!MXJY`2O"'D'8$6Z\<U)K8SJY(6'-DM"N8@C<\P[T#TS!1W/R[
M3"-7'>)^)!]E8-#E90/>2F@-2+K+,[S`@1L9#Y[AMG!7RY2X2J9`_%FLHOQS
MU\B#TX,&2_EFY/XLK*["?#NFHYB^Q*1`M%EXAEDP#Q.'Z.V#)G.Y^1`W1QX\
M,6&J\#_#3<"C3Y"I-2%A#\I[/F^DH#`GO'GES[("%!.`<H5)H4J4^J<?XB:C
M_$SCIB86^7'OTQ,X+QLX=7!,;7G9(6ZJ3(NI";^8:4[DN.7"^(0V(U?-@SH+
MVTF+C!A+:$QR<VQ$);GHH,U9[D<YK95/6X$Y<*.1?:.1-:-13RID9I0/\E:4
M_D5<N7RB<NC&M`M3'),">5R.Z.7(XW(X+K>8N6H\;C6D,7'(VVKX"A.:&FX4
M-&#:CNDY3,<Q*>76;DP4V\MPA6[,!S!1G+$4ZSSF$J9N3%LP[<)T&--7F-1P
MA"O&=8H1NPSS+9CBF#[`I$!>%>$^BK#/R@DPK`'PPV:Z0ZHEFV$SV4PW<YL5
MFY6;^<T6C505+BJ7EK&LA&4%F(WNUO9JMVBY,JVD;==RO%;0TF3Z<$)=6X%`
MLJIJ*W[?]J>V?[1QUM$#J@$U/=)H(!;X`-.7F#@X0GBL\5CCI:W<D?H/ZK^L
MYXZT?=#V91MWY/T/WO_R?>Y(\0?%7Q9S4INWMGST/+**;";;B<)/2DD#7F6*
M>=PJ;C.WG5/XN5*N`65!T:WOU6_1<V5Z2=^NYWB]H*<#^EWZN/ZP_JA>&5<=
M5AU5'5=]I5*VJ[I5O:HMJ@'5+I7*KRY5-Z@EE>*KQF;Z'A)U%^9Q3!2V8#X@
MEWBYYS#F1^7Z@%SOQKQ7KDN8M\LE$?,R5L(DXER_1[PMF`]@8GBL+F)>QNJ8
M1+3NO\.V7LP',%'Z.RDW6!:20I0/"2$*(?)5B!P-'0_1>.APB!YNK*7ORKM\
M%W?YKKS+=W'DN_+:[^*\6,(DXF[?D?'>0;QW9+QW$(^5?JBM&_->N21AWBZ7
M1,S+6(F^DQ!'FQN=]"Z<<1[F]V'Z`!,'I9@W8%HEU_P,@]Z%N41W#N87X85/
M=R8B:",1!#,@+P-R93#H]I3/:S33G3CE3IQR)T[":GY,#:R6/DQW)%H8[H[$
MN`RHK?B@<33>HFPK.V`W)@K3,+]/+I5BWB"7=LLXYC/U..;'Y5(OYKO.C)LG
ME_R8GQ[+T9T8=V#)3#=BZT9)3\'A0)_,:M%8D_1@8JG5GZ1[$P4\@L$,2##0
MF$,YI+V1?"'G/Y?S^^3\-CF?+>=F22\:_RX:_TTT/B(:&W5T$H2P^2LY_TS.
METFFD/'3D/&ED/&G(>,#(>,A\A$$L2,@>8+&/P:-_QXT/A4T/AXTWAHTS@T:
MIP>-4X)LJ@(0P$A]+"<7R7FNY!2,WPG&#P7CJX+Q%<%XOV#L%(RU`J*3O^!]
M:B1WR_D=<E[U5*717VGT51H/4K1,Y,*$&;2'*"47@I'3):+U_B2GE0$-)-K"
M"'(3;8T(O(FV&0@\B;;5"'(2;;?Z&[743/:@L^*G)K)'PZ`A$;T*N_49H$E$
M+T*@3$1K_$F22D1%!-\F>GP(_I'HR4-P*M%3B>!K!IXF?X4>BM.0_TCTW(O3
MDS]!`9N6?`(1^@3"9**M`;&?RJQ.]D(]"6-S`KT^AO9D(HJ;(X\FH@4('DE$
M0P@>SH"?)J)^!/<G>DH0W)OHN17!/8F>$PAV)@I6L/EV0($\SYT0D>&:1)L7
MN_L2;6R&WD1;*8)5B;8J!,L3]:\C6)JH/\&&7DSV$)1LT@-1>:?S$SU1[)XW
M<I`N*)"[YT*5//-YB39&DO%LDD8C:1TY2`OZ]:R[B>R19Y$2T3)$JT]$(PC&
M92A7E^B)(1B3*$`:D]&)@GN1<M4C"Q0R_CQ-0K@--I&8B#Z!2/Y$3R&"O$1/
M*P(O&XF;RAE9U0KU\J8LB2C#XA-1P?\LT4.//*,.(F3G?O\PSOMM?9)<D/#_
M0TIJ2,+_30&"_?[/VQ;X_]R61(_7_R=4X2?V^S]`U/?KL2CI_<>B)_SO]03]
MOXHBAN3U_S):XG\ALL&?+#CD'VS+\^_!C<5[%OAW]\@S_#R"PQ+^1PN2E.#H
M73U3_'=&8_X[(DFVAQ\C\E:V!DYT772#_^K(5?Y+4136MFWSKXGZ_+T%%_F7
M%;"%G/ZET1G^)7B0BW',XIZ+_?.CM_J[J^0=7Q1]W3^S2C[#Y![Y1!/KY8X)
M/3/\XW$'V-'`.G`'8U$NRW%H2=4A1B/T5)H'7_>?/_IIBK<PV8)IM52B?D9]
MI7J!>I:Z">^;?'58'5#GJ6T:JX;7F#0&C4ZCT:@T"@W5@`:H+9D^+L4`K9=-
MQ3.@4K!<(9=YRG+,F$]"B8;B0RN>PTVFDV<VQ4?')B?5Z1GQ,;')<4W[A1U[
M"/E1)YD</[P0)B\0XJ=FBDFBFSXGKA2;2-PZ&2;/:G(A<IS>D"0PJR-)TFS$
M==ZXM;GC`!!2=-W-7@;'7W=S9R<XUC6X&JSUEIKQ+3^0=8_DK2VQ[X,K=G9P
MQ7SQVR?/[(@_[NN,E[-"VM<Y.5XX4YC;<8"NH,M:6P[0Y0QT=AP@2^B*UAFL
MG2QIZ42TL3(:U-/EB`9M#"`:G0OU#`W;YYZ%1O9@<\N>^OH,TC2RAR&ATDR3
MD>9DD)K/1N)N),TR4C-WHXQT;V;!*.X#%Y080#3E"HC*"T:5*V0T%T/;$XG@
M3#T1AK*G/(((>R+E<O?T[[L+,MT_RW3_C'4G"?F^ORJ2V6T!1.05(K0`<6+_
MC6%QTW^%\0.!#(Y;M[*C=;'8VBVV+L;4';]QW1)7?,L"0=BS<AWK$.)<I'O!
MPB4,SE\<7R<N;HFO%%N$/>,Z?J"[@W6/$UOV0$?KK(X]'=+BEL0X:5RK.+^E
M<W#J56/ZSEEKVYFUQESU`Y-=Q28;P]::VO<#W7VL>RI;JX^MU<?6FBI-E=>:
M/*.)3&[OV*.!IL[FN1DX2/4ZU)9N;Z"SR<'WULNJ,S;@NM)[4`'D4=#'.N,&
ML2ENQ,2ZBAN+&UD7JC3K,F&S>:3+=>78@/<@>72DB\=FB]@$:UVM2UOPMP;#
MVK678D`:KUF3H;4KT[$VUBKW(\):+*V5`V)BF:4U<NM(_UJX]/L0BV5P84VL
MN6-/6UNK:VF+%YWX0>9WQSK70"R663`6`UP33RT[^@[9T=>K'!5OM_VQ[>LV
M[K#LX1_%=%SV\`^C=W\4TW'T\/.XP_5'ZX_7<X?;CK8=1]SWC[Y__'WN</'1
MXN/%W.B1';"E.@GN\/MX:6S-I:PY1N33RN=F&\%-8X&=^C09UL@=:V7"8,BT
MRT-C.%'LS/#8]X4UF<Y+Y2&9UC6Q,P$[V/1K+XW]:QAI11/\/P""4VR:"F5N
M9'-T<F5A;0IE;F1O8FH*,34@,"!O8FH*/#P*+T9I;'1E<B]&;&%T941E8V]D
M90HO3&5N9W1H(#$U.#@*/CX*<W1R96%M"EA'?5C;;MM&$'W75Q!]X@8AO1=>
M^R;+-NJBM1.'05,T?7`L*Q9J*8HE-<G?=RZ[W"$E%08HDCL[>V;FS(4^[R9G
M5SHQ2;>8&)WK2C=UHN&O?["V26IX:IJD6TTT+;Y\GOR5SBY5G=YU<+E6;7JE
MC*&;V509FW9X>ZLRN+W!YP1N=?H&A=[?X8MWJDK?X\V4UCL6Z'A+HFRI_^Y^
MG=C<5I5-,I.;HM0NZ2[@8-.P\/N<?MXI5Z5\.\N5U7B6U70`(IP1PML;90,*
MXTKE=*KIH3\*SG"-*YO18=-WRE1^X_0"H3+$-\J:M+N\"(;9@6'D@]XP0-,I
M6Z<CX[(JUV5KV+RJ00?CB01\QDZ\O6']K4;$54"LO2IRNO<<'O`+O;U,O%^J
M='JGG$W/`8)+&1.Z!%<R!:]8RX??X-TE[O_3VXF2Y+=$F2-G642@M>TM.;LR
M3*&LR<M":Y-D-B\:W;)%UVO>]Z!,D7[!S>LU>>417]#;'9VQI.L7M-5O^89A
M6^Y4DS[1#@*T4X:>G=?`HF\1]9YN[_'MR^Y1.?B!?77Z_$,5V@O>H:FT<4,Z
M"!&(F=K#8#$&RO=7X#$66W$\#;D@>ZN&X@OT:@A(UH)!3?J9CF+]O/D#!H6E
M?H<TH?4YVT[.N%=9E3ZCD:^5":BO4?6:`)-0'I<^GO#(3\HVZ8R`K3;>,;;P
M2GZH$B0^*A9=J*QFQ[._^&WT.[FRC[<>)<G7_;VW$;:><OOF,<J(0,]YE38Q
MLODCHIRKK#<0"<L!8^4KVOY)!7,E9J?1WM=^-[)5&^?+`GD`?+M5MDV#X>!6
MAO-,5XY&8)\+I`P>CAR,KB&'2Y@4H#V'/&PG?M/J5K4L3T[S-J,MS(Y+),[W
M!U44Z9.0^"P"ZV.*D-@5RRTJ74K*ROM3<>Q>0?#FY))=-)ZP"7'V+@5E3/*/
M*?)F=\@\D6,AO9`:P#?<'**#1UP/7ABL/N#T]3SN(C7?8LY,<R%]C@>Q'!U$
MEW_0&U*G2!Y)SR5[$"Z,98;*V!A:HI.%N5@&EJQ&1.8!/8.9'O.6Q6]I*S/L
M`=Y4AVP=.U30++B3<'GK.-J;<+C%-"[TP%3BGCB'-#()%Y3S05AR8+-G8?3;
M'@_B$W:>ZIRL?0[U#1AC$IHP]>#@0UF<;%%#Q_59V;_V>=AG`GIG3@5A(ZCH
M\W"SCVS8*@<8/3[%Y1I!!GR6CVQUY5/JJ)?'3O8FB#+V*;HA2B+@#"E_BX7_
MNZ@8Y%K/3R+$H)6(LRU=H7N*$B6B3B>>L&OEJ^F@"L/@X-OL/PR4-E"ZR(+&
MY>/G?K/+R[JQ%AMUJ8NZ]*-5'D%UV/`/O`0S3DSLOEU(8\G6/:4!`PBNL4C.
MS#?2U887EQ$CLP%5R+K[I"*W!VVN\)5*%(FO>TI;\68E^LI.E/TQ([;4AY&$
M/([X!N7KIW%0Z$"6:1IZYA>T2R8S#04EU/*H]Y!YJ/<@P6G('+:.FL<>WS).
M!CUT"R.ZA17=POIQSD]9?:FCX`5@\&Q:5[R.5#M(S\K7GN!/2WT:F35JMP+$
M7*(>\,S^+\^,+[\<-@(IN,8X1)X,VIZ8,4GE+M1EH='C[CLN+YVB&$H<:6?F
M".N9'X*#@_E'T'(;QK[U;BN*H@1"!G*.B):R"N:$(ED,>AD#\/(FX.0C-]3!
MQ;0]:)+V5._Q`Q("$Z$E-<L8B>>3!!T'Q`^Z(<,PAS@J!^QA-@XSG!K4<\1_
MA,PAZ^2\Z5W6=T*!YX26D_X8]V(U'`:HV.7"J[UC3)-K5W#)K8HZ?.Z=];:<
MA73%^2>ZX.009,,1AS.0\S-0?_AE-]%Y9>';7ESA,][I.B^*I&AM7MO$N@(^
MVV`5[E\>)XNX[')>M06LPH56R\+D54.KA7^?A=7!SN'2XA5@`7K$"P#I==F\
MK7A#/.@0Y7$<M#S:^Y666YL438T_!C49DY=DXA_)>O)V<M[%3]CC_P4)"!H#
MY@S_#S(-L7)'8V5]`9:<.%=%[7-S-+2*3VK+>,;?6M?KD/I`Z1><^NEQ%:DQ
M>T)UR\<%/]*'.TRM\.Y^+?-V.*G"_0*'6&K17KEKVN'GO05'&ULXXG!;EC['
M+SB_>,10_>S"NF^(CO^JD$:0-^[4QYL1Q=`/2BAGG"3R?\=O\;L*96YD<W1R
M96%M"F5N9&]B:@HQ(#`@;V)J"CP\"B]#<F5A=&]R*&5$;V-U;65N="!,:6)R
M87)Y('9E<G-I;VX@,BXV*0HO0W)E871I;VY$871E*$0Z,C`Q,S$Q,#$P-C0X
M-#(M,#<G,#`G*0HO36]D1&%T92A$.C(P,3,Q,3`Q,#8T.#0R+3`W)S`P)RD*
M+U!R;V1U8V5R*&5$;V-U;65N="!,:6)R87)Y('9E<G-I;VX@,BXV(%!$1B!&
M:6QT97(I"B]!=71H;W(H*0HO5&ET;&4H*0H^/@IE;F1O8FH*,B`P(&]B:@H\
M/`HO5'EP92]086=E<PHO2VED<ULU(#`@4ET*+T-O=6YT(#$*/CX*96YD;V)J
M"GAR968*,"`S"C`P,#`P,#`P,#`@-C4U,S4@9B`*,#`P,#`V,30X,2`P,#`P
M,"!N(`HP,#`P,#8Q-C@V(#`P,#`P(&X@"G1R86EL97(*/#P*+U-I>F4@,PHO
M241;/#0S1C8Y04$V-S="1CE!131&.48V1C(S1C(U03DQ,$-"/CPT,T8V.4%!
M-C<W0D8Y044T1CE&-D8R,T8R-4$Y,3!#0CY="CX^"G-T87)T>')E9@HQ-S,*
&)25%3T8*
`
end
</PDF>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>10
<FILENAME>cdom-20130930.xml
<DESCRIPTION>XBRL
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 3.6b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: CDOM 09%2D30%2D2013.xfr; Date: 2013%2D11%2D01T13:50:37 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80030000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2013-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap="http://fasb.org/us-gaap/2013-01-31" xmlns:us-roles="http://fasb.org/us-roles/2013-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2013-01-31" xmlns:CDOM="http://cardomedical.com/20130930">
    <link:schemaRef xlink:href="cdom-20130930.xsd" xlink:type="simple" />
    <xbrli:context id="AsOf2011-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000925741</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000925741</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-01-01to2013-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000925741</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-01-01to2012-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000925741</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-11-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000925741</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-11-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000925741</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2012-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000925741</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-07-01to2013-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000925741</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-07-01</xbrli:startDate>
        <xbrli:endDate>2013-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2012-07-01to2012-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000925741</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-07-01</xbrli:startDate>
        <xbrli:endDate>2012-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Years">
      <xbrli:measure>utr:Y</xbrli:measure>
    </xbrli:unit>
    <dei:EntityRegistrantName contextRef="From2013-01-01to2013-09-30">Tiger X Medical, Inc.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2013-01-01to2013-09-30">0000925741</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2013-01-01to2013-09-30">10-Q</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2013-01-01to2013-09-30">2013-09-30</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2013-01-01to2013-09-30">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2013-01-01to2013-09-30">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2013-01-01to2013-09-30">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2013-01-01to2013-09-30">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2013-01-01to2013-09-30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="From2013-01-01to2013-09-30">Smaller Reporting Company</dei:EntityFilerCategory>
    <dei:DocumentFiscalPeriodFocus contextRef="From2013-01-01to2013-09-30">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2013-01-01to2013-09-30">2013</dei:DocumentFiscalYearFocus>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2013-11-01" unitRef="Shares" decimals="INF">230293141</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2012-12-31" unitRef="USD" decimals="-3">33000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2013-09-30" unitRef="USD" decimals="-3">45000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:Assets contextRef="AsOf2012-12-31" unitRef="USD" decimals="-3">13301000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2013-09-30" unitRef="USD" decimals="-3">13308000</us-gaap:Assets>
    <us-gaap:Liabilities contextRef="AsOf2012-12-31" unitRef="USD" decimals="-3">12000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2013-09-30" unitRef="USD" decimals="-3">3000</us-gaap:Liabilities>
    <us-gaap:CommonStockValue contextRef="AsOf2012-12-31" unitRef="USD" decimals="-3">230000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2013-09-30" unitRef="USD" decimals="-3">230000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2012-12-31" unitRef="USD" decimals="-3">25766000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2013-09-30" unitRef="USD" decimals="-3">25768000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2012-12-31" unitRef="USD" decimals="-3">-12707000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2013-09-30" unitRef="USD" decimals="-3">-12707000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2012-12-31" unitRef="USD" decimals="-3">13301000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2013-09-30" unitRef="USD" decimals="-3">13308000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2012-12-31" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2013-09-30" unitRef="USDPShares" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2012-12-31" unitRef="Shares" decimals="INF">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2013-09-30" unitRef="Shares" decimals="INF">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2012-12-31" unitRef="Shares" decimals="INF">230293141</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2013-09-30" unitRef="Shares" decimals="INF">230293141</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2012-12-31" unitRef="Shares" decimals="INF">230293141</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2013-09-30" unitRef="Shares" decimals="INF">230293141</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2013-01-01to2013-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;b&gt;1. &lt;/b&gt; &lt;b&gt;SUMMARY OF SIGNIFICANT ACCOUNTING&#13;POLICIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;Tiger X Medical, Inc. (&amp;#34;Tiger X&amp;#34;&#13;or the &amp;#34;Company&amp;#34;), formerly known as Cardo Medical, Inc., previously operated as an orthopedic medical device company&#13;specializing in designing, developing and marketing high performance reconstructive joint devices and spinal surgical devices.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;During 2010, the Company discontinued its&#13;operations and sold the assets from its previous business lines during 2011. Beginning on January 1, 2013, the Company became classified&#13;as a development stage entity. Our continuing operations include the collection and management of our royalty income earned in&#13;connection with the Asset Purchase Agreement with Arthrex, as well as continuing to promote our former products sold to Arthrex&#13;and seeking a joint venture partner or buyer for the remaining intellectual property owned by the Company. The Company will also&#13;be evaluating future investment opportunities and uses for its cash.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;b&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;The accompanying condensed consolidated balance&#13;sheet as of December 31, 2012, which has been derived from the Company's audited financial statements as of that date, and the&#13;unaudited condensed consolidated financial information of the Company as of September 30, 2013 and for the three and nine months&#13;ended September 30, 2013 and 2012, has been prepared in accordance with accounting principles generally accepted in the United&#13;States of America (&amp;#34;U.S. GAAP&amp;#34;) for interim financial information and with the instructions to Form 10-Q and Article&#13;8-03 of Regulation S-X. In the opinion of management, such financial information includes all adjustments considered necessary&#13;for a fair presentation of the Company's financial position at such date and the operating results and cash flows for such periods.&#13;Operating results for the interim period ended September 30, 2013 are not necessarily indicative of the results that may be expected&#13;for the entire year.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;Certain information and footnote disclosure&#13;normally included in financial statements in accordance with generally accepted accounting principles have been omitted pursuant&#13;to the rules of the United States Securities and Exchange Commission (&amp;#34;SEC&amp;#34;). These unaudited financial statements should&#13;be read in conjunction with our audited financial statements and accompanying notes included in the Company's Annual Report on&#13;Form 10-K for the year ended December 31, 2012 filed on March 22, 2013.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;b&gt;&lt;i&gt;Principles of Consolidation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;The condensed consolidated financial statements&#13;include the accounts of Tiger X Medical, Inc., Accelerated Innovation, Inc. (&amp;#34;Accelerated&amp;#34;), Uni-Knee LLC (&amp;#34;Uni&amp;#34;)&#13;and Cervical Xpand LLC (&amp;#34;Cervical&amp;#34;). All significant intercompany transactions have been eliminated in consolidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;b&gt;&lt;i&gt;Royalty Agreement&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;On January 24, 2011, the Company entered into&#13;an Asset Purchase Agreement with Arthrex, Inc. (&amp;#34;Arthrex&amp;#34;) (the agreement being the &amp;#34;Arthrex Asset Purchase Agreement&amp;#34;),&#13;pursuant to which the Company agreed to sell the assets of the Reconstructive Division to Arthrex. The Arthrex Asset Purchase Agreement&#13;also provides for the Company to receive royalty payments equal to 5% of net sales of the Company's products made by Arthrex on&#13;a quarterly basis for a term up to and including the 20th anniversary of the closing date. During the three and nine months ended&#13;September 30, 2013, the Company received total royalty payments of $71,000 and $178,000, respectively, from Arthrex. During the&#13;three and nine months ended September 30, 2012, the Company received total royalty payments of $19,000 and $47,000, respectively.&#13;These amounts are reflected as revenue on the accompanying condensed consolidated statements of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;b&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;Financial statements prepared in accordance&#13;with U.S. GAAP require management to make estimates and assumptions that affect the reported amounts of assets and liabilities&#13;at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Among other&#13;things, management makes estimates relating to share-based payments and deferred income tax assets. Given the short operating history&#13;of Tiger X, actual results could differ from those estimates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;b&gt;&lt;i&gt;Revenue Recognition&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;The Company's revenue consists of royalty&#13;revenue from Arthrex pursuant to the Arthrex Asset Purchase Agreement. Revenue is recognized as the amount becomes known and collectability&#13;is reasonably assured.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;b&gt;&lt;i&gt;Net Income Per Share&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;Basic net income per share is computed by&#13;using the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed giving&#13;effect to all dilutive potential common shares that were outstanding during the period. Dilutive potential common shares consist&#13;of incremental common shares issuable upon exercise of stock options or warrants. No dilutive potential common shares are included&#13;in the computation of any diluted per share amount because their impact was anti-dilutive.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;b&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;Income taxes are accounted for under the asset&#13;and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences&#13;between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases as well as operating&#13;loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to&#13;taxable income in the years in which those temporary differences are expected to be recovered or settled. The likelihood of realizing&#13;the tax benefits related to a potential deferred tax asset is evaluated, and a valuation allowance is recognized to reduce that&#13;deferred tax asset if it is more likely than not that all or some portion of the deferred tax asset will not be realized. Deferred&#13;tax assets and liabilities are calculated at the beginning and end of the year; the change in the sum of the deferred tax asset,&#13;valuation allowance and deferred tax liability during the year generally is recognized as a deferred tax expense or benefit. The&#13;effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes&#13;the enactment date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;The Company evaluates the accounting for uncertainty&#13;in income tax recognized in its financial statements and determines whether it is more likely than not that a tax position will&#13;be sustained upon examination by the appropriate taxing authorities before any part of the benefit is recorded in its financial&#13;statements. For those tax positions where it is &amp;#34;not more likely than not&amp;#34; that a tax benefit will be sustained, no tax&#13;benefit is recognized. Where applicable, associated interest and penalties are also recorded. The Company has not accrued for any&#13;such uncertain tax positions as of September 30, 2013 (unaudited) or December 31, 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;b&gt;&lt;i&gt;Concentration of Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;The cash and cash equivalents held in&#13;the Company's business money market and other bank accounts are with local and national banking institutions and subjected to&#13;FDIC insurance limits of $250,000 per banking institution. As of September 30, 2013, the Company's balances in these bank&#13;accounts exceeded the insured amount by $12,927,193.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;b&gt;&lt;i&gt;Recent Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;There are no recently issued accounting pronouncements&#13;that the Company has yet to adopt that are expected to have a material effect on its financial position, results of operations,&#13;or cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2013-01-01to2013-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;b&gt;3. STOCKHOLDERS' EQUITY &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;Our authorized capital consists of 750,000,000&#13;shares of common stock and 50,000,000 shares of preferred stock. Our preferred stock may be designated into series pursuant to&#13;authority granted by our Certificate of Incorporation, and on approval from our Board of Directors. As of September 30, 2013 and&#13;December 31, 2012, we did not have any preferred stock issued.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2013-01-01to2013-09-30" unitRef="USD" decimals="-3">172000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="-3">320000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2013-07-01to2013-09-30" unitRef="USD" decimals="-3">45000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="-3">102000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss contextRef="From2013-01-01to2013-09-30" unitRef="USD" decimals="-3">6000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="-3">-273000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2013-07-01to2013-09-30" unitRef="USD" decimals="-3">26000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="-3">-83000</us-gaap:OperatingIncomeLoss>
    <us-gaap:ShareBasedCompensation contextRef="From2013-01-01to2013-09-30" unitRef="USD" decimals="-3">2000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="-3">5000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2013-01-01to2013-09-30" unitRef="USD" decimals="-3">0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="-3">43000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2013-01-01to2013-09-30" unitRef="USD" decimals="-3">-12000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="-3">77000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2013-01-01to2013-09-30" unitRef="USD" decimals="-3">-9000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="-3">-615000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:InterestPaid contextRef="From2013-01-01to2013-09-30" unitRef="USD" decimals="-3">0</us-gaap:InterestPaid>
    <us-gaap:InterestPaid contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="-3">0</us-gaap:InterestPaid>
    <us-gaap:IncomeTaxesPaid contextRef="From2013-01-01to2013-09-30" unitRef="USD" decimals="-3">26000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="-3">553000</us-gaap:IncomeTaxesPaid>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2013-01-01to2013-09-30" unitRef="Shares" decimals="INF">230293141</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2012-01-01to2012-09-30" unitRef="Shares" decimals="INF">230293141</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2013-07-01to2013-09-30" unitRef="Shares" decimals="INF">230293141</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2012-07-01to2012-09-30" unitRef="Shares" decimals="INF">230293141</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2013-01-01to2013-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;b&gt;NOTE 2 - SHARE BASED PAYMENT&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;On August 29, 2008, the Company issued options&#13;to certain employees and Board members to purchase membership units in the Company. The options give the grantees the right to&#13;purchase up to 2,398,400 shares of the Company's common stock at an exercise price of $0.23 per share. The options vest 20% each&#13;year over a five-year period and expire after ten years. Stock option compensation recognized for the nine months ended September&#13;30, 2013 and 2012 in the accompanying condensed consolidated statements of operations amounted to $2,000 and $5,000, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;A summary of stock option activity as of September&#13;30, 2013, and changes during the period then ended is presented below.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Remaining &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Life (Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="background-color: white"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;385,000&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.23&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.66&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="background-color: white"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;- &amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;- &amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="background-color: white"&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;- &amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;- &amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="background-color: white"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;- &amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;- &amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="background-color: white"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at September 30, 2013 (unaudited)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;385,000&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.23&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.92&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="background-color: white"&gt;&lt;font style="font-size: 10pt"&gt;Vested and expected to vest&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="background-color: white"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; at September 30, 2013 (unaudited)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;385,000&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.23&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.92&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="background-color: white"&gt;&lt;font style="font-size: 10pt"&gt;Exercisable at September 30, 2013 (unaudited)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;385,000&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.23&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.92&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;The Company had 575,613 warrants outstanding&#13;as of September 30, 2013 which entitle the holders to immediately purchase one share of the Company's common stock at an exercise&#13;price of $0.44 per share. The warrants expire on November 13, 2014.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:OtherOperatingIncomeExpenseNet contextRef="From2013-01-01to2013-09-30" unitRef="USD" decimals="-3">8000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="-3">8000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet contextRef="From2013-07-01to2013-09-30" unitRef="USD" decimals="-3">4000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="-3">2000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="From2013-01-01to2013-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;Tiger X Medical, Inc. (&amp;#34;Tiger X&amp;#34;&#13;or the &amp;#34;Company&amp;#34;), formerly known as Cardo Medical, Inc., previously operated as an orthopedic medical device company&#13;specializing in designing, developing and marketing high performance reconstructive joint devices and spinal surgical devices.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;During 2010, the Company discontinued its&#13;operations and sold the assets from its previous business lines during 2011. Beginning on January 1, 2013, the Company became classified&#13;as a development stage entity. Our continuing operations include the collection and management of our royalty income earned in&#13;connection with the Asset Purchase Agreement with Arthrex, as well as continuing to promote our former products sold to Arthrex&#13;and seeking a joint venture partner or buyer for the remaining intellectual property owned by the Company. The Company will also&#13;be evaluating future investment opportunities and uses for its cash.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2013-01-01to2013-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;Principles of Consolidation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;The condensed consolidated financial statements&#13;include the accounts of Tiger X Medical, Inc., Accelerated Innovation, Inc. (&amp;#34;Accelerated&amp;#34;), Uni-Knee LLC (&amp;#34;Uni&amp;#34;)&#13;and Cervical Xpand LLC (&amp;#34;Cervical&amp;#34;). All significant intercompany transactions have been eliminated in consolidation.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2013-01-01to2013-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;Financial statements prepared in accordance&#13;with U.S. GAAP require management to make estimates and assumptions that affect the reported amounts of assets and liabilities&#13;at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Among other&#13;things, management makes estimates relating to share-based payments and deferred income tax assets. Given the short operating history&#13;of Tiger X, actual results could differ from those estimates.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2013-01-01to2013-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;Revenue Recognition&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;The Company's revenue consists of royalty&#13;revenue from the Arthrex Asset Purchase Agreement, which is recognized as the amount becomes known and collectability is reasonably&#13;assured.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2013-01-01to2013-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;b&gt;&lt;i&gt;Net Income Per Share&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;Basic net income per share is computed by&#13;using the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed giving&#13;effect to all dilutive potential common shares that were outstanding during the period. Dilutive potential common shares consist&#13;of incremental common shares issuable upon exercise of stock options or warrants. No dilutive potential common shares are included&#13;in the computation of any diluted per share amount because their impact was anti-dilutive.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2013-01-01to2013-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;Income taxes are accounted for under the asset&#13;and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences&#13;between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases as well as operating&#13;loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to&#13;taxable income in the years in which those temporary differences are expected to be recovered or settled. The likelihood of realizing&#13;the tax benefits related to a potential deferred tax asset is evaluated, and a valuation allowance is recognized to reduce that&#13;deferred tax asset if it is more likely than not that all or some portion of the deferred tax asset will not be realized. Deferred&#13;tax assets and liabilities are calculated at the beginning and end of the year; the change in the sum of the deferred tax asset,&#13;valuation allowance and deferred tax liability during the year generally is recognized as a deferred tax expense or benefit. The&#13;effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes&#13;the enactment date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;The Company evaluates the accounting for uncertainty&#13;in income tax recognized in its financial statements and determines whether it is more likely than not that a tax position will&#13;be sustained upon examination by the appropriate taxing authorities before any part of the benefit is recorded in its financial&#13;statements. For those tax positions where it is &amp;#34;not more likely than not&amp;#34; that a tax benefit will be sustained, no tax&#13;benefit is recognized. Where applicable, associated interest and penalties are also recorded. The Company has not accrued for any&#13;such uncertain tax positions as of September 30, 2013 (unaudited) or December 31, 2012.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2013-01-01to2013-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;b&gt;&lt;i&gt;Concentration of Credit Risk&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;The cash and cash equivalents held in&#13;the Company's business money market and other bank accounts are with local and national banking institutions and subjected to&#13;FDIC insurance limits of $250,000 per banking institution. As of September 30, 2013, the Company's balances in these bank&#13;accounts exceeded the insured amount by $12,965,872.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted contextRef="From2013-01-01to2013-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;Recent Accounting Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;There are no recently issued accounting standards that the&#13;Company has yet to adopt that are expected to have a material effect on its financial position, results of operations, or cash&#13;flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;</us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="From2013-01-01to2013-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;A summary of stock option activity as of September&#13;30, 2013, and changes during the period then ended is presented below.&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted-&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Remaining &lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Life (Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="background-color: white"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2012&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;385,000&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.23&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.66&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="background-color: white"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;- &amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;- &amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="background-color: white"&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;- &amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;- &amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="background-color: white"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;- &amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;- &amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="background-color: white"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at September 30, 2013 (unaudited)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;385,000&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.23&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.92&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="background-color: white"&gt;&lt;font style="font-size: 10pt"&gt;Vested and expected to vest&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="background-color: white"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160; at September 30, 2013 (unaudited)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;385,000&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.23&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.92&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="background-color: white"&gt;&lt;font style="font-size: 10pt"&gt;Exercisable at September 30, 2013 (unaudited)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;385,000&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.23&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.92&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="background-color: white; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2012-12-31" unitRef="Shares" decimals="INF">385000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2013-09-30" unitRef="Shares" decimals="INF">385000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2013-01-01to2013-09-30" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2013-01-01to2013-09-30" unitRef="Shares" decimals="INF">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="From2013-01-01to2013-09-30" unitRef="Shares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="AsOf2013-09-30" unitRef="Shares" decimals="INF">385000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2013-09-30" unitRef="Shares" decimals="INF">308000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2013-09-30" unitRef="USDPShares" decimals="INF">0.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2013-01-01to2013-09-30" unitRef="USDPShares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice contextRef="AsOf2012-12-31" unitRef="USDPShares" decimals="INF">0.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2012-12-31" unitRef="USDPShares" decimals="INF">0.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2013-09-30" unitRef="USD" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue contextRef="AsOf2013-09-30" unitRef="USD" decimals="0">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2013-09-30" unitRef="USD" decimals="0">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="AsOf2013-09-30" unitRef="Shares" decimals="INF">2398400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2013-09-30" unitRef="Shares" decimals="INF">575613</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2013-09-30" unitRef="USDPShares" decimals="INF">0.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <CDOM:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExpireDate contextRef="AsOf2013-09-30">2014-11-13</CDOM:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExpireDate>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2012-12-31" unitRef="Shares" decimals="INF">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2013-09-30" unitRef="Shares" decimals="INF">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2012-12-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2013-09-30" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="AsOf2012-12-31" unitRef="USD" decimals="-3">13289000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2013-09-30" unitRef="USD" decimals="-3">13305000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="From2013-01-01to2013-09-30" unitRef="USD" decimals="-3">14000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="-3">267000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2013-07-01to2013-09-30" unitRef="USD" decimals="-3">30000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="-3">451000</us-gaap:NetIncomeLoss>
    <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="AsOf2012-12-31" unitRef="USD" decimals="-3">0</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
    <us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage contextRef="AsOf2013-09-30" unitRef="USD" decimals="-3">-14000</us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2012-12-31" unitRef="USD" decimals="-3">12000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2013-09-30" unitRef="USD" decimals="-3">3000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2013-01-01to2013-09-30" unitRef="USD" decimals="-3">14000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="-3">-265000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2013-07-01to2013-09-30" unitRef="USD" decimals="-3">30000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="-3">-81000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2013-01-01to2013-09-30" unitRef="USD" decimals="-3">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="-3">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2013-07-01to2013-09-30" unitRef="USD" decimals="-3">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="-3">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2013-01-01to2013-09-30" unitRef="USD" decimals="-3">-5000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="-3">145000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2011-12-31" unitRef="USD" decimals="-3">12678000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2012-12-31" unitRef="USD" decimals="-3">13268000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2013-09-30" unitRef="USD" decimals="-3">13263000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2012-09-30" unitRef="USD" decimals="-3">12823000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RoyaltyRevenue contextRef="From2013-01-01to2013-09-30" unitRef="USD" decimals="-3">178000</us-gaap:RoyaltyRevenue>
    <us-gaap:RoyaltyRevenue contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="-3">47000</us-gaap:RoyaltyRevenue>
    <us-gaap:RoyaltyRevenue contextRef="From2013-07-01to2013-09-30" unitRef="USD" decimals="-3">71000</us-gaap:RoyaltyRevenue>
    <us-gaap:RoyaltyRevenue contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="-3">19000</us-gaap:RoyaltyRevenue>
    <us-gaap:RevenueRecognitionServicesRoyaltyFees contextRef="From2013-01-01to2013-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;b&gt;&lt;i&gt;Royalty Agreement&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;On January 24, 2011, the Company entered&#13;into an Asset Purchase Agreement with Arthrex, Inc. (&amp;#34;Arthrex&amp;#34;) (the agreement being the &amp;#34;Arthrex Asset Purchase&#13;Agreement&amp;#34;), pursuant to which the Company agreed to sell the assets of the Reconstructive Division to Arthrex. The Arthrex&#13;Asset Purchase Agreement also provides for the Company to receive royalty payments equal to 5% of net sales of the Company's products&#13;made by Arthrex on a quarterly basis for a term up to and including the 20th anniversary of the closing date. During the three&#13;and nine months ended September 30, 2013, the Company received total royalty payments of $71,000 and $178,000, respectively, from&#13;Arthrex. During the three and nine months ended September 30, 2012, the Company received total royalty payments of $19,000 and&#13;$47,000, respectively. These amounts are reflected as revenue on the accompanying condensed consolidated statements of operations.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;&lt;/p&gt;</us-gaap:RevenueRecognitionServicesRoyaltyFees>
    <us-gaap:CashUninsuredAmount contextRef="AsOf2013-09-30" unitRef="USD" decimals="0">12927193</us-gaap:CashUninsuredAmount>
    <us-gaap:IncreaseDecreaseInRestrictedCash contextRef="From2013-01-01to2013-09-30" unitRef="USD" decimals="-3">0</us-gaap:IncreaseDecreaseInRestrictedCash>
    <us-gaap:IncreaseDecreaseInRestrictedCash contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="-3">-900000</us-gaap:IncreaseDecreaseInRestrictedCash>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2013-01-01to2013-09-30" unitRef="USD" decimals="-3">0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="-3">900000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:CashFDICInsuredAmount contextRef="AsOf2013-09-30" unitRef="USD" decimals="0">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2013-01-01to2013-09-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;The accompanying condensed consolidated balance&#13;sheet as of December 31, 2012, which has been derived from the Company's audited financial statements as of that date, and the&#13;unaudited condensed consolidated financial information of the Company as of September 30, 2013 and for the three and nine months&#13;ended September 30, 2013 and 2012, has been prepared in accordance with accounting principles generally accepted in the United&#13;States of America (&amp;#34;U.S. GAAP&amp;#34;) for interim financial information and with the instructions to Form 10-Q and Article&#13;8-03 of Regulation S-X. In the opinion of management, such financial information includes all adjustments considered necessary&#13;for a fair presentation of the Company's financial position at such date and the operating results and cash flows for such periods.&#13;Operating results for the interim period ended September 30, 2013 are not necessarily indicative of the results that may be expected&#13;for the entire year.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"&gt;Certain information and footnote disclosure&#13;normally included in financial statements in accordance with generally accepted accounting principles have been omitted pursuant&#13;to the rules of the United States Securities and Exchange Commission (&amp;#34;SEC&amp;#34;). These unaudited financial statements should&#13;be read in conjunction with our audited financial statements and accompanying notes included in the Company's Annual Report on&#13;Form 10-K for the year ended December 31, 2012 filed on March 22, 2013.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2013-01-01to2013-09-30" unitRef="USDPShares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2013-01-01to2013-09-30" unitRef="USDPShares" decimals="INF">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2012-01-01to2012-09-30">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2012-01-01to2012-09-30">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2013-01-01to2013-09-30">P5Y8M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <CDOM:WeightedaverageRemainingContractualTermInYearsOfOptionsOutstandingAtEndOfPeriod contextRef="From2013-01-01to2013-09-30">P4Y11M1D</CDOM:WeightedaverageRemainingContractualTermInYearsOfOptionsOutstandingAtEndOfPeriod>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="AsOf2012-12-31" unitRef="USD" decimals="0">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued contextRef="AsOf2013-09-30" unitRef="USD" decimals="0">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2013-01-01to2013-09-30" unitRef="USD" decimals="-3">14000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="-3">-265000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2013-07-01to2013-09-30" unitRef="USD" decimals="-3">30000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="-3">-81000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax contextRef="From2013-01-01to2013-09-30" unitRef="USD" decimals="-3">0</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
    <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="-3">532000</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
    <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax contextRef="From2013-07-01to2013-09-30" unitRef="USD" decimals="-3">0</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
    <us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax contextRef="From2012-07-01to2012-09-30" unitRef="USD" decimals="-3">532000</us-gaap:DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare contextRef="From2013-01-01to2013-09-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare contextRef="From2012-01-01to2012-09-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare contextRef="From2013-07-01to2013-09-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare contextRef="From2012-07-01to2012-09-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare contextRef="From2013-01-01to2013-09-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare contextRef="From2012-01-01to2012-09-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare contextRef="From2013-07-01to2013-09-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare contextRef="From2012-07-01to2012-09-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2013-01-01to2013-09-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2012-01-01to2012-09-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2013-07-01to2013-09-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2012-07-01to2012-09-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable contextRef="From2013-01-01to2013-09-30" unitRef="USD" decimals="-3">0</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="-3">-532000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2013-01-01to2013-09-30" unitRef="USD" decimals="-3">-5000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2012-01-01to2012-09-30" unitRef="USD" decimals="-3">-755000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="From2013-01-01to2013-09-30">P4Y11M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2013-01-01to2013-09-30">P4Y11M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>cdom-20130930.xsd
<DESCRIPTION>XBRL
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 3.6b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: CDOM 09%2D30%2D2013.xfr; Date: 2013%2D11%2D01T13:50:37 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80030000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +qsps7xRiXgOn8uFZHxMOamEubOdw5pyeZlBtWZxbclqXykrsajo4Cv7etA24WMP -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2013-01-31" xmlns:us-roles="http://fasb.org/us-roles/2013-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2013-01-31" xmlns:CDOM="http://cardomedical.com/20130930" elementFormDefault="qualified" targetNamespace="http://cardomedical.com/20130930">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://cardomedical.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://cardomedical.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
	  <link:definition>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://cardomedical.com/role/ConsolidatedBalanceSheetsParenthetical" id="ConsolidatedBalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://cardomedical.com/role/ConsolidatedStatementsOfOperations" id="ConsolidatedStatementsOfOperations">
	  <link:definition>00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://cardomedical.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
	  <link:definition>00000005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000006 - Disclosure - 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://cardomedical.com/role/ShareBasedPayment" id="ShareBasedPayment">
	  <link:definition>00000007 - Disclosure - 2. SHARE BASED PAYMENT</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://cardomedical.com/role/StockholdersEquity" id="StockholdersEquity">
	  <link:definition>00000008 - Disclosure - 3. STOCKHOLDERS' EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://cardomedical.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000009 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://cardomedical.com/role/ShareBasedPaymentTables" id="ShareBasedPaymentTables">
	  <link:definition>00000010 - Disclosure - Share Based Payment (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetails" id="SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetails">
	  <link:definition>00000011 - Disclosure - Summary of Significant Accounting Polices (Royalty Agreement) (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetails" id="SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetails">
	  <link:definition>00000012 - Disclosure - Summary of Significant Accounting Polices (Income Taxes) (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesConcentrationOfCreditRiskNarrativeDetails" id="SummaryOfSignificantAccountingPolicesConcentrationOfCreditRiskNarrativeDetails">
	  <link:definition>00000013 - Disclosure - Summary of Significant Accounting Polices (Concentration of Credit Risk) (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://cardomedical.com/role/Share-BasedPaymentStockOptionActivityDetails" id="Share-BasedPaymentStockOptionActivityDetails">
	  <link:definition>00000014 - Disclosure - Share-Based Payment (Stock Option Activity) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://cardomedical.com/role/Share-BasedPaymentNarrativeDetails1" id="Share-BasedPaymentNarrativeDetails1">
	  <link:definition>00000015 - Disclosure - Share-Based Payment (Narrative) (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://cardomedical.com/role/Share-BasedPaymentNarrativeDetails2" id="Share-BasedPaymentNarrativeDetails2">
	  <link:definition>00000016 - Disclosure - Share-Based Payment (Narrative) (Details 2)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://cardomedical.com/role/StockholdersEquityNarrativeDetails" id="StockholdersEquityNarrativeDetails">
	  <link:definition>00000017 - Disclosure - Stockholders' Equity (Narrative) (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="cdom-20130930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="cdom-20130930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="cdom-20130930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="cdom-20130930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2013-01-31" schemaLocation="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2013-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2013-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2013/elts/us-types-2013-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <element id="CDOM_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="CDOM_DiscontinuedOperationsNote1Abstract" name="DiscontinuedOperationsNote1Abstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="CDOM_NotesToFinancialStatementsAbstract" name="NotesToFinancialStatementsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="CDOM_ShareBasedPaymentTablesAbstract" name="ShareBasedPaymentTablesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="CDOM_SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetailsAbstract" name="SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="CDOM_SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetailsAbstract" name="SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="CDOM_ConcentrationOfCreditRiskNarrativeDetailsAbstract" name="ConcentrationOfCreditRiskNarrativeDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="CDOM_StockbasedCompensationStockOptionActivityDetailsAbstract" name="StockbasedCompensationStockOptionActivityDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="CDOM_WeightedaverageRemainingContractualTermInYearsOfOptionsOutstandingAtEndOfPeriod" name="WeightedaverageRemainingContractualTermInYearsOfOptionsOutstandingAtEndOfPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="CDOM_ShareBasedPaymentNarrativeDetails1Abstract" name="ShareBasedPaymentNarrativeDetails1Abstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="CDOM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExpireDate" name="SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExpireDate" nillable="true" xbrli:periodType="instant" type="us-types:dateStringItemType" substitutionGroup="xbrli:item" />
    <element id="CDOM_ShareBasedPaymentNarrativeDetails2Abstract" name="ShareBasedPaymentNarrativeDetails2Abstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="CDOM_StockholdersEquityNarrativeDetailsAbstract" name="StockholdersEquityNarrativeDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>cdom-20130930_cal.xml
<DESCRIPTION>XBRL
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 3.6b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: CDOM 09%2D30%2D2013.xfr; Date: 2013%2D11%2D01T13:50:37 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80030000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://cardomedical.com/role/DocumentAndEntityInformation" xlink:href="cdom-20130930.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/ConsolidatedBalanceSheets" xlink:href="cdom-20130930.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="cdom-20130930.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/ConsolidatedStatementsOfOperations" xlink:href="cdom-20130930.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="cdom-20130930.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="cdom-20130930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/ShareBasedPayment" xlink:href="cdom-20130930.xsd#ShareBasedPayment" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/StockholdersEquity" xlink:href="cdom-20130930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cdom-20130930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/ShareBasedPaymentTables" xlink:href="cdom-20130930.xsd#ShareBasedPaymentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetails" xlink:href="cdom-20130930.xsd#SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetails" xlink:href="cdom-20130930.xsd#SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesConcentrationOfCreditRiskNarrativeDetails" xlink:href="cdom-20130930.xsd#SummaryOfSignificantAccountingPolicesConcentrationOfCreditRiskNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/Share-BasedPaymentStockOptionActivityDetails" xlink:href="cdom-20130930.xsd#Share-BasedPaymentStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/Share-BasedPaymentNarrativeDetails1" xlink:href="cdom-20130930.xsd#Share-BasedPaymentNarrativeDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/Share-BasedPaymentNarrativeDetails2" xlink:href="cdom-20130930.xsd#Share-BasedPaymentNarrativeDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/StockholdersEquityNarrativeDetails" xlink:href="cdom-20130930.xsd#StockholdersEquityNarrativeDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:label="loc_us-gaapDevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapDevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RoyaltyRevenue" xlink:label="loc_us-gaapRoyaltyRevenue" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapRoyaltyRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="loc_us-gaapOtherOperatingIncomeExpenseNet" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOtherOperatingIncomeExpenseNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:label="loc_us-gaapDiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapDiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicAndDilutedShare" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInIncomeTaxesReceivable" />
      <link:calculationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInIncomeTaxesReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCash" xlink:label="loc_us-gaapIncreaseDecreaseInRestrictedCash" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInRestrictedCash" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000006 - Disclosure - 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/ShareBasedPayment" xlink:title="00000007 - Disclosure - 2. SHARE BASED PAYMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/StockholdersEquity" xlink:title="00000008 - Disclosure - 3. STOCKHOLDERS' EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000009 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/ShareBasedPaymentTables" xlink:title="00000010 - Disclosure - Share Based Payment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetails" xlink:title="00000011 - Disclosure - Summary of Significant Accounting Polices (Royalty Agreement) (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetails" xlink:title="00000012 - Disclosure - Summary of Significant Accounting Polices (Income Taxes) (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesConcentrationOfCreditRiskNarrativeDetails" xlink:title="00000013 - Disclosure - Summary of Significant Accounting Polices (Concentration of Credit Risk) (Narrative) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/Share-BasedPaymentStockOptionActivityDetails" xlink:title="00000014 - Disclosure - Share-Based Payment (Stock Option Activity) (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/Share-BasedPaymentNarrativeDetails1" xlink:title="00000015 - Disclosure - Share-Based Payment (Narrative) (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/Share-BasedPaymentNarrativeDetails2" xlink:title="00000016 - Disclosure - Share-Based Payment (Narrative) (Details 2)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/StockholdersEquityNarrativeDetails" xlink:title="00000017 - Disclosure - Stockholders' Equity (Narrative) (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>cdom-20130930_def.xml
<DESCRIPTION>XBRL
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 3.6b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: CDOM 09%2D30%2D2013.xfr; Date: 2013%2D11%2D01T13:50:37 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80030000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://cardomedical.com/role/DocumentAndEntityInformation" xlink:href="cdom-20130930.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/ConsolidatedBalanceSheets" xlink:href="cdom-20130930.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="cdom-20130930.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/ConsolidatedStatementsOfOperations" xlink:href="cdom-20130930.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="cdom-20130930.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="cdom-20130930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/ShareBasedPayment" xlink:href="cdom-20130930.xsd#ShareBasedPayment" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/StockholdersEquity" xlink:href="cdom-20130930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cdom-20130930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/ShareBasedPaymentTables" xlink:href="cdom-20130930.xsd#ShareBasedPaymentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetails" xlink:href="cdom-20130930.xsd#SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetails" xlink:href="cdom-20130930.xsd#SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesConcentrationOfCreditRiskNarrativeDetails" xlink:href="cdom-20130930.xsd#SummaryOfSignificantAccountingPolicesConcentrationOfCreditRiskNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/Share-BasedPaymentStockOptionActivityDetails" xlink:href="cdom-20130930.xsd#Share-BasedPaymentStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/Share-BasedPaymentNarrativeDetails1" xlink:href="cdom-20130930.xsd#Share-BasedPaymentNarrativeDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/Share-BasedPaymentNarrativeDetails2" xlink:href="cdom-20130930.xsd#Share-BasedPaymentNarrativeDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/StockholdersEquityNarrativeDetails" xlink:href="cdom-20130930.xsd#StockholdersEquityNarrativeDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cardomedical.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cardomedical.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cardomedical.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cardomedical.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cardomedical.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000006 - Disclosure - 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cardomedical.com/role/ShareBasedPayment" xlink:title="00000007 - Disclosure - 2. SHARE BASED PAYMENT" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cardomedical.com/role/StockholdersEquity" xlink:title="00000008 - Disclosure - 3. STOCKHOLDERS' EQUITY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cardomedical.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000009 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cardomedical.com/role/ShareBasedPaymentTables" xlink:title="00000010 - Disclosure - Share Based Payment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetails" xlink:title="00000011 - Disclosure - Summary of Significant Accounting Polices (Royalty Agreement) (Narrative) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetails" xlink:title="00000012 - Disclosure - Summary of Significant Accounting Polices (Income Taxes) (Narrative) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesConcentrationOfCreditRiskNarrativeDetails" xlink:title="00000013 - Disclosure - Summary of Significant Accounting Polices (Concentration of Credit Risk) (Narrative) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cardomedical.com/role/Share-BasedPaymentStockOptionActivityDetails" xlink:title="00000014 - Disclosure - Share-Based Payment (Stock Option Activity) (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cardomedical.com/role/Share-BasedPaymentNarrativeDetails1" xlink:title="00000015 - Disclosure - Share-Based Payment (Narrative) (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cardomedical.com/role/Share-BasedPaymentNarrativeDetails2" xlink:title="00000016 - Disclosure - Share-Based Payment (Narrative) (Details 2)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://cardomedical.com/role/StockholdersEquityNarrativeDetails" xlink:title="00000017 - Disclosure - Stockholders' Equity (Narrative) (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>cdom-20130930_lab.xml
<DESCRIPTION>XBRL
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 3.6b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: CDOM 09%2D30%2D2013.xfr; Date: 2013%2D11%2D01T13:50:37 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80030000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_DocumentAndEntityInformationAbstract" xlink:label="CDOM_DocumentAndEntityInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CDOM_DocumentAndEntityInformationAbstract" xlink:to="CDOM_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CDOM_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document And Entity Information</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Is Entity a Well-known Seasoned Issuer?</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Is Entity a Voluntary Filer?</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Is Entity's Reporting Status Current?</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.001 parvalue, 750,000,000 shares authorized, 230,293,141 issued and outstanding as of September 30, 2013 (unaudited) and December 31, 2012</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_lbl" xml:lang="en-US">Earnings accumulated during the development stage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Accounts receivable allowance for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_2_lbl" xml:lang="en-US">Stockholders' equity:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RoyaltyRevenue" xlink:label="us-gaap_RoyaltyRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyRevenue" xlink:to="us-gaap_RoyaltyRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RoyaltyRevenue_lbl" xml:lang="en-US">Royalty income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Income (loss) from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="us-gaap_OtherOperatingIncomeExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOperatingIncomeExpenseNet_lbl" xml:lang="en-US">Interest income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income (loss) before income tax provision</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">Loss from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_DiscontinuedOperationsNote1Abstract" xlink:label="CDOM_DiscontinuedOperationsNote1Abstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CDOM_DiscontinuedOperationsNote1Abstract" xlink:to="CDOM_DiscontinuedOperationsNote1Abstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CDOM_DiscontinuedOperationsNote1Abstract_lbl" xml:lang="en-US">Discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:label="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:to="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_lbl" xml:lang="en-US">Gain from sale of discontinued Reconstructive and Spine Divisions, net of income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Net income (loss) per share:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xml:lang="en-US">Basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_lbl" xml:lang="en-US">Continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare_lbl" xml:lang="en-US">Discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US">Weighted average shares outstanding:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock option compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_lbl" xml:lang="en-US">Income tax receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCash" xlink:label="us-gaap_IncreaseDecreaseInRestrictedCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInRestrictedCash" xlink:to="us-gaap_IncreaseDecreaseInRestrictedCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInRestrictedCash_lbl" xml:lang="en-US">Decrease in restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided by investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Net change in cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash, beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">Cash, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_NotesToFinancialStatementsAbstract" xlink:label="CDOM_NotesToFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CDOM_NotesToFinancialStatementsAbstract" xlink:to="CDOM_NotesToFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CDOM_NotesToFinancialStatementsAbstract_lbl" xml:lang="en-US">Notes to Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">2. SHARE BASED PAYMENT</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">3. STOCKHOLDERS' EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Summary of Significant Accounting Policies (Policies)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionServicesRoyaltyFees" xlink:label="us-gaap_RevenueRecognitionServicesRoyaltyFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionServicesRoyaltyFees" xlink:to="us-gaap_RevenueRecognitionServicesRoyaltyFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionServicesRoyaltyFees_lbl" xml:lang="en-US">Royalty Agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net Income Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:label="us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:to="us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_ShareBasedPaymentTablesAbstract" xlink:label="CDOM_ShareBasedPaymentTablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CDOM_ShareBasedPaymentTablesAbstract" xlink:to="CDOM_ShareBasedPaymentTablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CDOM_ShareBasedPaymentTablesAbstract_lbl" xml:lang="en-US">Share Based Payment Tables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xml:lang="en-US">Summary of Stock Option Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetailsAbstract" xlink:label="CDOM_SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetailsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CDOM_SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetailsAbstract" xlink:to="CDOM_SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetailsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CDOM_SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetailsAbstract_lbl" xml:lang="en-US">Summary Of Significant Accounting Polices Royalty Agreement Narrative Details</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyRevenue" xlink:to="us-gaap_RoyaltyRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RoyaltyRevenue_2_lbl" xml:lang="en-US">Royalty Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetailsAbstract" xlink:label="CDOM_SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetailsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CDOM_SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetailsAbstract" xlink:to="CDOM_SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetailsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CDOM_SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetailsAbstract_lbl" xml:lang="en-US">Summary Of Significant Accounting Polices Income Taxes Narrative Details</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xml:lang="en-US">Accrual for uncertain tax positions</link:label>
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_ConcentrationOfCreditRiskNarrativeDetailsAbstract" xlink:label="CDOM_ConcentrationOfCreditRiskNarrativeDetailsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CDOM_ConcentrationOfCreditRiskNarrativeDetailsAbstract" xlink:to="CDOM_ConcentrationOfCreditRiskNarrativeDetailsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CDOM_ConcentrationOfCreditRiskNarrativeDetailsAbstract_lbl" xml:lang="en-US">Summary Of Significant Accounting Polices Concentration Of Credit Risk Narrative Details</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="us-gaap_CashFDICInsuredAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xml:lang="en-US">FDIC current limits on bank accounts per banking institution</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashUninsuredAmount" xlink:label="us-gaap_CashUninsuredAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashUninsuredAmount" xlink:to="us-gaap_CashUninsuredAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashUninsuredAmount_lbl" xml:lang="en-US">Company bank balances in these bank accounts exceeding the insured amount</link:label>
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_StockbasedCompensationStockOptionActivityDetailsAbstract" xlink:label="CDOM_StockbasedCompensationStockOptionActivityDetailsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CDOM_StockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="CDOM_StockbasedCompensationStockOptionActivityDetailsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CDOM_StockbasedCompensationStockOptionActivityDetailsAbstract_lbl" xml:lang="en-US">Share-Based Payment Stock Option Activity Details</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Outstanding at December 31, 2012</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Outstanding at September 30, 2013 (unaudited)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US">Vested and expected to vest at September 30, 2013</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Exercisable at September 30, 2013</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-average exercise price of options outstanding, beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-average exercise price of options granted during period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-average exercise price of options exercised during the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-average exercise price of options forfeited, cancelled or expired during the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted-average exercise price of options outstanding, ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-average exercise price of options vested and expected to vest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted-average exercise price of options exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted-average remaining contractual term (in years) of options outstanding at December 31, 2012</link:label>
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_WeightedaverageRemainingContractualTermInYearsOfOptionsOutstandingAtEndOfPeriod" xlink:label="CDOM_WeightedaverageRemainingContractualTermInYearsOfOptionsOutstandingAtEndOfPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CDOM_WeightedaverageRemainingContractualTermInYearsOfOptionsOutstandingAtEndOfPeriod" xlink:to="CDOM_WeightedaverageRemainingContractualTermInYearsOfOptionsOutstandingAtEndOfPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CDOM_WeightedaverageRemainingContractualTermInYearsOfOptionsOutstandingAtEndOfPeriod_lbl" xml:lang="en-US">Weighted-average remaining contractual term (in years) of options outstanding at September 30, 2013</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted-average remaining contractual term (in years) of options vested and expected to vest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted-average remaining contractual term (in years) of options exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value of options outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate intrinsic value of options vested and expected to vest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Aggregate intrinsic value of options exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_ShareBasedPaymentNarrativeDetails1Abstract" xlink:label="CDOM_ShareBasedPaymentNarrativeDetails1Abstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CDOM_ShareBasedPaymentNarrativeDetails1Abstract" xlink:to="CDOM_ShareBasedPaymentNarrativeDetails1Abstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CDOM_ShareBasedPaymentNarrativeDetails1Abstract_lbl" xml:lang="en-US">Share-Based Payment Narrative Details 1</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US">Shares made available under option grants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Option grant exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Option vesting period, in years</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Option expiration period, in years</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Number of shares of common stock available for purchase under warrants outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Warrant exercise price, per share</link:label>
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExpireDate" xlink:label="CDOM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExpireDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CDOM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExpireDate" xlink:to="CDOM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExpireDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CDOM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExpireDate_lbl" xml:lang="en-US">Warrant expiration date</link:label>
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_ShareBasedPaymentNarrativeDetails2Abstract" xlink:label="CDOM_ShareBasedPaymentNarrativeDetails2Abstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CDOM_ShareBasedPaymentNarrativeDetails2Abstract" xlink:to="CDOM_ShareBasedPaymentNarrativeDetails2Abstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CDOM_ShareBasedPaymentNarrativeDetails2Abstract_lbl" xml:lang="en-US">Share-Based Payment Narrative Details 2</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Share-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_StockholdersEquityNarrativeDetailsAbstract" xlink:label="CDOM_StockholdersEquityNarrativeDetailsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CDOM_StockholdersEquityNarrativeDetailsAbstract" xlink:to="CDOM_StockholdersEquityNarrativeDetailsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="CDOM_StockholdersEquityNarrativeDetailsAbstract_lbl" xml:lang="en-US">Stockholders Equity Narrative Details</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred Shares Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_2_lbl" xml:lang="en-US">Common Shares Authorized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CDOM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExpireDate" xlink:to="CDOM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExpireDate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CDOM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExpireDate_doc" xml:lang="en-US">Warrant expiration date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CDOM_WeightedaverageRemainingContractualTermInYearsOfOptionsOutstandingAtEndOfPeriod" xlink:to="CDOM_WeightedaverageRemainingContractualTermInYearsOfOptionsOutstandingAtEndOfPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="CDOM_WeightedaverageRemainingContractualTermInYearsOfOptionsOutstandingAtEndOfPeriod_doc" xml:lang="en-US">Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format at the end of the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:to="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage_2_lbl" xml:lang="en-US">Development Stage Enterprise, Deficit Accumulated During Development Stage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare_2_lbl" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_2_lbl" xml:lang="en-US">Earnings Per Share, Basic and Diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInRestrictedCash" xlink:to="us-gaap_IncreaseDecreaseInRestrictedCash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInRestrictedCash_2_lbl" xml:lang="en-US">Increase (Decrease) in Restricted Cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>cdom-20130930_pre.xml
<DESCRIPTION>XBRL
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 3.6b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: CDOM 09%2D30%2D2013.xfr; Date: 2013%2D11%2D01T13:50:37 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80030000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://cardomedical.com/role/DocumentAndEntityInformation" xlink:href="cdom-20130930.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/ConsolidatedBalanceSheets" xlink:href="cdom-20130930.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="cdom-20130930.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/ConsolidatedStatementsOfOperations" xlink:href="cdom-20130930.xsd#ConsolidatedStatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="cdom-20130930.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="cdom-20130930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/ShareBasedPayment" xlink:href="cdom-20130930.xsd#ShareBasedPayment" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/StockholdersEquity" xlink:href="cdom-20130930.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cdom-20130930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/ShareBasedPaymentTables" xlink:href="cdom-20130930.xsd#ShareBasedPaymentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetails" xlink:href="cdom-20130930.xsd#SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetails" xlink:href="cdom-20130930.xsd#SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesConcentrationOfCreditRiskNarrativeDetails" xlink:href="cdom-20130930.xsd#SummaryOfSignificantAccountingPolicesConcentrationOfCreditRiskNarrativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/Share-BasedPaymentStockOptionActivityDetails" xlink:href="cdom-20130930.xsd#Share-BasedPaymentStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/Share-BasedPaymentNarrativeDetails1" xlink:href="cdom-20130930.xsd#Share-BasedPaymentNarrativeDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/Share-BasedPaymentNarrativeDetails2" xlink:href="cdom-20130930.xsd#Share-BasedPaymentNarrativeDetails2" xlink:type="simple" />
    <link:roleRef roleURI="http://cardomedical.com/role/StockholdersEquityNarrativeDetails" xlink:href="cdom-20130930.xsd#StockholdersEquityNarrativeDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_DocumentAndEntityInformationAbstract" xlink:label="loc_CDOMDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMDocumentAndEntityInformationAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMDocumentAndEntityInformationAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2013/dei-2013-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/ConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONSOLIDATED BALANCE SHEETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:label="loc_us-gaapDevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapDevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/ConsolidatedStatementsOfOperations" xlink:title="00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RoyaltyRevenue" xlink:label="loc_us-gaapRoyaltyRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRoyaltyRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet" xlink:label="loc_us-gaapOtherOperatingIncomeExpenseNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherOperatingIncomeExpenseNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_DiscontinuedOperationsNote1Abstract" xlink:label="loc_CDOMDiscontinuedOperationsNote1Abstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_CDOMDiscontinuedOperationsNote1Abstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:label="loc_us-gaapDiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMDiscontinuedOperationsNote1Abstract" xlink:to="loc_us-gaapDiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicAndDilutedShare" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicAndDilutedShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/ConsolidatedStatementsOfCashFlows" xlink:title="00000005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInIncomeTaxesReceivable" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInIncomeTaxesReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCash" xlink:label="loc_us-gaapIncreaseDecreaseInRestrictedCash" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInRestrictedCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000006 - Disclosure - 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_NotesToFinancialStatementsAbstract" xlink:label="loc_CDOMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/ShareBasedPayment" xlink:title="00000007 - Disclosure - 2. SHARE BASED PAYMENT">
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_NotesToFinancialStatementsAbstract" xlink:label="loc_CDOMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/StockholdersEquity" xlink:title="00000008 - Disclosure - 3. STOCKHOLDERS' EQUITY">
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_NotesToFinancialStatementsAbstract" xlink:label="loc_CDOMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000009 - Disclosure - Summary of Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_NotesToFinancialStatementsAbstract" xlink:label="loc_CDOMNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionServicesRoyaltyFees" xlink:label="loc_us-gaapRevenueRecognitionServicesRoyaltyFees" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapRevenueRecognitionServicesRoyaltyFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaapConcentrationRiskDisclosureTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapConcentrationRiskDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:label="loc_us-gaapDescriptionOfNewAccountingPronouncementsNotYetAdopted" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapDescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/ShareBasedPaymentTables" xlink:title="00000010 - Disclosure - Share Based Payment (Tables)">
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_ShareBasedPaymentTablesAbstract" xlink:label="loc_CDOMShareBasedPaymentTablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMShareBasedPaymentTablesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetails" xlink:title="00000011 - Disclosure - Summary of Significant Accounting Polices (Royalty Agreement) (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetailsAbstract" xlink:label="loc_CDOMSummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RoyaltyRevenue" xlink:label="loc_us-gaapRoyaltyRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMSummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetailsAbstract" xlink:to="loc_us-gaapRoyaltyRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetails" xlink:title="00000012 - Disclosure - Summary of Significant Accounting Polices (Income Taxes) (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetailsAbstract" xlink:label="loc_CDOMSummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="loc_us-gaapUnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMSummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetailsAbstract" xlink:to="loc_us-gaapUnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesConcentrationOfCreditRiskNarrativeDetails" xlink:title="00000013 - Disclosure - Summary of Significant Accounting Polices (Concentration of Credit Risk) (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_ConcentrationOfCreditRiskNarrativeDetailsAbstract" xlink:label="loc_CDOMConcentrationOfCreditRiskNarrativeDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMConcentrationOfCreditRiskNarrativeDetailsAbstract" xlink:to="loc_us-gaapCashFDICInsuredAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CashUninsuredAmount" xlink:label="loc_us-gaapCashUninsuredAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMConcentrationOfCreditRiskNarrativeDetailsAbstract" xlink:to="loc_us-gaapCashUninsuredAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/Share-BasedPaymentStockOptionActivityDetails" xlink:title="00000014 - Disclosure - Share-Based Payment (Stock Option Activity) (Details)">
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_StockbasedCompensationStockOptionActivityDetailsAbstract" xlink:label="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_WeightedaverageRemainingContractualTermInYearsOfOptionsOutstandingAtEndOfPeriod" xlink:label="loc_CDOMWeightedaverageRemainingContractualTermInYearsOfOptionsOutstandingAtEndOfPeriod" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_CDOMWeightedaverageRemainingContractualTermInYearsOfOptionsOutstandingAtEndOfPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockbasedCompensationStockOptionActivityDetailsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/Share-BasedPaymentNarrativeDetails1" xlink:title="00000015 - Disclosure - Share-Based Payment (Narrative) (Details 1)">
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_ShareBasedPaymentNarrativeDetails1Abstract" xlink:label="loc_CDOMShareBasedPaymentNarrativeDetails1Abstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMShareBasedPaymentNarrativeDetails1Abstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMShareBasedPaymentNarrativeDetails1Abstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMShareBasedPaymentNarrativeDetails1Abstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMShareBasedPaymentNarrativeDetails1Abstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMShareBasedPaymentNarrativeDetails1Abstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMShareBasedPaymentNarrativeDetails1Abstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExpireDate" xlink:label="loc_CDOMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExpireDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMShareBasedPaymentNarrativeDetails1Abstract" xlink:to="loc_CDOMSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExpireDate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/Share-BasedPaymentNarrativeDetails2" xlink:title="00000016 - Disclosure - Share-Based Payment (Narrative) (Details 2)">
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_ShareBasedPaymentNarrativeDetails2Abstract" xlink:label="loc_CDOMShareBasedPaymentNarrativeDetails2Abstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMShareBasedPaymentNarrativeDetails2Abstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://cardomedical.com/role/StockholdersEquityNarrativeDetails" xlink:title="00000017 - Disclosure - Stockholders' Equity (Narrative) (Details)">
      <link:loc xlink:type="locator" xlink:href="cdom-20130930.xsd#CDOM_StockholdersEquityNarrativeDetailsAbstract" xlink:label="loc_CDOMStockholdersEquityNarrativeDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockholdersEquityNarrativeDetailsAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockholdersEquityNarrativeDetailsAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_CDOMStockholdersEquityNarrativeDetailsAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E4CAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Stockholders' Equity (Narrative) (Details)<br></strong></div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_CDOM_StockholdersEquityNarrativeDetailsAbstract', window );"><strong>Stockholders Equity Narrative Details</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Shares Authorized</a></td>
        <td class="nump">50,000,000<span></span></td>
        <td class="nump">50,000,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Shares Outstanding</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Shares Authorized</a></td>
        <td class="nump">750,000,000<span></span></td>
        <td class="nump">750,000,000<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CDOM_StockholdersEquityNarrativeDetailsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>CDOM_StockholdersEquityNarrativeDetailsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>CDOM_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PreferredStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>17
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0`!@`(````(0!1PT*[H0$``!@-```3``@"6T-O;G1E;G1?5'EP97-=
M+GAM;""B!`(HH``"````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````````````````````#,EUUOPB`4AN^7[#\TW"Z6
MXC;G%JL7^[C<3.9^`"NGEDB!`#K]]Z/XD<5T&C.3<5-2X)SW*4G?O`Q&RUHD
M"S"6*YDCDF8H`5DHQN4T1Q^3ETX?)=91R:A0$G*T`HM&P\N+P62EP2:^6MH<
M5<[I!XQM44%-;:HT2+]2*E-3YU_-%&M:S.@4<#?+>KA0TH%T'=?T0,/!$Y1T
M+ESRO/33:Q(#PJ+D<;VQT<H1U5KP@CI/BA>2[:ET-@JIKPQ[;,6UO?(8"+<J
M-"N_"VSJWOS1&,X@&5/C7FGM,?!2X"]E9I]*S=+#35HH55GR`I@JYK4_@=1J
M`Y39"L#5(@UC6E,NM]P'],-FB\-`S@S2?%]H?")'-Q*.ZT@X;B+AN(V$HQ<)
MQUTD'/U(..XCX2!9+""Q."J)Q5))+)Y*8C%5$HNKDEALE?R7KSJ?.P&'Y]]_
MW-#F2/"Q;B7`GMFLUDV/*5?4`'MWQB?TLP/\['V(P^?7L5':^B1OX/13V$;U
MIKJC?2,PCL,NK+>%WIVBOP6<+KB7NJ&Y9S!@+=HXW&N&WP```/__`P!02P,$
M%``&``@````A`+55,"/U````3`(```L`"`)?<F5L<R\N<F5L<R"B!`(HH``"
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M``````````````````````",DL].PS`,QN](O$/D^^IN2`BAI;M,2+LA5![`
M).X?M8VC)$#W]H0#@DICV]'VY\\_6][NYFE4'QQB+T[#NBA!L3-B>]=J>*V?
M5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7^ZBRBXL:NI3\(V(T'4\4"_'L<J61
M,%'*86C1DQFH9=R4Y3V&OQY0+3S5P6H(!WL'JC[Z//FRMS1-;W@OYGUBETZ,
M0)X3.\MVY4-F"ZG/VZB:0LM)@Q7SG-,1R?LB8P.>)MI<3_3_MCAQ(DN)T$C@
M\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X8<'%#U1?````__\#`%!+`P04``8`
M"````"$`T45'SVP!``"="P``&@`(`7AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS(*($`2B@``$`````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````O);+
M:L,P$$7WA?Z#T;Z1Y21.4F)G4PK9MND'"'O\(+9D)/61O^]@@M-`F&8AM#%(
MPC.'<^7!V]U/WT5?8&RK5<;$+&81J$*7K:HS]G%X?5JSR#JI2MEI!1D[@66[
M_/%A^P:==/B2;=K!1EA%V8PUS@W/G-NB@5[:F1Y`X4FE32\=+DW-!UD<90T\
MB>.4F[\U6'Y5,]J7&3/[$OL?3@-V_K^VKJJV@!==?/:@W(T6_%N;HVT`'!:5
MI@:7L6G+\O%D/4-BQF_#B'E@&C$G<;S*<1@:7,2,2SX^!0416@EI9!4XGQ5E
M1B2!:41"XH26(T@[H>70;M+04:545`F.87]3SS;20/GN#`YUBX7/D^]JFZ(1
M/F&F>7L!F;;.(Y@<-Z&#(G,2P=60;I:!@UJ2MR8TC:!QO'Y2TY4E;G%,VMGX
MS,JZ4X<_9I=/>UQ3_1<^V]]A8T'!>'5Q!\R&@A&AU8C)#;_ZJ<Y_`0``__\#
M`%!+`P04``8`"````"$`\5*-')\"``")!@``#P```'AL+W=O<FMB;V]K+GAM
M;)2576^;,!2&[R?M/R#N5S[2;S6I:$)7M!:RFK3JE>6"$ZR"S8QIFG^_8Z(D
M3MFB[8H8XX?SON?EY.KZHRJM=RH;)OC0]HY<VZ(\$SGCBZ$]2V^_G=M6HPC/
M22DX'=HKVMC7HZ]?KI9"OKT*\68!@#=#NU"JOG2<)BMH19HC45,..W,A*Z)@
M*1=.4TM*\J:@5%6EX[ONJ5,1QNTUX5+^"T/,YRRC$Y&U%>5J#9&T)`K*;PI6
M-_;H:LY*^K169)&ZCDD%=7^4ME621H4Y4S0?VB>P%$NZ=T.V]4W+2MB]&+@#
MVQEM14ZEE=,Y:4N5@KP-'?SRCWW_5#^IK7AB=-GL#NFE]?',>"Z6^E&P=K5=
M#:"`9;?US')5P+[KNMM[=Y0M"K6Y"7C'X'<.PGNZJ\4[>1M','0*AUPQM<(1
M7[O/!+10NQZ!,L^VY"6#'S+*/5VX21DG,4KNHTF0AA-\$]P'\3C$Z"X,4V0B
M(!);AO\?##PE!F9@4#JS_UH)2J&@AS!.$4YN<3(-#<JQ03D^6,L^91R8DL#X
MK:*3SQ0/H]G#0_#XHM^.HN]Q=!N-@SC%P7B<S(Q:O`L#TZ7"E.2#D\%C"+XB
M<'<:O&A%QFF=CVT19Y^+&&"4)N,?=\G])'Q$./PYB](7\[39V///IU%;542N
ML)ACQ!:<P4=$N,)!EHF6*Q/C&T5<]#`%D13?D(;FT,N5_@1Q2EY+F`F[A/EF
M8SVWQSA8"JC81=64Y/7">E@3Z-B!3%%>+[&'0:!F!]J3U@LMTO;LNX.4R-YP
M4L-\,CEF:KU>;/_`B8F4,.3>*9Z8'#.W7B^XASE[5I\:;?=ZT>U4%*+,8:KB
M\%>KI\NN(K.@,Y/3A=CIW(-QE9$R@SFJ+WH0=<%P-O\BH]\```#__P,`4$L#
M!!0`!@`(````(0"K[N_TM@0``&D3```8````>&PO=V]R:W-H965T<R]S:&5E
M=#0N>&ULE%A=CZLV$'VOU/^`>$^(R7>4Y.J"V?9*K515_7@FQ$G0`HZ`W>S^
M^XZ9!#QF`_1E-W".#SZ>\0QX^^TC3:QWD1>QS'8V&T]L2V21/,;9>6?__=?+
M:&5;11EFQS"1F=C9GZ*PO^U__FE[D_EK<1&BM$`A*W;VI2RO&\<IHHM(PV(L
MKR(#Y"3S-"SA,C\[Q347X;$:E":..YDLG#2,,QL5-OD0#7DZQ9'@,GI+15:B
M2"Z2L(3Y%Y?X6CS4TFB(7!KFKV_74233*T@<XB0N/RM1VTJCS8]S)O/PD(#O
M#S8+HX=V==&23^,HEX4\E6.0<W"B;<]K9^V`TGY[C,&!6G8K%Z>=_9UM`K:V
MG?VV6J!_8G$KM-]6<9&W7_+X^%N<"5AMB).*P$'*5T7]<52W8+#3&OU21>"/
MW#J*4_B6E'_*VZ\B/E]*"/<<'"ECF^,G%T4$*PHR8W>NE"*9P`3@KY7&*C5@
M1<*/ZO\M/I:7G3U=C.?+R90!W3J(HGR)E:1M16]%*=-_D<3N4BCBWD5@Q%V$
MN6-W-6?S1;^*@S.J#/*P#/?;7-XLR!IX9G$-50ZR#2@_G.$\:J_/K()')?)=
MJ51:X**`^+SOY^[6>8<EC>X4#RE+VVHH,TKQ'Q2U@$J6/VXT8Q@=$CP8*GK@
MJ+8%BV7:FD+8OP[8PX4:9+B8TN=Y;8KATV\SYG,JPML40R1H,S018G1*C78;
M5&3(/3T&"SHW#RDSG4(9?B^#]S*"+@:Q!Q/1X]AM3Y%W-JQ=DV)+.GD/*:LJ
M19=&,ODZR-9T)"?@<D710$=GS4.)%]A>P[THLN'%>*:'E%GE96;DF*^#;&+D
M%R?HTD`#'9VZD]HJ<;/X/VX4V7!CK*^'%'3C&EGIZ^!H96Q*KJ/&R$#'1NZR
M&4K,0%D:'AI%IF86S1I5A<M#RCTT]?I5F*]CQLIS'3/"'7R-$1OJ?<,HYOU5
M3PTR[!@;PT,*VID:7GT='*V,H5Q'F5'P`QT<N8LFAXFK-77570,4V7!C++*'
M%'1CFNG`>`<6?(T1&PSZCQZ=;A\5VS#2)"]FV9WS)"X$;0>&P*W($/1Y:)CJ
MOUK&]7C";@W%OR[0"R,EO$IQ9T,]K3E-6N`&ZJ?P?DK02:&!4]U8,ZG>D690
M(WO,8@_7NY&6X/<`(N?K5&0Z.)\:6<P);*1Q0$!]+#6FVK!FK,<0-FUBR*BV
M'D,.]M=6I2#H;&Z6"@*W,U*7=A=/>BQ3C7BX)6S;H%PGFR9\CQ%R.A.RE\*K
M>76F==!)H7%3#7JX26SG)&Y&;_'4QPR438R;D4Q^%\B[P.`)2,VH#CW<#/9S
M8J950I#SQ$P'R%D'&#P!J1G5I(>;P99.S)BO10PY3\QT@+QK9/`$I&94>QYN
M!INYOI>61B9Y[-'PF_W6*NZ]%-ZO$G12J$G5N8>;Q#Y/(M94HGO!0,ZB>B]W
MIQ-W/64SH];Y<%JA-EPGB0\AJ7./+B4TBR<;^.&?BOPL?)$DA17)-W5JX<)4
MZ[MXHN*Q#7R.PU>U<9^KDY;JK*0&X*#C&I[%[V%^CK/"2L0))"?C)924'(]*
M\**4U^KC^B!+..*H?E[@2$O`A_YD#.23E.7C0GW.UX=D^_\```#__P,`4$L#
M!!0`!@`(````(0`C,Q]Z,`,``-,)```9````>&PO=V]R:W-H965T<R]S:&5E
M=#$U+GAM;)2676^;,!2&[R?M/UB^+U\)"40A59.J6Z5-FJ9]7#M@@E7`R'::
M]M_O&(?/-*R]"8&\?GG.>PPGZ]N7(D?/5$C&RPB[EH,1+6.>L/(0X=^_'FX"
MC*0B94)R7M((OU*);S>?/ZU/7#S)C%*%P*&4$<Z4JE:V+>.,%D1:O*(E_))R
M41`%I^)@RTI0DM2+BMSV'&=A%X25V#BLQ'L\>)JRF-[S^%C04AD307.B@%]F
MK)*-6Q&_QZX@XNE8W<2\J,!BSW*F7FM3C(IX]7@HN2#['.I^<><D;KSKDPO[
M@L6"2YXJ"^QL`WI9<VB'-CAMU@F#"G3L2-`TPG?N:N<ZV-ZLZX#^,'J2O>](
M9OST1;#D&RLII`U]TAW8<_ZDI8^)O@2+[8O5#W4'?@B4T)0<<_63G[Y2=L@4
MM-N'BG1AJ^3UGLH8$@4;R_.U4\QS`(!/5#"]-2`1\E(?3RQ1681G"\M?.C,7
MY&A/I7I@VA*C^"@5+_X:D7NV,B;>V02.9Q/7M^:>OPP^XC([N\"Q<?$L+_!=
M?_%_%MO45<=T3Q39K`4_(=A[0"XKHG>RNP+G)A]339O8M<`@*6URIUTBO,0(
MLI#0Y>>-&\S6]C-T)CYKMD8#GYUFJ-@U"MU0P&L9(;<^X]N]:U"T6*/H7FJV
MK;G0OZ_OCVY\*?%:Q8`$$NJ3Z+1FL">GB?0BT/4+#^:MOX$TFGE/,V:<4@P8
MP>3CC'I1A"&'KCG!B&!K-%.,1K&H-X`W"X.YX[1U#ACAV>DS3N>GQ6.V1>MK
M\C.:*3:C"&LV>-B[W3D`6WP$3(O'8,L1F-'TP=P@&&IVEYHN^@$=/&#OCTV+
MQW3A\,Y;HQG0A5W+ZFAWEYHK='IFCEXE<TA]NKEZT8@R=$>41M.G[`@,HU&8
MC><O_85[I;WA$'$:38O':-U[P>P[HYE",XIFW\V[!W_069B!@_"FR6KU&*TK
MV:"=15-L;TC<<$QH9JL9&@45![JC>2Y1S(]Z;KKP0+57VYE^Y]53N?T!1FI%
M#O0[$0=62I33%)8ZUA*VAS!#V9PH7M4C:<\5#-/Z:P9_GBB\QQT+Q"GGJCG1
M4Z+].[;Y!P``__\#`%!+`P04``8`"````"$`-<*@VG0"``#?!0``&0```'AL
M+W=O<FMS:&5E=',O<VAE970Q-BYX;6R45-N.FS`4?*_4?[#\OAB2D)M"5INL
MMEVI*U55+\^.,6`%8V0[E_W['MNYD;3;[0M@/!YFYIS#['XO:[3EV@C59#B)
M8HQXPU0NFC+#/[X_W8TQ,I8V.:U5PS/\R@V^GW_\,-LIO385YQ8!0V,R7%G;
M3@DQK.*2FDBUO(&=0FE)+2QU24RK.<W](5F37AP/B:2BP8%AJM_#H8I",/ZH
MV$;RQ@82S6MJ0;^I1&N.;)*]ATY2O=ZT=TS)%BA6HA;VU9-B)-GTN6R4IJL:
M?.^3`65';K^XH9>":65482.@(T'HK><)F1!@FL]R`0Y<[$CS(L,/R70YP&0^
M\_G\%'QG+IZ1J=3NDQ;Y%]%P"!O*Y`JP4FKMH,^Y>P6'R<WI)U^`KQKEO*";
MVGY3N\]<E)6%:J=@R/F:YJ^/W#`(%&BB7NJ8F*I!`%R1%*XS(!"Z]_>=R&V5
MX?XP2D=Q/P$X6G%CGX2CQ(AMC%7R5P`E!ZI`TCN0]$']8;\7]<9ID@[_S4*"
M(F_PD5HZGVFU0]`T\$W34M>"R128C\Z"CI/7OUD%CX[DP;%X+G!AH#S;>3))
M9V0+F;(#9A$P(XS.F"YB>42X4H"\DT9P?JVQ#S7\<_I'2>Y05U(_[GYO<0OI
M=1'+6T1ZMM71"-G]OT9W"'KA,I+)L"MA$3"#"\Q9@0]_^1:BHQ%(+C6^G9\#
M9Q@".)=K,KK2%C!C7_#KZ"[WSHJ#GC!HH0\EUR5?\KHVB*F-&Z($^$YOPWPO
M8+[]-)#3!LQ72TO^0G4I&H-J7L#1.!K!0.DPH6%A5>O;8*4L3)9_K.!'RJ%M
MXPC`A5+VN'"-=_HUSW\#``#__P,`4$L#!!0`!@`(````(0`ES?>;90(``#<&
M```9````>&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;(R4VX[:,!"&[ROU'2S?
M;YP`80$15@N(=J56JJH>KHWC$(LXCFQS>ON.;:`$MA0N(";__/YFQN/QRUY6
M:,NU$:K.<!+%&/&:J5S4JPS__+%X&F!D+*US6JF:9_C`#7Z9?/PPWBF]-B7G
M%H%#;3)<6MN,"#&LY)*:2#6\AC>%TI):6.H5,8WF-/=!LB*=..X3246-@\-(
M/^*ABD(P/E=L(WEM@XGF%;7`;TK1F).;9(_82:K7F^:)*=F`Q5)4PAZ\*4:2
MC=Y6M=)T64'>^Z1'V<G;+V[LI6!:&578".Q(`+W->4B&!)PFXUQ`!J[L2/,B
MPZ_):)9B,AG[^OP2?&<NGI$IU>Z3%OD747,H-K3)-6"IU-I)WW+W%P23F^B%
M;\`WC7)>T$UEOZO=9RY6I85NIY"0RVN4'^;<,"@HV$0=C\%4!0#PC:1P)P,*
M0O?^=R=R6V:XVX_2Y[B;@!PMN;$+X2PQ8AMCE?P=1(F#.IMTCB9=H#^^[T2=
M09JD_?^[D$#D$YQ32R=CK78(#@WL:1KJCF`R`F>761?J\WYF0.-B7EV0#P6U
M@6YL)\EP,"9;*"$[:J:WFDY;,;M5=).SA`#?&1)2OX2\#^?$D`1&%W##LZ]/
M8!HTO0M-VE;,[BE:;+#1XVQ.G&'P/K/!(+=WG@9-WY<UC<.G+9G=E;3H(,7'
MZ9SXFNYO1T+E@J;GZ:[(9^^_:_'`<7^<QXFO>:X.T31H0K6>_U&N^YK`%V8_
MC$9#5_PKU2M1&U3Q`GH51\]@HL/DAX55C1^!I;(PL?ZQA`N:PWS$$8@+I>QI
MX>Z6\Y4_^0,``/__`P!02P,$%``&``@````A`/MBI6V4!@``IQL``!,```!X
M;"]T:&5M92]T:&5M93$N>&UL[%E/;]LV%+\/V'<@=&]M)[8;!W6*V+&;K4T;
MQ&Z''FF9EEA3HD#227T;VN.``<.Z89<!N^TP;"O0`KMTGR9;AZT#^A7V2$JR
M&,M+T@8;UM6'1")_?/_?XR-U]=J#B*%#(B3E<=NK7:YZB,0^'],X:'MWAOU+
M&QZ2"L=CS'A,VMZ<2._:UOOO7<6;*B010;`^EINX[85*)9N5BO1A&,O+/"$Q
MS$VXB+""5Q%4Q@(?`=V(5=:JU68EPC3V4(PC('M[,J$^04--TMO*B/<8O,9*
MZ@&?B8$F39P5!CN>UC1"SF67"72(6=L#/F-^-"0/E(<8E@HFVE[5_+S*UM4*
MWDP7,;5B;6%=W_S2=>F"\73-\!3!*&=:Z]=;5W9R^@;`U#*NU^MU>[6<G@%@
MWP=-K2Q%FO7^1JV3T2R`[.,R[6ZU4:V[^`+]]2696YU.I]%*9;%$#<@^UI?P
M&]5F?7O-P1N0Q3>6\/7.=K?;=/`&9/'-)7S_2JM9=_$&%#(:3Y?0VJ']?DH]
MATPXVRV%;P!\HYK"%RB(ACRZ-(L)C]6J6(OP?2[Z`-!`AA6-D9HG9()]B.(N
MCD:"8LT`;Q)<F+%#OEP:TKR0]`5-5-O[,,&0$0MZKYY__^KY4_3J^9/CA\^.
M'_YT_.C1\<,?+2UGX2Z.@^+"E]]^]N?7'Z,_GG[S\O$7Y7A9Q/_ZPR>__/QY
M.1`R:"'1BR^?_/;LR8NO/OW]N\<E\&V!1T7XD$9$HEOD"!WP"'0SAG$E)R-Q
MOA7#$%-G!0Z!=@GIG@H=X*TY9F6X#G&-=U=`\2@#7I_==V0=A&*F:`GG&V'D
M`/<X9QTN2@UP0_,J6'@XBX-RYF)6Q!U@?%C&NXMCQ[6]60)5,PM*Q_;=D#AB
M[C,<*QR0F"BDY_B4D!+M[E'JV'6/^H)+/E'H'D4=3$M-,J0C)Y`6BW9I!'Z9
ME^D,KG9LLW<7=3@KTWJ''+I(2`C,2H0?$N:8\3J>*1R5D1SBB!4-?A.KL$S(
MP5SX15Q/*O!T0!A'O3&1LFS-;0'Z%IQ^`T.]*G7['IM'+E(H.BVC>1-S7D3N
M\&DWQ%%2AAW0."QB/Y!3"%&,]KDJ@^]Q-T/T._@!QRO=?9<2Q]VG%X([-'!$
M6@2(GIF)$E]>)]R)W\&<33`Q509*NE.I(QK_7=EF%.JVY?"N;+>];=C$RI)G
M]T2Q7H7[#Y;H'3R+]PEDQ?(6]:Y"OZO0WEM?H5?E\L77Y44IABJM&Q+;:YO.
M.UK9>$\H8P,U9^2F-+VWA`UHW(=!O<X<.DE^$$M">-29#`P<7""P68,$5Q]1
M%0Y"G$#?7O,TD4"FI`.)$B[AO&B&2VEK//3^RIXV&_H<8BN'Q&J/C^WPNA[.
MCALY&2-58,ZT&:-U3>"LS-:OI$1!M]=A5M-"G9E;S8AFBJ+#+5=9F]B<R\'D
MN6HPF%L3.AL$_1!8N0G'?LT:SCN8D;&VN_51YA;CA8MTD0SQF*0^TGHO^ZAF
MG)3%RI(B6@\;#/KL>(K5"MQ:FNP;<#N+DXKLZBO89=Y[$R]E$;SP$E`[F8XL
M+B8GB]%1VVLUUAH>\G'2]B9P5(;'*`&O2]U,8A;`?9.OA`W[4Y/99/G"FZU,
M,3<):G#[8>V^I+!3!Q(AU0Z6H0T-,Y6&`(LU)RO_6@/,>E$*E%2CLTFQO@'!
M\*])`79T74LF$^*KHK,+(]IV]C4MI7RFB!B$XR,T8C-Q@,'].E1!GS&5<.-A
M*H)^@>LY;6TSY1;G-.F*EV(&9\<Q2T*<EEN=HEDF6[@I2+D,YJT@'NA6*KM1
M[ORJF)2_(%6*8?P_4T7O)W`%L3[6'O#A=EA@I#.E[7&A0@Y5*`FIWQ?0.)C:
M`=$"5[PP#4$%=]3FOR"'^K_-.4O#I#6<)-4!#9"@L!^I4!"R#V7)1-\IQ&KI
MWF5)LI20B:B"N#*Q8H_((6%#70.;>F_W4`BA;JI)6@8,[F3\N>]I!HT"W>04
M\\VI9/G>:W/@G^Y\;#*#4FX=-@U-9O]<Q+P]6.RJ=KU9GNV]147TQ*+-JF=9
M`<P*6T$K3?O7%.&<6ZVM6$L:KS4RX<"+RQK#8-X0)7"1A/0?V/^H\)G]X*$W
MU"$_@-J*X/N%)@9A`U%]R38>2!=(.SB"QLD.VF#2I*QIT]9)6RW;K"^XT\WY
MGC"VENPL_CZGL?/FS&7GY.)%&CNUL&-K.[;2U.#9DRD*0Y/L(&,<8[Z4%3]F
M\=%]</0.?#:8,25-,,&G*H&AAQZ8/(#DMQS-TJV_````__\#`%!+`P04``8`
M"````"$`_/$/9!T*```V4@``#0```'AL+W-T>6QE<RYX;6SD7&UOX\81_EZ@
M_X'@M44"U)9$49;D6`Y.LMD><+T&.1<MT!0%+5$V8[ZH)'5G)^A_[S/+MUGK
M;651V@^-D+-(<6>>>69V=G>6Y-7WSV%@?/&2U(^CD=DY;YN&%TWCF1\]C,R_
MW3EG`]-(,S>:N4$<>2/SQ4O-[Z]_^YNK-'L)O,^/GI<9$!&E(_,QRQ:7K58Z
M??1"-SV/%UZ$7^9Q$KH9#I.'5KI(/'>64J,P:%GM]D4K=/W(S"5<AE,5(:&;
M/"T79],X7+B9?^\'?O8B9)E&.+W\\!#%B7L?`.ISQW:GI6QQL"(^]*=)G,;S
M[!SB6O%\[D^]593#UK`%2==7T3)TPBPUIO$RRD:F59TR\E\^S$;FA6GD)D_B
M&4#\X3_+./ON=_F?=W]\]Z[][V^_^^>/WNQ?/WVS^MM/WYJM4@V3"1]LEWG>
MWBH6/^>26X4%UU?S.&*&=$`3L77Y%,5?(X=^0S#`/+KL^BK]Q?CB!CC3(7C3
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M+/2#H)JU=6V:U^#,]14FD)F71`X.C.+[W<L"LYH(<UVBII5?M^/JA\1]Z5AB
M;%=KD,:!/R,4#Q,QERK&LLG%K3.Y%7H9,E44&X0ZSJ1_!*&WX^&D>:23X;!I
MH9:#3\-"W_?HT[!0!_]-&N.TR&9V4R`K>4;FT]JG?=X?#H>#SL5@,!C:W8YM
M"Y+OBXCVHYGW[-%RJ#&:5A'T@&#8'0PO+`!IVP.AZJ0(N@#0[_4&O<[0LO&_
M2)_'1]`TISU3MU<9`DU>90@T>55,OUL-9/ZBIZ`2H;FO,@2:O,H0:/)JO^$,
MW-?N589`DU<9`DU>%46C!OLJ*GR:^RI#H,FK#($FKS8V^2PR\%"[5QD"35YE
M"$[MU6)911-K1Y005F=FF^?'8B6'M>-]G,RP/5+6_#M4],_/75\%WCS#*C'Q
M'Q[I;Q8O\.]]G&783+B^FOGN0QRY`;ZVRA;EWRTML=V"G961F3WZTR<HDU;S
M.=Y<Q;$T5)G(IAF^W;?;?;MG7>2+J(94A][,7X:KUE6ZU\8*:"1N=QO..(PJ
M)44XU!6E%GFA<)]B"^%JX6G%!HB),B046S1A8UU=5;61M5"SD350M)&U4+41
M76==YRJ9G,5+[/2]=K#C#-KMO)"EJF>[0`9\3<2L!\':K/*YL\D:1G>VV==6
MY)>5OC&VZ"-FK&LLW=%BU<X=#=98N:.%JHURW)3>E817Y01*SVN0O.);NOQM
M,*`H;\CPL`Q?I">JK^<5=N5L)UN[HN:5)?OI*48N#(13+P@^T]#TCWDU&J+H
M<WWU/&=;U;A_@/9R:2><OJ*R6GS-1[[\`!`W-;(V-C+<Q2)X^;0,[[W$$3<5
M"!7B+%5PZZ.Q&++KX_>!_Q"%GBA;F;F8'Y(X\Z:9N.E!5)PWX>ENP(,=<V4\
MA^BW-^@'3R?1C[+(6B>"%ZWZ$5S*^IN,![J]HPAJN(`']38\32+`XK=$`"?H
M0$"WHQ0<(#QU(,"BHD2``*T1`,Z6J#BD'W98-D,,U"JA_U@JD6-**R651[1R
M4_J%_BU6.E+Z/8AFEF\1Z#7-.-@"X""5FU*LKA3#W(Z>5E.`@RT4.!AUFQGR
M.IMROC9"6-(%AIH1I(%MC#07E2SG0F<-8#LCXP;G(2PH*!7IA@`X6B`P1Z`2
MHQ^#IA&81X.F(9A#D,;@$_8)'@W2"*D)`_!HZ17U/*$CC1@GI(%!T)4A6318
MNE(DQZ`K1]:NL'2E2`9!5X;DGM"5(CD&73F2N4)7BF00P(B6#,D]H2M%<@RZ
M<F3MBJZN%,D@Z,J0S!/=(Z?(%B^;YD545C^U!F^JGQK/\YV%U,ZF11/\7C;/
M5T_YRA&^$&LIMI2F!X#<LG9J/,:)_PL6F?0@T!3%5"\QZ<&QS)_R,U\3=W'G
M/6,IFN_`/,\WUWJ!I*QOO`Y&&>%&3+5^5/!-8Q_EC?-S`);#B=AIN5C4[RS,
MOXH,N=B^,T)V@J#BCFX,Q'6!H?$0:*B+4,_531,&2>T8N*LP8*KE"@?,4?+9
MD<UVQBI73F04!6^<EB8P<J(Z@G):RFA3KJS[*!F:T=Y]O8S8QKLC"G\[0X#W
M5K%WO><`PD+RV/#*\?:M4?O_B&\OKC;ZDHJMZK$V+BJ^>\7>H<YM)"4=VAF.
MW%</F%Q12:S1!+J&JH;@';N;%EFN(;12W.WJ)V_J&<?$BRZZK5]KPGOX@/O6
MM"=Y$P?;R-DXVN^EO.E^N4ZY6'YCP<UN7Y)O7JJ6YP8](XMW>K1_;YP9[Z>4
ME*L0Z5"Y9ND'N$6?UMU4.IDN4]R).LY/%HO=;;)09L@9M6@FPV2A-KFO+$@H
M9%$YC<D"H_O*@OI<5A?6,EFXLVMO62AQ%K*HV%GCLK&@V1<7FA2R9.Y[BMS;
MZ_PHM@5J7&2R"BXNJ_8C%969+)B\KZS:CW`<EP63]Y55^Q$(F2P;2O:55?L1
M7N"R$&[[RJK\:%."J?GJ*7)_L=:/<JQ2#4\%%Y=5^U&.U:YBK')9M1_E6"63
M]\55^Q%2&5\V?MA75NU'.4_8BGF"VUC[4>:^I\C]ZXPJ1[RE&/&YE-IW^,8X
MHNF3"D>YE-IK<I1W%:,\EU+[2XYO6S&^<RFUIR"/663C!W6+*A]U979M17;'
M[JS,NG+`6(J4X.U/TV6`MW+%]$XO4:/&*Z.X0;0CJ6+0Y-&;/AD3W')<"9+[
M`PVC*H)NGQ>!&[E9G+P85)>NQ,E.[RF*^U,<5QS)$BP<J@#Z,]Z`AI>K&>`E
M9TB.8:I)[B.FZ@LR/1U%CY5HT#I'(\<?K9WV08/6N1@YJ=+\247,AVBQK#PD
MYU(:NE5$?/2C)V\F1X[,L`60*I(^><LL<:OXD[L4-F[4A-"-ZI4,.47D;SHI
M[ZHOYI^?<%]Z22+5[%DRH"66"O"_+C-&H[A;K!YW+<6\=.=G>+*F[,0R#L!2
MP7$78Z^H$O$JHRC*^+N;1-1;I*[[*D8W6%3OO&'V/WNN'UH0O&?TCD#Q.$.U
M'@"],V_N+H/LKOIQ9-;?_R*>64,P%5?]X'^),R%B9-;?/]+#@.C%>,8!Z>9C
MB@?,\-=8)O[(_/5VW!_>W#K6V:`]'IS97:]W-NR-;\YZ]F1\<^,,VU9[\E]0
M1B]4O,0;^0YX8:%XL2+VWCKV91K@M89)86P!_G-];F2R@QR^>`((L/%H3&E$
M*ZU>^'C]/P```/__`P!02P,$%``&``@````A`%>5QP,$%P``3D@``!0```!X
M;"]S:&%R9613=')I;F=S+GAM;.Q<VW+;1K9]/U7G'[I8GI)<1<HB)5^4<9QB
M*,G1Q)84D8[C.G4>(+`E(@8!#BZ2-5\SWS)?=M;:W0V`#5"2QTG-RYDI5R2B
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ML@#[.0V6VA^U-8NN=:9^4^_U/`J#N(^MACO^*#O7!%K)@AA#YOJ+^EG?^>.V
M=O&_@]'SE_M#_U&UG=G=JBW%<'?PR\8WSG46I33%7!T&1>OE,8PU%X,=Q\&U
M/\O651#GK7<F999A,^HXRK%I]4D'V<;YMP:#X6BPU]K1"4TNWA&HCSJ.!Y^3
M]#914QWD\-VY.LGS4F<_M`0Z3?V/FC/]FL9E4@39'62+.UZOQF[EZD*OTJQ`
M[*AI$11EKNRVVFM^TKF_J)5=5E$3Z/4ZS=H&G2Z#&&(TEIJDRU60M$;:Z?!T
MF4()11I^[JOI(LATKL[*0H(:DOI25&YA+6%M?8P8;$F\]4LK@OS7Q9#=+W<%
MX.3L='KV[N1P/#LZ5#^.WXU/)T=J^M/1T6RJMC],#]63I[[`)XF:+=(R!SCD
M?8!(K/-<I<5"9[=1KE6^TF%T%;6!X%"'``(3ZR-_4N>.09[KHK7O29`O_#?.
M,[T*HKG27P!_.71,L!(Q5&A]NWNR65K`X;N?.3'B*+B,XJB(VEXS#@5#<[4*
M[H++6,NZ01AF)3S>">,+:]:\9U9QET4:SY$9MI3^>PG,]2>QGI4;SWJRN[.[
M.X04V4T0E[JO7C[?[0-\^$_EQNV"LEBD6?0//0?"`H-'!WO]X?Y010S,N=%8
M[9G0B4JO$+ZK0B\OX?(.M=5VF03E/"KT_*F\!%/:$1O,.9YC-%(%%$TC#:)$
MA<$J@N+]31T%68*H@/E"))TR1AC.U;S,&-/P*377-SI.5X)N"*'K%I#!'O5[
M^BH*H\)?PVA?]/:`BEMVDNT^YLU[`^D<((`,J0LFF*>;`JO+![[S][+N!+"^
M$O.K%>PE5K__A99C/&JX\9='#4UK?VJ-;V+-=`;(>7]T"IPY.U9GYT<7X]D)
M!FQ2SCKJZ"\AO-2@JYH'1?`U0+3W:+[2@BE0@W2I)=EH<<G_&5^26X3%__J[
MO4CO@AC$*9)7_*=O=:)))`A:P7P9)4)1BNA&;\00N_9VG.;Y4W65I4L%YI<%
MC+,68IXDA4;B*38LOS[7I0:WTW:H*H(O:I6E-Q$IJB_WN7N@\$KCC39.OH.8
M1LH0[#!*2D;T9H$/P4/,.,3_YF%OP6+-K'D`[`5<S9LO7FA,`H.4H:B2VIVN
MHD2KP\CL!QDKT07?,W;A;MNRGV)(M]U^#/(H%*O-H[@$5OD*FCQFLP(S_IL?
M=72](/H%*`\`=`[$&Q'51H/-(3493W]2Q^_./FX,*695=16GM]9.5NLP$_P9
M^NK,?O/?R[R@Z^>J2%5&?8>@::)5I])4?@LY?9EC0S!9U]RMW0@`8B@]&I7*
MDHE=W-M7U601)-=(^>L3"W40VS02;6N1*G]#=AW=,(7[T]OH8"!L'D0?D2U*
MK,RQS<L[)$JSWZ>=&_;7\0T0)3<(6<;)9@,@]:*T`\_"WAG@61329RB)/WVG
MA(]90UX4%7.5KJDI>5]=HK)*F+T93X`BU"B^#&8@RI/-0Z;E:A4+F@(/&<T`
MN!)PA#FYM'@HY*C*SY9%*ZPCU?`%J&T)?^D:,-Q1TP_OWX\O/C$134_>GIX<
MGTS&IS,UGDS./IS.3D[?JG-PY,G)T=2?_30M,"T"X3A*`@0"=L!"1';3PN3.
M0E-M]^SG/05$)>7I(<>O4&#TGO:)LDN=Q7?*E%9@:),@FZ?KQ6H?>*UO(G!R
M##211A@A)<:<H(`KEK9J:0I<4JHHU!)@6,40]B"._D%#PMYSG4?7M&K?D2_Q
M2)AP&62?P6$P;`&HHL7%*`DF$R"H@??W-$)M:18RS#Q?04.Q@F6O28+<LU:A
M?6BH'VH5M`RH#:N,=9R/`#\64H#W$O,YR+.\8)B]21(<YW2C+LL<J0!9*>9_
M',G$2G"!'VM73M3?@J1D_6G[$NMR7.H07005QEA'ZAQ1M%-5S5/1UF%IO(/:
M+X.N.U(@E!W&Y5R+U&&**A.P"^1CUEH&"5*`S(8X2#%%ML8G%.IUEMB,SS1)
M[)NW4;&0V<;$0G5>9N&"6#&^SK293$:,X1.9_M*GY+>HV_G?AH1P9V#:$JXM
M"QL7Y$=SI-5<&46GRLYBE*_U9_$292Q_@\TSAL%/"Q`=>O9E>8<?,)D(F*%S
M!=(C'E=`!&R@A%=@$7@56!/Z"`91&RZP@[JS]H?;B(+'>0H84IHD&*D"\UV5
MLK+!.:/`%9L$Z'8QH8FX0&GD/!(8[(<@TW)#YGFIALX!LMA,9QJB."A;3+1R
M;2AQSF(4>`RW3.,(U)3;"&*``Q,Z^G%4-DS:*J'ZZG81A0L%@V%'FG&8@0[.
MC2,WU("VARW&U%6%.BB-+.K8^8M%@`#$A[`R_(GO5T7<)CGKZ1IP2V$;J]OI
M.XI$+N/,2_\RE3%LK!4:(NP/(@U@/QM>11R.^O7N$;5P'@R'AU/'V5Q4*/[+
MWTL&U#4<!D$4(7_DZMI0:D`@GK.&E7<I^@>8G@M31Z)\-,R0-P-@[X>=Z8YZ
M.QZ?]T"IZ1#DS=&RH=FF*KC%*L8B1S2)0$P!@&K%-IXH'-$1A>!%KP:[>U0A
MNI`L;AG?T\%O.^@@BE;3%:(`GV%$'?)]P"0\H=L<%C3@!/3_!AVCRT5P&NP4
M>`"<(X1Q3X&Z"J(,JJH]V3,J7*I>;)7F4KLK.)#(02^JG,BB+E2/Z<H8\4.E
M5(G:A)6\9@A!#@#$3R8VW2O.39RVS=![_`-0DJ1%M:\(1HX2MFN%YEL/=;.+
MZR^#.P$&=(>$(+DEB<J8[0[XV0KZ":"']85O\JLT+;`\FA$U.TG8;8]%#@%Q
M<;9:B8UX['#@#E?M]ND%:@&#!NDR*NC$JS++2_:RX7'T[:RD[UL-K#OZ5*,1
M5H/>T1<D`]!F9M0E*GJZW79O>C3I/15D19ZH$:)S)SG:?DBRP%N>+D!-!)+?
MR\2D+0D,9JK[T0G>PKT*PV$$4[%D\K46&V@#QQPG2,8QXH<@KB"SB[.?*[2A
M,:WSM&`5CAU#;7CO?8!LJ$8`&39"6\8_KY$$VIQ4^`TUO?8./&;0.W;>!?6=
M>FOF>6MG,5DG(>RK,>`+'6=$'5KH29+>"&R8<PE8K/&8#!$V'_R<`&W?O9L0
MT)((4,:8A#>#YT%UOZWXJWGL/J3-QP`0H7IHFM&C)!JM910/3'*6(42WV@UU
M'*%9(:(9\]LLAV$MC;H.2,4^?#V>U51KM"]F`>-J6)\42O`,DJ78DWHDK3G!
M`0X596@.U+'-28.*!%UJ.AX_<V,VSDP--T/.Y.BFC#(M$FRJ<E(I6<E4HC8H
M+]9[$JX3P3>LA(;8V%\VBF+(#AC2#5#>X&Q3#DQGBE5$IZ6*Z%";2AW]9/@!
M1CS_"Z$B`0MA^Z3"#2`"?.0.T5:QO&4`8HJ*UDF%``H4ILE@$:#>I?`CDUWP
MR5*5*\Y/1S/>[C0\V@4E#5`E\LR3&<EJA54>QS"Y["C+^KF?KZ,.Z_YB%4!K
ML,??T@/6?O)R*!UR2OID^/*5M,R9RY@G(&1\AZ*+O;7*-O^N;`":IGT>(]OP
MH)9M_V5;-(?3P9+\!ZD7F2S35V3/P`H01Y2!.BG!VPV[6`/:#8C5R%103UU4
MM<+Y`Q($1ASE181SYG;3[+B+C*[NH7$5]X+8./#`7FH*1&=:!I_![-URXENH
MN<JE](=`N<AP@ZLK;%X4C960(:@'JQT(B_$X3I)7&STA,AN:1H@-1O'G3N"F
MD_!AU]16U69R=^[CBLKZ)?JXH3<`7/!@]$KPD$40GN3]YI:Y7Y#D:L.9)F$D
M4@%;>*`S0-1A?U584[RYOM(XR96P8VN:32NS:_!:^+-Q!&1N)L^*B"W0;L9A
M)^UIDQ#*!%.".18%BHU</X^@8)1MC`@T$N`"E7PM![FPSD?`0P.!J<-'_!F4
M68.-\U9X)JHMV`GBN)AUSYJQN(;$5+$#ITUY80>TP00$BCD$(,7"81@CA:\;
M1P&?0=*#YFV+!4JUQ;@Y`P35Y,L\TT:S$-4%?!`*;VV?73-D'AKA'"J;TF+^
M_DW[F/@+E.1(6,38EHO@DQ5[RL1=]BI,CKJU?>&!ZPLGI9S.05EX@6?-XAS0
M7GWTTO1#YWV'IF$MZ'_OZM?H_6)M;4,+J(Z\)NUN^)-:@:^!0P->UU>7<+Q%
MNGZ4'/?-9-V!W@`YT2G`>JWE>"0EQZ_E"AK07W06\O09[\AI'7S=4!?4/[=!
MQML?J$1.TX?W04S%LFS,,*C$48QAA(9Q!7;-;/N_8<#:FP+T%_@>BJX(B17X
M=`N/@PC1P*FQY3TGQA]F7<<1]ID<50CF6Q()`9F!2S!1TU61P%]#NSMT_1"W
M<Z18!Q0U0JR-E-Z(Y),J3%S-9%LJ?)&V`5CCRA(")BC0?KXL"[$#0,J`A7EV
MJ8M;=C$89QW8BHHQR^[H9@VTUE^``O+9!M@V<`RUUOE:`(^X"''J;E:-=#PM
MDWV*](C;J#!K8W-PC#F\XK&:60(#&/DV-G4"R^(W3DRR#NAVQ2:9$)K:=T1N
M/!;]P*<8\-:C6++(^84CE(16='"0PDB2FIJD0S9GOF0^"E/P*2P.\R/#%2AQ
M#(F,H\^@Z(L4MX7@J$`MV]>E&2CH)9HD5^QZ27*A]!"U$=-5.N%@XTX`)MM>
MXS4"YIQ`SIQ-.``;TEMIS:Q#+.:%?&7(0&`GJN5]*D)X`P=S=(>P0Q$<"D.)
M*J6^R>X`'NY0D!(9#!F%V^)F.B:4CF""-H%HB#NG5AYK751*H;U^8.E!?;S!
M3=LS#*Y-X_U5I+`5M34JN,EF\?J=2EM+X=2YHRGP`13O-@5(@5LW#=8U36A9
M5X=E(U2=M;=Q#HOH4&);>R9(W.H$`P*=:FRP<O/UY;'WFC0Z]S8YQYC>@JE)
MN1(TTI45XN_GQQFT.S'%2.5T-E?7/3^#>:%IUL@).P&;/D(%-M(\1*.K=\"/
MV>U<LW21PX!;7,X@+7O0(V6-JD4F+@=WRTO0:$P$;##I*)`JF?Z*7$Z?`1Z@
MMYU%``I.(2AG;N=(5]H>P3.SL&?NW,B:SS`0-D&QPCV[VF%S!,L)F$`73DX`
M(S8'\)%XZS%&NH*N9PP6-)$"_4X$87.+.$$75'.^Y80SW&I'?92EB']H*^!T
M%9B1YRG.Q@B6TF,`A10<6<$;8M.4AW#2RZ?UN$OCL,X5V!.GT,A[<LV*'B!'
M5VR3HO]D^W8T?[UEO`,7[N@V-V\S8:)6RZB5FR<XXP8',5<M..G$Y)&+*/_<
MY<'2#65DRP^L;7`\@0G02-'@U!8M[.90=%<'4R!S&AE;CME$0Z96N`R2S](T
M*UW1)[VV.&5WA^N@(0-7PR\<2==B;SHJ2D.!."(O+W\W52*`^?CP9,(A)6@1
M`)HM'4.^GXS,'3)A-1USH839H-2U6I=;,D<>DN+@_DANZYO@!1Y-;V9LB"CX
MV3&H.U3FH_[!Z&5_>-!NU%V@N8UN%=I@[A#@/$L3_(P[:51RAT7H7?@'OX5_
M80S;MO8*7#T+XK,QBPD%2M=TPCLP=V;,.>BE#1;,V\S.TBH+8$-`"TERC;GK
M4.3\M`^13!\=?E4#:9_@77?56RXYPJGU3^.+(]S9G.+FYOGX$^]2^5L_/9L=
MJ9$:/&;L&=IKY35P3(T.V(O;?;5F4Z<PQZNA!1=V8"UQ>J?)P.!I/Z9@56"=
MK%$`W3A+=*>0]K-%M$+,4AOK@6!"WLV/(H340:MK.&G!R?E+QBLR:Y.:OM.H
MOW?PJK]?WWR$,ANV@T,B/TBIQ,N3K/]!,ZJB`;",,,`KN%,YVJLI_;I$O)L!
MO?P%1Z]`'4G))&%(DE>0=2`?V+Q'/<`IV-((KN`(8':)O`&VN?&2"WW3%:@$
M.,K_5:=G3I_?TO6Q,<C`3-634=V.>M[1C?+=;0R860*]I*_0+,/86^"%(A;/
MW:!LB*5A&]71/#50,0EHT)P?@GZL$#,(8TAYB<NAMZWH<%>I!IZ$_`+%=SDJ
M,GRQ0N;(;G3OS1A6Y'TK;[#[W/NX>XZ+ZCS;&_YF?(V^\S7@P']P9&M6_W-D
M&[E1B):M_^@$3P"64>@_.#/5KO\QSC3"UKKOHBNMMC^Q`&G=[?Z55XG]61J7
MUQDYK7SIC]][)<[RKW_Z#Y[X'S#<VL.>[[QXT?YTT/[HK4!#Z\K/0+6'.F6W
M!H,P76D>#_NR>;N^GT?X+^_O'(S:0OP*!&&:,^A0I6,"BS_!O_YI_D^%?]W2
M=J=2<W[URS-$7)WOYNKYR^?]%\.]JH6RUMO9%,OV(@,"-$)A*CAFKUT35*(E
M[R$A'I"$J]0`WF/;8/\V<._O^\#M^CX.BD'&\7TC<W%]N"?G3?LMZ-@#0L_.
M)C__=/;N\.ABNJ6.?OEP,OODV:<;!#:\VP(6W@BJK^8CS:]X,UYZ*ZX-VG&9
M'YI93V)PH_:5?XP"LJ%GR^Z`8+"Y@>1]"((BY^,X2<)E+T?->8:5L?9K'GE9
M20'>)A5+>Y+GO!/0;MR`PB&\)$]VJ;(5^A=DG0;/H7&I>T!_30N9KQF"`#D/
MD1]#M*&1%#?12HF5%N#@J@S/XL%[41,8PL6Z:7W;EK"T##RM4]24]]SLX6>3
M3N+B3D@M;)_;GUHXV8@3<`O7J[:-2TEQG7UL)K2'>M;N'M!ZE8U8X\N.(?\Q
M'6ONXO]KE3^D5GGQO/_JY:CE;-`P.2#^W5][H'N`;WRB&PDK`[1IZAJ&<U!'
M(;W_^;)CRD,-A5,,@,NY.5U6VS/FFC:7Z!IKAGI@^J89DL+/#9U!B6=8XWWC
M[PEA1O"%/0JO[B#@,L`ISP-XUHN?#S7Z-C&^3['=_64W)]H9.@GW+]5:"=\V
MM>N`,LDJ_C[<*_:0RG_LU@94/K#V-K$7_:\93P_^M!TV%WEX<P#4C+<.6,IL
M:-%\PX;O:\G\:0I87Q0NT>@#/:P0Z;K@1A:_"E;U7-`?7&ONH-R13[PFCJ\I
M!P[R\N-Z+:Z7O-YL\2>6H!UX`6Y*5B\H'Q,\<FB]/EGG7)L"Y!["W$V,_>T\
M2(;]%ZK*T1VV:ENE@5[8)D'5H3#5A^O3FT+U&^9S*^'0O>[\?_.L"#]3W_21
MZM$BPU5K.34R[8D_=JW&`72?Q3I=SCKG-^B%Y=$CJZ:OL)[5-E/7@[+5E]7!
M\%QMCIX.KCUMHX?%S@]0%S#M7*.AB$=5S%O/S23JE;LJ/<3EE-87@%O;^U;!
MVI6EKXNM?2O9</@GB_8M9OYJ/=QC_:I?@W::[;;8K]AV&]C7V*/>_XK-/FJ^
M>_;3B>@5-:E17`WQ\P82U('CU0P.NU7KST/(RCC>#7"3,+@!S9*>A+FM8"+%
M5)2MCKW--%)N>EU:7]MV*/5)M#%PV6<G5*+2'^X"S?_<3B.@:,ZU'YQIN-N]
MQ&EU.R>GVJ087*_;*U60&E4M$*.7JF?1@!!?V(_F/HNG&=Q3!7>0-3>_@):T
MV1Y/7_UA6[@7O3\8#@?MO]/R:"<:?:,3M;YQ;5;F!0]>RZJ_$LJF#K]JXV]"
M^$7U+?\C^4,*W93_OC>5?;'EY?Y+YU73003%=?7J3RX\.+318?3'@M_QM.*>
M.9_A[P&]^3\!````__\#`%!+`P04``8`"````"$`&U9A;(8"``#9!@``&```
M`'AL+W=O<FMS:&5E=',O<VAE970S+GAM;)256V_:,!B&[R?M/UB^)\Z!A(((
M5:'K5FF3IFF':^,XQ&H<1[8I[;_?9YO2!C;&N(`8/W[]OI\/F5\_R18]<FV$
MZDJ<1#%&O&.J$MVFQ#^^WXVN,#*6=A5M5<=+_,P-OEZ\?S??*?U@&LXM`H7.
ME+BQMI\18EC#)361ZGD'/;72DEIHZ@TQO>:T\H-D2](X+HBDHL-!8:8OT5!U
M+1B_56PK>6>#B.8MM>#?-*(W+VJ272(GJ7[8]B.F9`\2:]$*^^Q%,9)L=K_I
ME*;K%G(_)6/*7K1]XT1>"J:54;6-0(X$HZ>9IV1*0&DQKP0D<&5'FM<EODEF
MJP*3Q=S7YZ?@._/F&9E&[3YJ47T6'8=BPS*Y!5@K]>#0^\K]!8/)R>@[OP!?
M-:IX3;>M_:9VG[C8-!96.X=`+M>L>K[EAD%!029*<Z?$5`L&X!M)X78&%(0^
M^=^=J&Q3XJR(\DF<)8"C-3?V3CA)C-C66"5_!2C92P61="^2@?M]?QJE5WF2
M%_]6(<&1#WA++5W,M=HAV#0PI^FIVX+)#)1=L@SJ\^=D$,F-N7&#_%"@#:S&
MXV)<S,DC5)#MD>4ID@Z)U2F1)0>$@+V#1TC^UN-Y;PZ&#!B]>IL<9+W]94#&
M;Y!\2*S.$0-K,,_EUAQ<8M!^M78UG'@9D*FO:?)AE`V[5W_M'IB"9)>;<O"1
MJ>EPUF5`"F]JDL?A,V16YYF!/=CRE]MS\-!>'@^G7@8DV$NS.)UFR?AU)_DE
M7YUG!O:*_['GX"-[1U,O`W+>WGDFV`NW4SB\/=WP+U1O1&=0RVO83W$T@8PZ
MW$VA857O#^E:6;A3_&,#KQ`.)SB.`*Z5LB\-=_L=7DJ+WP```/__`P!02P,$
M%``&``@````A`#_>^[C.`P``%@T``!@```!X;"]W;W)K<VAE971S+W-H965T
M,BYX;6R45UUOFS`4?9^T_X!X;\"0D#1*,@VJ;I,V:9KV\>R`DZ`"1MAIVG^_
M>^T$L&EI^I($^_AP[KGV]<WJTU-9.(^L$3FOUBZ9^*[#JI1G>;5?NW]^W]\L
M7$=(6F6TX!5;N\],N)\V'S^L3KQY$`?&I`,,E5B[!RGKI>>)],!**B:\9A7,
M['A34@F/S=X3=<-HIA:5A1?X?N25-*]<S;!LKN'@NUV>LCN>'DM624W2L()*
MT"\.>2TN;&5Z#5U)FX=C?9/RL@:*;5[D\EF1NDZ9+K_M*][0;0%Q/Y$I32_<
MZF%`7^9IPP7?R0G0>5KH,.9;[]8#ILTJRR$"M-UIV&[M?B;+A$2NMUDI@_[F
M["1ZOQUQX*<O39Y]SRL&;D.>,`-;SA\0^BW#(5CL#5;?JPS\;)R,[>BQD+_X
MZ2O+]P<)Z9Y!1!C8,GN^8R(%1X%F$LR0*>4%"(!/I\QQ:X`C]$E]G_),'M9N
M&$UF<S\D`'>V3,C['"E=)ST*R<M_&D3.5)HD.).$H/X\'TR"Q8S,HK=9/*U(
M!7A')=VL&GYR8-?`.T5-<0^2)3!C9"'X\W)D$!*N^8R+U%)`"TC'XR:X77F/
MX&!ZAL0:,G>=#F(BDB$B)"W$`WFM1HC\_1IQD:DQ]%MZ%4:L(7/E,L:5]`8,
M`6!,7\"X.0@&$WN1AX'U8@V9]B`S$Y&,(0QI0'*]-`2O78BR34H8FB^.-62A
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M.1U>"/8E%$,?BA(O-^CP1A@`NHVK)>HV5'=I)6OV+&%%(9R4'['%#."8M:.Z
M_8W)$GH9:#NM\03:8C7NM1/0E=9TSW[09I]7PBG8#BC]"1:"1O>U^D'R6C5/
M6RZA'U4_#_#_@T&7Y$\`O.-<7AZP<V[_T6S^`P``__\#`%!+`P04``8`"```
M`"$`C^L3EKD#``";#0``&````'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;)27
M78^;.!2&[U?:_X!\WX#)QS112#4PFMU*NU+5W;;7#CB)-8!9VYG,_/L]QH38
M)FG)31+@Y3V/S_&QG?6GMZH,7JF0C-<)PI,(!;3.><'J?8*^_?O\X2,*I")U
M04I>TP2]4XD^;7[_;7WBXD4>*%4!.-0R00>EFE48ROQ`*R(GO*$U/-EQ41$%
MEV(?RD904K0O56481]$BK`BKD7%8B3$>?+=C.7WB^;&BM3(F@I9$`;\\L$:>
MW:I\C%U%Q,NQ^9#SJ@&++2N9>F]-45#EJ\_[F@NR+6'<;WA&\K-W>S&PKU@N
MN.0[-0&[T(`.Q[P,ER$X;=8%@Q'HM`>"[A+TB%<97J!PLVX3])W1D[1^!_+`
M3W\(5OS%:@K9ACHILOV'EC17M(#*H4!79,OYBW[U,]R*((AL!3J(_.\<YC'6
M4<(^C/W['/*Y+=L7$11T1XZE^LI/?U*V/RB(-(<TZ&RLBO<G*G,H`\2:Q'/M
MFO,2+.`SJ)B>3Y!&\F;H6*$."9HN)O.':(I!'FRI5,],6Z(@/TK%JQ]&A#LK
M8Q)W)O!],L_C^TVFG0E\=R8X'DL2FE&U"7LBBFS6@I\"F*[`+1NB)S]>@?'U
MK$`ZM/91BQ/T`'5+D(32O&ZB=?@*R<\[16H4\-DKL*O(S@I=/V#H02`UXT&T
M6(/H<FFRU-RPX\9>W*%BVBL<$,C">!`MAAEAC7?6NQHRHYA9BKFKR'ZF<,C`
M9#R9%B<(1MU78N'&38W")GMP%=E0<6%WR*`3QI-IL4OVT8V;&H5-MG05V5!Q
M@VQQ#YD6NV38G^!&8J-A?X8/)3?8H)'&9TV+/39OBJ=&,F\;<X;G,[^<YKG-
M?@-,;YBC%P4M]L`NG65ZP$CLP-AKDVPHN<&VO(=-BSVVBZUA,Q*'S6N4;"BY
MF#AM@&%+LQ.G]YHIW/O%JJK?\BB]TJ6M<X(<3*]KLBN:6YQZ$1Y=8&R6;'LI
MP5X_IIWFYWS&Q];<XM.+]7@^L[3;?+'?MMAH[-BQW[=7-+?X])(]GL\L\`Z?
MW[IXN`G$7A=E5S2W^&"<-M_(>:C?<N=A[+5IBHW&SN.%H6VHK),LVF4HGD;Q
M<HIGEUR[#7/7QJ&/;3Z@%SWM-#9@[/?S%<W%QN6[:_N`L^^`;]#(P]TA'C3R
M4./SF:.O.<E55.QI1LM2!CD_ZJ,LAMSW=_NS>7=H[A_`*;<A>_HW$7M6RZ"D
M.W@UFCQ`EH4Y)YL+Q9OVG+CE"LZW[<\#_`FB<.Z*)B#><:[.%_I4U_^MVOP/
M``#__P,`4$L#!!0`!@`(````(0!`8OIG1`0``!H2```9````>&PO=V]R:W-H
M965T<R]S:&5E=#$T+GAM;)R878^B2A"&[S<Y_X%POT*C`AIU,SJ9LYOL)B<G
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M%4QV6K-?5`;^*JP=W4?G5/S-+M]I<C@*2/<45B07-M]]/%,>0T3!9N1-I5/,
M4@"`5RM+Y-:`B$3OZOV2[,1Q:8_]T31PQP3DUI9R\9)(2]N*SURP['\M(L9*
MFWC&!-Z-B><];#(V)O!N3(@W\L(IF?K]*(Y>EHK2<R2BU:)@%PNV'H#S4R0W
M,IF#<QD>O9@J8+?B!8&2)D_296D'M@6AX)#DMQ7Q)POG#1(3&\U::^#UJFDJ
M-J5"YA/P*D8(6YVQ.W4EBA1+%)E*R;;67]3_KX?^;ULQ)I6D00(1JI/(:(UA
M2]XGDI-`5U^X/ZW\-:363&H:I-C<4S08P:3.>)]-BI<V!.":%"]$;%KCJ[2.
MPZGKNDW!1@O@M3*YPC?0X,0,1Y-BA#;&>TIK)@H-4Y5CO53^(U12C*G\9CS6
M6M--58[U4L%A&AXK*<94`:+2FFZJ<JR72K9%5"[Z#X"<A.GP)M.:.YM,"P9L
MLMEG$.4DA.CCM&K-'40M&(!(H&;4PWC_C"HUAL/9-2)#YX;M4VH40_!D(7XX
MRT27[T8M\7&:C2CL/+%F<`BA+-F/$^I"WR2<H6-"M.@&H1X<0BCK-2*<0$GJ
M2;6N\@W"`!6V-=&B&X2#^P2!56#"_K.L9J'-&%R[I>YF1C3361YYXV:,-V9\
M2!AE%4=A'`"I:W\SC*CKK^53()SY;@BUCHV1=*RCT=8(ZB##'@O4+!Q)%*FU
M$=V%U"VE%Q(U%`DY8$-V=)8`=V'2;A\DN#X"F%BV15=),YP=368`:4>7"7`)
M)^TN0@)42C<=HEND';UF`&E'LPE:A;+=3#I(VZ(;I![J.,.RKV;A+8H+IA'5
MMVB;M$-TB_13S<?K:#XA+IQ&U%TX;PPV=J8GR__#U4C-0E$,<<DTHN['LVJP
M]_D,KM*?(>QH.R&NE\IZ:=^(7G_;T5=T??G,:'&@&YJFW(K965Z_"?2*ZMOJ
MIX$G3UWNJP&XF9^B`_T5%8<DYU9*]S#5'050R@M]M]<?!#NIJ^V6";B3JS^/
M\!L,A?N@.P+QGC%1?I"WS>I7G=5O````__\#`%!+`P04``8`"````"$`DGQT
MW#P"```!!0``&0```'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6R,E,N.VC`4
MAO>5^@Z6]Q,G@3"`$D8#B':D5JJJ7M;&<8A%'$>V(?#V/;8!P=!.9Y/$\7\^
M_^>2Y$\'V:`]UT:HML!)%&/$6Z9*T6X*_//'ZF&,D;&T+6FC6E[@(S?X:?;Q
M0]XKO34UYQ8!H34%KJWMIH085G-)3:0ZWL).I;2D%I9Z0TRG.2U]D&Q(&L<C
M(JEH<2!,]7L8JJH$XTO%=I*W-D`T;Z@%_Z86G3G3)'L/3E*]W74/3,D.$&O1
M"'OT4(PDF[YL6J7INH&\#\F0LC/;+^[P4C"MC*IL!#@2C-[G/"$3`J197@K(
MP)4=:5X5^#F9+@:8S')?GU^"]^;J&9E:]9^T*+^(ED.QH4VN`6NEMD[Z4KI7
M$$SNHE>^`=\T*GE%=XW]KOK/7&QJ"]W.("&7U[0\+KEA4%#`1&GF2$PU8`"N
M2`HW&5`0>O#W7I2V+O!@%&6/\2`!.5IS8U?"(3%B.V.5_!U$R0D5(.D),@#W
MI_TT2L=9DHW^3R'!D4]P22V=Y5KU"(8&SC0==2.83('L,AO^,S-(R<4\NR`?
M"FH#W=C/DNPQ)WLH(3MIYO>:]%:QN%<,DHN$@+^+24C]M<D!-/'OY3^;=$%0
M:(RN3(XO?)_(/&B&5YKL5K%X2W'C$0ZZ]OBV-R<N,+"OO$UN3YX'S=B7-[[=
M@UEW\:_W@I\PQ:')'=WPKU1O1&M0PRLX+8X>H;TZS'!86-7Y9JZ5A=GSCS7\
M:CAT.HY`7"EESPOWE5Q^7K,_````__\#`%!+`P04``8`"````"$`1V8`2$`$
M```8$```&````'AL+W=O<FMS:&5E=',O<VAE970U+GAM;)Q778^B2A!]W^3^
M!\+[B`WRH5$W"Y.YN\G>Y.;F?CPCM$H&:$+C.//OM[H+@6X4G?LRH];IXM2I
MZBIJ_?6]R(TW6O.,E1N3S.:F0<N$I5EYV)C__/WR%)@&;^(RC7-6THWY0;GY
M=?O;E_69U:_\2&EC@(>2;\QCTU0KR^+)D18QG[&*EF#9L[J(&_A:'RQ>U31.
MY:$BM^SYW+.*."M-]+"J'_'!]OLLH<\L.16T;-!)3?.X`?[\F%7\XJU('G%7
MQ/7KJ7I*6%&!BUV69\V'=&H:1;+Z<2A9'>]RB/N=+.+DXEM^&;DOLJ1FG.V;
M&;BSD.@XYJ6UM,#3=IUF$(&0W:CI?F-^(ZO()J:U74N!_LWHF0\^&_S(SK_7
M6?HS*RFH#7D2&=@Q]BJ@/U+Q$QRV1J=?9`;^K(V4[N-3WOS%SM]I=C@VD&X7
M(A*!K=*/9\H34!3<S&Q7>$I8#@3@KU%DHC1`D?A=_C]G:7/<F(XW<_VY0P!N
M["AO7C+ATC22$V]8\1^"9$2=$[MUX@#[UF[/[,`EKG??BX6,9(#/<1-OUS4[
M&U`U\$Q>Q:(&R0H\7R)#'EVLMT*%&(63;\*+]`51<,C/V]8G:^L-)$U:2(@0
MWS0ZB(:(+@B1"6#7483`=8H.I/"Z^!=&XI#*R)EKC,806T5$8X3K=A"%(T@W
MY#C-38"A!`92^-J30X0L!I#^P5+R:`JA4`,GCU,3X(T)<7=9\KPN8OG@$"&!
MS#)9J,9H:+0]O[,JC*#FAXQ$S=U/J#BDB>9T[I$90H!"1UX7;0JA4/14BM/Y
M%&!5-%_3)43(0HJFY3H:VGK""AVX-I]73!S2%.O=HV((F5)L"J%0%+-NT$BF
M%1-@33&]S!""BFDW-QK:%GT5*'R6G^$CP!J?OG91*H1<YS.T/;E.GV"%$8&F
M-93HL;J7IU1NCEY=+0;)/9'^^9)ZI)C]/C"5W95)</]6$FS:PX;A]`]`Y5I,
MRVZI7MI(M7JD+U&5GNC%@_IZ4#SLX$-Z?J`2"`EB6GK]XUOM%*M_J_\3T8X'
M]*;+7Z*UJZGI$K:8J;LY"5'5$WWY<7H"K99<H%W!D"#F^GU0C,MY?U8E];_F
M@'COTLEI;Q)AB[E![C($Q&O*;7*?F@!D/`("[1:&+>96G0VG`%GT9:A*I@V"
M.V6&S7M8_4'?+=O+B1@/Q[EC>]KUB(@"@)G>`U1JGQH`9#P!@E%70TQ/3>,>
MM4Y:@!W8/4"EILV"!WL'=O7A:UK0IZ55[]+Y;[]RD"F(0M/6YL-T<B5:NZ3Z
M#&TQU^_!#:-*21L*=RB-AT&@#P,;,?CZ:&N$Q1(G+C=:75?/)RYHN+\4M#[0
MB.8Y-Q)V$LL7@1KN?L7%,(3%4&Y15F>`O:R*#_2/N#YD)3=RNH>C\YD/7:'&
MS0Z_-*R2^\..-;"1R8]'V,`IK#OS&8#WC#67+V)CZ7;Z[2\```#__P,`4$L#
M!!0`!@`(````(0"UPA:O504``+$9```8````>&PO=V]R:W-H965T<R]S:&5E
M=#8N>&ULG%G;;N,V$'TOT'\0]+[6W8X-VXND0=H%ND!1]/*LR+0M1!(-2;GL
MWW=F*"DB1=IB7X)X?'B&P^$Y9)CMUX^R<-Y8W>2\VKG!PG<=5F7\D%>GG?OW
M7T]?[ERG:=/JD!:\8COW!VO<K_N??]J^\_JE.3/6.L!0-3OWW+:7C><UV9F5
M:;/@%U;!-T=>EVD+'^N3UUQJEAYH4%EXH>\OO3+-*U<P;.HY'/QXS#/VR+/7
MDE6M(*E9D;8P_^:<7YJ>K<SFT)5I_?)Z^9+Q\@(4SWF1MS^(U'7*;//M5/$Z
M?2Z@[H\@3K.>FSY,Z,L\JWG#C^T"Z#PQT6G-:V_M`=-^>\BA`EQVIV;'G7L?
M;!Z2I>OMM[1`_^3LO1G][C1G_OYKG1]^SRL&JPU]P@X\<_Z"T&\'#,%@;S+Z
MB3KP1^T<V#%]+=H_^?MO+#^=6VAW`A5A89O#CT?69+"B0+,($V3*>`$3@)].
MF>/6@!5)/W9N"(GS0WO>N=%RD:S\*`"X\\R:]BE'2M?)7IN6E_\*4$"3$EPT
MM<>T3??;FK\[T&]`-Y<4=T^P`>)^3H)AF*5IDC`[)+E'EIV[<AW(W\#*ONWO
M[K;>&RQ&UD$>!`1^#I!@0'@PF6%&,(OQC/2KTR=&,";&U<*9/(C`.$VH3Q/9
MI$$P+/=H\G?K@58D%I!X!$D&A%0?0.;7AV!HC91975F!F9$9=LG\S`BFS,/2
MBDA,VVG<L*5,BULH7.(6-NSLOG<X3L[014!9PR89[2-I%6&OS:\%P7(F$9G6
M@EZKR&$-T[F^"7&03-]%QMMP[>NWPUK.>#T3@N5,(C(M)(!9JY6$?KQ8W6P+
MC923]"&I'H-\`P"-$U\OB-!*,B38N9J2K)PAZ)P@^O2&/@3?#/MK;;`'E)Q%
M&4+],&A0"Q%HRU`,@/2RAN"-E1(REU)T(:DMD7Z;X4%C48_0NI1,A#1MT>@_
M6,+)=+.BJ0$$74BJ*#949&4!P=0#NI"F(L4%;C1F*O^@"TD;S7`<!%8&0&A%
M+R8+"#46<-O,:)2<H0])75GJNQ*B>D<.>GWM"*TD0P*=;D(K^1-:8>X<0>K*
MRE"&E?S#J?R[T'1SA?]/_C1,J4<G_\_+@71<XFELT9:I_(E`VQ9%_C<:/M5\
MV(6DMGS>KN0RK#0?3C7?A31M430O+L+1C/,RG.J_#XT%$_B&"T!H90"$5O:!
MR0`BQ0"NMX;0,G,?&K<F\`T'?V2E?$(KV4S*CU"X(T_!WBSCVP<,C5-R(!6$
MY,X8[@"1E0D06LDF?&&ZVR+%!&YTIA/ZZ'9!!)!,[HSA[(^LQ$]HI0[A!YHZ
M%/&3:E;K&9?_:&H$?4CNC>'TCZR<@-!*3<(<-#4I3G"C-U/U1UU([HWA^(^L
MU$]HI0Z3^F-%_=B;*%G-<#0:*6?I0W)O#'>`&(4\TNOU%22TD@T)=(=-K'&"
M8`W!&REPF)*B"\D%&6X#L941$%K)9C*"V,H("*TP=]X`Y0Q_TP2^X1806QD!
MH95L)B.(=4;@AW,VV]0(B`P2R[TQ7`EB*R,@M%*3R0AB*R,@M,*L,X+`<`V(
MK8R`T$HVDQ$D&B.8<WS2.#E''Y(Z$Q@N!`FJ>+8-$%K)A@0Z&TA0O/.9I^HG
M`D@FWD;'CUF)E=0)K4S:)/7$2NJ$5I@[J6LF;:7K1(AX_,=]%YH>AO`>;K/2
M4RT3@;S2XH%<O$*7K#ZQ7UA1-$[&7_'Q.X3GXR$Z/,S?A_BRHL;CS;UXL/>&
M;^#!_)*>V/>T/N55XQ3L")P^^5`MGMS%AY9?8%;P;,Y;>"JG7\_PKQ$&;\@^
MWBR/G+?]!\CL#?]LV?\'``#__P,`4$L#!!0`!@`(````(0!Y#LWC1P(``#`%
M```9````>&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;)24RXZ;,!2&]Y7Z#I;W
M@X&$W`2,)HK2CM1*5=7+VC$&K&",;"<D;]]CG&329*J9L@`,__G\GPNDCP?9
MH#W71J@VPU$08L1;I@K15AG^^6/],,/(6-H6M%$MS_"1&_R8?_R0]DIO3<VY
M14!H389K:[L%(8;57%(3J(ZW\*946E(+2UT1TVE.BR%(-B0.PPF15+38$Q;Z
M/0Q5EH+QE6([R5OK(9HWU()_4XO.G&F2O0<GJ=[NN@>F9`>(C6B$/0Y0C"1;
M/%>MTG330-Z':$S9F3TL[O!2,*V,*FT`..*-WN<\)W,"I#PM!&3@RHXT+S/\
M%"V68TSR=*C/+\%[<W6/3*WZ3UH47T3+H=C0)M>`C5);)WTNW",()G?1ZZ$!
MWS0J>$EWC?VN^L]<5+6%;B>0D,MK41Q7W#`H*&"".'$DIAHP`&<DA9L,*`@]
M#-=>%+;.\&@2)--P%($<;;BQ:^&0&+&=L4K^]J+HA/*0^`2!ZPD2Q4$\2Z)D
M\C:%>$=#@BMJ:9YJU2,8&MC3=-2-8+0`LLML_,_,("47\^2"AE!0&^C&/H\F
M84KV4$)VTBSO-?%%06#SBP/8]?\=N""H(D97#J(+?W"Y])KQE2:Y*/YR`)A;
M!R.8D=>[>ZZ!"\HP[''EX"5#[\!K9D.%XB2$XW4#X/'6P-M-<$&W!D87OC?@
M-=Y`%,_C:31_D?@:^*'W,]'1BG^ENA*M00TO(;,PF,(T:#_R?F%5-_1^HRR,
MZG!;PY^)PV"$`8A+I>QYX3ZJR[\N_P,``/__`P!02P,$%``&``@````A`&!'
MJCF8"0``:#```!@```!X;"]W;W)K<VAE971S+W-H965T-RYX;6RLFUUOX[82
MAN\+]#\8OF\<2\Z7D:2(]2VUP,%!VW/M.$IBK&T9EK/9_?<=2AR1PU?1Q@=[
M4V\>S8R&+X?DR%9O?_^VW8R^EH=Z7>WNQM.S\_&HW*VJI_7NY6[\]U_Q;]?C
M47U<[IZ6FVI7WHV_E_7X]_M??[E]KPY?ZM>R/(XHPJZ^&[\>C_OY9%*O7LOM
MLCZK]N6.KCQ7A^WR2'\>7B;U_E`NGQJG[6;BG9]?3K;+]6[<1I@?/A.C>GY>
MK\JP6KUMR]VQ#7(H-\LCY5^_KO<U1]NN/A-NNSQ\>=O_MJJV>PKQN-ZLC]^;
MH./1=C7/7G;58?FXH7%_F\Z6*X[=_`'AM^O5H:JKY^,9A9NTB>*8;R8W$XIT
M?_NTIA$HV4>'\OEN_#"=%_[%>')_VPCTS[I\KZU_C^K7ZCTYK)_^6.]*4IOF
M2<W`8U5]4:;9DT+D/`'ON)F!_QQ&3^7S\FUS_&_UGI;KE]<C3?<%C4@-;/[T
M/2SK%2E*8<Z\)HU5M:$$Z+^C[5J5!BFR_-9\OJ^?CJ]W8X]*X[&LC_%:A1J/
M5F_UL=K^K[TX5<ETSIYVID_M[%^>75R=^U.ZUV>#^#H(?>H@4\I@X*XS[4"?
MG#+Y#CA0+LT8Z5,[S$R6`WZ7VN^J\_.&;T1Y-S>B3\Z,8@S<X48[T"<[#-]A
M2@72SI>JE'9./C>8:3?3](_N9F<S[^+JNIDN3'/2UDI3>N'RN+R_/53O(UK/
M%*'>+]7N,)VKN%QT;8BN##^J0JH@%>5!A;D;D[I4:#4MG:_WTZEW._E*Y;[2
M-HL>&VD1L(4J3!4V=$'D@M@%B0M2%V0NR%U06&!".G5BT>+X&6*I,$HL'N:"
M@5'/T2Y@"W8)71"Y('9!XH+4!9D+<A<4%A#*4*G_#&54F+LQ_;<KH^L;62.+
MUD1M2IW-A30).I-.+2`1D!A(`B0%D@')@10V$:K1MO<S5%-A:/W2;3I)</6U
M1H.Z=2:=;D`B(#&0!$@*)`.2`REL(G2CR1>Z]9^0O#<IZT8>'M:B):0%DP!(
M""0"$@-)@*1`,B`YD,(F8NAT")TP=&4MA]X2CSZL6O&=!=09L3XAD`A(#"0!
MD@+)@.1`"IL(->C`.4$-92W5:(E="$!"(!&0&$@")`62`<F!%#810Z?&1`Q=
M'=S^M>H,=9?RZ;-;19*RM,2C>UM%,G.*I#/JB@1(!"0&D@!)@61`<B"%3812
MU)$)I89W"V4MU6B)721`0B`1D!A(`B0%D@')@10V$4-7/>8)8V_,Y>`U<FK!
M/7&-55<,B")$,:($48HH0Y0C*@22RJ@>SVY\AZM"M<9.66ADUP6B$%&$*$:4
M($H198AR1(5`4@;5T)T@0]O_4:O!\[R8:C3K4(`H1!0ABA$EB%)&M--9V].E
MW)XRMKKL\LH1%8R:[*4RJFL[09FVR1/*:&0:_4#U:*J,3%(AH@A1S&APS`E;
MF?`I(^EXY8H%>>7L:&(5C'K$4JW:"6*UG1W%,V6DD2V61B:#<`HH0A0SDF.^
MEF-.V,J$3QE)1^<))&,KXY@C*AB)6-YYEX0L-K(Z13]E[NS3&MGZ:63R#-77
M2;+^(D0Q(S(V"\R;=JDWS^8)6YGP*2/IZ#S+9FQE''-$!2,9RW2J4C_5(=KU
MUWZ-<7:EO%_7JR^+BD9">WC/+N_3UQ7Z2XRVSQ1EJ9$MJT;4;UCJ.-U12$L<
ME`84LY6,Y9RN"5L9P5)&TA'V0+ACSHXF5L%(QC);A%1:-:1#2O]5[3]2FH[*
M3NJVKQ52:V1+K9%)-IP"BA#%B!)$*2-S=&6(<D2%0%(>$E'(TU-PM@S*W%G(
M&M$XK?)R-J]`?:^J'*GSLZR<G2HT5KS/1HQH(S6.OMF6FI40LY4([\,.T"7!
MX=-^1]@!P#%GQ\&\"K:2>7VT*:BVV"[5'\R%,G?F0B,Q%[ZSU`,U"3`7ODE*
M?Y796;%8$3N:^HL9D;$U/;`A0*ST4XZ9L>(D<D8FB8*13,(,2%2\=]HC1F,N
M568D57;VLH"M/DJJ5=E8\0`C1F:`,2,9RU796'&LU*"!Z<F,%3OFC$P2!2.9
MQ$<JNX\K_]<!Y^%3C$8J&:O@S.;?R!JP%?E;5B97+7X;GHQYW!$[>AV*&5'+
M:<4"\2%6RHXR"<<Q,U:<1,[()%$PDK',@&2)NP])2OSFB5BU%GS@?;[/\/`I
M2B-G&MQ=GZW$)NFYNSY;V=/0WE%=L31W=WUV%.%AUV<K$SYE)!V=O#*V,HXY
MH\&\"K:2X3^:+/4H8^_Z[DKA^1H^#=3/@\YIP,BLX8#135?>(:*(D7&,&1G'
M!%&**$.4,S+A"T9->%G+)**0YP<R*'-GN]9(;-<SIY8"3UN9`8:((D8F]9B1
M<4P0I8@R1#DC$[Y@U*,,/2N<HHPR=Y312"KC=$T!M7_8+N`B[JQX&XO8D90=
M6L2=HVWE))%P+*-R:I#M"(NX"\]YY>PXF%?!5I\[[M2#B[V(?U"E^CG'^CY!
M_<*AIL=,?<#(C#E$%#$RCC$CXY@@2A%EB')&)GS!J*<DJ9).D4&9.R6ID2Q)
MIQ\/U%FF',7<8$EV5CSU$3L.3GW,5B(\GBL0/NUWA)($QYP=!_,JV$KF]=&Y
MHIY93BA)_8ACEV2+:"&P?H%Z08>$MU"(*$(4(TH0I8@R1#FB0B!Y?I!8I\B@
MS)V2;)$2WVQC,Z.Z[C@[*Q8K]`!%B&)$":(4488H1U0())3Q3WL0:LRE,AI9
MU1`@"A%%B&)$":(4488H1U0()&50C?OGUXG?]OGV%T$:48'PU`>(0D01HAA1
M@BA%E"'*$14"21E4QWV"#&V#+F1HD:@&0*$/*$(4(TH0I8@R1#FB0B`I@]N-
M#Q_D/G;=&HEJ:*TL%*)5A"A&E"!*$66(<D2%0%(&.HA.J09E[NP-+1+5`"CT
M`46(8D0)HA11ABA'5`@D95#-XPF+0O>:UAE*[]\V!Z:]-P`*T2I"%"-*$*6(
M,D0Y(O6JL$FUE:%]];=]_W);'E[*H-QLZM&J>E.O]=)W$O>W'6[?.5[XZJ7C
MYHD9KGATI?E*`Z[X=*41#:[,Z$K3>L*5"[K2=";NE9LYO5]`.['+I^=S]?MZ
MWQ7*F7YR[KGB7<]5;]%WA6Y#9VO/%9_N0\<-7J'WL1]ZQZ]NWV._(,%Z[95<
M/?8/L_E#OR2D8J^(I&&OA)=S>H4)!["XFM/[/3V<5&I$FG2:TWO>^^5+^>?R
M\++>U:--^4P%<][\OG5HWQ1O_SCJ7U\>JR.]Z4U;"+W12V_TE_0R[?D9%>1S
M51WY#[KQI/M_!.[_!0``__\#`%!+`P04``8`"````"$`(M5_&AX'``!C)@``
M&````'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;)2:6X^C-A3'WROU.R#>=\*=
M)$JRRG:U[4JM5%6]/#.$3-`D(0)F9_?;]_C8!OO8)/AE-'/X<RZV?\>88?/Q
M^^7L?:O:KFZN6S]\"GRONI;-H;Z^;/U__O[R8>E[75]<#\6YN59;_T?5^1]W
M/_^T>6_:U^Y45;T''J[=UC_U_6V]6'3EJ;H4W5-SJZYPY=BTEZ*'/]N717=K
MJ^*`-UW.BR@(LL6EJ*\^][!NY_AHCL>ZK#XWY=NENO;<25N=BQ[R[T[UK9/>
M+N4<=Y>B?7V[?2B;RPU</-?GNO^!3GWO4JZ_OER;MG@^0]W?PZ0HI6_\PW!_
MJ<NVZ9IC_P3N%CQ1L^;58K4`3[O-H88*V+![;77<^OMP_6F9^8O=!@?HW[IZ
M[Y3?O>[4O/_:UH??ZVL%HPWSQ&;@N6E>F?3K@9G@YH5Q]Q><@3];[U`=B[=S
M_U?S_EM5OYQZF.X4*F*%K0\_/E=="2,*;IZBE'DJFS,D`#^]2\V6!HQ(\7WK
M1Q"X/O2GK1]G3VD>Q"'(O>>JZ[_4S*7OE6]=WUS^XZ(0D^*^,+7/15_L-FWS
M[L%\@[J[%6SUA&MP+'/B'H8LIY*$[)B3/?.R]7/?@_@=C.RW79CDF\4W&(U2
M:#YQ#?P<-8-B`=D,*4$::DKVX9&1F9A%9L/%4OG$#6J8R!XF=@G#Q##>2O++
MU>"6!^:21)&D@T*K#R3SZV-BF!LULCFT7#0C-*R3^:&9&$,/8\LM"2XH=<8R
MW2U;1"O`X_[,L9MT]\*BSMTJL(\A++7YA3"Q'HE;S$)8JR4T1$'RE$/A]XMA
M-^HAA$4K)K07L]*CWH_$Q'HD;C&+"6$*U&KN^T6U[EB:>`=1)SR$LAQ<,S5Q
M+4P6UT[XAP)WE8_5"#PG4XAF\,$X<ZB+(P\W#82@`R@5TAK:G)*/U@="AJVR
MVA[,#X=<"R9,ED%T`IUM0G1^IE`/+:Q'*TCD0?8F[>@)ADHC)+83$CKQCFJR
MWJ:(#RW(AQGLJP\K,I%'7[2B9*(B)^A#DWIA,K&/G+!'M3Y6TF0NJ\@)>U03
MUY/81T[8HYJX%IW`DK43U-$`M4+PN).+APPN@F4_4#Y*-,@CQNALR%%-ZA*0
M:QUE*I@3]NRID6`O399!)-S?QSTR<1<FRWHE;,][>H@XT&H[E":MH61V_"*"
M_8-R3-;1P=:WE.,$=F2"+4WF',1.9*-:7TO29''M1'8L,`8*AO6_HL_[0C2#
MD=B)?523NCC[YF3$3NBCFG@6W4"C;ZQ40SUV0AW5)!A'W5(&X9HA,F/3C4W`
MI4EC9&EG)'9"'M6D'MX%+/40Y._3%YNH2Y-E(3N!'9M@"Y,E:2>P8Q-L:3*3
M3IS`1C6.M$(?/8T*T0SZ$B?T4:U/LS1IC(SY:(PD3JBCF@2;0CTAJ/,W&?&,
MLQO>2:(([%5,PF#B+)HX<8]J$FV*^X1P?Y\35!//H@-8EIP3W(FYGTN3Q;43
MW8E)MS197#O1G0QTCZ"$P7@(Y\]R0C6'%*<.D)@=0)I44M2$-%12IZ:`:GWR
MI<D<QM0)>503U\R![>DG)7PS"K/D\6D*[R,Q..G:^3!,)O:JE-!_GQ14DVB<
M>+/MITYTHYIXYG1#'?"60)]A)[Q3<S>7)HMK)[Q3$V]ILKAVPCL=\%89'(_Y
MG$&AFL%@ZM0!4$VF@S<%RT0[T9V:=$N33O=8JC;WF1/=J-;K$":SCHS`C1MA
MOF+_4WCPD@;O)%$XZ#J$P<0[C8S`?Q]"5&,T=66,)UN^,H1JQLK(G%H`JDFM
M8M/7YV],2)\_I[:0B1Z@O"F4)A.PS*DMH)H4PCN%96F0KL"61ISF,YZ1,K-#
M2!.LD.$0&`83Y^W,J6F@FM3$^XBE)M(0<+FO8`X?K+[AV6!X=YL)DU[0Q&$O
M<^H6J"8%\09B%I0[=094ZYZER5Q9.6D-]X<(U<3UT`[H7I8[L8]J=*VNG7%O
MY^P+U0SV<R?V44T*F]K^<R?.44T\"_3UKC*6JG45]H^F^6\+44VB3:&?6]`/
M@V@&^G@GB2*Z@49*,G'DRYW01S6)-H5^3M!_L)Q-XM$!!+.0XH1W;CX,").)
M]]();U3KPR%-9M)+)[Q1C:X5!L/QC,L9%*H9#"Z=.@"J26',`9@T4I2$-%*6
M3L2CFD03N[UE&`GR<\\P2T&ZLLE+DP9*.HZQ7I(3_$M.NOH"7)HL)1'Z[Y,"
M'\'0?PQ(D^*:?^?"/R:Y5.U+]4MU/G=>V;RQ;UB`J=UF,(L/;)+E>@\'"]@[
MZ)4T7^_A\=-R)8O6>]B)+%=RN`(P6*XL0[ABC0,7(ML=R7K/NP!-+(0@\-\F
M2Y`H7N_AA;KE2@Q1X&6?Y4H2K/?P=@.N+(9`\(G/K7BI_BC:E_K:>>?J",,7
M8&-N^4="_(^^N<&PPH<^30\?]^"O)_B8JX*/7@)VP#XV32__8`&&S\-V_P,`
M`/__`P!02P,$%``&``@````A`/K]1L6T`@``\08``!D```!X;"]W;W)K<VAE
M971S+W-H965T,3$N>&ULC)5=;YLP%(;O)^T_6+XO7PE-BD*J)J3;I$V:IGU<
M.\8$JQ@CVVG:?[]C'!B$]>,FP?9['OR><VQ6MT^B0H],:2[K%(=>@!&KJ<QY
M?4CQKY_W5TN,M"%U3BI9LQ0_,XUOUQ\_K$Y2/>B2,8.`4.L4E\8TB>]K6C)!
MM"<;5L-*(94@!H;JX.M&,9*W0:+RHR"X]@7A-7:$1+V'(8N"4Y9)>A2L-@ZB
M6$4,[%^7O-$=3=#WX`11#\?FBDK1`&+/*VZ>6RA&@B9?#K549%^![Z=P3FC'
M;@<3O.!422T+XP'.=QN=>K[Q;WP@K5<Y!P<V[4BQ(L5W8;*;8W^]:O/SF[.3
M'CPC7<K3)\7SK[QFD&PHDRW`7LH'*_V2VRD(]B?1]VT!OBN4LX(<*_-#GCXS
M?B@-5#L&0]97DC]G3%-(*&"\*+8D*BO8`/PBP6UG0$+(4_M_XKDI4SR[]N)%
M,`M!CO9,FWMND1C1HS92_'&B\(QRD.@,@8@S)(R\:!F'\?7;%-_MJ#68$4/6
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MMDV8P+&`[KZ8S^#&:^?]?@%NG(8<V#>B#KS6J&(%(`-O`=V@W)WE!D8V;9/O
MI8&[IGTLX=/"X,`%'H@+*4TWL,>J_UBM_P(``/__`P!02P,$%``&``@````A
M`.9V8R&!"```$BD``!D```!X;"]W;W)K<VAE971S+W-H965T,3`N>&ULK)I=
M;^)*$H;O5]K_@+@_$!O(EY(<#?C;YTBKU>SN-0$G00,886<R\^]/M=WE[NH7
M./%J;B:3QU5%]=O5U=W$#[__V&T'WXMCM2GWCT-O=#4<%/M5N=[L7Q^'__D:
M_78['%3U<K]>;LM]\3C\653#WY_^^8^'C_+XK7HKBGI`$?;5X_"MK@_WXW&U
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M?%24+RK,X_!F.*`*J:CTOS]Y,^]A_)W*=:5MYB=LI,6"+51MJK"!"T(71"Z(
M79"X('5!YH+<`F/2J1.+JOI7B*7"*+%XF',&1CW?488MV"5P0>B"R`6Q"Q(7
MI"[(7)!;0"A#2_57**/"4-L19>1(,6]M5#OI:FWFJ-69='(!"8%$0&(@"9`4
M2`8DMXF0;?IK9%-A:`'3QW22>+.)%&7>&EW4K3/I=`,2`HF`Q$`2("F0#$AN
M$Z$;3;XHM]-;'#<G9=W(P\.:MX2T8+(`$@`)@41`8B`)D!1(!B2WB1CZ=:^A
M*VLY]);XHE5[[@+JC%B?`$@()`(2`TF`I$`R(+E-A!HTC!Z%H*RE&BVQ"P%(
M`"0$$@&)@21`4B`9D-PF8NCJV&[OW)?7@+*60]=D:M8`D`!(""0"$@-)-*&B
M-@W*NY8-*M5&UUU"&9#<#BW4N.NEAK*6:FAB-N6%)B:=`$@()-+DXDAC<$M.
MNMTX`H%;!B37I)E5(9`ZAO:HE\9<2L3(THB1)1*B$%'$2.IT*P<<LY4)GS"2
MCG?2,64KXY@ARAF)6/Y5%TOJIPZ%GU]OZBSME!@C6S]M9?(,V,J@$%'$2*;N
MG+ACMC*Q$D;2T3ECI6QE'#-$.2,9RYP[I'[JZ&CKU]XT1NH^5K]M5M_F)?4&
MTN-$'YO0C4+?,]H#*!UU>&>:>QK9LFI$W<+T&W_:3:R^7&@K,\B08QD4,9*Q
MG`TS9BOCF#"2CF[38ROCF"'*&<E8IC](I=5Q\Y+27\O#.:5I)^RD;D^M0FJ-
M;*DU,OD'ZARJ2M^@$%&$*$:4,#*[5(HH0Y0+).51ITI;GA,%9\O0'D(IGJDX
MC6AKMLK+:5X+3UM11[:LG$X5&"L.'S(B?^,X,6VIJ=Z(K43X"72`+@D.GYQV
MA`X`CAD[7LPK9RN9U[FF0(N_SUPH<V=3TDC,Q<19Z@OU-9AR/)>4;@B=%8L5
MLJ.IOXB1C`4-`6(EGW),C14GD3$R2>2,9!+G5%;'YQX5WYZV1<5K)%5V>MF"
M5OQG5.ZL>(`A.YH!1HSD`$%EB)5\RC$U5IQ$QL@DD3.229Q369W4;97_OPU.
M17%*O$4^'>"L?F":?U.\"T];T0YJ69E<=8EW5CSND!W]KL%%C*B16[%`?(B5
ML*-,PG%,C14GD3$R2>2,9"PS(-G4:6<$\9M+KCI:\(;7XYRAXCG3T")G&J#K
M:RO1)'WH^MJJ_?)<?=49>AK1H<32'+K^J?#8]2%\PN%%7A,GKY2M3%X9HXMY
MY6PEPY^;+%I/,%G>S!P%>;[^9F=689PYTLBLX87J^6WKYV(+$(6,C&/$J/F+
M3;-Z8D0)HA11QLB$SQDUX44MJPH3\ER6H3&7,C"B!6IJ:>K4TH*MS``#1"$C
MDWK$R#C&B!)$*:*,D0F?,SJA#/6"/LHH<T<9C:0RSJEIX6LK*AVC'RQB8\65
M%3*2R\`1/F(K$1X6L;'B\(E!5EZPB(T5.V:,+N:5LY7,Z\PB]M7MR=[N_J9*
M]67+.D8W$6AZS-0O&)G*"A"%C(QCQ,@XQH@21"FBC)$)GS,Z49+JLM-#!GTW
MLF702):D<QY?^-I*S`V69&?%4Q^RX\6IC]A*A,>2A/#):4=W7S%6G%?&Z&)>
M.5O)O,Z5),7J,Q?*W&D/+;*_#_8!!8A"1!&B&%&"*$64(<H%DON'NGKT*$E]
M4[%+LD5T?N+I6I`D2BP+!8A"1!&B&%&"*$64(<H%DC*HNT$/&?15PI:A1?01
M1@9`@0\H1!0ABA$EB%)$&:)<("F#.J7WD$&9.XNB1=;4+]3)VJT&0"%:18AB
M1`FB%%&&*!=(RJ".Q#UD:$_0]AW8UX=J>U$`"M`J1!0ABA$EB%)$&:)<("D#
M-=(^,BASIQI:1$J;10$HH/><G`()$46(8D0)HA11ADB];&62:&5H7YYJWX#9
M%<?78E%LM]5@5;ZK%Z/H6Y6GAPZW;VW-_1F]MM6T`'AR34^:;SGAR0T]:12"
M)[?TY%9I!T_NZ$ESP'">T'MC7YI[L</G]#Y9<U%SN4^!3GW"Y)[>1,!/_C*E
M^*<^>#Z]IS_!H\.<%#DI".EQ4@Y2X[08]`&TC]$GC+LQT!MIA^5K\>?R^+K9
M5X-M\4(3<]7<#8_M.VWM+[7^$ONYK.EE-)H[>G>)WCTLZ"Y]-:+-ZJ4L:_Y%
M?4#W-N/37P```/__`P!02P,$%``&``@````A`)UQ*N[0`@``/P@``!@```!X
M;"]W;W)K<VAE971S+W-H965T."YX;6R45=]OFS`0?I^T_\'R>T.@)&U02)6N
MZE9IDZ9I/YX=8\`JQLAVFO:_W]DF#$J6TA?`QW??=W<^G]<WSZ)"3TQI+NL4
MA[,Y1JRF,N-UD>)?/^\OKC'2AM09J63-4OS"-+[9?/RP/DCUJ$O&#`*&6J>X
M-*9)@D#3D@FB9[)A-?S)I1+$P%(5@6X4(YES$E40S>?+0!!>8\^0J"D<,L\Y
M97>2[@6KC2=1K"(&XM<E;_213=`I=(*HQWUS0:5H@&+'*VY>'"E&@B8/12T5
MV560]W,8$WKD=HL1O>!422US,P.ZP`<ZSGD5K`)@VJPS#AG8LB/%\A1OP^0V
MC'"P6;L"_>;LH'O?2)?R\%GQ["NO&50;]LGNP$[*1PM]R*P)G(.1][W;@>\*
M92PG^\K\D(<OC!>E@>U>0$8VL21[N6.:0D6!9A8M+!.5%00`3R2X;0VH"'EV
M[P//3)GB"%ICQ[2YYY8*([K71HH__F?84GCGJ'6&=^M\N9PMKN:7(6B]01+X
M0%Q>=\20S5K)`X)F`4G=$-MZ80+$IQ.!#"QV:\$IOL((8M50_:=-&,?KX`DJ
M1EO,K<?`\Q^F0P0@VBF#VG1E"[;*MJ0VE%MOZ,M$IV4NWR-CP2F&9Q?\]:JC
M]<(>$O<@BPXQR`\@T_.S8-B"OO*XM!XT01K:8;JT!3OIKK;>$KN3T-^QY7MH
M+7A(VUK@T'75#>/_%`]Z;'H&%CR4\I9Q!G8.][K='=]P,8.$SS>^]1LJM)9^
M`X;Q\G0GK(:JYZ4L>"CE+>-D0JAD/YOSO`X])#Z:W)@9]&YH3W&O4&]06_0K
M:F\Z$?2[CCW,\A%S:^H%[<>U'VN"J8)]8E6E$95[.XHC&%2=M;LFMNZ6>&V/
MDZV_/H+N#XSOAA3L&U$%KS6J6`Z<\]D5](SR%X!?&-E`"6`.2P,#W'V6<%$S
M&%9SVV"YE.:XL%=,=_5O_@(``/__`P!02P,$%``&``@````A`"V60,4Q`0``
M0`(``!$`"`%D;V-0<F]P<R]C;W)E+GAM;""B!`$HH``!````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````````````````````````)R104O#,!B&[X+_H>3>IEG'D-!FH+*3`\&)
MLEM,OFW!)@U)M.V_-^NZ.M&3Q_"^>?)\7\IEI^OD$YQ7C:D0R7*4@!&-5&9?
MH>?-*KU!B0_<2%XW!BK4@T=+=GU5"DM%X^#1-19<4."32#*>"ENA0PB68NS%
M`33W66R8&.X:IWF(1[?'EHMWO@<\R_,%UA"XY('C(S"U$Q&-2"DFI/UP]0"0
M`D,-&DSPF&0$?W<#..W_O#`D%TVM0F_C3*/N)5N*4SBU.Z^F8MNV65L,&M&?
MX-?UP],P:JK,<5<"$#ONI^8^K.,J=PKD;<^Z-U<GWA]*_#LKI1CLJ'#``\@D
MOD=/=N?DI;B[WZP0F^6D2`E)<[(A<YK/:;'8EOC<&N^S":A'@7\3SP`V>/_\
M<_8%``#__P,`4$L#!!0`!@`(````(0`J%>A];`(``#,&```0``@!9&]C4')O
M<',O87!P+GAM;""B!`$HH``!````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````)Q5WV_:,!!^G[3_(<I[&Z#5.E4F51K2@0:$U:%3GRS7<<!JL#/;H-*_
M?F<B2MBR'^7M?/?=W7>7NPNZ>5F5WH9K(Y3L^]WSCN]QR50NY*+OS[.[L\^^
M9RR5.2V5Y'U_RXU_$W[\@&9:55Q;P8T'(:3I^TMKJ^L@,&S)5]2<@UF"I5!Z
M12T\]2)012$8'RBV7G%I@UZG\RG@+Y;+G.=GU5M`OXYXO;&G!LT5<_S,0[:M
M@'"(HJHJ!:,6J@PG@FEE5&&]Y(7Q$@5-(P)VF+.U%G8;=E#0?"+,:,EC"!P6
MM#0<!0<%&G+JFC:C0IL0;>SUAC.KM&?$*[2MYWM/U'!'I^]OJ!946J#E8/5C
M)Y>5L3K\KO2S67)N#0H`4"MW8A/;E,5EV+W:(4`Z1KH(-1,P''/,A"VY28L9
MU;:%<O>JR7G'HF9<$]I_10*S01)IH5]D).NO+523^5L-<3K%Z7@TB+)D0&ZC
M<32-$X*'29+A]^+)C/[;!6>0:9),,TS2.Y+.DO>ZQ%$[L2[!\\DDNG]T<?'H
MRW1T-XJC:4:B.$[GK5EZ4&ATGT#9&(J?18^.5ROR@N`LC;\.T_$@N<<D^38?
M98^M2+Q>K:C>$E40+!92P'+!6)&(,;66MMUE234GMS"*.;1PZ]:09/0)YJ`=
M_M<,W1-\>B?X7+3[N%*.*\%6L6>25K#F_^LRI5K#6=AP,CC!Y0\=<#26JLSA
MK)+DQ]JMQB%/,\W1=OZRCV,AG\V\RM2`6KX_.,=*A%T/<EC%O?V@0$.X-;IT
M0>(EE0N>[S&_&]QY?*C_`6'W\KQST8'+U]"AX'#MPY\```#__P,`4$L!`BT`
M%``&``@````A`%'#0KNA`0``&`T``!,``````````````````````%M#;VYT
M96YT7U1Y<&5S72YX;6Q02P$"+0`4``8`"````"$`M54P(_4```!,`@``"P``
M``````````````#:`P``7W)E;',O+G)E;'-02P$"+0`4``8`"````"$`T45'
MSVP!``"="P``&@``````````````````!P``>&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"+0`4``8`"````"$`\5*-')\"``")!@``#P``````````
M``````"L"0``>&PO=V]R:V)O;VLN>&UL4$L!`BT`%``&``@````A`*ON[_2V
M!```:1,``!@`````````````````>`P``'AL+W=O<FMS:&5E=',O<VAE970T
M+GAM;%!+`0(M`!0`!@`(````(0`C,Q]Z,`,``-,)```9````````````````
M`&01``!X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L!`BT`%``&``@````A
M`#7"H-IT`@``WP4``!D`````````````````RQ0``'AL+W=O<FMS:&5E=',O
M<VAE970Q-BYX;6Q02P$"+0`4``8`"````"$`)<WWFV4"```W!@``&0``````
M``````````!V%P``>&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+`0(M`!0`
M!@`(````(0#[8J5ME`8``*<;```3`````````````````!(:``!X;"]T:&5M
M92]T:&5M93$N>&UL4$L!`BT`%``&``@````A`/SQ#V0="@``-E(```T`````
M````````````UR```'AL+W-T>6QE<RYX;6Q02P$"+0`4``8`"````"$`5Y7'
M`P07``!.2```%``````````````````?*P``>&PO<VAA<F5D4W1R:6YG<RYX
M;6Q02P$"+0`4``8`"````"$`&U9A;(8"``#9!@``&`````````````````!5
M0@``>&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L!`BT`%``&``@````A`#_>
M^[C.`P``%@T``!@`````````````````$44``'AL+W=O<FMS:&5E=',O<VAE
M970R+GAM;%!+`0(M`!0`!@`(````(0"/ZQ.6N0,``)L-```8````````````
M`````!5)``!X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"+0`4``8`"```
M`"$`0&+Z9T0$```:$@``&0`````````````````$30``>&PO=V]R:W-H965T
M<R]S:&5E=#$T+GAM;%!+`0(M`!0`!@`(````(0"2?'3</`(```$%```9````
M`````````````']1``!X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L!`BT`
M%``&``@````A`$=F`$A`!```&!```!@`````````````````\E,``'AL+W=O
M<FMS:&5E=',O<VAE970U+GAM;%!+`0(M`!0`!@`(````(0"UPA:O504``+$9
M```8`````````````````&A8``!X;"]W;W)K<VAE971S+W-H965T-BYX;6Q0
M2P$"+0`4``8`"````"$`>0[-XT<"```P!0``&0````````````````#S70``
M>&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+`0(M`!0`!@`(````(0!@1ZHY
MF`D``&@P```8`````````````````'%@``!X;"]W;W)K<VAE971S+W-H965T
M-RYX;6Q02P$"+0`4``8`"````"$`(M5_&AX'``!C)@``&```````````````
M```_:@``>&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L!`BT`%``&``@````A
M`/K]1L6T`@``\08``!D`````````````````DW$``'AL+W=O<FMS:&5E=',O
M<VAE970Q,2YX;6Q02P$"+0`4``8`"````"$`YG9C(8$(```2*0``&0``````
M``````````!^=```>&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+`0(M`!0`
M!@`(````(0"=<2KNT`(``#\(```8`````````````````#9]``!X;"]W;W)K
M<VAE971S+W-H965T."YX;6Q02P$"+0`4``8`"````"$`+99`Q3$!``!``@``
M$0`````````````````\@```9&]C4')O<',O8V]R92YX;6Q02P$"+0`4``8`
M"````"$`*A7H?6P"```S!@``$`````````````````"D@@``9&]C4')O<',O
=87!P+GAM;%!+!08`````&@`:`.@&``!&A@``````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EAFAG">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)<br>In Thousands, except Share data, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyRevenue', window );">Royalty income</a></td>
        <td class="nump">$ 71<span></span></td>
        <td class="nump">$ 19<span></span></td>
        <td class="nump">$ 178<span></span></td>
        <td class="nump">$ 47<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
        <td class="nump">45<span></span></td>
        <td class="nump">102<span></span></td>
        <td class="nump">172<span></span></td>
        <td class="nump">320<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
        <td class="nump">26<span></span></td>
        <td class="num">(83)<span></span></td>
        <td class="nump">6<span></span></td>
        <td class="num">(273)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Interest income</a></td>
        <td class="nump">4<span></span></td>
        <td class="nump">2<span></span></td>
        <td class="nump">8<span></span></td>
        <td class="nump">8<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income tax provision</a></td>
        <td class="nump">30<span></span></td>
        <td class="num">(81)<span></span></td>
        <td class="nump">14<span></span></td>
        <td class="num">(265)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Loss from continuing operations</a></td>
        <td class="nump">30<span></span></td>
        <td class="num">(81)<span></span></td>
        <td class="nump">14<span></span></td>
        <td class="num">(265)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_CDOM_DiscontinuedOperationsNote1Abstract', window );"><strong>Discontinued operations</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax', window );">Gain from sale of discontinued Reconstructive and Spine Divisions, net of income taxes</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">532<span></span></td>
        <td class="nump">0<span></span></td>
        <td class="nump">532<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
        <td class="nump">$ 30<span></span></td>
        <td class="nump">$ 451<span></span></td>
        <td class="nump">$ 14<span></span></td>
        <td class="nump">$ 267<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Basic and diluted</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare', window );">Continuing operations</a></td>
        <td class="nump">$ 0.00<span></span></td>
        <td class="nump">$ 0.00<span></span></td>
        <td class="nump">$ 0.00<span></span></td>
        <td class="nump">$ 0.00<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare', window );">Discontinued operations</a></td>
        <td class="nump">$ 0.00<span></span></td>
        <td class="nump">$ 0.00<span></span></td>
        <td class="nump">$ 0.00<span></span></td>
        <td class="nump">$ 0.00<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Total</a></td>
        <td class="nump">$ 0.00<span></span></td>
        <td class="nump">$ 0.00<span></span></td>
        <td class="nump">$ 0.00<span></span></td>
        <td class="nump">$ 0.00<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Basic and diluted</a></td>
        <td class="nump">230,293,141<span></span></td>
        <td class="nump">230,293,141<span></span></td>
        <td class="nump">230,293,141<span></span></td>
        <td class="nump">230,293,141<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CDOM_DiscontinuedOperationsNote1Abstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>CDOM_DiscontinuedOperationsNote1Abstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>CDOM_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of gain (loss), after tax expense or benefit and not previously recognized, resulting from the sale of a business component.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 20<br><br> -Section 45<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6892542&amp;loc=d3e957-107759<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 205<br><br> -SubTopic 20<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6360339&amp;loc=d3e1361-107760<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasicAndDiluted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerShareBasicAndDilutedAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_GeneralAndAdministrativeExpense</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of income (loss) from continuing operations attributable to the parent. Also defined as revenue less expenses and taxes from ongoing operations before extraordinary items but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 18<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7656940&amp;loc=SL4613673-111683<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.13)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeLossFromContinuingOperations</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 10<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Per basic and diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation, when the per share amount is the same.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeStatementAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(h))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph h<br><br> -Article 4<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Income Tax Expense (or Benefit)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -Subparagraph (a),(b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxExpenseBenefit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-108580<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net result for the period of deducting operating expenses from operating revenues.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OperatingIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OtherOperatingIncomeExpenseNet</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Revenue earned during the period from the leasing or otherwise lending to a third party the entity's rights or title to certain property. Royalty revenue is derived from a percentage or stated amount of sales proceeds or revenue generated by the third party using the entity's property. Examples of property from which royalties may be derived include patents and oil and mineral rights.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RoyaltyRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 16<br><br> -URI http://asc.fasb.org/extlink&amp;oid=7655603&amp;loc=d3e1505-109256<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ELE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Share Based Payment (Tables)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_CDOM_ShareBasedPaymentTablesAbstract', window );"><strong>Share Based Payment Tables</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Summary of Stock Option Activity</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">A summary of stock option activity as of September
30, 2013, and changes during the period then ended is presented below.</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b>Weighted-</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b>Weighted-</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b>Average </b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b>Remaining </b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b>Aggregate</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b>Exercise</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b>Contractual</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b>Intrinsic</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Options</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Price</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Life (Years)</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Value</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="background-color: white"><font style="font-size: 10pt">Outstanding at December 31, 2012</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">385,000&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.23&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.66&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="background-color: white"><font style="font-size: 10pt">Granted</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">- &#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">- &#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="background-color: white"><font style="font-size: 10pt">Exercised</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">- &#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">- &#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td></tr>
<tr style="vertical-align: top">
    <td style="background-color: white"><font style="font-size: 10pt">Forfeited</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">- &#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">- &#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td></tr>
<tr style="vertical-align: top">
    <td style="background-color: white"><font style="font-size: 10pt">Outstanding at September 30, 2013 (unaudited)</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">385,000&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.23&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">4.92&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="background-color: white"><font style="font-size: 10pt">Vested and expected to vest</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="background-color: white"><font style="font-size: 10pt">&#160;&#160;&#160;&#160; at September 30, 2013 (unaudited)</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">385,000&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.23&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4.92&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="background-color: white"><font style="font-size: 10pt">Exercisable at September 30, 2013 (unaudited)</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">385,000&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.23&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4.92&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CDOM_ShareBasedPaymentTablesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>CDOM_ShareBasedPaymentTablesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>CDOM_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ELE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_CDOM_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>1. </b> <b>SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Tiger X Medical, Inc. (&#34;Tiger X&#34;
or the &#34;Company&#34;), formerly known as Cardo Medical, Inc., previously operated as an orthopedic medical device company
specializing in designing, developing and marketing high performance reconstructive joint devices and spinal surgical devices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">During 2010, the Company discontinued its
operations and sold the assets from its previous business lines during 2011. Beginning on January 1, 2013, the Company became classified
as a development stage entity. Our continuing operations include the collection and management of our royalty income earned in
connection with the Asset Purchase Agreement with Arthrex, as well as continuing to promote our former products sold to Arthrex
and seeking a joint venture partner or buyer for the remaining intellectual property owned by the Company. The Company will also
be evaluating future investment opportunities and uses for its cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b><i>Basis of Presentation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The accompanying condensed consolidated balance
sheet as of December 31, 2012, which has been derived from the Company's audited financial statements as of that date, and the
unaudited condensed consolidated financial information of the Company as of September 30, 2013 and for the three and nine months
ended September 30, 2013 and 2012, has been prepared in accordance with accounting principles generally accepted in the United
States of America (&#34;U.S. GAAP&#34;) for interim financial information and with the instructions to Form 10-Q and Article
8-03 of Regulation S-X. In the opinion of management, such financial information includes all adjustments considered necessary
for a fair presentation of the Company's financial position at such date and the operating results and cash flows for such periods.
Operating results for the interim period ended September 30, 2013 are not necessarily indicative of the results that may be expected
for the entire year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Certain information and footnote disclosure
normally included in financial statements in accordance with generally accepted accounting principles have been omitted pursuant
to the rules of the United States Securities and Exchange Commission (&#34;SEC&#34;). These unaudited financial statements should
be read in conjunction with our audited financial statements and accompanying notes included in the Company's Annual Report on
Form 10-K for the year ended December 31, 2012 filed on March 22, 2013.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b><i>Principles of Consolidation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The condensed consolidated financial statements
include the accounts of Tiger X Medical, Inc., Accelerated Innovation, Inc. (&#34;Accelerated&#34;), Uni-Knee LLC (&#34;Uni&#34;)
and Cervical Xpand LLC (&#34;Cervical&#34;). All significant intercompany transactions have been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b><i>Royalty Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On January 24, 2011, the Company entered into
an Asset Purchase Agreement with Arthrex, Inc. (&#34;Arthrex&#34;) (the agreement being the &#34;Arthrex Asset Purchase Agreement&#34;),
pursuant to which the Company agreed to sell the assets of the Reconstructive Division to Arthrex. The Arthrex Asset Purchase Agreement
also provides for the Company to receive royalty payments equal to 5% of net sales of the Company's products made by Arthrex on
a quarterly basis for a term up to and including the 20th anniversary of the closing date. During the three and nine months ended
September 30, 2013, the Company received total royalty payments of $71,000 and $178,000, respectively, from Arthrex. During the
three and nine months ended September 30, 2012, the Company received total royalty payments of $19,000 and $47,000, respectively.
These amounts are reflected as revenue on the accompanying condensed consolidated statements of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b><i>Use of Estimates</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Financial statements prepared in accordance
with U.S. GAAP require management to make estimates and assumptions that affect the reported amounts of assets and liabilities
at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Among other
things, management makes estimates relating to share-based payments and deferred income tax assets. Given the short operating history
of Tiger X, actual results could differ from those estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b><i>Revenue Recognition</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The Company's revenue consists of royalty
revenue from Arthrex pursuant to the Arthrex Asset Purchase Agreement. Revenue is recognized as the amount becomes known and collectability
is reasonably assured.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b><i>Net Income Per Share</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Basic net income per share is computed by
using the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed giving
effect to all dilutive potential common shares that were outstanding during the period. Dilutive potential common shares consist
of incremental common shares issuable upon exercise of stock options or warrants. No dilutive potential common shares are included
in the computation of any diluted per share amount because their impact was anti-dilutive.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b><i>Income Taxes</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Income taxes are accounted for under the asset
and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences
between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases as well as operating
loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to
taxable income in the years in which those temporary differences are expected to be recovered or settled. The likelihood of realizing
the tax benefits related to a potential deferred tax asset is evaluated, and a valuation allowance is recognized to reduce that
deferred tax asset if it is more likely than not that all or some portion of the deferred tax asset will not be realized. Deferred
tax assets and liabilities are calculated at the beginning and end of the year; the change in the sum of the deferred tax asset,
valuation allowance and deferred tax liability during the year generally is recognized as a deferred tax expense or benefit. The
effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes
the enactment date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The Company evaluates the accounting for uncertainty
in income tax recognized in its financial statements and determines whether it is more likely than not that a tax position will
be sustained upon examination by the appropriate taxing authorities before any part of the benefit is recorded in its financial
statements. For those tax positions where it is &#34;not more likely than not&#34; that a tax benefit will be sustained, no tax
benefit is recognized. Where applicable, associated interest and penalties are also recorded. The Company has not accrued for any
such uncertain tax positions as of September 30, 2013 (unaudited) or December 31, 2012.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b><i>Concentration of Credit Risk</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The cash and cash equivalents held in
the Company's business money market and other bank accounts are with local and national banking institutions and subjected to
FDIC insurance limits of $250,000 per banking institution. As of September 30, 2013, the Company's balances in these bank
accounts exceeded the insured amount by $12,927,193.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b><i>Recent Accounting Pronouncements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">There are no recently issued accounting pronouncements
that the Company has yet to adopt that are expected to have a material effect on its financial position, results of operations,
or cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CDOM_NotesToFinancialStatementsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>CDOM_NotesToFinancialStatementsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>CDOM_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for all significant accounting policies of the reporting entity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18861-107790<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18743-107790<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18854-107790<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SignificantAccountingPoliciesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ELE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>3. STOCKHOLDERS' EQUITY<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_CDOM_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">3. STOCKHOLDERS' EQUITY</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>3. STOCKHOLDERS' EQUITY </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Our authorized capital consists of 750,000,000
shares of common stock and 50,000,000 shares of preferred stock. Our preferred stock may be designated into series pursuant to
authority granted by our Certificate of Incorporation, and on approval from our Board of Directors. As of September 30, 2013 and
December 31, 2012, we did not have any preferred stock issued.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CDOM_NotesToFinancialStatementsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>CDOM_NotesToFinancialStatementsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>CDOM_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29-31)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30, 31<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 310<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SAB TOPIC 4.E)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 4<br><br> -Subparagraph (SAB TOPIC 4.C)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Article 4<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section C<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 4<br><br> -Section E<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.4-08.(d),(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Preferred Stock<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br><br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br><br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 11<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br><br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 5<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br><br><br>Reference 17: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br><br><br>Reference 18: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 08<br><br> -Paragraph d<br><br> -Article 4<br><br><br><br>Reference 19: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 30<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityNoteDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EHEAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Polices (Royalty Agreement) (Narrative) (Details) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">3 Months Ended</th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_CDOM_SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetailsAbstract', window );"><strong>Summary Of Significant Accounting Polices Royalty Agreement Narrative Details</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyRevenue', window );">Royalty Revenue</a></td>
        <td class="nump">$ 71<span></span></td>
        <td class="nump">$ 19<span></span></td>
        <td class="nump">$ 178<span></span></td>
        <td class="nump">$ 47<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CDOM_SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetailsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>CDOM_SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetailsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>CDOM_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyRevenue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Revenue earned during the period from the leasing or otherwise lending to a third party the entity's rights or title to certain property. Royalty revenue is derived from a percentage or stated amount of sales proceeds or revenue generated by the third party using the entity's property. Examples of property from which royalties may be derived include patents and oil and mineral rights.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.1(e))<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RoyaltyRevenue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EKJAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_CDOM_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies (Policies)</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Tiger X Medical, Inc. (&#34;Tiger X&#34;
or the &#34;Company&#34;), formerly known as Cardo Medical, Inc., previously operated as an orthopedic medical device company
specializing in designing, developing and marketing high performance reconstructive joint devices and spinal surgical devices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">During 2010, the Company discontinued its
operations and sold the assets from its previous business lines during 2011. Beginning on January 1, 2013, the Company became classified
as a development stage entity. Our continuing operations include the collection and management of our royalty income earned in
connection with the Asset Purchase Agreement with Arthrex, as well as continuing to promote our former products sold to Arthrex
and seeking a joint venture partner or buyer for the remaining intellectual property owned by the Company. The Company will also
be evaluating future investment opportunities and uses for its cash.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Basis of Presentation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The accompanying condensed consolidated balance
sheet as of December 31, 2012, which has been derived from the Company's audited financial statements as of that date, and the
unaudited condensed consolidated financial information of the Company as of September 30, 2013 and for the three and nine months
ended September 30, 2013 and 2012, has been prepared in accordance with accounting principles generally accepted in the United
States of America (&#34;U.S. GAAP&#34;) for interim financial information and with the instructions to Form 10-Q and Article
8-03 of Regulation S-X. In the opinion of management, such financial information includes all adjustments considered necessary
for a fair presentation of the Company's financial position at such date and the operating results and cash flows for such periods.
Operating results for the interim period ended September 30, 2013 are not necessarily indicative of the results that may be expected
for the entire year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Certain information and footnote disclosure
normally included in financial statements in accordance with generally accepted accounting principles have been omitted pursuant
to the rules of the United States Securities and Exchange Commission (&#34;SEC&#34;). These unaudited financial statements should
be read in conjunction with our audited financial statements and accompanying notes included in the Company's Annual Report on
Form 10-K for the year ended December 31, 2012 filed on March 22, 2013.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Principles of Consolidation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The condensed consolidated financial statements
include the accounts of Tiger X Medical, Inc., Accelerated Innovation, Inc. (&#34;Accelerated&#34;), Uni-Knee LLC (&#34;Uni&#34;)
and Cervical Xpand LLC (&#34;Cervical&#34;). All significant intercompany transactions have been eliminated in consolidation.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionServicesRoyaltyFees', window );">Royalty Agreement</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b><i>Royalty Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On January 24, 2011, the Company entered
into an Asset Purchase Agreement with Arthrex, Inc. (&#34;Arthrex&#34;) (the agreement being the &#34;Arthrex Asset Purchase
Agreement&#34;), pursuant to which the Company agreed to sell the assets of the Reconstructive Division to Arthrex. The Arthrex
Asset Purchase Agreement also provides for the Company to receive royalty payments equal to 5% of net sales of the Company's products
made by Arthrex on a quarterly basis for a term up to and including the 20th anniversary of the closing date. During the three
and nine months ended September 30, 2013, the Company received total royalty payments of $71,000 and $178,000, respectively, from
Arthrex. During the three and nine months ended September 30, 2012, the Company received total royalty payments of $19,000 and
$47,000, respectively. These amounts are reflected as revenue on the accompanying condensed consolidated statements of operations.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Use of Estimates</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Financial statements prepared in accordance
with U.S. GAAP require management to make estimates and assumptions that affect the reported amounts of assets and liabilities
at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Among other
things, management makes estimates relating to share-based payments and deferred income tax assets. Given the short operating history
of Tiger X, actual results could differ from those estimates.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Revenue Recognition</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The Company's revenue consists of royalty
revenue from the Arthrex Asset Purchase Agreement, which is recognized as the amount becomes known and collectability is reasonably
assured.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income Per Share</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b><i>Net Income Per Share</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Basic net income per share is computed by
using the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed giving
effect to all dilutive potential common shares that were outstanding during the period. Dilutive potential common shares consist
of incremental common shares issuable upon exercise of stock options or warrants. No dilutive potential common shares are included
in the computation of any diluted per share amount because their impact was anti-dilutive.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Income Taxes</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">Income taxes are accounted for under the asset
and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences
between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases as well as operating
loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to
taxable income in the years in which those temporary differences are expected to be recovered or settled. The likelihood of realizing
the tax benefits related to a potential deferred tax asset is evaluated, and a valuation allowance is recognized to reduce that
deferred tax asset if it is more likely than not that all or some portion of the deferred tax asset will not be realized. Deferred
tax assets and liabilities are calculated at the beginning and end of the year; the change in the sum of the deferred tax asset,
valuation allowance and deferred tax liability during the year generally is recognized as a deferred tax expense or benefit. The
effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes
the enactment date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The Company evaluates the accounting for uncertainty
in income tax recognized in its financial statements and determines whether it is more likely than not that a tax position will
be sustained upon examination by the appropriate taxing authorities before any part of the benefit is recorded in its financial
statements. For those tax positions where it is &#34;not more likely than not&#34; that a tax benefit will be sustained, no tax
benefit is recognized. Where applicable, associated interest and penalties are also recorded. The Company has not accrued for any
such uncertain tax positions as of September 30, 2013 (unaudited) or December 31, 2012.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p><span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Concentration of Credit Risk</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b><i>Concentration of Credit Risk</i></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The cash and cash equivalents held in
the Company's business money market and other bank accounts are with local and national banking institutions and subjected to
FDIC insurance limits of $250,000 per banking institution. As of September 30, 2013, the Company's balances in these bank
accounts exceeded the insured amount by $12,965,872.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p><span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted', window );">Recent Accounting Pronouncements</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Recent Accounting Pronouncements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">There are no recently issued accounting standards that the
Company has yet to adopt that are expected to have a material effect on its financial position, results of operations, or cash
flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CDOM_NotesToFinancialStatementsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>CDOM_NotesToFinancialStatementsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>CDOM_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_BasisOfAccountingPolicyPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 16<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6327-108592<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6404-108592<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 20<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13531-108611<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 18<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6351-108592<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 825<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 21<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28364263&amp;loc=d3e13537-108611<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 21<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6442-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConcentrationRiskDisclosureTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02, 03<br><br> -Article 3A<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2197480<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 860<br><br> -SubTopic 40<br><br> -Section 45<br><br> -URI http://asc.fasb.org/section&amp;trid=2197723<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 323<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2196966<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 325<br><br> -SubTopic 20<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2197087<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.3A-02)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 323<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=16385135&amp;loc=d3e33801-111570<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 810<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=18733093&amp;loc=d3e5614-111684<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph k<br><br> -Article 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ConsolidationPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 250<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 5<br><br> -Subparagraph (SAB TOPIC 11.M)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26874127&amp;loc=d3e31137-122693<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 11<br><br> -Section M<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144384<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_EarningsPerSharePolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144681<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 30<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2144749<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 19<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32840-109319<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 954<br><br> -SubTopic 740<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 17<br><br> -Subparagraph (b)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32809-109319<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32247-109318<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=21917399&amp;loc=d3e32280-109318<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6003-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18726-107790<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 13<br><br> -Section B<br><br> -Paragraph Question 1<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 13.B.Q1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18823-107790<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueRecognitionPolicyTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionServicesRoyaltyFees">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for revenue recognition for royalty fees, which is consideration or a share of the proceeds paid by another party to the owner of a right (that is, the entity) for its use.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 235<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 3<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367646&amp;loc=d3e18780-107790<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 20<br><br> -URI http://asc.fasb.org/subtopic&amp;trid=2197248<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 13<br><br> -Section B<br><br> -Paragraph Question 1<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 605<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SAB TOPIC 13.B.Q1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RevenueRecognitionServicesRoyaltyFees</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 9<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6143-108592<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 8<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6132-108592<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 275<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6927468&amp;loc=d3e6061-108592<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UseOfEstimates</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>25
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
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M<B!E9&ET;W(@9&]E<VXG="!S=7!P;W)T(%=E8B!!<F-H:79E(&9I;&5S+B`@
M4&QE87-E(&1O=VYL;V%D(&$@8G)O=W-E<B!T:&%T('-U<'!O<G1S(%=E8B!!
M<F-H:79E+"!S=6-H(&%S($UI8W)O<V]F="!);G1E<FYE="!%>'!L;W)E<BX-
M"@T*+2TM+2TM/5].97AT4&%R=%\T-C(P,S$T-5\R9F8P7S0U.61?.#=C,5]A
M,#9F,&$R8C)C,&8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#8R
M,#,Q-#5?,F9F,%\T-3ED7S@W8S%?83`V9C!A,F(R8S!F+U=O<FMB;V]K+FAT
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M;V9T+6-O;3IO9F9I8V4Z97AC96PB('AM;&YS/3-$(FAT='`Z+R]W=W<N=S,N
M;W)G+U12+U)%0RUH=&UL-#`B/@T*/&AE860^#0H\;65T82!N86UE/3-$(D5X
M8V5L(%=O<FMB;V]K($9R86UE<V5T(CX-"@T*/&UE=&$@;F%M93TS1%!R;V=)
M9"!C;VYT96YT/3-$17AC96PN4VAE970^#0H\;&EN:R!R96P],T1&:6QE+4QI
M<W0@:')E9CTS1")7;W)K<VAE971S+V9I;&5L:7-T+GAM;"(^#0H-"CPA+2U;
M:68@9W1E(&US;R`Y73X\>&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T<SX-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^1&]C=6UE;G1?86YD7T5N=&ET>5]);F9O<FUA=&EO/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`Q+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0T].4T],241!5$5$
M7T)!3$%.0T5?4TA%1513/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U
M<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`R+FAT;6PB+SX-"B`@(#PO
M>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@
M(#QX.DYA;64^0T].4T],241!5$5$7T)!3$%.0T5?4TA%15137U!A/"]X.DYA
M;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T
M<R]3:&5E=#`S+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@
M(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^0T].4T],241!5$5$
M7U-4051%345.5%-?3T9?3U!%/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`T+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^0T].4T],241!5$5$7U-4051%345.5%-?3T9?0T%3/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#`U+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^,5]354U-05)9
M7T]&7U-)1TY)1DE#04Y47T%#0T]5/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H
M965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`V+FAT;6PB+SX-
M"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T
M/@T*("`@(#QX.DYA;64^,E]32$%215]"05-%1%]005E-14Y4/"]X.DYA;64^
M#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3
M:&5E=#`W+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX
M.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^,U]35$]#2TA/3$1%4E-?
M15%52519/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968]
M,T0B5V]R:W-H965T<R]3:&5E=#`X+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O
M<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*("`@(#QX.DYA;64^
M4W5M;6%R>5]O9E]3:6=N:69I8V%N=%]!8V-O=6YT/"]X.DYA;64^#0H@("`@
M/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#`Y
M+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L
M5V]R:W-H965T/@T*("`@(#QX.DYA;64^4VAA<F5?0F%S961?4&%Y;65N=%]4
M86)L97,\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS
M1")7;W)K<VAE971S+U-H965T,3`N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R
M:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3
M=6UM87)Y7V]F7U-I9VYI9FEC86YT7T%C8V]U;G0Q/"]X.DYA;64^#0H@("`@
M/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$Q
M+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L
M5V]R:W-H965T/@T*("`@(#QX.DYA;64^4W5M;6%R>5]O9E]3:6=N:69I8V%N
M=%]!8V-O=6YT,CPO>#I.86UE/@T*("`@(#QX.E=O<FMS:&5E=%-O=7)C92!(
M4F5F/3-$(E=O<FMS:&5E=',O4VAE970Q,BYH=&UL(B\^#0H@("`\+W@Z17AC
M96Q7;W)K<VAE970^#0H@("`\>#I%>&-E;%=O<FMS:&5E=#X-"B`@("`\>#I.
M86UE/E-U;6UA<GE?;V9?4VEG;FEF:6-A;G1?06-C;W5N=#,\+W@Z3F%M93X-
M"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S+U-H
M965T,3,N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z
M17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3:&%R94)A<V5D7U!A>6UE
M;G1?4W1O8VM?3W!T:6\\+W@Z3F%M93X-"B`@("`\>#I7;W)K<VAE9713;W5R
M8V4@2%)E9CTS1")7;W)K<VAE971S+U-H965T,30N:'1M;"(O/@T*("`@/"]X
M.D5X8V5L5V]R:W-H965T/@T*("`@/'@Z17AC96Q7;W)K<VAE970^#0H@("`@
M/'@Z3F%M93Y3:&%R94)A<V5D7U!A>6UE;G1?3F%R<F%T:79E7T0\+W@Z3F%M
M93X-"B`@("`\>#I7;W)K<VAE9713;W5R8V4@2%)E9CTS1")7;W)K<VAE971S
M+U-H965T,34N:'1M;"(O/@T*("`@/"]X.D5X8V5L5V]R:W-H965T/@T*("`@
M/'@Z17AC96Q7;W)K<VAE970^#0H@("`@/'@Z3F%M93Y3:&%R94)A<V5D7U!A
M>6UE;G1?3F%R<F%T:79E7T0Q/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U<F-E($A2968],T0B5V]R:W-H965T<R]3:&5E=#$V+FAT;6PB+SX-"B`@
M(#PO>#I%>&-E;%=O<FMS:&5E=#X-"B`@(#QX.D5X8V5L5V]R:W-H965T/@T*
M("`@(#QX.DYA;64^4W1O8VMH;VQD97)S7T5Q=6ET>5].87)R871I=F5?/"]X
M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U<F-E($A2968],T0B5V]R:W-H
M965T<R]3:&5E=#$W+FAT;6PB+SX-"B`@(#PO>#I%>&-E;%=O<FMS:&5E=#X-
M"B`@/"]X.D5X8V5L5V]R:W-H965T<SX-"B`@/'@Z4W1Y;&5S:&5E="!(4F5F
M/3-$(E=O<FMS:&5E=',O<F5P;W)T+F-S<R(O/@T*("`\>#I!8W1I=F53:&5E
M=#XP/"]X.D%C=&EV95-H965T/@T*("`\>#I0<F]T96-T4W1R=6-T=7)E/D9A
M;'-E/"]X.E!R;W1E8W13=')U8W1U<F4^#0H@(#QX.E!R;W1E8W17:6YD;W=S
M/D9A;'-E/"]X.E!R;W1E8W17:6YD;W=S/@T*(#PO>#I%>&-E;%=O<FMB;V]K
M/@T*/"]X;6P^/"%;96YD:69=+2T^#0H\+VAE860^#0H@(#QB;V1Y/@T*("`@
M/'`^5&AI<R!P86=E('-H;W5L9"!B92!O<&5N960@=VET:"!-:6-R;W-O9G0@
M17AC96P@6%`@;W(@;F5W97(N/"]P/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-
M"BTM+2TM+3U?3F5X=%!A<G1?-#8R,#,Q-#5?,F9F,%\T-3ED7S@W8S%?83`V
M9C!A,F(R8S!F#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S0V,C`S
M,30U7S)F9C!?-#4Y9%\X-V,Q7V$P-F8P83)B,F,P9B]7;W)K<VAE971S+U-H
M965T,#$N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D
M+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970]
M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T
M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@
M8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T
M('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@
M*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S
M<STS1')E<&]R="!I9#TS1$E$,$5.1T%%/@T*("`@("`@/'1R/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R
M;VYG/D1O8W5M96YT(&%N9"!%;G1I='D@26YF;W)M871I;VX\8G(^/"]S=')O
M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^
M.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C
M;VQS<&%N/3-$,3X\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,SQB<CX\+W1H/@T*
M("`@("`@("`\=&@@8VQA<W,],T1T:#Y.;W8N(#`Q+"`R,#$S/&)R/CPO=&@^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D1O8W5M96YT
M($%N9"!%;G1I='D@26YF;W)M871I;VX\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%;G1I='D@4F5G:7-T<F%N="!.86UE
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG5&EG97(@6"!-961I
M8V%L+"!);F,N/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^16YT:71Y($-E;G1R86P@26YD97@@2V5Y/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,#`P,#DR-3<T,3QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1O8W5M96YT
M(%1Y<&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<Q,"U1/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M1&]C=6UE;G0@4&5R:6]D($5N9"!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#Y397`@,S`L#0H)"3(P,3,\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y!;65N9&UE;G0@1FQA9SPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)V9A;'-E/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0W5R<F5N
M="!&:7-C86P@665A<B!%;F0@1&%T93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)RTM,3(M,S$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y)<R!%;G1I='D@82!796QL+6MN;W=N(%-E
M87-O;F5D($ES<W5E<C\\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B=.;SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DES($5N=&ET>2!A(%9O;'5N=&%R>2!&:6QE<C\\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B=.;SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DES($5N=&ET>2=S(%)E<&]R
M=&EN9R!3=&%T=7,@0W5R<F5N=#\\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B=997,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y%;G1I='D@1FEL97(@0V%T96=O<GD\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B=3;6%L;&5R(%)E<&]R=&EN9R!#;VUP
M86YY/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^16YT:71Y($-O;6UO;B!3=&]C:RP@4VAA<F5S($]U='-T86YD:6YG
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C,P+#(Y,RPQ-#$\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D1O8W5M96YT($9I<V-A;"!097)I;V0@1F]C=7,\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1T97AT/B=1,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D1O8W5M96YT($9I<V-A;"!996%R($9O
M8W5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG,C`Q,SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@
M/"]B;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S0V,C`S,30U
M7S)F9C!?-#4Y9%\X-V,Q7V$P-F8P83)B,F,P9@T*0V]N=&5N="U,;V-A=&EO
M;CH@9FEL93HO+R]#.B\T-C(P,S$T-5\R9F8P7S0U.61?.#=C,5]A,#9F,&$R
M8C)C,&8O5V]R:W-H965T<R]3:&5E=#`R+FAT;6P-"D-O;G1E;G0M5')A;G-F
M97(M16YC;V1I;F<Z('%U;W1E9"UP<FEN=&%B;&4-"D-O;G1E;G0M5'EP93H@
M=&5X="]H=&UL.R!C:&%R<V5T/2)U<RUA<V-I:2(-"@T*/&AT;6P^#0H@(#QH
M96%D/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N
M=&5N=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP
M93TS1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!2
M96UO=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D
M>3X-"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%4$E!13X-
M"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS
M1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY#3TY33TQ)1$%4140@0D%,04Y#12!3
M2$5%5%,@*%531"`D*3QB<CY);B!4:&]U<V%N9',L('5N;&5S<R!O=&AE<G=I
M<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^4V5P+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y$96,N(#,Q+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-U<G)E;G0@87-S971S/"]S=')O;F<^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*
M("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:#PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q,RPR-C,\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$S+#(V.#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M4')E<&%I9"!E>'!E;G-E<R!A;F0@;W1H97(@8W5R<F5N="!A<W-E=',\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C0U/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S,\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!A<W-E
M=',\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$S+#,P.#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$S+#,P
M,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^/'-T<F]N9SY#=7)R96YT(&QI86)I;&ET:65S/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06-C;W5N=',@<&%Y86)L
M92!A;F0@86-C<G5E9"!E>'!E;G-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F5U/@T*("`@("`@("`\=&0@8VQA<W,],T1P
M;"!V86QI9VX],T1T;W`^5&]T86P@;&EA8FEL:71I97,\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XQ,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3=&]C:VAO;&1E<G,G
M(&5Q=6ET>3PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D-O;6UO;B!S=&]C:RP@)#`N,#`Q('!A<G9A;'5E+"`W-3`L,#`P
M+#`P,"!S:&%R97,@875T:&]R:7IE9"P@,C,P+#(Y,RPQ-#$@:7-S=65D(&%N
M9"!O=71S=&%N9&EN9R!A<R!O9B!397!T96UB97(@,S`L(#(P,3,@*'5N875D
M:71E9"D@86YD($1E8V5M8F5R(#,Q+"`R,#$R/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$;G5M<#XR,S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XR,S`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%D9&ET:6]N86P@<&%I9"UI;B!C87!I
M=&%L/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-2PW-C@\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-2PW
M-C8\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/D5A<FYI;F=S(&%C8W5M=6QA=&5D(&1U<FEN9R!T:&4@9&5V96QO<&UE
M;G0@<W1A9V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M06-C=6UU;&%T960@9&5F:6-I=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;3XH,3(L-S`W*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6T^*#$R+#<P-RD\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y4;W1A;"!S=&]C:VAO;&1E<G,G(&5Q
M=6ET>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3,L,S`U/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3,L
M,C@Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^5&]T86P@;&EA8FEL:71I97,@86YD('-T;V-K:&]L9&5R<R<@97%U
M:71Y/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$S+#,P.#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@
M,3,L,S`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO
M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R
M=%\T-C(P,S$T-5\R9F8P7S0U.61?.#=C,5]A,#9F,&$R8C)C,&8-"D-O;G1E
M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#8R,#,Q-#5?,F9F,%\T-3ED7S@W
M8S%?83`V9C!A,F(R8S!F+U=O<FMS:&5E=',O4VAE970P,RYH=&UL#0I#;VYT
M96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT
M96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH
M=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N
M="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\
M<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO
M*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A
M9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$
M240P13-&04,^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L
M(&-O;'-P86X],T0Q(')O=W-P86X],T0Q/CQS=')O;F<^0T].4T],241!5$5$
M($)!3$%.0T4@4TA%1513("A087)E;G1H971I8V%L*2`H55-$("0I/&)R/CPO
M<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L
M(#(P,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S
M,2P@,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY3=&]C:VAO;&1E<G,G(&5Q=6ET>3H\+W-T<F]N9SX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VLL('!A
M<B!V86QU92!P97(@<VAA<F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,"XP,#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#`N,#`Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VLL('-H87)E<R!A=71H
M;W)I>F5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW-3`L,#`P
M+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C<U,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@<W1O8VLL('-H87)E<R!I<W-U960\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(S,"PR.3,L,30Q/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C,P
M+#(Y,RPQ-#$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D-O;6UO;B!S=&]C:RP@<VAA<F5S(&]U='-T86YD:6YG/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,S`L,CDS+#$T,3QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(S,"PR
M.3,L,30Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO
M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R
M=%\T-C(P,S$T-5\R9F8P7S0U.61?.#=C,5]A,#9F,&$R8C)C,&8-"D-O;G1E
M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#8R,#,Q-#5?,F9F,%\T-3ED7S@W
M8S%?83`V9C!A,F(R8S!F+U=O<FMS:&5E=',O4VAE970P-"YH=&UL#0I#;VYT
M96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT
M96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-"CQH
M=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N=&5N
M="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX)SX\
M<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ<SXO
M*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO:&5A
M9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED/3-$
M240P14%&04<^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L
M(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^0T].4T],241!5$5$
M(%-4051%345.5%,@3T8@3U!%4D%424].4R`H55-$("0I/&)R/DEN(%1H;W5S
M86YD<RP@97AC97!T(%-H87)E(&1A=&$L('5N;&5S<R!O=&AE<G=I<V4@<W!E
M8VEF:65D/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@
M8V]L<W!A;CTS1#(^,R!-;VYT:',@16YD960\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXY($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y397`N(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1H/E-E<"X@,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&@^4V5P+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y397`N(#,P+"`R,#$R/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#X\<W1R;VYG/DEN8V]M92!3=&%T96UE;G0@6T%B<W1R
M86-T73PO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X
M=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^4F]Y86QT>2!I;F-O;64\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@-S$\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XD(#$Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`Q-S@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#0W/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'96YE<F%L(&%N9"!A9&UI;FES
M=')A=&EV92!E>'!E;G-E<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^-#4\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XQ,#(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XQ-S(\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XS,C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;W4^#0H@("`@("`@(#QT9"!C;&%S<STS
M1'!L('9A;&EG;CTS1'1O<#Y);F-O;64@*&QO<W,I(&9R;VT@;W!E<F%T:6]N
M<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C8\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@X,RD\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH,C<S*3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M26YT97)E<W0@:6YC;VUE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XT/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C@\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XX/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^26YC;VUE("AL;W-S*2!B969O<F4@:6YC;VUE('1A>"!P<F]V
M:7-I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH.#$I/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,30\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R
M-C4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y0<F]V:7-I;VX@9F]R(&EN8V]M92!T87AE<SPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DQO<W,@9G)O;2!C;VYT:6YU:6YG
M(&]P97)A=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M.#$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,30\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M/B@R-C4I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#X\<W1R;VYG/D1I<V-O;G1I;G5E9"!O<&5R871I;VYS/"]S
M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y'
M86EN(&9R;VT@<V%L92!O9B!D:7-C;VYT:6YU960@4F5C;VYS=')U8W1I=F4@
M86YD(%-P:6YE($1I=FES:6]N<RP@;F5T(&]F(&EN8V]M92!T87AE<SPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C4S,CQS<&%N/CPO<W!A;CX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU,S(\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R974^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y.970@:6YC
M;VUE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`T-3$\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD
M(#$T/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`R-C<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/CQS=')O;F<^0F%S:6,@86YD(&1I;'5T960\+W-T<F]N9SX\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;G1I;G5I
M;F<@;W!E<F%T:6]N<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^)"`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y$:7-C;VYT:6YU960@;W!E<F%T:6]N<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F5U
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5&]T86P\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,#QS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,#QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M/'-T<F]N9SY796EG:'1E9"!A=F5R86=E('-H87)E<R!O=71S=&%N9&EN9SH\
M+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/D)A<VEC(&%N9"!D:6QU=&5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M;G5M<#XR,S`L,CDS+#$T,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/C(S,"PR.3,L,30Q/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,C,P+#(Y,RPQ-#$\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,S`L,CDS
M+#$T,3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A
M8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?
M-#8R,#,Q-#5?,F9F,%\T-3ED7S@W8S%?83`V9C!A,F(R8S!F#0I#;VYT96YT
M+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S0V,C`S,30U7S)F9C!?-#4Y9%\X-V,Q
M7V$P-F8P83)B,F,P9B]7;W)K<VAE971S+U-H965T,#4N:'1M;`T*0V]N=&5N
M="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N
M="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C
M<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@
M1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^
M#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$
M,$5744%%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C
M;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/D-/3E-/3$E$051%1"!3
M5$%414U%3E13($]&($-!4T@@1DQ/5U,@*%531"`D*3QB<CY);B!4:&]U<V%N
M9',L('5N;&5S<R!O=&AE<G=I<V4@<W!E8VEF:65D/"]S=')O;F<^/"]T:#X-
M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#(^.2!-;VYT:',@
M16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$R/&)R/CPO=&@^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/D-A<V@@9FQO=W,@9G)O
M;2!O<&5R871I;F<@86-T:79I=&EE<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!I;F-O;64\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1N=6UP/B0@,30\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(V-SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY!9&IU<W1M
M96YT<R!T;R!R96-O;F-I;&4@;F5T(&EN8V]M92!T;R!N970@8V%S:"!U<V5D
M(&EN(&]P97)A=&EN9R!A8W1I=FET:65S.CPO<W1R;VYG/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-T;V-K(&]P=&EO;B!C;VUP96YS
M871I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$
M<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R
M;VYG/D-H86YG97,@:6X@;W!E<F%T:6YG(&%S<V5T<R!A;F0@;&EA8FEL:71I
M97,Z/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^06-C;W5N=',@<F5C96EV86)L93PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/C0S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y);F-O;64@=&%X(')E8V5I=F%B;&4\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@U,S(I/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y0<F5P86ED(&5X<&5N<V5S
M(&%N9"!O=&AE<B!C=7)R96YT(&%S<V5T<SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;3XH,3(I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-S<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/D%C8V]U;G1S('!A>6%B;&4@86YD(&%C8W)U
M960@97AP96YS97,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6T^*#DI
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M-C$U*3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')O=3X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/DYE="!C87-H('!R;W9I9&5D(&)Y("AU<V5D(&EN*2!O<&5R871I
M;F<@86-T:79I=&EE<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;3XH
M-2D\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M/B@W-34I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/D-A<V@@9FQO=W,@9G)O;2!I;G9E<W1I;F<@86-T
M:79I=&EE<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E
M>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/D1E8W)E87-E(&EN(')E<W1R:6-T960@8V%S:#PO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1N=6UP/CDP,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E=3X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!C87-H('!R;W9I9&5D
M(&)Y(&EN=F5S=&EN9R!A8W1I=FET:65S/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^.3`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R(&-L87-S/3-$<F]U/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^3F5T(&-H86YG92!I;B!C87-H/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M/B@U*3QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C$T-3QS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V%S:"P@8F5G:6YN:6YG
M(&]F('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,3,L
M,C8X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU
M;7`^,3(L-C<X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A
M;&EG;CTS1'1O<#Y#87-H+"!E;F0@;V8@<&5R:6]D/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$;G5M<#XQ,RPR-C,\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,BPX,C,\<W!A;CX\+W-P86X^/"]T
M9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W5P<&QE
M;65N=&%L(&1I<V-L;W-U<F4@;V8@8V%S:"!F;&]W(&EN9F]R;6%T:6]N.CPO
M<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN
M=&5R97-T('!A:60\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\
M<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O
M<#Y);F-O;64@=&%X97,@<&%I9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS
M1&YU;7`^)"`R-CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@-34S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R
M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM
M/5].97AT4&%R=%\T-C(P,S$T-5\R9F8P7S0U.61?.#=C,5]A,#9F,&$R8C)C
M,&8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#8R,#,Q-#5?,F9F
M,%\T-3ED7S@W8S%?83`V9C!A,F(R8S!F+U=O<FMS:&5E=',O4VAE970P-BYH
M=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A
M8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C
M:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV
M/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T
M/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$
M4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R
M:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P
M;W)T(&ED/3-$240P14Q%/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/C$N(%-5
M34U!4ED@3T8@4TE'3DE&24-!3E0@04-#3U5.5$E.1R!03TQ)0TE%4SQB<CX\
M+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N
M/3-$,3XY($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$S/&)R
M/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#X\<W1R;VYG/DYO
M=&5S('1O($9I;F%N8VEA;"!3=&%T96UE;G1S/"]S=')O;F<^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#XQ+B!354U-05)9($]&(%-)1TY)
M1DE#04Y4($%#0T]53E1)3D<@4$],24-)15,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XM<FEG:'0Z(#`[(&UA<F=I
M;BUL969T.B`P)SX\8CXQ+B`\+V(^(#QB/E-534U!4ED@3T8@4TE'3DE&24-!
M3E0@04-#3U5.5$E.1PT*4$],24-)15,\+V(^/"]P/@T*#0H\<"!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M
M87)G:6XM<FEG:'0Z(#`[(&UA<F=I;BUL969T.B`P)SX\+W`^#0H-"CQP('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[(&UA<F=I;BUR:6=H=#H@,#L@;6%R9VEN+6QE9G0Z(#`G/E1I9V5R(%@@
M365D:6-A;"P@26YC+B`H)B,S-#M4:6=E<B!8)B,S-#L-"F]R('1H92`F(S,T
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M<W5R9VEC86P@9&5V:6-E<RX\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;BUR:6=H
M=#H@,#L@;6%R9VEN+6QE9G0Z(#`G/D1U<FEN9R`R,#$P+"!T:&4@0V]M<&%N
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M:71I97,@86YD('5S97,@9F]R(&ET<R!C87-H+CPO<#X-"@T*/'`@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M;6%R9VEN+7)I9VAT.B`P.R!M87)G:6XM;&5F=#H@,"<^/&(^/&D^0F%S:7,@
M;V8@4')E<V5N=&%T:6]N/"]I/CPO8CX\+W`^#0H-"CQP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;BUR:6=H=#H@,#L@;6%R9VEN+6QE9G0Z(#`G/E1H92!A8V-O;7!A;GEI;F<@
M8V]N9&5N<V5D(&-O;G-O;&ED871E9"!B86QA;F-E#0IS:&5E="!A<R!O9B!$
M96-E;6)E<B`S,2P@,C`Q,BP@=VAI8V@@:&%S(&)E96X@9&5R:79E9"!F<F]M
M('1H92!#;VUP86YY)W,@875D:71E9"!F:6YA;F-I86P@<W1A=&5M96YT<R!A
M<R!O9B!T:&%T(&1A=&4L(&%N9"!T:&4-"G5N875D:71E9"!C;VYD96YS960@
M8V]N<V]L:61A=&5D(&9I;F%N8VEA;"!I;F9O<FUA=&EO;B!O9B!T:&4@0V]M
M<&%N>2!A<R!O9B!397!T96UB97(@,S`L(#(P,3,@86YD(&9O<B!T:&4@=&AR
M964@86YD(&YI;F4@;6]N=&AS#0IE;F1E9"!397!T96UB97(@,S`L(#(P,3,@
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M=&5M8F5R(#,P+"`R,#$S(&%R92!N;W0@;F5C97-S87)I;'D@:6YD:6-A=&EV
M92!O9B!T:&4@<F5S=6QT<R!T:&%T(&UA>2!B92!E>'!E8W1E9`T*9F]R('1H
M92!E;G1I<F4@>65A<BX\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;BUR:6=H=#H@
M,#L@;6%R9VEN+6QE9G0Z(#`G/D-E<G1A:6X@:6YF;W)M871I;VX@86YD(&9O
M;W1N;W1E(&1I<V-L;W-U<F4-"FYO<FUA;&QY(&EN8VQU9&5D(&EN(&9I;F%N
M8VEA;"!S=&%T96UE;G1S(&EN(&%C8V]R9&%N8V4@=VET:"!G96YE<F%L;'D@
M86-C97!T960@86-C;W5N=&EN9R!P<FEN8VEP;&5S(&AA=F4@8F5E;B!O;6ET
M=&5D('!U<G-U86YT#0IT;R!T:&4@<G5L97,@;V8@=&AE(%5N:71E9"!3=&%T
M97,@4V5C=7)I=&EE<R!A;F0@17AC:&%N9V4@0V]M;6ES<VEO;B`H)B,S-#M3
M14,F(S,T.RDN(%1H97-E('5N875D:71E9"!F:6YA;F-I86P@<W1A=&5M96YT
M<R!S:&]U;&0-"F)E(')E860@:6X@8V]N:G5N8W1I;VX@=VET:"!O=7(@875D
M:71E9"!F:6YA;F-I86P@<W1A=&5M96YT<R!A;F0@86-C;VUP86YY:6YG(&YO
M=&5S(&EN8VQU9&5D(&EN('1H92!#;VUP86YY)W,@06YN=6%L(%)E<&]R="!O
M;@T*1F]R;2`Q,"U+(&9O<B!T:&4@>65A<B!E;F1E9"!$96-E;6)E<B`S,2P@
M,C`Q,B!F:6QE9"!O;B!-87)C:"`R,BP@,C`Q,RX\+W`^#0H-"CQP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(&UA<F=I;BUR:6=H=#H@,#L@;6%R9VEN+6QE9G0Z(#`G/CQB/CQI/E!R:6YC
M:7!L97,@;V8@0V]N<V]L:61A=&EO;CPO:3X\+V(^/"]P/@T*#0H\<"!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!M87)G:6XM<FEG:'0Z(#`[(&UA<F=I;BUL969T.B`P)SY4:&4@8V]N9&5N
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M;6EN871E9"!I;B!C;VYS;VQI9&%T:6]N+CPO<#X-"@T*/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN+7)I9VAT.B`P.R!M87)G:6XM;&5F=#H@,"<^/&(^/&D^4F]Y86QT>2!!
M9W)E96UE;G0\+VD^/"]B/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN+7)I9VAT
M.B`P.R!M87)G:6XM;&5F=#H@,"<^3VX@2F%N=6%R>2`R-"P@,C`Q,2P@=&AE
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M;"!T;R`U)2!O9B!N970@<V%L97,@;V8@=&AE($-O;7!A;GDG<R!P<F]D=6-T
M<R!M861E(&)Y($%R=&AR97@@;VX-"F$@<75A<G1E<FQY(&)A<VES(&9O<B!A
M('1E<FT@=7`@=&\@86YD(&EN8VQU9&EN9R!T:&4@,C!T:"!A;FYI=F5R<V%R
M>2!O9B!T:&4@8VQO<VEN9R!D871E+B!$=7)I;F<@=&AE('1H<F5E(&%N9"!N
M:6YE(&UO;G1H<R!E;F1E9`T*4V5P=&5M8F5R(#,P+"`R,#$S+"!T:&4@0V]M
M<&%N>2!R96-E:79E9"!T;W1A;"!R;WEA;'1Y('!A>6UE;G1S(&]F("0W,2PP
M,#`@86YD("0Q-S@L,#`P+"!R97-P96-T:79E;'DL(&9R;VT@07)T:')E>"X@
M1'5R:6YG('1H90T*=&AR964@86YD(&YI;F4@;6]N=&AS(&5N9&5D(%-E<'1E
M;6)E<B`S,"P@,C`Q,BP@=&AE($-O;7!A;GD@<F5C96EV960@=&]T86P@<F]Y
M86QT>2!P87EM96YT<R!O9B`D,3DL,#`P(&%N9"`D-#<L,#`P+"!R97-P96-T
M:79E;'DN#0I4:&5S92!A;6]U;G1S(&%R92!R969L96-T960@87,@<F5V96YU
M92!O;B!T:&4@86-C;VUP86YY:6YG(&-O;F1E;G-E9"!C;VYS;VQI9&%T960@
M<W1A=&5M96YT<R!O9B!O<&5R871I;VYS+CPO<#X-"@T*/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN+7)I9VAT.B`P.R!M87)G:6XM;&5F=#H@,"<^/&(^/&D^57-E(&]F($5S
M=&EM871E<SPO:3X\+V(^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XM<FEG:'0Z
M(#`[(&UA<F=I;BUL969T.B`P)SY&:6YA;F-I86P@<W1A=&5M96YT<R!P<F5P
M87)E9"!I;B!A8V-O<F1A;F-E#0IW:71H(%4N4RX@1T%!4"!R97%U:7)E(&UA
M;F%G96UE;G0@=&\@;6%K92!E<W1I;6%T97,@86YD(&%S<W5M<'1I;VYS('1H
M870@869F96-T('1H92!R97!O<G1E9"!A;6]U;G1S(&]F(&%S<V5T<R!A;F0@
M;&EA8FEL:71I97,-"F%T('1H92!D871E(&]F('1H92!F:6YA;F-I86P@<W1A
M=&5M96YT<R!A;F0@=&AE(')E<&]R=&5D(&%M;W5N=',@;V8@<F5V96YU97,@
M86YD(&5X<&5N<V5S(&1U<FEN9R!T:&4@<F5P;W)T:6YG('!E<FEO9"X@06UO
M;F<@;W1H97(-"G1H:6YG<RP@;6%N86=E;65N="!M86ME<R!E<W1I;6%T97,@
M<F5L871I;F<@=&\@<VAA<F4M8F%S960@<&%Y;65N=',@86YD(&1E9F5R<F5D
M(&EN8V]M92!T87@@87-S971S+B!':79E;B!T:&4@<VAO<G0@;W!E<F%T:6YG
M(&AI<W1O<GD-"F]F(%1I9V5R(%@L(&%C='5A;"!R97-U;'1S(&-O=6QD(&1I
M9F9E<B!F<F]M('1H;W-E(&5S=&EM871E<RX\+W`^#0H-"CQP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;BUR:6=H=#H@,#L@;6%R9VEN+6QE9G0Z(#`G/CQB/CQI/E)E=F5N=64@
M4F5C;V=N:71I;VX\+VD^/"]B/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN+7)I
M9VAT.B`P.R!M87)G:6XM;&5F=#H@,"<^5&AE($-O;7!A;GDG<R!R979E;G5E
M(&-O;G-I<W1S(&]F(')O>6%L='D-"G)E=F5N=64@9G)O;2!!<G1H<F5X('!U
M<G-U86YT('1O('1H92!!<G1H<F5X($%S<V5T(%!U<F-H87-E($%G<F5E;65N
M="X@4F5V96YU92!I<R!R96-O9VYI>F5D(&%S('1H92!A;6]U;G0@8F5C;VUE
M<R!K;F]W;B!A;F0@8V]L;&5C=&%B:6QI='D-"FES(')E87-O;F%B;'D@87-S
M=7)E9"X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W
M(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;BUR:6=H=#H@,#L@;6%R9VEN
M+6QE9G0Z(#`G/CQB/CQI/DYE="!);F-O;64@4&5R(%-H87)E/"]I/CPO8CX\
M+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;BUR:6=H=#H@,#L@;6%R9VEN+6QE9G0Z
M(#`G/D)A<VEC(&YE="!I;F-O;64@<&5R('-H87)E(&ES(&-O;7!U=&5D(&)Y
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M=7-E('1H96ER(&EM<&%C="!W87,@86YT:2UD:6QU=&EV92X\+W`^#0H-"CQP
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[(&UA<F=I;BUR:6=H=#H@,#L@;6%R9VEN+6QE9G0Z(#`G/CQB/CQI
M/DEN8V]M92!487AE<SPO:3X\+V(^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT
M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XM
M<FEG:'0Z(#`[(&UA<F=I;BUL969T.B`P)SY);F-O;64@=&%X97,@87)E(&%C
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M:&4@96YA8W1M96YT(&1A=&4N/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XM<FEG
M:'0Z(#`[(&UA<F=I;BUL969T.B`P)SY4:&4@0V]M<&%N>2!E=F%L=6%T97,@
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M('!O<VET:6]N<R!W:&5R92!I="!I<R`F(S,T.VYO="!M;W)E(&QI:V5L>2!T
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M4V5P=&5M8F5R(#,P+"`R,#$S("AU;F%U9&ET960I(&]R($1E8V5M8F5R(#,Q
M+"`R,#$R+CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN+7)I9VAT.B`P.R!M87)G
M:6XM;&5F=#H@,"<^/&(^/&D^0V]N8V5N=')A=&EO;B!O9B!#<F5D:70@4FES
M:SPO:3X\+V(^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XM<FEG:'0Z(#`[(&UA
M<F=I;BUL969T.B`P)SY4:&4@8V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<R!H
M96QD(&EN#0IT:&4@0V]M<&%N>2=S(&)U<VEN97-S(&UO;F5Y(&UA<FME="!A
M;F0@;W1H97(@8F%N:R!A8V-O=6YT<R!A<F4@=VET:"!L;V-A;"!A;F0@;F%T
M:6]N86P@8F%N:VEN9R!I;G-T:71U=&EO;G,@86YD('-U8FIE8W1E9"!T;PT*
M1D1)0R!I;G-U<F%N8V4@;&EM:71S(&]F("0R-3`L,#`P('!E<B!B86YK:6YG
M(&EN<W1I='5T:6]N+B!!<R!O9B!397!T96UB97(@,S`L(#(P,3,L('1H92!#
M;VUP86YY)W,@8F%L86YC97,@:6X@=&AE<V4@8F%N:PT*86-C;W5N=',@97AC
M965D960@=&AE(&EN<W5R960@86UO=6YT(&)Y("0Q,BPY,C<L,3DS+CPO<#X-
M"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN+7)I9VAT.B`P.R!M87)G:6XM;&5F=#H@,"<^
M/&(^/&D^4F5C96YT($%C8V]U;G1I;F<@4')O;F]U;F-E;65N=',\+VD^/"]B
M/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN+7)I9VAT.B`P.R!M87)G:6XM;&5F
M=#H@,"<^5&AE<F4@87)E(&YO(')E8V5N=&QY(&ES<W5E9"!A8V-O=6YT:6YG
M('!R;VYO=6YC96UE;G1S#0IT:&%T('1H92!#;VUP86YY(&AA<R!Y970@=&\@
M861O<'0@=&AA="!A<F4@97AP96-T960@=&\@:&%V92!A(&UA=&5R:6%L(&5F
M9F5C="!O;B!I=',@9FEN86YC:6%L('!O<VET:6]N+"!R97-U;'1S(&]F(&]P
M97)A=&EO;G,L#0IO<B!C87-H(&9L;W=S+CPO<#X-"@T*/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN+7)I9VAT.B`P.R!M87)G:6XM;&5F=#H@,"<^)B,Q-C`[/"]P/@T*#0H\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XM<FEG:'0Z(#`[(&UA<F=I;BUL969T.B`P)SXF(S$V
M,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;BUR:6=H=#H@,#L@;6%R9VEN+6QE
M9G0Z(#`G/B8C,38P.SPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN+7)I9VAT.B`P
M.R!M87)G:6XM;&5F=#H@,"<^/"]P/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-
M"BTM+2TM+3U?3F5X=%!A<G1?-#8R,#,Q-#5?,F9F,%\T-3ED7S@W8S%?83`V
M9C!A,F(R8S!F#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S0V,C`S
M,30U7S)F9C!?-#4Y9%\X-V,Q7V$P-F8P83)B,F,P9B]7;W)K<VAE971S+U-H
M965T,#<N:'1M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D
M+7!R:6YT86)L90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970]
M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T
M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@
M8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T
M('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@
M*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S
M<STS1')E<&]R="!I9#TS1$E$,$5,13X-"B`@("`@(#QT<CX-"B`@("`@("`@
M/'1H(&-L87-S/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N
M9SXR+B!32$%212!"05-%1"!005E-14Y4/&)R/CPO<W1R;VYG/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N
M9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT
M:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3,\8G(^/"]T:#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3F]T97,@=&\@1FEN86YC:6%L
M(%-T871E;65N=',\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/C(N(%-(05)%($)!4T5$(%!!64U%3E0\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XM<FEG:'0Z(#`[
M(&UA<F=I;BUL969T.B`P)SX\8CY.3U1%(#(@+2!32$%212!"05-%1"!005E-
M14Y4/"]B/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN+7)I9VAT.B`P.R!M87)G
M:6XM;&5F=#H@,"<^3VX@075G=7-T(#(Y+"`R,#`X+"!T:&4@0V]M<&%N>2!I
M<W-U960@;W!T:6]N<PT*=&\@8V5R=&%I;B!E;7!L;WEE97,@86YD($)O87)D
M(&UE;6)E<G,@=&\@<'5R8VAA<V4@;65M8F5R<VAI<"!U;FET<R!I;B!T:&4@
M0V]M<&%N>2X@5&AE(&]P=&EO;G,@9VEV92!T:&4@9W)A;G1E97,@=&AE(')I
M9VAT('1O#0IP=7)C:&%S92!U<"!T;R`R+#,Y."PT,#`@<VAA<F5S(&]F('1H
M92!#;VUP86YY)W,@8V]M;6]N('-T;V-K(&%T(&%N(&5X97)C:7-E('!R:6-E
M(&]F("0P+C(S('!E<B!S:&%R92X@5&AE(&]P=&EO;G,@=F5S="`R,"4@96%C
M:`T*>65A<B!O=F5R(&$@9FEV92UY96%R('!E<FEO9"!A;F0@97AP:7)E(&%F
M=&5R('1E;B!Y96%R<RX@4W1O8VL@;W!T:6]N(&-O;7!E;G-A=&EO;B!R96-O
M9VYI>F5D(&9O<B!T:&4@;FEN92!M;VYT:',@96YD960@4V5P=&5M8F5R#0HS
M,"P@,C`Q,R!A;F0@,C`Q,B!I;B!T:&4@86-C;VUP86YY:6YG(&-O;F1E;G-E
M9"!C;VYS;VQI9&%T960@<W1A=&5M96YT<R!O9B!O<&5R871I;VYS(&%M;W5N
M=&5D('1O("0R+#`P,"!A;F0@)#4L,#`P+"!R97-P96-T:79E;'DN/"]P/@T*
M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!M87)G:6XM<FEG:'0Z(#`[(&UA<F=I;BUL969T.B`P)SY!
M('-U;6UA<GD@;V8@<W1O8VL@;W!T:6]N(&%C=&EV:71Y(&%S(&]F(%-E<'1E
M;6)E<@T*,S`L(#(P,3,L(&%N9"!C:&%N9V5S(&1U<FEN9R!T:&4@<&5R:6]D
M('1H96X@96YD960@:7,@<')E<V5N=&5D(&)E;&]W+CPO<#X-"@T*/'1A8FQE
M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@=VED=&@Z
M(#$P,"4G/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M(&)A8VMG<F]U;F0M8V]L;W(Z('=H:71E)SX-"B`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D
M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/E=E:6=H=&5D+3PO
M8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4]
M,T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@
M=VAI=&4G/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/CQF;VYT('-T
M>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^/&(^5V5I9VAT960M/"]B/CPO9F]N
M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G
M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E
M;G1E<B<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SX\8CY!=F5R
M86=E(#PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@
M<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC
M;VQO<CH@=VAI=&4G/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^/&(^079E<F%G93PO8CX\
M+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N
M=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!C96YT97(G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^/&(^
M4F5M86EN:6YG(#PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T)SX\8CY!9V=R96=A=&4\+V(^/"]F;VYT/CPO=&0^
M/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B
M86-K9W)O=6YD+6-O;&]R.B!W:&ET92<^#0H@("`@/'1D/B8C,38P.SPO=&0^
M#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SXF
M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT
M97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(&-E;G1E<B<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SX\8CY%
M>&5R8VES93PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!C96YT97(G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P="<^/&(^0V]N=')A8W1U86P\+V(^/"]F;VYT/CPO=&0^#0H@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^/&(^26YT<FEN<VEC/"]B
M/CPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@=VAI=&4G/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M
M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/D]P=&EO;G,\+V(^/"]F
M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E
M<B<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/E!R:6-E/"]B
M/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C
M96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB
M;W1T;VTZ(&)L86-K(#$N-7!T('-O;&ED.R!T97AT+6%L:6=N.B!C96YT97(G
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^/&(^3&EF92`H665A
M<G,I/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&-E;G1E<B<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4]
M,T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,2XU<'0@<V]L:60[('1E>'0M86QI
M9VXZ(&-E;G1E<B<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SX\
M8CY686QU93PO8CX\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E
M<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z('=H:71E
M)SX-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO
M=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V
M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG
M:'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(')I9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC
M86PM86QI9VXZ(&)O='1O;2<^#0H@("`@/'1D('-T>6QE/3-$)V)A8VMG<F]U
M;F0M8V]L;W(Z('=H:71E)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0G/D]U='-T86YD:6YG(&%T($1E8V5M8F5R(#,Q+"`R,#$R/"]F;VYT/CPO
M=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N
M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C,X-2PP,#`F(S$V,#L\+V9O
M;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G
M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L
M;W(Z('=H:71E.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T)SXD/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0G/C`N,C,F(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F
M;VYT+7-I>F4Z(#$P<'0G/C4N-C8F(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@
M("`@/'1D('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z('=H:71E.R!T97AT
M+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M)SXD/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/BTF(S$V
M,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L
M:6=N.B!B;W1T;VTG/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O
M;&]R.B!W:&ET92<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SY'
M<F%N=&5D/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/BTF
M(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)A8VMG
M<F]U;F0M8V]L;W(Z('=H:71E.R!T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^+2`F(S$V,#L\+V9O;G0^
M/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B8C
M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/BT@)B,Q-C`[/"]F
M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O
M;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/BTF(S$V,#L\+V9O;G0^/"]T9#X\+W1R
M/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VTG/@T*("`@
M(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET92<^/&9O;G0@
M<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SY%>&5R8VES960\+V9O;G0^/"]T
M9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^+28C,38P.SPO9F]N=#X\+W1D
M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@=VAI
M=&4[('1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N
M="US:7IE.B`Q,'!T)SXM("8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P="<^+2`F(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@
M("`@/'1D('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z('=H:71E.R!T97AT
M+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P="<^+28C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G
M=F5R=&EC86PM86QI9VXZ('1O<"<^#0H@("`@/'1D('-T>6QE/3-$)V)A8VMG
M<F]U;F0M8V]L;W(Z('=H:71E)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0G/D9O<F9E:71E9#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T)SXM)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL
M93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@<FEG
M:'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T
M;VTZ(&)L86-K(#$N-7!T('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SXM("8C,38P.SPO9F]N=#X\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^+2`F(S$V,#L\+V9O
M;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G
M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L
M;W(Z('=H:71E.R!T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P="<^+28C,38P.SPO9F]N=#X\+W1D/CPO='(^
M#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ('1O<"<^#0H@("`@/'1D
M('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z('=H:71E)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/D]U='-T86YD:6YG(&%T(%-E<'1E;6)E
M<B`S,"P@,C`Q,R`H=6YA=61I=&5D*3PO9F]N=#X\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T
M97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q
M,'!T)SXS.#4L,#`P)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@
M<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^)#PO9F]N
M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C
M:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T)SXP+C(S)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R
M+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T)SXT+CDR)B,Q-C`[/"]F;VYT/CPO=&0^#0H@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D
M/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@
M=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P="<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M
M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H
M="<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SXM)B,Q-C`[/"]F
M;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M)SX-"B`@("`\=&0@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@
M=VAI=&4[('1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P.SPO=&0^
M#0H@("`@/'1D('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z('=H:71E.R!T
M97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P.SPO=&0^
M#0H@("`@/'1D('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z('=H:71E.R!T
M97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P.SPO=&0^/"]T<CX-"CQT<B!S
M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX-"B`@("`\=&0@<W1Y
M;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@=VAI=&4G/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P="<^5F5S=&5D(&%N9"!E>'!E8W1E9"!T;R!V97-T
M/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I
M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F%C:V=R
M;W5N9"UC;VQO<CH@=VAI=&4[('1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G
M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I
M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F%C:V=R
M;W5N9"UC;VQO<CH@=VAI=&4[('1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q
M-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B
M;W1T;VTG/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W
M:&ET92<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SXF(S$V,#LF
M(S$V,#LF(S$V,#LF(S$V,#L@870@4V5P=&5M8F5R(#,P+"`R,#$S("AU;F%U
M9&ET960I/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C,X
M-2PP,#`F(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$
M)V)A8VMG<F]U;F0M8V]L;W(Z('=H:71E.R!T97AT+6%L:6=N.B!R:6=H="<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SXD/"]F;VYT/CPO=&0^
M#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C`N,C,F(S$V,#L\+V9O;G0^/"]T
M9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P
M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C0N.3(F(S$V,#L\+V9O
M;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G
M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L
M;W(Z('=H:71E.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T)SXD/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0G/BTF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE
M/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VTG/@T*("`@(#QT9"!S='EL93TS
M1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@<FEG:'0G
M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I
M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F%C:V=R
M;W5N9"UC;VQO<CH@=VAI=&4[('1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q
M-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G
M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I
M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F%C:V=R
M;W5N9"UC;VQO<CH@=VAI=&4[('1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q
M-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B
M;W1T;VTG/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W
M:&ET92<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SY%>&5R8VES
M86)L92!A="!397!T96UB97(@,S`L(#(P,3,@*'5N875D:71E9"D\+V9O;G0^
M/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^,S@U+#`P,"8C,38P.SPO
M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H
M="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F%C:V=R;W5N9"UC
M;VQO<CH@=VAI=&4[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P="<^,"XR,R8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P="<^-"XY,B8C,38P.SPO9F]N=#X\+W1D/@T*("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@=VAI=&4[('1E
M>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P
M<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^+28C
M,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\+W1A8FQE/@T*/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN+7)I9VAT.B`P.R!M87)G:6XM;&5F=#H@,"<^/"]P/@T*#0H\<"!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!M87)G:6XM<FEG:'0Z(#`[(&UA<F=I;BUL969T.B`P)SY4:&4@0V]M<&%N
M>2!H860@-3<U+#8Q,R!W87)R86YT<R!O=71S=&%N9&EN9PT*87,@;V8@4V5P
M=&5M8F5R(#,P+"`R,#$S('=H:6-H(&5N=&ET;&4@=&AE(&AO;&1E<G,@=&\@
M:6UM961I871E;'D@<'5R8VAA<V4@;VYE('-H87)E(&]F('1H92!#;VUP86YY
M)W,@8V]M;6]N('-T;V-K(&%T(&%N(&5X97)C:7-E#0IP<FEC92!O9B`D,"XT
M-"!P97(@<VAA<F4N(%1H92!W87)R86YT<R!E>'!I<F4@;VX@3F]V96UB97(@
M,3,L(#(P,30N/"]P/@T*#0H-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN+7)I9VAT.B`P
M.R!M87)G:6XM;&5F=#H@,"<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XM<FEG:'0Z(#`[(&UA<F=I;BUL969T.B`P)SXF(S$V,#L\+W`^#0H-"CQP
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[(&UA<F=I;BUR:6=H=#H@,#L@;6%R9VEN+6QE9G0Z(#`G/B8C,38P
M.SPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN+7)I9VAT.B`P.R!M87)G:6XM;&5F
M=#H@,"<^/"]P/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X
M=%!A<G1?-#8R,#,Q-#5?,F9F,%\T-3ED7S@W8S%?83`V9C!A,F(R8S!F#0I#
M;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S0V,C`S,30U7S)F9C!?-#4Y
M9%\X-V,Q7V$P-F8P83)B,F,P9B]7;W)K<VAE971S+U-H965T,#@N:'1M;`T*
M0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*
M0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*
M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O
M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M
M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N
M:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\
M+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I
M9#TS1$E$,$5,13X-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#(^/'-T<F]N9SXS+B!35$]#2TA/
M3$1%4E,G($5154E463QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@
M8VQA<W,],T1T:"!C;VQS<&%N/3-$,3XY($UO;G1H<R!%;F1E9#PO=&@^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M:#Y397`N(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#X\<W1R;VYG/DYO=&5S('1O($9I;F%N8VEA;"!3=&%T96UE;G1S
M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#XS
M+B!35$]#2TA/3$1%4E,G($5154E463PO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;BUR:6=H=#H@,#L@;6%R9VEN+6QE
M9G0Z(#`G/CQB/C,N(%-43T-+2$],1$524R<@15%52519(#PO8CX\+W`^#0H-
M"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;BUR:6=H=#H@,#L@;6%R9VEN+6QE9G0Z(#`G/D]U
M<B!A=71H;W)I>F5D(&-A<&ET86P@8V]N<VES=',@;V8@-S4P+#`P,"PP,#`-
M"G-H87)E<R!O9B!C;VUM;VX@<W1O8VL@86YD(#4P+#`P,"PP,#`@<VAA<F5S
M(&]F('!R969E<G)E9"!S=&]C:RX@3W5R('!R969E<G)E9"!S=&]C:R!M87D@
M8F4@9&5S:6=N871E9"!I;G1O('-E<FEE<R!P=7)S=6%N="!T;PT*875T:&]R
M:71Y(&=R86YT960@8GD@;W5R($-E<G1I9FEC871E(&]F($EN8V]R<&]R871I
M;VXL(&%N9"!O;B!A<'!R;W9A;"!F<F]M(&]U<B!";V%R9"!O9B!$:7)E8W1O
M<G,N($%S(&]F(%-E<'1E;6)E<B`S,"P@,C`Q,R!A;F0-"D1E8V5M8F5R(#,Q
M+"`R,#$R+"!W92!D:60@;F]T(&AA=F4@86YY('!R969E<G)E9"!S=&]C:R!I
M<W-U960N/"]P/@T*#0H-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN+7)I9VAT.B`P.R!M
M87)G:6XM;&5F=#H@,"<^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XM<FEG:'0Z
M(#`[(&UA<F=I;BUL969T.B`P)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;BUR:6=H=#H@,#L@;6%R9VEN+6QE9G0Z(#`G/B8C,38P.SPO<#X-"@T*
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN+7)I9VAT.B`P.R!M87)G:6XM;&5F=#H@,"<^/"]P
M/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE
M/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-#8R
M,#,Q-#5?,F9F,%\T-3ED7S@W8S%?83`V9C!A,F(R8S!F#0I#;VYT96YT+4QO
M8V%T:6]N.B!F:6QE.B\O+T,Z+S0V,C`S,30U7S)F9C!?-#4Y9%\X-V,Q7V$P
M-F8P83)B,F,P9B]7;W)K<VAE971S+U-H965T,#DN:'1M;`T*0V]N=&5N="U4
M<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4
M>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-
M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP
M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP
M="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@
M3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@
M(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$5+
M2D%#/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS
M<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-U;6UA<GD@;V8@4VEG;FEF
M:6-A;G0@06-C;W5N=&EN9R!0;VQI8VEE<R`H4&]L:6-I97,I/&)R/CPO<W1R
M;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q
M/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(^
M#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P,3,\8G(^/"]T
M:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@
M("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^3F]T97,@
M=&\@1FEN86YC:6%L(%-T871E;65N=',\+W-T<F]N9SX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/E-U;6UA<GD@;V8@4VEG;FEF:6-A;G0@
M06-C;W5N=&EN9R!0;VQI8VEE<R`H4&]L:6-I97,I/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX\+W`^#0H-
M"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;BUR:6=H=#H@,#L@;6%R9VEN+6QE9G0Z(#`G/E1I
M9V5R(%@@365D:6-A;"P@26YC+B`H)B,S-#M4:6=E<B!8)B,S-#L-"F]R('1H
M92`F(S,T.T-O;7!A;GDF(S,T.RDL(&9O<FUE<FQY(&MN;W=N(&%S($-A<F1O
M($UE9&EC86PL($EN8RXL('!R979I;W5S;'D@;W!E<F%T960@87,@86X@;W)T
M:&]P961I8R!M961I8V%L(&1E=FEC92!C;VUP86YY#0IS<&5C:6%L:7II;F<@
M:6X@9&5S:6=N:6YG+"!D979E;&]P:6YG(&%N9"!M87)K971I;F<@:&EG:"!P
M97)F;W)M86YC92!R96-O;G-T<G5C=&EV92!J;VEN="!D979I8V5S(&%N9"!S
M<&EN86P@<W5R9VEC86P@9&5V:6-E<RX\+W`^#0H-"CQP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;BUR:6=H=#H@,#L@;6%R9VEN+6QE9G0Z(#`G/D1U<FEN9R`R,#$P+"!T:&4@
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M<RP@4V5R:68[(&UA<F=I;CH@,"<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M
M87)G:6XZ(#`G/B8C,38P.SPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P
M="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX\
M+W`^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y"87-I<R!O9B!0<F5S96YT871I;VX\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/CQB/CQI/D)A<VES
M(&]F(%!R97-E;G1A=&EO;CPO:3X\+V(^/"]P/@T*#0H\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`G/B8C,38P.SPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SX\+W`^
M#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;BUR:6=H=#H@,#L@;6%R9VEN+6QE9G0Z(#`G
M/E1H92!A8V-O;7!A;GEI;F<@8V]N9&5N<V5D(&-O;G-O;&ED871E9"!B86QA
M;F-E#0IS:&5E="!A<R!O9B!$96-E;6)E<B`S,2P@,C`Q,BP@=VAI8V@@:&%S
M(&)E96X@9&5R:79E9"!F<F]M('1H92!#;VUP86YY)W,@875D:71E9"!F:6YA
M;F-I86P@<W1A=&5M96YT<R!A<R!O9B!T:&%T(&1A=&4L(&%N9"!T:&4-"G5N
M875D:71E9"!C;VYD96YS960@8V]N<V]L:61A=&5D(&9I;F%N8VEA;"!I;F9O
M<FUA=&EO;B!O9B!T:&4@0V]M<&%N>2!A<R!O9B!397!T96UB97(@,S`L(#(P
M,3,@86YD(&9O<B!T:&4@=&AR964@86YD(&YI;F4@;6]N=&AS#0IE;F1E9"!3
M97!T96UB97(@,S`L(#(P,3,@86YD(#(P,3(L(&AA<R!B965N('!R97!A<F5D
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M;2!P97)I;V0@96YD960@4V5P=&5M8F5R(#,P+"`R,#$S(&%R92!N;W0@;F5C
M97-S87)I;'D@:6YD:6-A=&EV92!O9B!T:&4@<F5S=6QT<R!T:&%T(&UA>2!B
M92!E>'!E8W1E9`T*9F]R('1H92!E;G1I<F4@>65A<BX\+W`^#0H-"CQP('-T
M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R
M:68[(&UA<F=I;BUR:6=H=#H@,#L@;6%R9VEN+6QE9G0Z(#`G/D-E<G1A:6X@
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M0V]M;6ES<VEO;B`H)B,S-#M314,F(S,T.RDN(%1H97-E('5N875D:71E9"!F
M:6YA;F-I86P@<W1A=&5M96YT<R!S:&]U;&0-"F)E(')E860@:6X@8V]N:G5N
M8W1I;VX@=VET:"!O=7(@875D:71E9"!F:6YA;F-I86P@<W1A=&5M96YT<R!A
M;F0@86-C;VUP86YY:6YG(&YO=&5S(&EN8VQU9&5D(&EN('1H92!#;VUP86YY
M)W,@06YN=6%L(%)E<&]R="!O;@T*1F]R;2`Q,"U+(&9O<B!T:&4@>65A<B!E
M;F1E9"!$96-E;6)E<B`S,2P@,C`Q,B!F:6QE9"!O;B!-87)C:"`R,BP@,C`Q
M,RX\+W`^#0H-"@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/B8C,38P.SPO<#X-
M"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN.B`P)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE
M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[
M(&UA<F=I;CH@,"<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G
M/CPO<#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\
M='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N
M/3-$=&]P/E!R:6YC:7!L97,@;V8@0V]N<V]L:61A=&EO;CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^/&(^
M/&D^4')I;F-I<&QE<R!O9B!#;VYS;VQI9&%T:6]N/"]I/CPO8CX\+W`^#0H-
M"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;CH@,"<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS
M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M
M87)G:6XZ(#`G/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE
M<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN+7)I9VAT.B`P.R!M
M87)G:6XM;&5F=#H@,"<^5&AE(&-O;F1E;G-E9"!C;VYS;VQI9&%T960@9FEN
M86YC:6%L('-T871E;65N=',-"FEN8VQU9&4@=&AE(&%C8V]U;G1S(&]F(%1I
M9V5R(%@@365D:6-A;"P@26YC+BP@06-C96QE<F%T960@26YN;W9A=&EO;BP@
M26YC+B`H)B,S-#M!8V-E;&5R871E9"8C,S0[*2P@56YI+4MN964@3$Q#("@F
M(S,T.U5N:28C,S0[*0T*86YD($-E<G9I8V%L(%AP86YD($Q,0R`H)B,S-#M#
M97)V:6-A;"8C,S0[*2X@06QL('-I9VYI9FEC86YT(&EN=&5R8V]M<&%N>2!T
M<F%N<V%C=&EO;G,@:&%V92!B965N(&5L:6UI;F%T960@:6X@8V]N<V]L:61A
M=&EO;BX\+W`^#0H-"@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/CPO<#X-"@T*
M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN.B`P)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$
M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA
M<F=I;CH@,"<^)B,Q-C`[/"]P/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^4F]Y86QT>2!!9W)E96UE;G0\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XM<FEG
M:'0Z(#`[(&UA<F=I;BUL969T.B`P)SX\8CX\:3Y2;WEA;'1Y($%G<F5E;65N
M=#PO:3X\+V(^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XM<FEG:'0Z(#`[(&UA
M<F=I;BUL969T.B`P)SY/;B!*86YU87)Y(#(T+"`R,#$Q+"!T:&4@0V]M<&%N
M>2!E;G1E<F5D#0II;G1O(&%N($%S<V5T(%!U<F-H87-E($%G<F5E;65N="!W
M:71H($%R=&AR97@L($EN8RX@*"8C,S0[07)T:')E>"8C,S0[*2`H=&AE(&%G
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M<"!T;R!A;F0@:6YC;'5D:6YG('1H92`R,'1H(&%N;FEV97)S87)Y(&]F('1H
M92!C;&]S:6YG(&1A=&4N($1U<FEN9R!T:&4@=&AR964-"F%N9"!N:6YE(&UO
M;G1H<R!E;F1E9"!397!T96UB97(@,S`L(#(P,3,L('1H92!#;VUP86YY(')E
M8V5I=F5D('1O=&%L(')O>6%L='D@<&%Y;65N=',@;V8@)#<Q+#`P,"!A;F0@
M)#$W."PP,#`L(')E<W!E8W1I=F5L>2P@9G)O;0T*07)T:')E>"X@1'5R:6YG
M('1H92!T:')E92!A;F0@;FEN92!M;VYT:',@96YD960@4V5P=&5M8F5R(#,P
M+"`R,#$R+"!T:&4@0V]M<&%N>2!R96-E:79E9"!T;W1A;"!R;WEA;'1Y('!A
M>6UE;G1S(&]F("0Q.2PP,#`@86YD#0HD-#<L,#`P+"!R97-P96-T:79E;'DN
M(%1H97-E(&%M;W5N=',@87)E(')E9FQE8W1E9"!A<R!R979E;G5E(&]N('1H
M92!A8V-O;7!A;GEI;F<@8V]N9&5N<V5D(&-O;G-O;&ED871E9"!S=&%T96UE
M;G1S(&]F(&]P97)A=&EO;G,N/"]P/@T*#0H-"@T*/'`@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN
M+7)I9VAT.B`P.R!M87)G:6XM;&5F=#H@,"<^)B,Q-C`[/"]P/@T*#0H\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XM<FEG:'0Z(#`[(&UA<F=I;BUL969T.B`P)SXF(S$V,#L\
M+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N
M+"!4:6UE<RP@4V5R:68[(&UA<F=I;BUR:6=H=#H@,#L@;6%R9VEN+6QE9G0Z
M(#`G/CPO<#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/E5S92!O9B!%<W1I;6%T97,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1T97AT/B<\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/CQB/CQI/E5S92!O
M9B!%<W1I;6%T97,\+VD^/"]B/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M)SX\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^/"]P/@T*#0H\<"!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!M87)G:6XZ(#`G/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN+7)I9VAT.B`P
M.R!M87)G:6XM;&5F=#H@,"<^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q
M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XM<FEG
M:'0Z(#`[(&UA<F=I;BUL969T.B`P)SY&:6YA;F-I86P@<W1A=&5M96YT<R!P
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M(&1I9F9E<B!F<F]M('1H;W-E(&5S=&EM871E<RX\+W`^#0H-"@T*#0H\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`G/B8C,38P.SPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N
M=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN
M.B`P)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^)B,Q-C`[
M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA
M;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/CPO<#X\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@
M("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E)E=F5N=64@4F5C
M;V=N:71I;VX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`G/CQB/CPO8CX\+W`^#0H-"CQP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,"<^/&(^/&D^4F5V96YU92!296-O9VYI=&EO;CPO:3X\+V(^/"]P/@T*
M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!M87)G:6XZ(#`G/B8C,38P.SPO<#X-"@T*/'`@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M;6%R9VEN.B`P)SX\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM
M97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;BUR:6=H=#H@,#L@
M;6%R9VEN+6QE9G0Z(#`G/E1H92!#;VUP86YY)W,@<F5V96YU92!C;VYS:7-T
M<R!O9B!R;WEA;'1Y#0IR979E;G5E(&9R;VT@=&AE($%R=&AR97@@07-S970@
M4'5R8VAA<V4@06=R965M96YT+"!W:&EC:"!I<R!R96-O9VYI>F5D(&%S('1H
M92!A;6]U;G0@8F5C;VUE<R!K;F]W;B!A;F0@8V]L;&5C=&%B:6QI='D@:7,@
M<F5A<V]N86)L>0T*87-S=7)E9"X\+W`^#0H-"@T*#0H\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`G/B8C,38P.SPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4
M:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P)SXF(S$V
M,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O
M;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^/"]P/@T*#0H\<"!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!M87)G:6XZ(#`G/B8C,38P.SPO<#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYE="!);F-O;64@4&5R(%-H87)E
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'`@<W1Y;&4],T0G
M9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R
M9VEN.B`P)SX\8CX\+V(^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T
M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XM<FEG:'0Z
M(#`[(&UA<F=I;BUL969T.B`P)SX\8CX\:3Y.970@26YC;VUE(%!E<B!3:&%R
M93PO:3X\+V(^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XM<FEG:'0Z(#`[(&UA
M<F=I;BUL969T.B`P)SX\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;BUR:6=H=#H@
M,#L@;6%R9VEN+6QE9G0Z(#`G/D)A<VEC(&YE="!I;F-O;64@<&5R('-H87)E
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M=&EV92X\+W`^#0H-"@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S
M($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XM<FEG:'0Z(#`[(&UA
M<F=I;BUL969T.B`P)SX\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;BUR:6=H=#H@
M,#L@;6%R9VEN+6QE9G0Z(#`G/CPO<#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DEN8V]M92!487AE<SPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^
M/&(^/&D^/"]I/CPO8CX\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@
M5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^/&(^
M/&D^26YC;VUE(%1A>&5S/"]I/CPO8CX\+W`^#0H-"CQP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,"<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I
M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/CPO<#X-
M"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I
M;65S+"!397)I9CL@;6%R9VEN+7)I9VAT.B`P.R!M87)G:6XM;&5F=#H@,"<^
M26YC;VUE('1A>&5S(&%R92!A8V-O=6YT960@9F]R('5N9&5R('1H92!A<W-E
M=`T*86YD(&QI86)I;&ET>2!M971H;V0N($1E9F5R<F5D('1A>"!A<W-E=',@
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M;2!O9B!T:&4@9&5F97)R960@=&%X(&%S<V5T+`T*=F%L=6%T:6]N(&%L;&]W
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M/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S
M+"!397)I9CL@;6%R9VEN+7)I9VAT.B`P.R!M87)G:6XM;&5F=#H@,"<^5&AE
M($-O;7!A;GD@979A;'5A=&5S('1H92!A8V-O=6YT:6YG(&9O<B!U;F-E<G1A
M:6YT>0T*:6X@:6YC;VUE('1A>"!R96-O9VYI>F5D(&EN(&ET<R!F:6YA;F-I
M86P@<W1A=&5M96YT<R!A;F0@9&5T97)M:6YE<R!W:&5T:&5R(&ET(&ES(&UO
M<F4@;&EK96QY('1H86X@;F]T('1H870@82!T87@@<&]S:71I;VX@=VEL;`T*
M8F4@<W5S=&%I;F5D('5P;VX@97AA;6EN871I;VX@8GD@=&AE(&%P<')O<')I
M871E('1A>&EN9R!A=71H;W)I=&EE<R!B969O<F4@86YY('!A<G0@;V8@=&AE
M(&)E;F5F:70@:7,@<F5C;W)D960@:6X@:71S(&9I;F%N8VEA;`T*<W1A=&5M
M96YT<RX@1F]R('1H;W-E('1A>"!P;W-I=&EO;G,@=VAE<F4@:70@:7,@)B,S
M-#MN;W0@;6]R92!L:6ME;'D@=&AA;B!N;W0F(S,T.R!T:&%T(&$@=&%X(&)E
M;F5F:70@=VEL;"!B92!S=7-T86EN960L(&YO('1A>`T*8F5N969I="!I<R!R
M96-O9VYI>F5D+B!7:&5R92!A<'!L:6-A8FQE+"!A<W-O8VEA=&5D(&EN=&5R
M97-T(&%N9"!P96YA;'1I97,@87)E(&%L<V\@<F5C;W)D960N(%1H92!#;VUP
M86YY(&AA<R!N;W0@86-C<G5E9"!F;W(@86YY#0IS=6-H('5N8V5R=&%I;B!T
M87@@<&]S:71I;VYS(&%S(&]F(%-E<'1E;6)E<B`S,"P@,C`Q,R`H=6YA=61I
M=&5D*2!O<B!$96-E;6)E<B`S,2P@,C`Q,BX\+W`^#0H-"@T*#0H\<"!S='EL
M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF
M.R!M87)G:6XZ(#`G/B8C,38P.SPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@
M,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN.B`P
M)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^/"]P/@T*#0H\
M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L
M(%-E<FEF.R!M87)G:6XZ(#`G/CPO<#X\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D
M(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D-O;F-E;G1R871I;VX@;V8@0W)E
M9&ET(%)I<VL\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!S
M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E
M<FEF.R!M87)G:6XZ(#`G/CQB/CPO8CX\+W`^#0H-"CQP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,"<^/&(^/&D^/"]I/CPO8CX\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,"<^/&(^/&D^/"]I/CPO8CX\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P
M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;BUR:6=H
M=#H@,#L@;6%R9VEN+6QE9G0Z(#`G/CQB/CQI/D-O;F-E;G1R871I;VX@;V8@
M0W)E9&ET(%)I<VL\+VD^/"]B/CPO<#X-"@T*#0H-"CQP('-T>6QE/3-$)V9O
M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I
M;CH@,"<^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE
M=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G:6XM<FEG:'0Z(#`[(&UA<F=I
M;BUL969T.B`P)SY4:&4@8V%S:"!A;F0@8V%S:"!E<75I=F%L96YT<R!H96QD
M(&EN#0IT:&4@0V]M<&%N>2=S(&)U<VEN97-S(&UO;F5Y(&UA<FME="!A;F0@
M;W1H97(@8F%N:R!A8V-O=6YT<R!A<F4@=VET:"!L;V-A;"!A;F0@;F%T:6]N
M86P@8F%N:VEN9R!I;G-T:71U=&EO;G,@86YD('-U8FIE8W1E9"!T;PT*1D1)
M0R!I;G-U<F%N8V4@;&EM:71S(&]F("0R-3`L,#`P('!E<B!B86YK:6YG(&EN
M<W1I='5T:6]N+B!!<R!O9B!397!T96UB97(@,S`L(#(P,3,L('1H92!#;VUP
M86YY)W,@8F%L86YC97,@:6X@=&AE<V4@8F%N:PT*86-C;W5N=',@97AC965D
M960@=&AE(&EN<W5R960@86UO=6YT(&)Y("0Q,BPY-C4L.#<R+CPO<#X-"@T*
M#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4
M:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^/"]P/@T*#0H\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XM<FEG:'0Z(#`[(&UA<F=I;BUL969T.B`P)SXF(S$V,#L\+W`^#0H-"CQP
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[(&UA<F=I;BUR:6=H=#H@,#L@;6%R9VEN+6QE9G0Z(#`G/B8C,38P
M.SPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M
M86XL(%1I;65S+"!397)I9CL@;6%R9VEN+7)I9VAT.B`P.R!M87)G:6XM;&5F
M=#H@,"<^/"]P/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4F5C96YT($%C8V]U;G1I;F<@4')O;F]U;F-E;65N=',\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`G/CQB/CQI/E)E8V5N="!!8V-O=6YT:6YG(%!R;VYO=6YC96UE;G1S
M/"]I/CPO8CX\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^)B,Q-C`[/"]P
M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/E1H97)E(&%R92!N;R!R96-E;G1L
M>2!I<W-U960@86-C;W5N=&EN9R!S=&%N9&%R9',@=&AA="!T:&4-"D-O;7!A
M;GD@:&%S('EE="!T;R!A9&]P="!T:&%T(&%R92!E>'!E8W1E9"!T;R!H879E
M(&$@;6%T97)I86P@969F96-T(&]N(&ET<R!F:6YA;F-I86P@<&]S:71I;VXL
M(')E<W5L=',@;V8@;W!E<F%T:6]N<RP@;W(@8V%S:`T*9FQO=W,N/"]P/@T*
M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM
M97,L(%-E<FEF.R!M87)G:6XZ(#`G/B8C,38P.SPO<#X-"@T*/'`@<W1Y;&4]
M,T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I9CL@
M;6%R9VEN.B`P)SXF(S$V,#L\+W`^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*
M+2TM+2TM/5].97AT4&%R=%\T-C(P,S$T-5\R9F8P7S0U.61?.#=C,5]A,#9F
M,&$R8C)C,&8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#8R,#,Q
M-#5?,F9F,%\T-3ED7S@W8S%?83`V9C!A,F(R8S!F+U=O<FMS:&5E=',O4VAE
M970Q,"YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M
M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB
M=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P
M+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C
M:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@
M<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J
M+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S
M/3-$<F5P;W)T(&ED/3-$240P14Q%/@T*("`@("`@/'1R/@T*("`@("`@("`\
M=&@@8VQA<W,],T1T;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG
M/E-H87)E($)A<V5D(%!A>6UE;G0@*%1A8FQE<RD\8G(^/"]S=')O;F<^/"]T
M:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^.2!-;VYT
M:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<CX-"B`@("`@
M("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T<F]N9SY3:&%R92!"87-E9"!0
M87EM96YT(%1A8FQE<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@
M("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V
M86QI9VX],T1T;W`^4W5M;6%R>2!O9B!3=&]C:R!/<'1I;VX@06-T:79I='D\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<"!S='EL93TS1"=F
M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E<FEF.R!M87)G
M:6XZ(#`G/CPO<#X-"@T*/'`@<W1Y;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.
M97<@4F]M86XL(%1I;65S+"!397)I9CL@;6%R9VEN+7)I9VAT.B`P.R!M87)G
M:6XM;&5F=#H@,"<^02!S=6UM87)Y(&]F('-T;V-K(&]P=&EO;B!A8W1I=FET
M>2!A<R!O9B!397!T96UB97(-"C,P+"`R,#$S+"!A;F0@8VAA;F=E<R!D=7)I
M;F<@=&AE('!E<FEO9"!T:&5N(&5N9&5D(&ES('!R97-E;G1E9"!B96QO=RX\
M+W`^#0H-"CQT86)L92!C96QL<W!A8VEN9STS1#`@8V5L;'!A9&1I;F<],T0P
M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@
M4V5R:68[('=I9'1H.B`Q,#`E)SX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA
M;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD+6-O;&]R.B!W:&ET92<^#0H@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P
M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF
M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H
M="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M<FEG:'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&-E;G1E<B<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SX\
M8CY796EG:'1E9"T\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&-E;G1E<B<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X\+W1R
M/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG
M<F]U;F0M8V]L;W(Z('=H:71E)SX-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D
M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B8C,38P
M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N
M=&5R)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/E=E:6=H
M=&5D+3PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!C96YT97(G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P="<^/&(^079E<F%G92`\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T
M>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^)B,Q-C`[/"]T9#X-"B`@("`\
M=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T
M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[
M(&)A8VMG<F]U;F0M8V]L;W(Z('=H:71E)SX-"B`@("`\=&0^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V
M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G
M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E
M;G1E<B<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB
M/D%V97)A9V4\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(&-E;G1E<B<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0G/CQB/E)E;6%I;FEN9R`\+V(^/"]F;VYT/CPO=&0^#0H@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^/&(^06=G<F5G871E/"]B
M/CPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI
M9VXZ(&)O='1O;3L@8F%C:V=R;W5N9"UC;VQO<CH@=VAI=&4G/@T*("`@(#QT
M9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C
M96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(&-E;G1E<B<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!C96YT97(G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ
M93H@,3!P="<^/&(^17AE<F-I<V4\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL
M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/D-O;G1R86-T=6%L/"]B/CPO9F]N
M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G
M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E
M;G1E<B<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB
M/DEN=')I;G-I8SPO8CX\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$
M)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VT[(&)A8VMG<F]U;F0M8V]L;W(Z('=H
M:71E)SX-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G
M8F]R9&5R+6)O='1O;3H@8FQA8VL@,2XU<'0@<V]L:60[('1E>'0M86QI9VXZ
M(&-E;G1E<B<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SX\8CY/
M<'1I;VYS/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$
M)W1E>'0M86QI9VXZ(&-E;G1E<B<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,2XU<'0@<V]L:60[('1E>'0M
M86QI9VXZ(&-E;G1E<B<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M)SX\8CY0<FEC93PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G
M=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL
M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA
M;&EG;CH@8V5N=&5R)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G
M/CQB/DQI9F4@*%EE87)S*3PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y
M;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT
M9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@
M("`@/'1D('-T>6QE/3-$)V)O<F1E<BUB;W1T;VTZ(&)L86-K(#$N-7!T('-O
M;&ED.R!T97AT+6%L:6=N.B!C96YT97(G/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P="<^/&(^5F%L=64\+V(^/"]F;VYT/CPO=&0^/"]T<CX-"CQT
M<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B86-K9W)O=6YD
M+6-O;&]R.B!W:&ET92<^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^)B,Q-C`[/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D
M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B8C,38P
M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E<B<^
M)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@8V5N
M=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA
M;&EG;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E
M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T
M>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!B;W1T;VTG/@T*("`@(#QT9"!S='EL
M93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET92<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T)SY/=71S=&%N9&EN9R!A="!$96-E;6)E<B`S,2P@
M,C`Q,CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N
M.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SXS.#4L
M,#`P)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B
M86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@<FEG:'0G/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^)#PO9F]N=#X\+W1D/@T*
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T)SXP+C(S)B,Q-C`[/"]F;VYT/CPO=&0^
M#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\
M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O
M;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SXU+C8V)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF
M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R
M.B!W:&ET93L@=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O
M;G0M<VEZ93H@,3!P="<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS
M1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE
M.B`Q,'!T)SXM)B,Q-C`[/"]F;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS
M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX-"B`@("`\=&0@<W1Y;&4],T0G
M8F%C:V=R;W5N9"UC;VQO<CH@=VAI=&4G/CQF;VYT('-T>6QE/3-$)V9O;G0M
M<VEZ93H@,3!P="<^1W)A;G1E9#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T)SXM)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S
M='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@
M<FEG:'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/BT@
M)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T
M)SXM("8C,38P.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT
M+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G
M8F%C:V=R;W5N9"UC;VQO<CH@=VAI=&4[('1E>'0M86QI9VXZ(')I9VAT)SXF
M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H
M="<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SXM)B,Q-C`[/"]F
M;VYT/CPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@
M8F]T=&]M)SX-"B`@("`\=&0@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@
M=VAI=&4G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^17AE<F-I
M<V5D/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/BTF(S$V
M,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@
M<FEG:'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)A8VMG<F]U
M;F0M8V]L;W(Z('=H:71E.R!T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT
M('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^+2`F(S$V,#L\+V9O;G0^/"]T
M9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P
M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/BT@)B,Q-C`[/"]F;VYT
M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF
M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R
M.B!W:&ET93L@=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@("`@
M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0G/BTF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*
M/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!T;W`G/@T*("`@(#QT9"!S
M='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET92<^/&9O;G0@<W1Y;&4]
M,T0G9F]N="US:7IE.B`Q,'!T)SY&;W)F96ET960\+V9O;G0^/"]T9#X-"B`@
M("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE
M/3-$)V9O;G0M<VEZ93H@,3!P="<^+28C,38P.SPO9F]N=#X\+W1D/@T*("`@
M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-
M"B`@("`\=&0@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@=VAI=&4[('1E
M>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS
M1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q+C5P="!S;VQI9#L@=&5X="UA;&EG
M;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^+2`F
M(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G
M/BT@)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B
M86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@<FEG:'0G/B8C
M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/BTF(S$V,#L\+V9O
M;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E<G1I8V%L+6%L:6=N.B!T
M;W`G/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET
M92<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SY/=71S=&%N9&EN
M9R!A="!397!T96UB97(@,S`L(#(P,3,@*'5N875D:71E9"D\+V9O;G0^/"]T
M9#X-"B`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR
M-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$
M)V9O;G0M<VEZ93H@,3!P="<^,S@U+#`P,"8C,38P.SPO9F]N=#X\+W1D/@T*
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T
M9#X-"B`@("`\=&0@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@=VAI=&4[
M('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z
M(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F]R9&5R
M+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG
M:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^,"XR,R8C,38P
M.SPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R
M:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F]R9&5R+6)O
M='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L93L@=&5X="UA;&EG;CH@<FEG:'0G
M/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^-"XY,B8C,38P.SPO
M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H
M="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G8F%C:V=R;W5N9"UC
M;VQO<CH@=VAI=&4[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS
M1"=F;VYT+7-I>F4Z(#$P<'0G/B0\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y
M;&4],T0G8F]R9&5R+6)O='1O;3H@8FQA8VL@,BXR-7!T(&1O=6)L93L@=&5X
M="UA;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P
M="<^+28C,38P.SPO9F]N=#X\+W1D/CPO='(^#0H\='(@<W1Y;&4],T0G=F5R
M=&EC86PM86QI9VXZ(&)O='1O;2<^#0H@("`@/'1D('-T>6QE/3-$)V)A8VMG
M<F]U;F0M8V]L;W(Z('=H:71E.R!T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B8C
M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O
M;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D
M/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[
M/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B8C
M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT
M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O
M;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@
M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D
M/CPO='(^#0H\='(@<W1Y;&4],T0G=F5R=&EC86PM86QI9VXZ(&)O='1O;2<^
M#0H@("`@/'1D('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z('=H:71E)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/E9E<W1E9"!A;F0@97AP
M96-T960@=&\@=F5S=#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T
M>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z('=H:71E.R!T97AT+6%L:6=N.B!R
M:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T
M>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z('=H:71E.R!T97AT+6%L:6=N.B!R
M:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0G/B8C,38P.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T
M:6-A;"UA;&EG;CH@8F]T=&]M)SX-"B`@("`\=&0@<W1Y;&4],T0G8F%C:V=R
M;W5N9"UC;VQO<CH@=VAI=&4G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P="<^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[(&%T(%-E<'1E;6)E<B`S
M,"P@,C`Q,R`H=6YA=61I=&5D*3PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL
M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N="US
M:7IE.B`Q,'!T)SXS.#4L,#`P)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D
M('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@
M(#QT9"!S='EL93TS1"=B86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA
M;&EG;CH@<FEG:'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^
M)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R
M:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SXP+C(S)B,Q
M-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ
M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L
M:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SXT
M+CDR)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B
M86-K9W)O=6YD+6-O;&]R.B!W:&ET93L@=&5X="UA;&EG;CH@<FEG:'0G/CQF
M;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@,3!P="<^)#PO9F]N=#X\+W1D/@T*
M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y
M;&4],T0G9F]N="US:7IE.B`Q,'!T)SXM)B,Q-C`[/"]F;VYT/CPO=&0^/"]T
M<CX-"CQT<B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M)SX-"B`@
M("`\=&0@<W1Y;&4],T0G8F%C:V=R;W5N9"UC;VQO<CH@=VAI=&4[('1E>'0M
M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T
M>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z('=H:71E.R!T97AT+6%L:6=N.B!R
M:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M
M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T
M97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4]
M,T0G=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T
M>6QE/3-$)V)A8VMG<F]U;F0M8V]L;W(Z('=H:71E.R!T97AT+6%L:6=N.B!R
M:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG
M;CH@<FEG:'0G/B8C,38P.SPO=&0^/"]T<CX-"CQT<B!S='EL93TS1"=V97)T
M:6-A;"UA;&EG;CH@8F]T=&]M)SX-"B`@("`\=&0@<W1Y;&4],T0G8F%C:V=R
M;W5N9"UC;VQO<CH@=VAI=&4G/CQF;VYT('-T>6QE/3-$)V9O;G0M<VEZ93H@
M,3!P="<^17AE<F-I<V%B;&4@870@4V5P=&5M8F5R(#,P+"`R,#$S("AU;F%U
M9&ET960I/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI
M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C,X
M-2PP,#`F(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X
M="UA;&EG;CH@<FEG:'0G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$
M)V)A8VMG<F]U;F0M8V]L;W(Z('=H:71E.R!T97AT+6%L:6=N.B!R:6=H="<^
M/&9O;G0@<W1Y;&4],T0G9F]N="US:7IE.B`Q,'!T)SXD/"]F;VYT/CPO=&0^
M#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S
M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C`N,C,F(S$V,#L\+V9O;G0^/"]T
M9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G/B8C,38P
M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\
M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C0N.3(F(S$V,#L\+V9O
M;G0^/"]T9#X-"B`@("`\=&0@<W1Y;&4],T0G=&5X="UA;&EG;CH@<FEG:'0G
M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)A8VMG<F]U;F0M8V]L
M;W(Z('=H:71E.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@<W1Y;&4],T0G
M9F]N="US:7IE.B`Q,'!T)SXD/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE
M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I
M>F4Z(#$P<'0G/BTF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/"]T86)L93X-
M"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE
M<RP@4V5R:68[(&UA<F=I;BUR:6=H=#H@,#L@;6%R9VEN+6QE9G0Z(#`G/B8C
M,38P.SPO<#X-"@T*#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@
M3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@,"<^)B,Q-C`[/"]P
M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@
M5&EM97,L(%-E<FEF.R!M87)G:6XZ(#`G/B8C,38P.SPO<#X-"@T*/'`@<W1Y
M;&4],T0G9F]N=#H@,3!P="!4:6UE<R!.97<@4F]M86XL(%1I;65S+"!397)I
M9CL@;6%R9VEN.B`P)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z
M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE<RP@4V5R:68[(&UA<F=I;CH@
M,"<^/"]P/CQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\
M+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A
M<G1?-#8R,#,Q-#5?,F9F,%\T-3ED7S@W8S%?83`V9C!A,F(R8S!F#0I#;VYT
M96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S0V,C`S,30U7S)F9C!?-#4Y9%\X
M-V,Q7V$P-F8P83)B,F,P9B]7;W)K<VAE971S+U-H965T,3$N:'1M;`T*0V]N
M=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N
M=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\
M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E
M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^
M/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^
M+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE
M860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS
M1$E$,$5(14%#/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T
M;"!C;VQS<&%N/3-$,2!R;W=S<&%N/3-$,CX\<W1R;VYG/E-U;6UA<GD@;V8@
M4VEG;FEF:6-A;G0@06-C;W5N=&EN9R!0;VQI8V5S("A2;WEA;'1Y($%G<F5E
M;65N="D@*$YA<G)A=&EV92D@*$1E=&%I;',I("A54T0@)"D\8G(^26X@5&AO
M=7-A;F1S+"!U;FQE<W,@;W1H97)W:7-E('-P96-I9FEE9#PO<W1R;VYG/CPO
M=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0R/C,@36]N
M=&AS($5N9&5D/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A
M;CTS1#(^.2!-;VYT:',@16YD960\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<CX-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@,C`Q,SQB
M<CX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$R
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E<"X@,S`L(#(P
M,3,\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^4V5P+B`S,"P@
M,C`Q,CQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^/'-T
M<F]N9SY3=6UM87)Y($]F(%-I9VYI9FEC86YT($%C8V]U;G1I;F<@4&]L:6-E
M<R!2;WEA;'1Y($%G<F5E;65N="!.87)R871I=F4@1&5T86EL<SPO<W1R;VYG
M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O
M/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^4F]Y86QT
M>2!2979E;G5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#<Q
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^
M)"`Q.3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/B0@,3<X/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1&YU;7`^)"`T-SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?
M3F5X=%!A<G1?-#8R,#,Q-#5?,F9F,%\T-3ED7S@W8S%?83`V9C!A,F(R8S!F
M#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S0V,C`S,30U7S)F9C!?
M-#4Y9%\X-V,Q7V$P-F8P83)B,F,P9B]7;W)K<VAE971S+U-H965T,3(N:'1M
M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L
M90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI
M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS
M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU
M=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H
M;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP
M=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R
M="!I9#TS1$E$,$4T1SX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY3=6UM87)Y
M(&]F(%-I9VYI9FEC86YT($%C8V]U;G1I;F<@4&]L:6-E<R`H26YC;VUE(%1A
M>&5S*2`H3F%R<F%T:79E*2`H1&5T86EL<RD@*%531"`D*3QB<CX\+W-T<F]N
M9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$S
M/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P
M,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O
M;F<^4W5M;6%R>2!/9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC97,@
M26YC;VUE(%1A>&5S($YA<G)A=&EV92!$971A:6QS/"]S=')O;F<^/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06-C<G5A;"!F;W(@=6YC
M97)T86EN('1A>"!P;W-I=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/B0@,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1N=6UP/B0@,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-
M"B`@("`\+W1A8FQE/@T*("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?
M3F5X=%!A<G1?-#8R,#,Q-#5?,F9F,%\T-3ED7S@W8S%?83`V9C!A,F(R8S!F
M#0I#;VYT96YT+4QO8V%T:6]N.B!F:6QE.B\O+T,Z+S0V,C`S,30U7S)F9C!?
M-#4Y9%\X-V,Q7V$P-F8P83)B,F,P9B]7;W)K<VAE971S+U-H965T,3,N:'1M
M;`T*0V]N=&5N="U4<F%N<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L
M90T*0V]N=&5N="U4>7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI
M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS
M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU
M=&8M."<^/'-C<FEP="!T>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H
M;W<N:G,^+RH@1&\@3F]T(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP
M=#X\+VAE860^#0H@(#QB;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R
M="!I9#TS1$E$,$4V1CX-"B`@("`@(#QT<CX-"B`@("`@("`@/'1H(&-L87-S
M/3-$=&P@8V]L<W!A;CTS1#$@<F]W<W!A;CTS1#$^/'-T<F]N9SY3=6UM87)Y
M(&]F(%-I9VYI9FEC86YT($%C8V]U;G1I;F<@4&]L:6-E<R`H0V]N8V5N=')A
M=&EO;B!O9B!#<F5D:70@4FES:RD@*$YA<G)A=&EV92D@*$1E=&%I;',I("A5
M4T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$
M=&@^4V5P+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@
M(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI
M9VX],T1T;W`^/'-T<F]N9SY3=6UM87)Y($]F(%-I9VYI9FEC86YT($%C8V]U
M;G1I;F<@4&]L:6-E<R!#;VYC96YT<F%T:6]N($]F($-R961I="!2:7-K($YA
M<G)A=&EV92!$971A:6QS/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L
M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L
M('9A;&EG;CTS1'1O<#Y&1$E#(&-U<G)E;G0@;&EM:71S(&]N(&)A;FL@86-C
M;W5N=',@<&5R(&)A;FMI;F<@:6YS=&ET=71I;VX\+W1D/@T*("`@("`@("`\
M=&0@8VQA<W,],T1N=6UP/B0@,C4P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\
M=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^0V]M<&%N>2!B86YK(&)A;&%N
M8V5S(&EN('1H97-E(&)A;FL@86-C;W5N=',@97AC965D:6YG('1H92!I;G-U
M<F5D(&%M;W5N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`Q
M,BPY,C<L,3DS/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT
M4&%R=%\T-C(P,S$T-5\R9F8P7S0U.61?.#=C,5]A,#9F,&$R8C)C,&8-"D-O
M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#8R,#,Q-#5?,F9F,%\T-3ED
M7S@W8S%?83`V9C!A,F(R8S!F+U=O<FMS:&5E=',O4VAE970Q-"YH=&UL#0I#
M;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#
M;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E=#TB=7,M87-C:6DB#0H-
M"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H='1P+65Q=6EV/3-$0V]N
M=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R<V5T/75T9BTX
M)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I<'0@<W)C/3-$4VAO=RYJ
M<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N="`J+SPO<V-R:7!T/CPO
M:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L87-S/3-$<F5P;W)T(&ED
M/3-$240P14M7044^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS
M1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS=')O;F<^4VAA<F4M0F%S
M960@4&%Y;65N="`H4W1O8VL@3W!T:6]N($%C=&EV:71Y*2`H1&5T86EL<RD@
M*%531"`D*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@("`@("`\=&@@8VQA<W,]
M,T1T:"!C;VQS<&%N/3-$,3XY($UO;G1H<R!%;F1E9#PO=&@^#0H@("`@("`@
M(#QT:"!C;&%S<STS1'1H(&-O;'-P86X],T0Q/CPO=&@^#0H@("`@("`\+W1R
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P
M+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@
M,S$L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA
M<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P
M/CQS=')O;F<^4VAA<F4M0F%S960@4&%Y;65N="!3=&]C:R!/<'1I;VX@06-T
M:79I='D@1&5T86EL<SPO<W1R;VYG/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA
M<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@
M("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@
M=F%L:6=N/3-$=&]P/D]U='-T86YD:6YG(&%T($1E8V5M8F5R(#,Q+"`R,#$R
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS.#4L,#`P/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS
M1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^1W)A
M;G1E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D5X97)C
M:7-E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D9O<F9E
M:71E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,#QS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R
M;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/D]U='-T
M86YD:6YG(&%T(%-E<'1E;6)E<B`S,"P@,C`Q,R`H=6YA=61I=&5D*3PO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^,S@U+#`P,#QS<&%N/CPO<W!A
M;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-
M"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E9E<W1E9"!A
M;F0@97AP96-T960@=&\@=F5S="!A="!397!T96UB97(@,S`L(#(P,3,\+W1D
M/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C,X-2PP,#`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y%>&5R8VES
M86)L92!A="!397!T96UB97(@,S`L(#(P,3,\+W1D/@T*("`@("`@("`\=&0@
M8VQA<W,],T1N=6UP/C,P."PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C
M;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E9"UA=F5R86=E(&5X97)C
M:7-E('!R:6-E(&]F(&]P=&EO;G,@9W)A;G1E9"!D=7)I;F<@<&5R:6]D/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#`\<W!A;CX\+W-P86X^
M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E9"UA
M=F5R86=E(&5X97)C:7-E('!R:6-E(&]F(&]P=&EO;G,@97AE<F-I<V5D(&1U
M<FEN9R!T:&4@<&5R:6]D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XD(#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y796EG:'1E9"UA=F5R86=E(&5X97)C:7-E('!R:6-E(&]F(&]P
M=&EO;G,@9F]R9F5I=&5D+"!C86YC96QL960@;W(@97AP:7)E9"!D=7)I;F<@
M=&AE('!E<FEO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^5V5I9VAT960M879E<F%G92!E>&5R8VES92!P<FEC92!O9B!O<'1I;VYS
M(&]U='-T86YD:6YG+"!E;F1I;F<@8F%L86YC93PO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`P+C(S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@
M("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@
M8VQA<W,],T1P;"!V86QI9VX],T1T;W`^5V5I9VAT960M879E<F%G92!E>&5R
M8VES92!P<FEC92!O9B!O<'1I;VYS('9E<W1E9"!A;F0@97AP96-T960@=&\@
M=F5S=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,"XR,SQS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S
M<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^
M5V5I9VAT960M879E<F%G92!E>&5R8VES92!P<FEC92!O9B!O<'1I;VYS(&5X
M97)C:7-A8FQE/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^)"`P
M+C(S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R
M(&-L87-S/3-$<F4^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS
M1'1O<#Y796EG:'1E9"UA=F5R86=E(')E;6%I;FEN9R!C;VYT<F%C='5A;"!T
M97)M("AI;B!Y96%R<RD@;V8@;W!T:6]N<R!O=71S=&%N9&EN9R!A="!$96-E
M;6)E<B`S,2P@,C`Q,CPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^
M)S4@>65A<G,@."!M;VYT:',@,2!D87D\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y796EG:'1E9"UA=F5R86=E(')E
M;6%I;FEN9R!C;VYT<F%C='5A;"!T97)M("AI;B!Y96%R<RD@;V8@;W!T:6]N
M<R!O=71S=&%N9&EN9R!A="!397!T96UB97(@,S`L(#(P,3,\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<T('EE87)S(#$Q(&UO;G1H<R`Q(&1A
M>3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT
M/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@
M8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$
M=&]P/E=E:6=H=&5D+6%V97)A9V4@<F5M86EN:6YG(&-O;G1R86-T=6%L('1E
M<FT@*&EN('EE87)S*2!O9B!O<'1I;VYS('9E<W1E9"!A;F0@97AP96-T960@
M=&\@=F5S=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S0@>65A
M<G,@,3$@;6]N=&AS(#$@9&%Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA
M<W,],T1P;"!V86QI9VX],T1T;W`^5V5I9VAT960M879E<F%G92!R96UA:6YI
M;F<@8V]N=')A8W1U86P@=&5R;2`H:6X@>65A<G,I(&]F(&]P=&EO;G,@97AE
M<F-I<V%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<T('EE
M87)S(#$Q(&UO;G1H<R`Q(&1A>3QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@
M("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L
M87-S/3-$<&P@=F%L:6=N/3-$=&]P/D%G9W)E9V%T92!I;G1R:6YS:6,@=F%L
M=64@;V8@;W!T:6]N<R!O=71S=&%N9&EN9SPO=&0^#0H@("`@("`@(#QT9"!C
M;&%S<STS1&YU;7`^)"`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^)"`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\
M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S
M<STS1'!L('9A;&EG;CTS1'1O<#Y!9V=R96=A=&4@:6YT<FEN<VEC('9A;'5E
M(&]F(&]P=&EO;G,@=F5S=&5D(&%N9"!E>'!E8W1E9"!T;R!V97-T/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D
M/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C;&%S<STS1')E/@T*("`@("`@
M("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T;W`^06=G<F5G871E(&EN=')I
M;G-I8R!V86QU92!O9B!O<'1I;VYS(&5X97)C:7-A8FQE/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M<#XD(#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-
M"@T*+2TM+2TM/5].97AT4&%R=%\T-C(P,S$T-5\R9F8P7S0U.61?.#=C,5]A
M,#9F,&$R8C)C,&8-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#8R
M,#,Q-#5?,F9F,%\T-3ED7S@W8S%?83`V9C!A,F(R8S!F+U=O<FMS:&5E=',O
M4VAE970Q-2YH=&UL#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T
M960M<')I;G1A8FQE#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA<G-E
M=#TB=7,M87-C:6DB#0H-"CQH=&UL/@T*("`\:&5A9#X-"B`@("`\345402!H
M='1P+65Q=6EV/3-$0V]N=&5N="U4>7!E(&-O;G1E;G0],T0G=&5X="]H=&UL
M.R!C:&%R<V5T/75T9BTX)SX\<V-R:7!T('1Y<&4],T1T97AT+VIA=F%S8W)I
M<'0@<W)C/3-$4VAO=RYJ<SXO*B!$;R!.;W0@4F5M;W9E(%1H:7,@0V]M;65N
M="`J+SPO<V-R:7!T/CPO:&5A9#X-"B`@/&)O9'D^#0H@("`@/'1A8FQE(&-L
M87-S/3-$<F5P;W)T(&ED/3-$240P14-,04,^#0H@("`@("`\='(^#0H@("`@
M("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O=W-P86X],T0R/CQS
M=')O;F<^4VAA<F4M0F%S960@4&%Y;65N="`H3F%R<F%T:79E*2`H1&5T86EL
M<R`Q*2`H55-$("0I/&)R/CPO<W1R;VYG/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H(&-O;'-P86X],T0Q/CD@36]N=&AS($5N9&5D/"]T:#X-"B`@
M("`@("`@/'1H(&-L87-S/3-$=&@@8V]L<W!A;CTS1#$^/"]T:#X-"B`@("`@
M(#PO='(^#0H@("`@("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1H/E-E
M<"X@,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^
M4V5P+B`S,"P@,C`Q,SQB<CX\+W1H/@T*("`@("`@/"]T<CX-"B`@("`@(#QT
M<B!C;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX]
M,T1T;W`^/'-T<F]N9SY3:&%R92U"87-E9"!087EM96YT($YA<G)A=&EV92!$
M971A:6QS(#$\+W-T<F]N9SX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T
M97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$
M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG
M;CTS1'1O<#Y3:&%R97,@;6%D92!A=F%I;&%B;&4@=6YD97(@;W!T:6]N(&=R
M86YT<SPO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO
M<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C(L,SDX+#0P
M,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`@(#QT<B!C
M;&%S<STS1')E/@T*("`@("`@("`\=&0@8VQA<W,],T1P;"!V86QI9VX],T1T
M;W`^3W!T:6]N(&=R86YT(&5X97)C:7-E('!R:6-E/"]T9#X-"B`@("`@("`@
M/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@
M(#QT9"!C;&%S<STS1&YU;7`^)"`P+C(S/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y/<'1I;VX@=F5S=&EN9R!P97)I
M;V0L(&EN('EE87)S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG
M-2!Y96%R<SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@
M("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L
M:6=N/3-$=&]P/D]P=&EO;B!E>'!I<F%T:6]N('!E<FEO9"P@:6X@>65A<G,\
M+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<Q,"!Y96%R<SQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A
M;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,]
M,T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/DYU
M;6)E<B!O9B!S:&%R97,@;V8@8V]M;6]N('-T;V-K(&%V86EL86)L92!F;W(@
M<'5R8VAA<V4@=6YD97(@=V%R<F%N=',@;W5T<W1A;F1I;F<\+W1D/@T*("`@
M("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@
M("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-S4L-C$S/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F4^#0H@("`@
M("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y787)R86YT(&5X97)C
M:7-E('!R:6-E+"!P97(@<VAA<F4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XD(#`N-#0\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/E=A<G)A;G0@97AP:7)A=&EO;B!D871E/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)S(P,30M,3$M,3,\<W!A;CX\
M+W-P86X^/"]T9#X-"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B
M;V1Y/@T*/"]H=&UL/@T*#0HM+2TM+2T]7TYE>'1087)T7S0V,C`S,30U7S)F
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M/@T*("`@(#Q-151!(&AT='`M97%U:78],T1#;VYT96YT+51Y<&4@8V]N=&5N
M=#TS1"=T97AT+VAT;6P[(&-H87)S970]=71F+3@G/CQS8W)I<'0@='EP93TS
M1'1E>'0O:F%V87-C<FEP="!S<F,],T13:&]W+FIS/B\J($1O($YO="!296UO
M=F4@5&AI<R!#;VUM96YT("HO/"]S8W)I<'0^/"]H96%D/@T*("`\8F]D>3X-
M"B`@("`\=&%B;&4@8VQA<W,],T1R97!O<G0@:60],T1)1#!%1T@^#0H@("`@
M("`\='(^#0H@("`@("`@(#QT:"!C;&%S<STS1'1L(&-O;'-P86X],T0Q(')O
M=W-P86X],T0R/CQS=')O;F<^4VAA<F4M0F%S960@4&%Y;65N="`H3F%R<F%T
M:79E*2`H1&5T86EL<R`R*2`H55-$("0I/&)R/DEN(%1H;W5S86YD<RP@=6YL
M97-S(&]T:&5R=VES92!S<&5C:69I960\+W-T<F]N9SX\+W1H/@T*("`@("`@
M("`\=&@@8VQA<W,],T1T:"!C;VQS<&%N/3-$,CXY($UO;G1H<R!%;F1E9#PO
M=&@^#0H@("`@("`\+W1R/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA
M<W,],T1T:#Y397`N(#,P+"`R,#$S/&)R/CPO=&@^#0H@("`@("`@(#QT:"!C
M;&%S<STS1'1H/E-E<"X@,S`L(#(P,3(\8G(^/"]T:#X-"B`@("`@(#PO='(^
M#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S/3-$
M<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4VAA<F4M0F%S960@4&%Y;65N="!.
M87)R871I=F4@1&5T86EL<R`R/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D
M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T
M<CX-"B`@("`@(#QT<B!C;&%S<STS1')O/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1P;"!V86QI9VX],T1T;W`^4VAA<F4M8F%S960@8V]M<&5N<V%T:6]N(&5X
M<&5N<V4\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@,CQS<&%N
M/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/B0@-3QS
M<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@/"]T<CX-"B`@("`\+W1A8FQE/@T*
M("`\+V)O9'D^#0H\+VAT;6P^#0H-"BTM+2TM+3U?3F5X=%!A<G1?-#8R,#,Q
M-#5?,F9F,%\T-3ED7S@W8S%?83`V9C!A,F(R8S!F#0I#;VYT96YT+4QO8V%T
M:6]N.B!F:6QE.B\O+T,Z+S0V,C`S,30U7S)F9C!?-#4Y9%\X-V,Q7V$P-F8P
M83)B,F,P9B]7;W)K<VAE971S+U-H965T,3<N:'1M;`T*0V]N=&5N="U4<F%N
M<V9E<BU%;F-O9&EN9SH@<75O=&5D+7!R:6YT86)L90T*0V]N=&5N="U4>7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA<G-E=#UU=&8M."<^/'-C<FEP="!T
M>7!E/3-$=&5X="]J879A<V-R:7!T('-R8STS1%-H;W<N:G,^+RH@1&\@3F]T
M(%)E;6]V92!4:&ES($-O;6UE;G0@*B\\+W-C<FEP=#X\+VAE860^#0H@(#QB
M;V1Y/@T*("`@(#QT86)L92!C;&%S<STS1')E<&]R="!I9#TS1$E$,$4T0T%#
M/@T*("`@("`@/'1R/@T*("`@("`@("`\=&@@8VQA<W,],T1T;"!C;VQS<&%N
M/3-$,2!R;W=S<&%N/3-$,3X\<W1R;VYG/E-T;V-K:&]L9&5R<R<@17%U:71Y
M("A.87)R871I=F4I("A$971A:6QS*3QB<CX\+W-T<F]N9SX\+W1H/@T*("`@
M("`@("`\=&@@8VQA<W,],T1T:#Y397`N(#,P+"`R,#$S/&)R/CPO=&@^#0H@
M("`@("`@(#QT:"!C;&%S<STS1'1H/D1E8RX@,S$L(#(P,3(\8G(^/"]T:#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/CQS=')O;F<^4W1O8VMH;VQD
M97)S($5Q=6ET>2!.87)R871I=F4@1&5T86EL<SPO<W1R;VYG/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S<STS1'1E>'0^)SQS<&%N/CPO<W!A;CX\+W1D/@T*
M("`@("`@("`\=&0@8VQA<W,],T1T97AT/B<\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@("`\='(@8VQA<W,],T1R;SX-"B`@("`@("`@
M/'1D(&-L87-S/3-$<&P@=F%L:6=N/3-$=&]P/E!R969E<G)E9"!3:&%R97,@
M075T:&]R:7IE9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S<STS1&YU;7`^-3`L
M,#`P+#`P,#QS<&%N/CPO<W!A;CX\+W1D/@T*("`@("`@("`\=&0@8VQA<W,]
M,T1N=6UP/C4P+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-"B`@("`@(#PO
M='(^#0H@("`@("`\='(@8VQA<W,],T1R93X-"B`@("`@("`@/'1D(&-L87-S
M/3-$<&P@=F%L:6=N/3-$=&]P/E!R969E<G)E9"!3:&%R97,@3W5T<W1A;F1I
M;F<\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N=6UP/C`\<W!A;CX\+W-P
M86X^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$<F\^
M#0H@("`@("`@(#QT9"!C;&%S<STS1'!L('9A;&EG;CTS1'1O<#Y#;VUM;VX@
M4VAA<F5S($%U=&AO<FEZ960\+W1D/@T*("`@("`@("`\=&0@8VQA<W,],T1N
M=6UP/C<U,"PP,#`L,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S<STS1&YU;7`^-S4P+#`P,"PP,#`\<W!A;CX\+W-P86X^/"]T9#X-
M"B`@("`@(#PO='(^#0H@("`@/"]T86)L93X-"B`@/"]B;V1Y/@T*/"]H=&UL
M/@T*#0HM+2TM+2T]7TYE>'1087)T7S0V,C`S,30U7S)F9C!?-#4Y9%\X-V,Q
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M(E-H965T,#$N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#`R+FAT
M;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P,RYH=&UL(B\^#0H@/&\Z
M1FEL92!(4F5F/3-$(E-H965T,#0N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS
M1")3:&5E=#`U+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970P-BYH
M=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,#<N:'1M;"(O/@T*(#QO
M.D9I;&4@2%)E9CTS1")3:&5E=#`X+FAT;6PB+SX-"B`\;SI&:6QE($A2968]
M,T0B4VAE970P.2YH=&UL(B\^#0H@/&\Z1FEL92!(4F5F/3-$(E-H965T,3`N
M:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$Q+FAT;6PB+SX-"B`\
M;SI&:6QE($A2968],T0B4VAE970Q,BYH=&UL(B\^#0H@/&\Z1FEL92!(4F5F
M/3-$(E-H965T,3,N:'1M;"(O/@T*(#QO.D9I;&4@2%)E9CTS1")3:&5E=#$T
M+FAT;6PB+SX-"B`\;SI&:6QE($A2968],T0B4VAE970Q-2YH=&UL(B\^#0H@
M/&\Z1FEL92!(4F5F/3-$(E-H965T,38N:'1M;"(O/@T*(#QO.D9I;&4@2%)E
M9CTS1")3:&5E=#$W+FAT;6PB+SX-"CPO>&UL/@T*+2TM+2TM/5].97AT4&%R
J=%\T-C(P,S$T-5\R9F8P7S0U.61?.#=C,5]A,#9F,&$R8C)C,&8M+0T*
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <Version>2.4.0.8</Version>
  <ProcessingTime />
  <ReportFormat>Html</ReportFormat>
  <ContextCount>9</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cardomedical.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
    </Report>
    <Report>
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cardomedical.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cardomedical.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cardomedical.com/role/ConsolidatedStatementsOfOperations</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cardomedical.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Disclosure - 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cardomedical.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - 2. SHARE BASED PAYMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cardomedical.com/role/ShareBasedPayment</Role>
      <ShortName>2. SHARE BASED PAYMENT</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - 3. STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cardomedical.com/role/StockholdersEquity</Role>
      <ShortName>3. STOCKHOLDERS' EQUITY</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cardomedical.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Share Based Payment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cardomedical.com/role/ShareBasedPaymentTables</Role>
      <ShortName>Share Based Payment (Tables)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Summary of Significant Accounting Polices (Royalty Agreement) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesRoyaltyAgreementNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Polices (Royalty Agreement) (Narrative) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Summary of Significant Accounting Polices (Income Taxes) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Polices (Income Taxes) (Narrative) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Summary of Significant Accounting Polices (Concentration of Credit Risk) (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cardomedical.com/role/SummaryOfSignificantAccountingPolicesConcentrationOfCreditRiskNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Polices (Concentration of Credit Risk) (Narrative) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Share-Based Payment (Stock Option Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cardomedical.com/role/Share-BasedPaymentStockOptionActivityDetails</Role>
      <ShortName>Share-Based Payment (Stock Option Activity) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Share-Based Payment (Narrative) (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cardomedical.com/role/Share-BasedPaymentNarrativeDetails1</Role>
      <ShortName>Share-Based Payment (Narrative) (Details 1)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Share-Based Payment (Narrative) (Details 2)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cardomedical.com/role/Share-BasedPaymentNarrativeDetails2</Role>
      <ShortName>Share-Based Payment (Narrative) (Details 2)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Stockholders' Equity (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cardomedical.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity (Narrative) (Details)</ShortName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Info">Process Flow-Through: 00000002 - Statement - CONSOLIDATED BALANCE SHEETS</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Sep. 30, 2012'</Log>
    <Log type="Info">	Process Flow-Through: Removing column 'Dec. 31, 2011'</Log>
    <Log type="Info">Process Flow-Through: 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</Log>
    <Log type="Info">Process Flow-Through: 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</Log>
    <Log type="Info">Process Flow-Through: 00000005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</Log>
  </Logs>
  <InputFiles>
    <File>cdom-20130930.xml</File>
    <File>cdom-20130930.xsd</File>
    <File>cdom-20130930_cal.xml</File>
    <File>cdom-20130930_def.xml</File>
    <File>cdom-20130930_lab.xml</File>
    <File>cdom-20130930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles />
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E3FAC">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share</a></td>
        <td class="nump">$ 0.001<span></span></td>
        <td class="nump">$ 0.001<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
        <td class="nump">750,000,000<span></span></td>
        <td class="nump">750,000,000<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
        <td class="nump">230,293,141<span></span></td>
        <td class="nump">230,293,141<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
        <td class="nump">230,293,141<span></span></td>
        <td class="nump">230,293,141<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Face amount or stated value per share of common stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockParOrStatedValuePerShare</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesIssued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EKWAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Share-Based Payment (Stock Option Activity) (Details) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_CDOM_StockbasedCompensationStockOptionActivityDetailsAbstract', window );"><strong>Share-Based Payment Stock Option Activity Details</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at December 31, 2012</a></td>
        <td class="nump">385,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted</a></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Forfeited</a></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at September 30, 2013 (unaudited)</a></td>
        <td class="nump">385,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest at September 30, 2013</a></td>
        <td class="nump">385,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at September 30, 2013</a></td>
        <td class="nump">308,000<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted-average exercise price of options granted during period</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted-average exercise price of options exercised during the period</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted-average exercise price of options forfeited, cancelled or expired during the period</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-average exercise price of options outstanding, ending balance</a></td>
        <td class="nump">$ 0.23<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted-average exercise price of options vested and expected to vest</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.23<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted-average exercise price of options exercisable</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.23<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining contractual term (in years) of options outstanding at December 31, 2012</a></td>
        <td class="text">5 years 8 months 1 day<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_CDOM_WeightedaverageRemainingContractualTermInYearsOfOptionsOutstandingAtEndOfPeriod', window );">Weighted-average remaining contractual term (in years) of options outstanding at September 30, 2013</a></td>
        <td class="text">4 years 11 months 1 day<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual term (in years) of options vested and expected to vest</a></td>
        <td class="text">4 years 11 months 1 day<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual term (in years) of options exercisable</a></td>
        <td class="text">4 years 11 months 1 day<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of options outstanding</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value of options vested and expected to vest</a></td>
        <td class="nump">0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of options exercisable</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CDOM_StockbasedCompensationStockOptionActivityDetailsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>CDOM_StockbasedCompensationStockOptionActivityDetailsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>CDOM_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CDOM_WeightedaverageRemainingContractualTermInYearsOfOptionsOutstandingAtEndOfPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format at the end of the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>CDOM_WeightedaverageRemainingContractualTermInYearsOfOptionsOutstandingAtEndOfPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>CDOM_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price of options that were either forfeited or expired.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(3)-(4)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Net number of share options (or share units) granted during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of options outstanding, including both vested and non-vested options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount by which the current fair value of the underlying stock exceeds the exercise price of fully vested and expected to vest options outstanding.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>As of the balance sheet date, the number of shares into which fully vested and expected to vest stock options outstanding can be converted under the option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>As of the balance sheet date, the weighted-average exercise price for outstanding stock options that are fully vested or expected to vest.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (e)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Number of share options (or share units) exercised during the current period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Article 3<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.3-04)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.28,29)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(iv)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 29, 30<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EWQAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
        <td class="nump">$ 14<span></span></td>
        <td class="nump">$ 267<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash used in operating activities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock option compensation</a></td>
        <td class="nump">2<span></span></td>
        <td class="nump">5<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">43<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable', window );">Income tax receivable</a></td>
        <td class="nump">0<span></span></td>
        <td class="num">(532)<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
        <td class="num">(12)<span></span></td>
        <td class="nump">77<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
        <td class="num">(9)<span></span></td>
        <td class="num">(615)<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
        <td class="num">(5)<span></span></td>
        <td class="num">(755)<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInRestrictedCash', window );">Decrease in restricted cash</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">900<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">900<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net change in cash</a></td>
        <td class="num">(5)<span></span></td>
        <td class="nump">145<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash, beginning of period</a></td>
        <td class="nump">13,268<span></span></td>
        <td class="nump">12,678<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash, end of period</a></td>
        <td class="nump">13,263<span></span></td>
        <td class="nump">12,823<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid</a></td>
        <td class="nump">0<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
        <td class="nump">$ 26<span></span></td>
        <td class="nump">$ 553<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Cash Equivalents<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 02<br><br> -Paragraph 1<br><br> -Article 5<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.5-02.1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 210<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 1<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 830<br><br> -SubTopic 230<br><br> -Section 45<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6450594&amp;loc=d3e33268-110906<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -Subparagraph (f)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncomeTaxesPaid</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInAccountsReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInIncomeTaxesReceivable</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInRestrictedCash">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The net cash inflow or outflow for the increase (decrease) associated with funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as investing activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 12<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3179-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Investing Activities<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 13<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3213-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_IncreaseDecreaseInRestrictedCash</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash paid for interest during the period.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -Subparagraph (e)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_InterestPaid</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 26<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3574-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 24<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3521-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 25<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3536-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 04<br><br> -Paragraph 20<br><br> -Article 9<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Other Comprehensive Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6519514<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Glossary Net Income<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6518256<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 260<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.19)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 225<br><br> -SubTopic 10<br><br> -Section S99<br><br> -Paragraph 2<br><br> -Subparagraph (SX 210.5-03.18)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br><br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 944<br><br> -SubTopic 225<br><br> -Section S99<br><br> -Paragraph 1<br><br> -Subparagraph (SX 210.7-04.22)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br><br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 220<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 6<br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358780&amp;loc=d3e565-108580<br><br><br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation S-X (SX)<br><br> -Number 210<br><br> -Section 03<br><br> -Paragraph 19<br><br> -Article 5<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_NetIncomeLoss</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SupplementalCashFlowInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EPIAE">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
        <td class="nump">$ 13,263<span></span></td>
        <td class="nump">$ 13,268<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
        <td class="nump">45<span></span></td>
        <td class="nump">33<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
        <td class="nump">13,308<span></span></td>
        <td class="nump">13,301<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
        <td class="nump">3<span></span></td>
        <td class="nump">12<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
        <td class="nump">3<span></span></td>
        <td class="nump">12<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 parvalue, 750,000,000 shares authorized, 230,293,141 issued and outstanding as of September 30, 2013 (unaudited) and December 31, 2012</a></td>
        <td class="nump">230<span></span></td>
        <td class="nump">230<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
        <td class="nump">25,768<span></span></td>
        <td class="nump">25,766<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage', window );">Earnings accumulated during the development stage</a></td>
        <td class="nump">14<span></span></td>
        <td class="nump">0<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
        <td class="num">(12,707)<span></span></td>
        <td class="num">(12,707)<span></span></td>
      </tr>
      <tr class="reu">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
        <td class="nump">13,305<span></span></td>
        <td class="nump">13,289<span></span></td>
      </tr>
      <tr class="rou">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
        <td class="nump">$ 13,308<span></span></td>
        <td class="nump">$ 13,301<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19,20)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 20<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 19<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.30(a)(1))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AdditionalPaidInCapital</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.18)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 12<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 18<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Assets</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_AssetsCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Glossary Cash Equivalents<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 1<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.1)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (a)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 230<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 4<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3044-108585<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashAndCashEquivalentsAtCarryingValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 30<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CommonStockValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Cumulative net losses reported during the development stage.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 915<br><br><br><br> -SubTopic 210<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6472335&amp;loc=d3e37729-110921<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.19-26)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_Liabilities</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.32)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 03<br><br><br><br> -Paragraph 25<br><br><br><br> -Article 7<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 32<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesAndStockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_LiabilitiesCurrentAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 8<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section 45<br><br><br><br> -Paragraph 1<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_PrepaidExpenseAndOtherAssetsCurrent</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 04<br><br><br><br> -Article 3<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.31(a)(3))<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_RetainedEarningsAccumulatedDeficit</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 310<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 2<br><br><br><br> -Subparagraph (SAB TOPIC 4.E)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br><br><br><br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Staff Accounting Bulletin (SAB)<br><br><br><br> -Number Topic 4<br><br><br><br> -Section E<br><br><br><br><br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher FASB<br><br><br><br> -Name Accounting Standards Codification<br><br><br><br> -Topic 210<br><br><br><br> -SubTopic 10<br><br><br><br> -Section S99<br><br><br><br> -Paragraph 1<br><br><br><br> -Subparagraph (SX 210.5-02.29-31)<br><br><br><br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br><br><br><br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br><br><br> -Publisher SEC<br><br><br><br> -Name Regulation S-X (SX)<br><br><br><br> -Number 210<br><br><br><br> -Section 02<br><br><br><br> -Paragraph 29, 30, 31<br><br><br><br> -Article 5<br><br><br><br><br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquity</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_StockholdersEquityAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E6F">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Polices (Concentration of Credit Risk) (Narrative) (Details) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_CDOM_ConcentrationOfCreditRiskNarrativeDetailsAbstract', window );"><strong>Summary Of Significant Accounting Polices Concentration Of Credit Risk Narrative Details</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">FDIC current limits on bank accounts per banking institution</a></td>
        <td class="nump">$ 250,000<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashUninsuredAmount', window );">Company bank balances in these bank accounts exceeding the insured amount</a></td>
        <td class="nump">$ 12,927,193<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CDOM_ConcentrationOfCreditRiskNarrativeDetailsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>CDOM_ConcentrationOfCreditRiskNarrativeDetailsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>CDOM_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashFDICInsuredAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashUninsuredAmount">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_CashUninsuredAmount</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0EGH">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Share-Based Payment (Narrative) (Details 2) (USD $)<br>In Thousands, unless otherwise specified</strong></div>
        </th>
        <th class="th" colspan="2">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_CDOM_ShareBasedPaymentNarrativeDetails2Abstract', window );"><strong>Share-Based Payment Narrative Details 2</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
        <td class="nump">$ 2<span></span></td>
        <td class="nump">$ 5<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CDOM_ShareBasedPaymentNarrativeDetails2Abstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>CDOM_ShareBasedPaymentNarrativeDetails2Abstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>CDOM_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 230<br><br> -SubTopic 10<br><br> -Section 45<br><br> -Paragraph 28<br><br> -Subparagraph (a)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=31042434&amp;loc=d3e3602-108585<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensation</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>debit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0E4G">
      <tr>
        <th class="tl" colspan="1" rowspan="1">
          <div style="width: 200px;"><strong>Summary of Significant Accounting Polices (Income Taxes) (Narrative) (Details) (USD $)<br></strong></div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Dec. 31, 2012</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_CDOM_SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetailsAbstract', window );"><strong>Summary Of Significant Accounting Polices Income Taxes Narrative Details</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrual for uncertain tax positions</a></td>
        <td class="nump">$ 0<span></span></td>
        <td class="nump">$ 0<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CDOM_SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetailsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>CDOM_SummaryOfSignificantAccountingPolicesIncomeTaxesNarrativeDetailsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>CDOM_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 740<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 15<br><br> -Subparagraph (c)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-109319<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:monetaryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>credit</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ELE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>2. SHARE BASED PAYMENT<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_CDOM_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">2. SHARE BASED PAYMENT</a></td>
        <td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"><b>NOTE 2 - SHARE BASED PAYMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">On August 29, 2008, the Company issued options
to certain employees and Board members to purchase membership units in the Company. The options give the grantees the right to
purchase up to 2,398,400 shares of the Company's common stock at an exercise price of $0.23 per share. The options vest 20% each
year over a five-year period and expire after ten years. Stock option compensation recognized for the nine months ended September
30, 2013 and 2012 in the accompanying condensed consolidated statements of operations amounted to $2,000 and $5,000, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">A summary of stock option activity as of September
30, 2013, and changes during the period then ended is presented below.</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b>Weighted-</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b>Weighted-</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b>Average </b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b>Remaining </b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b>Aggregate</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b>Exercise</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b>Contractual</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt"><b>Intrinsic</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Options</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Price</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Life (Years)</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Value</b></font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="background-color: white"><font style="font-size: 10pt">Outstanding at December 31, 2012</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">385,000&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.23&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.66&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="background-color: white"><font style="font-size: 10pt">Granted</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">- &#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">- &#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="background-color: white"><font style="font-size: 10pt">Exercised</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">- &#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">- &#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td></tr>
<tr style="vertical-align: top">
    <td style="background-color: white"><font style="font-size: 10pt">Forfeited</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">- &#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">- &#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td></tr>
<tr style="vertical-align: top">
    <td style="background-color: white"><font style="font-size: 10pt">Outstanding at September 30, 2013 (unaudited)</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">385,000&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.23&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">4.92&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="background-color: white"><font style="font-size: 10pt">Vested and expected to vest</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="background-color: white"><font style="font-size: 10pt">&#160;&#160;&#160;&#160; at September 30, 2013 (unaudited)</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">385,000&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.23&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4.92&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right">&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="background-color: white"><font style="font-size: 10pt">Exercisable at September 30, 2013 (unaudited)</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">385,000&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.23&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4.92&#160;</font></td>
    <td style="text-align: right">&#160;</td>
    <td style="background-color: white; text-align: right"><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-&#160;</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">The Company had 575,613 warrants outstanding
as of September 30, 2013 which entitle the holders to immediately purchase one share of the Company's common stock at an exercise
price of $0.44 per share. The warrants expire on November 13, 2014.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0"></p><span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CDOM_NotesToFinancialStatementsAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>CDOM_NotesToFinancialStatementsAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>CDOM_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br><br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 505<br><br> -SubTopic 50<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6406099&amp;loc=d3e25284-112666<br><br><br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 40<br><br> -Section 50<br><br> -Paragraph 1<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6418621&amp;loc=d3e17540-113929<br><br><br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 4<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br><br><br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Staff Accounting Bulletin (SAB)<br><br> -Number Topic 14<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>nonnum:textBlockItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	word-wrap: break-word;
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ECLAC">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Share-Based Payment (Narrative) (Details 1) (USD $)<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2012</div>
        </th>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_CDOM_ShareBasedPaymentNarrativeDetails1Abstract', window );"><strong>Share-Based Payment Narrative Details 1</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares made available under option grants</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">2,398,400<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Option grant exercise price</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.23<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Option vesting period, in years</a></td>
        <td class="text">5 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Option expiration period, in years</a></td>
        <td class="text">10 years<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of shares of common stock available for purchase under warrants outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">575,613<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Warrant exercise price, per share</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">$ 0.44<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_CDOM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExpireDate', window );">Warrant expiration date</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">2014-11-13<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CDOM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExpireDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Warrant expiration date</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>CDOM_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExpireDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>CDOM_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>us-types:dateStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CDOM_ShareBasedPaymentNarrativeDetails1Abstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>CDOM_ShareBasedPaymentNarrativeDetails1Abstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>CDOM_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(1)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(2)(i)-(ii)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(2)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:durationItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (a)(3)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher FASB<br><br> -Name Accounting Standards Codification<br><br> -Topic 718<br><br> -SubTopic 10<br><br> -Section 50<br><br> -Paragraph 2<br><br> -Subparagraph (c)(1)(i)<br><br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>us-gaap_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>num:perShareItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
  <head>
    <META http-equiv="Content-Type" content="text/html; charset=us-ascii">
    <link rel="StyleSheet" type="text/css" href="report.css"><script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script></head>
  <body><span style="display: none;">v2.4.0.8</span><table class="report" border="0" cellspacing="2" id="ID0ENGAE">
      <tr>
        <th class="tl" colspan="1" rowspan="2">
          <div style="width: 200px;"><strong>Document and Entity Information<br></strong></div>
        </th>
        <th class="th" colspan="1">9 Months Ended</th>
        <th class="th" colspan="1"></th>
      </tr>
      <tr>
        <th class="th">
          <div>Sep. 30, 2013</div>
        </th>
        <th class="th">
          <div>Nov. 01, 2013</div>
        </th>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_CDOM_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information</strong></a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
        <td class="text">Tiger X Medical, Inc.<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
        <td class="text">0000925741<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
        <td class="text">10-Q<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
        <td class="text">Sep. 30,
				 2013<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
        <td class="text">false<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
        <td class="text">--12-31<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Is Entity a Well-known Seasoned Issuer?</a></td>
        <td class="text">No<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Is Entity a Voluntary Filer?</a></td>
        <td class="text">No<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Is Entity's Reporting Status Current?</a></td>
        <td class="text">Yes<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
        <td class="text">Smaller Reporting Company<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
        <td class="text">&#xA0;<span></span></td>
        <td class="nump">230,293,141<span></span></td>
      </tr>
      <tr class="re">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
        <td class="text">Q3<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
      <tr class="ro">
        <td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
        <td class="text">2013<span></span></td>
        <td class="text">&#xA0;<span></span></td>
      </tr>
    </table>
    <div style="display: none;">
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_CDOM_DocumentAndEntityInformationAbstract">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div>
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>CDOM_DocumentAndEntityInformationAbstract</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>CDOM_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:stringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_AmendmentFlag</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:booleanItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>End date of current fiscal year in the format --MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_CurrentFiscalYearEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gMonthDayItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalPeriodFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:fiscalPeriodItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentFiscalYearFocus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:gYearItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentPeriodEndDate</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:dateItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_DocumentType</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:submissionTypeItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCentralIndexKey</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:centralIndexKeyItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCommonStockSharesOutstanding</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:sharesItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>instant</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityCurrentReportingStatus</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityFilerCategory</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:filerCategoryItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br><br> -Publisher SEC<br><br> -Name Regulation 12B<br><br> -Number 240<br><br> -Section 12b<br><br> -Subsection 1<br><br><br><br></p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityRegistrantName</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>xbrli:normalizedStringItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityVoluntaryFilers</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
      <table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
        <tr>
          <td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td>
        </tr>
        <tr>
          <td>
            <div class="body" style="padding: 2px;"><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div>
                <p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;">
                <p>No definition available.</p>
              </div><a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;">
                <table border="0" cellpadding="0" cellspacing="0">
                  <tr>
                    <td><strong> Name:</strong></td>
                    <td><nobr>dei_EntityWellKnownSeasonedIssuer</nobr></td>
                  </tr>
                  <tr>
                    <td style="padding-right: 4px;"><nobr><strong> Namespace Prefix:</strong></nobr></td>
                    <td>dei_</td>
                  </tr>
                  <tr>
                    <td><strong> Data Type:</strong></td>
                    <td>dei:yesNoItemType</td>
                  </tr>
                  <tr>
                    <td><strong> Balance Type:</strong></td>
                    <td>na</td>
                  </tr>
                  <tr>
                    <td><strong> Period Type:</strong></td>
                    <td>duration</td>
                  </tr>
                </table>
              </div>
            </div>
          </td>
        </tr>
      </table>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>38
<FILENAME>0001136261-13-000486-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001136261-13-000486-xbrl.zip
M4$L#!!0````(`(9084-@H(F5=RP``$^``0`1`!P`8V1O;2TR,#$S,#DS,"YX
M;6Q55`D``]RT<U+<M'-2=7@+``$$)0X```0Y`0``[#W[<]LVTK_?S/T/.%_;
M:V<D60\[CIW'C2([/7U);-=RVN9'BH0D-!3!$J0?_>N_W07`AT3)DBS+<NK.
MU)%(8'>QV#>6U.O_WHQ]=L4C)63P9J=1J^\P'KC2$\'PS<[G7K7=ZW2[.^R_
M;__Y#P;_O?Y7M<K>"^Y[1^Q8NM5N,)"OV*DSYD?L9Q[PR(EE](K]ZO@)7I&_
MO[OX"%\U_"/6JKWHLVIU`6"_\L"3T>>+;@IL%,?AT>[N]?5U+9!7SK6,OJJ:
M*Q<#UY-)Y/(45N?X[!.K'W[?/&[5X4^SWFC5;@9`^+$3PVW\#I<;#?A3;UPV
M6D?[]:/6P8*H8B=.5(JJ?O.R7F_5X3\]_?5-/_+%$?YEP/M`'=TH\68GM[KK
M5DU&P]UFO=[8_?W3QYX[XF.G*@(5.X'+=^PL7P1?R^8U#@\/=^FN'3HU$I%;
M'*U=O-UW5`89"9PS?HH2N.O%Z83\X/U=?;,P5)0.?:&'"CO4XQ/C%'=K0WFU
M"S=V<8.J]4:UU;##(SZ82?*+7;AK!PHE]YJ-@WGKTR/LA"2.9@X^W(6[Z4!5
M'3I.F`X>.*I/`\V-$JKA3B1]KDKGT)V228$,@F1<3I,71[OQ;<AW85`51O%(
MN.F\NR<5)P`->+F<.KI30AVJ5CK!=2)/CKDG7,<'71W3^/IAJ[YC%0F%[TB1
MB%_P`2.Y/1K1;KHPM6HGU&Z4MV-N(^HW.TJ,0Q^$<->"THKERB#F-S$3WIN=
MMCH;`(!&M=%$"LW`="@/8A'?IE?3Z\+#.P/!(T:4\0+;K!QVNA]VWJ)>'S;W
M#_8:KW<G)V?H=DOQ&6PAL%QZ)520FL5OLP6D*,R=2?@%2/:BX<>=3&H^=28U
M'Y))[R,YMK)>;\12?SZL9I+\1!@&3(EB]')OL^582-F]J6G@C7.3<-T9>J\P
M92U\;N;XW'SZ?&ZNPN?F0_+9*'VKVD#"GAAO<TIO%O"@EO%I*GJ!205)>B#W
M\<29U'Q()F7NX^#;<A\'V^H^#KXM][$\G]?N/I)`:"9_[AU/<7/,'95$_*W)
MG8Y@C`5F;Q51(+09\'LC)^)J)@K#!!JT,@Z@[WP&'D]<P39.\Q;GGF*"A"6.
MW.WE>3!)8QG4'-)C'LBQ".Y">S=?)O&6`;;W"UQ8@*'G@.:.+0OAX\H;]H4[
MT6R9@"S\Z,OBL#TNCDY('R_X4*@X`DN/Q1MF!/\"T\]Y(?^E&()]^)U]TJEM
MA74#M_9Z=Q;<:;P=,`>1XW<#C]]\X+<+(\Z;G)G0\NB.I0O2%<27D#,OC*51
MK_ZBX>>GEX$])_-QHHW+PO#S;F`FM#RZ-MSU<,1[WQDNC&;@^(IK#`4`><B=
M)(KPLE"PCRADRZZE:M/.>="F!>`W[OL?`GD=]$!:9<"]KE()R-2B:$]E7@!F
M0)M&^ZOTDP#\Q^U[X?-(K8AN`DJ)>&L^7/!01K$(AKHFNC"V+VC![H(VC96H
MZ0"[AS):7*5Z8\>'>2P%SSIR'#K!;9Z$`N@R1=!;K@7X/5Q;?+&_M(I*,`5I
M-CJ4L.60X><R="FDDKV4X[$,>K%TOVJ/>9;$&!OC$4$![T1.R=#BT@WC:)G'
M70',5F]VNJ?O@996O7G8:DR8LCG8+&VFGGIT'O'0$=[)3<@#Q=N!=Q:/>-16
MBL?*R$P9@;;2E1&($4V.NFIKYVT+2_:O=Y=`M2;J[%;-I6YO_[[4Z9LKLZ<!
M_&D4:-``%T>ST#H1S<L%T'P43E_X(A;\'DMJ%A#E0"Z);:&5M19%EE,(.E%:
M>7U-.H3*<$X"7@7Q0DM=%G';\X`3,@`C"$+=#3I.*&+'7WWA^P<O7A2%J!S#
M/0A9C!%`R,M5"+G@L2/`JY\X40!V4+5=L-V)#^[(.^8#X8K5[1R,.:@?%(BZ
M&]MZZ%N(9VNA+Z=>8!Q)\D;2]R!T.?DS`:>S1C-X%ZIUD+:BZ5R6M)R>GCO1
M681A%_=(92$Z(>^\,./.9\0`]5H="QM+H%P3E:4\W`B5&D<[B4<R$G]Q;S$>
MSJ#L``.!F>9U$M4]J9KFV6:HHF3F?GS*Q9IWH+D'-0OS9XW4W!&,KY5!<T+Q
MY9.$-;)J#ET],0P$^`0GB,%-2,A:8="Y],%+<'4)1+WS`<S"Z=,/?OPJ9"J^
M]?F;G0%,.F*->ABS2S&&6/"47[,+.7:"BKY083W(X@:OV-B)AB*H1F(X@AGU
M](+/!_A]YX=A_`I!]_%#H\;P\RY]8>GEWN=/G]H77]C9>];K_GS:?=_MM$\O
M6;O3.?M\>MD]_?F'?S=:K\[//G8[W9->!H$^A?0)!^@_#[N,#:(K+<2Q'W]P
MQN&K?[?V[/WT.]$C(P;Y$4LOFGP__?Y3A0UD-.:1?\N^8E6%.8IUL)6EB*?"
MPHA?"9DH&"A#K.&"88"Q3L!D!.8MQ-',]+^`9%\)%YV1QH:4J!"DW?'%7Z@F
M(H`A"@4V&%9P-/=EB#=`M''M7SE5)T;`#P;(D$1LPV(1!_%5<92XL;CB[`\I
M(+/4R!3-50`%\*L$V)<1HFH;WJOC)$+Z09_J%=H`PW?F"84**`*TJR)6>I.(
MGQ`;FS5`I$*3')U1#D!+<6RZ!:R?*(@*E6(^_L.\%!LHU#L.Q"!?F0S8_SE!
MXD2WK%&A1K\B+7WN4B'8!SQXD.,1,;BG=D>P:`(,<H:<Z3.=&CM+=.$.5D`X
M,M)%X/J)QPF%*WV?NWC=[&@`,`B:'#`)(")YZ_@0\L$D"31PB&^1(0&1`/`#
M,_M:Q"."2,DP.T\B=^0H^#J,N`9((]H@@A&_J:!$7G/?QW]S5,82>"?',N:$
M7$L\7O)`D)1AN+10-!MP(SC_2D)I!.T*\"408X5.%`<``)2KG]QR`DA$1GP,
MX;H6\)@3"Q(00D`$;(+5@G[!*ONW^6VHL<O<GEP+)-Y7DHCH`V>N(-9R2!L&
M"6$7P157L69FB'4\]"O"R'^BX`.2@_+B.FJT:<E/C3A^$/CAG:.$PGT_!_\%
M5).X$%4BM:*/8;Z1[8YK3)3QW1X6E2C@`9D0'AFYON.C[=%&;,1!"AU:SC%W
M^;@/N]_2VM6LL.N1<$<,!!1TBZ.)B\!*>5J!<UO^']BK!+)AO`7F*D"[B&H6
MDT0K`S\>.6#;X&*%=A;F$PE)8.?.H#<#*0(RG*1(!#"3,XVBQ\/8K*&N+02A
MLN*,VL#I"L@T9Q")Q"-ML3A@]F9-U[Q(N1!BQ2XB[29^1QZ9<M);)PU48!C8
M`A'ZL*U#ZJ[VP=/`?<1!<Y&BSP&NG$B@3(16T:9.3B?G"C_7>C7V<[M]GODY
MK12@E9$8SV`1TI[:&V'=#)HVL`WO81C#PR(:!I9"N+[>D)?5>@O)N.!#S,P1
M4J_Z>PW<)@%"OV8V(#.#%?!0("GE=!A#"G*`ML#[(]':3A9-"1`JX`?81[#_
M8-J)!%R;PP:.0*.6*=G$IH/890A#J81>=:QI0>&Q@F;-.FP+@$O\6!L7M"=L
MX,MK;6)HFCY4!P>+=)Q-3;.B9#FOA[/9\@,&+I!QNC[AHX_`H((<OEF0A4XJ
M,G;0E3%^`P&&%0Z+%KT60+P%_[)I0]@!BP_.8$K"!E+&`7HB#`5\B<>W1$J`
MHWQ:+FT_R7RI>2C1HQ*-*5>MD0-<)+648Q'CN#")5`(Y`Q$!@D[\37RN++.U
MSC&C;SWN0K21^IN3&_#'P9!D;"P4/OJ0T\/>22?30')TX+HS`U:Z.C62B>]9
M]Q=QAQ@!HO]'$N1B`O3C\XUHX!7-.S)=%;A;U(UV$*"SUF=C$#P1"5;M/Z22
MC+)DY'?*`P`E/EP'&C\Y$*BP9E.+]>,[X?-,!&!;.ZF_V!Y7?*<WR_:6R,F'
MFT;6:6VE:5*%04K,?9.V=`-\J@;7/I5$Y8;E<R30@>J'`)SAQX^=O)\)1#8J
M#1M!\Z\H^?@]Q*_%*?9F7B_:8.=5EKUK8VDDEV%GA7*,(\K4E_N"^EFX58]L
M0Q]?VBY,=)]&Z5L@8V=9-M3<([5L%-,ACEPG=L;2[.6B6<>D$)D\(@L^?B0I
M36?W.64E^<3<S)F),2>-1)PUVQB;Z+"S$-[A-,II%&9#N632&/6+8B)]+*X$
MV>XL"])YR9UD$:,@7\$D!]NH,I=O:0&0D+9S1&.SOM"YU4::_XDF%T;L?X^4
M!8!#.3G?DUGG-%D;.Z#TD$)9RHRA=AB`BF(J9/0IX]!!$5P9LR1$'*B,VFI8
M[C?K&(-"MHQ/!:)D&+3HEW$,FJ`:,\G\S(A8>P,=E$Y%-$49,XS`G<'3M2E^
M`/[O#AH5?((.D7S7.'B)7RH8\6!X`W/]VXI.*-)]RNC3/GPVC=,15W-Y^AJ'
M&7U[!]/DZ5!0^WIGK.TRAG41'_@4H6'R$7%(IA..KC)>,`_+^78L(J2%A\<W
M=Y\51:8G*A9C#)*VP-J]+PN)RC,Q(H7L69HVP?;\F6#@G"O<@`*-G:\04MM5
MZ@A+J60<FBP)HW%G,(!--E$Z1E*XW^/4.QLKA%/][(Q.:[">17F(T<.9@=TL
M\$:L]""N>T32^E@VB8)BRD3`^8*"#)G$+A*C/GC06LDO'=>M<@N/N*^S'+2O
M6):OXC.E7J8FB-WC`QYI9E.)*W9NS.J!QZ`H6O`AVL5@,\V;1D+%TF1U63!3
M@>VB2I)-?%R,D2&#`&9'MKP@56YS'E\I+HR&HZ<9!F*+(LW,J5@K1(FU,B*D
M;1X18N_G[2W+>]YX`1=98Y850E$!&[CQE[:"9/I(>K$8*W%UI@B/V;:NH6HE
MT?00`.QZ=/J8ZBE,'KW'W^I36'=72_DYR".=5&W!7F/AT:68PJA@B`\ZT"FY
M4'0VD5!]3_,V4=9&7'.$RKTJ!-L1UKZ#A%PF"(=+YW$:"$A+[N`O9V.L93D6
M/B&XDX(A1%_!4!?6C/F45/SQ$`(&3B'DKI#+4T-.G@(RN=<0MBY$RSQ(1@6L
MX0%Z(Y+>J8&0Y"<@?I#'AW"1WT"F(K3_4WA,";9,>P.(OJZ="-O"P>"=RKO7
M0EPQV;G)\,Q9`K(I+6CI4Q3-V8R=F18YB:*D4$1,@)X#,Z_IF"H654O"XVN,
MT99+YV8KHH5NZJ+,/IB$FNM:<`+Q6)0E$6FB:SWX+1MS\#\H9M;I9=YNTM>;
M6#`U@S9=,*<;.!%E$0(0'M"I7AQ'H@\"@#(72^/TZ)XI$L77W'C3DGB!N2"$
M%%;FP@1^`Z).UV:0J$,,$*$LL"7*T,^K_"%3ZKF)%D@;S&1<!?!!&/RP2%`&
M3RW.(?-D!Y[H(*$\<"ATQED1!2&VWDFV(@Q]3+1T`./<$*^,R3%:A&4K*AW:
M9!'#!6`1A$.8^.2X2NCST/MZOZXH.\:Z+X]C'_P.)8B^^,I],9+2T_&7.>$U
MH93A&@_X``^D*'`R).?L@#?%$S2/YN2+>_K\PV'F)`SKJ+XOKZGZ672IE&I"
MFLC),!(-9;#!O!&&L8S,`O!$#M)]K#SK*!9V%U=*-AL#QJR87@*0#NUPKBY8
M^DA+MM-V4^;MMNOXKF[K8R8,[J?'N!3*!I[%CQOY2AM&77DU&PQQ^&P2=<V@
MC(&%4!7'9TJ=<R-4],R*S%.!C%.$82)O.B#5>T_"DO=P,B@A<YHY:/#S"TW%
MOT@"W"J<1.=\G]Y0>Z:2RB4I%!D(2O(?+PQ-Y5SE2YETWDNFU]7G"#8"#/+Y
M1)$#J&$S,R:/8R6$V@6N1QRSG;N5@'"D!T4HY;8LKQ*E&U-M%.!0,1*'F=-M
M,$F1#".!V1R`(4'6;7"TKWT^0+RX?CQ-MY)KI,7N;N25K$P?Q*:KJ^'1G+5G
M.7IIG1A2$+2T?(:K*UMR.B"_=DL.*7A^V168@B,,/PI$ZPVIL=\(/9IFX:)!
MQN8$)5UA:K98;%0Q[0TH"Z0<UA90-<VNOM@=@&>JN``0DB@QOC/MK\'3N%1<
M)E@Q\[CWQ_0TYB?4UJD3C<</E3H2UH3/_%DCW-%^]4*HKUL0.M'1!9Z+I@>D
M6#H!E2;-&W$_[6HIUC/3%AZ(@/FMZ7DB(%2*@$@C^)J=:Z!<4(G&EWBP0,4]
M1W?3TTC=<@(Q39SD^HB2_A_6B>O#K.-N!X<E$9E^/$$P-;WF?IV*>J'!/`&O
M!LEMN0`5RH>X+-TL86TPZ"2"TQ&C70R_<3E'S3;G[!3FV`#^EGW7:%8.FP>5
MQN$6G)M=<!0^EC54LO-(!A+U3!]%;84$HM6@@W,JX`8QN6AJW2V<`A<(UR)I
MHHV\@;GE.O_T(),SQG`B(*13*(=AH2E"5Y.Y]*(+LO:GDM:M"H7;BNU0S/H*
M-K[A9/4;+^H;[QW]^R%.T67MS8NU+$\U.D\]SG$*J<1QVDZQG;W.K1KK79YU
M/OSO[./QR47O/^SDE\_=RR_LT>S&&7509`]!9$]\I;70`^T6\'_3_J;K7EDA
MC$H^Z&RRD2P;%48VQ*>!NGMTXJ+MW]']P#8XPH/+"".B7+55>Q$31-ZR(=:6
M=#LE-H-@OPW)DCX^P))&A,FM-D#D6`,=E8)SUA5=G/9.0EY.[7P";&<L(S7;
MV2$4(J*L]0\;>CR*SK1YQ,AV8J7:)I?;N,VJX#=N:K;*QBUJK2;-G'['K-\.
MO+8'V16]8P,+4>;1YT6-V_PGYPZ*3P+?@7,-)):][F[^T\/-^H9)+'MUU3*/
MJ&^$B5,O?9J_S_5[[7/:UZD+Q1^QS+D.\2L^JER"945"EA:R:O.@]4"T+"U-
MS0?DRG)24WVY-%/H[.\=GH9C2@&RI-/V=0A+48++$:U.SM(BL[\".5T\58-!
M$#_0O]W`A+WJ@AIOJ&Z_#E[E*%L$Y[KH7)J)>T4!6P^MYA4AMOY>^JJ0M7"Y
M.O$>C=5(>;@%+;T=!P<;68_=U'/G%G<4O9`N:,YZV\C*&W2XH'C-H^3AUK.\
MFWK1V'^0%>EB-+Z88_WF)X.]+-ZE^;,P7G1?=/B^MB5/>.T)%"M0L+Q#VI\R
MIO-(^,UTN;1UD\LI];B<#4S3ROPGVQ=BTN)/N2])R@.L9#ZSG])*YH>;3VDE
M\\/5C:TDR]3/!OG8[D+W,G2DBE46_9V;%M#MK$&>GEV>L":KLM[_VA<G[%V[
M=W+,SMM?/IV<7C[F@QGM9)BHF#4/L9I6?UGL23<G&::OS#ZF9L\Y^3CTY2TW
M33NZFC>FXAP]MAG:=DQS;21"DB$U\?R7/F>UO6M#ZO>!"[K&:([F:16V#ID"
MUL\6-"NMPY>5O4+ULW@R5JR8XE%?UCP71OBV!#R(J]>:K:RMK4@5/O8-_/F>
M<<<=$1'4EH&-.?CT)]!<I0NF[\&T0&,;MS.(L8&+![H-J,9ZN58]:K!+4Z.2
MSJPYCQ$0%5,/_UK>WJ>KWQP(Z@.G[YK9(P?[94\<;%9BV]AL,S;/B^2['K%-
M6UQA<7KBP+W`)UV-UDTM:KI9$S\&AM%"V0=ZL=#-?7D]<ZVZ0<[EOJ]"QZ7?
MM`)[B=]#Q_/L]Z7Y<2V\>(1#Z]_O9$@17V2!76'EW77\JN.+87#$^C*.Y?@5
MZSONUV$$N^A57>G+Z`A[SV*>@4$[2Z`\"PHMI05#6U!6SXV]9P@;AN#2PW&I
M,T'QR8M258'!T/)4=#C6]U8GO`M.2K^L1,4:%O)`W*2/T</IRB,O?_M`?#,"
MN<Q"3#0[>7R\%>MX5JQO`\0*\KB-XKC,,B[2-SAMXTHVO:?#8<2'$)\OP(MG
MY=SBC3PQB>8VRO0RZ^A(;`2F1V&W<2D;YD87F"$")=PGJ)Y][&Z/JAH38/0!
M%6O4]B$AI=K`*[8.#IV9FM'3EI7-\.H<:U"/R:G-+/.C&'#V(_W$TD_/<K$`
MP^A=WT_0PFS''GV3(+:A(O7P$%80Z'FES;FBOH!"YD_+G'CZ2:U[F+`<)Q8@
MI/622O`33+LWYF4,7SDKB_9NN45]MS'VX0G/(_)N=<+W:R]>/&_Z:IBJ"S!N
MR^S-S_KQBJUBT;;(UD;TK<J>I)EX5+*W<R.?GO+;@M&S^O\]]>B)DKV=&[EN
M]8]E^)"Z_UY&`RZ>7?_]02]5GWE":O9$R7ZV#NLO0\Q_I<R26URJ,,U:$S7&
MDTG?OU>V]URW>'`6/W)MXV$7MU<[;#X+S\/Q=WO2I`?T"!N%\(TO;QL@;`F+
MMZQ\\"M7]"I+\Q)V^]XH?(!A6X+5I[?'WS*$+6'QEJE1CLBYG]8>B#\'V<^'
M@\_!\:8V_3GP?6QQ>&++VP8(6\+B+?/8YMR,'L5\=LK?B'U^=LI_PTU?T2GO
MTF/8A4O?QLL\BZ^A]]C^P7[E!=@S^QL_^1\@(EIFOG)>_P`)_O1'[.NW+)BW
M8V*)0(S'W,-7Y/NWV;L;9,#-S_PL\U8%HB+_9H6]O<DW*Z3$F_<D`*13>:7I
MQ>?T@=Z]1WQ=:U$"_P[O3WTTQ"FZ[+TQ]WSQR]1+&O$-:1-O4#3O3\/?3UO'
M.ZA>%M_6.!?A_<E;^@55FR5O^;>X;II[R[V,LWD?\J*A$XB_2'P+O_W=#KQS
M_7X1^GHV2'\WM)>^E^7_V[OVWK:-)/Y5B"*'MH#MLV0[MJ^'`/(CA:^I[;/C
MN_9/2EQ%3"A279).=)_^YK%++A^R2)N2:(5`FT02N3LS.S,[,_OXI78`3U>[
ML7T]EQYM:B8L`Q@WT)_5[\EGHD==I9-\J6:PY///.WC=SI3@BQ4$9&B=V]()
M\D#F,RD>W2`.X4&^+4<A,/E6(*,)?`5/6U-^!U3H$><_=0T/48+7YL#X$DH7
M7M3#]Z[#AQU\6GC!3(-.,28)HY)^FN#<B202=(C,PD=_#EP$4J+.%/8(M((@
M1#&(+R5D[?@."AH95&X_>ZF4`TH=H/+BU5*N@L,P;Q]"'B`L,:&SZ<YXEW%T
M:0A2$!>/@)6<I+?>GG66`'@%*?)XKPP4&D$+IP@Z#?V`;2G$,(6J12-".%40
M77T2'#?-^29]Q0'U8:)?$=25PDXD#%&ZFHA&-,&TQ<N6H`F-\*Q`I80M?9$@
MUD#[OGJ;P&<([;0:(KH!D6=0&1%,^#3`*_JA<];X%-J;!9X@D+,8<""$($0:
M6RG:(_2'6(&('.4C,*>$D9@+F=Q8)9-3_(BS1")`]%Q$I!(2N`7[8N"`P@U@
M>DP(\0F1F(B(H=`H783+Q4B%KH_K62S,&8+$H??6Z(%QJ)#045\0WV258>0:
MPJ=U=E$2BZU[`LM/H)D^Z>GY!B>[H?X'`0_=@M,9N3./+YW+4$JB7#4ZT494
M8VTY[X)KZ\IP]H@<T_LFB%<IDG=^-@<=%)Z:Q:]\/WA4>"6YF,)XS`P9'GQW
M]S=?".O#AW/C:?@Z?2KQHN="/M)<_,<,/V9?T3^F[^U9`W"!86HNC%FG0@DK
M@L0YM$<\Y1#BR1!16`6"BFD4%T-D""*V#@_XFI6[I(O4`S[E@?+>ZB&$E/4R
M@:O?L']Z8'3HA)[U.J6NX5:5$=^7X9/.\%9YR2X#?:9T,,D@4BBJ?-B[W[-^
M'0QN(;#[*\9"G1'(0KPXM;]`@);H.Z$%AV$\5?>F,H:=`E:GZ!"CM01SD$%F
M2^%GV7?R6XX"EEJ`,YV`1I<V#PF#@%0C3+9$^6'VZD]^B6#Z%&+[8!I@7(]Y
M/I$13>!7$+;!.O(=&HP3O+**LZG*N8MXU0[$R7,3"%9A4ADXLLP]R!B2.84F
M/`D0E547&"`##*-`<@:9SF8[%E_&D^#[P7P'(3R#27.^Q,"L"8U=&-RF+DKF
MF>S<D9]9[EB/[_B2X'8%PVN82;(3FQ*&94BC"[B;6F3Z,=1.,X-(J.H51(C^
M7?D9H>L&"VL4.VKMJ0!?3L&Z`J`5Z!5#783#BYJYAJ)1T>EE.PQ\>^C-5:6&
M(&P[U[;YV.G)$'JI\\I[NTM;8A$IO!62%GJVWM?514?&M0U>>[!`1A8):2TN
ML%4Q[9D=NB/+%Y$.J9)59G06F##'C%-*A&#)F&.^K_HN8EO=Y>L3-(4)KZJP
M!(PS=X7KXO<LA62QG()/[J->G5>0S8CS#%F^@RU@(7\61%A@)AA8DP(*H;\B
MSG056IYJ23ES'4BZ"&"$OKGP(,(^T#ZJ>!884`FY&_=#+/[J9?P]ZSI8S@M)
MA:LTCBK9J%HYBLG6,/.\2L"23<69SA)V'%*5QY66"S,6"/,K+<-$[JXFX?M!
M>BWQMDN<YT)$I/8XV=2)K;-:D>U>>5="<>J"RQ<IZ562[RHGH,JS"NDD]ATA
MT^6^I&RJRP%S:RH@F44?IS/H-'7.%PZH_1(H%;5TA"^B(Q1_Q<*G)=,HDNXP
M9@R/*%`9-/VF%J"BKT*EYB7%!VL$'I!05HR:@_@&?I:^6T`BURO`?Z58*D09
M%@U"<P4O*0,0+1["B]++R`7(P57]`Y/@B9VPNH2F$$ACZ&SQI"A\FX^*P5N2
M*AKFZ3%[-O/F&GX''B%9J?E.N7!"M\$/'.=S[0%$A#C@<FY*E;HW6Q_R>,%,
MC%A#X.Y%%'D0U-.JH.=^$9X["0*'BSEJ^5S59934A"_&N-HG>7\0D6Q,0DY!
M)C@WJV5%X3`HC&VI949<L/6\X"NMMF?S%6@7FHE'@F9EHJ&L;9A;J8=I(!4#
MN-QI^P11SB4Q&%WDE`(&K#[QQ$?%KF*#M"**[Y*D4`+"L`4]*$^-]LCV1C'+
M1M74ALD:.=7%?$?WCP/Y"\_*!).C!SB,IXM)W"$BR@28J7OA\ZE1&S$,@2=]
M8F1D;U[,$NUL&ZJ,1ZO///:D+&9X%?@E9!:%@]&&R6BB_ED2X*?,,G\6,\B.
M=%03)GI)!D4.`JN7Z]Y\8:ZG:ST/S84Q6DPGUZO0O%1B#ZP9Q<FL!-#"%I9?
M'1$).:6]&%\G`DNGRXV`^I@%H:OV.7B>7O(/XQ")0O?$(:A-2UOXF-HZ`"Y)
M!C.)^U6Q&5+D&+R.Y'$=BC'VB_SC5@6MN4I;].A*IX0SWJJ3<+=GO:<9A/R9
M02_QB?$LM98LWB%W92PG#YB\:W+(P$VV=^`5?$+)(T,T#\B>]5_J'EVS.T*'
MC#L_PF#DJA5`QN"DL0%CL;W$%^#6BH3[[-:+"9@:,F`S;BEI2+)Y*0:WGJA+
M3A0+=QP;9R[06@M7IW:5F\U7;DHRB$4I0<GF#+S4F!WCG1M^23=\M"&-6'O.
ML.&4I24%H"Q1&1VA?3(<N**Z5":XY;9483.+'4ZXIHW_P+54F)9I]IP(+]GV
MESUAD>QQG`:^F*M-H=0(K4U"MN!_27>ZH&^G-5LP.IB?\3&>,N$#/LE[\B`O
MB6)CHV4\_*P#<:+@_<75.3X62PK?<$\)YS1O^D?[!`4Y4SWGVMNS!@LF@<R6
M2V3+]FQ*!#B.@GD5F^.L3S,COHV$P-D97R5RDE5=C`#>]/H[IV^/=DZ.US.#
MK-F&ND,@%>>6`F*P"$?2G?%^1*#(V&<H`S_`\(6"NNL@^E-$`R>81:(R"/FJ
MZEQW`OFT4EJM++';5GSZR($K_.]3(`H\>@G6L)&?4+$;JQH<,D<JP3.#U;G@
M0CH.I`JL<\4%VA]G6[BD+C%M2=/#;#JC8]F=9$-%!A-W!Z-7=-U$PABRVQ5L
MJ&_-CK=GF5'>%N]'$^'$GK@9IT>US,-<#/\]X*0-,IH'K`(2.C)C!]W"+!&>
MS?5]R`22<X>)^O=QUJ5#.O8:AK%ITQT.70O%%K826+8]EV]TD$^=0M9DI$,Z
M[@RKA?K81G6LPT:'=&R.:8=TW-XFZ@QDAW2\C:/:(1TODU"'=-PA'>?8[)".
M:PJL0SKNFFAA1>J[NT2U0SK>CBLT7^V]J1W2\39<9EZ9Y`[I>-,8>!V8X98,
MY.LS_@[I>/-:TYG_E@QDT^;?(1V_#I7ID([;17;G'9HO0W1(QZ\KA>V0CCO<
MF)8J3WO2I&U!1-MR]MK00DM$W++R08=T_(I4N`TMM$3$+3,C@\@G_]6!*K8K
M3GJU`707''_?BX/;,J5M.7MM:*$E(F[9C-TA'6^A?^XFY>]PT-N/=)REK[NG
MJQU=)`VG5S:L_K:%POT.I?T,\#YH!DDYFQ<P>@=X2ZDZ,&$L\ESS[=OF=0Z#
M\&9,^*SPWT'/P&=E1DR(UJOK]S^\@^DG@]+:.'4;8;^(GKLM[-/.O_#*O^7K
M*&IC,"^00X,BR%)8X!]-YXKNK&&D4WZ,R3+L*DQV.:V$Q]I4-#V.EPC?SG?D
MM'DP2\AL6A)<CQ[XSJ6J1G\,\*MVVWE5HIM7FR2':4(J^R>-2J5`W0J=O[XL
M0IUMSTS`U83R<']QN\B"(*M8R:3P%-5-"TOM%8LQ?B%%S5MR91%6<D9/B;,Y
M6;Z(J?6[KKI:6HS;UJ:E+V-FA8[N%<FP(M4K=(O)N7,Z&EI9/*9<]ALUV(6T
M;50(I>YK"X2PW(B3>T-:)Z1GTUXJQ.%R0H;+K3C;4:\I*:V$N,9TB6,W51$Q
M:A\OBC7[!Z<GAXT$FXO(:XS_R[]B-YI?^6$D8[JO\P:OC?XXL7TU!M>!_TC*
MVD`,?G1\]+;7Q!14E^H-B"LW)U*EX`+,^;WMRGI>:/%T?GBX5EDN94F+^?SB
MYO?G&W]U@B@D%DC"4\)\!_\^W.WU=E'UUD]:7O=NI<*<H=I+%;]3N<")>?]^
M)LM]NK.7DU;=]%=`FGD$X"5B6T*4T4T#5#VGLE63*GIJ$GB.D"%K[+-BX]V#
M'][U#OHGI]FZ2:'QYW6_-)3@[@_VCVIV?RTBAB;Y@$AHSTGM"U0<9DC(=%"[
M][[1>[]*[_VWQPUV#PP?UV+^8+]9YH]K,7]XU*O>_85X%%XP0\=\'V$>BA?,
MS"1DHA=B[([<:#`:Q5/&..-2>/Z-9]O)OGDQ^DNI6`]?E49_-Z?[S3.G[HT/
M89K%.!]2H@$C2WU((=C.8W!^B*/X7"_6SS!1H\N&J:UL<8T0FUH*FA_>6>CZ
M,0S)30)9<$80:`F2DX",*Y)V(&%6L>7\*A)3C&B0$1EX'F?TC!FV`K^Z0G(W
M+)G:/G^W__;H.Y'-2R>D[95,[<ER]Z2W6=%`$Y<,NWFF\`B;<!,%C@K=O(":
MVJ:Y4FIJ&\.J95-/`>M3<VZ'$YC2\*_+%.^,5[>N$'S>QLB"_VY$F7:S?K5.
M_TW37EOU>H>K)GX0G2NHZH4EJEZU@.OM\4D%6G/]-49DU=SV[2:)K)@!]]\>
M;%2258CLG_0;(/(NF-M>-+^#C,&/FS'W7DX-LUW4)Z"VS1X>-]I_[0GBN-<T
M__6FA-YIG?[YZSM&,*8MJ4(^NB,1JO?>"U&YI/,R1*^Z"*:*0&OP20HJ(=,&
MW,WBK-[XUK]L/T9\L/XA'?OH97`V+;J!5Z'#NSZ"Y/G6@.#D;V,YFN"\E?##
MN*$#&4VD^+9CP?RR9_W$&YD/#G]1WR>??[9^(@3NY.VAT.!B^7=R/1(QJ123
M!G>L62S#V/8)S>_KQ!U-,KQ05W2Z.Q2>Q_C?C.>N<+U1JZAPC]!HPKIP']T0
MH=+@#44)`UUK5HB.1<(@@.R9#!Y=!T9I3.C?*2T18Q9B-U+IQ8Q7$4*$=;4]
M?.+H;TB9#^V'X!T3,E,,5&C>`6(9+WYJ.P)13;70$./-@J8DC*`WMX9VZ#(=
MMH4@ZU8\(]!#WU&P\UKZ_?T(,69]H$V&"CD.OT?43'R&D.BMBQ0+#KOC02&T
M6-<7"#4;34*%#+<$RU4+`D<F`L8+\D#8V.,>H<9B!V_`8^,'PEC$I7%XUYOO
M6&,P=!X2/59Y&JV*]/7KT]<[U?01"6\.CXLDDO*`CC``+4/M2C'V^-(!&W'9
MV:L&/BOG:,04J'4"!Z-D6F.A.[D(H3U%F,\B3:X2S[:MZ*\;Z[CD($6E>:HL
M!'OP%4[Q@&&*G[G%HM<_[1_W3@^R\5:N\9+$+Y,17/EWD,A+%_437U]!KOYD
M?TW05[^P=KI?*!_5HO):1/CU+;M^YVS^`%9[Y5_1LB]NVV'@3;=ZG%)5GM5[
M;I;FVC+.B_CYA.-K"#9^U831](_V"RE*H?$\!6<XK]Z,#7!;<,ZC.?^9''O:
M-#HT48E3Q"UCM-(LL98`=",GVM;B]S]6G*,54CV1$TX$A',,N5O`1=A102MB
M4@^%\$$[)04>&-KD0C]U,MO`GC9"`5O%BG9$T1JC^&KDZ^14]R)ZTR9='^+%
M*>E*+OC,HP:GI\:Q*QWMED9=1,2BR)`>9EDD4IA),8-8">-4DK=T4)R<;1A`
MWS,(]D;N#`/E3\*'0,B#J!=^%X3.[G),!3-@I-*9>Y07<3&8@IQ'MI&L/.S=
M[UF_#@:W1KJ"3+F8#KG3!2)"VHDJ[,G5F02(%@/M]_`8J-[NO^FQ`1[W]WA`
M3G;W#Y",._$)ET6QI?O=/_8@@:*&@IGKJP$`1;5Y^]&.%<:@*>5T<#P/O($(
M+-OY'(<1ZP4.,SA8E*4/RA=B>$\D<%HPMEVI09S+!OW',JASO#R`:$'ET8JF
M(U$8%@V$3D#2.$D3[#E)DUYC)&D(6)&.F\)K6I6TY!7P]&+](4#X*.'/15!X
MWX'AI9Q.,:1;)Q.9VI`=I7COB4#P09"$"RW.A2V;1VI_VKV<"QG9KE_0L'$0
M1,"AL!PWQ)P,IB8BQ<>G/&*7AI]TOM0]E-A1B<64F];$!BF26093-\+G=-)-
M1("BDWQC(U]EF[.4O=V+$:1E%$H@-Y??&%T<=6SJAI1OIW9X?WF>6J#.GU('
M5LI=.`EBCT=QB"-MDR!`]3_'/IDC<QS$<HD3]9VL>T>AAQGI9FUCX/N8N-^)
M62`C2.*(!&WVOR6:C+JD]+<P`P`E'GP/-/YN2S".?I_5>I7IW):=:M_,P?EJ
M46#M3<9AK=/%K3S!UAP+C4M/M_ZZ!5B+B\:VN=,?_^'TC+OM54T-W]T>_=G`
MKO02"AH[^I*>I%Q\&+V<M=Y^GK<F^F_Z3,_B8XP)JK0!8/M1R&F_<@8+HWOR
M>^^BN3,^SR`V<\Q`OV0__=*53U";-^-BMX/HTG=NQO4N)GAW>_AGKT>26`49
M>95X\"47&_\GG(_V-[6;(DQV6=P*W_8P[!KXCMZCH_8)-G`N\@6]KYB1F@?2
M&F1D^>:JS>R1;(;.=>Q8;$RB*]X_V)A$5[V;K[!O'%)(?DPXR5._@E_"1FY\
M^!G2?-N[&9<^>"VBFS'81--U[&:H6A^OM4WAZ""[W?RU,?R238BOC=?:5KF>
MP5UNZQ`F8%8Z@HGJPO5BB#PHRFHVC]FKYW\6T+12YI9:YVMF;JDEOF;FEIK>
M1IDK-==0V^NFK>]9U*V)X9589)L97HF5MIGAE5AN(PQ?VA*3;C1Y758RWUFA
M?2[IN0%"&[*KU1/:D#VL1:)-Z'%-0HL[CHSS5W>T&Y&N;5_Y=JS2;ANDMGX-
M(1]</Y/F!1N.DN7GAO=HY8X45>^]6;KKB_OXJ"G*7UH$KGT?WZ+Z:NDRQ9+Z
M;?N86.$E7Z]`CL^@%@3VS[]_&TK/_0?^"1__#U!+`P04````"`"&4&%#_%05
MF[T(``#"5@``%0`<`&-D;VTM,C`Q,S`Y,S!?8V%L+GAM;%54"0`#W+1S4MRT
M<U)U>`L``00E#@``!#D!``#M7%N3XK82?D_5^0\*J50V#QYLV-UDR,Y)>8#9
M=1T&"#`YV:>4QA:,:HU%)#,#__ZTC,U@XRLW>ZH.#UR,NO5]W:V66@A_^GTU
MM]$SX8(RYZ:F7:DU1!R36=29W=0>QHH^;AM&#0D7.Q:VF4-N:@ZK_?[O?WV'
MX/'I>T5!=Y385@MUF*D8SI3]AOIX3EKH,W$(QR[COZ$_L;V45]A?MZ,>?-QT
MUT+-JX^/2%%R*/N3.!;C#R-CJ^S)=1>M>OWEY>7*8<_XA?%OXLID^=2-V9*;
M9*NKW1G<(_7ZQT:GJ<)30]6:5ZLI`.]@%[Z6G^&RIL&3JDVT9NN#VFK^DK,K
M%[M+L>U*7?VJJDT5'AOQ3S9UOK7DTR,6!($W'-%:"7I3VR'XTKQB?%9OJ*I6
M_^N^-S:?R!PKU)%>,4DMD)):XN2TZ^OKNO=MT'2OY>J1VT$?S7H`9ZL9OJ4I
M[7>0"-H2'KP>,['K!55F-RBQA?RD!,T4>4G1&DI3NUH)JQ88W[,@9S89D2F2
MKQ`FVUY-S"TV)Q8UL0WA,:_+!G5PTG).'%=WK*[C4G<M/<;G'F`@X6E\XF1Z
M4S-!6I$!H%XW5=GM#WEDW?4"!HJ@\X4-1JD?@;3-',%L:D$@6K?8EE8>/Q'B
MBBR8F8(7P#C$'`SU1%S9_F#`L5K.@UX.5B*=*P;3P4*F+W!J(5.G:S@_ZC86
M3W<V>SD8])Z"TV$>+^=SS->#Z9C.'#J%+V$4F29;PC!R9D-`8U*2";R8EA.B
M?X(XO(4\9`WQ6AHK$VB2P`DQN<S\]L1L"V;4[C]+2$:9H!(E+NWGT_K[@GZ?
MX$<[!^QTL8M:FX@16V/;7>LS3KR!WL=<IJ9GTB$NIO8IG)"_DPMS-V`].R<3
MO"+B++1SZ+\P8\CM)MA_,_E`2N>@Q1U1\>TL_`OW=N*QJ>R.,B^_#182BFY"
MWY#@\G(]0-<YF42MIQ4GD*CBDK@;Q^-N7&+F+#PV<FM(0PV@S*7M#9T>?`Y)
MD)4+92^Q`CT2^`D*&[@L]:B;AX84%$CMOH5Z'VU4H)".L\+/+EI"V!L`>+MV
MA??M07\\Z!D=?=+MH%N]I_?;733^TNU.QD&U&`"WF1D":\MRE?&PTWVL7DTZ
MQ>+1*TR70IEAO*C+8*@3VQ7!%2\\%%7SZ],?_,M_ZT+L,+#Q([&]_O[V&P3?
MU\N#*!?]$#+R18;R,[9E,:"[;8CH-61Z;_,BF4%.\2C!G>#1N8D8AZ%T4]-4
M->@)<S,4-/L;!'Z+NI`3E52D4(B&0'[*V3S6U+Y9V2$L=ET"W=?0"Z&S)Q>`
ME^K"(2<+3*WN:D$<08#'`$IFOB'<7G*^4W_L.S"7<#[W-<IR7P$#5,YY/8H?
MJ4W=G0)FWTFA1B6"]1>``B9K6=*`I>$*7Q)K!V!FQ!524G[BB'%0)/P.L$KE
MPC!Y<V#?@7%MRYS!V'S.'`]4UF2UU[+\\$K9E6$9X"L:2KH%12#PQO80DK+A
MM/&"NJ_;MS$)(4F@_&DGMW<R2%?.21WR3&RVV-2Z>$9@O4_X@E,!%0P4^U36
M^LNY-#:Q.DL.:Z"H1+(_3Z$[G^N;57#]Z4P9$R5*N6$RDN6L0ZPNY@X`%[M4
M-N22PR"/;#XWOZ^"F_.;HG*#?6<=`HN3(E-]MF3Y,VA>=A%_QJWK<CGN\K/0
M@0RS?O!)(OJI'K?!4\KF3_P/P*&=H&;^G2#T+J3OYPMN:67\.!QB]#Z-T7@"
M+_?=/K`9W*'!L#O2)P8T*'&7R^?CS#8_A_282"EE8QN7.<-M?KD:P93LI-4.
MT7;EY[T4LT>GKEB.E9NF-L?&;%D_6W/J4.%N]M3]?9UDWV0*EI_"\SLKIQ6J
MMU9\978'["'Y`=TE,'Y-=[=DRCC9^=&TNP)R8'WJ8+XVP'ZBS^!;QP73VIZQ
M8"E-1,HB\ZR=EC_&+V#32/BE!6K5$H:WS1L![`^3/DD)FBRY\M-%"7[/9<O*
MA4"VH8[)'6\C!21X]!(Q5,UP`"Y^Z-["9#I-VZ1(%'@+.2#5\8E&J-[*`1),
MGM(ATJS\H1F+N_`HK.Q@ZE!A;O`2:POW,Z:.9#-PX.L%$]@>3&,;@G$&4PC"
ME'WB$^DO?ZCF"8336K-RP1)LBPX)#\Z_4A.*F`ZUE^[KMLE^%&0*ECZ=I`U>
M0!T![)$X9M&1J++\A)?3R8538(85*Q?L84:Q`U8$(_;("#E0>?DY\12Q<I1E
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MSV>,M`%4L;VO@G=N"6V`?93_3:;"M)E8<@(?M"LT?KB_UT=?Y:;7V/C<-^Z,
MMMZ?(+W='CST)T;_,QH.>D;;Z([/?,8S^4XO(0Z_1#DT@,,7?=1%M_JXVT%#
M_:O<Q3LWV.0#P2&TOT;1-@'M9-#^SY=!K],=C7]"W3\>C,G7<\,][/8O(2K7
M42J^4L2F:$<M>M6+`H7H7?#NW`>%LVX8L\M(4_<826GDB2-?'KW;:#@[\)/>
M&R9$4SO0<=)O?H]HV^7/Z-VV5WCO=UP)Z^2YA4S(,(TC#+/I#'F]5=@FQ6\K
M$[)0\P@+A;J6`IO.D>R])(L=<G.:D#W>QV8,)9(Q/*UHHQ8%>LNDF7P+FQ"[
M#[G8Q3@.:>5S:L1SVEORY.;4.#NG_/>^"5':6P'M*H(%A:<J;8#YBU;Y)&\)
M"E?^!U!+`P04````"`"&4&%#V[&!:_P$```D(@``%0`<`&-D;VTM,C`Q,S`Y
M,S!?9&5F+GAM;%54"0`#W+1S4MRT<U)U>`L``00E#@``!#D!``#-6EUWHD@0
M?=]S]C_TNF?/9AX0D,G,Z"0[AR!).&O$%3,[>6RAC9Q`MP-MU'^_U2BLQ"\T
M8L(#\E%UZ]ZJ[@8JN?@V#0/T3*+89_2RHE:5"B+499Y/'R\K]XZD.X9E55#,
M,?5PP"BYK%!6^?;7K[\@V"Y^DR1T[9/`:Z`F<R6+#MA7U,8A::`;0DF$.8N^
MHN\X&(LK[,=5MP6G\W`-I%4_]9$D%0#[3JC'HONNE8$-.1\U9'DRF50I>\83
M%CW%59<5@W/8.'))AF4T[3NDU/^H-34%=C5%U:K3`1!O8@ZWQ3E<5E78*6I/
MU1KG2D/[7#`4QWP<9Z&4Z1=%T138YNX7@4^?&F+7QS%!4`T:-Z:Q?UE9$CC1
MJBQZE&N*HLH_[EJ..R0AEGPJJN*22NHE4-;YJ?5Z74[NIJ8KEM-^%*0Q-#FE
MDR'#78]G#LO&Y_+\YK*IOP5ZB73L-^)$28NYF"?C;R<CM-%"G$FIF20N26I-
MTM3J-/8J:9V29$<L(%TR0.(71E06U<61QT+B^2X.8"2%LC"0H9[CD%"N4\^D
MW.<S4=PH3`B#B`1Q&)'!9<4%;TF,%:6N*2+L[T5\^6P$<RKVPU$`29%?P=1@
M-&:![\&8]:YP(++L#`GA\2Z:.QU/P+&#(TC4D'!A?S#AM2CEL!?SFHCBQO;`
M'HF5#HJZ5ZJW(Y3/VL#Q\#I@DX-)KP`<C[,S#D,<S>R!XS]2?P`W81:Y+AO#
M-**/'6#C^F0G\?U0CLA^"./P"M8AKX-G(ED[B6YR."(GSMRG(0L\>/B:/\>P
M&.TDM='CU'4^;KU/6/<>[@<%:&]W.VFV2=QE,QSPF?X8D62BMW$DEJ9GTB0<
M^\$QBE`\R(FU6_#J&Y(>GI*X%-D%\$^L&-9V%_(_?_C`DAX!"N_Z\5,I^O>.
M=N2Y*2W/LF1]LT>"BNY";%C@BFH]`*M,)2^SI^XO8"/$*7G77L^[=HHGY]YS
MHS#"-M8X<E/BZXR7*6SX2DH_UL3GT7G";`@0D3ON$\GS(9UQ\F&R"+2<F0S%
MIUP&4WEA(Z\%*)]W%DR"9&-_3]*KWB=@G$220A+V2;0GW;QK^5QQ$.S','$H
MGQ=E7-^76NISTC%)!G@<\(,'9>J>YPR7?>J+1TP+3G.\R903ZA$O92X`C]#7
M@,L"1YEO*I)0ZK5\B*F'YA`HAU$F^]TMBQSU&O#-OESAV+#;CMVRFGK/;*(K
MO:6W#1,YMZ;9<]Z(]_K.14Z$5EP$.LOA?3B=J!U-C9R@C]L$.3WXN3/;(,:^
M1G;'[.H]"PS>1LIJJR.GY+RX$D-W;M%UR_ZW9"5[]CYR<CZ)Z>W';L#B<43@
M1*TBY_[N3N\^"`F.==.VKBU#;_>0;ACV?;MGM6]0!Q0;EEFVKHVMDIR$SR\E
MU$#"K=XU8:8X4)2._B!*4C+7S1V4'-DO+\EJ0+9G&W_?VJVFV77^1.8_]U;O
MX3V,F.TCI_Y2R0(4L0%:@D7_XZ(4$-:LQ5')R]6N=LNR(%59$22\4>*.%O[H
M;(Y0-N^C-E9R*M4#RR:JMHB(LI`?T%D6%8X7@=]#<HJT7W)YJ;TB+_-@*(GV
M?E.R?T<FER#M%0G*A18.\^!(1'^;A!W2ULFEX^/:U4)ZL5HDJ&@.BU+<-U2Y
MN?>3$W=>2-R:LB'US275UDM:>=$I+*E6MJ3B+:.<HI7WGF4@>(](H+9-KHOD
M;^W9?R3`E?\`4$L#!!0````(`(9084,BQYL^(AX``!>F`0`5`!P`8V1O;2TR
M,#$S,#DS,%]L86(N>&UL550)``/<M'-2W+1S4G5X"P`!!"4.```$.0$``.U=
M>W/CN)'__ZKN.^`F=[4S5?;X=4EN)KN7DBU[H\JLY;,]FTRE4ELP"=FXH4@%
MI#Q6/OWA05)\@00I$FQY;ZMV;$O=C6[@AT:C\?K^CR]+#ST3%M+`_^'-R?OC
M-XCX3N!2__&'-Y_O#B=W%[/9&Q1&V'>Q%_CDAS=^\.:/__VO_X+X?]__V^$A
MNJ+$<S^B:>`<SOQ%\`=TC9?D(_J1^(3A*&!_0#]C;RT^"?YZ?ON)_ZF*^XC.
MWO_N`1T>&@C[F?ANP#[?SE)A3U&T^GAT].W;M_=^\(R_!>QK^-X)S,3=!6OF
MD%36Q73^$SK^\!^GT[-C_L_I\<G9^Y<%5WR*(_ZU^)M_?'+"_SD^N3\Y^_C;
MXX]GOS<L*L+1.DR+.G[YK^/CLV/^GV+_WJ/^UX_BGP<<$L1;PP\_OH3TAS<9
M`[^=O0_8X]'I\?')T5]_^G3G/)$E/J2^:!6'O$FXA)0JOI,/'SX<R6\3TA+E
MRP/SDC+.CA)U4LG\6UI#G]$DI!]#J=ZGP,&1!%5C,4A+(?XZ3,@.Q4>')Z>'
M9R?O7T+W35+YL@99X)%;LD#2S(_19L6!&M+ERA-*R<^>&%E4*^,Q=B3XCWSR
MR!O<%05]$`6=_$X4])OXXT_X@7AOD*#D0-3:]2$G*V8ZLJWL#6$T<"_];EH7
MN4=2G_<=%NU@0);?N@GW082]3LIG.:VK?4VZU?B6SWY-\_&$=*OI#&=>;4]\
M^(G_EE.<O$1\(")NHKJ05>/@9%'2[\:R4^F!DY/K"6<9L'R-.&ZP/!1CS_&'
MLV-IKQBG?N$#S'I)_&CB\PX:T6@C1ANVE,YV\A!&##M1(DA:\<.;%GQ'14V%
MA`E+U,7,:;`YICAR`CX@K*)#3]6N8E^P8-E*G;B2@A9,OW@/:7FJ=KE*&L-R
M9(R$,BQHU;A9Z]K6=JSITN.<(MPB_N'GNS?_G;`BSHL4,\IP?W^T+:P+K&*#
MI#$A<=X_!L]'+J%'`FGB%PFYP^.3>)C]#?_H%Z7%+7FD0G,_$J%-P6H]F0U(
M-2DI$*2C&1TP#8H5\1%#8DLK(\WQ8''!L<JP-^..\>7/9*,UKD1G%Q@:-?/(
M*!`!@D:U9AILQ,1(4B-./@8Z$C]VS\56F)7_VA86JI1*()#]#D3+5RBD'2P$
MS9BMG$X9Q)RYQI8"G>UVKU2S"(`<$2@D5&FFA80BYB&$*Q,98Z!CPA5QA3)7
M'GZLL*OPO2TT5*J5H"#W)8C6K]*HV.HI#1)$8[3UQ9HQH2,-'>Q](9CIG8&>
MU!8"FI1-P*"C`X&+!N6*$(G)D:)'@F%4YZ""E;\0S_NS'WSS[P@.`Y^XLS!<
M$U9A;@.]W7"R0>U\6*DA!@$B$PV+2)J%R<04(\%Y^%6PHH07*>8_C@>JGP-O
M[4>8;:ZH1UBH-;M$9Q=$&C7SX"D0`0)-M69U8$DYD&09$2&Q,[PEJX!%U']4
MZS3ZZ9>&W/(<ME;IPE2VDA80>FH5U(+HNQ"E'/'B&HHEC8@FB>8+/HX^!DR?
M`2E0V<5.I8IYR.1(`"&E2B]-YD.2HH1V1/<2+)>!?Q<%SM>[)\RK9+Z.Y"(Z
MAZV^1]0R678U!@84'$X-!R`P&:BIRZI)3B19#Y!B1AGN,=,O*J97,_XK_EG5
M2%9#:SL-HU6WF(HI$8)`4I-VVI1,//6*,S.297S4B(F@&68RE.,@IJ1J-5Y2
M,H!H*>K6A!4Y3>\=*0L</DCUU^'A(\8K!1?B16'R21$W\<>_B)B+"`7GBROJ
M8]^AO`<$(:U9?V[':@-978P14&O#-SKV.BA;!&/*BH(%2IE1PHW^EO#_'08X
M)V%(HK`!AD4BFX"K5C`+K3P%&!!5JE5*0DLB2%"(IX9&B"C1V@>&1MTR/@J$
MP&!2K9TN'XT!H>8"AT\3WQ4_+O^QIL_8XQJ&D^@",[;A,;[<QJNQW9#7)JI:
MF9-%F1$C&-2UT;:$0LX$`WLWC*PP=2]?5L0/";=G'CT1ENM1&ON-.&WBKH4I
M6=09L('!G+FN1<3%G(@HUA!AWT6!X$8.0)>H3*KU]V,,E?JQT2I$HLQF[9H:
MTD!!;O4&U=J?*'Z@'H_N2<@Q+7-=3X'G$A8*SQIM&B(I<W:;B&EK5!93IKQ@
M'%-+A8N0S+!+QY05\!U2(L!!U2S,KV,8"8X&`;^>&B+DVH7^WI81!J8FCA.L
M>>QX@S?XP1/#.O^$K8E;-E'G[]M(L#ILMC<M-[::LX/!97N=2QF-6`):*1'2
M)6(E)`W@8$`W8U-S-QW-X35X.%BQ6UFQZ@`.G!MK';=!B=3:Q69[$(VUCK_R
M\18!%&]E5LYKTV`E,JL9+XV2N>16@08,6#2*E:(GM1$A5!L1_OWX_?'Q"1^@
MV+/@.4"__^WQP?&Q_!^%:I<"7D=/`:/_).X!.CT[/CC]<'9P\I\GB(J-FJY*
M0&PW,O`)J5CON>-5398/A"'.(6]!0&_7/EZ[-"+N.\DT)4Y,<2(I3F$@=>*Z
M<GT*>S>8NC/_`J\H]].Z*$%';34ZJU<Y%XE5DX)!<;U^I0@KI48B*W9(?>0H
M!AA8FI)GX@4KL0AZ%^%'<NE'A*T8#<F4+*A#(QXBKI=K3YPGGZX9[SY%#DTU
M]2'8)D+[JX@LF'>7:@?WE==Z#-2NNFUHF/F<.A3SCT0`<J4$%#T1Y&[%B`M[
M'GL]U-&]`]V2"%.?N(GZ6?-5A6@JTH319@<P-R0+\&8N,([;6-6*6?(6D(H2
M!O;*T;=QF#[VO,=LO@-KOJS5KWK:'(*=ZC3ET#NFWF&M>G19[8"%-T-M&Y,V
M<BX#%XT3SPN^B0O6K@(V#=8/T6+M)8G)6SX#H\\B-=F0EFXGP^K4IXMYN0E1
M&P%@1MLN6FO3TRQE0#B1BQ8!0VXL602-DK0.TON0V#NUVH#/A#T$Z1UA;3-\
MIRUR?!]A^)I,"NH&LSF3.X!=F8VZ(4P>>FE.7NDY1TH%-IFBR0[JV,#X$'-=
MZW.(*\R0S!ZB%6$J:0@.CNK`U23-9#9729EC)/CI5-?`KD@.$6X:'>MA5LI&
M`P69O+_`&&`)]:C@RJM<"RQ%"A=4.?V,`*66,8""27_RUXQE5%AI3OV:T,,%
M6/.)WTJ4!<,<]>T.M9GO!$N2GM%J6.+74ML$6(/*66QI2,'`JEZ_T@46DAIM
M#]1!.SIW&VRP)ZX@?2:^=FV_2&0U_5ZI8"[5GJ,``Y1*M8KXB(D0E3B!`0GU
MA(,GMLVY2^K+ZV8C^DSB,P\:<QNY;(+&T(0LBAI8P,#*3,\BSF(NM8\QQP=L
M.^-\)9X/X6.M\IR?@E"WK;&2TB;(:E3-`JN"#%8Z7:^@9C1[ZW&2=TC4!@H4
M<^!#P8\X4%6P*.X:UT07(S4Q6465D0$Y@-5R@'%<1FJ6$1<1KD@$:H#<]I,K
MWG07@<\-6G.;YFE?.">+@!%%=X]?2'CYPMUMP/@D`K/-C,>"X36'`N?DU>;)
MZE!VU@:=`Y5H?R(P:-65)Q.#%`?+AP]O:/U8\""EQ[T41?@%K5CP3,.>7Z[8
MM<]RPV.7<\X#HH5V#Y*6VGY?T:I<QGF)%(SOK]>O?%(ZAHY<RMQB"DJ,VMS9
M.O=2:-ZXFU/=-]^H.Q/+6524ZZ1,/0:\NI>>:!@71]RMBM=!1$YJ'WHR8;/W
MSI.Y$=MGGIIY1G=H+14MW?*6X00W=:HTZT=,?=$/YC[_>A6$V)LO*@EY##]?
M<`^OZ81]";>Z];W7"LEM?^]%\NB]81!S2JDK+D=Y82Z"B!-*;K87W1+^.^]T
M:T=FL^3=!2OJ$S2E*H@(#Y!/Y$UV\"();GICGJM`8[,#5*J7Q7&.`-:H7Z5:
M$5J<!E1B(=F!GVSB:5C:TY/;!$F3TEF\Z&C!>+(&!?4`2B;"Z48J(!O[B@:=
MXY`Z$]^=4F\=$;<EPK3<8P*NP:0Z_&E8P<*Q7M\B.B6U'!%=10\#DLWS,6YN
MP=*Z':@[R(,UV6XPN]T<7",,#+1WM:"\=V>`*?H0@-?,'N,@>!?H=Y0\7B?8
MJ2KTW:&36&CG"_HS::^2$`TC7K=Q$E1\TB$N@36S,E.V\O0=#(S]A=#')Q$^
M\6Z('\GU6MQE,E^4=HDV!,?MQ=A$85<CL[!L*P-,<-%1\2)F$S$(*SD56X*!
M3/,T!F='`X,=Z:VE``!TDXD&>-:)@!82=%-_3V:%F>=*Q-WL5U[PK>E%CWJ6
MD1Z4T2JO>4BF1`_&B1HH6?MPC&!"D@O<KG<>.`OMY$8#E[CGF\\A<6=^NCMM
M(A83U`4#]1#L(LAR!K^CH84T?TLI8$#<6?6J!R/00J(YN_%57)N7BACID'W+
M91J[1^D;&J="+^BK-!/W?]=A)+R<W#''<2%WS]T'<BG2H1[)V74?].-JAB_6
M[L6'=BHQ?X/BL&6"Z5>6#"W?Z9@6BZ)`7$ZB"I/K[\GB>R#_$CJA-2^'?U[I
M2H',JY($!W$O@J78NBAS9;J`24-L-1*M53@7@U92@L%PK7J5-ZMP',G7"9T,
M/0P4\:[&"!8W0:J?F<X5WY+:?(C76(#E='Y+PPI9>T-N,*ALK7(IC'SB?XF[
M"W)N3[X$).?DF>O)@+C`LLGEZZJ,:ZN*=5S`ZHVIAVJ9#S!(M<H:W"P&%869
MHRP=@*CA'A>+M2;5P[&2%3`BZ_35'#42IXK@PS)^YF]*%H0Q4OU0H'$MF0D;
M%[1M#*['L(DD:#GYG:S8\R<B]>-,W<M+K0>M>F$PH@<3@\WBB3I)\,'?PHH]
M?G/+/*F\<U8:ZG+!;LL$L#:TM-:[*D,M,UJK6`1ZV*"W<7KK7>NE@M&!//.?
M2=C'.EBM(`#`-C#4`.`U4L!$X)U5;UH'HXD$<.`NCTZW7%-&G8C(-^.-![4B
MV[@A1[41]<%%G@?:TSF&^I;VL<;D(I?&4@;IB&$`T+S/[=QIH7K3W;SH7H0)
M>KV-P@2X_E,8RP-X\4-<</^,/;&R=T,8#=QBE]5463L15J^\[6!<[@K<%ORP
M8-Q!\TH@RX4,)-_MJW>XUEMQPOLI8QO>I_1O@9HP6MXILY)-<!=A%K5O/YWJ
M5>';`7H@C]3WY5FI!5+EOLX6/!NA!2_]VFBGG>+5[4=$7M"DY2SNE%BO5I[<
M^XF]9+OHS%\$;"D7XINV\IIR6]U+T<ZDW.8*,U8PT\-V^I:V7V2XY>T<7A"N
MF;RKPTFFBWRD2,6!6=E6-]R)]VJU4Y,LB=V)7UFY_"1O^ST8&%4HI;W14ZQT
M0,%!NA99"X4"U2AW`>95K+P#4)$`PD257OHU7A+V`@W-[6KBEJ[P/KBB/O8=
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MZI]JU3"#P6U;C8L(/>,(O9]?_/E/\T_3R]N[[]#E_WR>W7^!`=$Y>\0^_:?L
MB!>!'_+!R54S=]^]X34IIN;BS_FB(K;:UH%X3GN7,,6^&E:?YABIDG./?5C6
M`4SW'<GP<JIKN<1L(U);&3EH*P@EDM#;Y+=W,'R$N/@AG"\*-F_4OTT]VY39
M9G]L9U"V%YEQ@L%^*W6K[OL(!5ZSO00&(G/]V`R']2QV'TUM5C[_:*J>'@S2
M#)0L;UJGW-NN/")!EA,``V7Q"XSB[#-WV$*O.\*>J4/"^/7%*Z+=@6/(:_5!
MS#;FY-[)-&$$@\0VVNI>U9P\,B(#`!A`_!SR*?-E&-$ECTMTB"L2V816M8)9
M#.4IP("E4JTB*CB1\%`I&0Q0E'%N-A`:\(WKE0R&Q$8F,``SU;3DB10?RC#"
M@%WQ$D\ST#5RC7G/J@'@&EC`P,U,SZIM>?$Z*F=$DA,&VM(U8#.8Z<E'67,W
M`):.%@RB&A34+,??PWDJYT(TF!^IRZIO:?C5//]NQFIY[FAL3&$.V<@'!G(M
ME*VXS'_+*J>5C+@T0D(*##A.2>@PNE(9QVOR+9.;88'/?W5(?/]6](5$$S=8
MZ6\O[RC+ZGKH+N;F5D&["`(#Z5VT+X>&`N*YS'%.QD`;H$I+L_?BL'7M[J=&
M%FM;GPR53_<]-="/CJL62I86(@07DFPHYD.*$8:#O'.>B+OV2'SK>NDF-W5=
M]60=/06,_I.XGWV7![MBC78N^]<-MS8\WUR^$.;0D-PPZI!;<>2D<;7=0L%6
ME^FM561N?7_P4D?O?-9-K5M+E!<8*GDH/DBX&6H$4,5R<[4+H6F2-<V@7F,F
MHK%G,B41IE[]>-%O`?9&ER$J9CL6]2E]],XSF$FZ3C*O7W`G(2IE_5%:%(K+
M&NF06ZQ9G`RLS(3F*"P?/#2XZ4>CGV[A):8;TX%ECAWT[KN,9,-R6RVJHYW'
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MJNTO'019/T'?R=#24?I64J!=X-S9@B*,T^^!`'G'KGOYLJ(J.33TR%!9TCX-
M#S55U><845',JQDH]+:5,DP!6Q#:,%X`!LM(0?P8UP$W7"8[G)$-8?P=;^(X
MCC^6<?P9>KOV\=H5L`)RX<&NE?,S";DQ$U^^X27>%K@/Q$>V9MKFQ>^3HV];
MJ7UV:=.R7\V0T-+@8I]7[/(A+A(+$'<LB@<+JGW`Z^CW<10J-E,/VL$KRMFG
MGJRMIGX#MD(AKV\,UIFHF1RIM_%>;^_+.*>_$/KX)!S8,V'XD>1V6`\?$-67
MOD\]M665#A1%UQ7]RA/D!J87>WO"<H@5#Q^!%1-:"2YQ:"!0Y:!@6U#V:8]X
M@7=/O$+8*@TZA&?H4P-0WJ'_JFWE(?HK?G_B\MYMWL$]/*JU`>3*U"RL1V-V
MK<>DJD9U#"V5V"O?T*F">W4/K31X/1ZBB]D[.(GDF]1-B$U?>^4J&NHSSGFO
MF=RE7I$K'V&RL:-.H!R)C>KO<V*RDT+[XV8LU,(.7F>1+$0=($?,53R/.Z"`
MB6PC96U]$6#T[\$$_'4O;AF9WM<4G*A5LOV:?^^\DC#"^+FK4OLT@/;3`'97
MTWX50V@OU;"#ZWG6+]*]#M>36?<8P<<8E[Y/SJ1EE0ZTH`?&/=A>YK,RE1<%
M`7(`I0,^Y9I[:!W'W9(EIF*QXR+PY9F@-?;N"5N>UK6A;4VL.X9QJKKD).RJ
M`2N>&,7V1I_!$@'(V4I`$1>!WE(?;0AFX3O-M&:0LSN:<Z")XKC>[IG_16@\
M7Y1K;A)Q;SY?5.ZY'J8(:Z=&!ZJ<]#!IS_)'[Y<#&C5XAP.]QV<'']=ZSJ1K
ML).!G'"?"N[3^-]_P_09%O2GW>A>"6R5]._3]B-!L4,;Z&=VMMU6)TWVR3_M
M4-5].J(.:KP:C]/=]OY="\Q41S]+5C->`]0/J?,S]M86MCL7R]NG?&9CM0VT
MHIHO#%87']#"TFV.CX],GA)'-"%'SX)>,[5Y'7VU.?1*Z\5*7]Y!GWWJZSM7
MN]TU4(TRK\97[%H#G7S)KVE*D:\U"S.'4H%[.D'05-Q`\X!":;#Z]Y`F=NK`
M/0;NIN]<%6\!/FGUY%4-]WBO7S6:I'\(2\LZ.G"[Z6MR"V3I1F9T`FBTZ#(&
MJ_/"\<-%F2>*^A[K]>7L1>385$V]1(2Z0D;O4$-;5MGU0K3$+D'XF?<S>6)]
M+5[-BOV_.I(VUFL\OX+-W&?[#[J.%I>N+<H`KK!G:L]]O_Q'3+72^_9JYP:]
M%;$7'K^F<GKICQ7R][_+Z8W2]*IG11N?S3E`28X>4,_J,O/9'H-JOK.Q'_E[
M,</654LO$^JB<%B]J4>+-%V)I-20>U,7KW+YCS6--C.?3]?6XL-P'CT1=O^$
M_7B(OPY\E<\;YK*M]N7OQ0C7M5I[&?[:%@ZK-UNTN-C;U9<B$Q:J61+_S0F6
M2][M0_E&Q7;"))Y&6W';G[@J\>SIFTA@B+=97L]:FGF]%L)_>8/*%$?D"E,V
MR+):KZJ],I]BW!B6W4VC7K\F3V1:&:5].<K-%*;+!_+-,>FVADS9=PJUC*M$
M!F5$5((VZVQ/`;L+![8K-K_V8*OTT?OW:";K>W$ZLW`Y]5C+;:<[+;>=0EQN
M*YEDOMQVNF?+;45]NRVWU9X7LQX0F8<HEB]'X</U0Q"2]H>1M3>9J.:1WD9,
M-U(&N7O&#P=S"F)*\Q1X?.X2*L_6YI'E-MQVWVQL95+^E48C5B!.H:V^)=1E
M!"`E`>JKR#=<%F&,N%)GP^7T)B:;<SXS`[*NKIYC=`BV4K.(O)0)Q8O16PZX
M>,LL=;:HBQS7V(BK,*$)<AD6T)@KZ]D(NKE9EF[`-KJ0J45CEU!##B\$,E&V
MX@%LD6IMY13^?U*^^PS5#1QKT.%E2<5R,?YXDW-E>@^3\Z%PN&_W28#"TC#&
MZ0Y*(H.#DF+9*-YEAP5H"W=34A]]=^-_\7_RI_?^G_B/N^\$RQ++%YW$1:O$
M=\6JU/;.U?<C#5Z3,"116#5.J6\L#TEU`4-!H=*6>/DU^MN4+/#:BY`<UOX^
M4K5^HOB!>C2BI+)N,U\#JN`JK8JUG*$9J6JGY)EXP4IXC+M(;%'T>9=<,1KR
M"?.".C2:.-R?K#WQGJYZ*+?(4=4BNTL%U)`]&E-L_PPADI1H*_P`Q>)11CY2
M!:`2XUAIRE+"I3)%6:("U+PURM5EA[Y+TD.3*&+T81W)'1!1@&YX'.;7GNFS
MXRDGOFO6.DT\@-K*6-4:1RN/8"KRD1IISH,4',F3ZDZP))^"L')8JR`#U!1U
MVI4W#,:T2!&CMX*\]LG=`:M_J_`5_UR$O=1?<^5B+7FL>TYX?$D4W3U^(>'E
M"X]8`\;C4<PVLX@LQ;Q)QK&!YZDK!PBOX*BJ&0<L#A`<;%A9A%4.3$@T,MH6
MC+8EHP=9=`(^6?@!RA6/9/D'**\!2E0`B]1N@-LKW.S>_*!&Z+S!4QHZ2F?B
M;C6^)M%\P6'*9]CG.*0.'^NFU%OS^$]F>9H;O9-8L*C8S1H#V&0+R`)'1`K\
MNU408D\D&#1TW&V02'S/M3E`7!\D%8K9I4HJ?SL2Y"XQ$XF7D&N6+,)GJZL*
M3@TL@*!BJFGI:>*83[:7Y#PH-]M(#5;8!9D<9LW"NVG=JJ4(0`W:57-M!C(6
MA+8;V<N+70<CMSAW2HQ@D5%0/V?^#2,K3-UIO$!WJ7:]<&#+#+X^T=A-$J#V
MW]&`"G<OQ:"WB<!W(J,<RT2Q,-GII3BDY('!P<1Q@K4?A3=X(^(7;C7_A/$!
MJ"$IVDT2:!RT,L`0!XE,%`N50(C%HO'3LSRPN,#ATPT+GJE+W//-YY"X,S^=
M4$^<B#YK,6#.#:C=.RA=.K+$PS$A`R5"T,,&O15R>)._0]MTQ%86F/Y^RZ>;
MC(KKP80%9CT[SP.H+8U5->RM6V[9OK`ZY<R/#Y=WZI05W(`:LH/2+3ME*FK\
M3BFTY(.+^"'RQ,_8$SLGU')W$=&5>Y):\`-JXTYJE[8KB1868ZC\)2-'3HRY
M)%31M4'ML>]TT<L`!Y9UA;S.FW(*MM6=!LB6A3*%"7^2I4L.=<@2#U!<YD%^
MVJ?*'7/U=!:&ZV3A6'41-3V57Q9>5J^^P**U%$!.9P?EA\1(^I2]G"ON\SO.
MF<LPAW-2I4(@(6PPVRP`4)0ZMI/JK_Z@/MSY*L':Z?WPP2!<RL8F^J`;S<5V
MV8\^\=_XQ\E'_!]1-/_D_P!02P,$%`````@`AE!A0]B."^,J$P``%B0!`!4`
M'`!C9&]M+3(P,3,P.3,P7W!R92YX;6Q55`D``]RT<U+<M'-2=7@+``$$)0X`
M``0Y`0``[5U;=]LV$G[?<_8_<-VSI^F#;,ENVL9M=H^L2Z)31])*<MH\Y=`D
M)'-#$5J`LJW^^AV0E$3Q"O`B0$[RX-@2+C/S#0;`8##X[=_/2UM[1(1:V'E[
MUCIOGFG(,;!I.8NW9W?31GO:&0S.-.KJCJG;V$%OSQQ\]N]__?UO&OS[[1^-
MAM:WD&U>:UUL-`;.'/^J#?4ENM;>(0<1W<7D5^VC;J_9)_C/F\DM_.EW=ZU=
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M6^%[$B381A,TU]C_H":[7@V=F'B)3,O0;5"/Y04K<`$@K9?(<=N.V7-<R]TP
MQ,C2(QB8\%I\(&C^]LR`V@VF`,TW5TW6[7<\==W-"@8*M98K&X1R48+2#G8H
MMBT3%-&\T6TFY>D#0B[-(S.WXA%H'.L$!/6`7%:^,,&)K=1#/1NLB(%+1_/1
MBIDO`%5(U-DMU$]U1Z</?1L_%28ZUD!U-$_7RZ5.-J/YU%HXUAR^A%%D&'@-
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MJ\M7]:((L8%XO8TH1<;Y`C]>F,BZ8/2S7SQ&&LU6L`W]#C[Z[-,P00N+=<T4
M>(D2*(>BR26CA(:UHDT,#1/0,D!LVZ9.C`-=B.^<@Q(7*V_SU#`>+'NG1G."
MEZ*B#,2&<Q@)2Q=(.#H$'6\BL@<P:IY_1YLL#&)%.4%HJ8=""M<R8-CR,8-F
MDZ5_6()3Z)<J"3V)1YFR'B-B8>#`9.[*;*%'BG)*_TI%Z2=R+0.&-E!C,HKZ
MMKY(%G^D"*?8?U1)[(E<RA!W9TT8BWV+PL+G$]))IN*GE^8$X;5*(.3Q+F_B
M_0/9]N\.?G*F2*?80>:`TC4B61-P:A5.9'Y2"1DN*<B#YR.V8<\.6_F^9<-^
M)0N66%%..'Y6#XX4KB4N3_WQ.T$K3)@'Q3\<S%REIM3@!.47]4#)EH$\;#P=
MZ8`Q76"2N7&(%.1$XHUZ2"1R+'%PX.42.YY;Q7,)T=':]>(.0$DRATAF/>Y=
MG7KX\`A$YK[#7X;XZ_`^?)9BR#**\X*CU)X[EWWYF+"E(3<BH<*\>"BY'4]A
M/0&-WRX2?:^U.F;SXS$.O+*76D/;'<O#[YW1<#JZ'73;LUY7NVG?MH>=GC9]
MW^O-IH5<LF$=F^OTWL-K31L+75_YBH9LEVX_B6I<\/'G'86C>=]R@"<+!@2F
M5HX'-ZC.5[OT$"K.7IM2`"B?D6@Y6>Y<(;D>CJ,43JHW:&71"):/O*#$BDMS
M.%8%3HH`U,"(10^!^6;_L3.Q1]T&4FG;[>B$;&#9XD5!IF/&65V:VY(+"%R$
M)95`'!.TTBVS][Q"#D5`_,A]0.2`Z70(N2I+<X`6`%!`&FK`YY.69Q@E.D"K
MLH0)8@<>Y@@P,6]]ME,I]<ATL:O;7DFI@-U:^KUE`]^(@GK%XPKRYSK^%J0Y
M\\J#+BHF-49CB&KNI4M6'6GNIDH!5'H1$T2XT;&^83&;H&SP"5F#48DQD&%E
M11J1YZ3BAP879T\E<$/T<0U`F4ZJHN`D\'CJ<V216;&">;!5VQZBA!T]E:DO
MY+_.V_?%2O+B4]L6@4/(.(<'E;!HFZ:G6J!DL)D9.!U]9;G[ZU0)\U=:!5YD
M:MPW""*3P[L:`'71([+QRH\[UQ>HY[B(K(A%41?-+<-B<??KY=IF_N/NFEC.
M(EHC'<LJVN:%O?JHC**P5R=1\<GSC3]Y.FC!6I<_?4Y81+J#S)Y.'&"4AEGW
MA9&N/3QU>;6CQGVEH';P2T0-^Y!^<8]GX<./4/41(T41RKNJ>+J+V3Q/1G%'
M#S_.-3H(!''FE4:EJ"MU!)Q\P_W@//B*_SQ8>W70W@_?SH=?Q(FD@AO1$SB0
M;-LV?F(CK8])%Z_OW?G:WOJN)LA`UB-S7^5[\\2:D7:5J,#Y5B$)J0&N)*?0
MR?N$Q*;/1T3N,47RETTA#PO,<"/BB<OTG"UC1+P022X74WIEV>?299Q.>2)1
M8\C&8EK;:_<!$^NO_4HJ$[MX)?G'V,4Q2Q.!HEAYMUE$<-I6D':CIS*,#EE7
M%)_L@/DTUHJ$RZOCQRD8)"][_Y>3)^Q@[_=CUMYO.H/_/O2&L.\;];71N#=I
MSP900.*NST^(LZ,X?TV66D&FQ]1/9C1!C\C).KJ*EI.\F\N1?=0)FLBD&M;-
MSQ]JL\@"<VDY7IH)EEPE",1+1R2WHNS=F1A&G')0`[3`E#D+G\=;3#.B+!(+
MRX[/%@,G@]]3=U)[8:X1_@*=&Z(,8YY73_8F6Q!@+BFH,?CV.M@'IF&U`22O
M@>K]^N(&S3%!H81UO6=@'B1N.3K9#$`B=(CA6\<%>=H>PRX"?'+G[IHZE;T?
M%].5(\C_U(W*CO5@#-W`Y#;/.GQ.K2![VU]$-5+Y/A7[4<8,R/<"5#V:Y0_*
MM,1Z%C5\>I&Y)W>(7=3*RZO'4U.VCX`31VY^5!J#B02_TRV'*>+(@:]7F.KV
M:)Y8$)8DHSE8F8Q0L(K:EYM_1`!57`O[*JD,4,6SVXH4DWV/1,P8)_)XZHNA
M;>C9]J0FWU&67D/Z)04Q//-85V-D1:F\T:EEM!VS:]EK%YGB>*4V("_Q!B\@
MV?CE2$8-./-7=,!.A).<4^4234J_@2**H>CR.$>8*NI$RL(BF/9+:D?!QJ7?
MA*E23TH)^/0C6')$67@B4>!63CDMX13,J:_X_D#6XH%)`S127Z#A>GF/R&@>
M.[C.7UF(MR3]BH;8"K&HJ-285E*H#ULUOF@-X8:DW_,H#!P7_GD2K'B.4"E,
M)/XRVT&4R&O^*)%.>_I>Z]^._E`D=]R.,Z$[`0FUY'IA&$%C@A\MP/MF<T>1
M.7!V1X?!"T+LDDLNDT7:4N<602J:<9].08FI8>-K];O5YJ<I(74QEYS4R^[_
M75/7,YOL.!78]8Y69WB"8/=A6#8Z('Z&*QNY]?<L.SZF,OTY%DAJJ.3^.<@.
M7K(CX(,7N1+FN93RLJ-GCH8:YA*'2A`#UP3I++N`_W^(SR#C!%<D+'<;LH-C
M)*F"N)A558_X+3L1Q4BJK4!0C"@V>>"F"TE56$/A7<6036E`@?"9JL'-%)6J
M^`8)8;N!=R$Q,:P(W'SM*1!T4S7Z(H(\?=]_NFG+RJ%89$;(;D]:Y$[]<P2/
M($]?D?AW8%5XF.1'"E7IL1`4W*F?-Z5P/'`>$:W(*9G9EO2HI.K<DAPR4W7!
M,@'"B66XR'N%0&1&B=:4'J94`IR\22192J>?^H]?9%6,?07BFBK3$7')G?I\
MD?Q8B?_$673$I&N+6"O2(U<JTY<BTGN9&B/IP9_ZDL_6K"/YSP&)*<?*TSE8
M_!#WZU"1SY<*!#@=5TD8RY6H2<]18)4R7:]6MK=2U^WM2CWC^<>$`S/>!A1(
MD"J\)Q&4CBH;$?_N,DNZGK7I")?B/MVN#1Q!24=W%7&650%CYVG/PR-2D!>2
M^O;P)2%)9%R1E%#3]7*ID\UH/K46CC6'+QTW\&:"G1]CVS+"VXN#@+^?M(;&
MXNEM3-<$P1^M<VUZ]^%#>_*)!?E-!^^&@_Z@TQ[.M':G,[H;S@;#=]IX=#OH
M#'K%(O]2[ANSFY=TAG<Y*_=1BSG7C7DJRIR4LD"9`=PWT/F7C#F)L[ZLV#U>
M")+G)"'AJ#+>=G$D8WW#N$P>6C]'A]8E#*WW[4E/NVE/>UUMW/[$@FF_C2&^
M"^V^&&&Y$XK=F2#OK84.IBZ-H<(SN$HW?)*CKB)QJC(<TY/]'XS'7Z+C\0K&
MXVS4^?W]Z+;;FTR_UWK_N1O,/GT;D$629C."]]+EF=?XFSC)028L(E6&$]=J
M,GM5^28ZU()&-3S70LUJ^W:U;8/:J^UOQ=Z<^,H&XH@L=,?ZRT-_?^>'C0O'
M'(<T(Y0,?L_!'B+V9DK)=>KQ*3E)LR`+,#4\".Q*+AW-(_1N_)\<2L9;7]H%
MF5*Z(28=-1`]T&%N'+-K2;N>4@H]'DFH@5F0JIF%V(,)8>1.$7FT#$2#7,Y]
ME'60SUE=VBV34B@*R48-..\H[.-ZU+66P&,&;M%RTNY^E`(HF5LUD(@K#[=%
MY*@J[6)&Q0-*:=L832+"#6!N16E7+TK!QRD/-<#;G=-PHY9>0]I=B5)PY4E`
M#9Q@J60`,W[FIHE%OPAYCOAJ2TTN6F81R2T9-;#L(FH0:^7O68?H*;1[(=B!
M7PT47.]T/R&W;>)59I*J@LU)NU]0SA%?1G:J^`NC!P4S=GTFV3'8:L8<@ZRV
MYE77@OK:*[^%2OU_*53F./]R:\ETP1L/R%S;*,B*%+O7'GT6[@YP)9Y3>N0I
MW-C6'7JSZ3TC8E@4C0GL<2:ZL^#RW1^A;YG>/4YMB7K\CX:(*D,__ZA@MVUN
M+PCRC-E0)_[;0UWDZI:=8BA:!4\0V`%"T*.VZ_('[=6N5_@]Z+A:^U*%*/*L
M4;5]?'L73<PFU(&PZ%-JIYJ.CDMXH2@[/B-Q6<)(^)UI7F^JV(<,`51A&KB:
ME^G'=(CO)(*Y$:@,GK?9DSU&#HP.%OGNF-L@V>".=H;3LTRCRML;`8V)NE'+
M"_N45B$'^^K1O`,FU'+9_IK/TER5L#0'7;,*?N<:Z_T(EH>;\QP34Z`=R?>%
M^MU!9^`PP,SVDL&2X5)*+BYS_!?&+>$>4*HDU'`A,1+O'(L?JEAAJ>?]52*5
M(@953"W;P3;"&^/0]C6XF;;)-*0_)CJ`&A$'D->JYC>K;=NM:V7&^KJ/[=53
M^<I;B15N3KG$DFW07F?A[6-N-C&72/L)5,1G*9Q#V\^QG>$ZJKXKJ:NTDMK#
ME:*R`B!>QBW@LN)Y!P79&M>_3E^?DD;[D3H]*::BR1BHL1#QA#*@%#8YW35A
MNP=?^SW';4AB=.NCS=*A`FU)#7RK6D\*R_+TT^64'2.]YY45/&M4O[%*[$QJ
M\)YB%BL##47,U@DOWP22;M03B*B8LB4*J)(UG!HI.DJ*YR.B[#T?QTOTRO*L
MS3#[Z(@:S$^!U(`_Q=1:%+>785B#I0T+'JA;+1.ZDAH!IYC^I2+QS:@>S#F1
M%],.8E&.LBK()H![(_TUZ+0@;%^)"X@*^1]JTO<JB9"7_UB&SE</WXDL)?(8
MW_(F6W4%Z9"7[5E%[2T$XHDH<`[K?4SFR'+7Q`LI2?"IR%EZE"1+7J)J!1<D
ME4#\,K3]5);4(CEOOS;_6Y[<OFT@^;T[<@9!6;KDI957<&14`_++,.\A=Y(<
MS>8F0%[6>P556!"V%V/:8PC$178O/!].T%*W6&Z`#G8\T-:Z/4-D>9FC]<<F
M1EY*_[I&@!PXRUKNE/C++1EZ-AD#YQ/2"1W-XXRT71AIHWEJG`3KIO)>>+5*
M[=.56D2CW$1?8KP(+WK2Q->JSRI62:.\ART4-);5@_\R!D7Z,DJ"]A<B1MX3
M(0JJ>0DX%=+G:GP^`^#3<JAEY#PH56.7\MY*47#'E@O-R]#`_)FFO5@0+[SY
M6!I:@B1>#7X99WYU0ZN0AE<SR1RR>9RE0:Q/7AT]G8.[6L%1]@)J]([MGN*#
M>Z>ON>Z=)MS%UUKUYB&+T2^:DBRC`=GFHHC5]*,S@Q1:H619-4QTZ5TIE7LL
M5T.JFK#R1*_01/05G,S+OC4J30U+1[>>HG)Z/S[Z3_SZ?M2\=5%EO<B]ZB=-
MS3(DKI`N%5G4[0.ON*Z.5M.%W#M\E6A1E;)62(6*#`[_P;*!`T);>W&M(_<!
MD=F#[@36>8B]!\F16=N])G$2Y-ZWDV;(BF+UU:AH9/G@W2#HZB[JZQ:IRXE6
M*752GR(X!<7F1KBF&(;BTP<WB]Y$@QA368Z!X]$@]W)I89V4(*D3<Z#MXWT.
M'&BQA^*Y'6B7QW6@799UH%TJ[$`3G:D4=V7%L.*:.DJ'9RJ4%SO^2#!7/MK8
MV_+AAK[7_*:.D-4ZEWR>;(F<#4@<C..M>GGT\KNF\^I)SUPHA%UD</()18U=
M1A*M(0>C&(('%>6G]JL:PP2YJ`$BS`'+X)"4?PAF5I*?;Z\,>!SR.-H4&7S#
M?K!E,WSR?U!+`P04````"`"&4&%#HG)(/84'``#8-0``$0`<`&-D;VTM,C`Q
M,S`Y,S`N>'-D550)``/<M'-2W+1S4G5X"P`!!"4.```$.0$``.U;6W/B1A9^
MWJW:_]"A:FMG*B6$8#PS)G92,N`QM8`(PIG+2ZJ1&NA8ZF9:+1O^?4[KPDT@
M9&QOG+5YP*)U[M\Y???9+W/?0[=$!)2S\Y)1KI0080YW*9N<EZYMS;0;[78)
M_?+SO_Z)X'/V@Z:A2TH\MXZ:W-':;,Q_0CWLDSKZ1!@16'+Q$_H->Z%JX5\N
M!AWX&<NOHUKY_0AI6@%AOQ'F<G$]:"^%3:6<U77][NZNS/@MON/B)B@[O)@X
MFX?"(4M9C:;51973?U>;M0I\52M&K3P?@^%-+.&U^@W-A@%?%6-HU.HGE7KM
M0T%5$LLP6*JJS#]6*K4*?(JQ=VG@+)E__![,@@_S`?TRL=C'\/+;U;QK8;\5
MCBSW[F2V(-^\"_GYVWSD>-^_+&Y$@/_@[QJW'X@TJ^\^=_NQRK/`F1(?(X":
M!>>EM4#>U<I<3/1JI6+H7[H=.Z(KQ83UN4?9S2YRX_3T5(_>IJ09ROE(>*GH
MFJY>CW!`EI+A+<VAIRR0F#D;]*Y<,JP3G^CQRPU2NI/T?4Q*4](PT"88SY:T
M8QR,(MKDA:[20*L86LU88Q'<(\%.GNC-#B;&&0O]W>ZZ4NAR,2,Z$&E`101U
MEGR'F389P`;5O-NZZ,T.ZU0I+!D<+%SN$Y<ZV(/:\B/ZRFE-]0H>\0F3EUSX
M33+&H0=X?`^Q1\>4N"4DL9@0J5(XF&&'%)"8U@)FC$/)0/^0M*BVV8Q"34##
M/\Y4\M15;(?@`5(/T"OLEZ\(="BJ4%EK,K?%))4+56'"C[24$'7/2[D42B]8
M$6EVR9@R&IE7B3\&TE#*OOZ(F8MB66A-V)F^+69->!@0UV(_1\\S00(0$S%U
MH"%A3$CV,('73NC=CV=ERDZ6I"&-^-$8-#@+N$==Z%'="^RI>K:GA,@@!F#_
MZ_SH5R'DJHLE2?@;5L^V.NVF.6PUT879,7N-%K*O6JVA_1KZ[=CVL0`_IT0J
M^@,X;-+F@U(K#@IZLR'X[2M($/AE[`)K;,W4+`JT[RB4/73YX+S+`\<>PI]N
MJP?`6)?(ZK<&YK`-!*^P;(6[@8/II<?O#J"R(LL'Y:0X*`W3OD*7'>OSRP7%
M#GT?BX4UMNF$P8S#P3!R.PX/8;AEDSX`X5"2(%.0-A^>]VI@AYFXQX-0$/AA
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M5*.E[K?HS5(]/"<6O.9"+H!M!O1DB.<D>$`:Y$G)SX#J`S(@UHHBM:_@'P$^
MK*8<<#I>S\(B2H`4.:#!S0-2H;C,_,2H/2`Q-FQ0#+$52)GQFB@[AFIM?3B.
MIK/63&DV'0@3S&<WT^`^'/D@O]LYJ&M;@WHD'L7R4:K@%;M=V&T7F;$/LBQA
M/E(GA9#:45G(>,5G?]BK1?&I'L`GLW-2&)_J"\8GLW#?,_`=ILM')[.SLBX1
M5ON1S/_W@4E]J>/H`1FCZ!B[K@Y'STL!]6>>.G2.VJ:"C,]+#J"EI6>6OX-K
MY;GOI21*=,XQ=@3M=C02Q:D(+)R,E,PQ.PCA,R(D+.7UU/A4@*12L??7U""E
M!S)&?PR7/3RZK\O`0KPG]+6CY#^JDZH8[^GD5L(^D:N-E99'=1A*Y[X.;U;;
M$_G;7"I9=S>Y%:"OK@4DO[>O#IR!XUQ(Q#+W$/(NF<378SK<B43EL*A?6LJG
MJ2;-J&HUHSP/W)6E]S%B%8;[&9'R'6%$)"T@3GG";P%4NG$G9(\5.WG4@[9B
M+JH_]YI-GOZ=C#KQ9)"V/-":[!69X\V)9!UA3X';044R99VS%S.J5#E5J6*\
M?Z`QQQERR(KD@E%\NMJTNK_G7=$Q1P&LJAU9BJS.O\ZSHL7)TWE)BA!JCE'/
M4_NTZ>_H7EH=NBC*W6'4D[JA2"X-Q3UK3`%28)G?EL175!"($`13&2K*3X*'
MLY20`DFNBS`5XVK/((1)R_(\O\<E,3(>%B%]=@XJ^X(AOZ0,NDR*O=51^;9_
M12B?G7M[3A"V?3M(]OP<>XP]]TP8'E?HWS-H.3O41\6KD+QG%ZK"F[/;,3F"
M\=DY'ZVYU>S-;7!_1E@0*=N_=YG)BZ/YGUTH/A,ZF4KBXEL8T2:PHO`QS/_9
M!&".#`VQ-R3";[.O!(OHTELT[%FA5)-P]5\*IFPQUQKW(YO3"#V^V",#E;8^
MQ5B3V3D]..SD<#R[S(B,SR2Y"0ZP241ZL5B1)/Z9=UBX\1Y6&U9I(HPOY<DI
M$<,I9@G*/<YN20#9T9K/J"#J7SXV(O8_5'HPR/%B4Z8Q3A<6=77OT'ZR64QF
MS_?>F55]SIEU<!-U9X=;D.,O=/=,CU=D\/@G4$L!`AX#%`````@`AE!A0V"@
MB95W+```3X`!`!$`&````````0```*2!`````&-D;VTM,C`Q,S`Y,S`N>&UL
M550%``/<M'-2=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`AE!A0_Q4%9N]
M"```PE8``!4`&````````0```*2!PBP``&-D;VTM,C`Q,S`Y,S!?8V%L+GAM
M;%54!0`#W+1S4G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`(9084/;L8%K
M_`0``"0B```5`!@```````$```"D@<XU``!C9&]M+3(P,3,P.3,P7V1E9BYX
M;6Q55`4``]RT<U)U>`L``00E#@``!#D!``!02P$"'@,4````"`"&4&%#(L>;
M/B(>```7I@$`%0`8```````!````I($9.P``8V1O;2TR,#$S,#DS,%]L86(N
M>&UL550%``/<M'-2=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`AE!A0]B.
M"^,J$P``%B0!`!4`&````````0```*2!BED``&-D;VTM,C`Q,S`Y,S!?<')E
M+GAM;%54!0`#W+1S4G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`(9084.B
M<D@]A0<``-@U```1`!@```````$```"D@0-M``!C9&]M+3(P,3,P.3,P+GAS
M9%54!0`#W+1S4G5X"P`!!"4.```$.0$``%!+!08`````!@`&`!H"``#3=```
"````
`
end

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
